Citrus Sinensis ID: 022500
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | 2.2.26 [Sep-21-2011] | |||||||
| Q39011 | 380 | Shaggy-related protein ki | yes | no | 1.0 | 0.778 | 0.922 | 1e-166 | |
| Q39010 | 412 | Shaggy-related protein ki | no | no | 0.996 | 0.716 | 0.884 | 1e-160 | |
| Q39012 | 407 | Shaggy-related protein ki | no | no | 0.966 | 0.702 | 0.902 | 1e-158 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.962 | 0.695 | 0.814 | 1e-142 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.962 | 0.696 | 0.786 | 1e-139 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.972 | 0.711 | 0.780 | 1e-138 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.972 | 0.704 | 0.777 | 1e-137 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.972 | 0.700 | 0.770 | 1e-136 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.972 | 0.700 | 0.764 | 1e-136 | |
| Q96287 | 472 | Shaggy-related protein ki | no | no | 0.956 | 0.599 | 0.764 | 1e-135 |
| >sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 585 bits (1508), Expect = e-166, Method: Compositional matrix adjust.
Identities = 273/296 (92%), Positives = 287/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY
Sbjct: 85 MRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSR
Sbjct: 145 MYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 325 DELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 380
|
Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 563 bits (1450), Expect = e-160, Method: Compositional matrix adjust.
Identities = 261/295 (88%), Positives = 283/295 (95%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++YRVLKHY+S+NQRMP+ YVKLY
Sbjct: 117 MRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLY 176
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+CDFGSAK L+ GEANISYICSR
Sbjct: 177 TYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSR 236
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREE
Sbjct: 237 YYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREE 296
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 297 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 356
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAG 295
+ELREPNARLPNGRPLPPLFNFKQELSGASPEL+N+LIP+HV+RQ+ F AG
Sbjct: 357 NELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 556 bits (1433), Expect = e-158, Method: Compositional matrix adjust.
Identities = 258/286 (90%), Positives = 277/286 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE++YRVL+HY+S+NQRMP+ YVKLY
Sbjct: 115 MRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLY 174
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 175 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSR 234
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREE
Sbjct: 235 YYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREE 294
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 295 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 354
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQL 286
+ELREPNARLPNGRPLPPLFNFKQEL GAS EL+N+LIP+HV+RQ+
Sbjct: 355 NELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQM 400
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 233/286 (81%), Positives = 261/286 (91%), Gaps = 1/286 (0%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++YRV KHYS ANQRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQI R LAYIH VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 179 TYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 238
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SRLLQYSP+LR TA+EA HPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFF 358
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 285
DELR+PN RLPNGR LPPLFNFK QEL GAS EL++KLIPDH ++Q
Sbjct: 359 DELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQ 404
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1271), Expect = e-139, Method: Compositional matrix adjust.
Identities = 225/286 (78%), Positives = 260/286 (90%), Gaps = 1/286 (0%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHY+ NQRMPL+YVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLY 177
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 178 TYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRC AL++ HPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFF 357
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 285
DELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+H ++Q
Sbjct: 358 DELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQ 403
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 489 bits (1259), Expect = e-138, Method: Compositional matrix adjust.
Identities = 228/292 (78%), Positives = 261/292 (89%), Gaps = 4/292 (1%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHY+ NQRMPLIYVKLY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 293
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LR AL+ HPFF
Sbjct: 294 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFF 353
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ---LGL 288
DELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+H ++Q LGL
Sbjct: 354 DELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 227/292 (77%), Positives = 259/292 (88%), Gaps = 4/292 (1%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+ LKHCFFSTT K+E++LNLV+EYVPE+++RV+KHY+ NQRMPLI VKLY
Sbjct: 118 MRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLY 177
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 178 TYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNY +F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRCTALEA H FF
Sbjct: 298 IKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFF 357
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ---LGL 288
DELR+PN RLPNGR LPPLFNFK EL G S E + KL+P+H ++Q LGL
Sbjct: 358 DELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEHARKQCPSLGL 409
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1245), Expect = e-136, Method: Compositional matrix adjust.
Identities = 225/292 (77%), Positives = 257/292 (88%), Gaps = 4/292 (1%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHYS NQRMP+IYVKLY
Sbjct: 120 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLY 179
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 180 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 239
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+ID+WS GCVLAELLLGQPLFPGE VDQLVEIIKVLGTPTREE
Sbjct: 240 YYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREE 299
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIKAHPWHK+FHKRMP EA+DL SRLLQYSP+LRC AL+ HPFF
Sbjct: 300 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCLTHPFF 359
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ---LGL 288
DELR+PNARLP GR LPPLFNFK EL G E + KL+P+H ++Q LGL
Sbjct: 360 DELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHARKQCPFLGL 411
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 483 bits (1243), Expect = e-136, Method: Compositional matrix adjust.
Identities = 221/289 (76%), Positives = 256/289 (88%), Gaps = 1/289 (0%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++ RV++HY+ NQRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLY 178
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+YQI R LAYIH VCHRD+KPQNLLV+P THQ+KICDFGSAK L+ GE NISYICSR
Sbjct: 179 SYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSR 238
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LR TALEA HPF+
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFY 358
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQLGL 288
D++R+PN RLPNGR LPPLFNFK EL G E++ KL+P H ++Q L
Sbjct: 359 DDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCAL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 482 bits (1240), Expect = e-135, Method: Compositional matrix adjust.
Identities = 217/284 (76%), Positives = 251/284 (88%), Gaps = 1/284 (0%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR+ DHPNV+ L+H FFSTT K+EL+LNLV+EYVPE++YR KHY+ NQ MP+I+V+LY
Sbjct: 183 MRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLY 242
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQI R L Y+H V VCHRD+KPQNLLV+P THQ+KICDFGSAK L+ GE NISYICSR
Sbjct: 243 TYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSR 302
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFPGE+ +DQLVEIIK+LGTPTREE
Sbjct: 303 YYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREE 362
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRCTALEACAHPFF
Sbjct: 363 IRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFF 422
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVK 283
D+LR+PN LPNGR LPPLFNF QEL+GAS EL +LIP H +
Sbjct: 423 DDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | ||||||
| 255562450 | 380 | Glycogen synthase kinase-3 beta, putativ | 1.0 | 0.778 | 0.942 | 1e-167 | |
| 224116828 | 380 | predicted protein [Populus trichocarpa] | 1.0 | 0.778 | 0.945 | 1e-167 | |
| 359483773 | 380 | PREDICTED: shaggy-related protein kinase | 1.0 | 0.778 | 0.939 | 1e-167 | |
| 224079065 | 380 | predicted protein [Populus trichocarpa] | 1.0 | 0.778 | 0.935 | 1e-165 | |
| 356507479 | 380 | PREDICTED: shaggy-related protein kinase | 1.0 | 0.778 | 0.918 | 1e-165 | |
| 297804284 | 380 | hypothetical protein ARALYDRAFT_914806 [ | 1.0 | 0.778 | 0.925 | 1e-165 | |
| 118487502 | 380 | unknown [Populus trichocarpa] | 1.0 | 0.778 | 0.932 | 1e-165 | |
| 15233984 | 380 | Shaggy-related protein kinase eta [Arabi | 1.0 | 0.778 | 0.922 | 1e-165 | |
| 1161512 | 380 | shaggy-like kinase etha [Arabidopsis tha | 1.0 | 0.778 | 0.915 | 1e-164 | |
| 227204507 | 374 | AT4G18710 [Arabidopsis thaliana] | 1.0 | 0.791 | 0.922 | 1e-164 |
| >gi|255562450|ref|XP_002522231.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223538484|gb|EEF40089.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1528), Expect = e-167, Method: Compositional matrix adjust.
Identities = 279/296 (94%), Positives = 288/296 (97%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPESMYRVLKHYS+A Q MPL+YVKLY
Sbjct: 85 MRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPESMYRVLKHYSNAKQTMPLVYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIHTVP VCHRDLKPQN+LVDPLTHQVK+CDFGSAK L+ GEANISYICSR
Sbjct: 145 MYQIFRGLAYIHTVPGVCHRDLKPQNILVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRPLPPLFNFKQEL+GASPELVNKLIPDH+KRQ+GLNFLH AGT
Sbjct: 325 DELREPNARLPNGRPLPPLFNFKQELNGASPELVNKLIPDHMKRQMGLNFLHLAGT 380
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116828|ref|XP_002317404.1| predicted protein [Populus trichocarpa] gi|222860469|gb|EEE98016.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1527), Expect = e-167, Method: Compositional matrix adjust.
Identities = 280/296 (94%), Positives = 286/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNVISLKHCFFSTT NELFLNLVMEYVPESMYRVLKHYS+A Q MPLIYVKLY
Sbjct: 85 MRVMDHPNVISLKHCFFSTTDNNELFLNLVMEYVPESMYRVLKHYSNAKQAMPLIYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK+CDFGSAK L+ GEANISYICSR
Sbjct: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF GENAVDQLVEIIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFSGENAVDQLVEIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRPLP LFNFKQEL+GASPELVNKLIPDHVKRQ+GLN +H AGT
Sbjct: 325 DELREPNARLPNGRPLPALFNFKQELNGASPELVNKLIPDHVKRQMGLNLMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483773|ref|XP_003633016.1| PREDICTED: shaggy-related protein kinase eta-like [Vitis vinifera] gi|297740523|emb|CBI30705.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1526), Expect = e-167, Method: Compositional matrix adjust.
Identities = 278/296 (93%), Positives = 290/296 (97%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE+MYRVLKHYS+A QRMPLIYVKLY
Sbjct: 85 MRTMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETMYRVLKHYSNAKQRMPLIYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFRGLAYIH+VP VCHRDLKPQNLLVDPLTHQVK+CDFGSAK L+ GEANISYICSR
Sbjct: 145 TYQIFRGLAYIHSVPGVCHRDLKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNP+YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPSYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIP+HV+RQ+GL+F HPAGT
Sbjct: 325 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPEHVRRQIGLSFFHPAGT 380
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079065|ref|XP_002305736.1| predicted protein [Populus trichocarpa] gi|222848700|gb|EEE86247.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1513), Expect = e-165, Method: Compositional matrix adjust.
Identities = 277/296 (93%), Positives = 286/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPESMYRVLKHYS+A Q MPLIYVKLY
Sbjct: 85 MRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPESMYRVLKHYSNAKQTMPLIYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIH VP VCHRDLKPQNLLVDPLTHQVK+CDFGSAK L+ GEANISYICSR
Sbjct: 145 MYQIFRGLAYIHAVPGVCHRDLKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV+IIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVDIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRPLP LFNFKQEL+GASPELVNKLIP+HVKRQ+GLNF+H AGT
Sbjct: 325 DELREPNARLPNGRPLPSLFNFKQELNGASPELVNKLIPEHVKRQMGLNFMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507479|ref|XP_003522493.1| PREDICTED: shaggy-related protein kinase eta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1512), Expect = e-165, Method: Compositional matrix adjust.
Identities = 272/296 (91%), Positives = 286/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNVISLKHCFFSTTS +ELFLNLVMEYVPESMYRVLKHYS+ANQRMP+IYVKLY
Sbjct: 85 MRVMDHPNVISLKHCFFSTTSTDELFLNLVMEYVPESMYRVLKHYSNANQRMPIIYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIHTVP+VCHRDLKPQN+LVDPLTHQVK+CDFGSAK L+ GEANISYICSR
Sbjct: 145 MYQIFRGLAYIHTVPKVCHRDLKPQNILVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGENAVDQLV IIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENAVDQLVHIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
+RCMNPNY DFRFPQIKAHPWHK+FHK+MPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 VRCMNPNYNDFRFPQIKAHPWHKIFHKKMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRP PPLFNFKQELSGASPELVNKLIPDHVKRQ+GL F+H G+
Sbjct: 325 DELREPNARLPNGRPFPPLFNFKQELSGASPELVNKLIPDHVKRQMGLQFMHLGGS 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297804284|ref|XP_002870026.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] gi|297315862|gb|EFH46285.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1511), Expect = e-165, Method: Compositional matrix adjust.
Identities = 274/296 (92%), Positives = 287/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY
Sbjct: 85 MRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSR
Sbjct: 145 MYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRP PPLFNFKQE++GASPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 325 DELREPNARLPNGRPFPPLFNFKQEVAGASPELVNKLIPDHIKRQLGLSFLNQSGT 380
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118487502|gb|ABK95578.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1509), Expect = e-165, Method: Compositional matrix adjust.
Identities = 276/296 (93%), Positives = 286/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPESMYRVLKHYS+A Q MPLIYVKLY
Sbjct: 85 MRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPESMYRVLKHYSNAKQTMPLIYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIH VP VCHRDLKPQNLLVDPLTH+VK+CDFGSAK L+ GEANISYICSR
Sbjct: 145 MYQIFRGLAYIHAVPGVCHRDLKPQNLLVDPLTHEVKLCDFGSAKVLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV+IIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVDIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRPLP LFNFKQEL+GASPELVNKLIP+HVKRQ+GLNF+H AGT
Sbjct: 325 DELREPNARLPNGRPLPSLFNFKQELNGASPELVNKLIPEHVKRQMGLNFMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233984|ref|NP_193606.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] gi|47117893|sp|Q39011.2|KSG7_ARATH RecName: Full=Shaggy-related protein kinase eta; AltName: Full=ASK-eta; AltName: Full=Protein BRASSINOSTEROID INSENSITIVE 2; AltName: Full=Protein ULTRACURVATA 1 gi|4539390|emb|CAB37456.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|7268665|emb|CAB78873.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|21554512|gb|AAM63594.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|25140476|gb|AAN71719.1| glycogen synthase kinase 3 beta protein kinase DWARF12 [Arabidopsis thaliana] gi|109946417|gb|ABG48387.1| At4g18710 [Arabidopsis thaliana] gi|332658679|gb|AEE84079.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1508), Expect = e-165, Method: Compositional matrix adjust.
Identities = 273/296 (92%), Positives = 287/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY
Sbjct: 85 MRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSR
Sbjct: 145 MYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 325 DELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1161512|emb|CAA64409.1| shaggy-like kinase etha [Arabidopsis thaliana] gi|1627516|emb|CAA70144.1| shaggy-like kinase etha [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 271/296 (91%), Positives = 289/296 (97%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNV+ LKHCFFSTT K+ELFLNLVMEYVPE++YRVLKHYSSANQRMPL+YVKLY
Sbjct: 85 MRVMDHPNVVCLKHCFFSTTEKDELFLNLVMEYVPETLYRVLKHYSSANQRMPLVYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+YQIFRGLAYIH+ P VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GE NISYICSR
Sbjct: 145 SYQIFRGLAYIHSCPGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEPNISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDF+FPQIKAHPWHK+FHKRMPPEA+DLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPNYTDFKFPQIKAHPWHKIFHKRMPPEAVDLASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRPLPPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 325 DELREPNARLPNGRPLPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|227204507|dbj|BAH57105.1| AT4G18710 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 273/296 (92%), Positives = 287/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY
Sbjct: 79 MRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLY 138
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSR
Sbjct: 139 MYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSR 198
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE
Sbjct: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFF
Sbjct: 259 IRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFF 318
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 319 DELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 374
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | ||||||
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 1.0 | 0.778 | 0.922 | 2e-152 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.996 | 0.716 | 0.884 | 3.9e-147 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.966 | 0.702 | 0.902 | 4e-145 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.962 | 0.695 | 0.814 | 2.2e-130 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.962 | 0.696 | 0.786 | 5.2e-129 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.972 | 0.711 | 0.780 | 5.9e-128 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.949 | 0.595 | 0.769 | 4.9e-124 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.986 | 0.693 | 0.733 | 6.5e-122 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.959 | 0.648 | 0.719 | 3.4e-116 | |
| ZFIN|ZDB-GENE-990714-4 | 421 | gsk3b "glycogen synthase kinas | 0.993 | 0.698 | 0.665 | 1.9e-108 |
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1487 (528.5 bits), Expect = 2.0e-152, P = 2.0e-152
Identities = 273/296 (92%), Positives = 287/296 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY
Sbjct: 85 MRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLY 144
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSR
Sbjct: 145 MYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSR 204
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE
Sbjct: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFF
Sbjct: 265 IRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFF 324
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
DELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 325 DELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 380
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1437 (510.9 bits), Expect = 3.9e-147, P = 3.9e-147
Identities = 261/295 (88%), Positives = 283/295 (95%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++YRVLKHY+S+NQRMP+ YVKLY
Sbjct: 117 MRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLY 176
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+CDFGSAK L+ GEANISYICSR
Sbjct: 177 TYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSR 236
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREE
Sbjct: 237 YYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREE 296
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 297 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 356
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAG 295
+ELREPNARLPNGRPLPPLFNFKQELSGASPEL+N+LIP+HV+RQ+ F AG
Sbjct: 357 NELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1418 (504.2 bits), Expect = 4.0e-145, P = 4.0e-145
Identities = 258/286 (90%), Positives = 277/286 (96%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE++YRVL+HY+S+NQRMP+ YVKLY
Sbjct: 115 MRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLY 174
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 175 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSR 234
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREE
Sbjct: 235 YYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREE 294
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF
Sbjct: 295 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 354
Query: 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQL 286
+ELREPNARLPNGRPLPPLFNFKQEL GAS EL+N+LIP+HV+RQ+
Sbjct: 355 NELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQM 400
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
Identities = 233/286 (81%), Positives = 261/286 (91%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++YRV KHYS ANQRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQI R LAYIH VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 179 TYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 238
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SRLLQYSP+LR TA+EA HPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFF 358
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 285
DELR+PN RLPNGR LPPLFNFK QEL GAS EL++KLIPDH ++Q
Sbjct: 359 DELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQ 404
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1266 (450.7 bits), Expect = 5.2e-129, P = 5.2e-129
Identities = 225/286 (78%), Positives = 260/286 (90%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHY+ NQRMPL+YVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLY 177
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 178 TYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRC AL++ HPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFF 357
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 285
DELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+H ++Q
Sbjct: 358 DELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQ 403
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1256 (447.2 bits), Expect = 5.9e-128, P = 5.9e-128
Identities = 228/292 (78%), Positives = 261/292 (89%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHY+ NQRMPLIYVKLY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 293
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LR AL+ HPFF
Sbjct: 294 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFF 353
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ---LGL 288
DELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+H ++Q LGL
Sbjct: 354 DELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1219 (434.2 bits), Expect = 4.9e-124, P = 4.9e-124
Identities = 217/282 (76%), Positives = 250/282 (88%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR+ DHPNV+ L+H FFSTT K+EL+LNLV+EYVPE++YR KHY+ NQ MP+I+V+LY
Sbjct: 183 MRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLY 242
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQI R L Y+H V VCHRD+KPQNLLV+P THQ+KICDFGSAK L+ GE NISYICSR
Sbjct: 243 TYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSR 302
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFPGE+ +DQLVEIIK+LGTPTREE
Sbjct: 303 YYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREE 362
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
IRCMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRCTALEACAHPFF
Sbjct: 363 IRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFF 422
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 281
D+LR+PN LPNGR LPPLFNF QEL+GAS EL +LIP H
Sbjct: 423 DDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAH 464
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1199 (427.1 bits), Expect = 6.5e-122, P = 6.5e-122
Identities = 215/293 (73%), Positives = 251/293 (85%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M+++DHPN ++LKH FFS T E++LNLV+E+VPE++ RV + YS NQ MPLIYVKLY
Sbjct: 128 MQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLY 187
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQI R LAYIH +CHRD+KPQNLLV+P THQ+KICDFGSAK L+ GE N+SYICSR
Sbjct: 188 TYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSR 247
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGA+EYTT+IDIWS GCV+AELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct: 248 YYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 307
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL R QYSP+LRCTALEAC HP F
Sbjct: 308 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLF 367
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQLGLNFLH 292
DELR+PN RLPNGRPLPPLFNFK QELSG PE+VN+L+P+H ++Q LH
Sbjct: 368 DELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMALH 420
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1145 (408.1 bits), Expect = 3.4e-116, P = 3.4e-116
Identities = 205/285 (71%), Positives = 247/285 (86%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR++DHPNV+ LKH FFSTT K+EL+LNLV+EYVPE++YR + Y+ NQ MPLIY++LY
Sbjct: 154 MRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLY 213
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQI R + Y+H V VCHRD+KPQNLLV+ +TH+VKICDFGSAK LI GE NISYICSR
Sbjct: 214 TYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSR 273
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPELIFGATEYT++ID+WS GCV+AEL LG PLFPGE +VDQLVEIIK+LGTP REE
Sbjct: 274 YYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREE 333
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I+ MNP Y DF+FPQIKA PWHK+F +++ PEA+DLASRLLQYSP+LRCTALEACAHPFF
Sbjct: 334 IKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFF 393
Query: 241 DELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKR 284
D+LR+P A LPNGR LPPLF+F QEL+GAS EL ++LIP+H ++
Sbjct: 394 DDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPEHARK 438
|
|
| ZFIN|ZDB-GENE-990714-4 gsk3b "glycogen synthase kinase 3 beta" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1072 (382.4 bits), Expect = 1.9e-108, P = 1.9e-108
Identities = 199/299 (66%), Positives = 247/299 (82%)
Query: 1 MRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS A Q +P++YVKL
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGDKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPMVYVKL 160
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL+ GE N+SYICS
Sbjct: 161 YMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T LEACAH F
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 240 FDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQLGLNF-LHPAGT 296
FDELREPN +LPNGR P LFNF QELS ++P L + LIP H + Q G + +P+ T
Sbjct: 340 FDELREPNVKLPNGREKPSLFNFTTQELS-SNPTLASILIPAHARNQAGASTPTNPSAT 397
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5612 | 0.9628 | 0.7364 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9020 | 0.9662 | 0.7027 | no | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9222 | 1.0 | 0.7789 | yes | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5036 | 0.9155 | 0.7324 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6538 | 0.8716 | 0.7127 | yes | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7773 | 0.9729 | 0.7041 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6713 | 0.9594 | 0.6761 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6103 | 0.9662 | 0.6124 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7705 | 0.9729 | 0.7007 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7577 | 0.9729 | 0.7007 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7647 | 0.9729 | 0.7007 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7605 | 0.9560 | 0.6047 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6713 | 0.9594 | 0.6761 | yes | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6713 | 0.9594 | 0.6761 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 296 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-113 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-75 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-74 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-70 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-67 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-63 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-62 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-62 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-61 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-60 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-60 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-60 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-59 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-57 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-56 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-56 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-53 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-53 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-51 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-51 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-50 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-50 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-50 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-50 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-50 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-49 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-48 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-48 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-48 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-48 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-47 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-47 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-46 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-46 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-44 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-44 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-44 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-43 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-43 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-42 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-42 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-42 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-41 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-40 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-40 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-40 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-36 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-34 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-33 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-32 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-32 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-32 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-31 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-31 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-27 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-22 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-16 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-14 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 0.001 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 0.001 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.001 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.003 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 333 bits (856), Expect = e-113
Identities = 149/287 (51%), Positives = 206/287 (71%), Gaps = 6/287 (2%)
Query: 1 MRVMDHPNVISLKHCFFSTT-SKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 57
M+ ++H N+I LK +++ KNE +FLN+VME++P+++++ +KHY+ N +PL V
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV 172
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
KLY+YQ+ R LAYIH+ +CHRDLKPQNLL+DP TH +K+CDFGSAK L+AG+ ++SYI
Sbjct: 173 KLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
CSRFYRAPEL+ GAT YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
++++ MNPNY D +FP +K KVF K P +AI+ S+ L+Y P R +EA A
Sbjct: 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351
Query: 238 PFFDELREPNARLPNG-RPLPPLFNF-KQELSGASPELVNKLIPDHV 282
PFFD+LR+P +LP LP LFNF E+ S K+IP
Sbjct: 352 PFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCT 398
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 5e-75
Identities = 96/256 (37%), Positives = 149/256 (58%), Gaps = 18/256 (7%)
Query: 1 MRVMDHPNVISLKHCF--FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
+R + H N+I L S N++++ V E + +++V+K Q + +++
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQ 106
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--- 115
+ YQI RGL Y+H+ V HRDLKP N+LV+ +KICDFG A+ + E
Sbjct: 107 YFLYQILRGLKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 116 -YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
Y+ +R+YRAPEL+ ++ YT +IDIWS GC+ AELL +PLFPG + +DQL I++VLG
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224
Query: 175 TPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231
TP+ E+++ + + ++ P+ P K+F PEAIDL ++L + P R TA
Sbjct: 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITA 283
Query: 232 LEACAHPFFDELREPN 247
EA AHP+ +L +P
Sbjct: 284 DEALAHPYLAQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 3e-74
Identities = 91/243 (37%), Positives = 141/243 (58%), Gaps = 15/243 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN++ L ++ +L+L V EY + + L + +K
Sbjct: 52 LKELKHPNIVKLLDVI---HTERKLYL--VFEYCDMDLKKYLDKRPGP---LSPNLIKSI 103
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICS 119
YQ+ RGLAY H+ R+ HRDLKPQN+L++ +K+ DFG A+ I + +
Sbjct: 104 MYQLLRGLAYCHSH-RILHRDLKPQNILINR-DGVLKLADFGLARAFGIPLRTYTHEVVT 161
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
+YRAPE++ G+ Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE 221
Query: 180 EIR--CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
P+Y FP+ KV R+ PE IDL S++LQY+P+ R +A EA H
Sbjct: 222 SWPGVTKLPDYKP-TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279
Query: 238 PFF 240
P+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 2e-70
Identities = 96/243 (39%), Positives = 135/243 (55%), Gaps = 19/243 (7%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
HP V+ L F + LVMEY+P + VL+ + +P VK Y
Sbjct: 56 CQHPYVVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRM 107
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSR 120
+ +G+AY+H + HRDLKP NLL+ +KI DFG A+ L + E Y + +R
Sbjct: 108 LLKGVAYMHAN-GIMHRDLKPANLLISA-DGVLKIADFGLAR-LFSEEEPRLYSHQVATR 164
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE- 179
+YRAPEL++GA +Y +D+W+ GC+ AELL G PLFPGEN ++QL + + LGTP E
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET 224
Query: 180 --EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
+ + P+Y FP+ K P ++F PEA+DL LL Y PS R +A EA H
Sbjct: 225 WPGLTSL-PDYNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRH 282
Query: 238 PFF 240
P+F
Sbjct: 283 PYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 5e-67
Identities = 92/243 (37%), Positives = 138/243 (56%), Gaps = 14/243 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ ++HPN+I L F L LV E++ +Y+++K + +P +K Y
Sbjct: 52 LKELNHPNIIKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSY 103
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICS 119
YQ+ +GLA+ H+ + HRDLKP+NLL++ +K+ DFG A+ Y+ +
Sbjct: 104 LYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVT 161
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPEL+ G Y+T +DIWS GC+ AELL +PLFPG++ +DQL +I + LGTP E
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE 221
Query: 180 EIRCMNPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
F FP+ P K+F P+A+DL S++L Y P R TA +A AH
Sbjct: 222 VWPKFTSLARNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAH 280
Query: 238 PFF 240
P+F
Sbjct: 281 PYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 203 bits (520), Expect = 6e-65
Identities = 82/241 (34%), Positives = 117/241 (48%), Gaps = 38/241 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + HPN++ L F L LVMEY ++ +LK R+ +
Sbjct: 51 LKKLKHPNIVRLYDVFEDED-----KLYLVMEYCEGGDLFDLLKK----RGRLSEDEARF 101
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y QI L Y+H+ + HRDLKP+N+L+D VK+ DFG A+QL GE +++ +
Sbjct: 102 YLRQILSALEYLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGT 159
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
Y APE++ G Y ++DIWS G +L ELL G+P FPG++ QL+E+ K +G P
Sbjct: 160 PEYMAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPP 215
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+ PEA DL +LL P R TA EA HPF
Sbjct: 216 FPP----------------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 253
Query: 240 F 240
F
Sbjct: 254 F 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 1e-63
Identities = 82/241 (34%), Positives = 115/241 (47%), Gaps = 33/241 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R + HPN++ L F + L LVMEY L Y S + K
Sbjct: 52 LRRLSHPNIVRLIDAF--EDKDH---LYLVMEYCEGG---DLFDYLSRGGPLSEDEAKKI 103
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICS 119
QI RGL Y+H+ + HRDLKP+N+L+D VKI DFG AK+L+ + +++ +
Sbjct: 104 ALQILRGLEYLHSN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGT 161
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
+Y APE++ G Y +D+WS G +L ELL G+P F GEN +DQL I ++LG P
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-- 219
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+ + EA DL + L PS R TA E HP+
Sbjct: 220 --------------------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259
Query: 240 F 240
F
Sbjct: 260 F 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 3e-62
Identities = 91/247 (36%), Positives = 141/247 (57%), Gaps = 22/247 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ +HPN++ LK F +EL+ V EY+ ++Y+++K + ++
Sbjct: 52 RKLNEHPNIVKLKEVF---RENDELYF--VFEYMEGNLYQLMKDR--KGKPFSESVIRSI 104
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQI +GLA+IH HRDLKP+NLLV VKI DFG A+++ + Y+ +R
Sbjct: 105 IYQILQGLAHIHKHGFF-HRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTR 162
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPE++ +T Y++ +DIW+ GC++AEL +PLFPG + +DQL +I VLGTPT+++
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222
Query: 181 -------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
+ FRFPQ H++ PEAIDL +L++ P R TA +
Sbjct: 223 WPEGYKLASKLG-----FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQ 276
Query: 234 ACAHPFF 240
A HP+F
Sbjct: 277 ALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 9e-62
Identities = 89/245 (36%), Positives = 132/245 (53%), Gaps = 20/245 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN+I L F K+ +NLV E++ + +V+K + + +K Y
Sbjct: 56 LQELKHPNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSY 107
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-- 118
RGL Y+H + HRDLKP NLL+ +K+ DFG A+ G N
Sbjct: 108 MLMTLRGLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSF--GSPNRKMTHQV 163
Query: 119 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+R+YRAPEL+FGA Y +D+WS GC+ AELLL P PG++ +DQL +I + LGTPT
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223
Query: 178 REEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
E + P+Y +F+ P ++F +A+DL RLL +P+ R TA +A
Sbjct: 224 EENWPGVTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQAL 280
Query: 236 AHPFF 240
HP+F
Sbjct: 281 EHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-61
Identities = 74/243 (30%), Positives = 125/243 (51%), Gaps = 16/243 (6%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
+ HPN++ LK S K +++ V EY+ + +L + +K Y Q
Sbjct: 55 LRHPNIVRLKEIVTSKG-KGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQ 108
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSR 120
+ GL Y+H+ + HRD+K N+L++ +K+ DFG A+ + Y + +
Sbjct: 109 LLEGLQYLHSN-GILHRDIKGSNILINN-DGVLKLADFGLARP-YTKRNSADYTNRVITL 165
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE- 179
+YR PEL+ GAT Y +D+WS GC+LAEL LG+P+F G ++QL +I ++ G+PT E
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225
Query: 180 --EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
+ + P + + + + + F + P A+DL +LL P R +A +A H
Sbjct: 226 WPGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284
Query: 238 PFF 240
+F
Sbjct: 285 EYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-60
Identities = 86/245 (35%), Positives = 137/245 (55%), Gaps = 15/245 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R + H N+++LK F K L+L V EYV ++ +L+ +P V+ Y
Sbjct: 54 LRQLRHENIVNLKEAF---RRKGRLYL--VFEYVERTLLELLEASPGG---LPPDAVRSY 105
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC 118
+Q+ + +AY H+ + HRD+KP+N+LV + +K+CDFG A+ L A A+ Y+
Sbjct: 106 IWQLLQAIAYCHSH-NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVA 163
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TP 176
+R+YRAPEL+ G T Y +D+W+ GC++AELL G+PLFPG++ +DQL I K LG P
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223
Query: 177 TREEIRCMNPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
+ +E+ NP + FP+ + + ++ A+D L+ P R T E
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283
Query: 236 AHPFF 240
HP+F
Sbjct: 284 QHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 3e-60
Identities = 88/251 (35%), Positives = 143/251 (56%), Gaps = 20/251 (7%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
DHPN++ L + ++N+ + LV EY+ ++ V++ AN ++ + YQ+
Sbjct: 65 DHPNIVKLLNVI---KAENDKDIYLVFEYMETDLHAVIR----ANILED-VHKRYIMYQL 116
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------YIC 118
+ L YIH+ V HRDLKP N+L++ VK+ DFG A+ L E N Y+
Sbjct: 117 LKALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+R+YRAPE++ G+T YT +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 179 EEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
E+I + + P P ++ + +A+DL +LL ++P+ R TA EA
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEAL 293
Query: 236 AHPFFDELREP 246
HP+ + P
Sbjct: 294 EHPYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 8e-60
Identities = 98/280 (35%), Positives = 154/280 (55%), Gaps = 27/280 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
+R H N+I + + S N++++ V E + +Y+++K +N +++
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSND-----HIQ 109
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--- 115
+ YQI RGL YIH+ V HRDLKP NLL++ +KICDFG A+ +
Sbjct: 110 YFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLT 167
Query: 116 -YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
Y+ +R+YRAPE++ + YT +IDIWS GC+LAE+L +PLFPG++ + QL I+ VLG
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227
Query: 175 TPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231
TP++E++ C+ + ++ P PW+K+F P+A+DL ++L ++P R T
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITV 286
Query: 232 LEACAHPF----FDELREPNARLPNGRPLPPLFNFKQELS 267
EA AHP+ D EP A P P F +L
Sbjct: 287 EEALAHPYLEQYHDPSDEPVAE----EPFPFDFELFDDLP 322
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 1e-59
Identities = 90/252 (35%), Positives = 138/252 (54%), Gaps = 16/252 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ MDH NVI L F +S + + LV + + ++K Q++ +++
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQF 122
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQI RGL YIH+ + HRDLKP N+ V+ ++KI DFG A+ + Y+ +
Sbjct: 123 LVYQILRGLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLARH--TDDEMTGYVAT 178
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+ ++GTP E
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 180 EIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
++ ++ NY PQ+ + +VF P AIDL ++L P R TA EA
Sbjct: 239 LLQKISSESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEAL 296
Query: 236 AHPFFDELREPN 247
AHP+ E +P
Sbjct: 297 AHPYLAEYHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 6e-57
Identities = 88/243 (36%), Positives = 135/243 (55%), Gaps = 20/243 (8%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYT 61
++HPN++ L S E L LV E++ LK Y SS + +K Y
Sbjct: 55 LNHPNIVRLLDVVHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYL 105
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSR 120
YQ+ +G+AY H+ RV HRDLKPQNLL+D +K+ DFG A+ + + +
Sbjct: 106 YQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTL 163
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE- 179
+YRAPE++ G+ +Y+T +DIWS GC+ AE++ +PLFPG++ +DQL I + LGTP +
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223
Query: 180 --EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
+ + P+Y FP+ KV + + +DL S++L Y P+ R +A A H
Sbjct: 224 WPGVTSL-PDYKP-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280
Query: 238 PFF 240
P+F
Sbjct: 281 PYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 3e-56
Identities = 98/282 (34%), Positives = 157/282 (55%), Gaps = 15/282 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R +DH NVI++K + + +V E + ++++++ ++Q + + + +
Sbjct: 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR----SSQTLSDDHCQYF 113
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICS 119
YQ+ RGL YIH+ V HRDLKP NLL++ +KICDFG A+ G+ Y+ +
Sbjct: 114 LYQLLRGLKYIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVT 171
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPEL+ +EYTT+ID+WS GC+ AELL +PLFPG++ V QL I ++LG+P+ E
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231
Query: 180 EIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
++ + N + P + ++F P AIDL ++L + PS R T EA A
Sbjct: 232 DLGFIRNEKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALA 290
Query: 237 HPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 278
HP+ L +P+ P F+F E + E + +LI
Sbjct: 291 HPYLASLHDPSDEPVCQTP----FSFDFEEDALTEEDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 4e-56
Identities = 102/292 (34%), Positives = 154/292 (52%), Gaps = 26/292 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLN--LVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
+R H N+I+++ F + +VM+ M L H ++Q + +++
Sbjct: 58 LRHFKHDNIIAIRDIL---RPPGADFKDVYVVMDL----MESDLHHIIHSDQPLTEEHIR 110
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----- 113
+ YQ+ RGL YIH+ V HRDLKP NLLV+ ++I DFG A+ L +
Sbjct: 111 YFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFM 168
Query: 114 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
Y+ +R+YRAPEL+ EYTT+ID+WS GC+ AE+L + LFPG+N V QL I+ VL
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228
Query: 174 GTPTREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229
G+P+ E + + Y P+ + PW K+F K PEA+DL S++LQ+ P R
Sbjct: 229 GSPSEEVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERI 286
Query: 230 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 281
T +A HPF + +P+ + PP F+F E S E + + I
Sbjct: 287 TVEQALQHPFLAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-53
Identities = 87/241 (36%), Positives = 131/241 (54%), Gaps = 17/241 (7%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQI 64
H N+++L + + L LV EY + LK Y + + V+L+ +Q+
Sbjct: 62 HANIVTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQL 112
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYR 123
RGLAY H RV HRDLKPQNLL+ ++K+ DFG A+ + + + + + + +YR
Sbjct: 113 LRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR 182
P+++ G+TEY+TS+D+W GC+ E+ G+PLFPG + DQL +I +VLGTPT E
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230
Query: 183 --CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
NP + + FP P + P +LA + LQY P R +A EA HP+
Sbjct: 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
Query: 240 F 240
F
Sbjct: 291 F 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 9e-53
Identities = 95/246 (38%), Positives = 143/246 (58%), Gaps = 19/246 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR-MPLIYV 57
M+ + H N++ L H T +K L LV EY M + LK Y + + + V
Sbjct: 52 MKELKHENIVRL-HDVIHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTV 102
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISY 116
K +TYQ+ +G+A+ H RV HRDLKPQNLL++ ++K+ DFG A+ I +
Sbjct: 103 KSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNE 160
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ + +YRAP+++ G+ Y+TSIDIWS GC++AE++ G+PLFPG N DQL++I +++GTP
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP 220
Query: 177 TREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
T ++ P Y FP+ ++F P IDL RLLQ +P LR +A +A
Sbjct: 221 TESTWPGISQLPEYKP-TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDA 278
Query: 235 CAHPFF 240
HP+F
Sbjct: 279 LQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 1e-51
Identities = 96/268 (35%), Positives = 135/268 (50%), Gaps = 37/268 (13%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLY 60
R + H NV+SL F K+ + L+ +Y +++++K + A + P VK
Sbjct: 57 RELKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA-------KQLIAG 110
+QI G+ Y+H+ V HRDLKP N+LV P VKI D G A K L
Sbjct: 114 LWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 111 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-------- 162
+ + I +YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F G A
Sbjct: 173 DPVVVTI---WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229
Query: 163 -VDQLVEIIKVLGTPTREE---IRCMNPNY----TDFRFPQIKAHPWHKVFHKRMP--PE 212
DQL I +VLGTPT ++ I+ M P Y DF+ ++ K K +
Sbjct: 230 QRDQLERIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288
Query: 213 AIDLASRLLQYSPSLRCTALEACAHPFF 240
DL +LL+Y P+ R TA EA HP+F
Sbjct: 289 GFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-51
Identities = 83/221 (37%), Positives = 125/221 (56%), Gaps = 12/221 (5%)
Query: 27 LNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 85
L LV EY+ + + + + + +P +K + YQ+ +G+A+ H V HRDLKPQ
Sbjct: 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-VMHRDLKPQ 139
Query: 86 NLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 144
NLLVD +KI D G + I ++ I + +YRAPE++ G+T Y+T +DIWS G
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199
Query: 145 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR----FPQIKAHP 200
C+ AE+ QPLFPG++ + QL+ I K+LGTPT + P + R FPQ K
Sbjct: 200 CIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLRDWHEFPQWKPQD 255
Query: 201 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241
+ + PE +DL ++L+Y P+ R +A A HP+FD
Sbjct: 256 LSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-50
Identities = 94/252 (37%), Positives = 140/252 (55%), Gaps = 23/252 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLI 55
++ M H N++ L+ S E L LV EY+ + KH S+ N R+
Sbjct: 55 LKEMQHGNIVRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL--- 103
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANI 114
+K Y YQI RG+AY H+ RV HRDLKPQNLL+D T+ +K+ DFG A+ I
Sbjct: 104 -IKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+ + +YRAPE++ G+ Y+T +DIWS GC+ AE++ +PLFPG++ +D+L +I ++LG
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG 221
Query: 175 TPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
TP E + P+Y FP+ V + P +DL S++L+ PS R TA
Sbjct: 222 TPNEETWPGVTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITAR 279
Query: 233 EACAHPFFDELR 244
A H +F +L
Sbjct: 280 AALEHEYFKDLG 291
|
Length = 294 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-50
Identities = 88/251 (35%), Positives = 137/251 (54%), Gaps = 18/251 (7%)
Query: 6 HPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
H N+ L NEL+L E + ++++++ + Q + + + + YQI
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYL--YEELMEADLHQIIR----SGQPLTDAHFQSFIYQI 114
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----YICS 119
GL YIH+ V HRDLKP NLLV+ ++KICDFG A+ + Y+ +
Sbjct: 115 LCGLKYIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE++ YT +ID+WS GC+LAELL +P+F G++ VDQL +I++VLGTP E
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 180 EI-RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+ R +P ++ P I P+ +F P A+DL +LL + P+ R + EA
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALE 291
Query: 237 HPFFDELREPN 247
HP+ +P+
Sbjct: 292 HPYLAIWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-50
Identities = 82/247 (33%), Positives = 125/247 (50%), Gaps = 29/247 (11%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
+HPN++ L + EL L LV E+V + + L +P +K Q+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQL 116
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 124
RG+ ++H+ R+ HRDLKPQN+LV QVKI DFG A+ A S + + +YRA
Sbjct: 117 LRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 125 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 184
PE++ ++ Y T +D+WS GC+ AEL +PLF G + DQL +I V+G P+ EE
Sbjct: 175 PEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE---- 229
Query: 185 NPNYTDFRFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALE 233
+P+ + P F + E +DL ++L ++P R +A E
Sbjct: 230 --------WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280
Query: 234 ACAHPFF 240
A HP+F
Sbjct: 281 ALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-50
Identities = 83/242 (34%), Positives = 127/242 (52%), Gaps = 15/242 (6%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKL 59
R+ HPN++ L F + L LV E + ++Y ++K ++ PL VK
Sbjct: 53 RLSPHPNILRLIEVLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKS 104
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y YQ+ + L ++H + HRD+KP+N+L+ +K+ DFGS + + + YI +
Sbjct: 105 YMYQLLKSLDHMHR-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYIST 161
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE + Y +DIW+ GCV E+L PLFPG N +DQ+ +I VLGTP E
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE 221
Query: 180 EIRCMNP-NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
++ + ++ FP K K+ E +DL +LL Y P R TA +A HP
Sbjct: 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 239 FF 240
+F
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 8e-50
Identities = 91/244 (37%), Positives = 142/244 (58%), Gaps = 15/244 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N+++L F K L+L V E+V ++ L+ Y + + V+ Y
Sbjct: 54 LKQLRHENLVNLIEVF---RRKKRLYL--VFEFVDHTVLDDLEKYPNG---LDESRVRKY 105
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICS 119
+QI RG+ + H+ + HRD+KP+N+LV + VK+CDFG A+ L A GE Y+ +
Sbjct: 106 LFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVAT 163
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PT 177
R+YRAPEL+ G T+Y ++DIW+ GC++ E+L G+PLFPG++ +DQL IIK LG P
Sbjct: 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223
Query: 178 REEIRCMNPNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+EI NP + R P++K P K F K + +DLA + L+ P R ++ +
Sbjct: 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
Query: 237 HPFF 240
H FF
Sbjct: 283 HEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-49
Identities = 89/252 (35%), Positives = 140/252 (55%), Gaps = 16/252 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ M H NVI L F S + LVM ++ + +++KH + R ++
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQF 122
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ +GL YIH + HRDLKP NL V+ ++KI DFG A+Q Y+ +
Sbjct: 123 LVYQMLKGLKYIHAAG-IIHRDLKPGNLAVNE-DCELKILDFGLARQ--TDSEMTGYVVT 178
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238
Query: 180 EIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
++ + NY + P+ + + + P A+++ ++L R TA EA
Sbjct: 239 FVQKLQSEDAKNYVK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEAL 296
Query: 236 AHPFFDELREPN 247
AHP+F+E +P
Sbjct: 297 AHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-48
Identities = 87/248 (35%), Positives = 136/248 (54%), Gaps = 28/248 (11%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
HPN++++K + +++++ VMEYV + +++ Q VK Q+
Sbjct: 62 QHPNIVTVKEVVVGSNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQL 115
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISY---ICS 119
G+A++H + HRDLK NLL L + +KICDFG A++ G Y + +
Sbjct: 116 LSGVAHLHD-NWILHRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVT 169
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
+YRAPEL+ GA EY+T+ID+WS GC+ AELL +PLFPG++ +DQL +I K+LGTPT +
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229
Query: 180 EIRCMNPNYTDFRFPQIKAHPWH------KVF-HKRMPPEAIDLASRLLQYSPSLRCTAL 232
P +++ + K + K F + DL +RLL Y P+ R +A
Sbjct: 230 IW----PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE 285
Query: 233 EACAHPFF 240
+A HP+F
Sbjct: 286 DALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 4e-48
Identities = 91/250 (36%), Positives = 137/250 (54%), Gaps = 19/250 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N+ISL F S + V E + ++R+L Q +++ +
Sbjct: 63 LKHLRHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYF 113
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQI RGL Y+H+ V HRDLKP N+L++ +KICDFG A+ I Y+ +R
Sbjct: 114 LYQILRGLKYVHSAG-VVHRDLKPSNILINE-NCDLKICDFGLAR--IQDPQMTGYVSTR 169
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPE++ +Y +DIWSAGC+ AE+L G+PLFPG++ V+Q I +LGTP +
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 181 IRCMNPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
I + T RF P+ + P+ + F K P AIDL ++L + P R +A EA A
Sbjct: 230 INTICSENT-LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 237 HPFFDELREP 246
HP+ +P
Sbjct: 288 HPYLAPYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-48
Identities = 101/275 (36%), Positives = 153/275 (55%), Gaps = 21/275 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R++ HP+++ +KH + + + +V E + +++V+K AN + + + +
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFF 108
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISY 116
YQ+ R L YIHT V HRDLKP+N+L + ++KICDFG A+ Y
Sbjct: 109 LYQLLRALKYIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 117 ICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+ +R+YRAPEL G+ ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL I +LG
Sbjct: 167 VATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225
Query: 175 TPTREEI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCT 230
TP+ E I R N + K P F ++ P P A+ L RLL + P R T
Sbjct: 226 TPSPETISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
Query: 231 ALEACAHPFFDELREPNARLPNGRPLPPL-FNFKQ 264
A EA A P+F L + R P+ +P+ L F F++
Sbjct: 284 AEEALADPYFKGLAKVE-REPSAQPITKLEFEFER 317
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 6e-48
Identities = 89/252 (35%), Positives = 138/252 (54%), Gaps = 17/252 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ M H NVI L F S S +E LVM Y+ + +++ H S ++ V+
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQY 121
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ GL YIH+ + HRDLKP NL V+ ++KI DFG A+ A Y+ +
Sbjct: 122 LVYQMLCGLKYIHSAG-IIHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVT 177
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237
Query: 180 EIRCMN----PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
++ + +Y P+ + +F + P+A+DL ++L+ R TA EA
Sbjct: 238 FVQKLEDKAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEAL 295
Query: 236 AHPFFDELREPN 247
HP+FD R+ +
Sbjct: 296 EHPYFDSFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 5e-47
Identities = 87/245 (35%), Positives = 135/245 (55%), Gaps = 18/245 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N++ L S + L LV EY + + K++ S N + VK +
Sbjct: 53 LKELKHKNIVRLYDVLHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSF 104
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICS 119
+Q+ +GLA+ H+ V HRDLKPQNLL++ ++K+ DFG A+ I + + +
Sbjct: 105 MFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVVT 162
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTR 178
+YR P+++FGA Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222
Query: 179 EEIRCMN--PNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
E ++ P+Y + +P + V ++ DL LL +P R +A EA
Sbjct: 223 ESWPGVSKLPDYKPYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEAL 279
Query: 236 AHPFF 240
HP+F
Sbjct: 280 QHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-47
Identities = 89/250 (35%), Positives = 145/250 (58%), Gaps = 28/250 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVK 58
++ ++HPN++ L + +N+L+L V E+ +++ LK + +S +PL +K
Sbjct: 53 LKELNHPNIVKLLDVIHT---ENKLYL--VFEF----LHQDLKKFMDASPLSGIPLPLIK 103
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-- 116
Y +Q+ +GLA+ H+ RV HRDLKPQNLL++ +K+ DFG A+ G +Y
Sbjct: 104 SYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTH 159
Query: 117 -ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
+ + +YRAPE++ G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGT
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 219
Query: 176 PTREEIRCMNPNYT---DFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
P + P T D++ FP+ + KV + + DL S++L Y P+ R +
Sbjct: 220 PDEV----VWPGVTSLPDYKPSFPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRIS 274
Query: 231 ALEACAHPFF 240
A A AHPFF
Sbjct: 275 AKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-46
Identities = 86/241 (35%), Positives = 134/241 (55%), Gaps = 19/241 (7%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTY 62
HPN++ L+ ++ L+L + E++ SM LK Y Q M VK Y Y
Sbjct: 58 HPNIVCLQDVLMQ---ESRLYL--IFEFL--SMD--LKKYLDSLPKGQYMDAELVKSYLY 108
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRF 121
QI +G+ + H+ RV HRDLKPQNLL+D +K+ DFG A+ I + + +
Sbjct: 109 QILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLW 166
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
YRAPE++ G+ Y+T +DIWS G + AE+ +PLF G++ +DQL I ++LGTPT +
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226
Query: 182 RCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+ P+Y + FP+ K + K + + +DL ++L Y P+ R +A +A HP+
Sbjct: 227 PGVTSLPDYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
Query: 240 F 240
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-46
Identities = 74/261 (28%), Positives = 132/261 (50%), Gaps = 34/261 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQR 51
+R +DH N++ + + S + +V EY+ + VL+
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GP 110
Query: 52 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 111
+ + +L+ YQ+ RGL YIH+ V HRDLKP N+ ++ +KI DFG A+ +
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169
Query: 112 ANISYI----CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL- 166
++ Y+ +++YR+P L+ YT +ID+W+AGC+ AE+L G+PLF G + ++Q+
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
Query: 167 --VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW--HKVFHKRMP---PEAIDLASR 219
+E + V+ R E+ + P++ ++ + +P PEA+D +
Sbjct: 230 LILESVPVVREEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQ 282
Query: 220 LLQYSPSLRCTALEACAHPFF 240
+L ++P R TA EA HP+
Sbjct: 283 ILTFNPMDRLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-44
Identities = 87/256 (33%), Positives = 142/256 (55%), Gaps = 16/256 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKL 59
++ + H N+++L + S L LV EY+ + LK Y + + VKL
Sbjct: 58 LKDLKHANIVTLHDIIHTEKS-----LTLVFEYLDKD----LKQYLDDCGNSINMHNVKL 108
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYIC 118
+ +Q+ RGL Y H +V HRDLKPQNLL++ ++K+ DFG A+ + I + + +
Sbjct: 109 FLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEVV 166
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ +YR P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226
Query: 179 EEIRCM--NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
E + N + + +P+ +A H R+ + +L S+LLQ+ R +A EA
Sbjct: 227 ETWPGILSNEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285
Query: 237 HPFFDELREPNARLPN 252
HP+F L E +LP+
Sbjct: 286 HPYFHCLGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-44
Identities = 92/254 (36%), Positives = 129/254 (50%), Gaps = 40/254 (15%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 65
HPN++ LK + +FL VMEY + + +L + + VK Q+
Sbjct: 65 HPNIVELKEVVVGK-HLDSIFL--VMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLL 118
Query: 66 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC----- 118
RGL Y+H + HRDLK NLL LT + +KI DFG A+
Sbjct: 119 RGLQYLHE-NFIIHRDLKVSNLL---LTDKGCLKIADFGLAR-------TYGLPAKPMTP 167
Query: 119 ---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
+ +YRAPEL+ G T YTT+ID+W+ GC+LAELL +PL PG++ ++QL II++LGT
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227
Query: 176 PTREEI----RCMNPNYTDFRFPQIKAHPWHKVFHKRMP--PEA-IDLASRLLQYSPSLR 228
P E I + P F P+ P++ + HK P EA + L + LL Y P R
Sbjct: 228 PN-ESIWPGFSDL-PLVGKFTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKR 281
Query: 229 CTALEACAHPFFDE 242
TA EA +F E
Sbjct: 282 ATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 8e-44
Identities = 86/258 (33%), Positives = 123/258 (47%), Gaps = 33/258 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M + H N++ L + F+NLVM+ M LK R+ VK
Sbjct: 74 MNEIKHENIMGLVDVYVE-----GDFINLVMDI----MASDLKKVVDRKIRLTESQVKCI 124
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-----LIAGEANIS 115
QI GL +H HRDL P N+ ++ KI DFG A++ +
Sbjct: 125 LLQILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 116 YICSR----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 165
+ R +YRAPEL+ GA +Y ++D+WS GC+ AELL G+PLFPGEN +DQ
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242
Query: 166 LVEIIKVLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222
L I ++LGTP + + + + P YT+F + K K +AIDL LL+
Sbjct: 243 LGRIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLK 298
Query: 223 YSPSLRCTALEACAHPFF 240
+P R +A EA H +F
Sbjct: 299 LNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-43
Identities = 78/189 (41%), Positives = 117/189 (61%), Gaps = 7/189 (3%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANIS 115
V+L+ +Q+ RGLAYIH + HRDLKPQNLL+ L ++K+ DFG A+ + I + S
Sbjct: 105 VRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSS 162
Query: 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLG 174
+ + +YR P+++ GAT+Y++++DIW AGC+ E+L GQP FPG + +QL +I VLG
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG 222
Query: 175 TPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTA 231
PT + ++ PNY F K V+ + PP+A DLAS++L P R +A
Sbjct: 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282
Query: 232 LEACAHPFF 240
+A HP+F
Sbjct: 283 QDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 79/241 (32%), Positives = 125/241 (51%), Gaps = 19/241 (7%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 65
HPN+++L F + + L+LV EY ++ L+ + +P +K +Q
Sbjct: 59 HPNLVNLIEVF-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTL 110
Query: 66 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRA 124
+ + + H HRD+KP+N+L+ Q+K+CDFG A+ L + + Y+ +R+YRA
Sbjct: 111 QAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168
Query: 125 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIR 182
PEL+ G T+Y +D+W+ GCV AELL GQPL+PG++ VDQL I K LG P ++I
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPF 239
N + F+ I + + P A+ LQ P+ R + E HP+
Sbjct: 229 STN-QF--FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
Query: 240 F 240
F
Sbjct: 286 F 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 2e-42
Identities = 89/253 (35%), Positives = 141/253 (55%), Gaps = 18/253 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSK---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 57
++ M H NVI L F TS NE++L V + + ++K Q++ +V
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKC-----QKLSDEHV 120
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
+ YQ+ RGL YIH+ + HRDLKP N+ V+ +++I DFG A+Q A + Y+
Sbjct: 121 QFLIYQLLRGLKYIHSAG-IIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYV 176
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+R+YRAPE++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++V+GTP+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 178 REEIRCMNPNYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
E ++ ++ + P + K+F + P AIDL ++L R +A EA
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEA 295
Query: 235 CAHPFFDELREPN 247
AHP+F + +P
Sbjct: 296 LAHPYFSQYHDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 2e-42
Identities = 74/201 (36%), Positives = 111/201 (55%), Gaps = 7/201 (3%)
Query: 49 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 108
Q + +VK++ YQI RGL Y+H+ + HRD+KP NLLV+ +KICDFG A+
Sbjct: 97 PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEE 154
Query: 109 AGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 166
E+ + +++YRAPE++ G+ YT+++DIWS GC+ AELL + LF ++ + QL
Sbjct: 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214
Query: 167 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQY 223
I +LGTP+ E +R P V + EA+ L R+L +
Sbjct: 215 DLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVF 274
Query: 224 SPSLRCTALEACAHPFFDELR 244
P R +A +A AHP+ DE R
Sbjct: 275 DPDKRISAADALAHPYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 8e-42
Identities = 88/248 (35%), Positives = 140/248 (56%), Gaps = 18/248 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKL 59
++ + H N+++L + S L LV EY+ + LK Y M + VK+
Sbjct: 58 LKDLKHANIVTLHDIVHTDKS-----LTLVFEYLDKD----LKQYMDDCGNIMSMHNVKI 108
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYIC 118
+ YQI RGLAY H +V HRDLKPQNLL++ ++K+ DFG A+ + + + + +
Sbjct: 109 FLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVV 166
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ +YR P+++ G++EY+T ID+W GC+ E+ G+PLFPG D+L I ++LGTPT
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226
Query: 179 EEIRCMNPN--YTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEAC 235
E ++ N + ++ FP+ K P + H R+ E I+L ++ LQY R +A EA
Sbjct: 227 ETWPGISSNDEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284
Query: 236 AHPFFDEL 243
H +F L
Sbjct: 285 KHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 9e-42
Identities = 74/244 (30%), Positives = 108/244 (44%), Gaps = 40/244 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ + HPN++ + S + + LN+ +EYV S L ++P ++
Sbjct: 53 LSSLQHPNIV---RYYGSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRK 105
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISY 116
YT QI GLAY+H+ + HRD+K N+LVD VK+ DFG AK+L GE S
Sbjct: 106 YTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSV 163
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ ++ APE+I G EY + DIWS GC + E+ G+P + + I G P
Sbjct: 164 RGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP 222
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
P+I H + EA D + L+ P R TA E
Sbjct: 223 -----------------PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQ 256
Query: 237 HPFF 240
HPF
Sbjct: 257 HPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 87/252 (34%), Positives = 135/252 (53%), Gaps = 16/252 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ M H NVI L F S E + LV + + ++K Q++ +V+
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQF 124
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQI RGL YIH+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +
Sbjct: 125 LIYQILRGLKYIHSAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVAT 180
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240
Query: 180 EIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
++ ++ NY Q+ + VF P A+DL ++L R TA +A
Sbjct: 241 LLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 236 AHPFFDELREPN 247
AH +F + +P+
Sbjct: 299 AHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-40
Identities = 88/246 (35%), Positives = 138/246 (56%), Gaps = 18/246 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R + N++ LK F + +L+L V EYV ++M +L+ + +P V+ Y
Sbjct: 54 LRTLKQENIVELKEAF---RRRGKLYL--VFEYVEKNMLELLEEMPNG---VPPEKVRSY 105
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANIS-YIC 118
YQ+ + + + H + HRD+KP+NLL+ +K+CDFG A+ L G AN + Y+
Sbjct: 106 IYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVA 163
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+R+YR+PEL+ GA Y ++D+WS GC+L EL GQPLFPGE+ +DQL I KVLG
Sbjct: 164 TRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222
Query: 179 EEIRCM--NPNYTDFRFPQIKAHP--WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
E+++ NP + RFP + HP + + + +DL LL+ +P+ R +
Sbjct: 223 EQMKLFYSNPRFHGLRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281
Query: 235 CAHPFF 240
HP F
Sbjct: 282 LNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 85/244 (34%), Positives = 135/244 (55%), Gaps = 16/244 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKL 59
++ + H N+++L H T E L LV EY+ LK Y + M + VK+
Sbjct: 57 LKNLKHANIVTL-HDIIHT----ERCLTLVFEYLDSD----LKQYLDNCGNLMSMHNVKI 107
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYIC 118
+ +Q+ RGL+Y H ++ HRDLKPQNLL++ ++K+ DFG A+ + + + + +
Sbjct: 108 FMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEVV 165
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ +YR P+++ G+TEY+T ID+W GC+L E+ G+P+FPG ++L I ++LGTPT
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225
Query: 179 EEIR--CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
E N + + FPQ +A P R+ + IDL S LL Y R +A A
Sbjct: 226 ETWPGITSNEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284
Query: 237 HPFF 240
H +F
Sbjct: 285 HSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 79/258 (30%), Positives = 121/258 (46%), Gaps = 35/258 (13%)
Query: 6 HPNVISLKHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
HPNV+ L S + +++ V Y+ + +L S I K Y
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLL-ENPSVKLTESQI--KCY 120
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---------QLIAGE 111
Q+ G+ Y+H + HRD+K N+L+D +KI DFG A+ + G
Sbjct: 121 MLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 112 ANISY---ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 168
Y + +R+YR PEL+ G YTT++DIW GCV AE+ +P+ G++ +DQL
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
Query: 169 IIKVLGTPTREEIRCMNPNYTDF-RFPQIKAHPWH-----KVFHKRMPPEAIDLASRLLQ 222
I K+ GTPT E P + + + + + F ++ PE +DL S+LL
Sbjct: 239 IFKLCGTPTEETW----PGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLS 293
Query: 223 YSPSLRCTALEACAHPFF 240
P R TA +A HP+F
Sbjct: 294 LDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 86/273 (31%), Positives = 142/273 (52%), Gaps = 33/273 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
M++++H N+I L + F S E + LVME + ++ +V+ ++RM +
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSYL---- 123
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYIC 118
YQ+ G+ ++H+ + HRDLKP N++V T +KI DFG A+ Y+
Sbjct: 124 -LYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVV 179
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+R+YRAPE+I G Y ++DIWS GC++ E++ G LFPG + +DQ +II+ LGTP+
Sbjct: 180 TRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238
Query: 179 EEIRCMNP---NYTDFRFPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQY 223
E + + P NY + R P+ + + ++F +K +A DL S++L
Sbjct: 239 EFMSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 224 SPSLRCTALEACAHPF----FDELREPNARLPN 252
P R + +A HP+ +D E A P
Sbjct: 298 DPEKRISVDDALQHPYINVWYDP-SEVEAPPPA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 141 bits (355), Expect = 2e-39
Identities = 76/288 (26%), Positives = 114/288 (39%), Gaps = 37/288 (12%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 61
+ PN++ L F ++E L LVMEYV L +
Sbjct: 53 SLNHPPNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFIL 107
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI------- 114
QI L Y+H+ + HRD+KP+N+L+D VK+ DFG AK L +
Sbjct: 108 AQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166
Query: 115 SYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEI 169
+ + + Y APE++ G + ++S DIWS G L ELL G P F GE A Q ++I
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226
Query: 170 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229
I L TP A P + + A DL +LL P R
Sbjct: 227 ILELPTP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267
Query: 230 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKL 277
++ +H L+ + L + + L + L++ L
Sbjct: 268 SSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 35/203 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ ++HPN++ L F ++E L LVMEY S+ +LK ++ +
Sbjct: 45 LKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILR 96
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
QI GL Y+H+ + HRDLKP+N+L+D +VK+ DFG +K L + ++ + I
Sbjct: 97 ILLQILEGLEYLHSNG-IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ G Y+ DIWS G +L EL +L ++I+
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------PELKDLIR------- 195
Query: 179 EEIRCMNPNYTD-FRFPQIKAHP 200
+ + + +I H
Sbjct: 196 ---KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 2e-36
Identities = 78/243 (32%), Positives = 115/243 (47%), Gaps = 48/243 (19%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
++HP ++ L H F T K L LV+EY P E L + S R + Y
Sbjct: 50 INHPFIVKL-HYAFQTEEK----LYLVLEYAPGGE-----LFSHLSKEGRFSEERARFYA 99
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 120
+I L Y+H++ + +RDLKP+N+L+D H +K+ DFG AK+L + + + C +
Sbjct: 100 AEIVLALEYLHSL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y APE++ G Y ++D WS G +L E+L G+P F E+ ++ E I
Sbjct: 158 EYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL--------- 206
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AH 237
RFP + + PEA DL S LLQ P+ R + A AH
Sbjct: 207 -------KDPLRFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247
Query: 238 PFF 240
PFF
Sbjct: 248 PFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 7e-34
Identities = 81/251 (32%), Positives = 133/251 (52%), Gaps = 21/251 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N++ L + + L LV EYV + + + + + VKL+
Sbjct: 57 LKGLKHANIVLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGG---LHPENVKLF 108
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICS 119
+Q+ RGL+YIH + HRDLKPQNLL+ T ++K+ DFG A+ + + + + +
Sbjct: 109 LFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 178
+YR P+++ G+TEY+T +D+W GC+ E++ G FPG + DQL I VLGTP
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE 226
Query: 179 EEIRCMN--PNYTDFRFPQIKA----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
+ ++ P++ RF W+K+ + A DLAS+LLQ P R +A
Sbjct: 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQ 283
Query: 233 EACAHPFFDEL 243
A +H +F +L
Sbjct: 284 AALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 73/236 (30%), Positives = 114/236 (48%), Gaps = 7/236 (2%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
DHPN++ L ++ + E + LV E+V + + L +P +K Q
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQF 117
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 124
RGL ++H + HRDLKP+N+LV QVK+ DFG A+ A + + +YRA
Sbjct: 118 LRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 125 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 184
PE++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++
Sbjct: 176 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 233
Query: 185 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
+ F P V + L +L ++P R +A A HPFF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 83/261 (31%), Positives = 137/261 (52%), Gaps = 25/261 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ ++H N+ISL + F S E + LVME + ++ +V+ H ++RM +
Sbjct: 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL--- 129
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +
Sbjct: 130 --YQMLCGIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVT 185
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I G Y ++DIWS GC++ EL+ G +F G + +DQ ++I+ LGTP+ E
Sbjct: 186 RYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244
Query: 180 EIRCMNP---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSP 225
+ + P NY + R PQ + ++F + P +A DL S++L P
Sbjct: 245 FMNRLQPTVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP 303
Query: 226 SLRCTALEACAHPFFDELREP 246
R + EA HP+ +P
Sbjct: 304 DKRISVDEALRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-32
Identities = 80/244 (32%), Positives = 128/244 (52%), Gaps = 15/244 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ +HPNV+ L + + E L LV E+V + + L +P +K
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDM 115
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+Q+ RGL ++H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + +
Sbjct: 116 MFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPE++ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+
Sbjct: 174 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL----QYSPSLRCTALEACA 236
P D P+ H ++ + +L LL ++P+ R +A A +
Sbjct: 233 W----PR--DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286
Query: 237 HPFF 240
HP+F
Sbjct: 287 HPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 73/257 (28%), Positives = 122/257 (47%), Gaps = 33/257 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTS-----KNELFLNLVMEYVPESMYRVLK----HYSSANQR 51
+R ++H N+++LK K++ LV EY+ + +L+ H+S +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-- 117
Query: 52 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 111
+K + Q+ GL Y H HRD+K N+L++ Q+K+ DFG A+ + E
Sbjct: 118 -----IKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEE 170
Query: 112 AN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
+ + + + +YR PEL+ G Y +ID+WS GC+L EL +P+F + QL I
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 170 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQ 222
++ G+P + P+ + P K + +R +P A+DL +L
Sbjct: 231 SRLCGSPCPA----VWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLT 284
Query: 223 YSPSLRCTALEACAHPF 239
PS RCTA EA P+
Sbjct: 285 LDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-31
Identities = 83/273 (30%), Positives = 142/273 (52%), Gaps = 31/273 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
M+ ++H N+I L + F S E + +VME + ++ +V++ ++RM +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL--- 132
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +
Sbjct: 133 --YQMLCGIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E
Sbjct: 189 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247
Query: 180 EIRCMNP---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSP 225
++ + P Y + R P+ + + K+F + P +A DL S++L
Sbjct: 248 FMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 226 SLRCTALEACAHPFFD------ELREPNARLPN 252
S R + EA HP+ + E P ++P+
Sbjct: 307 SKRISVDEALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 83/261 (31%), Positives = 140/261 (53%), Gaps = 25/261 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
M+ ++H N+ISL + F S E + LVME + ++ +V++ ++RM +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL--- 125
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +
Sbjct: 126 --YQMLCGIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E
Sbjct: 182 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 180 EIRCMNP---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSP 225
++ + P NY + R P+ + K+F + P +A DL S++L P
Sbjct: 241 FMKKLQPTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 226 SLRCTALEACAHPFFDELREP 246
+ R + EA HP+ + +P
Sbjct: 300 AKRISVDEALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-31
Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ HPN++ + K+EL++ VME+ S+ +LK NQ + +
Sbjct: 51 LKKCKHPNIVKYYGSYLK---KDELWI--VMEFCSGGSLKDLLKST---NQTLTESQIAY 102
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 117
++ +GL Y+H+ + HRD+K N+L LT +VK+ DFG + QL +A + +
Sbjct: 103 VCKELLKGLEYLHSN-GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMV 158
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ ++ APE+I G Y DIWS G EL G+P + + L +I G P
Sbjct: 159 GTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG 216
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
R P W F D + LQ +P R TA + H
Sbjct: 217 -------------LRNP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKH 251
Query: 238 PF 239
PF
Sbjct: 252 PF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-31
Identities = 95/273 (34%), Positives = 135/273 (49%), Gaps = 40/273 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLI 55
+R + HPNVISL+ F S + + L+ +Y ++ ++K + S AN++ +P
Sbjct: 52 LRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 108
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IA 109
VK YQI G+ Y+H V HRDLKP N+LV P +VKI D G A+ +
Sbjct: 109 MVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 110 GEANISYICSRF-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------ 162
A++ + F YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227
Query: 163 ---VDQLVEIIKVLGTPTR---EEIRCMNPNYT---DFR------FPQIKAHPWHKVFHK 207
DQL I V+G P E+I+ M + T DFR IK HKV
Sbjct: 228 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV--- 284
Query: 208 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
+ +A L +LL P R T+ +A P+F
Sbjct: 285 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-31
Identities = 75/235 (31%), Positives = 110/235 (46%), Gaps = 39/235 (16%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQI 64
HPN++ + T + E L + +E VP S+ ++LK Y S P ++LYT QI
Sbjct: 61 HPNIVQ-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQI 111
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 124
GL Y+H HRD+K N+LVD VK+ DFG AKQ++ S+ S ++ A
Sbjct: 112 LLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMA 169
Query: 125 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 184
PE+I Y + DIWS GC + E+ G+P + + ++ + + K+ + I
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI--- 223
Query: 185 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
P H + EA D + LQ PSLR TA E HPF
Sbjct: 224 ---------------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 8e-31
Identities = 93/271 (34%), Positives = 136/271 (50%), Gaps = 36/271 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLI 55
+R + HPNVI+L+ F S + + + L+ +Y ++ ++K + S AN++ +P
Sbjct: 52 LRELKHPNVIALQKVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRS 108
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IA 109
VK YQI G+ Y+H V HRDLKP N+LV P +VKI D G A+ +
Sbjct: 109 MVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 110 GEANISYICSRF-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------ 162
A++ + F YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227
Query: 163 ---VDQLVEIIKVLGTPTR---EEIRCMNPNY----TDFRFPQIKAHPWHKVFHK-RMPP 211
DQL I V+G P E+IR M P Y DFR K K ++ P
Sbjct: 228 PFHHDQLDRIFSVMGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKP 286
Query: 212 EA--IDLASRLLQYSPSLRCTALEACAHPFF 240
++ L +LL P+ R T+ +A P+F
Sbjct: 287 DSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 70/243 (28%), Positives = 102/243 (41%), Gaps = 49/243 (20%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 63
+ P V+ F+ +++V+EY+ S+ +LK ++P + Q
Sbjct: 57 ESPYVVKCYGAFYKEGE-----ISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQ 107
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 121
I +GL Y+HT + HRD+KP NLL++ +VKI DFG +K L N C+ F
Sbjct: 108 ILKGLDYLHTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVG 162
Query: 122 ---YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTP 176
Y +PE I G + Y+ + DIWS G L E LG+ P P +L++ I
Sbjct: 163 TVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------ 215
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
C P + PE D S LQ P R +A E
Sbjct: 216 ------CDGPPP----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255
Query: 237 HPF 239
HPF
Sbjct: 256 HPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 52/248 (20%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQI 64
P V+ L ++S K L+L VMEY+P + +L++ S ++ + ++Y +I
Sbjct: 52 SPYVVKL---YYSFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEI 102
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK----QLIAGEANISYICSR 120
L Y+H+ + HRDLKP N+L+D H +K+ DFG +K + + R
Sbjct: 103 VLALEYLHSN-GIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 121 F-----YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
Y APE+I G ++ ++D WS GC+L E L+G P F GE
Sbjct: 161 IVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP------------- 206
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL--- 232
EEI N +P+ + EAIDL S+LL P R A
Sbjct: 207 ---EEI-FQNILNGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIE 252
Query: 233 EACAHPFF 240
E HPFF
Sbjct: 253 EIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 6e-28
Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 38/242 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ ++HPN+I F L +VMEY + + +K + P +
Sbjct: 53 LKKLNHPNIIKYYESFEEKGK-----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYIC 118
+ Q+ L Y+H+ ++ HRD+KPQN+ + VK+ DFG +K L + + +
Sbjct: 108 WFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ +Y +PEL Y DIWS GCVL EL + F GEN + +L K+L +
Sbjct: 166 TPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----K 217
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ + Y E +L S LLQ P R + + P
Sbjct: 218 GQYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQILQSP 256
Query: 239 FF 240
F
Sbjct: 257 FI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 71/266 (26%), Positives = 109/266 (40%), Gaps = 67/266 (25%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
R+ HP +I L + F ++E L V+EY P + + ++ Y S +++ +
Sbjct: 56 TRLNGHPGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRF 106
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANIS 115
Y +I L Y+H+ + HRDLKP+N+L+D H +KI DFG+AK L
Sbjct: 107 YAAEILLALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGD 164
Query: 116 YICSRF-----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158
Y +PEL+ S D+W+ GC++ ++L G+P F
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
Query: 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 218
G N +I+K ++ FP PP+A DL
Sbjct: 224 GSNEYLTFQKILK-----------------LEYSFPPN------------FPPDAKDLIE 254
Query: 219 RLLQYSPSLRCTALEAC----AHPFF 240
+LL P R E AHPFF
Sbjct: 255 KLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 44/242 (18%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
+ P ++ F++ ++ + MEY+ S+ ++LK R+P +
Sbjct: 57 NSPYIVGFYGAFYN---NGDISI--CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVA 108
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 123
+ +GL Y+H ++ HRD+KP N+LV+ Q+K+CDFG + QL+ A +++ + Y
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYM 166
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTR 178
APE I G +Y+ DIWS G L EL G+ +P EN + L I+
Sbjct: 167 APERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------- 218
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
P P++ + + P+ D + L P R + E HP
Sbjct: 219 -----EPP-------PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHP 258
Query: 239 FF 240
F
Sbjct: 259 FI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-27
Identities = 71/255 (27%), Positives = 117/255 (45%), Gaps = 24/255 (9%)
Query: 1 MRVMDHPNVISLKH-CFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 57
++++ H NV++L C T ++ + LV E+ + +L S+ N + L +
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEI 121
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---QLIAGEAN- 113
K + GL YIH ++ HRD+K N+L+ +K+ DFG A+ + N
Sbjct: 122 KKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNR 179
Query: 114 -ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
+ + + +YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
Query: 173 LGTPTREEIRCMNPN------YTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225
G+ T E + P + PQ K ++ P A+DL +LL P
Sbjct: 240 CGSITPE----VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295
Query: 226 SLRCTALEACAHPFF 240
+ R A A H FF
Sbjct: 296 AKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 63/247 (25%), Positives = 107/247 (43%), Gaps = 44/247 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ ++ HPN++ + + ++ + MEY ++ +L+H + + +++
Sbjct: 53 LELLKHPNLVK---YYGVEVHREKV--YIFMEYCSGGTLEELLEH----GRILDEHVIRV 103
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANI 114
YT Q+ GLAY+H+ + HRD+KP N+ +D +K+ DFG A +L GE
Sbjct: 104 YTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 115 SYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
S + Y APE+I G + + DIWS GCV+ E+ G+ + + Q++ +
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA 221
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
P P ++ PE D R L+ P R TA
Sbjct: 222 GHKPP---------------IPD----------SLQLSPEGKDFLDRCLESDPKKRPTAS 256
Query: 233 EACAHPF 239
E HPF
Sbjct: 257 ELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 74/243 (30%), Positives = 110/243 (45%), Gaps = 50/243 (20%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLY 60
+ P V L ++S SK+ L+L VMEY+ S+ + L +P + K Y
Sbjct: 55 ESPYVAKL---YYSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQY 102
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
++ G+ +H + HRD+KP+NLL+D H +K+ DFG ++ G N ++ +
Sbjct: 103 IAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSR---NGLENKKFVGTP 157
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y APE I G + D WS GCV+ E L G P F E D + + I
Sbjct: 158 DYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNI---------L 206
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAH 237
R +N W + + PEA+DL +RLL P+ R A E +H
Sbjct: 207 SRRIN---------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251
Query: 238 PFF 240
PFF
Sbjct: 252 PFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-25
Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 41/246 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M ++HP++I +T + NL +E++ S+ +L Y + + + +
Sbjct: 57 MARLNHPHII---RMLGATCEDSHF--NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN- 107
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-----AGEANI 114
YT Q+ RGL+Y+H ++ HRD+K NLL+D +++I DFG+A +L AGE
Sbjct: 108 YTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+ + + APE++ G +Y S D+WS GCV+ E+ +P + E + L I K
Sbjct: 167 QLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK--- 222
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
I P I H + P D+ R L+ P R + E
Sbjct: 223 ------IASATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSREL 261
Query: 235 CAHPFF 240
HP F
Sbjct: 262 LKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 63/242 (26%), Positives = 109/242 (45%), Gaps = 42/242 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + HPN++ + L +++EY S+ +++K + + + V +
Sbjct: 53 LKNLKHPNIVKYIGSI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAV 103
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYIC 118
Y YQ+ +GLAY+H V HRD+K N+L VK+ DFG A +L + S +
Sbjct: 104 YVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVG 161
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ ++ APE+I + +T+ DIWS GC + ELL G P + N + L I++
Sbjct: 162 TPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------- 213
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ + P + + PE D + Q P+LR TA + HP
Sbjct: 214 ------DDHP---PLP------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252
Query: 239 FF 240
+
Sbjct: 253 WI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 39/244 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ +DH N++ E +L++ +EYVP S+ L+ Y +++ V+
Sbjct: 62 LKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRF 112
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ---LIAGEANISY 116
+T Q+ GLAY+H+ + HRDLK NLLVD KI DFG +K+ + + N+S
Sbjct: 113 FTEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 117 ICSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
S F+ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E A+ + ++
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------ 224
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
+ A P + P A+D + +P R TA E
Sbjct: 225 -----------------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
Query: 236 AHPF 239
HPF
Sbjct: 268 QHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 45/248 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
+ +HP ++ L + F K++ ++ ++MEY E L +
Sbjct: 47 LEECNHPFIVKL-YRTF----KDKKYIYMLMEYCLGGE-----LWTILRDRGLFDEYTAR 96
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y + Y+H + +RDLKP+NLL+D VK+ DFG AK+L +G+ ++
Sbjct: 97 FYIACVVLAFEYLHNR-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE+I Y S+D WS G +L ELL G+P F GE+ D +
Sbjct: 155 TPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IY 203
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-- 236
+I N FP + A DL +LL+ +P R L+
Sbjct: 204 NDILKGNGKLE---FPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKD 248
Query: 237 ---HPFFD 241
H +F+
Sbjct: 249 IKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 68/228 (29%), Positives = 108/228 (47%), Gaps = 25/228 (10%)
Query: 27 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 85
+++ ME++ S+ +VLK R+P + + + RGL Y+ ++ HRD+KP
Sbjct: 74 ISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 86 NLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145
N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T YT DIWS G
Sbjct: 130 NILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYTVQSDIWSLGL 186
Query: 146 VLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREEIRCMNPNYTDFRFPQ----- 195
L E+ +G+ P +A E+ + G P +E R ++ + D P
Sbjct: 187 SLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFEL 242
Query: 196 ---IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
I P K+ E D + L+ +P R E HPF
Sbjct: 243 LDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 7e-22
Identities = 54/180 (30%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVK 58
MR +DHPN++ L T + L + VMEY+P L Y + + + L +
Sbjct: 55 MRKLDHPNIVKLLGV---CTEEEPLMI--VMEYMP---GGDLLDYLRKNRPKELSLSDLL 106
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+ QI RG+ Y+ + HRDL +N LV VKI DFG ++ L + Y
Sbjct: 107 SFALQIARGMEYLESK-NFIHRDLAARNCLVGE-NLVVKISDFGLSRDL----YDDDYYK 160
Query: 119 SRF----YR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 171
+ R APE + ++T+ D+WS G +L E+ LG+ +PG + +++E +K
Sbjct: 161 VKGGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-21
Identities = 73/248 (29%), Positives = 113/248 (45%), Gaps = 53/248 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ + HP +++L F +++ L LVMEYVP E L + + R P +
Sbjct: 55 LQSIRHPFLVNLYGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVAR 104
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y Q+ L Y+H++ V +RDLKP+NLL+D + +KI DFG AK++ + +C
Sbjct: 105 FYAAQVVLALEYLHSLDIV-YRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLC 159
Query: 119 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ Y APE+I Y ++D W+ G ++ E+L G P F +N Q+ E K+L
Sbjct: 160 GTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--- 212
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 236
RFP P+A DL LLQ + R L+
Sbjct: 213 -----------GKVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVN 249
Query: 237 ----HPFF 240
HP+F
Sbjct: 250 DIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-21
Identities = 74/250 (29%), Positives = 114/250 (45%), Gaps = 54/250 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + H N++ S + LN+ +EYVP S+ +L +Y + + + V+
Sbjct: 60 LKELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRN 110
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----- 114
+ QI +GL Y+H + HRD+K N+LVD +KI DFG +K+L EAN
Sbjct: 111 FVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISKKL---EANSLSTKT 165
Query: 115 -----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
S S F+ APE++ T YT DIWS GC++ E+L G+ FP QL I
Sbjct: 166 NGARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAI 221
Query: 170 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229
K+ + P+I ++ + EAID + + + R
Sbjct: 222 FKIGENAS----------------PEIPSN---------ISSEAIDFLEKTFEIDHNKRP 256
Query: 230 TALEACAHPF 239
TA E HPF
Sbjct: 257 TAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 27 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 86
L L MEYVP +R L + + + + Y ++F + +H + HRDLKP+N
Sbjct: 76 LYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALHELG-YIHRDLKPEN 131
Query: 87 LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 146
L+D H +K+ DFG +K ++ AN S + S Y APE++ G Y ++D WS GC+
Sbjct: 132 FLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCM 187
Query: 147 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 206
L E L G P F G + + T R P Y D RF
Sbjct: 188 LYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF------------- 227
Query: 207 KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 243
+ EA DL ++L+ + + HPFF E+
Sbjct: 228 -NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 5e-21
Identities = 69/249 (27%), Positives = 105/249 (42%), Gaps = 52/249 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
MR +DHPNV+ L T + L++ VMEY+ L Y N+ ++ L +
Sbjct: 55 MRKLDHPNVVKLLGV---CTEEEPLYI--VMEYME---GGDLLSYLRKNRPKLSLSDLLS 106
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ QI RG+ Y+ + + HRDL +N LV VKI DFG ++ L +
Sbjct: 107 FALQIARGMEYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYRKRGGK 164
Query: 120 RFYR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 176
R APE + ++T+ D+WS G +L E+ LG+ +PG + ++++E +K
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK----- 217
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+R PQ PPE DL + P R T
Sbjct: 218 ------------NGYRLPQP----------PNCPPELYDLMLQCWAEDPEDRPT------ 249
Query: 237 HPFFDELRE 245
F EL E
Sbjct: 250 ---FSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 8e-21
Identities = 64/246 (26%), Positives = 93/246 (37%), Gaps = 63/246 (25%)
Query: 26 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84
L LVMEY+P + +L P + Y ++ L +H + + HRD+KP
Sbjct: 75 HLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLGFI-HRDIKP 129
Query: 85 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----------------------- 121
N+L+D H +K+ DFG K++ + Y+
Sbjct: 130 DNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188
Query: 122 -------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
Y APE++ G T Y D WS G +L E+L G P F + +
Sbjct: 189 STVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE---------- 237
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
T +I +N RFP + PEAIDL RLL + E
Sbjct: 238 --TYNKI--INWK-ESLRFPP----------DPPVSPEAIDLICRLLCDPEDRLGSFEEI 282
Query: 235 CAHPFF 240
+HPFF
Sbjct: 283 KSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 16/179 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+R + HPN++ +++ L +VMEY + ++++ + + ++
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR 109
Query: 60 YTYQIFRGLAYIHTV----PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI- 114
Q+ L H V HRDLKP N+ +D + VK+ DFG AK L G +
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSF 166
Query: 115 --SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
+Y+ + +Y +PE + + Y DIWS GC++ EL P F N QL IK
Sbjct: 167 AKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 79/275 (28%), Positives = 118/275 (42%), Gaps = 53/275 (19%)
Query: 12 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 71
L H F + +K LF VMEY+ L + ++ R + Y +I GL ++
Sbjct: 58 LTHLFCTFQTKEHLFF--VMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 72 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 130
H + +RDLK N+L+D H +KI DFG K+ + GE S C + Y APE++ G
Sbjct: 113 HK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 131 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 190
+Y S+D WS G +L E+L+GQ F GE+ D+L + I +
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI-------LNDR--------- 212
Query: 191 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACAHPFFDELREPNAR 249
P F + + EA D S+L + P+ R + HPFF R +
Sbjct: 213 ---------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWE 257
Query: 250 LPNGRPLPPLF-----------NFKQELSGASPEL 273
R +PP F NF +E + L
Sbjct: 258 RLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 70/246 (28%), Positives = 106/246 (43%), Gaps = 50/246 (20%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
HP + L H F T K+ LF VMEYV + M+ + + + R + Y +
Sbjct: 55 HPFLTQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAE 104
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 122
I GL ++H + +RDLK N+L+D H +KI DFG K+ I G S C + Y
Sbjct: 105 IVLGLQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDY 162
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APE++ Y ++D W+ G +L E+L GQ F G++ D+L + I
Sbjct: 163 IAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL----------- 209
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----H 237
+ R+P + + EA + L +P R L H
Sbjct: 210 -----EDEVRYP------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252
Query: 238 PFFDEL 243
PFF E+
Sbjct: 253 PFFREI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-20
Identities = 53/192 (27%), Positives = 83/192 (43%), Gaps = 14/192 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R PN+ + L ++MEY R L ++ Y+ +
Sbjct: 56 LRQSQPPNITKYYGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVI 106
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICS 119
++ L YIH V V HRD+K N+LV T VK+CDFG A L + +++ +
Sbjct: 107 IREVLVALKYIHKVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGT 164
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
++ APE+I Y T DIWS G + E+ G P + +A ++ I K P R
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRL 222
Query: 180 EIRCMNPNYTDF 191
E + +F
Sbjct: 223 EDNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-20
Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 44/245 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + H ++ C +++ L++ MEY+P S+ LK Y + + + +
Sbjct: 58 LKNLQHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRK 108
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANIS 115
YT QI G+ Y+H+ + HRD+K N+L D VK+ DFG++K+L +G S
Sbjct: 109 YTRQILEGVEYLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
+ ++ +PE+I G Y D+WS GC + E+L +P + + + I K+
Sbjct: 167 VTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQ 222
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
PT PQ+ +H + P+A + R + R +A E
Sbjct: 223 PTN---------------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELL 258
Query: 236 AHPFF 240
H F
Sbjct: 259 RHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 49/247 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP---LIY 56
M+ HPN++ + +EL++ VMEY+ S+ ++ RM + Y
Sbjct: 69 MKDCKHPNIVDYYDSYLV---GDELWV--VMEYMDGGSLTDIITQNFV---RMNEPQIAY 120
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN- 113
V ++ +GL Y+H+ + HRD+K N+L L+ VK+ DFG A QL ++
Sbjct: 121 VCR---EVLQGLEYLHSQNVI-HRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 114 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
S + + ++ APE+I +Y +DIWS G + E+ G+P + E + L I
Sbjct: 174 NSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-K 231
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
G P + W F D ++ L P R +A E
Sbjct: 232 GIPPLKN-----------------PEKWSPEF--------KDFLNKCLVKDPEKRPSAEE 266
Query: 234 ACAHPFF 240
HPF
Sbjct: 267 LLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 39/242 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKL 59
++ D P ++ +F +L++ VMEY S+ ++K N+ + +
Sbjct: 52 LKQCDSPYIVKYYGSYFK---NTDLWI--VMEYCGAGSVSDIMK---ITNKTLTEEEIAA 103
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYIC 118
YQ +GL Y+H+ + HRD+K N+L++ Q K+ DFG + QL A + I
Sbjct: 104 ILYQTLKGLEYLHSN-KKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIG 161
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ F+ APE+I Y DIWS G E+ G+P + + + + I
Sbjct: 162 TPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN------- 213
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
P P + P ++ PE D + L P R +A++ HP
Sbjct: 214 ------KP-------PPTLSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254
Query: 239 FF 240
F
Sbjct: 255 FI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 34/245 (13%)
Query: 14 HCFFSTTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 69
C ++ T LF + ME + S+ + K +P + I + L
Sbjct: 58 DCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 70 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 129
Y+H+ V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 130 GATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 186
Y D+WS G + EL G+ FP ++ ++ +V+ P+
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS--------- 225
Query: 187 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 246
PQ+ A ++ PE D ++ L+ + R E HPFF+
Sbjct: 226 -------PQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270
Query: 247 NARLP 251
N +
Sbjct: 271 NTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 59/275 (21%)
Query: 14 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 71
+C F T K LF VME++ + M+ + R L Y +I GL ++
Sbjct: 62 YCTFQT--KEHLFF--VMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQFL 112
Query: 72 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 130
H+ + +RDLK N+++D H +KI DFG K+ + G+ S C + Y APE++ G
Sbjct: 113 HS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 131 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 190
+YT S+D WS G +L E+L+GQ F G++ D+L E I+V TP
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP-------------- 213
Query: 191 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPNAR 249
+P+ W + E+ D+ +L + P+ R + HPFF + N
Sbjct: 214 -HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NWT 257
Query: 250 LPNGRPLPPLF-----------NFKQELSGASPEL 273
R L P F NF +E P L
Sbjct: 258 ALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 38/225 (16%)
Query: 31 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 90
MEY+ L A + +P ++ TY + +GL ++ + HRD+KP N+LV+
Sbjct: 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137
Query: 91 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI-----FGATEYTTSIDIWSAGC 145
QVK+CDFG + L+A A + C Y APE I YT D+WS G
Sbjct: 138 G-NGQVKLCDFGVSGNLVASLAKTNIGCQS-YMAPERIKSGGPNQNPTYTVQSDVWSLGL 195
Query: 146 VLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 202
+ E+ LG+ +P E N QL I+ G P + Y+
Sbjct: 196 SILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGYS------------- 235
Query: 203 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 247
+A D ++ L P+ R T + HP+ + + +
Sbjct: 236 --------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 23 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81
NE + + ME++ S+ R+ K +P+ + + GL Y++ V R+ HRD
Sbjct: 74 NENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129
Query: 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIW 141
+KP N+LV+ Q+K+CDFG + +LI A+ +++ + Y +PE I G +YT D+W
Sbjct: 130 IKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYTVKSDVW 186
Query: 142 SAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP 200
S G + EL LG+ P D + + +L QI P
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQQIVQEP 229
Query: 201 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-HPFFDELREPNARL 250
++ P + D L P+ R T + CA PF LR N L
Sbjct: 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 78/283 (27%), Positives = 119/283 (42%), Gaps = 58/283 (20%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTY 62
+HP L H + + +K LF VMEY+ + M+ + + + L Y
Sbjct: 54 EHP---FLTHLYCTFQTKENLFF--VMEYLNGGDLMFHI-----QSCHKFDLPRATFYAA 103
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRF 121
+I GL ++H+ + +RDLK N+L+D H +KI DFG K+ + G+A C +
Sbjct: 104 EIICGLQFLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPD 161
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
Y APE++ G +Y TS+D WS G +L E+L+GQ F G + + + I
Sbjct: 162 YIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSI 208
Query: 182 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFF 240
R NP Y + + EA D+ +L P R + HPFF
Sbjct: 209 RMDNPCYPRW-----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFF 251
Query: 241 DELREPNARLPNGRPLPPL----------FNFKQELSGASPEL 273
E+ + L PP NF +E P L
Sbjct: 252 REIDW--SALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-18
Identities = 53/168 (31%), Positives = 77/168 (45%), Gaps = 12/168 (7%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQI 64
HPN+IS K F L +VMEY P + + + + +P + Q+
Sbjct: 58 HPNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112
Query: 65 FRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 123
RGL +H ++ HRDLK N LLV VKI D G +K L A + I + Y
Sbjct: 113 LRGLQALHEQ-KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYM 168
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
APE ++ Y+ DIWS GC+L E+ P F + D ++ +
Sbjct: 169 APE-VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 37/236 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP----ESMY-RVLKHYSSANQRMPLI 55
+ P ++ F +S + + + MEY +S+Y +V K ++ L
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLG 108
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 115
+ + +GL+Y+H+ ++ HRD+KP N+L+ QVK+CDFG + +L+ A +
Sbjct: 109 KI---AESVLKGLSYLHS-RKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAG-T 162
Query: 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIK 171
+ + FY APE I G Y+ + D+WS G L E+ + FP E +L+ I
Sbjct: 163 FTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221
Query: 172 VLGTPT-----------REEIR-----CMNPNYTDFRFP-QIKAHPWHKVFHKRMP 210
+ P EE + C+ + T P + HPW K K+
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 34/193 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
+R +DH N++ K ++ L L+MEY+P L+ Y ++ ++ L + L
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRS---LRLIMEYLP---SGSLRDYLQRHRDQINLKRLLL 113
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
++ QI +G+ Y+ + R HRDL +N+LV+ VKI DFG AK L + Y
Sbjct: 114 FSSQICKGMDYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDK---DYYYV 168
Query: 120 R-------FYRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FP 158
+ F+ APE + + + S D+WS G L EL + L
Sbjct: 169 KEPGESPIFWYAPECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ 227
Query: 159 GENAVDQLVEIIK 171
G+ V +L+E++K
Sbjct: 228 GQMIVTRLLELLK 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 10/164 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ +DHPNVI F NEL N+V+E + R++KH+ + +P +
Sbjct: 56 LKQLDHPNVIKYLASFIE---NNEL--NIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYIC 118
Y Q+ L ++H+ R+ HRD+KP N+ + T VK+ D G + + A S +
Sbjct: 111 YFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162
+ +Y +PE I Y DIWS GC+L E+ Q F G+
Sbjct: 169 TPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-17
Identities = 72/259 (27%), Positives = 109/259 (42%), Gaps = 58/259 (22%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 63
++P V+S+ C F T L +VMEYV +LK+ + +P+ ++Y +
Sbjct: 59 ENPFVVSM-FCSFETKR----HLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAE 109
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYI 117
L Y+H V HRDLKP NLL+ + H +K+ DFG +K + E +I
Sbjct: 110 TVLALEYLHNYGIV-HRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 118 CSRF----------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 167
F Y APE+I Y +D W+ G +L E L+G F G+ +
Sbjct: 168 TREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226
Query: 168 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227
++I ++I P + +P +A DL SRLL+ +P
Sbjct: 227 QVIS-------DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLE 260
Query: 228 RC---TALEACAHPFFDEL 243
R A E H FF L
Sbjct: 261 RLGTGGAFEVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-17
Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++++ HPN+I F + L +VMEY P ++ ++ N + +
Sbjct: 53 LKLLSHPNIIEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILH 105
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ QI L ++HT + HRDLK QN+L+D VKI DFG +K L + + + +
Sbjct: 106 FFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGT 164
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161
Y +PEL G Y DIW+ GCVL EL + F N
Sbjct: 165 PCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-17
Identities = 69/250 (27%), Positives = 107/250 (42%), Gaps = 44/250 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN I K C+ + LVMEY S +L+ + Q + + +
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAW-----LVMEYCLGSASDILEVHKKPLQEVEIAAI--- 120
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ +GLAY+H+ R+ HRD+K N LL +P VK+ DFGSA + AN S++ +
Sbjct: 121 CHGALQGLAYLHSHERI-HRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SFVGT 174
Query: 120 RFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
++ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------ 228
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
N + P + ++ W F +D LQ P R ++ E H
Sbjct: 229 -------NDS------PTLSSNDWSDYFRN-----FVDSC---LQKIPQDRPSSEELLKH 267
Query: 238 PFFDELREPN 247
F R P
Sbjct: 268 RFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-17
Identities = 69/248 (27%), Positives = 111/248 (44%), Gaps = 41/248 (16%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 61
V P +++L H F T +K L+L+++YV + + H + V++Y
Sbjct: 60 AVRRCPFLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYI 111
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSR 120
+I L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E +Y C
Sbjct: 112 AEIVLALDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 121 F-YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
Y APE+I G + + ++D WS G + ELL G F + + EI +
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR------- 222
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEAC 235
R + K+ P F K M EA D +LL+ P R A E
Sbjct: 223 ---RIL------------KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264
Query: 236 AHPFFDEL 243
HPFF +
Sbjct: 265 NHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 17/173 (9%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 63
+ P ++ F+S +++ ME++ S+ +VLK +R+P + +
Sbjct: 61 NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIA 111
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 123
+ RGLAY+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYM 169
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+PE + G T Y+ DIWS G L EL +G+ P +A E+ + G P
Sbjct: 170 SPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (192), Expect = 1e-16
Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKL 59
M+ + HPN++ L T L++ V EY+P L + +++ L +
Sbjct: 55 MKKLSHPNIVRLLGVC---TQGEPLYI--VTEYMP---GGDLLDFLRKHGEKLTLKDLLQ 106
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
QI +G+ Y+ + V HRDL +N LV VKI DFG ++ + +
Sbjct: 107 MALQIAKGMEYLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGG 164
Query: 120 RF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ + APE + ++T+ D+WS G +L E+ LG+ +PG
Sbjct: 165 KLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 50/163 (30%), Positives = 87/163 (53%), Gaps = 17/163 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + HP +I L T ++ FL ++MEYVP ++ L++ + L
Sbjct: 55 LKEVSHPFIIRLF-----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----F 105
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y +I L Y+H+ + +RDLKP+N+L+D H +K+ DFG AK+L +C
Sbjct: 106 YASEIVCALEYLHSK-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCG 160
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161
+ Y APE+I + + ++D W+ G ++ E+L+G P F +N
Sbjct: 161 TPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 70/259 (27%), Positives = 107/259 (41%), Gaps = 43/259 (16%)
Query: 7 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIF 65
++SL + F + L LVM + + H + + P Y QI
Sbjct: 53 RFIVSLAYAFETKDD-----LCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQII 105
Query: 66 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 125
GL ++H R+ +RDLKP+N+L+D + V+I D G A +L G+ + Y AP
Sbjct: 106 CGLEHLHQR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAP 163
Query: 126 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 185
E++ G Y S+D ++ GC L E++ G+ F Q E ++ +EE++
Sbjct: 164 EVLQGE-VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR- 209
Query: 186 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 240
+ + PEA DL LLQ P R +A E HP F
Sbjct: 210 ----------TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
Query: 241 DELREPNARLPNGRPLPPL 259
+L RL G PP
Sbjct: 258 KDLNWR--RLEAGMLEPPF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 50/243 (20%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
HP + +LK+ F + L VMEY E + + + + R + Y +
Sbjct: 54 HPFLTALKYSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE 103
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 122
I L Y+H+ V +RDLK +NL++D H +KI DFG K+ I+ A + C + Y
Sbjct: 104 IVSALGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APE + +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR 213
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAH 237
F + + PEA L + LL+ P R A E H
Sbjct: 214 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251
Query: 238 PFF 240
FF
Sbjct: 252 RFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-16
Identities = 81/270 (30%), Positives = 117/270 (43%), Gaps = 49/270 (18%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
++ P ++ LK FS S +L+L L E L H+ R L + YT +
Sbjct: 50 VNCPFIVPLK---FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAE 101
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 122
+ L +H V +RDLKP+N+L+D H + +CDFG K + + + C + Y
Sbjct: 102 LLCALENLHKF-NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APEL+ G YT ++D W+ G +L E+L G P F EN V+++ K+L P
Sbjct: 160 LAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEP------ 209
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPF 239
RFP +A DL LL P+ R A E HPF
Sbjct: 210 --------LRFPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249
Query: 240 FDELREPNARLPNGRPLPPLFNFKQELSGA 269
F +L +L PP FK +S A
Sbjct: 250 FSQLSW--KKLLMKGIQPP---FKPAVSSA 274
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN I K C+ + LVMEY S +L+ + Q + + +
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAW-----LVMEYCLGSASDLLEVHKKPLQEVEIAAI--- 126
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
T+ +GLAY+H+ + HRD+K N LL +P QVK+ DFGSA + AN S++ +
Sbjct: 127 THGALQGLAYLHSHNMI-HRDIKAGNILLTEP--GQVKLADFGSAS--KSSPAN-SFVGT 180
Query: 120 RFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
++ APE+I E Y +D+WS G EL +P NA+ L I
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-16
Identities = 80/289 (27%), Positives = 121/289 (41%), Gaps = 66/289 (22%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
HP + +L HC F T K+ LF VMEYV + M+++ + R + Y +
Sbjct: 55 HPFLTAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAE 104
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 122
+ L ++H V +RDLK N+L+D H K+ DFG K+ I + C + Y
Sbjct: 105 VTLALMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDY 162
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APE I EY S+D W+ G ++ E++ GQP F +N D L E I
Sbjct: 163 IAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL----------- 209
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----- 235
+ D +P W + EA+ + + +P+ R C A +
Sbjct: 210 -----HDDVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252
Query: 236 AHPFFDELREPNARLPNGRPLPPLF-----------NFKQELSGASPEL 273
HPFF +E + L R + P F NF Q+ + P L
Sbjct: 253 QHPFF---KEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVL 298
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-16
Identities = 55/166 (33%), Positives = 78/166 (46%), Gaps = 32/166 (19%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--------ESMYRVLKHYSSANQRMPLIYV 57
H N++ + + S+N F + ME VP S + LK +
Sbjct: 64 HRNIVQ----YLGSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQT--------I 110
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
YT QI GL Y+H ++ HRD+K N+LV+ + VKI DFG++K+L A I+
Sbjct: 111 IFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPC 165
Query: 118 CSRF-----YRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLF 157
F Y APE+I G Y DIWS GC + E+ G+P F
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-16
Identities = 50/186 (26%), Positives = 77/186 (41%), Gaps = 31/186 (16%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
VK + +I L Y+H+ + HRD+KP N+L+D H V I DF A ++ S
Sbjct: 102 VKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTST 159
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ Y APE++ Y+ ++D WS G E L G+ + G +
Sbjct: 160 SGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RT 205
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA 234
R++IR Q A + EAID ++LL+ P R +
Sbjct: 206 IRDQIRAK----------QETADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDL 252
Query: 235 CAHPFF 240
HP+F
Sbjct: 253 KNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-16
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 41/248 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVK 58
M +HPNV+ + F +EL+L VM Y+ S+ ++K Y +I
Sbjct: 53 MSQCNHPNVVKY-YTSF--VVGDELWL--VMPYLSGGSLLDIMKSSYPRGGLDEAIIATV 107
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAG-----EA 112
L ++ +GL Y+H+ ++ HRD+K N+L+ VKI DFG + L G +
Sbjct: 108 LK--EVLKGLEYLHSNGQI-HRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKV 162
Query: 113 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
+++ + + APE++ Y DIWS G EL G + + L+ ++
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ- 221
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
N P ++ +K + K + S LQ PS R TA
Sbjct: 222 ------------ND------PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAE 259
Query: 233 EACAHPFF 240
E H FF
Sbjct: 260 ELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-15
Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + H N++ + T ++ +++ ME+VP S+ +L + +P
Sbjct: 56 LKSLKHVNIVQ-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCK 106
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI-- 117
YT QI G+AY+H V HRD+K N+++ P +K+ DFG A++L + ++
Sbjct: 107 YTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 118 -----CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155
+ ++ APE+I + Y DIWS GC + E+ G+P
Sbjct: 165 LKSMHGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 45/255 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
MR HPN++ + + S +EL++ VME++ ++ ++ H RM +
Sbjct: 70 MRDYQHPNIVEM---YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIAT 119
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAG-EANISY 116
+ + L+++H V HRD+K ++L LT +VK+ DFG Q+ S
Sbjct: 120 VCLAVLKALSFLHA-QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSL 175
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ + ++ APE+I Y T +DIWS G ++ E++ G+P + E + +
Sbjct: 176 VGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---------- 224
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+ IR P P++K HKV P R+L P+ R TA E
Sbjct: 225 --KRIRDNLP-------PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLN 268
Query: 237 HPFFDELREPNARLP 251
HPF + P++ +P
Sbjct: 269 HPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 18/181 (9%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQI 64
H ++ C + L++ ME++P S+ LK Y + + + + YT QI
Sbjct: 63 HERIVQYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQI 115
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSR 120
G++Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S +
Sbjct: 116 LEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
++ +PE+I G Y DIWS GC + E+L +P + + + I K+ PT
Sbjct: 174 YWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPV 229
Query: 181 I 181
+
Sbjct: 230 L 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 59/286 (20%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
HP +++L CF T + F VMEY + M + S + Y
Sbjct: 59 ERHPFLVNLFACF--QTEDHVCF---VMEYAAGGDLMMHIHTDVFSEPR------AVFYA 107
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 120
+ GL Y+H ++ +RDLK NLL+D VKI DFG K+ + S C +
Sbjct: 108 ACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTP 165
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+ APE++ T YT ++D W G ++ E+L+G+ FPG++ + I+ +E
Sbjct: 166 EFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DE 217
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---- 236
+R +P + EAI + RLL+ +P R + E A
Sbjct: 218 VR----------------YPRF------LSREAISIMRRLLRRNPERRLGSGEKDAEDVK 255
Query: 237 -HPFF-----DEL---REPNARLPNGRPLPPLFNFKQELSGASPEL 273
PFF D+L + +P + + NF +E + +P L
Sbjct: 256 KQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVL 301
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 2e-15
Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 42/181 (23%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY---------SSANQR 51
M+ + HPNV+ L T + L+ LV+EY+ L Y S
Sbjct: 50 MKKLGHPNVVRLLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKST 101
Query: 52 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 111
+ L + + QI +G+ Y+ + + HRDL +N LV VKI DFG ++ + +
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD 159
Query: 112 ANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFP 158
+YR APE + +T+ D+WS G +L E+ LG +P
Sbjct: 160 ---------YYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYP 209
Query: 159 G 159
G
Sbjct: 210 G 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 14/171 (8%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 62
+D +I F LN+VMEY ++++LK + +P V +
Sbjct: 56 LDSSYIIRYYESFLDKGK-----LNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFI 108
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSR 120
QI GLA++H+ ++ HRD+K NL +D VKI D G AK L AN + + +
Sbjct: 109 QILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNFAN-TIVGTP 165
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
+Y +PEL Y D+W+ G VL E G+ F N +++II+
Sbjct: 166 YYLSPELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-15
Identities = 67/241 (27%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 62
+ HPN+I+ + F + L + MEY ++Y + Q V Y +
Sbjct: 56 LQHPNIIAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLF 108
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC-- 118
QI ++YIH + HRD+K N+ LT +K+ DFG +K L E +++
Sbjct: 109 QIVSAVSYIHKA-GILHRDIKTLNIF---LTKAGLIKLGDFGISKIL-GSEYSMAETVVG 163
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ +Y +PEL G +Y DIW+ GCVL ELL + F N ++ +V+I
Sbjct: 164 TPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------- 213
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ NYT E I L LLQ P R TA E P
Sbjct: 214 -----VQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQP 254
Query: 239 F 239
Sbjct: 255 L 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-15
Identities = 82/278 (29%), Positives = 119/278 (42%), Gaps = 54/278 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN I K C+ E LVMEY S +L+ + Q + + +
Sbjct: 79 LQRIKHPNSIEYKGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI--- 130
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
T+ +GLAY+H+ + HRD+K N LL +P QVK+ DFGSA IA AN S++ +
Sbjct: 131 THGALQGLAYLHS-HNMIHRDIKAGNILLTEP--GQVKLADFGSAS--IASPAN-SFVGT 184
Query: 120 RFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
++ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------ 238
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
N + P ++++ W F + LQ P R T+ E H
Sbjct: 239 -------NES------PTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKH 277
Query: 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVN 275
F LRE RP L + Q A EL N
Sbjct: 278 MFV--LRE--------RPETVLIDLIQRTKDAVRELDN 305
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-15
Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + H ++ C + E L + MEY+P S+ LK Y + + + +
Sbjct: 58 LKNLQHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRK 110
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANIS 115
YT QI G++Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S
Sbjct: 111 YTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
+ ++ +PE+I G Y D+WS GC + E+L +P + A + I K+
Sbjct: 169 VTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQ 224
Query: 176 PTREEI 181
PT ++
Sbjct: 225 PTNPQL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-15
Identities = 39/99 (39%), Positives = 61/99 (61%), Gaps = 3/99 (3%)
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 123
+ +GL Y+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYM 169
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162
+PE + G T Y+ DIWS G L E+ +G+ P +A
Sbjct: 170 SPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-15
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 7/152 (4%)
Query: 31 MEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 89
ME + S+ + K+ Y +P + + L Y+ ++ HRD+KP N+L+
Sbjct: 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL 141
Query: 90 DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVL 147
D +K+CDFG + QL+ A R Y APE I Y D+WS G L
Sbjct: 142 D-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITL 200
Query: 148 AELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 178
E+ G+ +P N+V DQL +++K G P
Sbjct: 201 YEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLY 60
+ HPN++ ++ T +N+ L +VM+ + + +H++S QR +
Sbjct: 66 LRHPNIVR----YYKTFLENDR-LYIVMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNI 118
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
Q+ L Y+H R+ HRDL P N+++ +V I DFG AKQ S + +
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y PE++ Y D+W+ GC+L ++ QP F N + +I++ + P E
Sbjct: 178 LYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236
Query: 181 I----------RCMNPN 187
+ C+ P+
Sbjct: 237 MYSEDVTDVITSCLTPD 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 58/288 (20%)
Query: 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL---KHYSSANQRMPLIYVK 58
V P +++L H F T +K L+L+++YV M+ L ++S V+
Sbjct: 61 VRQSPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE-------VR 108
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-I 117
Y+ +I L ++H + + +RD+K +N+L+D H V + DFG +K+ ++ E +Y
Sbjct: 109 FYSGEIILALEHLHKLG-IVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSF 166
Query: 118 CSRF-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
C Y APE+I G + ++D WS G ++ ELL G F E + E+
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV------- 219
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+R ++C P F + PEA DL +LL+ P R A A
Sbjct: 220 SRRILKCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGA 261
Query: 237 -----HPFFDEL-------REPNARL-PNGRPLPPLFNFKQELSGASP 271
HPFF L R+ N P+ R + NF +E + P
Sbjct: 262 SEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 39/231 (16%)
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLL-------VDPLTHQ--------VKICDFGSAKQ 106
+Q L Y HT + H DLKP+N+L VDP+T++ V+ICD G
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297
Query: 107 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 166
+ + + +R YR+PE++ G + S D+WS GC++ EL G+ L+ + ++ L
Sbjct: 298 --ERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354
Query: 167 VEIIKVLGT-PTREEIRCMNPN----YTDFRFPQIKAHPWH--KVFHKRMPPEAI----- 214
+ K LG P+ RC Y + P H ++ R E I
Sbjct: 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414
Query: 215 -DLASRLLQYSPSLRCTALEACAHP----FFDELRE-PNARLPNGRP-LPP 258
DL LL Y R A + HP ++ E R+ PN P+ R L P
Sbjct: 415 CDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463
|
Length = 467 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 56/172 (32%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN I + C+ E LVMEY S +L+ + Q + + V
Sbjct: 69 LQKLRHPNTIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV--- 120
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
T+ +GLAY+H+ + HRD+K N LL +P VK+ DFGSA I AN ++ +
Sbjct: 121 THGALQGLAYLHS-HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS--IMAPAN-XFVGT 174
Query: 120 RFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
++ APE+I E Y +D+WS G EL +P NA+ L I
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 76/288 (26%), Positives = 117/288 (40%), Gaps = 56/288 (19%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
HP ++ L H F T K L V++YV E + + + + P + Y +
Sbjct: 55 HPFLVGL-HYSFQTADK----LYFVLDYVNGGELFFHLQRE-----RSFPEPRARFYAAE 104
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 122
I L Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y
Sbjct: 105 IASALGYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEY 162
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APE++ Y ++D W G VL E+L G P F + ++ + +L P R
Sbjct: 163 LAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR---- 214
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHP 238
+ PN + A L LLQ + R A LE H
Sbjct: 215 -LKPNIS---------------------VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHV 252
Query: 239 FFDELREPNARLPNGRPLPPLFNFK----QELSGASPELVNKLIPDHV 282
FF + N + + P FN +L PE + +P+ V
Sbjct: 253 FFSSI---NWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSV 297
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 56/169 (33%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTY 62
P ++ H F T + L VMEYV + MY + + + P + Y
Sbjct: 58 GKPPFLTQLHSCFQTMDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--HAVFYAA 108
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRF 121
+I GL ++H+ + +RDLK N+++D H +KI DFG K+ I G C +
Sbjct: 109 EIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPD 166
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
Y APE+I Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 167 YIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 72/251 (28%), Positives = 112/251 (44%), Gaps = 54/251 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIY 56
++ HPN++ F S +++L++ VMEY + +Y+V + S Q + Y
Sbjct: 54 LKECRHPNIV---AYFGSYLRRDKLWI--VMEYCGGGSLQDIYQVTRGPLSELQ---IAY 105
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN- 113
V + +GLAY+H ++ HRD+K N+L LT VK+ DFG + QL A A
Sbjct: 106 V---CRETLKGLAYLHETGKI-HRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKR 158
Query: 114 ISYICSRFYRAPELIFGATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
S+I + ++ APE+ A E Y DIW+ G EL QP P + +
Sbjct: 159 KSFIGTPYWMAPEVA--AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-----LHP 209
Query: 170 IKVLGTPTREEIRCMNPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228
++ L ++ +F P++K W VFH D + L P R
Sbjct: 210 MRALFLISKS----------NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKR 251
Query: 229 CTALEACAHPF 239
TA + HPF
Sbjct: 252 PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 26/186 (13%)
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 123
+ +GL Y+ ++ ++ HRD+KP N+LV+ QVK+CDFG + QL+ A +Y+ + Y
Sbjct: 104 VVKGLTYLWSL-KILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYM 160
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R 182
APE I G +Y D+WS G EL LG+ +P +I K G+ ++ +
Sbjct: 161 APERISG-EQYGIHSDVWSLGISFMELALGRFPYP---------QIQKNQGSLMPLQLLQ 210
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242
C+ D P + + + F + ++ ++ P R HPF +
Sbjct: 211 CI----VDEDPPVLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQ 258
Query: 243 LREPNA 248
+ NA
Sbjct: 259 YNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-14
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
Y +I GL +H R+ +RDLKP+N+L+D H ++I D G A ++ GE
Sbjct: 104 AVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGR 161
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ + Y APE++ YT S D W GC++ E++ G+ F E +K
Sbjct: 162 VGTVGYMAPEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK----- 209
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--C---TA 231
REE+ ++K + + ++ A + +LL P R C A
Sbjct: 210 -REEVE-----------RRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGA 255
Query: 232 LEACAHPFFDELREPNARLPNGRPLPP 258
E AHPFF RL G PP
Sbjct: 256 EEVKAHPFFRTANF--KRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-14
Identities = 50/186 (26%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + H ++ C K L++ +EY+P S+ LK Y + + + +
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRR 110
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANIS 115
YT QI +G++Y+H+ + HRD+K N+L D VK+ DFG++K++ ++G S
Sbjct: 111 YTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
+ ++ +PE+I G Y D+WS C + E+L +P + A + I K+
Sbjct: 169 VTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQ 224
Query: 176 PTREEI 181
PT+ +
Sbjct: 225 PTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 52/165 (31%), Positives = 84/165 (50%), Gaps = 23/165 (13%)
Query: 5 DHPNVISLKHCFF---STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 60
+HPN+ + F + ++L+L VME S+ ++K +R+ ++
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWL--VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISY 116
+ RGLAY+H +V HRD+K QN+L LT +VK+ DFG + QL + G N ++
Sbjct: 119 LRETLRGLAYLHE-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRN-TF 173
Query: 117 ICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAELLLGQP 155
I + ++ APE+I A + Y D+WS G EL G+P
Sbjct: 174 IGTPYWMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 74/304 (24%), Positives = 108/304 (35%), Gaps = 96/304 (31%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK--LYT 61
D+P V+ L + F ++E +L L+MEY+P M +L + + Y+ +
Sbjct: 59 DNPWVVKLYYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILA 113
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-------------- 107
L YIH RD+KP NLL+D H +K+ DFG L
Sbjct: 114 IDSIHKLGYIH-------RDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 108 IAGEANISYICSRF-------------------------YRAPELIFGATEYTTSIDIWS 142
+ +I Y APE +F T Y D WS
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWS 224
Query: 143 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 202
G ++ E+L+G P F +N + +I +N T +FP
Sbjct: 225 LGVIMYEMLVGYPPFCSDNPQETYRKI--------------INWKET-LQFPD------- 262
Query: 203 KVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFF-----DELREPNARLPNGR 254
+ PEA DL RL R E +HPFF + +RE A
Sbjct: 263 ---EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------ 312
Query: 255 PLPP 258
P+ P
Sbjct: 313 PIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 60/259 (23%), Positives = 116/259 (44%), Gaps = 28/259 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ ++HP+VI +K S +V+ + +Y L + ++ +P+ +
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITC-----MVLPHYSSDLYTYL---TKRSRPLPIDQALII 162
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
QI GL Y+H R+ HRD+K +N+ ++ + QV I D G+A+ + A + +
Sbjct: 163 EKQILEGLRYLHAQ-RIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTV 220
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLL----------GQPLFPGENAVDQLVEII 170
APE + +Y + DIWSAG VL E+L P ++ L++II
Sbjct: 221 ETNAPE-VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 171 KVLGT-----PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYS 224
L P R + + ++ + + + + F + +P + L ++L +
Sbjct: 280 STLKVHPEEFPRDPGSR-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD 338
Query: 225 PSLRCTALEACAHPFFDEL 243
++R +A E +P F +L
Sbjct: 339 AAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 53/161 (32%), Positives = 81/161 (50%), Gaps = 26/161 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
++ + H N++ K +S +N L LVMEY+P Y L+ Y ++ R+ + L
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLL 112
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----------A 109
Y QI +G+ Y+ R HRDL +N+LV+ VKI DFG K L
Sbjct: 113 YASQICKGMEYL-GSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREP 170
Query: 110 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150
GE+ I F+ APE + ++++ + D+WS G VL EL
Sbjct: 171 GESPI------FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 69/243 (28%), Positives = 106/243 (43%), Gaps = 49/243 (20%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
HP + +LK+ F + L VMEY E + + + + R + Y +
Sbjct: 54 HPFLTALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE 103
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 122
I L Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y
Sbjct: 104 IVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEY 162
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APE + +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 163 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR 214
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAH 237
F + + PEA L S LL+ P R A E H
Sbjct: 215 ----------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252
Query: 238 PFF 240
FF
Sbjct: 253 KFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 35/193 (18%)
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANI 114
++ Q+ L ++H+ +V HRDLK N+L+ L VK+ DFG SAK +
Sbjct: 104 QIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRD 161
Query: 115 SYICSRFYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
++I + ++ APE++ F Y DIWS G L EL +P P + ++ + ++
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLL 218
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229
K+L + P + W F+ D L P R
Sbjct: 219 KILKSEP----------------PTLDQPSKWSSSFN--------DFLKSCLVKDPDDRP 254
Query: 230 TALEACAHPFFDE 242
TA E HPF +
Sbjct: 255 TAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 60/241 (24%), Positives = 92/241 (38%), Gaps = 48/241 (19%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 62
P + F + L ++MEY S +LK ++ Y+
Sbjct: 56 CRSPYITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILR 105
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YIC 118
++ GL Y+H HRD+K N+L+ VK+ DFG + QL + +S ++
Sbjct: 106 EVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL---TSTMSKRNTFVG 160
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ F+ APE+I + Y DIWS G EL G+P + + L I K
Sbjct: 161 TPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------- 212
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
NP P ++ + + K F D S L P R +A E H
Sbjct: 213 -----NNP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHK 252
Query: 239 F 239
F
Sbjct: 253 F 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 55/176 (31%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLI--- 55
+ + D P ++ H F T + L VMEYV + MY + Q++
Sbjct: 54 LALQDKPPFLTQLHSCFQTVDR----LYFVMEYVNGGDLMYHI--------QQVGKFKEP 101
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANI 114
Y +I GL ++H + +RDLK N+++D H +KI DFG K+ ++ G
Sbjct: 102 QAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTR 159
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
++ + Y APE+I Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 160 TFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 66/268 (24%), Positives = 114/268 (42%), Gaps = 52/268 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
+ + + P + L++ F K+ L+L VMEY P + + + ++ ++ M +
Sbjct: 55 LSISNSPWIPQLQYAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQ 105
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-- 116
Y ++ + +H + V HRD+KP+N+L+D H +K+ DFGSA +L A + S
Sbjct: 106 FYLAELVLAIHSVHQMGYV-HRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLP 163
Query: 117 ICSRFYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
+ + Y APE++ G Y D WS G + E++ G+ F + I+
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM- 222
Query: 172 VLGTPTREEIRCMNPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
N+ F +FP+ ++ + +DL LL R
Sbjct: 223 ---------------NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLG 256
Query: 231 ALEACAHPFFDELREPNARLPNGRPLPP 258
C HPFF ++ N R LPP
Sbjct: 257 YEGLCCHPFFSKIDWNNIR----NSLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 50/243 (20%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
HP + +LK+ F T + L VMEY E + + + +R + Y +
Sbjct: 54 HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 103
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 122
I L Y+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y
Sbjct: 104 IVSALEYLHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APE + +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 213
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAH 237
F + + PEA L + LL+ P R A E H
Sbjct: 214 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251
Query: 238 PFF 240
FF
Sbjct: 252 RFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 47/254 (18%)
Query: 2 RVMDH----PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 57
+V++H P +++L H F T +K L+L+++Y+ + H S +R V
Sbjct: 56 QVLEHIRQSPFLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEV 107
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY- 116
++Y+ +I L ++H + + +RD+K +N+L+D H V + DFG +K+ E +Y
Sbjct: 108 QIYSGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYS 165
Query: 117 ICSRF-YRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
C Y AP+++ G + ++D WS G ++ ELL G F + + EI + +
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI- 224
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----- 229
+K+ P + + M A D+ RLL P R
Sbjct: 225 ---------------------LKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPS 260
Query: 230 TALEACAHPFFDEL 243
A E HPFF ++
Sbjct: 261 DADEIKKHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 24/176 (13%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
VK Y ++ L ++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E
Sbjct: 100 VKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYS 157
Query: 117 ICSRF-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LG 174
C Y APE++ +T S D WS G ++ E+L G F G++ + + I+K LG
Sbjct: 158 FCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG 216
Query: 175 TP------TREEIRCM---NPNYTDFRFPQ----IKAHP------WHKVFHKRMPP 211
P + +R + NP P IK HP W+K++ + + P
Sbjct: 217 MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 50/177 (28%), Positives = 91/177 (51%), Gaps = 24/177 (13%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTY 62
+HP ++ L CF T S+ L V+E+V + M+ + + +++P + + Y+
Sbjct: 54 NHPFLVGLHSCF-QTESR----LFFVIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSA 103
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRF 121
+I L ++H + +RDLK N+L+D H +K+ D+G K+ I S C +
Sbjct: 104 EISLALNFLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPN 161
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 170
Y APE++ G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 162 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-13
Identities = 58/171 (33%), Positives = 83/171 (48%), Gaps = 22/171 (12%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYS---SANQRMPLIYVK 58
M HPN+++ F S LF+ VMEY + M R+ + S +Q +
Sbjct: 56 MKHPNIVTF---FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQ------IL 104
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+ QI GL +IH ++ HRD+K QN+ + K+ DFG A+QL ++Y C
Sbjct: 105 SWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTC 162
Query: 119 --SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 167
+ +Y +PE I Y DIWS GCVL EL + F G N + QLV
Sbjct: 163 VGTPYYLSPE-ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 16/160 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ + HP ++ L H F TT K L V+++V E + + + S R +
Sbjct: 50 LKNVKHPFLVGL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERSFPEPR-----AR 99
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y +I L Y+H++ + +RDLKP+N+L+D H V + DFG K+ IA + C
Sbjct: 100 FYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFC 157
Query: 119 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157
+ Y APE+I Y ++D W G VL E+L G P F
Sbjct: 158 GTPEYLAPEVI-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 50/175 (28%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
+HP ++ L CF + E L V+EYV L + +++P + + Y+ +I
Sbjct: 54 NHPFLVGLHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEI 105
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYR 123
L Y+H + +RDLK N+L+D H +K+ D+G K+ L G+ ++ + Y
Sbjct: 106 SLALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYI 163
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 170
APE++ G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 164 APEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 56/189 (29%), Positives = 83/189 (43%), Gaps = 38/189 (20%)
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
Y +I L ++H + +RDLKP+N+L+D H VK+ DFG K+ I
Sbjct: 103 CFYLSEISLALEHLHQQG-IIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTF 160
Query: 118 CSRF-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
C Y APE I + + ++D WS G ++ ++L G P F EN + +I+K
Sbjct: 161 CGTIEYMAPE-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---- 215
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TA 231
+ P Y + PEA DL +LL+ +PS R A
Sbjct: 216 -----KLNLPPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDA 250
Query: 232 LEACAHPFF 240
E +HPFF
Sbjct: 251 AEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYR--VLKHYSSANQRMPLIYVK 58
++ + H N++ K C + + L L+MEYVP R + KH + Q +
Sbjct: 60 LKTLYHENIVKYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------ 110
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
L+ QI G+AY+H+ HRDL +N+L+D VKI DFG AK + G Y
Sbjct: 111 LFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--EYYRV 166
Query: 119 SR------FYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
F+ A E + S D+WS G L ELL
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 58/290 (20%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTY 62
+HP + L CF + + LF VME+V + M+ + K ++R + Y
Sbjct: 54 NHPFLTQLYCCFQTP---DRLFF--VMEFVNGGDLMFHIQK-----SRRFDEARARFYAA 103
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRF 121
+I L ++H + +RDLK N+L+D H K+ DFG K+ I S C +
Sbjct: 104 EITSALMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPD 161
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
Y APE I Y S+D W+ G +L E+L G F EN D L E I +E+
Sbjct: 162 YIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV 213
Query: 182 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA----C 235
V+ + +A+D+ + +P++R L
Sbjct: 214 ----------------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAIL 251
Query: 236 AHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 285
HPFF EL + N R + P F + + S E V+ PD +K
Sbjct: 252 RHPFFKEL---DWEKLNRRQIEPPFRPRIK----SREDVSNFDPDFIKED 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 37/170 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M +DHP ++ L K E + LVME P + + LK + +P+ +K
Sbjct: 50 MAQLDHPCIVRL-----IGVCKGEPLM-LVMELAPLGPLLKYLKK----RREIPVSDLKE 99
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+Q+ G+AY+ + HRDL +N LLV+ HQ KI DFG ++ L AG
Sbjct: 100 LAHQVAMGMAYLESK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG-------- 148
Query: 119 SRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 155
S +YR APE I +++ D+WS G L E G
Sbjct: 149 SDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ ++HPNVI F NEL N+V+E + R++KH+ + +P V
Sbjct: 56 LKQLNHPNVIKYYASFIE---DNEL--NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYIC 118
Y Q+ L ++H+ RV HRD+KP N+ + T VK+ D G + + A S +
Sbjct: 111 YFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160
+ +Y +PE I Y DIWS GC+L E+ Q F G+
Sbjct: 169 TPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 16/173 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ + HP ++ L H F T K L V++Y+ E Y + + R +
Sbjct: 50 LKNVKHPFLVGL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----AR 99
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y +I L Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C
Sbjct: 100 FYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFC 157
Query: 119 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ Y APE++ Y ++D W G VL E+L G P F N + I+
Sbjct: 158 GTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 17/168 (10%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
HP + SLK+ F +K+ L VMEYV E + + + + R + Y +
Sbjct: 54 HPFLTSLKYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAE 103
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 122
I L Y+H+ ++ +RDLK +NL++D H +KI DFG K+ I A + C + Y
Sbjct: 104 IVSALDYLHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
APE + +Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 51/172 (29%), Positives = 85/172 (49%), Gaps = 25/172 (14%)
Query: 3 VMDHPN---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
+M H N ++ L H F +++ +L +VMEY+P L +N +P + +
Sbjct: 96 IMAHANSEWIVQL-HYAF----QDDKYLYMVMEYMPGGDLVNL----MSNYDIPEKWARF 146
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YT ++ L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ +AN C
Sbjct: 147 YTAEVVLALDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM---DANGMVRCD 201
Query: 120 RF-----YRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 163
Y +PE++ G Y D WS G L E+L+G F ++ V
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 35/206 (16%)
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y +I GL +H R+ +RDLKP+N+L+D H ++I D G A + G+ +
Sbjct: 106 FYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVG 163
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ YT S D W+ GC+L E++ GQ F Q + IK R
Sbjct: 164 TVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------R 210
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALE 233
EE+ + +K + + ++ P+A L LL P R A E
Sbjct: 211 EEVERL-----------VKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGARE 257
Query: 234 ACAHPFFDELREPNARLPNGRPLPPL 259
HP F ++ RL G PP
Sbjct: 258 VKEHPLFKQIN--FKRLEAGMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 30/189 (15%)
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFY 122
+ + L Y+H+ V HRD+K ++L+ L +VK+ DFG Q+ S + + ++
Sbjct: 126 VLQALCYLHS-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYW 183
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APE+I T Y T +DIWS G ++ E++ G+P + ++ V + + R+
Sbjct: 184 MAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-- 232
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242
P K HK+ P D R+L P R TA E HPF +
Sbjct: 233 -----------PPPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276
Query: 243 LREPNARLP 251
P +P
Sbjct: 277 TGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLI 55
MR + H N++ F + ++ L ++ME+ + ++ + K + +
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA--- 119
Query: 56 YVKLYTYQIFRGLAYIHTVP------RVCHRDLKPQNLL-------VDPLTHQV------ 96
+ T Q+ LAY H + RV HRDLKPQN+ + +T Q
Sbjct: 120 -IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178
Query: 97 ---KICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATE-YTTSIDIWSAGCVLAEL 150
KI DFG +K + G ++++ C + +Y +PEL+ T+ Y D+W+ GC++ EL
Sbjct: 179 PIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 151 LLGQPLFPGENAVDQLVEIIK 171
G+ F N QL+ +K
Sbjct: 237 CSGKTPFHKANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 30/158 (18%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT-- 61
M HPN+++ K F + + L +VMEY Q++ L KL+
Sbjct: 55 MKHPNIVAFKESF-----EADGHLYIVMEYCDGG---------DLMQKIKLQRGKLFPED 100
Query: 62 ------YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA-GEA 112
Q+ G+ +IH RV HRD+K +N+ LT +VK+ DFGSA+ L + G
Sbjct: 101 TILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAY 156
Query: 113 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150
+Y+ + +Y PE I+ Y DIWS GC+L EL
Sbjct: 157 ACTYVGTPYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 26/181 (14%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
++ Y +I GL ++H V +RDLKP N+L+D H V+I D G A + + S
Sbjct: 99 MRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS- 155
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-----ENAVDQLVEIIK 171
+ + Y APE++ Y +S D +S GC+L +LL G F ++ +D++ +
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215
Query: 172 V-----------------LGTPTREEIRCMNPNYTDFR-FPQIKAHPWHKVFHKRMPPEA 213
V L + C+ + + P ++ W VF ++ PP
Sbjct: 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275
Query: 214 I 214
I
Sbjct: 276 I 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 54/182 (29%), Positives = 95/182 (52%), Gaps = 24/182 (13%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
+P ++ L CF TTS+ L LV+EYV + M+ + + +++P + + Y +
Sbjct: 55 NPFLVGLHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAE 104
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFY 122
I L ++H + +RDLK N+L+D H +K+ D+G K+ + G+ ++ + Y
Sbjct: 105 ICIALNFLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNY 162
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTP 176
APE++ G EY S+D W+ G ++ E++ G+ F P N D L ++I L P
Sbjct: 163 IAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKP 219
Query: 177 TR 178
R
Sbjct: 220 IR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 16/167 (9%)
Query: 7 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
P ++ H F T + L VMEYV + MY++ + R + Y +I
Sbjct: 60 PPFLTQLHSCFQTMDR----LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEI 110
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYR 123
GL ++H+ + +RDLK N+++D H +KI DFG K+ + C + Y
Sbjct: 111 AIGLFFLHS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYI 168
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
APE+I Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 169 APEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
+ HP ++++ F +N ++ ++E+V + H A R P K Y +
Sbjct: 75 LSHPFIVNMMCSF---QDENRVYF--LLEFVVGG--ELFTHLRKAG-RFPNDVAKFYHAE 126
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 123
+ Y+H+ + +RDLKP+NLL+D H VK+ DFG AK++ + + + Y
Sbjct: 127 LVLAFEYLHSK-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYL 182
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157
APE+I + + ++D W+ G +L E + G P F
Sbjct: 183 APEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 60 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y++Q+ +G+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 184 YSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 174
+R + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 292
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 220
+E R P+YT Q WH +R P +L L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 45/211 (21%)
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYIC 118
YT QI GL ++H R+ +RDLKP+N+L+D + V+I D G A +L G++ Y
Sbjct: 102 YTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAG 159
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF--PGENAVDQLVEIIKVLGTP 176
+ + APEL+ G EY S+D ++ G L E++ + F GE KV
Sbjct: 160 TPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKE 208
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-------C 229
++ I + Y D + P + LL P R C
Sbjct: 209 LKQRILNDSVTYPD-----------------KFSPASKSFCEALLAKDPEKRLGFRDGNC 251
Query: 230 TALEACAHPFFDELREPNARLPNGRPLPPLF 260
L HP F +L N R LPP F
Sbjct: 252 DGLR--THPLFRDL---NWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 54/238 (22%), Positives = 103/238 (43%), Gaps = 39/238 (16%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTY 62
+DHP ++ F ++ + + F ++ EY + L+ + + V +
Sbjct: 59 LDHPAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI 113
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 121
Q+ G+ Y+H R+ HRDLK +N+ + + +KI DFG ++ L+ + ++ + +
Sbjct: 114 QLLLGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPY 170
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
Y +PE + Y + DIWS GC+L E+ F G+N L +++++ PT
Sbjct: 171 YMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT---- 222
Query: 182 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
P+ + + + +L PSLR +A E +PF
Sbjct: 223 ----PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 41/236 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ + HP ++ L H F T K L V++YV E + + + R +
Sbjct: 50 LKNLKHPFLVGL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----AR 99
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y ++ + Y+H++ + +RDLKP+N+L+D H V + DFG K+ + E S C
Sbjct: 100 FYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFC 157
Query: 119 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII------- 170
+ Y APE + Y ++D W G VL E+L G P F + V Q+ + I
Sbjct: 158 GTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQL 215
Query: 171 ---------KVLGTPTREEIRCMNPNYTDFRFPQIKAH------PWHKVFHKRMPP 211
+L ++ R DF +IK H W ++HKR+ P
Sbjct: 216 PGGKTVAACDLLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 41/105 (39%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICS 119
T I + L Y+ V HRD+KP N+L+D + VK+CDFG + +L+ +A S C+
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCA 178
Query: 120 RFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGEN 161
Y APE I +Y D+WS G L EL GQ FP +N
Sbjct: 179 A-YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-11
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ ++HPNVI F NEL N+V+E + +++K++ + +P V
Sbjct: 56 LKQLNHPNVIKYLDSFIE---DNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYIC 118
Y Q+ + ++H+ RV HRD+KP N+ + T VK+ D G + + A S +
Sbjct: 111 YFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160
+ +Y +PE I Y DIWS GC+L E+ Q F G+
Sbjct: 169 TPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 17/169 (10%)
Query: 60 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 179 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 174
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 236 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFC 287
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP-PEAIDLASRLLQ 222
++ R P +I W +R +++ LLQ
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTY 62
+ P ++ LK FS + ++L+L V +Y+ E + + K + R K Y
Sbjct: 54 ESPFIVGLK---FSFQTDSDLYL--VTDYMSGGELFWHLQKEGRFSEDR-----AKFYIA 103
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRF 121
++ L ++H + +RDLKP+N+L+D H + +CDFG +K + + C +
Sbjct: 104 ELVLALEHLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTE 161
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161
Y APE++ YT +D WS G ++ E+ G F E+
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 35/208 (16%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
Y +I GL +H +RDLKP+N+L+D H ++I D G A ++ GE+
Sbjct: 104 ALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGR 161
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ + Y APE++ YT S D W GC++ E++ GQ F G E +K
Sbjct: 162 VGTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK----- 209
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---A 231
REE+ D R + + +V+ + EA + LL P R C A
Sbjct: 210 -REEV--------DRRVLETE-----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGA 255
Query: 232 LEACAHPFFDELREPNARLPNGRPLPPL 259
E HPFF + RL G PP
Sbjct: 256 GEVKRHPFFRNMN--FKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 22/178 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M + P V+ L C F +++ +L +VMEY+P + ++ +Y +P + K
Sbjct: 97 MAFANSPWVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKF 146
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----S 115
YT ++ L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + +
Sbjct: 147 YTAEVVLALDAIHSMGLI-HRDVKPDNMLLDKHGH-LKLADFGTCMKM--DETGMVRCDT 202
Query: 116 YICSRFYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ + Y +PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 74/300 (24%), Positives = 120/300 (40%), Gaps = 93/300 (31%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 63
D P V+SL + F ++ +L L+ME++P + +L Y + ++ + + Y +
Sbjct: 59 DSPWVVSLYYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAE 109
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG------------SAKQLIAGE 111
+ +H + + HRD+KP N+L+D H +K+ DFG ++L+ G+
Sbjct: 110 CVLAIEAVHKLGFI-HRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGK 167
Query: 112 ANISYICSRF------------------------------------YRAPELIFGATEYT 135
+N + I +R Y APE IF Y
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYG 226
Query: 136 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 195
D WS G ++ E L+G P F EN+ + +II RE + FP
Sbjct: 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINW-----RETL----------YFPD 271
Query: 196 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFF-----DELREPNA 248
H + EA DL RL+ + + R A E +HPFF D +R+ A
Sbjct: 272 -DIH---------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA 321
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 16/193 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
MR HPN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 70 MRENKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV---- 120
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YIC 118
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S +
Sbjct: 121 -CRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ ++ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPEL 235
Query: 179 EEIRCMNPNYTDF 191
+ ++ + DF
Sbjct: 236 QNPEKLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-10
Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 16/193 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ + +PN+++ F +ELF+ VMEY+ S+ V+ ++ +
Sbjct: 70 MKELKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAAV---- 120
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YIC 118
+ + L ++H +V HRD+K N+L+ + VK+ DFG Q+ ++ S +
Sbjct: 121 -CRECLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ ++ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPEL 235
Query: 179 EEIRCMNPNYTDF 191
+ ++P + DF
Sbjct: 236 QNPEKLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y ++ GL + R+ +RDLKP+N+L+D H ++I D G A Q+ GE +
Sbjct: 106 FYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVG 163
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157
+ Y APE+I +YT S D W GC++ E++ GQ F
Sbjct: 164 TVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
+HP ++ L F+ L +++E+ P + P I ++ Q+
Sbjct: 67 NHPYIVKLLGAFYWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQM 119
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYR 123
L Y+H++ ++ HRDLK N+L+ L +K+ DFG SAK + + S+I + ++
Sbjct: 120 LEALQYLHSM-KIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177
Query: 124 APELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGT 175
APE++ T Y DIWS G L E+ +P N + L++I K L
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ 237
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHP 200
P++ + + DF + HP
Sbjct: 238 PSK-----WSMEFRDFLKTALDKHP 257
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 50/178 (28%), Positives = 74/178 (41%), Gaps = 32/178 (17%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRF 121
+I +GL Y+H+ ++ HRD+K N+L+ VK+ DFG A QL + +++ + F
Sbjct: 109 EILKGLDYLHSEKKI-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
+ APE+I + Y + DIWS G EL G+P P +
Sbjct: 167 WMAPEVI-QQSAYDSKADIWSLGITAIELAKGEP--PNSD-------------------- 203
Query: 182 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
M+P F P+ F K + L PS R TA E H F
Sbjct: 204 --MHPMRVLFLIPKNNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 60 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 178 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 174
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 235 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEFC 286
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWH 202
+E R P Y I WH
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 48/177 (27%), Positives = 90/177 (50%), Gaps = 20/177 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M + P V+ L + F +++ +L +VMEY+P + ++ +Y +P + +
Sbjct: 97 MAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARF 146
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SY 116
YT ++ L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + +
Sbjct: 147 YTAEVVLALDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTA 203
Query: 117 ICSRFYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ + Y +PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
+ ++ P +++L + F S T L LVM + + Y + Y+ + + + V
Sbjct: 47 LEKVNSPFIVNLAYAFESKTH-----LCLVMSLMNGGDLKYHI---YNVGERGLEMERVI 98
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y+ QI G+ ++H++ + +RD+KP+N+L+D ++ D G A +L G+
Sbjct: 99 HYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAG 156
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157
+ Y APE I Y+ +D ++ GC + E++ G+ F
Sbjct: 157 TNGYMAPE-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVK 58
M+ + H ++ L ++ S+ E +V EY+ + S+ LK R+P L+ +
Sbjct: 55 MKKLRHDKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM- 108
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI G+AY+ + HRDL +N+LV KI DFG A+ LI + +
Sbjct: 109 --AAQIAEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLAR-LIEDDEYTAREG 163
Query: 119 SRF---YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
++F + APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 164 AKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 17/174 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M +DHP+V+ L S+ + L+ + +P + +L + + + Y+ +
Sbjct: 63 MASVDHPHVVRLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNW 114
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
QI +G++Y+ R+ HRDL +N+LV H VKI DFG AK L E +
Sbjct: 115 CVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 121 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 168
+ A E I YT D+WS G + EL+ G + G AV+ L+E
Sbjct: 173 VPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 30/164 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R ++HP++I LK F T +K F L++ +Y Y +A + + + +
Sbjct: 137 LRAINHPSIIQLKGTF--TYNK---FTCLILPRYKTDLY----CYLAAKRNIAICDILAI 187
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC--DFGSAKQLIAGEANISYIC 118
+ R + Y+H R+ HRD+K +N+ ++ H +C DFG+A + AN
Sbjct: 188 ERSVLRAIQYLHE-NRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPVDINAN----- 238
Query: 119 SRFY--------RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154
++Y APEL+ Y ++DIWSAG VL E+
Sbjct: 239 -KYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-10
Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
+R + H N++ K T + L+ME++P LK Y N+ ++ L
Sbjct: 60 LRNLYHENIVKYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLK 113
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y QI +G+ Y+ + V HRDL +N+LV+ HQVKI DFG K + E + Y
Sbjct: 114 YAVQICKGMDYLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTV 168
Query: 120 R-------FYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+ F+ APE + + Y S D+WS G L ELL
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 37/105 (35%), Positives = 59/105 (56%), Gaps = 9/105 (8%)
Query: 60 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
++YQ+ +G+A++ + + C HRDL +N+L+ VKICDFG A+ ++ +
Sbjct: 146 FSYQVAKGMAFLAS--KNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+R + APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 ARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 33/201 (16%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKL 59
DHPN++ L F+ +N L++ ++E+ V M + + + +++
Sbjct: 60 DHPNIVKLLDAFYY---ENNLWI--LIEFCAGGAVDAVMLELERPLTEPQ-------IRV 107
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC 118
Q L Y+H ++ HRDLK N+L L +K+ DFG SAK + S+I
Sbjct: 108 VCKQTLEALNYLHE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIG 165
Query: 119 SRFYRAPELIFGATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK--- 171
+ ++ APE++ T Y D+WS G L E+ +P N + L++I K
Sbjct: 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP 225
Query: 172 -VLGTPTREEIRCMNPNYTDF 191
L P+R + + DF
Sbjct: 226 PTLAQPSR-----WSSEFKDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 4/94 (4%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 121
+I +GL Y+H+ ++ HRD+K N+L+ +VK+ DFG A QL + + ++ + F
Sbjct: 109 EILKGLDYLHSEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155
+ APE+I + Y + DIWS G EL G+P
Sbjct: 167 WMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ D+PN I L ++S T+ L +M+Y+ + ++ +LK ++ VK
Sbjct: 65 MK--DNPNFIKL---YYSVTTLKGHVL--IMDYIKDGDLFDLLKK----EGKLSEAEVKK 113
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Q+ L +H + H D+K +N+L D ++ +CD+G K I G Y +
Sbjct: 114 IIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG-TPSCYDGT 169
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI---------- 169
Y +PE I G Y S D W+ G + ELL G+ P + D+ +++
Sbjct: 170 LDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESLLKRQQKK 226
Query: 170 ---IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 201
IK + + ++ M N NY + +I HP+
Sbjct: 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 3/109 (2%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
++ Y +I GL ++H V +RDLKP N+L+D H V+I D G A + + S
Sbjct: 99 MRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS- 155
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 165
+ + Y APE++ T Y +S D +S GC+L +LL G F D+
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 38/103 (36%), Positives = 56/103 (54%), Gaps = 8/103 (7%)
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE-A 112
Y+ +I +GL Y+H+ R HRD+K N+L L+ Q VK+ DFG A QL +
Sbjct: 102 YIATILREILKGLDYLHS-ERKIHRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIK 157
Query: 113 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155
+++ + F+ APE+I + Y DIWS G EL G+P
Sbjct: 158 RNTFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 37/130 (28%), Positives = 69/130 (53%), Gaps = 5/130 (3%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 121
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 124 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 182 RCMNPNYTDF 191
++ + DF
Sbjct: 240 EKLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 42/107 (39%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 117
+TYQ+ RG+ ++ + HRDL +N+L L VKICDFG A+ I ++N
Sbjct: 242 FTYQVARGMEFLAS-KNCVHRDLAARNVL---LAQGKIVKICDFGLARD-IMHDSNYVSK 296
Query: 118 CSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
S F + APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 297 GSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
DHPNV+ ++ KN L LV+E S+ ++K + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG--EANISYICS 119
GL ++H V + HRD+K N+L LT + VK+ DFG + QL + N S + +
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGT 187
Query: 120 RFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 155
F+ APE+I + Y D+WS G EL G P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 66/253 (26%), Positives = 113/253 (44%), Gaps = 41/253 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 73 MRDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 123
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYIC 118
+ R L+Y+H V HRD+K ++L+ ++K+ DFG Q ++ E S +
Sbjct: 124 CLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQ-VSKEVPKRKSLVG 180
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ ++ APE+I Y T +DIWS G ++ E++ G+P + E P
Sbjct: 181 TPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---------------PPL 224
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ +R + N P++K HKV + +DL +L PS R TA E HP
Sbjct: 225 QAMRRIRDNLP----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHP 273
Query: 239 FFDELREPNARLP 251
F P+ +P
Sbjct: 274 FLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 66/254 (25%), Positives = 110/254 (43%), Gaps = 43/254 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 71 MRDYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAG-EANISYI 117
+ + L+ +H V HRD+K ++L LTH +VK+ DFG Q+ S +
Sbjct: 122 CLAVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ ++ APELI Y +DIWS G ++ E++ G+P + E P
Sbjct: 178 GTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PP 221
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
+ ++ + N P++K HKV P RLL P+ R TA E H
Sbjct: 222 LKAMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKH 270
Query: 238 PFFDELREPNARLP 251
PF + P+ +P
Sbjct: 271 PFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 3e-09
Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 31/189 (16%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 121
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQ-- 236
Query: 182 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241
NP +R+ D +R L+ R +A E HPF
Sbjct: 237 ---NP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL- 272
Query: 242 ELREPNARL 250
+L +P + L
Sbjct: 273 KLAKPLSSL 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 66/273 (24%), Positives = 107/273 (39%), Gaps = 72/273 (26%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTY 62
+DHP + +L F + T +L LVM+Y P ++R+L+ + + + Y
Sbjct: 58 LDHPFLPTLYASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAA 110
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--------------- 107
++ L Y+H + V +RDLKP+N+L+ H + + DF +KQ
Sbjct: 111 EVLLALEYLHLLGIV-YRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 108 ---------------IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152
+ S++ + Y APE+I G + +++D W+ G +L E+L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLY 227
Query: 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE 212
G F G N + I+K + FP +
Sbjct: 228 GTTPFKGSNRDETFSNILK-----------------KEVTFPG----------SPPVSSS 260
Query: 213 AIDLASRLLQYSPSLRC----TALEACAHPFFD 241
A DL +LL PS R A E HPFF
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 53/170 (31%), Positives = 85/170 (50%), Gaps = 25/170 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
MR DHP+++ L ++N +++ VME P L+ Y N+ + L + L
Sbjct: 61 MRQFDHPHIVKL----IGVITENPVWI--VMELAP---LGELRSYLQVNKYSLDLASLIL 111
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y+YQ+ LAY+ + R HRD+ +N+LV P VK+ DFG ++ L E Y
Sbjct: 112 YSYQLSTALAYLESK-RFVHRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKA 165
Query: 119 SRF-----YRAPELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 161
S+ + APE I +T++ D+W G C+ L+LG +P +N
Sbjct: 166 SKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 22 KNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80
++E L LVM+Y V + +L S R+P + Y ++ + +H + V HR
Sbjct: 71 QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV-HR 126
Query: 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANIS-----YICSRFYRAPELIFGAT 132
D+KP N+L+D H +++ DFGS +L+A ++N++ YI +A E G
Sbjct: 127 DIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME--DGKG 183
Query: 133 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 164
Y D WS G + E+L G+ F E+ V+
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 53/174 (30%), Positives = 79/174 (45%), Gaps = 14/174 (8%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 63
+HPNV+ F+ L LV+E S+ ++K QR+ + Y
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE--ANISYICS 119
GL ++H R+ HRD+K N+L LT + VK+ DFG + QL + N S + +
Sbjct: 137 ALLGLQHLHN-NRIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGT 191
Query: 120 RFYRAPELIFGATEYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
F+ APE+I +Y S D+WS G EL G P + V L +I
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 117
++YQ+ +G++++ HRDL +N+L LTH KICDFG A+ I ++N Y+
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARD-IRNDSN--YV 271
Query: 118 CSRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEII 170
R APE IF YT D+WS G +L E+ LG +PG + ++I
Sbjct: 272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 201
K E R ++P I W
Sbjct: 331 K-------EGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSR 120
+I RGLA++H +V HRD+K QN+L+ +VK+ DFG + QL G N ++I +
Sbjct: 129 EILRGLAHLH-AHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTP 185
Query: 121 FYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQP 155
++ APE+I Y DIWS G E+ G P
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 50/202 (24%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLK 43
M +M H N+I+L T + L++ V+EY P Y
Sbjct: 66 MEMMKMIGKHKNIINLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPD 120
Query: 44 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFG 102
+ + + + YQ+ RG+ ++ + + C HRDL +N+LV H +KI DFG
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTE-DHVMKIADFG 177
Query: 103 SAKQLIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL 150
A+ +I +I +YR APE +F YT D+WS G +L E+
Sbjct: 178 LAR-------DIHHI--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEI 227
Query: 151 L-LGQPLFPGENAVDQLVEIIK 171
LG +PG V++L +++K
Sbjct: 228 FTLGGSPYPGI-PVEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ ++HP ++L F K+E +L LV+E+V + + N+R P Y
Sbjct: 85 LNYINHPFCVNLYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFY 136
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 119
QI Y+ ++ + +RDLKP+NLL+D +K+ DFG AK + + +C +
Sbjct: 137 AAQIVLIFEYLQSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGT 191
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157
Y APE++ + + D W+ G + E+L+G P F
Sbjct: 192 PEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 22 KNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80
++E +L LVM+Y V + +L + R+P + Y ++ + IH + HR
Sbjct: 71 QDENYLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL-HYVHR 126
Query: 81 DLKPQNLLVDPLTHQVKICDFGSA-KQLIAGEANISY-ICSRFYRAPELIF----GATEY 134
D+KP N+L+D H +++ DFGS K G S + + Y +PE++ G +Y
Sbjct: 127 DIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185
Query: 135 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
D WS G + E+L G+ F E+ V+ +I+
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 22/175 (12%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY----VKL 59
M HPN++ + F + L +VM+Y Y N + +++ +
Sbjct: 56 MKHPNIVQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILD 105
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG-EANISY 116
+ QI L ++H ++ HRD+K QN+ LT +K+ DFG A+ L + E +
Sbjct: 106 WFVQICLALKHVHD-RKILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTC 161
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
I + +Y +PE I Y DIW+ GCVL E+ + F N + +++II+
Sbjct: 162 IGTPYYLSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 60 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
++ Q+ +G+ ++ + + C HRD+ +N+L+ KICDFG A+ I ++N Y+
Sbjct: 217 FSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDG-RVAKICDFGLARD-IMNDSN--YVV 270
Query: 119 SRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
R APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 271 KGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 65
H N+++ F S S+ +L++ MEY + + H + + + YV T Q
Sbjct: 65 HCNIVAY---FGSYLSREKLWI--CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ-- 117
Query: 66 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRA 124
GLAY+H+ ++ HRD+K N+L+ VK+ DFG A ++ A A S+I + ++ A
Sbjct: 118 -GLAYLHSKGKM-HRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 125 PELIFGATE----YTTSIDIWSAGCVLAELLLGQP 155
PE+ A E Y DIW+ G EL QP
Sbjct: 175 PEV--AAVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 26/165 (15%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
DHPN++ L K +++ VME VP L R+ + + +
Sbjct: 50 DHPNIVKL---IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDA 102
Query: 65 FRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 123
G+ Y+ + + C HRDL +N LV + +KI DFG +++ E Y S +
Sbjct: 103 AAGMEYLES--KNCIHRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLK 155
Query: 124 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
APE L +G YT+ D+WS G +L E LG +PG
Sbjct: 156 QIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEAN 113
V L YQI L +H+ ++ HRDLK N+ + P T +K+ DFG +KQ ++ +
Sbjct: 171 VGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 114 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159
S+ + +Y APEL + Y+ D+WS G +L ELL F G
Sbjct: 229 SSFCGTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 27 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 86
L LVM+Y +L S R+P + Y ++ + +H + V HRD+KP N
Sbjct: 76 LYLVMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV-HRDIKPDN 132
Query: 87 LLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIF----GATEYTTSIDI 140
+L+D + +++ DFGS +L+ S + + Y +PE++ G +Y D
Sbjct: 133 ILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDW 191
Query: 141 WSAGCVLAELLLGQPLFPGENAVDQLVEII 170
WS G + E+L G+ F E+ V+ +I+
Sbjct: 192 WSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 49 NQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106
N+ L Y+ L ++YQ+ G+ ++ + V HRDL +N+L+ VKICDFG A+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLARD 288
Query: 107 LIAGEANISYICSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 161
++ IS S F + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 289 IMRDSNYISK-GSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 210
+Q IK R P + +I W + F R
Sbjct: 347 MNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 39/187 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
++ ++HP+VI L + S++ L L++EY + Y L+ + ++++ Y+
Sbjct: 57 LKQVNHPHVIKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSD 108
Query: 60 -----------------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 96
+ +QI RG+ Y+ + V HRDL +N+LV ++
Sbjct: 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKM 166
Query: 97 KICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-L 152
KI DFG ++ + ++ + R + A E +F YTT D+WS G +L E++ L
Sbjct: 167 KISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 225
Query: 153 GQPLFPG 159
G +PG
Sbjct: 226 GGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 23/156 (14%)
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI Y
Sbjct: 143 TYQVARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDV----NNIDYYKKT 196
Query: 121 F-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKV 172
+ APE +F YT D+WS G ++ E+ LG +PG V++L +++K
Sbjct: 197 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKE 254
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 208
G + C N Y R WH + R
Sbjct: 255 -GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-08
Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 18/185 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ + H ++ L ++ +K E + ++ EY+ + S+ LK S ++ L +
Sbjct: 55 MKTLQHDKLVRL----YAVVTKEEP-IYIITEYMAKGSLLDFLK--SDEGGKVLLPKLID 107
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
++ QI G+AYI + HRDL+ N+LV KI DFG A+ +I + +
Sbjct: 108 FSAQIAEGMAYIERKNYI-HRDLRAANVLVSESL-MCKIADFGLAR-VIEDNEYTAREGA 164
Query: 120 RF---YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 174
+F + APE I FG+ +T D+WS G +L E++ G+ +PG + D + + +
Sbjct: 165 KFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR 222
Query: 175 TPTRE 179
P E
Sbjct: 223 MPRME 227
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSR 120
+I RGL+++H +V HRD+K QN+L+ +VK+ DFG + QL G N ++I +
Sbjct: 119 EILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTP 175
Query: 121 FYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQP 155
++ APE+I Y D+WS G E+ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 65/225 (28%)
Query: 36 ESMYRVLKH--------YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 87
+S++ VL+H + S +P VK + ++ L +H VC RDL P N+
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNI 116
Query: 88 LVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 144
L+D H +++ F ++ GEA Y APE + G +E T + D WS G
Sbjct: 117 LLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYCAPE-VGGISEETEACDWWSLG 169
Query: 145 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN----YTDFRFPQIKAHP 200
+L ELL G+ L + C +P+ +T P+
Sbjct: 170 AILFELLTGKTL------------------------VEC-HPSGINTHTTLNIPEW---- 200
Query: 201 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-----AHPFF 240
+ EA L +LLQ++P+ R A A +HPFF
Sbjct: 201 --------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 55/190 (28%), Positives = 80/190 (42%), Gaps = 40/190 (21%)
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI Y
Sbjct: 141 YQVARGMEYLAS-QKCIHRDLAARNVLVTE-DNVMKIADFGLARDV----HNIDYYKKTT 194
Query: 122 -------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 173
+ APE +F YT D+WS G +L E+ LG +PG V++L +++K
Sbjct: 195 NGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLK-- 250
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-----------------MPPEAIDL 216
E R P I WH V +R E +DL
Sbjct: 251 -----EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDL 305
Query: 217 ASRLLQYSPS 226
+ QYSP
Sbjct: 306 SVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 31/201 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H +I+L H + + + + +VM ++ Y + +PL
Sbjct: 140 LKTISHRAIINLIHAY-----RWKSTVCMVMPKYKCDLFT----YVDRSGPLPLEQAITI 190
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
++ LAY+H + HRD+K +N+ +D + V + DFG+A +L + C
Sbjct: 191 QRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYG 246
Query: 121 F-----YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLG 174
+ +PEL+ Y DIWSAG VL E+ + LF + K
Sbjct: 247 WSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSS 296
Query: 175 TPTREEIRCMNPNYTDFRFPQ 195
+ R IRCM + FPQ
Sbjct: 297 SQLRSIIRCMQVH--PLEFPQ 315
|
Length = 392 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 23/178 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKL 59
M +DH N+I L + +V E P S+ L+ A + +
Sbjct: 50 MHSLDHENLIRLYGVVLTHPLM------MVTELAPLGSLLDRLR--KDALGHFLISTLCD 101
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y QI G+ Y+ + R HRDL +N+L+ +VKI DFG + L E + Y+
Sbjct: 102 YAVQIANGMRYLES-KRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YV-M 156
Query: 120 RFYR-------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 169
+ APE + T ++ + D+W G L E+ G+ + G + L +I
Sbjct: 157 EEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ + HP ++ L ++ ++ +++ + EY+ S+ LK + ++ + +
Sbjct: 55 MKQLQHPRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLID 106
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
QI G+A+I + HRDL+ N+LV KI DFG A+ LI + +
Sbjct: 107 MAAQIAEGMAFIERKNYI-HRDLRAANILVSETLC-CKIADFGLAR-LIEDNEYTAREGA 163
Query: 120 RF---YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+F + APE I +G +T D+WS G +L E++ G+ +PG
Sbjct: 164 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 58/220 (26%), Positives = 83/220 (37%), Gaps = 69/220 (31%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF- 121
QI L +H+ V HRD+KPQN++ + KI D G+A L G I+YI F
Sbjct: 263 QILFALDGLHSTGIV-HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 122 ----YRAPELIFGATEYTTS----------------------IDIWSAGCVLAELLLGQP 155
Y APE +T+ T S DI+SAG L+ Q
Sbjct: 319 LDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQM 372
Query: 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---- 211
FP + L++ R+ R D+ W K+ R P
Sbjct: 373 AFPNLRSDSNLIQF-------NRQLKRN------DYDLVA-----WRKLVEPRASPDLRR 414
Query: 212 --EAIDLASR--------LLQYSPSLRCTALEACAHPFFD 241
E +DL ++++ R +A A AHP+FD
Sbjct: 415 GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 62
+ HPN+++ + + + L +VM + +Y LK + +P V +
Sbjct: 56 LKHPNIVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFV 109
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 121
QI L Y+H + HRDLK QN+ + T+ +K+ D G A+ L + + I + +
Sbjct: 110 QIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPY 167
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAEL 150
Y +PEL F Y D+W+ GC + E+
Sbjct: 168 YMSPEL-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 52/277 (18%), Positives = 89/277 (32%), Gaps = 44/277 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--KHYSSANQRMPLIYVK 58
R + HPN++ F +EL++ V + L H+ +P + +
Sbjct: 53 SRQLQHPNILPYVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHFPEG---LPELAIA 104
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYI 117
+ L YIH+ + HR +K ++L+ +V + + +I G+
Sbjct: 105 FILKDVLNALDYIHSKGFI-HRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 118 CSRFYRAPELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
L + + E Y DI+S G EL G F A L+E
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE- 221
Query: 170 IKVLGTP--------------TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 215
KV GT + + R N + + +
Sbjct: 222 -KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN-------NRDSVDHPYTRTFSEHFHQ 273
Query: 216 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 252
LQ P R +A + H FF + + N L +
Sbjct: 274 FVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 39/242 (16%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 65
HPN+++L + L V EYVP R L+ +A+ +P Q+
Sbjct: 37 HPNIVAL----LDSGEAPPGLLFAVFEYVPG---RTLREVLAADGALPAGETGRLMLQVL 89
Query: 66 RGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQLI-AGEANIS------- 115
LA H + HRDLKPQN++V + K+ DFG L +A+++
Sbjct: 90 DALACAHN-QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE 148
Query: 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
+ + Y APE + G T + D+++ G + E L GQ + G + + EI+
Sbjct: 149 VLGTPTYCAPEQLRGEPV-TPNSDLYAWGLIFLECLTGQRVVQGAS----VAEILY---- 199
Query: 176 PTREEIRCMNPNYTDFRFPQ-IKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTA 231
+ ++P D P I HP +V K + P + A L + +L A
Sbjct: 200 ------QQLSPV--DVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERFRALELCA 251
Query: 232 LE 233
L
Sbjct: 252 LV 253
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 19/165 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ + H ++ L + +K +++ + E++ + S+ LK S + PL +
Sbjct: 55 MKTLQHDKLVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLK--SDEGSKQPLPKLID 106
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
++ QI G+A+I + HRDL+ N+LV KI DFG A+ +I + +
Sbjct: 107 FSAQIAEGMAFIEQRNYI-HRDLRAANILVSASL-VCKIADFGLAR-VIEDNEYTAREGA 163
Query: 120 RF---YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+F + APE I FG+ +T D+WS G +L E++ G+ +PG
Sbjct: 164 KFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 39/189 (20%)
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
YQ+ RG+ Y+ + R HRDL +N+LV + +KI DFG A+ G +I Y
Sbjct: 141 YQVARGMEYLES-RRCIHRDLAARNVLVTE-DNVMKIADFGLAR----GVHDIDYYKKTS 194
Query: 122 -------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 173
+ APE +F YT D+WS G ++ E+ LG +PG V++L +++
Sbjct: 195 NGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLL--- 249
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR----------------MPPEAIDLA 217
RE R P+ + WH V +R + E +DL+
Sbjct: 250 ----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLS 305
Query: 218 SRLLQYSPS 226
QYSPS
Sbjct: 306 MPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 48/156 (30%), Positives = 72/156 (46%), Gaps = 18/156 (11%)
Query: 1 MRVMDHPNVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVK 58
M +D+P+V L C ST + L+ + +P + L Y ++ + Y+
Sbjct: 63 MASVDNPHVCRLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLL 112
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+ QI +G+ Y+ R+ HRDL +N+LV H VKI DFG AK L A E
Sbjct: 113 NWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEG 170
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+ + A E I YT D+WS G + EL+
Sbjct: 171 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 52/176 (29%), Positives = 91/176 (51%), Gaps = 21/176 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ + H ++ L ++ S+ +++ V EY+ + S+ LK ++P + V +
Sbjct: 55 MKKLRHDKLVQL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDM 107
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYIC 118
Q+ G+AYI + + HRDL+ N+LV D L KI DFG A+ LI +
Sbjct: 108 AA-QVAAGMAYIERMNYI-HRDLRSANILVGDGLV--CKIADFGLAR-LIEDNEYTARQG 162
Query: 119 SRF---YRAPEL-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 169
++F + APE ++G +T D+WS G +L EL+ G+ +PG N + L ++
Sbjct: 163 AKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 61/258 (23%), Positives = 98/258 (37%), Gaps = 58/258 (22%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLV-----MEYVPESMYRVLKHYSSANQRMPLI 55
M+ DHPNV+ L T ++E + + V M++ + + Q +P
Sbjct: 54 MKEFDHPNVMRLIGVCLQTV-ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 115
+ + I G+ Y+ + HRDL +N +++ V + DFG +K++ G+
Sbjct: 113 MLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNGD---Y 167
Query: 116 YICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENAVDQLV 167
Y R + P + + A E YTT D+WS G + E+ GQ +PG EN+
Sbjct: 168 YRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----- 221
Query: 168 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227
EI L R + PP+ +D YS
Sbjct: 222 EIYDYLRQGNR----------------------------LKQPPDCLDGL-----YSLMS 248
Query: 228 RCTALEACAHPFFDELRE 245
C L P F+ LR
Sbjct: 249 SCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 13/103 (12%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSR 120
QI G+AY+H + HRD+KP NLL++ VKI DFG ++ L N S + +
Sbjct: 176 QILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCN-SSVGTI 232
Query: 121 FYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 158
Y +PE I GA + DIWS G + E LG+ FP
Sbjct: 233 AYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M MDHP+++ L S T + LV + +P H N L+ +
Sbjct: 63 MASMDHPHLVRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN--W 114
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
QI +G+ Y+ R+ HRDL +N+LV H VKI DFG A+ L E + +
Sbjct: 115 CVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGK 172
Query: 121 F---YRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQP 155
+ A E I ++T D+WS G + EL+ G+P
Sbjct: 173 MPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 39/235 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIY 56
M+ HPNV+SL + LV+ +P + L+++ + P LI
Sbjct: 50 MKDFSHPNVLSLLGICLPSEG-----SPLVV--LPYMKHGDLRNFIRSETHNPTVKDLIG 102
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
L Q+ +G+ Y+ + + HRDL +N ++D + VK+ DFG A+ + E Y
Sbjct: 103 FGL---QVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----Y 153
Query: 117 ICSRFYRAPEL--IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 167
+ +L + A E +TT D+WS G +L EL+ G P +P ++ D V
Sbjct: 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV 213
Query: 168 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222
+++ G + C +P Y ++ WH R P +L SR+ Q
Sbjct: 214 YLLQ--GRRLLQPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 15/151 (9%)
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + + R
Sbjct: 147 YQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRL 204
Query: 122 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 177
+ APE +F YT D+WS G +L E+ LG +PG V++L +++K G
Sbjct: 205 PVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKE-GHRM 261
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 208
+ C N Y R WH V +R
Sbjct: 262 DKPSNCTNELYMMMR------DCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 26/102 (25%)
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
QI G+ Y+ + HRDL +N LV VKI DFG ++ + + + +
Sbjct: 131 IQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKISDFGLSRDIYSAD---------Y 179
Query: 122 YR------------APELI-FGATEYTTSIDIWSAGCVLAEL 150
YR PE I +G ++TT DIWS G VL E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 18/174 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIY 56
M+ DHPNV+ L F +S ++ +V M++ + + +++PL
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
+ + I G+ Y+ HRDL +N ++ V + DFG +K++ +G+ Y
Sbjct: 115 LLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---YY 169
Query: 117 ICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 162
R + P + + A E YT+ D+W+ G + E+ GQ +PG EN
Sbjct: 170 RQGRIAKMP-VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-06
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 21/166 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ + H ++ L ++ S+ +++ V EY+ + S+ LK R+P +
Sbjct: 55 MKKLRHEKLVQL----YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD-- 106
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI G+AY+ + V HRDL+ N+LV + L K+ DFG A+ LI +
Sbjct: 107 MAAQIASGMAYVERMNYV-HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEYTARQG 162
Query: 119 SRF---YRAPE-LIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 159
++F + APE ++G +T D+WS G +L EL G+ +PG
Sbjct: 163 AKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 48/183 (26%)
Query: 16 FFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 73
F+S K L+L +ME++P + M ++K + + + + Y + + IH
Sbjct: 67 FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQ 119
Query: 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFG------------------------------- 102
+ + HRD+KP NLL+D H VK+ DFG
Sbjct: 120 LGFI-HRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 103 SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 158 PGE 160
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 27/111 (24%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
+I G+AY+ + HRDL +N +V + LT VKI DFG + +I + +
Sbjct: 127 EIADGMAYLAAK-KFVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE--TDY 174
Query: 122 YR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
YR APE + +TT D+WS G VL E+ L + + G
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 27 LNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 85
+ LV + +P Y L Y N+ R+ + + QI +G++Y+ V R+ HRDL +
Sbjct: 83 VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAAR 138
Query: 86 NLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWS 142
N+LV H VKI DFG A+ L E + + A E I +T D+WS
Sbjct: 139 NVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL-HRRFTHQSDVWS 196
Query: 143 AGCVLAELL 151
G + EL+
Sbjct: 197 YGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 27/110 (24%)
Query: 54 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 113
L+Y+ QI G+ Y+ ++ V HRDL +N LV + +KI DFG ++ L + +
Sbjct: 132 LLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGKN-YTIKIADFGMSRNLYSSD-- 184
Query: 114 ISYICSRFY----RAP--------ELIFGATEYTTSIDIWSAGCVLAELL 151
+Y RAP E + ++TT D+W+ G L E+L
Sbjct: 185 -------YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 37/126 (29%), Positives = 49/126 (38%), Gaps = 38/126 (30%)
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
Y APE++ T YT D WS G +L E+L+GQP F + TP ++
Sbjct: 210 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQL 254
Query: 182 RCMNPNYTDFRFPQIKAHPWHKVFH----KRMPPEAIDLASRLLQYSPSLRC---TALEA 234
+ +N W H ++ EA DL RL R A E
Sbjct: 255 KVIN---------------WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEI 298
Query: 235 CAHPFF 240
AHPFF
Sbjct: 299 KAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 28/124 (22%)
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
Y APE++ YT D WS G +L E+L+GQP F + TPT ++
Sbjct: 214 YIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQL 258
Query: 182 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPF 239
+ +N T PQ+K + PEA+DL ++L + R A + AHPF
Sbjct: 259 KVINWENTLHIPPQVK-----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
Query: 240 FDEL 243
F E+
Sbjct: 308 FSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 14 HCFFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIH 72
H ++S S N ++L VMEY+ + L H Y ++ M + Y+ ++ L Y+H
Sbjct: 68 HLYYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLH 121
Query: 73 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
+ HRDLKP N+L+ H +K+ DFG +K + E N+ I
Sbjct: 122 R-HGIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 48/183 (26%)
Query: 16 FFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 73
F+S K L+L +ME++P + M ++K + + + Y + + IH
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119
Query: 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFG------------------------------- 102
+ + HRD+KP NLL+D H VK+ DFG
Sbjct: 120 LGFI-HRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 103 SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 158 PGE 160
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 47/230 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK- 58
M +HPN++ L ++ME + + L+ PL+ +K
Sbjct: 53 MSNFNHPNIVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE 107
Query: 59 --LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----VKICDFGSAKQLIAGEA 112
+ +G Y+ + HRDL +N LV + VKI DFG A+ +
Sbjct: 108 LLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--- 163
Query: 113 NISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFP 158
S +YR APE L+ G +TT D+WS G ++ E+L LGQ +P
Sbjct: 164 ------SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 208
N + L + R P + Q+ + W + +R
Sbjct: 216 ALNNQEVLQHV--------TAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ DHPN++ L T + +++ VME VP + L + + +
Sbjct: 46 LKQYDHPNIVKL---IGVCTQRQPIYI--VMELVPGGDF--LSFLRKKKDELKTKQLVKF 98
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYI 117
G+AY+ + HRDL +N LV + +KI DFG ++Q I + + I
Sbjct: 99 ALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQI 156
Query: 118 CSRFYRAPE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ + APE L +G Y++ D+WS G +L E LG +PG
Sbjct: 157 PIK-WTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 23/159 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M DHPN+I L+ +K+ + ++ EY+ S+ + L+ + V +
Sbjct: 59 MGQFDHPNIIRLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM 111
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV-KICDFGSAKQLIAGEANISY-- 116
I G+ Y+ + V HRDL +N+LV+ ++ V K+ DFG +++L ++ +Y
Sbjct: 112 -LRGIASGMKYLSEMNYV-HRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTT 165
Query: 117 ----ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
I R + APE I ++T++ D+WS G V+ E++
Sbjct: 166 KGGKIPIR-WTAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 18/116 (15%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQL-----IAGEANISY 116
Q+ G+AY+ HRDL +N+LV + L K+ DFG A+ + ++ + I Y
Sbjct: 112 QVAEGMAYLEE-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY 168
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 168
+ APE ++T D+WS G +L E+ GQ +PG N DQ+
Sbjct: 169 K----WTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 31/123 (25%)
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 178
Y APE++ T YT D WS G +L E+L+GQP F + ++ +++I L P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
Query: 179 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQY 223
+ ++P +D R P +IKAHP+ K ID +S L Q
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK---------TIDFSSDLRQQ 320
Query: 224 SPS 226
S
Sbjct: 321 SAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYV 57
M+ + HP +I L ++ + E + +M+Y S+ L+ + ++P LI +
Sbjct: 55 MKKLRHPKLIQL----YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM 108
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
Q+ G+AY+ + HRDL +N+LV + K+ DFG A+ + +
Sbjct: 109 ---AAQVASGMAYLEAQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-ARE 162
Query: 118 CSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
++F + APE ++ D+WS G +L E++ G+ +PG
Sbjct: 163 GAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 15/100 (15%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---- 118
QI G++Y+H V H+D+ +N ++D QVKI D ++ L + Y C
Sbjct: 125 QIACGMSYLHKR-GVIHKDIAARNCVIDE-ELQVKITDNALSRDLFPMD----YHCLGDN 178
Query: 119 -SRFYR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQ 154
+R + A E + EY+++ D+WS G +L EL+ LGQ
Sbjct: 179 ENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 27/231 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIY 56
M+ DHPNVI L + +K L + +V M++ + ++ +PL
Sbjct: 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
+ + I G+ Y+ + HRDL +N +++ V + DFG +K++ +G+
Sbjct: 115 LVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGDYYRQG 172
Query: 117 ICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIK 171
S+ + A E + YTT D+W+ G + E++ GQ + G EN+ EI
Sbjct: 173 CASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYN 226
Query: 172 VL--GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 220
L G ++ C+ Y ++ W R P L +L
Sbjct: 227 YLIKGNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 31/102 (30%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICS 119
Q+ + ++H+ + HRD+K N+L+ VK+ DFG +K ++ + ++ +
Sbjct: 151 QVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFGFSKMYAATVSDDVGRTFCGT 208
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161
+Y APE I+ Y+ D++S G +L ELL + F GEN
Sbjct: 209 PYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 9e-05
Identities = 40/164 (24%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKL 59
M+ + HPN++ L ++ F ++ E++ +L + N Q + + +
Sbjct: 56 MKEIKHPNLVQL----LGVCTREPPFY-IITEFMTYG--NLLDYLRECNRQEVNAVVLLY 108
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
QI + Y+ + HRDL +N LV H VK+ DFG ++ L+ G+ ++ +
Sbjct: 109 MATQISSAMEYLEKKNFI-HRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGA 165
Query: 120 RF---YRAPELIFGATEYTTSIDIWSAGCVLAEL-LLGQPLFPG 159
+F + APE + +++ D+W+ G +L E+ G +PG
Sbjct: 166 KFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 21/166 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ + H ++ L ++ S+ +++ V E++ + S+ LK ++P + V +
Sbjct: 55 MKKLRHDKLVPL----YAVVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDM 107
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI G+AYI + + HRDL+ N+LV D L KI DFG A+ LI +
Sbjct: 108 AA-QIADGMAYIERMNYI-HRDLRAANILVGDNLV--CKIADFGLAR-LIEDNEYTARQG 162
Query: 119 SRF---YRAPEL-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 159
++F + APE ++G +T D+WS G +L EL+ G+ +PG
Sbjct: 163 AKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 22/108 (20%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------QLIAGEANIS 115
+I + Y+H+ V HRDLKP N+L+ L +V I D+G+A L+ + +
Sbjct: 121 KICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 116 YICSRF------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 151
IC Y APE + G + S DI++ G +L ++L
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 25/75 (33%), Positives = 42/75 (56%), Gaps = 6/75 (8%)
Query: 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYT 135
HRDL +N LV T VK+ DFG + ++ E S ++F + PE +F ++Y+
Sbjct: 123 HRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPE-VFNFSKYS 179
Query: 136 TSIDIWSAGCVLAEL 150
+ D+WS G ++ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 110
+K Q+ GL +H + + HRD+KP+NLLV + QVKI DFG+A + G
Sbjct: 311 IKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 20/158 (12%)
Query: 67 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YR 123
G+AY+ + V HRDL +N LV VK+ DFG + + + S ++F +
Sbjct: 112 GMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWS 168
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 183
+PE +F ++Y++ D+WS G ++ E + + P EN + E+++ + R
Sbjct: 169 SPE-VFSFSKYSSKSDVWSFGVLMWE-VFSEGKTPYENRSNS--EVVETINA----GFRL 220
Query: 184 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 221
P ++ H W + PE S LL
Sbjct: 221 YKPRLASQSVYELMQHCW------KERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 29/121 (23%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 122
QI G+ Y+ ++ V HRDL +N LV +KI DFG ++ L AG+ +Y
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 123 R------------APELIFGATEYTTSIDIWSAGCVLAELLL---GQPLFPGENAVDQLV 167
R A E I ++TT+ D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 168 E 168
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 26/100 (26%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC--DFGSA-----------KQLIA 109
Q+ + YIH + HRD+K +N+LV+ IC DFG+A IA
Sbjct: 268 QLLSAIDYIHG-EGIIHRDIKTENVLVNG---PEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 110 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 149
G + + APE++ G YT S+DIWSAG V+ E
Sbjct: 324 GTVDTN--------APEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICS 119
Q+ G+AY+ V HRDL +N LV VKI DFG ++ + + + A+ +
Sbjct: 138 QVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIP 195
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150
+ PE IF YTT D+W+ G VL E+
Sbjct: 196 IRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 13/94 (13%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--- 119
+ + Y+ + HRDL +N LV + VK+ DFG A+ ++ + Y S
Sbjct: 108 DVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLDDQ----YTSSQGT 161
Query: 120 RF---YRAPELIFGATEYTTSIDIWSAGCVLAEL 150
+F + PE +F + +++ D+WS G ++ E+
Sbjct: 162 KFPVKWAPPE-VFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 21/155 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVK 58
M + HPN++ L L +V EY+ + L Y S + L
Sbjct: 54 MTTLRHPNLVQL--LGVVLQGNP---LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQL 105
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+ + G+ Y+ HRDL +N+LV K+ DFG AK EA+
Sbjct: 106 GFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDS 158
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAEL 150
+ + APE + +++T D+WS G +L E+
Sbjct: 159 GKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 41/133 (30%), Positives = 59/133 (44%), Gaps = 17/133 (12%)
Query: 27 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 86
L LVME K S + + V +Q+ G+ Y+ V HRDL +N
Sbjct: 69 LMLVMEMASGGPLN--KFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV-HRDLAARN 125
Query: 87 -LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAPELIFGATEYTTSI 138
LLV+ H KI DFG +K L A + SY +R + APE I ++++
Sbjct: 126 VLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAPECI-NFRKFSSRS 179
Query: 139 DIWSAGCVLAELL 151
D+WS G + E
Sbjct: 180 DVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKL 59
M DHPN+I L+ T S+ + + ME +S R + + +I +
Sbjct: 59 MGQFDHPNIIHLEGVV--TKSRPVMIITEFMENGALDSFLRQ------NDGQFTVIQLVG 110
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
I G+ Y+ + V HRDL +N+LV+ K+ DFG ++ L ++ +Y S
Sbjct: 111 MLRGIAAGMKYLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 120 R------FYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+ APE I ++T++ D+WS G V+ E++
Sbjct: 169 LGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 26/100 (26%), Positives = 50/100 (50%), Gaps = 14/100 (14%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTY 62
D+ V+ L ++S K+ L+ VM+Y+P + M +++ + Y
Sbjct: 59 DNEWVVKL---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIA 108
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 102
++ + +H + + HRD+KP N+L+D H +K+ DFG
Sbjct: 109 ELTCAIESVHKMGFI-HRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 23/164 (14%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQR 51
++ HPN+I+L ++ +L L +EY P RVL+ ++ AN
Sbjct: 63 KLGHHPNIINLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117
Query: 52 MPLIYVK---LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQL 107
+ + + + RG+ Y+ + + HRDL +N+LV + KI DFG S Q
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQE 175
Query: 108 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+ + + + R+ L + YTT+ D+WS G +L E++
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 7e-04
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 28/167 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-------SMYRVLKHYSSANQ--- 50
M + +PN+I L S L ++ EY+ S + ++ AN
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 51 --RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 108
L+Y+ + QI G+ Y+ ++ V HRDL +N LV + +KI DFG ++ L
Sbjct: 126 VSIANLLYMAV---QIASGMKYLASLNFV-HRDLATRNCLVGN-HYTIKIADFGMSRNLY 180
Query: 109 AGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+G+ + + R+ ++ G ++TT+ D+W+ G L E+
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M DHPN+I L+ T SK + +V EY+ S+ L+ + + +I +
Sbjct: 59 MGQFDHPNIIHLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKHDG---QFTVIQLVG 110
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
I G+ Y+ + V HRDL +N+LV+ K+ DFG ++ ++ + +Y
Sbjct: 111 MLRGIASGMKYLSDMGYV-HRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEAAYTTR 167
Query: 120 R-----FYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+ APE I ++T++ D+WS G V+ E++
Sbjct: 168 GGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 26/92 (28%), Positives = 51/92 (55%), Gaps = 7/92 (7%)
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
+ G+AY+ + + HRDL +N LVD VK+ DFG ++ ++ E S + S+F
Sbjct: 107 KDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKF 163
Query: 122 ---YRAPELIFGATEYTTSIDIWSAGCVLAEL 150
+ PE + +++++ D+W+ G ++ E+
Sbjct: 164 PVRWSPPE-VLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 16/127 (12%)
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
+Q+ G+ Y+ V HRDL +N+L+ H KI DFG +K L A E +Y ++
Sbjct: 102 HQVSMGMKYLEETNFV-HRDLAARNVLL-VTQHYAKISDFGLSKALGADE---NYYKAKT 156
Query: 122 -------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGE--NAVDQLVEIIK 171
+ APE + ++++ D+WS G ++ E GQ + G N V Q++E +
Sbjct: 157 HGKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215
Query: 172 VLGTPTR 178
+ P R
Sbjct: 216 RMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 118
QI G+ Y+ ++ V HRDL +N LV + +KI DFG ++ L +G+ + +
Sbjct: 138 QIASGMKYLSSLNFV-HRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLP 195
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
R+ ++ G ++TT+ D+W+ G L E+L
Sbjct: 196 IRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 20/162 (12%)
Query: 4 MDHPNVISL---------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 54
+ HPN++ L FS S ++L LVM + + + P
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 55 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGE-- 111
+V + T QI G+ ++ + V H+DL +N+LV D L VKI D G +++ A +
Sbjct: 125 DFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADYY 180
Query: 112 --ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
S + R+ +++G +++ DIWS G VL E+
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 68/242 (28%)
Query: 29 LVMEYVP----ESMYRVLKHYSSANQRMPLIYVK---LYTYQIFRGLAYIHTVPRVCHRD 81
+VME + +S R L+ + N P ++ +I G+AY++ + HRD
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRD 144
Query: 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------------APELIF 129
L +N +V VKI DFG + + + +YR APE +
Sbjct: 145 LAARNCMVAH-DFTVKIGDFGMTRDIYETD---------YYRKGGKGLLPVRWMAPESLK 194
Query: 130 GATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 187
+TTS D+WS G VL E+ L QP N +Q+++ + M+
Sbjct: 195 DGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV-------------MDGG 238
Query: 188 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFD 241
Y D P P DL Q++P +R T LE HP F
Sbjct: 239 YLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
Query: 242 EL 243
E+
Sbjct: 285 EV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 20/134 (14%)
Query: 27 LNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84
L LV + P + V +H S + + L + QI +G+ Y+ R+ HR+L
Sbjct: 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKGMYYLEE-HRMVHRNLAA 137
Query: 85 QNLLVDPLTHQVKICDFGSA-------KQLIAGEANISYICSRFYRAPELIFGATEYTTS 137
+N+L+ V+I DFG A K+ E ++ ++FG YT
Sbjct: 138 RNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPI---KWMALESILFG--RYTHQ 191
Query: 138 IDIWSAGCVLAELL 151
D+WS G + E++
Sbjct: 192 SDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 40/134 (29%), Positives = 56/134 (41%), Gaps = 33/134 (24%)
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICS 119
QI G+ Y+ HRDL +N LV L VKI DFG ++ + Y
Sbjct: 128 AVQIASGMVYL-ASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDV--------YTTD 176
Query: 120 RFYR------------APELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 165
+YR PE I +TT D+WS G VL E+ QP + N ++
Sbjct: 177 -YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EE 232
Query: 166 LVEIIK---VLGTP 176
++E I +L P
Sbjct: 233 VIECITQGRLLQRP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.65 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.61 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.35 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.35 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.35 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.34 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.3 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.17 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.06 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.0 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.73 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.7 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.61 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.56 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.48 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.19 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.85 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.66 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.57 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.42 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.99 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.41 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.25 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.21 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.9 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.86 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.71 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.65 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.94 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.7 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.65 | |
| PLN02236 | 344 | choline kinase | 93.6 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.42 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 93.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 92.97 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 92.69 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.03 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.93 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 91.89 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.71 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.4 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 89.32 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 87.95 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 87.88 | |
| KOG1234 | 363 | consensus ABC (ATP binding cassette) 1 protein [Ge | 87.05 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 86.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 86.75 | |
| cd05164 | 222 | PIKKc Phosphoinositide 3-kinase-related protein ki | 85.48 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-65 Score=427.85 Aligned_cols=293 Identities=72% Similarity=1.240 Sum_probs=279.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++|||||++.-+|....+.++.++.+||||++.+|.+.++++...+..++.-.++-|.+||+.||.|||+ .||+||
T Consensus 71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHR 149 (364)
T KOG0658|consen 71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHR 149 (364)
T ss_pred HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccC
Confidence 5678999999999998877766678899999999999999999988888999999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||.|+|+|...+.+||||||.|+.+..++...++.+|+.|+|||.+.|...|+.+.||||+||+++||+.|++.|+|.
T Consensus 150 DIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 150 DIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred CCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 99999999999889999999999999999998999999999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
+..+++..|++.+|+|+.+++.+++++|.+..+++....+|.+.+....++++.||+.++|+++|.+|.++.|++.||||
T Consensus 230 s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF 309 (364)
T KOG0658|consen 230 SSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF 309 (364)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence 99999999999999999999999999999999999999999998889999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHhhcCCCCCCCC
Q 022500 241 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPA 294 (296)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (296)
..++.++...++++++|++++|+....+..++..+.++|.+.....+....+++
T Consensus 310 delr~~~~~l~~g~~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~~~~~~~~ 363 (364)
T KOG0658|consen 310 DELRDPNTKLPNGRPLPPLFNFKRAELGISPELVNVLIPEHLREQEKDKILCES 363 (364)
T ss_pred HHhhCcCccCcCCCcCCCccCchHHHhccchHHHHhhccHhhhhhccccccccC
Confidence 999999999999999999999999999999999999999999998887766654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-55 Score=364.31 Aligned_cols=271 Identities=37% Similarity=0.653 Sum_probs=227.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++|+||+.+++++......+-..+|+|+|+++.+|.+.++. +..++...++.+++||+.||+|+|+ .||+||
T Consensus 75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHR 149 (359)
T KOG0660|consen 75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHR 149 (359)
T ss_pred HHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-cccccc
Confidence 46789999999999998755556667999999999998888873 4559999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCcccccc---CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||.|++++ .+..+||||||+|+.... ....+.++.|+||+|||++.....|+.+.||||+|||++||++|++.|
T Consensus 150 DLKPsNll~n-~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 150 DLKPSNLLLN-ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred ccchhheeec-cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 9999999999 578899999999998754 233367889999999999988888999999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCC-cCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNY-TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
+|.+...++..|++.+|+|+.+.+..+.... ..+ ..+.....++...++ ..++.+.||+.+||++||.+|+|++|+
T Consensus 229 pG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eA 307 (359)
T KOG0660|consen 229 PGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEA 307 (359)
T ss_pred CCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHH
Confidence 9999999999999999999999887765221 112 366777788888887 589999999999999999999999999
Q ss_pred hcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 235 CAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 235 l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
|+|||+..+..+........ ..+. .+.. .+.+.+++++..++..
T Consensus 308 L~hPYl~~~hdp~dEP~~~~---~~~~--~~~~-~~~~~~r~~i~~e~~~ 351 (359)
T KOG0660|consen 308 LAHPYLAPYHDPEDEPVCQP---IFDS--FEHE-LTEEELRELIYKEILD 351 (359)
T ss_pred hcChhhhhhcCCccCCCCCC---CCcc--cccc-ccHHHHHHHHHHHHHh
Confidence 99999999988765432221 1111 1222 6678888888887543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=371.59 Aligned_cols=234 Identities=37% Similarity=0.694 Sum_probs=211.1
Q ss_pred CCCCC-CCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+ |||||++.+++.+.. ..+|+|||||+.+|++++++ ++..|++..++.|++||+.||+|+|. +|+.|
T Consensus 62 L~kln~hpniikL~Evi~d~~----~~L~fVfE~Md~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk-~GfFH 133 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDND----RILYFVFEFMDCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHK-HGFFH 133 (538)
T ss_pred HHhcCCCCcchhhHHHhhccC----ceEeeeHHhhhhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHh-cCccc
Confidence 46788 999999999995433 26999999999999999997 36789999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+||+|||+.+ ...+||+|||+|+...+...-+.++.|+||+|||+++....|+.+.|+||+|||++|+.+=++.|+|
T Consensus 134 RDlKPENiLi~~-~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 134 RDLKPENILISG-NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred ccCChhheEecc-cceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 999999999984 6789999999999998888888999999999999999888999999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.++.+++.+|.+++|+|....+.... -.--.+.+|+....++...++. .++++.++|.+||.+||.+||||.++|+|
T Consensus 213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 99999999999999999988776531 1224567888888888888877 89999999999999999999999999999
Q ss_pred CCccccc
Q 022500 238 PFFDELR 244 (296)
Q Consensus 238 p~f~~~~ 244 (296)
|||....
T Consensus 292 pffq~~~ 298 (538)
T KOG0661|consen 292 PFFQVGR 298 (538)
T ss_pred ccccccc
Confidence 9997543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=346.44 Aligned_cols=234 Identities=35% Similarity=0.710 Sum_probs=204.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++|+|||+|.++++| ....-++||+|||+.++++.+..+. ..++...++.|++|++.|+.|+|+ ++++||
T Consensus 55 LKqLkH~NLVnLiEVF-----rrkrklhLVFE~~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHR 125 (396)
T KOG0593|consen 55 LKQLKHENLVNLIEVF-----RRKRKLHLVFEYCDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHK-NNCIHR 125 (396)
T ss_pred HHhcccchHHHHHHHH-----HhcceeEEEeeecchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhh-cCeecc
Confidence 5789999999999999 5555599999999998888887642 348888999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccc-cCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+|||++ .++.+||||||+|+.+. .+..-+.++.|+||+|||.+.|...|+.++||||+||++.||++|.+.|+|
T Consensus 126 DIKPENILit-~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 126 DIKPENILIT-QNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred cCChhheEEe-cCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 9999999999 58899999999999887 445557789999999999999988899999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHh--hcCcCCcCccCCCCC-CCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIR--CMNPNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.++.+++..|.+.+|...+.-.+ ..++.|....+|... .++.+..+++ ++.-+.||+++||..||.+|++.++++.
T Consensus 205 ~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 205 RSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhc
Confidence 99999999999999998776544 346677777777765 3445554544 7889999999999999999999999999
Q ss_pred CCCcccccC
Q 022500 237 HPFFDELRE 245 (296)
Q Consensus 237 hp~f~~~~~ 245 (296)
||||.++.+
T Consensus 284 H~yFd~~~e 292 (396)
T KOG0593|consen 284 HPYFDGFIE 292 (396)
T ss_pred ChHHHHHHH
Confidence 999977644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=335.36 Aligned_cols=231 Identities=39% Similarity=0.747 Sum_probs=201.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+.++++|...++ +.||+||++.+|...+++ ....++...++.|+.+++.||+|||+ +.|+||
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~-----l~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHR 125 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSN-----LSLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHR 125 (318)
T ss_pred HHHccCcchhhhhhhccCCCc-----eEEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcc
Confidence 467899999999999954444 889999999999988886 56779999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc-cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||.|+|++ .++.+||+|||+|+.+.+.... ...+-|+||+|||.+.|...|+..+|+||+|||++||+.|.+.|+|
T Consensus 126 DlKPnNLLis-~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG 204 (318)
T KOG0659|consen 126 DLKPNNLLIS-SDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG 204 (318)
T ss_pred cCCccceEEc-CCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence 9999999999 5889999999999987655433 3347899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.++.+++..|++.+|+|.++.|..+. ++|..+. .....+....++ ..++++.||+.+||.+||.+|+|+.|+++|
T Consensus 205 ~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~--~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 205 DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ--QFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CchHHHHHHHHHHcCCCCcccCccccccccHHHHh--cCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 99999999999999999999998875 4555554 223333333343 478889999999999999999999999999
Q ss_pred CCccccc
Q 022500 238 PFFDELR 244 (296)
Q Consensus 238 p~f~~~~ 244 (296)
+||++..
T Consensus 282 ~yf~~~P 288 (318)
T KOG0659|consen 282 PYFKSLP 288 (318)
T ss_pred hhhhcCC
Confidence 9999753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=360.30 Aligned_cols=209 Identities=32% Similarity=0.496 Sum_probs=171.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||+++++|. ...++|+||||++| +|++.+- .++.+.+...+.+++|++.|+.|||+ +||+|
T Consensus 230 LkkL~HP~IV~~~d~f~-----~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~H 299 (475)
T KOG0615|consen 230 LKKLSHPNIVRIKDFFE-----VPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIH 299 (475)
T ss_pred HHhcCCCCEEEEeeeee-----cCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCccc
Confidence 67899999999999994 44448999999995 6665554 56788999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+|||++.+ +..+||+|||+|+.........+.+|||.|.|||++.+. ..+..++|+||+||++|.+++|.+
T Consensus 300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 300 RDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred ccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 9999999999742 256899999999988776677889999999999999643 335568999999999999999999
Q ss_pred CCCCCChHH-HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 156 LFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 156 pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
||.+..... ...+|.+. .|. + ....+..+++++++||++||..||++|+|++|+
T Consensus 380 PFS~~~~~~sl~eQI~~G--------------~y~---f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 380 PFSEEYTDPSLKEQILKG--------------RYA---F--------GPLQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred CcccccCCccHHHHHhcC--------------ccc---c--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 998765433 44444331 111 1 111234589999999999999999999999999
Q ss_pred hcCCCccccc
Q 022500 235 CAHPFFDELR 244 (296)
Q Consensus 235 l~hp~f~~~~ 244 (296)
|+||||+...
T Consensus 435 L~hpW~~~~~ 444 (475)
T KOG0615|consen 435 LNHPWFKDAP 444 (475)
T ss_pred hcChhhhccc
Confidence 9999999764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=340.14 Aligned_cols=235 Identities=34% Similarity=0.580 Sum_probs=201.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.+.+|||||.+.++.+...-. .+|||||||+.+|...+.. -..+|...+++.++.|++.|++|||. +.|+|||
T Consensus 130 l~~~H~NIV~vkEVVvG~~~d---~iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRD 202 (419)
T KOG0663|consen 130 LKARHPNIVEVKEVVVGSNMD---KIYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRD 202 (419)
T ss_pred HhcCCCCeeeeEEEEeccccc---eeeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecc
Confidence 467899999999998755432 2789999999999888875 34689999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||++|+|++ +.|.+||+|||+|+.+.+... .+..+-|.||+|||++.|...|+.++|+||+|||+.||+++.+.|+|.
T Consensus 203 LK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 203 LKTSNLLLS-HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred cchhheeec-cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 999999999 688899999999998876644 345677999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCC-CCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+..+++.+|++.+|+|+...|..... ....+.++...-.++...+... +++...||++++|.+||.+|+||+++|+|
T Consensus 282 sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 282 SEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 99999999999999999887765532 1222344444444455555544 78999999999999999999999999999
Q ss_pred CCccccc
Q 022500 238 PFFDELR 244 (296)
Q Consensus 238 p~f~~~~ 244 (296)
+||.+..
T Consensus 362 ~~F~e~P 368 (419)
T KOG0663|consen 362 EYFRETP 368 (419)
T ss_pred cccccCC
Confidence 9999743
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=362.86 Aligned_cols=201 Identities=32% Similarity=0.524 Sum_probs=179.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++|+|||||+++++| ++..++|||+|+|. ++|.++++ .++.++|.+++.++.||+.||.|||+ .+|+||
T Consensus 73 r~L~HpnIV~f~~~F-----EDs~nVYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHR 142 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFF-----EDSNNVYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHR 142 (592)
T ss_pred HhcCCCcEEeeeeEe-----ecCCceEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceec
Confidence 679999999999999 66666999999999 67776666 45889999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||..|++++ .+.+|||+|||+|..+... +...+.+|||.|+|||++.. ..++..+||||+|||+|.||+|+|||..
T Consensus 143 DLKLGNlfL~-~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 143 DLKLGNLFLN-ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred ccchhheeec-CcCcEEecccceeeeecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 9999999999 5778999999999988644 66778899999999999974 5699999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+-.+.+.+|... ++. +|..++.+++|||.+||+.||.+|||++++|.|+|
T Consensus 221 k~vkety~~Ik~~-----------------~Y~------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 221 KTVKETYNKIKLN-----------------EYS------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred chHHHHHHHHHhc-----------------Ccc------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 9999999888762 222 33468999999999999999999999999999999
Q ss_pred cccc
Q 022500 240 FDEL 243 (296)
Q Consensus 240 f~~~ 243 (296)
|++-
T Consensus 272 f~~g 275 (592)
T KOG0575|consen 272 FKSG 275 (592)
T ss_pred hhCC
Confidence 9543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=365.69 Aligned_cols=283 Identities=51% Similarity=0.971 Sum_probs=237.9
Q ss_pred CCCCCCCCeeeeceeeeccC---CCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 1 MRVMDHPNVISLKHCFFSTT---SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~---~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
|+.++|||||++++++.... .....++++||||+++++.+.+..+......+++..++.++.||+.||+|||+ +||
T Consensus 113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~I 191 (440)
T PTZ00036 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFI 191 (440)
T ss_pred HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCE
Confidence 46789999999999875432 13345688999999999888887766677889999999999999999999999 799
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
+||||||+|||++..++.+||+|||+|+............||+.|+|||++.+...++.++||||+||++|+|++|.+||
T Consensus 192 iHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred ecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999986556799999999987755555556788999999999877667999999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+.+.++++..|.|..+.+..+.+.|..+.++......+...++...++++++||.+||++||.+|+|+.|+++|
T Consensus 272 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 272 SGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 99999999999999999999999888888888887887777777777778889999999999999999999999999999
Q ss_pred CCcccccCCCCCCCC-CCCCCCCCCchhhh-cCCCHHHHhhhcHHHHHh
Q 022500 238 PFFDELREPNARLPN-GRPLPPLFNFKQEL-SGASPELVNKLIPDHVKR 284 (296)
Q Consensus 238 p~f~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 284 (296)
|||..+++.....+. ....++.+++.... ...+.+....+++.....
T Consensus 352 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (440)
T PTZ00036 352 PFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYE 400 (440)
T ss_pred hhHHhhhcccccCCCCCCCCCCCcCCCHHHHhhCCHHHHHHHhhHHHHH
Confidence 999998776544433 24556677776443 467777777776654443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-51 Score=351.66 Aligned_cols=233 Identities=36% Similarity=0.605 Sum_probs=196.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++|+|||||+|.++..+. ....+|||+|||+.+|.-++.. ..-.|++.+++.|+.||+.||+|||+ +||+||
T Consensus 170 Lr~l~HpNIikL~eivt~~---~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHR 242 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSK---LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHR 242 (560)
T ss_pred HHhcCCCcccceeeEEEec---CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeec
Confidence 5789999999999988654 2334999999999988777663 55689999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||.+|||+| +++.+||+|||+|+.+.... ..++.+.|.||+|||+++|...|+.++|+||+|||+.||++|++.|+
T Consensus 243 DIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 243 DIKGSNILID-NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred cccccceEEc-CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 9999999999 68999999999999665443 34677889999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcC-cCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMN-PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
|.++.+++..|.+..|.|....|.... +.+..+.....-...+.+. ...+++.+.+|+.+||+.||.+|.||.++|+|
T Consensus 322 G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 999999999999999999998877222 2122222222212233333 45689999999999999999999999999999
Q ss_pred CCccc
Q 022500 238 PFFDE 242 (296)
Q Consensus 238 p~f~~ 242 (296)
+||..
T Consensus 401 eyF~t 405 (560)
T KOG0600|consen 401 EYFTT 405 (560)
T ss_pred ccccc
Confidence 99943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=338.14 Aligned_cols=207 Identities=30% Similarity=0.513 Sum_probs=178.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|.+++||+||+++-.| ++...+|+|+||+.| .|+.-+. ..+.+++..++.|+.+|+.||.|||+ +||+|
T Consensus 79 L~~v~hPFiv~l~ysF-----Qt~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiy 148 (357)
T KOG0598|consen 79 LSKIKHPFIVKLIYSF-----QTEEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIY 148 (357)
T ss_pred HHhCCCCcEeeeEEec-----ccCCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3568999999999999 555559999999996 5544443 56889999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ ..|.++|+|||+|+..... ....+.+||+.|||||++.+. .|+..+|+||+|+++|+|++|.+||.
T Consensus 149 RDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 149 RDLKPENILLD-EQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred ccCCHHHeeec-CCCcEEEeccccchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCc
Confidence 99999999999 5788999999999955443 455667999999999999875 59999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC----CHHHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEA 234 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~----t~~e~ 234 (296)
+.+....+.+|.+.-.. ..+..++++++|+|+++|++||++|. ++.++
T Consensus 227 ~~~~~~~~~~I~~~k~~----------------------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i 278 (357)
T KOG0598|consen 227 AEDVKKMYDKILKGKLP----------------------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI 278 (357)
T ss_pred CccHHHHHHHHhcCcCC----------------------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHh
Confidence 99999999988873210 11233899999999999999999996 68899
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
.+||||++++|..
T Consensus 279 k~HpfF~~inW~~ 291 (357)
T KOG0598|consen 279 KRHPFFKGINWEK 291 (357)
T ss_pred hcCcccccCCHHH
Confidence 9999999998863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=348.04 Aligned_cols=207 Identities=34% Similarity=0.613 Sum_probs=182.3
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
.+| .||.||+||..| +|...+|+|+||++ |+|+++++.+ +.|++..++.|+.||+.||+|||+ +||||
T Consensus 128 ~~L~~hPgivkLy~TF-----QD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIH 197 (604)
T KOG0592|consen 128 TQLSGHPGIVKLYFTF-----QDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIH 197 (604)
T ss_pred HHhhCCCCeEEEEEEe-----ecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCcee
Confidence 456 899999999999 55555999999999 7888888865 789999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--------------ccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
|||||+|||++ .++.+||+|||.|+.+..... ..+++||-.|.+||++.. ...+..+|+|+|||
T Consensus 198 RDlKPENILLd-~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGC 275 (604)
T KOG0592|consen 198 RDLKPENILLD-KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGC 275 (604)
T ss_pred ccCChhheeEc-CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHH
Confidence 99999999999 588999999999987643211 146899999999999965 45899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 146 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 146 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
|+|.|+.|.+||.+.++.-.+++|+++ ++ .++.++++.++|||+++|..||
T Consensus 276 ilyQmlaG~PPFra~NeyliFqkI~~l-----------------~y------------~fp~~fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 276 ILYQMLAGQPPFRAANEYLIFQKIQAL-----------------DY------------EFPEGFPEDARDLIKKLLVRDP 326 (604)
T ss_pred HHHHHhcCCCCCccccHHHHHHHHHHh-----------------cc------------cCCCCCCHHHHHHHHHHHccCc
Confidence 999999999999999999999999884 22 2445689999999999999999
Q ss_pred CCCCCHHHHhcCCCcccccCCCCC
Q 022500 226 SLRCTALEACAHPFFDELREPNAR 249 (296)
Q Consensus 226 ~~R~t~~e~l~hp~f~~~~~~~~~ 249 (296)
.+|+|+.+|.+||||.++.|.+..
T Consensus 327 ~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 327 SDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred cccccHHHHhhCcccccCChhhhh
Confidence 999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=334.77 Aligned_cols=207 Identities=32% Similarity=0.583 Sum_probs=174.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+..+|||||++|++|+.... .++|+||||+ |+|..+++. -++++|.....++.+++.||.|||+..+|+||
T Consensus 132 ~~~~spyIV~~ygaF~~~~~----~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHR 203 (364)
T KOG0581|consen 132 RSCQSPYIVGFYGAFYSNGE----EISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHR 203 (364)
T ss_pred hhCCCCCeeeEeEEEEeCCc----eEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeec
Confidence 56799999999999976552 3889999999 577766664 37799999999999999999999953699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+|||++ ..+.|||||||.++.+... ...+++||..|||||.+.+. .|+.++||||||+.++|+++|+.||...
T Consensus 204 DIKPsNlLvN-skGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 204 DIKPSNLLVN-SKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cCCHHHeeec-cCCCEEeccccccHHhhhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCc
Confidence 9999999999 5889999999999987665 56789999999999999775 5999999999999999999999999875
Q ss_pred -----ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCC-CCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 161 -----NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 161 -----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
+..+.+..|+.. .|+ .++. .+|+++++||..||++||++|+|+.++
T Consensus 281 ~~~~~~~~~Ll~~Iv~~--ppP--------------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL 332 (364)
T KOG0581|consen 281 NPPYLDIFELLCAIVDE--PPP--------------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQL 332 (364)
T ss_pred CCCCCCHHHHHHHHhcC--CCC--------------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 445555555541 111 1222 389999999999999999999999999
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
++|||+++....+
T Consensus 333 l~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 333 LQHPFIKKFEDPN 345 (364)
T ss_pred hcCHHHhhccccc
Confidence 9999999875543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=326.34 Aligned_cols=243 Identities=35% Similarity=0.708 Sum_probs=201.3
Q ss_pred CCCCCCCC-eeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 1 MRVMDHPN-VISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 1 l~~l~Hpn-Iv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
|+.|+|+| ||++++++.+... .....+++|+||++-+|..++.........++...++.+++||+.||+|||+ ++|+
T Consensus 64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~Il 142 (323)
T KOG0594|consen 64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGIL 142 (323)
T ss_pred HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCee
Confidence 46789999 9999999976552 2233588999999999988888654322457778999999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||||+|||+++ ++.+||+|||+|+...- .......++|.||+|||++.|...|+..+||||+|||++||+++++.|
T Consensus 143 HRDLKPQNlLi~~-~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF 221 (323)
T KOG0594|consen 143 HRDLKPQNLLISS-SGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF 221 (323)
T ss_pred cccCCcceEEECC-CCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence 9999999999995 88999999999997652 333456789999999999999988999999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCC-CCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
+|.++.+++.+|.+.+|+|..+.|+... +.|.. .++... ..++....+ ..++++.|++.+||+++|.+|.|+..+
T Consensus 222 pG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~-~f~~~~~~~~l~~~~~-~~~~~~~dll~~~L~y~p~~R~Sa~~a 299 (323)
T KOG0594|consen 222 PGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA-PFPKWPGPKDLSSILP-KLDPDGIELLSKLLQYDPAKRISAKGA 299 (323)
T ss_pred CCCcHHHHHHHHHHHcCCCCccCCCCccccccccc-cCcCCCCccchHHhcc-ccCccHHHHHHHHhccCcccCcCHHHH
Confidence 9999999999999999999998887653 33332 222222 333333333 355799999999999999999999999
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
+.||||.......
T Consensus 300 l~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 300 LTHPYFSELPEKS 312 (323)
T ss_pred hcChhhcccccch
Confidence 9999999876543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=346.78 Aligned_cols=207 Identities=34% Similarity=0.579 Sum_probs=181.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
||.+.||||+++|+++ ++..++|+|.||++ |.|++++. ..+++++.++.++++||+.|+.|+|. -+|+|
T Consensus 66 MkLi~HpnVl~LydVw-----e~~~~lylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icH 135 (786)
T KOG0588|consen 66 MKLIEHPNVLRLYDVW-----ENKQHLYLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHA-FNICH 135 (786)
T ss_pred HHHhcCCCeeeeeeee-----ccCceEEEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhh-hccee
Confidence 6789999999999999 66667999999999 56666665 46889999999999999999999999 59999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+||+|+|++. ..++||+|||+|..-..+....+.+|+|.|.|||++.|..+.+.++||||+|||+|.||+|..||.+
T Consensus 136 RDLKpENlLLd~-~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 136 RDLKPENLLLDV-KNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred ccCCchhhhhhc-ccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 999999999995 5569999999998777777778899999999999999988889999999999999999999999997
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+-...+.++-+ ..|. ++..++++++|||++||.+||++|+|.+|+++|||
T Consensus 215 dNir~LLlKV~~-----------------G~f~------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 215 DNIRVLLLKVQR-----------------GVFE------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ccHHHHHHHHHc-----------------Cccc------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 776666655543 1222 33468999999999999999999999999999999
Q ss_pred cccccCCC
Q 022500 240 FDELREPN 247 (296)
Q Consensus 240 f~~~~~~~ 247 (296)
+.......
T Consensus 266 l~g~~~~~ 273 (786)
T KOG0588|consen 266 LSGYTSLP 273 (786)
T ss_pred hhcCCCCC
Confidence 99876543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=316.88 Aligned_cols=204 Identities=30% Similarity=0.538 Sum_probs=179.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.+.||+++++++.+ ++..++|+||||++| .|+..++ ..+++++..++.|+.||+.||+|||+ .+|++
T Consensus 98 L~~v~~PFlv~l~~t~-----~d~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiY 167 (355)
T KOG0616|consen 98 LKAVSHPFLVKLYGTF-----KDNSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIY 167 (355)
T ss_pred HhhccCceeEEEEEee-----ccCCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeee
Confidence 4678899999999988 666679999999995 6666555 55789999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||+| .+|.+||+|||+|+.... ...+.+|||.|+|||++... .|+.++|+|||||++|||+.|.+||.+
T Consensus 168 RDLKPENiLlD-~~G~iKitDFGFAK~v~~--rT~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 168 RDLKPENLLLD-QNGHIKITDFGFAKRVSG--RTWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred ccCChHHeeec-cCCcEEEEeccceEEecC--cEEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 99999999999 588899999999997643 36678999999999999754 599999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+...++.+|++. .+. ++..++++++|||+++|++|-.+|. ...++
T Consensus 244 ~~~~~iY~KI~~~-----------------~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dI 294 (355)
T KOG0616|consen 244 DNPIQIYEKILEG-----------------KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDI 294 (355)
T ss_pred CChHHHHHHHHhC-----------------ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCcccc
Confidence 9999999999873 222 3445899999999999999999995 46799
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
.+||||+++.|..
T Consensus 295 k~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 295 KNHPWFKGVDWEA 307 (355)
T ss_pred ccCcccccccHHH
Confidence 9999999998763
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=307.61 Aligned_cols=206 Identities=32% Similarity=0.501 Sum_probs=175.6
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.|+|||||++.+.+ ....+.|||+|++.| +|+..+-. +..+++..+..+++||+.||.|+|. +||+||
T Consensus 65 ~~LqHP~IvrL~~ti-----~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHR 134 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHR 134 (355)
T ss_pred HhcCCCcEeehhhhh-----cccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceec
Confidence 358999999999987 666678999999996 66665543 2568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|+||+|+++.++ +.-+||+|||+|.....+..-..++|||.|||||++.. ..|+.++|||++|||+|-|+.|.+||.
T Consensus 135 DvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 135 DLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred cCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 999999999532 34699999999998886666778999999999999965 459999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+.+|++. .+.++. ..+..+++++++|+++||..||.+|+|+.|+|+||
T Consensus 214 ~~~~~rlye~I~~g-----------------~yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 214 DEDQHRLYEQIKAG-----------------AYDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred CccHHHHHHHHhcc-----------------ccCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 99999999988762 111111 12245899999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
|+.+-
T Consensus 269 Wi~~r 273 (355)
T KOG0033|consen 269 WICNR 273 (355)
T ss_pred hhcch
Confidence 99753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=330.47 Aligned_cols=211 Identities=32% Similarity=0.537 Sum_probs=174.9
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~-l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
..++|+||+||-.| ++..++||||||++|+ +..+| ...+.+++..++.|+.+++.|++.+|. .|+||||
T Consensus 197 ~~ds~~vVKLyYsF-----QD~~~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRD 266 (550)
T KOG0605|consen 197 EVDSPWVVKLYYSF-----QDKEYLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRD 266 (550)
T ss_pred hcCCCcEEEEEEEe-----cCCCeeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHH-cCccccc
Confidence 35789999999999 6777799999999975 33333 356889999999999999999999999 5999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCcccccc------------------------CC-----C-------------------c
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIA------------------------GE-----A-------------------N 113 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~------------------------~~-----~-------------------~ 113 (296)
|||+|+|+| ..|.+||+|||+|..+.. .. . .
T Consensus 267 IKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a 345 (550)
T KOG0605|consen 267 IKPDNLLID-AKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA 345 (550)
T ss_pred CChhheeec-CCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence 999999999 588899999999853211 00 0 0
Q ss_pred cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC
Q 022500 114 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 193 (296)
Q Consensus 114 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 193 (296)
.+.+|||.|+|||++.+.+ |+..+|+||||||+||||.|.+||.+.+..+...+|++-... +.+
T Consensus 346 ~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~f 409 (550)
T KOG0605|consen 346 YSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKF 409 (550)
T ss_pred hcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccC
Confidence 1458999999999998764 999999999999999999999999999999999999873111 111
Q ss_pred CCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC---HHHHhcCCCcccccCCCCCCC
Q 022500 194 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLP 251 (296)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---~~e~l~hp~f~~~~~~~~~~~ 251 (296)
|. ...++.+++|||.+||+ ||.+|.. ++||.+||||+.+.|......
T Consensus 410 P~----------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~ 459 (550)
T KOG0605|consen 410 PE----------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREM 459 (550)
T ss_pred CC----------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcC
Confidence 11 12368999999999999 9999985 899999999999999865433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=333.04 Aligned_cols=203 Identities=32% Similarity=0.516 Sum_probs=174.7
Q ss_pred CCCCC-CCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 1 MRVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 1 l~~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
|++++ ||||+++++++..... +|+|||||.| +|++.+.. .+++.+..++++++|+++|++|||+ +||+
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~-----~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~ 142 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTK-----IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIV 142 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCe-----EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEe
Confidence 35677 9999999999954443 9999999995 77777663 5889999999999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCcccc-ccCCCccceeecccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||||+|||++...+++||+|||++... .......+.+||+.|+|||++.+.. +-+.++||||+||++|.|++|..|
T Consensus 143 HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 143 HRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred eCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 99999999999953389999999999977 4556667899999999999998766 456999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCC-CHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-PPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|...+....+..|.+. .+. ++..+ |+++++|+++||..||.+|+|+.+++
T Consensus 223 F~d~~~~~l~~ki~~~-----------------~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 223 FDDSNVPNLYRKIRKG-----------------EFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCccHHHHHHHHhcC-----------------Ccc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 9998877777775541 122 22346 99999999999999999999999999
Q ss_pred cCCCccc
Q 022500 236 AHPFFDE 242 (296)
Q Consensus 236 ~hp~f~~ 242 (296)
+||||+.
T Consensus 274 ~h~w~~~ 280 (370)
T KOG0583|consen 274 EHPWFQK 280 (370)
T ss_pred hChhhcc
Confidence 9999996
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=309.79 Aligned_cols=207 Identities=33% Similarity=0.512 Sum_probs=180.1
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
+-||||+++.++| +...++++|+|.|+ |.|++++. ....+++...+.+++|++.|++|||. ++|+||||
T Consensus 80 ~GHP~II~l~D~y-----es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDL 149 (411)
T KOG0599|consen 80 MGHPYIIDLQDVY-----ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDL 149 (411)
T ss_pred cCCCcEEEeeeec-----cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhccc
Confidence 4699999999999 66677999999999 78877775 45779999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhcc-----CCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||+|||++ ++.++||+|||+|+.+..++.....+|||+|.|||.+. +...|+..+|+||+|||+|.|+.|.+||
T Consensus 150 KpENILld-dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 150 KPENILLD-DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred Chhheeec-cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 99999999 68899999999999999888888899999999999984 3456899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
..+...-++..|++.--....+ -+..++.+.+|||++||++||++|+|+.|+|+|
T Consensus 229 wHRkQmlMLR~ImeGkyqF~sp-------------------------eWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 229 WHRKQMLMLRMIMEGKYQFRSP-------------------------EWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hHHHHHHHHHHHHhcccccCCc-------------------------chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 9998888888887621111111 123479999999999999999999999999999
Q ss_pred CCcccccCC
Q 022500 238 PFFDELREP 246 (296)
Q Consensus 238 p~f~~~~~~ 246 (296)
|||..+-..
T Consensus 284 pff~q~~~~ 292 (411)
T KOG0599|consen 284 PFFIQIAQQ 292 (411)
T ss_pred hHHHHHHHh
Confidence 999766443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=336.48 Aligned_cols=202 Identities=31% Similarity=0.565 Sum_probs=175.8
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
+||.+++++.+| +...++|+||||+.|+. +.+ ......+++..++.|+.+++.||+|||+ +||||||||.
T Consensus 427 ~HPFL~~L~~~f-----QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKL 496 (694)
T KOG0694|consen 427 RHPFLVNLFSCF-----QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKL 496 (694)
T ss_pred cCCeEeeccccc-----ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecch
Confidence 699999999999 55556999999999863 222 2345789999999999999999999999 7999999999
Q ss_pred CcEEEcCCCCcEEEeeccCccccc-cCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 022500 85 QNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 163 (296)
Q Consensus 85 ~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 163 (296)
+|||+| ..|.+||+|||+|+... .+....+++|||.|+|||++.+. .|+.++|+|||||++|+|+.|..||+|++..
T Consensus 497 dNiLLD-~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 497 DNLLLD-TEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred hheEEc-ccCcEEecccccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 999999 47889999999999765 44456788999999999999765 5999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHHhcCC
Q 022500 164 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHP 238 (296)
Q Consensus 164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~l~hp 238 (296)
+....|+.. +.. ++..+|.++.++++++|++||++|+. ++++.+||
T Consensus 575 e~FdsI~~d-----------------~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hp 625 (694)
T KOG0694|consen 575 EVFDSIVND-----------------EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHP 625 (694)
T ss_pred HHHHHHhcC-----------------CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCC
Confidence 999998862 111 33458999999999999999999986 47899999
Q ss_pred CcccccCCC
Q 022500 239 FFDELREPN 247 (296)
Q Consensus 239 ~f~~~~~~~ 247 (296)
||+.+.|..
T Consensus 626 FFr~i~w~~ 634 (694)
T KOG0694|consen 626 FFRSIDWDD 634 (694)
T ss_pred ccccCCHHH
Confidence 999998863
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=315.36 Aligned_cols=213 Identities=29% Similarity=0.513 Sum_probs=178.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||.++.||..| +...+.|+|||||+| +|...++ .+.+..+++..++.|+.+++.||+|||.+ |||+
T Consensus 131 L~~lDHPFlPTLYa~f-----et~~~~cl~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml-GivY 202 (459)
T KOG0610|consen 131 LSLLDHPFLPTLYASF-----ETDKYSCLVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML-GIVY 202 (459)
T ss_pred HHhcCCCccchhhhee-----eccceeEEEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh-ceee
Confidence 4679999999999999 666779999999996 5544443 34667899999999999999999999995 9999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccc----------------------------------cCC--------------
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLI----------------------------------AGE-------------- 111 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~----------------------------------~~~-------------- 111 (296)
|||||+|||+. .+|.|.|+||.++.... ...
T Consensus 203 RDLKPENILvr-edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p 281 (459)
T KOG0610|consen 203 RDLKPENILVR-EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLP 281 (459)
T ss_pred ccCCcceeEEe-cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccch
Confidence 99999999998 58889999999974210 000
Q ss_pred ---------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Q 022500 112 ---------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182 (296)
Q Consensus 112 ---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 182 (296)
...+++||-.|.|||++.|. ..+.++|+|++|+++|||+.|..||.|.+..+.+.+|+..
T Consensus 282 ~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~---------- 350 (459)
T KOG0610|consen 282 ELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ---------- 350 (459)
T ss_pred hhhcCCCCccccccccccccccceeeecC-CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC----------
Confidence 11346889999999999876 4999999999999999999999999999999999998862
Q ss_pred hcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC----HHHHhcCCCcccccCCCCCC
Q 022500 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARL 250 (296)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t----~~e~l~hp~f~~~~~~~~~~ 250 (296)
+..++.. ..++..++|||+++|.+||++|+. |.||.+||||+.++|...+.
T Consensus 351 -------~l~Fp~~----------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 351 -------PLKFPEE----------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRC 405 (459)
T ss_pred -------CCcCCCC----------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheec
Confidence 2222221 137889999999999999999998 99999999999999985443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=329.58 Aligned_cols=203 Identities=30% Similarity=0.536 Sum_probs=175.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+..+|+|||++++.|.-... +++||||++| +|.+.+.. ..++|.++..+.++++.||+|||. +||+|
T Consensus 324 m~~~~H~NiVnfl~Sylv~de-----LWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiH 392 (550)
T KOG0578|consen 324 MRDLHHPNIVNFLDSYLVGDE-----LWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIH 392 (550)
T ss_pred HHhccchHHHHHHHHhcccce-----eEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceee
Confidence 577899999999998865433 9999999995 66666553 459999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||.+|||+. .++.+||+|||+|..+.... ...+-+|||+|||||++.. ..|+.++||||||+|++||+-|.+||-
T Consensus 393 rDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 393 RDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred eccccceeEec-cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCcc
Confidence 99999999999 57889999999999886654 4567899999999999964 469999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
.++....+..|.. .|+|... .+..+|+.++|||.+||++|+.+|++|.|+|+||
T Consensus 471 nE~PlrAlyLIa~-ng~P~lk-------------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 471 NENPLRALYLIAT-NGTPKLK-------------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred CCChHHHHHHHhh-cCCCCcC-------------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 9888888776654 3444422 2245899999999999999999999999999999
Q ss_pred Cccc
Q 022500 239 FFDE 242 (296)
Q Consensus 239 ~f~~ 242 (296)
||+.
T Consensus 525 Fl~~ 528 (550)
T KOG0578|consen 525 FLKM 528 (550)
T ss_pred hhhh
Confidence 9954
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=313.95 Aligned_cols=229 Identities=35% Similarity=0.701 Sum_probs=187.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++. ....+|+||||++|+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 57 l~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~ 127 (288)
T cd07871 57 LKNLKHANIVTLHDIIH-----TERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHR 127 (288)
T ss_pred HHhCCCCCEeeEEEEEc-----CCCeEEEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 35789999999999984 3345899999999988777653 23457899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++...... ......+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+
T Consensus 128 dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 128 DLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CCCHHHEEEC-CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998 57789999999997543222 223457799999999987666689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+..+.+..+.+..+.+..... .+....++.....++.. ....++++++|||++||++||.+|+|++|+++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 999999999999999998887765432 22333333333333322 223578999999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 286 p~f 288 (288)
T cd07871 286 SYF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=314.46 Aligned_cols=205 Identities=31% Similarity=0.537 Sum_probs=173.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||+++++. +...++|||||||+ |+|.+++. ..+.++++.++.++.||+.||++||+ ++|+|
T Consensus 63 Lkel~H~nIV~l~d~~-----~~~~~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiH 132 (429)
T KOG0595|consen 63 LKELKHPNIVRLLDCI-----EDDDFIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHE-NNIIH 132 (429)
T ss_pred HHhcCCcceeeEEEEE-----ecCCeEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 5788999999999999 44446999999999 57776666 45789999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCC--C---CcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPL--T---HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~--~---~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+|||++.. + ..+||+|||+|+.+.+.....+.+|+|.|||||++.. ..|+.|+|+||+|+|+|+|++|.
T Consensus 133 RDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 133 RDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred ccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCC
Confidence 9999999999752 1 4689999999999987777788999999999999964 46999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
+||...+..+.+..+-+... ....++..+++...+++...|+.||.+|.+..+-
T Consensus 212 ~Pf~a~t~~eL~~~~~k~~~--------------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 212 PPFDAETPKELLLYIKKGNE--------------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred CCccccCHHHHHHHHhcccc--------------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 99999998888775543211 1111233467788899999999999999999999
Q ss_pred hcCCCccc
Q 022500 235 CAHPFFDE 242 (296)
Q Consensus 235 l~hp~f~~ 242 (296)
+.|++...
T Consensus 266 ~~~~~l~~ 273 (429)
T KOG0595|consen 266 FDHPFLAA 273 (429)
T ss_pred hhhhhccc
Confidence 99998865
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=315.13 Aligned_cols=211 Identities=33% Similarity=0.547 Sum_probs=167.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||++++....... ..++|+|||++ |+|.+.+..+ ++.+++..++.+.+||+.||+|||+ +||+|
T Consensus 68 L~~l~~p~IV~~~G~~~~~~~---~~~~i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH 140 (313)
T KOG0198|consen 68 LSRLNHPNIVQYYGSSSSREN---DEYNIFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHS-KGIVH 140 (313)
T ss_pred HHhCCCCCEEeeCCccccccC---eeeEeeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 467899999999996432221 45889999999 5877777753 2279999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCcccccc----CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIA----GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+|||++..++.+||+|||.++.... ........||+.|||||++......+.++||||+||++.||+||.+
T Consensus 141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 999999999995367899999999987653 1223467899999999999742223459999999999999999999
Q ss_pred CCCC-CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 156 LFPG-ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 156 pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
||.. ....+.+..+..... .| .++..+++++++||.+||.+||.+||||+++
T Consensus 221 PW~~~~~~~~~~~~ig~~~~------------------~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL 273 (313)
T KOG0198|consen 221 PWSEFFEEAEALLLIGREDS------------------LP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL 273 (313)
T ss_pred cchhhcchHHHHHHHhccCC------------------CC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 9987 343333333332100 01 2455699999999999999999999999999
Q ss_pred hcCCCcccccC
Q 022500 235 CAHPFFDELRE 245 (296)
Q Consensus 235 l~hp~f~~~~~ 245 (296)
|+|||...-..
T Consensus 274 L~hpf~~~~~~ 284 (313)
T KOG0198|consen 274 LEHPFLKQNSI 284 (313)
T ss_pred hhChhhhcccc
Confidence 99999986443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=302.83 Aligned_cols=199 Identities=27% Similarity=0.443 Sum_probs=168.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CC-C
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--VP-R 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~--~~-~ 76 (296)
|++|+|||||++++.-+. +++..++||||||+ |+|.+.++++...+..+++..+.+++.|++.||..+|+ -+ -
T Consensus 72 LkQL~HpNIVqYy~~~f~---~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~ 148 (375)
T KOG0591|consen 72 LKQLNHPNIVQYYAHSFI---EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGT 148 (375)
T ss_pred HHhcCCchHHHHHHHhhh---ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccc
Confidence 579999999999984332 23334889999999 79999999999999999999999999999999999998 31 2
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|+||||||.||+++ .++.+||+|||+++.+.+... ..+.+|||+||+||.+.+. .|+.+|||||+||++|||..=++
T Consensus 149 VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 149 VMHRDIKPANIFLT-ANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred eeeccCcchheEEc-CCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCC
Confidence 89999999999999 688999999999998765443 3678999999999999765 59999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
||.|++..+...+|.+.--.|-+. ...|.++..+|.-|++.||+.||+.
T Consensus 227 PF~g~n~~~L~~KI~qgd~~~~p~---------------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 227 PFYGDNLLSLCKKIEQGDYPPLPD---------------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CcccccHHHHHHHHHcCCCCCCcH---------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 999998777777776531111110 2378899999999999999999986
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=326.14 Aligned_cols=227 Identities=36% Similarity=0.627 Sum_probs=185.3
Q ss_pred CCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCc
Q 022500 7 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 86 (296)
Q Consensus 7 pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~N 86 (296)
-|||+++++|. -..++|||+|.++-+|+++++.. ....++...++.++.||+.||.+||+ .||||+||||||
T Consensus 248 ~n~Vrm~d~F~-----fr~HlciVfELL~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPEN 319 (586)
T KOG0667|consen 248 YNIVRMLDYFY-----FRNHLCIVFELLSTNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPEN 319 (586)
T ss_pred eeEEEeeeccc-----cccceeeeehhhhhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhh
Confidence 48999999994 44559999999999999999863 34559999999999999999999999 599999999999
Q ss_pred EEEc-CCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 022500 87 LLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 165 (296)
Q Consensus 87 ill~-~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 165 (296)
|||. .....|||+|||+|... .....+++.++.|+|||+++|.. |+.+.||||||||++||++|.++|+|.+..++
T Consensus 320 ILL~~~~r~~vKVIDFGSSc~~--~q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 320 ILLKDPKRSRIKVIDFGSSCFE--SQRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred eeeccCCcCceeEEeccccccc--CCcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 9984 33457999999999864 33445899999999999999865 99999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHhhcCcCCcCccC----CC-----------------------------C-CCCCcccccCCCCCH
Q 022500 166 LVEIIKVLGTPTREEIRCMNPNYTDFRF----PQ-----------------------------I-KAHPWHKVFHKRMPP 211 (296)
Q Consensus 166 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~-----------------------------~-~~~~~~~~~~~~~~~ 211 (296)
++.|++.+|.|+...+.........+.. +. . ....+.......-..
T Consensus 397 l~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~ 476 (586)
T KOG0667|consen 397 LARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDK 476 (586)
T ss_pred HHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHH
Confidence 9999999999999887644322111111 00 0 111222222223445
Q ss_pred HHHHHHHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 212 EAIDLASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 212 ~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
.+.|||++||.+||.+|+|+.++|+||||....
T Consensus 477 ~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 477 LFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred HHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 789999999999999999999999999998543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=298.73 Aligned_cols=212 Identities=27% Similarity=0.461 Sum_probs=173.0
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
-.|||||+++++|..+. .+..++.+|||.++| .|+.-+.. +.+..++|.++..|+.||..|+.|||++ +|.||||
T Consensus 112 s~h~~iV~IidVyeNs~-~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDl 187 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSY-QGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDL 187 (400)
T ss_pred cCCCceEEeehhhhhhc-cCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc-chhhccC
Confidence 36999999999997665 567789999999995 66666654 3456799999999999999999999995 9999999
Q ss_pred CCCcEEEcC--CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 83 KPQNLLVDP--LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 83 kp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||+|+|+.. .+..+||+|||+|+.-.......+.+.||+|.|||++ |...|+...|+||+||++|.|++|.+||++.
T Consensus 188 KpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 188 KPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred ChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 999999953 3457999999999987666666788899999999998 6667999999999999999999999999877
Q ss_pred ChH----HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 161 NAV----DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 161 ~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
... .+-.+|.. ..+.+|. ..+..+|++++|+|+++|..+|++|+|+.++++
T Consensus 267 hg~aispgMk~rI~~-----------------gqy~FP~--------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 267 HGLAISPGMKRRIRT-----------------GQYEFPE--------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCccCChhHHhHhhc-----------------cCccCCC--------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 532 22222222 1122222 112348999999999999999999999999999
Q ss_pred CCCcccccC
Q 022500 237 HPFFDELRE 245 (296)
Q Consensus 237 hp~f~~~~~ 245 (296)
|||+.....
T Consensus 322 hpwi~~~~~ 330 (400)
T KOG0604|consen 322 HPWINQYEA 330 (400)
T ss_pred Cchhccccc
Confidence 999987644
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=314.76 Aligned_cols=209 Identities=27% Similarity=0.436 Sum_probs=187.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
||.++|||||++|++..+... +|||+|+-+ |+|++++.. ....+++..+++|+.||+.|+.|+|.+ .+||
T Consensus 71 MKLVQHpNiVRLYEViDTQTK-----lyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVH 141 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTK-----LYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVH 141 (864)
T ss_pred HHHhcCcCeeeeeehhcccce-----EEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh-hhhc
Confidence 677899999999999855554 999999998 599998864 345699999999999999999999996 9999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|+.+..+-|-|||+|||++-.+..++...+.+|+..|.|||++.|..+..+++||||||||+|-|.+|++||..
T Consensus 142 RDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 142 RDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred ccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 99999999987778889999999999998888889999999999999999988777899999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.++.+.+.+|+.+--+ ++..++.+++|||..||..||++|.+.+||..|+|
T Consensus 222 ANDSETLTmImDCKYt-----------------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 222 ANDSETLTMIMDCKYT-----------------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ccchhhhhhhhccccc-----------------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 9999999999874221 33458999999999999999999999999999999
Q ss_pred cccccCCC
Q 022500 240 FDELREPN 247 (296)
Q Consensus 240 f~~~~~~~ 247 (296)
++......
T Consensus 273 lq~~D~~~ 280 (864)
T KOG4717|consen 273 LQAGDRGL 280 (864)
T ss_pred ccCCCCCc
Confidence 99887654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.20 Aligned_cols=272 Identities=36% Similarity=0.653 Sum_probs=200.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++......+...+|+|||||+++|.+.+. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~ 127 (338)
T cd07859 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHR 127 (338)
T ss_pred HHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 4578999999999988755544455689999999998877665 34569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. ..++.++||||+||++|+|++|.+
T Consensus 128 dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 128 DLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred CCCHHHeEEC-CCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 9999999999 578899999999976432221 1345789999999998542 458899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC-cCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY-TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
||.+.+....+..+....|.+...........- ..+ ........+....+ ..+++++.++|.+||+.||++|||++
T Consensus 207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~ 285 (338)
T cd07859 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAE 285 (338)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHH
Confidence 999999888888888888888877655432110 000 00001111111112 23688999999999999999999999
Q ss_pred HHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHH
Q 022500 233 EACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 281 (296)
Q Consensus 233 e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (296)
|+++||||+.+...... +...+... ..+.-+..+.+.+.+...+.++
T Consensus 286 e~l~hp~f~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 332 (338)
T cd07859 286 EALADPYFKGLAKVERE-PSAQPITK-LEFEFERRRLTKEDVRELIYRE 332 (338)
T ss_pred HHhcCchhhhcCccccc-cccCcccc-ccccHHHHhcCHHHHHHHHHHH
Confidence 99999999987664322 22222221 2233334445555555555444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=307.63 Aligned_cols=218 Identities=25% Similarity=0.422 Sum_probs=179.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||++++..|..... +|+||.||. |+++++++.+...+ ++|..+..++++++.||.|||. +|.||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~-----LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~-~G~IH 149 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSE-----LWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQ-NGHIH 149 (516)
T ss_pred hhhcCCCCcceEEEEEEecce-----eEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHh-cCcee
Confidence 678999999999999976555 999999999 79999999875543 9999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc-----cceeecccccCchhc-cCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELI-FGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
||||+.|||++ .+|.|||+|||.+..+...... .+.+||++|||||++ .....|+.|+||||+|+...||.+|
T Consensus 150 RdvKAgnILi~-~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G 228 (516)
T KOG0582|consen 150 RDVKAGNILID-SDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG 228 (516)
T ss_pred cccccccEEEc-CCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence 99999999999 5899999999998766543321 456899999999994 4456799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
..||....++..+..-++ +.|+...... ......+.++..++.+|..||++||++|||+++
T Consensus 229 ~aPf~k~pPmkvLl~tLq--n~pp~~~t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk 289 (516)
T KOG0582|consen 229 HAPFSKYPPMKVLLLTLQ--NDPPTLLTSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASK 289 (516)
T ss_pred CCCcccCChHHHHHHHhc--CCCCCccccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence 999999888877655443 4443221110 001111346889999999999999999999999
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+|+|+||+.....
T Consensus 290 Llkh~FFk~~k~~ 302 (516)
T KOG0582|consen 290 LLKHAFFKKAKSK 302 (516)
T ss_pred HhccHHHhhccch
Confidence 9999999887544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=305.92 Aligned_cols=232 Identities=35% Similarity=0.603 Sum_probs=184.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++||||+++++++..........+++||||++++|.+.+... ....+++..++.++.|++.||.|||+ +||+|||
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~d 135 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRD 135 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCC
Confidence 34689999999998864443445568899999999888777642 23458999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|||+||+++ .++.+||+|||++.............+|+.|+|||++.+. .++.++|+||+||++|+|++|.+||.+.+
T Consensus 136 lkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 136 LKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred CCHHHEEEc-CCCCEEEccccceEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 999999998 4778999999999865444334456789999999999654 58999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
..+.+..+++..+.+..+.+..... .....+......+... +...+++.+++|+.+||+.||++|||+.++++||||
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 214 DVDQLGKILDVIGLPGEEDWPRDVA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 9999999998888777655432211 1111111111222222 223478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.87 Aligned_cols=234 Identities=33% Similarity=0.606 Sum_probs=178.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++.. ...+|+||||+++++.+.+.. ....+++..++.++.|++.||+|||+ +||+||
T Consensus 57 l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~ 127 (303)
T cd07869 57 LKGLKHANIVLLHDIIHT-----KETLTLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHR 127 (303)
T ss_pred HhhCCCCCcCeEEEEEec-----CCeEEEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 467899999999999843 345899999999988777653 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++...... .......+|+.|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus 128 dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 128 DLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCHHHEEEC-CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998 5788999999998754322 2223457799999999987666689999999999999999999999987
Q ss_pred CC-hHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccC-CCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 160 EN-AVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 160 ~~-~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
.. ..+.+..+....+.+....+..... .+..-.+.......+..... ...++++.|||++||+.||++|+|+.+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 207 MKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred CccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 64 4566777777777776554433211 11100111111111111111 12568899999999999999999999999
Q ss_pred cCCCccccc
Q 022500 236 AHPFFDELR 244 (296)
Q Consensus 236 ~hp~f~~~~ 244 (296)
+||||+++.
T Consensus 287 ~h~~f~~~~ 295 (303)
T cd07869 287 SHEYFSDLP 295 (303)
T ss_pred cCcccccCC
Confidence 999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=312.40 Aligned_cols=208 Identities=28% Similarity=0.452 Sum_probs=170.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
||+|+|||||+|+++..+.. ...+|||+|||+.+ .+.........+++.+++.|++.++.||+|||. +||+||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~---s~~~YlVley~s~G---~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHR 234 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPE---SDKLYLVLEYCSKG---EVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHR 234 (576)
T ss_pred HHhcCCcCeeEEEEeecCcc---cCceEEEEEeccCC---ccccCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeecc
Confidence 68999999999999985433 33488999999954 233222222339999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC------CccceeecccccCchhccC---CCCCCchhHHHHHHHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE------ANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll 151 (296)
||||+|+|++ .++++||+|||.+....... .....+|||.|+|||.+.+ ....+.+.||||+||.+|.|+
T Consensus 235 DIKPsNLLl~-~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll 313 (576)
T KOG0585|consen 235 DIKPSNLLLS-SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL 313 (576)
T ss_pred ccchhheEEc-CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence 9999999999 47899999999997652221 1235799999999999976 233578999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 152 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
.|+.||.++...+.+.+|++. ...+|.. ..+.++++|||.+||++||.+|+++
T Consensus 314 fG~~PF~~~~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l 366 (576)
T KOG0585|consen 314 FGQLPFFDDFELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITL 366 (576)
T ss_pred hccCCcccchHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeeh
Confidence 999999999999999999873 2222221 1368899999999999999999999
Q ss_pred HHHhcCCCcccc
Q 022500 232 LEACAHPFFDEL 243 (296)
Q Consensus 232 ~e~l~hp~f~~~ 243 (296)
.++..|||...-
T Consensus 367 ~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 367 PDIKLHPWVTRD 378 (576)
T ss_pred hhheecceeccC
Confidence 999999999765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=317.89 Aligned_cols=203 Identities=30% Similarity=0.577 Sum_probs=177.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.|+|||||.+++.| +...++++|+|||.|+|+.++. .++.++|+.++.++.|++.||.|||+ .+|+||
T Consensus 55 ~r~lkHpniv~m~esf-----Et~~~~~vVte~a~g~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhr 124 (808)
T KOG0597|consen 55 LRSLKHPNIVEMLESF-----ETSAHLWVVTEYAVGDLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHS-NRILHR 124 (808)
T ss_pred HHhcCCcchhhHHHhh-----cccceEEEEehhhhhhHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh-cCcccc
Confidence 4678999999999999 5555599999999999888776 46889999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc-cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|+||.|||+. .++.+|+||||+|+.+..+... .+.-|||.|||||++.+ +.|+..+|+||+|||+||++.|++||..
T Consensus 125 d~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 125 DMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred cCCcceeeec-CCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 9999999999 5889999999999988765543 45578999999999975 5699999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+-...+..|+...-.+ +..++..+..|+..+|.+||.+|+|..+++.|||
T Consensus 203 ~si~~Lv~~I~~d~v~~-----------------------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 203 RSITQLVKSILKDPVKP-----------------------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred HHHHHHHHHHhcCCCCC-----------------------------cccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 88777777776521111 1247999999999999999999999999999999
Q ss_pred ccccc
Q 022500 240 FDELR 244 (296)
Q Consensus 240 f~~~~ 244 (296)
.++-.
T Consensus 254 ~k~~~ 258 (808)
T KOG0597|consen 254 WKGKI 258 (808)
T ss_pred Hhhhh
Confidence 98643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=297.93 Aligned_cols=272 Identities=31% Similarity=0.558 Sum_probs=210.4
Q ss_pred CCCCCCCCeeeeceeeeccCCC-CcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~-~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|+||++++.+|...... ....+|+|||++.++|...+. ..++-..++.+++|++.|++|||+ .||+|
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~Iih 141 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIH 141 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceee
Confidence 4568999999999999754432 233488999999999887765 347778899999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||++. .++.+||+|||+|+.....-..+.++.|+.|+|||++.+.+ |.+.+||||+|||+.||++|...|+|
T Consensus 142 RdLkPsnivv~-~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 142 RDLKPSNIVVN-SDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cccCcccceec-chhheeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecC
Confidence 99999999999 58889999999998765554567789999999999998876 99999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc--cCCCCCCCCcccccCC-----------CCCHHHHHHHHcccccCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF--RFPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~dll~~~L~~~p~ 226 (296)
.+..++..++.+.+|+|.+..+..+.+.-..+ ..++.....+.+.+++ .-+..++|++.+||..||+
T Consensus 220 ~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe 299 (369)
T KOG0665|consen 220 KDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE 299 (369)
T ss_pred chHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChh
Confidence 99999999999999999998877664321111 1222222222222222 2345689999999999999
Q ss_pred CCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 227 LRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
+|.+++++|+|||++=+...+. . ..+.|+......++...+++...+++.+++.+
T Consensus 300 ~Risv~daL~HPY~~vw~~~~e--v-~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~ 354 (369)
T KOG0665|consen 300 KRISVDDALRHPYIKVWYDPDE--V-EAPPPEIYDKQLDEREHTIEEWKELIFKEVQR 354 (369)
T ss_pred hcccHHHHhcCCeeeeeccccc--c-cCCCCchhhhhcccccCCHHHHHHHHHHHHHh
Confidence 9999999999999992211111 1 12222223233455566688888888888764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=294.20 Aligned_cols=236 Identities=39% Similarity=0.668 Sum_probs=189.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~-~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|||||++..+|.+. +..+++++||++.+|.++++..... ...++...++.+++||+.|+.|||+ +.|+||
T Consensus 82 REl~h~nvi~Lv~Vfl~~----d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHR 156 (438)
T KOG0666|consen 82 RELKHPNVISLVKVFLSH----DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHR 156 (438)
T ss_pred HHhcCCcchhHHHHHhcc----CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeec
Confidence 578999999999999753 3449999999999999999865543 3468999999999999999999999 799999
Q ss_pred CCCCCcEEEcCC---CCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 81 DLKPQNLLVDPL---THQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 81 dlkp~Nill~~~---~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
||||.|||+..+ .|.|||+|+|+++.+.+.-. ....+.|.||+|||++.|...|+.+.|+||+|||+.||++-
T Consensus 157 DLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 157 DLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999999999632 37899999999997654322 23567799999999999999999999999999999999999
Q ss_pred CCCCCCCC---------hHHHHHHHHHhcCCCCHHHHhhcC--cCCcCc--cCC--C---CCCCCcccccCCCCCHHHHH
Q 022500 154 QPLFPGEN---------AVDQLVEIIKVLGTPTREEIRCMN--PNYTDF--RFP--Q---IKAHPWHKVFHKRMPPEAID 215 (296)
Q Consensus 154 ~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~--~~~--~---~~~~~~~~~~~~~~~~~~~d 215 (296)
.+.|.+.. ..+++.+|++.+|.|+...|..+. +.|... .++ . .....|.. ..+.=++.+.+
T Consensus 237 ~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~-~~k~k~~~a~~ 315 (438)
T KOG0666|consen 237 EPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYH-KHKVKDPSALD 315 (438)
T ss_pred CccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHH-HhcCCCchHHH
Confidence 99998763 458899999999999998887653 222110 011 0 00111111 11123566999
Q ss_pred HHHcccccCCCCCCCHHHHhcCCCcccc
Q 022500 216 LASRLLQYSPSLRCTALEACAHPFFDEL 243 (296)
Q Consensus 216 ll~~~L~~~p~~R~t~~e~l~hp~f~~~ 243 (296)
|+.+||++||.+|+|++++|+|+||..-
T Consensus 316 LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HHHHHhccCchhhccHHHHhcccccccC
Confidence 9999999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=272.55 Aligned_cols=230 Identities=35% Similarity=0.698 Sum_probs=195.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.|+|.|||+++++..+... +.+|+|||..+|..++.. -++.++...++.++.|++.||.++|+ +++.||
T Consensus 55 lkelkhknivrl~dvlhsdkk-----ltlvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchs-hnvlhr 125 (292)
T KOG0662|consen 55 LKELKHKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHR 125 (292)
T ss_pred HHHhhhcceeehhhhhccCce-----eEEeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhc
Confidence 467899999999999854443 889999999887666654 57889999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc-cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 158 (296)
|+||.|++++ .++.+|++|||+++.+.-.-.. ...+.|.||++|.++.|..-|+...|+||.|||+.|+.. |++.|+
T Consensus 126 dlkpqnllin-~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 126 DLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred cCCcceEEec-cCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 9999999999 5889999999999976433322 234669999999999998889999999999999999996 889999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCC-CCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|.+..+++.+|.+.+|.|..+.|..+.. .|.. +|-+. ...|.+..+ .++...+|+++++|.-+|..|+++++++
T Consensus 205 g~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~--yp~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 205 GNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP--YPIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred CCcHHHHHHHHHHHhCCCccccCCccccCCCCcc--cCCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHh
Confidence 9999999999999999999999887753 3333 33332 344555444 4788999999999999999999999999
Q ss_pred cCCCcccc
Q 022500 236 AHPFFDEL 243 (296)
Q Consensus 236 ~hp~f~~~ 243 (296)
+||||.+.
T Consensus 282 qhpyf~d~ 289 (292)
T KOG0662|consen 282 QHPYFSDF 289 (292)
T ss_pred cCcccccc
Confidence 99999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=300.22 Aligned_cols=229 Identities=36% Similarity=0.722 Sum_probs=179.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++. ....+|+||||+++++.+.+.. ....+++..++.++.|++.||.|||+ .||+||
T Consensus 54 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~ 124 (287)
T cd07848 54 LRTLKQENIVELKEAFR-----RRGKLYLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHR 124 (287)
T ss_pred HHhCCCccccchhhhEe-----cCCEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 35789999999999884 3345899999999877665543 34568999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++|+||+||++|+|++|.+||.
T Consensus 125 dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 125 DIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred CCCHHHEEEc-CCCcEEEeeccCcccccccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 9999999998 57889999999998754322 12345789999999999764 48999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCC-CCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
+.+..+....+.+..+..+........ +.+.....+.. ....+.......++.++.|||++||++||++|+|+++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 203 GESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred CCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 998888888888777776665544322 11111111111 111122223345789999999999999999999999999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
+||||
T Consensus 283 ~hp~f 287 (287)
T cd07848 283 NHPAF 287 (287)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=303.21 Aligned_cols=234 Identities=35% Similarity=0.702 Sum_probs=188.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.. ....|+||||+++++.+.+.. .+..+++..++.++.||+.||+|||+ +||+||
T Consensus 58 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~ 128 (309)
T cd07872 58 LKDLKHANIVTLHDIVHT-----DKSLTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHR 128 (309)
T ss_pred HHhCCCCCcceEEEEEee-----CCeEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 357899999999999843 334889999999988776653 34558899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+
T Consensus 129 dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 129 DLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred CCCHHHEEEC-CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 57789999999987543222 223456789999999987666689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+..+.+..+.+....+..... .+..+..+......+.. ....+++++++||.+||+.||.+|+|+.|+++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 208 STVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 999999999999999988877655432 12222233322222222 123478999999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+.+..
T Consensus 287 ~~~~~~~~ 294 (309)
T cd07872 287 AYFRSLGT 294 (309)
T ss_pred hhhhhccc
Confidence 99997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.47 Aligned_cols=238 Identities=33% Similarity=0.562 Sum_probs=186.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++..........+|+||||+.++|.+.+. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~ 127 (372)
T cd07853 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS-AGILHR 127 (372)
T ss_pred HHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCC
Confidence 3568999999999998654432333688999999988776664 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++ .++.+||+|||+++...... ......+++.|+|||++.+...++.++||||+||++|+|++|..||.
T Consensus 128 dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 128 DIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred CCChHHEEEC-CCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 9999999999 57889999999997543222 12345678999999999776668999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCC-CCCCc--ccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI-KAHPW--HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
+.+..+++..+.+..|.+..+.+............... ..... ...+....++++.+||.+||+.||.+|||+.+++
T Consensus 207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 99999999999999999988765433211100000000 00000 0112345689999999999999999999999999
Q ss_pred cCCCccccc
Q 022500 236 AHPFFDELR 244 (296)
Q Consensus 236 ~hp~f~~~~ 244 (296)
+||||+..+
T Consensus 287 ~hp~~~~~~ 295 (372)
T cd07853 287 AHPYLDEGR 295 (372)
T ss_pred cCHhhCCCc
Confidence 999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=307.76 Aligned_cols=238 Identities=32% Similarity=0.601 Sum_probs=185.9
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++..... .....+|+||||+++++.+.+. ..+++..+..++.|++.||+|||+ +||+|
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH 149 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIH 149 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeec
Confidence 356899999999998754332 2334578999999998877664 247888999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||+++............+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 150 ~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 150 RDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CCCCHHHEEEC-CCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999 4788999999999866444344456789999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcC----------CcCccCCCC---CCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPN----------YTDFRFPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
.+..+.+..+++..+.|..+........ +..+.+... ...++........+.+++|||.+||+.||.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 307 (364)
T cd07875 228 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307 (364)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc
Confidence 9999999999999998877654433221 111111000 011111112223467899999999999999
Q ss_pred CCCCHHHHhcCCCcccccCCC
Q 022500 227 LRCTALEACAHPFFDELREPN 247 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~~~~ 247 (296)
+|||+.++++||||.....+.
T Consensus 308 ~R~t~~e~L~hp~~~~~~~~~ 328 (364)
T cd07875 308 KRISVDEALQHPYINVWYDPS 328 (364)
T ss_pred cCCCHHHHhcCcccccccCcc
Confidence 999999999999998765554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.79 Aligned_cols=237 Identities=32% Similarity=0.601 Sum_probs=185.5
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++..... .....+|+||||+++++.+.+. ..+++..+..++.|++.||.|||+ +||+|
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givH 142 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIH 142 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 356899999999998864332 2234578999999998776654 248889999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||+++............+|+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 143 rDikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 143 RDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCCChHHEEEC-CCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998 5788999999999866444444556889999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCC----------cCccCCCC---CCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNY----------TDFRFPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----------~~~~~~~~---~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
.+..+....+++..+.+..+......+.. .....+.. ...+.........+.++++||.+||+.||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 300 (355)
T cd07874 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCch
Confidence 99999999999988888776554433211 11111110 001111122233567899999999999999
Q ss_pred CCCCHHHHhcCCCcccccCC
Q 022500 227 LRCTALEACAHPFFDELREP 246 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~~~ 246 (296)
+|||+.|+++||||.....+
T Consensus 301 ~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 301 KRISVDEALQHPYINVWYDP 320 (355)
T ss_pred hcCCHHHHhcCcchhcccCh
Confidence 99999999999999866543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=302.67 Aligned_cols=236 Identities=34% Similarity=0.594 Sum_probs=177.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVP 75 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~-----~~~~~~~~~~~~~~~qil~aL~~LH~~~ 75 (296)
|++++||||+++++++.... ...+|+||||+++++.+.+..... ....+++..++.++.||+.||+|||+ +
T Consensus 52 l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~ 127 (317)
T cd07868 52 LRELKHPNVISLQKVFLSHA---DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-N 127 (317)
T ss_pred HHhcCCCCCcceeeeEecCC---CcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-C
Confidence 45789999999999885432 345889999999998887753221 12358999999999999999999999 7
Q ss_pred CcccCCCCCCcEEEc---CCCCcEEEeeccCccccccCC----CccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 76 RVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 76 ~i~H~dlkp~Nill~---~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
||+||||||+|||++ ..++.+||+|||+|+...... ......+|+.|+|||++.+...++.++|+||+||++|
T Consensus 128 ~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 207 (317)
T cd07868 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHH
Confidence 999999999999994 245689999999997654322 1234578999999999977666899999999999999
Q ss_pred HHHhCCCCCCCCCh---------HHHHHHHHHhcCCCCHHHHhhcCcCCc------Cc---cCCCCCCCCcccccCCCCC
Q 022500 149 ELLLGQPLFPGENA---------VDQLVEIIKVLGTPTREEIRCMNPNYT------DF---RFPQIKAHPWHKVFHKRMP 210 (296)
Q Consensus 149 ~ll~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~~ 210 (296)
+|++|.+||.+... .+++..+.+.+|.|....+......-. .+ .........+........+
T Consensus 208 el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (317)
T cd07868 208 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 287 (317)
T ss_pred HHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCC
Confidence 99999999976542 466778888888888776654321100 00 0000000001111112346
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 211 PEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 211 ~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
.++.|||.+||++||.+|+|++|+++||||
T Consensus 288 ~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 288 SKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=296.80 Aligned_cols=231 Identities=31% Similarity=0.549 Sum_probs=182.5
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.++||||+++++++..........+++||||++++|...+... ....+++..++.++.|++.||+|||+ +||+||||
T Consensus 58 ~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~di 134 (288)
T cd07863 58 AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDL 134 (288)
T ss_pred hcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCC
Confidence 4589999999998865544455668899999999887777642 23458999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
||+||+++ .++.+||+|||++.............+|..|+|||++.+. .++.++|+||+||++|+|++|.+||.+...
T Consensus 135 kp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 135 KPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred CHHHEEEC-CCCCEEECccCccccccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 99999998 5788999999999866544444456789999999999654 589999999999999999999999999988
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
.+.+.++....+.+....+...... ....+.......+. .....++..+.|+|.+||++||++|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 213 ADQLGKIFDLIGLPPEDDWPRDVTL-PRGAFSPRGPRPVQ-SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHHHHHHHhCCCChhhCcccccc-cccccCCCCCCchH-HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8888899888887766554321100 00011111111111 1223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=307.64 Aligned_cols=237 Identities=32% Similarity=0.593 Sum_probs=183.3
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++..... .....+|+||||+++++.+.+. ..+++..+..++.|++.||.|||+ +||+|
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH 146 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIH 146 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 357899999999998864432 1223578999999998776653 348889999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||+++............+|+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 147 rDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 147 RDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CCCCHHHEEEC-CCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 5788999999999865444444556789999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc----------CCcCccCCCC-C--CCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP----------NYTDFRFPQI-K--AHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
.+..+....+.+..+.+..+....... .+....+... . ..+.........++++++||.+||+.||+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 304 (359)
T cd07876 225 TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304 (359)
T ss_pred CCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc
Confidence 998889999999988887654432211 1111100000 0 00000112223578899999999999999
Q ss_pred CCCCHHHHhcCCCcccccCC
Q 022500 227 LRCTALEACAHPFFDELREP 246 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~~~ 246 (296)
+|||+.|+++||||.....+
T Consensus 305 ~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 305 KRISVDEALRHPYITVWYDP 324 (359)
T ss_pred cCCCHHHHhcCchhhhhcCc
Confidence 99999999999999875544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=297.01 Aligned_cols=236 Identities=34% Similarity=0.662 Sum_probs=187.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++.. ...+|+||||++++|.+.+.. ....+++..++.++.|++.||+|||+ .||+||
T Consensus 58 l~~l~h~nI~~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~ 128 (301)
T cd07873 58 LKDLKHANIVTLHDIIHT-----EKSLTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHR 128 (301)
T ss_pred HHhcCCCCcceEEEEEec-----CCeEEEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCC
Confidence 357899999999999843 345899999999988777654 34568899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+
T Consensus 129 dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 129 DLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred CCCHHHEEEC-CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 57789999999987543222 223446789999999987666688999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+....+....+.+....+..... .+..+..+....... ......+++++++||.+||+.||.+|||++|+++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 208 STVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 998888888888888887766544321 122222222211111 12234578999999999999999999999999999
Q ss_pred CCcccccCCC
Q 022500 238 PFFDELREPN 247 (296)
Q Consensus 238 p~f~~~~~~~ 247 (296)
|||..+.+..
T Consensus 287 ~~f~~~~~~~ 296 (301)
T cd07873 287 PYFHCLGERI 296 (301)
T ss_pred cccccccchh
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=304.25 Aligned_cols=205 Identities=28% Similarity=0.450 Sum_probs=168.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++. +...+|+||||++| +|.+.+. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 49 l~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH 118 (323)
T cd05571 49 LQNTRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVY 118 (323)
T ss_pred HHhCCCCCCCCEEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEe
Confidence 35789999999999884 34458999999995 6555554 35678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 119 rDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 119 RDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred CCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCC
Confidence 99999999999 4778999999998754322 223456789999999999654 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e 233 (296)
+.+.......+... .. .++..+++++.+||++||+.||++|+ ++.+
T Consensus 197 ~~~~~~~~~~~~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05571 197 NQDHEKLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE 247 (323)
T ss_pred CCCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 87766555544321 00 12245799999999999999999999 8999
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||+.+.+.
T Consensus 248 ll~h~~f~~~~~~ 260 (323)
T cd05571 248 IMEHRFFASINWQ 260 (323)
T ss_pred HHcCCCcCCCCHH
Confidence 9999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.18 Aligned_cols=208 Identities=31% Similarity=0.515 Sum_probs=175.8
Q ss_pred CCCCC-CCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 1 MRVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 1 l~~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
|+++. |||||.+++.|.+. ..+|+|||+|. |.|++.+... .+++..+..++.|++.|++|||+ .||+
T Consensus 89 l~~l~~hpniv~l~~~~e~~-----~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvv 157 (382)
T KOG0032|consen 89 LQQLSGHPNIVQLKDAFEDP-----DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVV 157 (382)
T ss_pred HHhccCCCCEEEEEEEEEcC-----CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCce
Confidence 45677 99999999999544 45999999999 5777766643 39999999999999999999999 6999
Q ss_pred cCCCCCCcEEEcCC---CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 79 HRDLKPQNLLVDPL---THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 79 H~dlkp~Nill~~~---~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||||+|+|+... ++.+|++|||++............+||+.|+|||++.+ ..|+..+|+||+||++|.|++|.+
T Consensus 158 HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 158 HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred eccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCC
Confidence 99999999999643 24799999999998877666778899999999999964 469999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+.......|...- +.+ ....+..++..++|||++||..||.+|+|+.++|
T Consensus 237 PF~~~~~~~~~~~i~~~~-----------------~~f--------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L 291 (382)
T KOG0032|consen 237 PFWGETEFEIFLAILRGD-----------------FDF--------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQAL 291 (382)
T ss_pred CCcCCChhHHHHHHHcCC-----------------CCC--------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 999999888887776521 111 1112245899999999999999999999999999
Q ss_pred cCCCcccccC
Q 022500 236 AHPFFDELRE 245 (296)
Q Consensus 236 ~hp~f~~~~~ 245 (296)
+|||++....
T Consensus 292 ~HpWi~~~~~ 301 (382)
T KOG0032|consen 292 QHPWIKSIGE 301 (382)
T ss_pred cCccccCCcc
Confidence 9999987644
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.00 Aligned_cols=237 Identities=36% Similarity=0.660 Sum_probs=186.1
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++..... .....+|+++|+++++|.+.+. ...+++..++.++.||+.||.|||+ +||+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH 141 (343)
T cd07878 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIH 141 (343)
T ss_pred HHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 467899999999998854322 2234578999999888776654 2569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||+++.... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+
T Consensus 142 rdikp~Nil~~-~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 142 RDLKPSNVAVN-EDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred ccCChhhEEEC-CCCCEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999 578899999999986533 234567899999999997755689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc---cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+..+.+..+.+..+.+..+............ ..+......+.. .....++.+.+||.+||+.||.+|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99888899998888888766554332211100 011111111111 12346788999999999999999999999999
Q ss_pred CCCcccccCCC
Q 022500 237 HPFFDELREPN 247 (296)
Q Consensus 237 hp~f~~~~~~~ 247 (296)
||||.....+.
T Consensus 298 hp~~~~~~~~~ 308 (343)
T cd07878 298 HPYFSQYHDPE 308 (343)
T ss_pred CcchhccCCCc
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=296.38 Aligned_cols=201 Identities=30% Similarity=0.453 Sum_probs=166.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-cc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VC 78 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~-i~ 78 (296)
|++|+|||||++++++..... .++|||||++ |+|.+++... ....++...+..++.||+.|++|||+ ++ ||
T Consensus 93 l~~l~HpNIV~f~G~~~~~~~----~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iI 165 (362)
T KOG0192|consen 93 LSRLRHPNIVQFYGACTSPPG----SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPII 165 (362)
T ss_pred HHhCCCCCeeeEEEEEcCCCC----ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCee
Confidence 457999999999999854431 4889999999 6777777643 45789999999999999999999999 69 99
Q ss_pred cCCCCCCcEEEcCCCC-cEEEeeccCccccccC-CCccceeecccccCchhccC-CCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 79 HRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 79 H~dlkp~Nill~~~~~-~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||||+|||++. ++ ++||+|||+++..... ...+...||+.|||||++.+ ...|+.++||||+|+++|||+||..
T Consensus 166 HrDLK~~NiLv~~-~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 166 HRDLKSDNILVDL-KGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred ecccChhhEEEcC-CCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 9999999999994 65 8999999999876544 23344789999999999974 3469999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.........++....+|. ++...++.+..++.+||..||.+||+..+++
T Consensus 245 Pf~~~~~~~~~~~v~~~~~Rp~---------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGLRPP---------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred CCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 9999988655555554333222 2334789999999999999999999998876
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
.
T Consensus 298 ~ 298 (362)
T KOG0192|consen 298 S 298 (362)
T ss_pred H
Confidence 4
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=272.63 Aligned_cols=201 Identities=31% Similarity=0.505 Sum_probs=175.7
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.|+||||+++|++|.+.. ..||++||.. |.++..+.. ....++++..+..|+.|++.||.|+|. ++|+|||
T Consensus 78 ~L~hpnilrlY~~fhd~~-----riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRd 149 (281)
T KOG0580|consen 78 HLRHPNILRLYGYFHDSK-----RIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRD 149 (281)
T ss_pred ccCCccHHhhhhheeccc-----eeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCC
Confidence 589999999999995544 4999999999 677777763 355779999999999999999999999 8999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|||+|+|++ ..+.+|++|||-+.... .....+.+||..|.+||...+. .++..+|+|++|++.||++.|.+||.+.+
T Consensus 150 iKpenlLlg-~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 150 IKPENLLLG-SAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred CCHHHhccC-CCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 999999999 47889999999987654 4556678999999999999764 59999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~ 241 (296)
..+.+.+|.+. ++. ++..++.+++|+|.+||.++|.+|++..|++.|||..
T Consensus 227 ~~etYkrI~k~-----------------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 227 HSETYKRIRKV-----------------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred hHHHHHHHHHc-----------------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 88999988873 111 2345899999999999999999999999999999987
Q ss_pred cc
Q 022500 242 EL 243 (296)
Q Consensus 242 ~~ 243 (296)
..
T Consensus 278 a~ 279 (281)
T KOG0580|consen 278 AN 279 (281)
T ss_pred hc
Confidence 53
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=295.67 Aligned_cols=203 Identities=29% Similarity=0.463 Sum_probs=169.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++ .+..++|+||||++| +|.+.+. ..+.+++..++.++.|++.||+|||+ +||+|
T Consensus 55 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H 124 (291)
T cd05612 55 LKEVSHPFIIRLFWTE-----HDQRFLYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVY 124 (291)
T ss_pred HHhCCCCcHhhhHhhh-----ccCCeEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 4678999999999887 344568999999984 6766665 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++..... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 125 ~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 125 RDLKPENILLD-KEGHIKLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred cCCCHHHeEEC-CCCCEEEEecCcchhccC--CcccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998 578899999999986533 22345789999999998654 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~ 234 (296)
.+..+....+.... ..++..+++.+++||++||+.||.+|++ ++++
T Consensus 201 ~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 251 (291)
T cd05612 201 DNPFGIYEKILAGK-----------------------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDV 251 (291)
T ss_pred CCHHHHHHHHHhCC-----------------------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHH
Confidence 88776666654410 0122346889999999999999999995 9999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+.+.+.
T Consensus 252 l~h~~~~~~~~~ 263 (291)
T cd05612 252 KNHRWFKSVDWD 263 (291)
T ss_pred hcCccccCCCHH
Confidence 999999987664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=290.28 Aligned_cols=230 Identities=34% Similarity=0.579 Sum_probs=178.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.. ...+|+|+||+++++.+.+.. ....+++..++.++.||+.||.|||+ +|++||
T Consensus 53 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~ 123 (284)
T cd07839 53 LKELKHKNIVRLYDVLHS-----DKKLTLVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHR 123 (284)
T ss_pred HHhcCCCCeeeHHHHhcc-----CCceEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecC
Confidence 356899999999999843 345899999999988776653 34669999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-CC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~ 158 (296)
||||+||+++ .++.+||+|||++........ .....+++.|+|||++.+...++.++|+||+||++|+|++|..| |.
T Consensus 124 dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 124 DLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CCCHHHEEEc-CCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 9999999999 477899999999976533221 23346788999999987766679999999999999999998766 56
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..+.+..+.+....+......-.....+..............++++++++|.+||+.||.+|||++++++||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 203 GNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 67777788888888887776655443221111111111111111122335789999999999999999999999999999
Q ss_pred Cc
Q 022500 239 FF 240 (296)
Q Consensus 239 ~f 240 (296)
||
T Consensus 283 ~f 284 (284)
T cd07839 283 YF 284 (284)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=302.01 Aligned_cols=203 Identities=28% Similarity=0.450 Sum_probs=169.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||++++++. +...+|+||||++| +|.+.+. ....+++..++.++.|++.||.|||+ +||+|
T Consensus 85 l~~l~hp~Iv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH 154 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFK-----DESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVY 154 (340)
T ss_pred HHhCCCCCCcceEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEc
Confidence 35689999999999984 34458999999984 6666654 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+||+|||++..... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 155 rDLkp~NILl~-~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 155 RDLKPENLLLD-KDGFIKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred cCCCHHHEEEC-CCCCEEEecCCCCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCC
Confidence 99999999998 578899999999986532 23456789999999999654 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+.......+.... . .++..+++.+.++|++||+.||++|+ +++++
T Consensus 231 ~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 281 (340)
T PTZ00426 231 NEPLLIYQKILEGI-----------------I------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNV 281 (340)
T ss_pred CCHHHHHHHHhcCC-----------------C------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHH
Confidence 88776666654311 0 12234789999999999999999996 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+++.+.
T Consensus 282 ~~hp~f~~~~~~ 293 (340)
T PTZ00426 282 KEHPWFGNIDWV 293 (340)
T ss_pred HcCCCcCCCCHH
Confidence 999999987654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.95 Aligned_cols=230 Identities=23% Similarity=0.363 Sum_probs=171.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++|+|||||+++++|.. ....|+|+|++.++|...+.. ...+++..++.++.||+.||.|||+ +||+||
T Consensus 137 l~~l~HpnIv~~~~~~~~-----~~~~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHr 206 (391)
T PHA03212 137 LRAINHPSIIQLKGTFTY-----NKFTCLILPRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHR 206 (391)
T ss_pred HHhCCCCCCCCEeEEEEE-----CCeeEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 467899999999999843 334889999999988776653 3568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC--CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG--EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++ .++.+||+|||+|+..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 207 DiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 207 DIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred CCChHhEEEc-CCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9999999998 4778999999999753222 12234578999999999965 458999999999999999999998775
Q ss_pred CC-------ChHHHHHHHHHhcCCCCHHHHhhcC----cCC----cCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 159 GE-------NAVDQLVEIIKVLGTPTREEIRCMN----PNY----TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 159 ~~-------~~~~~~~~i~~~~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
+. +...++..+++..|.++.+...... ..+ ............|... ..++.++.+||.+||++
T Consensus 285 ~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~ 362 (391)
T PHA03212 285 EKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAF 362 (391)
T ss_pred CcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcC
Confidence 43 2345677777777765433210000 000 0000000001111111 13577899999999999
Q ss_pred CCCCCCCHHHHhcCCCccccc
Q 022500 224 SPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 224 ~p~~R~t~~e~l~hp~f~~~~ 244 (296)
||.+|||+.|+|+||||+.+.
T Consensus 363 dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 363 DAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred ChhhCCCHHHHhcChhhccCC
Confidence 999999999999999998754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=296.62 Aligned_cols=204 Identities=31% Similarity=0.535 Sum_probs=167.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++| +|.+.+. ....+++..++.++.||+.||.|||+ +||+|
T Consensus 47 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H 116 (312)
T cd05585 47 LAQVNCPFIVPLKFSFQS-----PEKLYLVLAFINGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHK-FNVIY 116 (312)
T ss_pred HHhCCCCcEeceeeEEec-----CCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEe
Confidence 356899999999998843 3458999999995 6666554 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 117 rDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 117 RDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred CCCCHHHeEEC-CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcC
Confidence 99999999998 5788999999999754322 223345789999999999764 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC---CHHHHh
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEAC 235 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~---t~~e~l 235 (296)
+.+..+....+... . ..++..+++++.++|.+||+.||.+|+ ++.+++
T Consensus 195 ~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 195 DENVNEMYRKILQE-----------------P------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCCHHHHHHHHHcC-----------------C------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 88776665555431 0 012235789999999999999999997 589999
Q ss_pred cCCCcccccC
Q 022500 236 AHPFFDELRE 245 (296)
Q Consensus 236 ~hp~f~~~~~ 245 (296)
+||||+...+
T Consensus 246 ~hp~~~~~~~ 255 (312)
T cd05585 246 NHPFFSQLSW 255 (312)
T ss_pred cCCCcCCCCH
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.11 Aligned_cols=203 Identities=27% Similarity=0.448 Sum_probs=167.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||+.| +|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 72 l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH 141 (329)
T PTZ00263 72 LMELSHPFIVNMMCSFQD-----ENRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS-KDIIY 141 (329)
T ss_pred HHhCCCCCCCcEEEEEEc-----CCEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 357899999999999843 3458999999985 6665554 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++..... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 142 ~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 142 RDLKPENLLLD-NKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred cCCCHHHEEEC-CCCCEEEeeccCceEcCC--CcceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCC
Confidence 99999999999 578899999999986533 22346789999999999654 489999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~ 234 (296)
.+..+....+.+. . . .++..++..+++||++||+.||.+|++ ++++
T Consensus 218 ~~~~~~~~~i~~~--~---------------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 268 (329)
T PTZ00263 218 DTPFRIYEKILAG--R---------------L------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADV 268 (329)
T ss_pred CCHHHHHHHHhcC--C---------------c------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence 8776666555431 0 0 012337889999999999999999997 7999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||++..+.
T Consensus 269 l~hp~f~~~~~~ 280 (329)
T PTZ00263 269 KNHPYFHGANWD 280 (329)
T ss_pred hcCCccCCCCHH
Confidence 999999886544
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=292.29 Aligned_cols=236 Identities=33% Similarity=0.587 Sum_probs=174.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVP 75 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~-----~~~~~~~~~~~~~~~qil~aL~~LH~~~ 75 (296)
|++++||||+++++++.... ...+|+||||+++++.+.+..... ....+++..++.++.||+.||.|||+ +
T Consensus 52 l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~ 127 (317)
T cd07867 52 LRELKHPNVIALQKVFLSHS---DRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-N 127 (317)
T ss_pred HHhCCCCCeeeEEEEEeccC---CCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-C
Confidence 45789999999999885432 334789999999998887753211 12358899999999999999999999 7
Q ss_pred CcccCCCCCCcEEEc---CCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 76 RVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 76 ~i~H~dlkp~Nill~---~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
||+||||||+||++. ..++.+||+|||+++....... .....+|+.|+|||++.+...++.++||||+||++|
T Consensus 128 ~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 207 (317)
T cd07867 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHH
Confidence 999999999999993 2456899999999986543221 234577999999999976566899999999999999
Q ss_pred HHHhCCCCCCCCCh---------HHHHHHHHHhcCCCCHHHHhhcCc--CCcCcc----CCCCC---CCCcccccCCCCC
Q 022500 149 ELLLGQPLFPGENA---------VDQLVEIIKVLGTPTREEIRCMNP--NYTDFR----FPQIK---AHPWHKVFHKRMP 210 (296)
Q Consensus 149 ~ll~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~----~~~~~---~~~~~~~~~~~~~ 210 (296)
+|++|.+||..... ..++..+...+|.+..+.+..... .+.... ..... ............+
T Consensus 208 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (317)
T cd07867 208 ELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD 287 (317)
T ss_pred HHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCC
Confidence 99999999975432 355677778888777666544321 111000 00000 0000011112346
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 211 PEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 211 ~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
..+.+||.+||+.||.+|||++|+++||||
T Consensus 288 ~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=289.42 Aligned_cols=200 Identities=27% Similarity=0.457 Sum_probs=175.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.|+||||+++|++|... .-+.|||||.+ |.|++++. ..+.+++.+++.+++||++|+.|+|. ++++|
T Consensus 107 MSsLNHPhII~IyEVFENk-----dKIvivMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHk-nrVvH 176 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENK-----DKIVIVMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHK-NRVVH 176 (668)
T ss_pred HhhcCCCceeehhhhhcCC-----ceEEEEEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhh-cccee
Confidence 6789999999999999443 34889999999 57776665 55889999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||.+|||+| .++++||+|||++..+....-..+++|+|.|.+||++.|..+-++.+|.|||||++|.|..|..||.|
T Consensus 177 RDLKLENILLD-~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 177 RDLKLENILLD-QNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred cccchhheeec-CCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 99999999999 58889999999998877777778999999999999998887778999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+....+.+|.+- .+.. ..-+.++.-||+.||.+||++|.|++++-.|=|
T Consensus 256 ~Dhk~lvrQIs~G-----------------aYrE-------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 256 RDHKRLVRQISRG-----------------AYRE-------------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred chHHHHHHHhhcc-----------------cccC-------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 9998888877651 1111 124778999999999999999999999999977
Q ss_pred cc
Q 022500 240 FD 241 (296)
Q Consensus 240 f~ 241 (296)
.+
T Consensus 306 vN 307 (668)
T KOG0611|consen 306 VN 307 (668)
T ss_pred ee
Confidence 64
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=298.82 Aligned_cols=207 Identities=29% Similarity=0.469 Sum_probs=181.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++|||||.+++.|+ .++.++||||+||+| ++.+.++.. .+..+++..+..|+.|++.|++|||+ ++|+|
T Consensus 57 is~~~hP~iv~y~ds~~----~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLH 129 (426)
T KOG0589|consen 57 LSKLLHPNIVEYKDSFE----EDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHE-NRVLH 129 (426)
T ss_pred HHhccCCCeeeeccchh----cCCceEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh-hhhhc
Confidence 35799999999999995 344459999999995 888877753 35779999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+.||+++. +..|||+|||+|+.+.+.. ...+.+|||.|++||++.+. .|+.++|||||||++|||++=+++|.
T Consensus 130 RDlK~~Nifltk-~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~ 207 (426)
T KOG0589|consen 130 RDLKCANIFLTK-DKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFK 207 (426)
T ss_pred ccchhhhhhccc-cCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccC
Confidence 999999999995 6668999999999887765 56788999999999999765 59999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+......+|.+....|. +...+.+++.+|+.||..+|..||++.++|.+|
T Consensus 208 a~~m~~Li~ki~~~~~~Pl----------------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 208 ASNMSELILKINRGLYSPL----------------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ccchHHHHHHHhhccCCCC----------------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 9999999999988653333 234789999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
......
T Consensus 260 ~l~~~~ 265 (426)
T KOG0589|consen 260 HLLRYL 265 (426)
T ss_pred hhhhHH
Confidence 887543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=274.87 Aligned_cols=236 Identities=28% Similarity=0.513 Sum_probs=191.9
Q ss_pred CCCCCCCeeeeceeeec---cCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 2 RVMDHPNVISLKHCFFS---TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~---~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
..|+|+|++.+++++-+ ....+...+|+|+++|+.+|+-++.. ...+++..++++++.+++.||.|+|+ ..|+
T Consensus 71 ~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kil 146 (376)
T KOG0669|consen 71 QLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKIL 146 (376)
T ss_pred HHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHH
Confidence 46799999999998743 33345566899999999998888764 44679999999999999999999999 6999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
|||+|++|+|++ .++.+||+|||+++.+...+. -+..+.|.||++||.+.|...|+++.|+|..|||+.+|++|
T Consensus 147 HRDmKaaNvLIt-~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtr 225 (376)
T KOG0669|consen 147 HRDMKAANVLIT-KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTR 225 (376)
T ss_pred hhcccHhhEEEc-CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHcc
Confidence 999999999999 578999999999987654332 23456799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCC---ccccc-CCCCCHHHHHHHHcccccCCCC
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHP---WHKVF-HKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~dll~~~L~~~p~~ 227 (296)
.+.+.+++...++..|....|..+.+.|..+. +-|..+..+...... ..... +-.-++++.||+.++|..||.+
T Consensus 226 spimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~k 305 (376)
T KOG0669|consen 226 SPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTK 305 (376)
T ss_pred CccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCccc
Confidence 99999999999999999999999988777653 233333222211111 11110 0112568999999999999999
Q ss_pred CCCHHHHhcCCCccc
Q 022500 228 RCTALEACAHPFFDE 242 (296)
Q Consensus 228 R~t~~e~l~hp~f~~ 242 (296)
|++++++++|.||..
T Consensus 306 R~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 306 RIDADQALNHDFFWK 320 (376)
T ss_pred CcchHhhhchhhhhc
Confidence 999999999999975
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=294.97 Aligned_cols=202 Identities=28% Similarity=0.478 Sum_probs=166.3
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.+||||+++++++.. ...+|+||||++| +|...+. ....+++..++.++.|++.||+|||+ +||+||||
T Consensus 53 ~~h~~iv~~~~~~~~-----~~~~~iv~Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dl 122 (320)
T cd05590 53 RNHPFLTQLYCCFQT-----PDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDL 122 (320)
T ss_pred cCCCchhceeeEEEc-----CCEEEEEEcCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCC
Confidence 479999999999843 3448999999995 6555444 34679999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
||+||+++ .++.+||+|||++...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+
T Consensus 123 kp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 123 KLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred CHHHeEEC-CCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 99999999 5788999999998754322 223345789999999999654 58999999999999999999999999888
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH------HHHh
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEAC 235 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~------~e~l 235 (296)
..+....+.+.. . .++..++.++.++|++||+.||.+|+++ ++++
T Consensus 201 ~~~~~~~i~~~~-----------------~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~ 251 (320)
T cd05590 201 EDDLFEAILNDE-----------------V------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAIL 251 (320)
T ss_pred HHHHHHHHhcCC-----------------C------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHH
Confidence 777666654310 0 0123478999999999999999999998 8999
Q ss_pred cCCCcccccCC
Q 022500 236 AHPFFDELREP 246 (296)
Q Consensus 236 ~hp~f~~~~~~ 246 (296)
+||||+.+.+.
T Consensus 252 ~h~~f~~~~~~ 262 (320)
T cd05590 252 RHPFFKELDWE 262 (320)
T ss_pred cCCCcCCCCHH
Confidence 99999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=291.14 Aligned_cols=211 Identities=25% Similarity=0.374 Sum_probs=167.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++++. +...+|+||||+++ +|...+.. .....+++..+..++.|++.||+|||+ +||+|
T Consensus 54 l~~l~~~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH 125 (285)
T cd05631 54 LEKVNSRFVVSLAYAYE-----TKDALCLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVY 125 (285)
T ss_pred HHhcCCCcEEEEEEEEc-----cCCeEEEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEe
Confidence 35689999999999884 33458999999995 66555542 123468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 126 ~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 126 RDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred CCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 99999999998 5778999999999876444334456789999999999754 589999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~ 234 (296)
.+.......+....... ...++..+++++.+||++||+.||.+|++ ++++
T Consensus 204 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 258 (285)
T cd05631 204 RKERVKREEVDRRVKED-------------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258 (285)
T ss_pred CCcchhHHHHHHHhhcc-------------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence 65433322222211000 01123457999999999999999999997 8999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+.+.+.
T Consensus 259 ~~h~~~~~~~~~ 270 (285)
T cd05631 259 KQHPIFKNINFK 270 (285)
T ss_pred hcCHhhcCCCHH
Confidence 999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=296.33 Aligned_cols=205 Identities=28% Similarity=0.447 Sum_probs=167.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. ...+|+||||++| +|...+. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 49 l~~l~hp~i~~~~~~~~~-----~~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH 118 (323)
T cd05595 49 LQNTRHPFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVY 118 (323)
T ss_pred HHhCCCCCCcceeeEEec-----CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEe
Confidence 357899999999998843 3458999999995 5554443 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 119 ~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 119 RDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cCCCHHHEEEc-CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCC
Confidence 99999999999 57889999999987543222 22345789999999998654 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e 233 (296)
+.+.......+... .. .++..+++++.++|.+||+.||++|+ ++.+
T Consensus 197 ~~~~~~~~~~~~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 197 NQDHERLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred CCCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 88776665554421 00 12235799999999999999999998 8999
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||.+..+.
T Consensus 248 ~l~h~~~~~~~~~ 260 (323)
T cd05595 248 VMEHRFFLSINWQ 260 (323)
T ss_pred HHcCCCcCCCCHH
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=297.62 Aligned_cols=204 Identities=29% Similarity=0.453 Sum_probs=166.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++. +...+|+||||++| +|...+. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 49 l~~l~hp~iv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH 118 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQ-----TKDRLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVY 118 (328)
T ss_pred HHhCCCCCCcceEEEEE-----cCCEEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEe
Confidence 45789999999999884 34458999999985 6554443 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 119 rDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 119 RDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred cccCHHHeEEC-CCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCC
Confidence 99999999999 5788999999998754322 222345789999999999654 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e 233 (296)
+.+..+....+... .. .++..+++++.+||++||+.||++|+ ++.+
T Consensus 197 ~~~~~~~~~~~~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 197 NQDHEKLFELILME-----------------DI------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred CCCHHHHHHHhccC-----------------Cc------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 87766554443321 00 12345799999999999999999997 8999
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++||||....+
T Consensus 248 il~h~~~~~~~~ 259 (328)
T cd05593 248 IMRHSFFTGVNW 259 (328)
T ss_pred HhcCCCcCCCCH
Confidence 999999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=286.84 Aligned_cols=230 Identities=35% Similarity=0.677 Sum_probs=177.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.. ...+|+||||++++|.+.+... ..+..+++..++.++.|++.||+|||+ +|++||
T Consensus 53 l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~ 125 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQ-----ESRLYLIFEFLSMDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHS-RRVLHR 125 (285)
T ss_pred HHhcCCCCEeeeEEEEee-----CCeEEEEEecCCCCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeec
Confidence 356899999999999853 3458999999998887776542 223568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+
T Consensus 126 dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 126 DLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred CCCHHHEEEc-CCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999998 57889999999987543221 122346688999999987666678999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.........+.+..+.+....+..... .+.. ..+....... ......++++++++|++||+.||++|||+.++++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 205 DSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN-TFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred CCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh-hccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 888888877877777666554432210 0100 0000000001 11123479999999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 283 ~~~ 285 (285)
T cd07861 283 PYF 285 (285)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=292.46 Aligned_cols=203 Identities=28% Similarity=0.491 Sum_probs=164.5
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.++||||+++++++. +..++|+||||+.| +|...+. ....+++..++.++.|++.||+|||+ +||+|||
T Consensus 52 ~~~~~~i~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrD 121 (316)
T cd05620 52 AWENPFLTHLYCTFQ-----TKEHLFFVMEFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRD 121 (316)
T ss_pred ccCCCCccCeeEEEE-----eCCEEEEEECCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecC
Confidence 358999999999984 44469999999995 6655554 34678999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus 122 lkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 122 LKLDNVMLD-RDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred CCHHHeEEC-CCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 999999999 477899999999875322 2223456789999999999754 5899999999999999999999999888
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH-HHHhcCCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPF 239 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~-~e~l~hp~ 239 (296)
+..+....+... .+ .++..++.+++++|++||+.||++|+++ +++++|||
T Consensus 200 ~~~~~~~~~~~~--~~---------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~ 250 (316)
T cd05620 200 DEDELFESIRVD--TP---------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPF 250 (316)
T ss_pred CHHHHHHHHHhC--CC---------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence 766555444321 00 0122378999999999999999999997 58999999
Q ss_pred cccccCC
Q 022500 240 FDELREP 246 (296)
Q Consensus 240 f~~~~~~ 246 (296)
|+...+.
T Consensus 251 f~~~~~~ 257 (316)
T cd05620 251 FKTINWT 257 (316)
T ss_pred cCCCCHH
Confidence 9987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=298.05 Aligned_cols=209 Identities=27% Similarity=0.398 Sum_probs=165.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++.+. +...+|+|||||+| +|.+.+. ..+.+++..++.++.|++.||+|||+ +||+|
T Consensus 55 l~~~~~~~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~givH 124 (363)
T cd05628 55 LVEADSLWVVKMFYSFQ-----DKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQ-LGFIH 124 (363)
T ss_pred HHhCCCCCcceEEEEEe-----cCCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEe
Confidence 35689999999999984 44458999999985 6666554 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC------------------------------------Cccceeeccccc
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE------------------------------------ANISYICSRFYR 123 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~------------------------------------~~~~~~~t~~y~ 123 (296)
|||||+|||++ .++.+||+|||+|+...... .....+||+.|+
T Consensus 125 rDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~ 203 (363)
T cd05628 125 RDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI 203 (363)
T ss_pred cCCCHHHeEEC-CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcccc
Confidence 99999999998 47889999999987542110 012357899999
Q ss_pred CchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCccc
Q 022500 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 203 (296)
Q Consensus 124 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (296)
|||++.+. .++.++|+||+||++|+|++|..||.+.+..+...++....... .++.
T Consensus 204 aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~-------- 259 (363)
T cd05628 204 APEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL---------------IFPP-------- 259 (363)
T ss_pred CHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcc---------------cCCC--------
Confidence 99999764 58999999999999999999999999988877777665421110 0110
Q ss_pred ccCCCCCHHHHHHHHcccccCCC---CCCCHHHHhcCCCcccccCCC
Q 022500 204 VFHKRMPPEAIDLASRLLQYSPS---LRCTALEACAHPFFDELREPN 247 (296)
Q Consensus 204 ~~~~~~~~~~~dll~~~L~~~p~---~R~t~~e~l~hp~f~~~~~~~ 247 (296)
...++++++++|.+|+. +|. .||+++|+++||||++..+..
T Consensus 260 --~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 260 --EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred --cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 01368999999999876 454 458999999999999886653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=291.88 Aligned_cols=270 Identities=35% Similarity=0.631 Sum_probs=204.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++||||+++++++..........+|+|+||++++|.+.+. ....+++..+..++.|++.||.|||+ ++++|||
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~d 133 (337)
T cd07858 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRD 133 (337)
T ss_pred HhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCC
Confidence 567999999999988654433445589999999988776665 34679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||++...... .......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.
T Consensus 134 lkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 134 LKPSNLLLN-ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CCHHHEEEc-CCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 999999998 4778999999999865433 22234567889999999865445899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcC-CcCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+.......+.+..|.+..+.+...... ...+ ..+........ .....+++++.++|++||+.+|++|||+.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 213 DYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 888888888888888877665332211 0000 00111111111 1223578999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHH
Q 022500 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 282 (296)
Q Consensus 238 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (296)
|||+.++........ +..+.++.+..+.+.+.+.+++-++.
T Consensus 292 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (337)
T cd07858 292 PYLASLHDPSDEPVC----QTPFSFDFEEDALTEEDIKELIYNEM 332 (337)
T ss_pred cchhhhcCcccCccC----CCccchhhhhhhcCHHHHHHHHHHHH
Confidence 999988776543221 23345555555567777777776654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=295.01 Aligned_cols=204 Identities=28% Similarity=0.466 Sum_probs=167.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++.+.. ...+|+||||++| +|...+. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 51 ~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~ 120 (323)
T cd05575 51 KNVKHPFLVGLHYSFQT-----ADKLYFVLDYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYR 120 (323)
T ss_pred hhCCCCCCCCeeEEEEe-----CCEEEEEEcCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeC
Confidence 56899999999998843 3448999999995 6655554 35679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++...... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 121 dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 121 DLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred CCCHHHeEEC-CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCC
Confidence 9999999999 5788999999998754322 223345789999999998654 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH----HHHh
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEAC 235 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~----~e~l 235 (296)
.+..+....+.... . .+...+++++.++|++||+.||.+|+++ .+++
T Consensus 199 ~~~~~~~~~i~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il 249 (323)
T cd05575 199 RDTAEMYDNILNKP-----------------L------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIK 249 (323)
T ss_pred CCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence 87776666554310 0 0123478999999999999999999987 6999
Q ss_pred cCCCcccccCC
Q 022500 236 AHPFFDELREP 246 (296)
Q Consensus 236 ~hp~f~~~~~~ 246 (296)
+||||+...+.
T Consensus 250 ~~~~~~~~~~~ 260 (323)
T cd05575 250 NHVFFSSINWD 260 (323)
T ss_pred cCCCcCCCCHH
Confidence 99999887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=292.82 Aligned_cols=204 Identities=29% Similarity=0.476 Sum_probs=167.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. +..+|+||||++| +|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 54 l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH 123 (323)
T cd05584 54 LEAVKHPFIVDLIYAFQT-----GGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIY 123 (323)
T ss_pred HHhCCCCchhceeeEEec-----CCeEEEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 467899999999999843 3348999999995 6655554 34678899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 124 ~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~ 201 (323)
T cd05584 124 RDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFT 201 (323)
T ss_pred CCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCC
Confidence 99999999998 47889999999987543222 23345789999999999654 58899999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e 233 (296)
+.+.......+.... . .++..+++++.+||++||+.||++|+ ++++
T Consensus 202 ~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 252 (323)
T cd05584 202 AENRKKTIDKILKGK-----------------L------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAE 252 (323)
T ss_pred CCCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHH
Confidence 888766665554310 0 12234789999999999999999999 8999
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++||||+...+
T Consensus 253 l~~h~~~~~~~~ 264 (323)
T cd05584 253 VQSHPFFRHVNW 264 (323)
T ss_pred HhcCCCcCCCCH
Confidence 999999987644
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=290.96 Aligned_cols=203 Identities=28% Similarity=0.492 Sum_probs=166.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.. ...+|+||||++| +|...+. ...+++..++.++.||+.||+|||+ +||+||
T Consensus 57 ~~l~hp~i~~~~~~~~~-----~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHr 125 (324)
T cd05589 57 NSERHPFLVNLFACFQT-----EDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYR 125 (324)
T ss_pred cccCCCChhceeeEEEc-----CCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEec
Confidence 46789999999999843 3458999999996 5443332 3569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++..... .......|++.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 126 dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 126 DLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred CCCHHHeEEC-CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 9999999999 4788999999998754322 223456789999999999654 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+..+....+..... .++..+++++.++|++||+.||.+|+ ++.++
T Consensus 204 ~~~~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 254 (324)
T cd05589 204 DDEEEVFDSIVNDEV-----------------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDV 254 (324)
T ss_pred CCHHHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence 887766665544100 02234789999999999999999999 69999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+++.+.
T Consensus 255 ~~~~~f~~~~~~ 266 (324)
T cd05589 255 KKQPFFRDINWD 266 (324)
T ss_pred hhCCCcCCCCHH
Confidence 999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=285.49 Aligned_cols=213 Identities=26% Similarity=0.391 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++.+++. ....+|+||||++| +|...+......+..+++..++.++.||+.||+|||+ +||+|
T Consensus 47 l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H 120 (280)
T cd05608 47 LAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIY 120 (280)
T ss_pred HHhCCCCcEeeeeEEEc-----CCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 45789999999999884 33448999999985 6665554433445679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++........ .....||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 121 ~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 121 RDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred CCCCHHHEEEC-CCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 477899999999976543322 2345789999999999764 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e 233 (296)
..+.......+....... ...++..+++++.+++.+||+.||++|+ |+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 253 (280)
T cd05608 199 ARGEKVENKELKQRILND-------------------------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDG 253 (280)
T ss_pred CCCcchhHHHHHHhhccc-------------------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 764332222221110000 0012234789999999999999999999 8899
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||+...+.
T Consensus 254 ~l~h~~~~~~~~~ 266 (280)
T cd05608 254 LRTHPLFRDLNWR 266 (280)
T ss_pred HhcChhhhcCCHh
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.21 Aligned_cols=211 Identities=28% Similarity=0.445 Sum_probs=169.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++. +..++|+||||++| +|.+.+. ....+++..++.++.||+.||.|||+ +||+|
T Consensus 55 l~~~~h~~iv~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH 124 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQ-----DDEYLYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE-LGYIH 124 (333)
T ss_pred HHhCCCCCCccEEEEEE-----cCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 35678999999999884 44458999999985 6666654 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++..... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 125 ~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 125 RDLKPENFLID-ASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred cCCCHHHEEEC-CCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCC
Confidence 99999999999 578899999999986533 33456789999999999765 689999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+....+........ .+.. ......++.++.+||.+||+.+|.+|+++.++++|||
T Consensus 201 ~~~~~~~~~i~~~~~~~~---------------~~~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 201 STPNETWENLKYWKETLQ---------------RPVY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred CCHHHHHHHHHhcccccc---------------CCCC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 887776665543211000 0000 0000246899999999999999999999999999999
Q ss_pred cccccCC
Q 022500 240 FDELREP 246 (296)
Q Consensus 240 f~~~~~~ 246 (296)
|++..+.
T Consensus 260 ~~~~~~~ 266 (333)
T cd05600 260 FKEVDWN 266 (333)
T ss_pred cCCCCHH
Confidence 9987553
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.33 Aligned_cols=209 Identities=30% Similarity=0.482 Sum_probs=163.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ..++|+||||++| +|.+.+. ....+++..++.++.||+.||+|||+ .||+|
T Consensus 55 l~~l~h~~iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~-~givH 124 (381)
T cd05626 55 LAEADNEWVVKLYYSFQD-----KDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHK-MGFIH 124 (381)
T ss_pred HHhcCCCCeeeeEEEEec-----CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 357899999999999843 3458999999985 6666654 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC------------------------------------------------
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE------------------------------------------------ 111 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~------------------------------------------------ 111 (296)
|||||+|||++ .++.+||+|||++.......
T Consensus 125 rDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (381)
T cd05626 125 RDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC 203 (381)
T ss_pred cCCcHHHEEEC-CCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccc
Confidence 99999999998 47889999999975321000
Q ss_pred CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc
Q 022500 112 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 191 (296)
Q Consensus 112 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 191 (296)
...+.+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+.......
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------- 267 (381)
T cd05626 204 LAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL--------------- 267 (381)
T ss_pred ccccccCCccccCHHHHcCC-CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------
Confidence 01235789999999999654 58999999999999999999999999887766655554311100
Q ss_pred cCCCCCCCCcccccCCCCCHHHHHHHHccccc--CCCCCCCHHHHhcCCCcccccCC
Q 022500 192 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY--SPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~--~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
..+ ....+++++++||.+|++. ++..|++++++++||||+.+.+.
T Consensus 268 ~~~----------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 268 HIP----------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred CCC----------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 000 0123789999999996654 45559999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=299.89 Aligned_cols=208 Identities=29% Similarity=0.470 Sum_probs=164.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++.+. +...+|+|||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+|
T Consensus 55 l~~~~h~~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivH 124 (382)
T cd05625 55 LAEADNEWVVRLYYSFQ-----DKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIH 124 (382)
T ss_pred HHhCCCCcCCeEEEEEE-----eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 35789999999999984 34458999999985 66666543 3568999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC------------------------------------------------C
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------------------------------------------------E 111 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~------------------------------------------------~ 111 (296)
|||||+|||++ .++.+||+|||+|...... .
T Consensus 125 rDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (382)
T cd05625 125 RDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRC 203 (382)
T ss_pred CCCCHHHEEEC-CCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence 99999999999 5788999999997532100 0
Q ss_pred CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc
Q 022500 112 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 191 (296)
Q Consensus 112 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 191 (296)
...+.+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+.......
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------- 267 (382)
T cd05625 204 LAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL--------------- 267 (382)
T ss_pred cccccccCcccCCHHHhcCC-CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------
Confidence 01234689999999999654 58999999999999999999999999888776665554321100
Q ss_pred cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC---HHHHhcCCCcccccCC
Q 022500 192 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 246 (296)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---~~e~l~hp~f~~~~~~ 246 (296)
..+ ....+++++.++|.+|+ .+|.+|++ ++++++||||+.+.+.
T Consensus 268 ~~p----------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 268 HIP----------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred CCC----------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 000 01247899999999976 59999997 9999999999987553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.34 Aligned_cols=232 Identities=25% Similarity=0.427 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++... ...|+|||++.++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 111 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHr 181 (357)
T PHA03209 111 LQNVNHPSVIRMKDTLVSG-----AITCMVLPHYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHR 181 (357)
T ss_pred HHhCCCCCCcChhheEEeC-----CeeEEEEEccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 4678999999999998543 34889999999988877753 34678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~ 159 (296)
||||+||+++ ..+.+||+|||+++............||+.|+|||++.+. .++.++|+||+||++|+|+++. ++|..
T Consensus 182 Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 182 DVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred CCCHHHEEEC-CCCCEEEecCccccccccCcccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 9999999999 4778999999999754433334456789999999999664 5899999999999999999865 44443
Q ss_pred CC---------hHHHHHHHHHhcCCCCHHHHhhcC----cCCcCcc-CCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 160 EN---------AVDQLVEIIKVLGTPTREEIRCMN----PNYTDFR-FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 160 ~~---------~~~~~~~i~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
.. ....+..++...+..+........ ..+..+. ........+.......++.++.+||.+||++||
T Consensus 260 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 339 (357)
T PHA03209 260 PPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDA 339 (357)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCc
Confidence 21 123344445544433222110000 0000000 000000000011112467889999999999999
Q ss_pred CCCCCHHHHhcCCCcccc
Q 022500 226 SLRCTALEACAHPFFDEL 243 (296)
Q Consensus 226 ~~R~t~~e~l~hp~f~~~ 243 (296)
.+|||+.|+++||||+++
T Consensus 340 ~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 340 AMRPSAEEILNYPMFAQL 357 (357)
T ss_pred ccCcCHHHHhcCchhccC
Confidence 999999999999999863
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=290.56 Aligned_cols=202 Identities=27% Similarity=0.465 Sum_probs=166.8
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.+||||+++++++.. ...+|+||||++| +|...+. ....+++..++.++.||+.||.|||+ +||+||||
T Consensus 53 ~~hp~i~~~~~~~~~-----~~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDi 122 (321)
T cd05591 53 AKHPFLTALHCCFQT-----KDRLFFVMEYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDL 122 (321)
T ss_pred cCCCCccceeeEEEc-----CCeEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCC
Confidence 489999999999843 3448999999995 6655554 34678999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
||+||+++ .++.+||+|||++...... .......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+
T Consensus 123 kp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 123 KLDNILLD-AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred CHHHeEEC-CCCCEEEeecccceecccCCccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 99999999 5788999999998754322 22344578999999999865 458999999999999999999999999988
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-------CHHHH
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-------TALEA 234 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-------t~~e~ 234 (296)
..+.+..+.... . .++..+++++.++|++||+.||++|+ ++.++
T Consensus 201 ~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~ 251 (321)
T cd05591 201 EDDLFESILHDD-----------------V------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAI 251 (321)
T ss_pred HHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHH
Confidence 777776665410 0 01223789999999999999999999 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||..+.+.
T Consensus 252 ~~hp~~~~~~~~ 263 (321)
T cd05591 252 KQHPFFKEIDWV 263 (321)
T ss_pred hcCCccCCCCHH
Confidence 999999887554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=297.75 Aligned_cols=208 Identities=32% Similarity=0.510 Sum_probs=166.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++. +..++|+|||||+| +|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 55 l~~l~h~~iv~~~~~~~-----~~~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH 124 (364)
T cd05599 55 LAEADNPWVVKLYYSFQ-----DENYLYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK-LGYIH 124 (364)
T ss_pred HHhCCCCCCcceEEEEE-----cCCeEEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEe
Confidence 35689999999999984 44459999999985 6655554 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---------------------------------------Cccceeecc
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---------------------------------------ANISYICSR 120 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---------------------------------------~~~~~~~t~ 120 (296)
|||||+|||++ .++.+||+|||++....... ...+.+||+
T Consensus 125 ~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 203 (364)
T cd05599 125 RDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP 203 (364)
T ss_pred ccCCHHHeEEC-CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCc
Confidence 99999999999 57889999999987542211 011246899
Q ss_pred cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCC
Q 022500 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP 200 (296)
Q Consensus 121 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (296)
.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+.+.... ...+.
T Consensus 204 ~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----- 262 (364)
T cd05599 204 DYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKET---------------LQFPD----- 262 (364)
T ss_pred cccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCc---------------cCCCC-----
Confidence 9999999865 45899999999999999999999999988877766655431100 00110
Q ss_pred cccccCCCCCHHHHHHHHcccccCCCCCCC---HHHHhcCCCcccccCC
Q 022500 201 WHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 246 (296)
Q Consensus 201 ~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---~~e~l~hp~f~~~~~~ 246 (296)
...+++++++||++||. +|.+|++ +.++++||||+...+.
T Consensus 263 -----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 263 -----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred -----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 01378999999999997 9999998 9999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.83 Aligned_cols=238 Identities=37% Similarity=0.732 Sum_probs=186.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++...........|+|+||+++++.+.+. ...+++..++.++.|++.||+|||+ .||+||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~ 130 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHR 130 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecc
Confidence 3568999999999987655444455688999999998776654 2569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||+||+++ .++.+||+|||++........ .....+++.|+|||.+.+...++.++|+||+||++|+|++|++|
T Consensus 131 dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~ 209 (336)
T cd07849 131 DLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209 (336)
T ss_pred CCCHHHEEEC-CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999 578899999999876533221 12346789999999876655689999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC-c--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
|.+.+.......+...++.+..+.+......... + ..+.....++... ....++++.++|.+||+.+|++|||+.+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e 288 (336)
T cd07849 210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEE 288 (336)
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence 9999888888888888888877766543211100 0 0111111111111 1236889999999999999999999999
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||+.+..+
T Consensus 289 ~l~hp~~~~~~~~ 301 (336)
T cd07849 289 ALAHPYLEQYHDP 301 (336)
T ss_pred HhcCccccccCCC
Confidence 9999999988664
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=294.23 Aligned_cols=203 Identities=29% Similarity=0.494 Sum_probs=165.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++.+.. ...+|+||||++| +|...+. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 51 ~~~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~ 120 (325)
T cd05604 51 KNVKHPFLVGLHYSFQT-----TEKLYFVLDFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYR 120 (325)
T ss_pred HhCCCCCCccEEEEEec-----CCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeec
Confidence 46899999999998843 3348999999995 5554443 45679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 121 Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 121 DLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred CCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCC
Confidence 9999999999 5778999999998754322 223456789999999999654 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH----HHHh
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEAC 235 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~----~e~l 235 (296)
.+..+....+.... . .+....+..+.++|++||+.||.+|+++ .+++
T Consensus 199 ~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 199 RDVAEMYDNILHKP-----------------L------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CCHHHHHHHHHcCC-----------------c------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 88776666554310 0 0112468899999999999999999976 6999
Q ss_pred cCCCcccccC
Q 022500 236 AHPFFDELRE 245 (296)
Q Consensus 236 ~hp~f~~~~~ 245 (296)
+||||+...+
T Consensus 250 ~h~~f~~~~~ 259 (325)
T cd05604 250 EHPFFESLSW 259 (325)
T ss_pred cCCCcCCCCH
Confidence 9999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=293.49 Aligned_cols=205 Identities=29% Similarity=0.439 Sum_probs=165.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. ....+|+||||++| +|...+. ....+++..++.++.||+.||+|||+.+||+||
T Consensus 50 ~~~~hp~i~~~~~~~~-----~~~~~~lv~E~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr 120 (325)
T cd05594 50 QNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120 (325)
T ss_pred HhCCCCCCCceEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 5679999999999884 33458999999995 5544443 346799999999999999999999962499999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 121 Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 121 DLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred CCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCC
Confidence 9999999999 5788999999998754322 222345789999999999654 589999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+.......+... .. .++..+++++.+||++||+.||++|+ ++.++
T Consensus 199 ~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~i 249 (325)
T cd05594 199 QDHEKLFELILME-----------------EI------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEI 249 (325)
T ss_pred CCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHH
Confidence 7765555444321 00 12245789999999999999999997 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||....+.
T Consensus 250 l~h~~~~~~~~~ 261 (325)
T cd05594 250 MQHKFFAGIVWQ 261 (325)
T ss_pred hcCCCcCCCCHH
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=294.52 Aligned_cols=202 Identities=28% Similarity=0.508 Sum_probs=164.6
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++.. ...+|+||||++| +|...+. ..+.+++..++.++.||+.||+|||+ +||+|||||
T Consensus 54 ~~p~i~~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlk 123 (330)
T cd05586 54 ESPFIVGLKFSFQT-----DSDLYLVTDYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLK 123 (330)
T ss_pred CCCcCcceEEEEec-----CCeEEEEEcCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCC
Confidence 79999999998843 3458999999985 6655544 45679999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+||+++ .++.+||+|||++...... .......||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.
T Consensus 124 p~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~ 202 (330)
T cd05586 124 PENILLD-ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202 (330)
T ss_pred HHHeEEC-CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence 9999999 5778999999998754332 2234567899999999997655689999999999999999999999998876
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC----CHHHHhcCC
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHP 238 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~----t~~e~l~hp 238 (296)
.+....+... ...++ ...+++++.+||++||+.||.+|+ ++.++++||
T Consensus 203 ~~~~~~i~~~-----------------~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 203 QQMYRNIAFG-----------------KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred HHHHHHHHcC-----------------CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 6655554321 00011 013689999999999999999998 789999999
Q ss_pred CcccccC
Q 022500 239 FFDELRE 245 (296)
Q Consensus 239 ~f~~~~~ 245 (296)
||+...+
T Consensus 255 ~~~~~~~ 261 (330)
T cd05586 255 FFADIDW 261 (330)
T ss_pred cccCCCH
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=302.90 Aligned_cols=207 Identities=27% Similarity=0.357 Sum_probs=171.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||++++++... ..+||||||++ |+|.+.+.........+++..+..++.||+.||.|||+ +||+|
T Consensus 119 l~~l~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH 192 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSD-----DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMH 192 (478)
T ss_pred HHhCCCCCEeEEEEEEEEC-----CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEE
Confidence 4578999999999998443 34899999998 58877776655556779999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++ .++.+||+|||+++...... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|..|
T Consensus 193 rDlkp~NIll~-~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~P 270 (478)
T PTZ00267 193 RDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRP 270 (478)
T ss_pred CCcCHHhEEEC-CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 99999999999 47789999999998654322 1234568999999999865 4589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+.+..+...... .++..++.++.++|.+||+.||++||++.+++.
T Consensus 271 f~~~~~~~~~~~~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 271 FKGPSQREIMQQVLYGKYD----------------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCHHHHHHHHHhCCCC----------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 9988777666655431100 012347889999999999999999999999999
Q ss_pred CCCcccc
Q 022500 237 HPFFDEL 243 (296)
Q Consensus 237 hp~f~~~ 243 (296)
|||++..
T Consensus 323 ~~~~~~~ 329 (478)
T PTZ00267 323 TEFLKYV 329 (478)
T ss_pred CHHHHHH
Confidence 9999654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=298.85 Aligned_cols=228 Identities=25% Similarity=0.406 Sum_probs=172.4
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
.+|++|+++++++.. +..++|+|||+++++|.+.+.. .+.+++..++.++.||+.||+|||+..||+|||||
T Consensus 188 ~~~~~i~~i~~~~~~----~~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK 259 (467)
T PTZ00284 188 ADRFPLMKIQRYFQN----ETGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259 (467)
T ss_pred ccCcceeeeEEEEEc----CCceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 356779999988853 2335889999999888877653 36799999999999999999999971299999999
Q ss_pred CCcEEEcCCC---------------CcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 84 PQNLLVDPLT---------------HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 84 p~Nill~~~~---------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
|+|||++..+ ..+||+|||.+... .......+||+.|+|||++.+. .++.++||||+||++|
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIY 336 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHH
Confidence 9999997432 14999999988643 2233456889999999999764 5999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC-----CcCcc--CCCCC---------CCCcccccCCCCCHH
Q 022500 149 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN-----YTDFR--FPQIK---------AHPWHKVFHKRMPPE 212 (296)
Q Consensus 149 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~---------~~~~~~~~~~~~~~~ 212 (296)
+|++|++||.+.+..+.+..+.+.+|.++.+........ +.... .+... ...+... .-++.
T Consensus 337 elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 413 (467)
T PTZ00284 337 ELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV---IRDDL 413 (467)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh---hchHH
Confidence 999999999999999999889888888765433211000 00000 00000 0000000 12567
Q ss_pred HHHHHHcccccCCCCCCCHHHHhcCCCcccccC
Q 022500 213 AIDLASRLLQYSPSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 213 ~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~ 245 (296)
+.|||.+||++||.+|+|++|+|+||||.....
T Consensus 414 ~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 414 LCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 889999999999999999999999999987644
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.29 Aligned_cols=207 Identities=29% Similarity=0.474 Sum_probs=163.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. +..++|+||||++ |+|.+.+. ....+++..++.++.|++.||+|||+ .||+|
T Consensus 55 l~~l~hp~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~givH 124 (377)
T cd05629 55 LAESDSPWVVSLYYSFQ-----DAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIH 124 (377)
T ss_pred HHhCCCCCcceEEEEEE-----cCCeeEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 35689999999999984 4445999999998 57666654 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC------------------------------------------------
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE------------------------------------------------ 111 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~------------------------------------------------ 111 (296)
|||||+||+++ .++.+||+|||+++......
T Consensus 125 rDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (377)
T cd05629 125 RDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL 203 (377)
T ss_pred cCCCHHHEEEC-CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence 99999999998 57889999999986321100
Q ss_pred CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc
Q 022500 112 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 191 (296)
Q Consensus 112 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 191 (296)
.....+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+...... .
T Consensus 204 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~ 267 (377)
T cd05629 204 MAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------L 267 (377)
T ss_pred cccccCCCccccCHHHHccC-CCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------c
Confidence 00124689999999999654 5899999999999999999999999988877666665531100 0
Q ss_pred cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCC---CCHHHHhcCCCcccccC
Q 022500 192 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDELRE 245 (296)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R---~t~~e~l~hp~f~~~~~ 245 (296)
.++. ...++.++++||.+||+ +|.+| +|+.++++||||+...+
T Consensus 268 ~~p~----------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 268 YFPD----------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred CCCC----------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 0110 01368999999999998 77765 59999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=280.86 Aligned_cols=231 Identities=36% Similarity=0.627 Sum_probs=183.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++.... ...+|+||||++++|.+.+.. ....+++..++.++.|++.||+|||+ +|++|+|
T Consensus 59 ~~l~h~ni~~~~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~d 131 (293)
T cd07843 59 LKLQHPNIVTVKEVVVGSN---LDKIYMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRD 131 (293)
T ss_pred HhcCCCCEEEEEEEEEecC---CCcEEEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecc
Confidence 5688999999999885432 245889999999988777654 23468999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||++....... ......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.
T Consensus 132 l~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 132 LKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred CCHHHEEEC-CCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999 57889999999998664432 2234567889999999876555789999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCC-CCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+..+...++....+.+....+..... ..............+...++.. +++.+.++|++||+.||++|||+.|+++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 211 SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 99988999988888887766554321 1111111111222223334443 68999999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 291 ~~f 293 (293)
T cd07843 291 PYF 293 (293)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.98 Aligned_cols=237 Identities=32% Similarity=0.601 Sum_probs=183.5
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++..... .+..+.|+||||+.++|.+.+.. .+++..+..++.|++.||+|||+ +|++|
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H 141 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIH 141 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 357899999999998864332 23345789999999988776652 28899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||+++............+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus 142 ~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 142 RDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred CCCCHHHEEEC-CCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999 4778999999999876444333455678999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCcc--CCCCCCCCcccc------------cCCCCCHHHHHHHHcccccCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR--FPQIKAHPWHKV------------FHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~------------~~~~~~~~~~dll~~~L~~~p 225 (296)
.+.......+++..|.|..+...........+. .+.....++... .....++.++++|.+||+.||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 299 (353)
T cd07850 220 TDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299 (353)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCCh
Confidence 998999999999999987765443321111110 000000011111 022356789999999999999
Q ss_pred CCCCCHHHHhcCCCcccccCC
Q 022500 226 SLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 226 ~~R~t~~e~l~hp~f~~~~~~ 246 (296)
++|||+.|+|+||||+.....
T Consensus 300 ~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 300 EKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhCcCHHHHhcChhHhhccCC
Confidence 999999999999999866553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=287.49 Aligned_cols=202 Identities=31% Similarity=0.525 Sum_probs=165.1
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
..+||||+++++++. ...++|+||||++| +|...+. ....+++..++.++.||+.||+|||+ +||+|||
T Consensus 52 ~~~hp~i~~~~~~~~-----~~~~~~lv~e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~d 121 (316)
T cd05592 52 AWEHPFLTHLFCTFQ-----TKEHLFFVMEYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRD 121 (316)
T ss_pred ccCCCCccceeeEEE-----cCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCC
Confidence 358999999999884 34458999999985 6655554 34679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus 122 lkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 122 LKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CCHHHeEEC-CCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 999999998 57789999999997643322 23345789999999999764 5899999999999999999999999988
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH-HHhcCCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPF 239 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~-e~l~hp~ 239 (296)
+..+....+.... + .++..++.++.++|.+||+.||++|+++. ++++|||
T Consensus 200 ~~~~~~~~i~~~~--~---------------------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 200 DEDELFDSILNDR--P---------------------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250 (316)
T ss_pred CHHHHHHHHHcCC--C---------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence 8766665543210 0 02234789999999999999999999864 8889999
Q ss_pred cccccC
Q 022500 240 FDELRE 245 (296)
Q Consensus 240 f~~~~~ 245 (296)
|+.+.+
T Consensus 251 ~~~~~~ 256 (316)
T cd05592 251 FRGIDW 256 (316)
T ss_pred cCCCCH
Confidence 998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=295.11 Aligned_cols=208 Identities=26% Similarity=0.470 Sum_probs=167.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++ .+..++|+||||++| +|.+.+.. ..+++..++.++.||+.||+|||+ +||+|
T Consensus 97 l~~~~h~~iv~~~~~~-----~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH 165 (370)
T cd05596 97 MAHANSEWIVQLHYAF-----QDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIH 165 (370)
T ss_pred HHhCCCCCcceEEEEE-----ecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 3578999999999988 444459999999984 67666542 458899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCC---CCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+|||++ .++.+||+|||++........ .....||+.|+|||++.+. ..++.++|+||+||++|+|++|.
T Consensus 166 rDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 244 (370)
T cd05596 166 RDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (370)
T ss_pred cCCCHHHEEEc-CCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCC
Confidence 99999999999 578899999999986543221 2345789999999998643 23788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC--CCCHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTAL 232 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~--R~t~~ 232 (296)
.||.+.+....+..+...... ..++. ...++.++++||++||+.+|.+ |+|++
T Consensus 245 ~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ 299 (370)
T cd05596 245 TPFYADSLVGTYSKIMDHKNS---------------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVD 299 (370)
T ss_pred CCcCCCCHHHHHHHHHcCCCc---------------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHH
Confidence 999998877776666542110 00110 1137899999999999999998 99999
Q ss_pred HHhcCCCcccccC
Q 022500 233 EACAHPFFDELRE 245 (296)
Q Consensus 233 e~l~hp~f~~~~~ 245 (296)
++++||||+...+
T Consensus 300 ell~h~~~~~~~~ 312 (370)
T cd05596 300 EIKSHPFFKNDQW 312 (370)
T ss_pred HHhcCcccCCCCh
Confidence 9999999987554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=287.12 Aligned_cols=200 Identities=29% Similarity=0.490 Sum_probs=164.6
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++.. ...+|+||||++| +|...+. ....+++..+..++.|++.||.|||+ +||+|||||
T Consensus 54 ~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlk 123 (318)
T cd05570 54 KHPFLTQLHSCFQT-----KDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLK 123 (318)
T ss_pred CCCCccceeeEEEc-----CCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCC
Confidence 79999999999843 3458999999985 6555444 34579999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+||+++ .++.+||+|||+++..... .......|++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.
T Consensus 124 p~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~ 201 (318)
T cd05570 124 LDNVLLD-SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201 (318)
T ss_pred HHHeEEC-CCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCH
Confidence 9999999 4778999999998753222 223345789999999999764 589999999999999999999999988876
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH-----HHHhcC
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAH 237 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~-----~e~l~h 237 (296)
......+.... ..++..++.++.+||++||+.||.+|+|+ .++++|
T Consensus 202 ~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 202 DELFQSILEDE-----------------------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHcCC-----------------------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 66555543310 01223478999999999999999999999 999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+...+
T Consensus 253 ~~~~~~~~ 260 (318)
T cd05570 253 PFFREIDW 260 (318)
T ss_pred CCcCCCCH
Confidence 99998765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=277.96 Aligned_cols=229 Identities=36% Similarity=0.675 Sum_probs=179.2
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+++ +||||+++++++... ....+++||||+++++.+.+.. ....+++..+..++.|++.||+|||+ +|++||
T Consensus 52 ~~l~~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~ 124 (282)
T cd07831 52 RRLSPHPNILRLIEVLFDR---KTGRLALVFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHR 124 (282)
T ss_pred hhcCCCCCccceEEEEecC---CCCcEEEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceec
Confidence 344 599999999998543 1134889999999988877653 23568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++. +.+||+|||++.............+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.
T Consensus 125 dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 125 DIKPENILIKD--DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred ccCHHHEEEcC--CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 99999999994 8899999999987654444445567899999998755555789999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcC-CcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPN-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
+..+.+..+.+..+.+........... ...+.++......... ....++.++.++|.+||.+||++|||++++++|||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 203 NELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 988888888888887776543222111 1111122111111111 12346899999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
|
T Consensus 282 ~ 282 (282)
T cd07831 282 F 282 (282)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.35 Aligned_cols=237 Identities=34% Similarity=0.617 Sum_probs=181.2
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~-~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
.+ +||||+++++++...........|+||||+++++.+.+...... ...+++..++.++.||+.||.|||+ +|++||
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~ 134 (295)
T cd07837 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHR 134 (295)
T ss_pred HccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeec
Confidence 45 56999999998865544344558899999999888877643322 3568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++..++.+||+|||++....... ......+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.+
T Consensus 135 dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 135 DLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred CCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999547889999999987653221 122335688999999987655688999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+....+.++.+..+.+....+............+......... ....+++++.+||.+||.+||.+||++++++.|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 215 DSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred CCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 98888888888877777655443221111111111111111111 12347899999999999999999999999999999
Q ss_pred cc
Q 022500 240 FD 241 (296)
Q Consensus 240 f~ 241 (296)
|+
T Consensus 294 ~~ 295 (295)
T cd07837 294 FD 295 (295)
T ss_pred cC
Confidence 85
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=286.02 Aligned_cols=203 Identities=30% Similarity=0.531 Sum_probs=164.8
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.++||||+++++++.. ...+|+||||++| +|...+. ....+++..+..++.|++.||.|||+ +||+|||
T Consensus 52 ~~~hp~iv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrd 121 (316)
T cd05619 52 AWEHPFLTHLYCTFQT-----KENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRD 121 (316)
T ss_pred ccCCCcCcceEEEEEe-----CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCC
Confidence 3589999999999843 3348999999984 6665554 34568999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||++...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus 122 ikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 122 LKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred CCHHHEEEC-CCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 999999999 4778999999998754222 223456789999999999654 5899999999999999999999999988
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH-HHhcCCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPF 239 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~-e~l~hp~ 239 (296)
+..+....+... .+ .++..++.++.++|.+||+.||++|+++. ++++|||
T Consensus 200 ~~~~~~~~i~~~--~~---------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 200 DEEELFQSIRMD--NP---------------------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPF 250 (316)
T ss_pred CHHHHHHHHHhC--CC---------------------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence 766555444221 00 01123688999999999999999999996 8999999
Q ss_pred cccccCC
Q 022500 240 FDELREP 246 (296)
Q Consensus 240 f~~~~~~ 246 (296)
|+.+.+.
T Consensus 251 ~~~~~~~ 257 (316)
T cd05619 251 FREIDWS 257 (316)
T ss_pred cCCCCHH
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.38 Aligned_cols=229 Identities=41% Similarity=0.767 Sum_probs=184.6
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++.. ...+|+|+||++++|.+.+.. ....+++..++.++.||+.||+|||+ .|++|+|
T Consensus 54 ~~~~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~d 124 (286)
T cd07832 54 QACQHPYVVKLLDVFPH-----GSGFVLVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRD 124 (286)
T ss_pred HhCCCCCCcceeeEEec-----CCeeEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCC
Confidence 56789999999999843 445899999997788777654 23669999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+||+++. ++.++|+|||.+........ .....++..|+|||.+.+...++.++||||+||++|+|++|.++|.+
T Consensus 125 l~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 125 LKPANLLISA-DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred cCHHHEEEcC-CCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 9999999994 77899999999986644321 23456788999999987666678999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+..+.+..+.+....+..... .+....++......+...+ ...+.++.++|.+||..||.+|||++++++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 204 ENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 999999999999988888766654321 2222223332222232222 3467899999999999999999999999999
Q ss_pred CCcc
Q 022500 238 PFFD 241 (296)
Q Consensus 238 p~f~ 241 (296)
|||.
T Consensus 283 ~~~~ 286 (286)
T cd07832 283 PYFT 286 (286)
T ss_pred cCcC
Confidence 9984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=283.13 Aligned_cols=235 Identities=34% Similarity=0.551 Sum_probs=183.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.... ...+++||||++++|.+.+... ...+++..+..++.|++.||+|||+ .|++||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 132 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKH---LDSIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHR 132 (309)
T ss_pred HHhCCCCCCcceEEEEecCC---CCeEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 35789999999999885422 2347899999999887777642 3568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+
T Consensus 133 dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 133 DLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred CCCHHHEEEC-CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 57789999999998664332 222334578899999987666689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+..+....+.+....+..... ....+..+......+... ....++++.++|.+||++||++|||+.+++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 212 KSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 999999999999888877655433211 111111111111111111 12368899999999999999999999999999
Q ss_pred CCccccc
Q 022500 238 PFFDELR 244 (296)
Q Consensus 238 p~f~~~~ 244 (296)
|||++..
T Consensus 291 ~~f~~~~ 297 (309)
T cd07845 291 SYFKEKP 297 (309)
T ss_pred hhhccCC
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=295.21 Aligned_cols=231 Identities=22% Similarity=0.331 Sum_probs=173.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++|||||++++++. ....+|+|||++.++|.+.+. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 140 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHr 209 (392)
T PHA03207 140 LKTISHRAIINLIHAYR-----WKSTVCMVMPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHR 209 (392)
T ss_pred HHhcCCCCccceeeeEe-----eCCEEEEEehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 46789999999999884 344589999999998877763 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+|||++ .++.++|+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus 210 Dlkp~Nill~-~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 210 DVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred CCCHHHEEEc-CCCCEEEccCccccccCcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999 577899999999976543322 2345789999999999654 5899999999999999999999999
Q ss_pred CCCC---hHHHHHHHHHhcCCCCHHHHhhcC----cCCcCccCCCCCCCCcccc-cCCCCCHHHHHHHHcccccCCCCCC
Q 022500 158 PGEN---AVDQLVEIIKVLGTPTREEIRCMN----PNYTDFRFPQIKAHPWHKV-FHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 158 ~~~~---~~~~~~~i~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
.+.. ....+..+++.++....+...... ..+..+............. ....++.++.++|++||++||++||
T Consensus 288 ~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp 367 (392)
T PHA03207 288 FGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367 (392)
T ss_pred CCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC
Confidence 7754 455666777766554332111100 0000010000000001111 1124678899999999999999999
Q ss_pred CHHHHhcCCCcccc
Q 022500 230 TALEACAHPFFDEL 243 (296)
Q Consensus 230 t~~e~l~hp~f~~~ 243 (296)
|+.|+++||||.+.
T Consensus 368 sa~e~l~~p~f~~~ 381 (392)
T PHA03207 368 SAQDILSLPLFTKE 381 (392)
T ss_pred CHHHHhhCchhhcc
Confidence 99999999999864
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.92 Aligned_cols=209 Identities=33% Similarity=0.545 Sum_probs=169.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++ .+..++|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+|
T Consensus 55 l~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH 124 (350)
T cd05573 55 LADADSPWIVKLYYSF-----QDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIH 124 (350)
T ss_pred HHhcCCCCccchhhhe-----ecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 3567899999999988 344458999999984 77666653 3679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC------------------------------CccceeecccccCchhcc
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE------------------------------ANISYICSRFYRAPELIF 129 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~------------------------------~~~~~~~t~~y~aPE~~~ 129 (296)
|||||+||+++ .++.+||+|||++....... ......||+.|+|||++.
T Consensus 125 ~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (350)
T cd05573 125 RDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203 (350)
T ss_pred cCCCHHHeEEC-CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 99999999999 57889999999998654332 123457899999999997
Q ss_pred CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCC
Q 022500 130 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM 209 (296)
Q Consensus 130 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (296)
+. .++.++||||+||++|+|++|..||.+.+..+...++...... ...+. ...+
T Consensus 204 ~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~ 257 (350)
T cd05573 204 GT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKES---------------LRFPP----------DPPV 257 (350)
T ss_pred CC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCC
Confidence 65 5899999999999999999999999988877666665542110 00110 1126
Q ss_pred CHHHHHHHHcccccCCCCCCC-HHHHhcCCCcccccCCC
Q 022500 210 PPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDELREPN 247 (296)
Q Consensus 210 ~~~~~dll~~~L~~~p~~R~t-~~e~l~hp~f~~~~~~~ 247 (296)
++++.+||.+||. ||.+|++ ++++++||||+.+.+..
T Consensus 258 ~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 258 SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred CHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 8999999999998 9999999 99999999999876643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.12 Aligned_cols=240 Identities=36% Similarity=0.718 Sum_probs=188.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.... .+...+|+||||++++|.+.+. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~ 131 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPG-ADFKDVYVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHR 131 (334)
T ss_pred HHhcCCCCccCHHHhccccC-CCCceEEEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 46789999999999875443 3445688999999987766554 34569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc-----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++ .++.+||+|||++......... ....++..|+|||.+.+...++.++|+||+||++|+|++|.+
T Consensus 132 dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~ 210 (334)
T cd07855 132 DLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210 (334)
T ss_pred CCCHHHEEEc-CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCC
Confidence 9999999999 5788999999999765332211 234678899999998665568999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC-c--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
||.+.+....+..+....|.|..+........... . ..+.....++.. .....++++.++|++||+.+|++|||++
T Consensus 211 pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 289 (334)
T cd07855 211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVE 289 (334)
T ss_pred ccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999998999999999998887665443221100 0 111111222222 2234689999999999999999999999
Q ss_pred HHhcCCCcccccCCCC
Q 022500 233 EACAHPFFDELREPNA 248 (296)
Q Consensus 233 e~l~hp~f~~~~~~~~ 248 (296)
+++.||||.....+..
T Consensus 290 ~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 290 QALQHPFLAQYHDPDD 305 (334)
T ss_pred HHHhChhhhhccCCcc
Confidence 9999999998766544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.06 Aligned_cols=204 Identities=28% Similarity=0.451 Sum_probs=168.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++ |+|.+.+. ....+++..++.++.||+.||.|||+ .||+|
T Consensus 52 l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H 121 (318)
T cd05582 52 LAEVNHPFIVKLHYAFQT-----EGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS-LGIIY 121 (318)
T ss_pred HHhCCCCCcccEEEEEEc-----CCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEec
Confidence 457899999999999843 345899999998 46665554 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 122 ~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~ 199 (318)
T cd05582 122 RDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQ 199 (318)
T ss_pred CCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCC
Confidence 99999999999 5778999999999765433 223346789999999999654 58899999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e 233 (296)
+.+..+....+.+.. . .++..+++++.++|++||+.||++|++ +.+
T Consensus 200 ~~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~ 250 (318)
T cd05582 200 GKDRKETMTMILKAK-----------------L------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEE 250 (318)
T ss_pred CCCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 888776666554310 0 022347899999999999999999999 788
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++||||+.+.+
T Consensus 251 ~~~~~~~~~~~~ 262 (318)
T cd05582 251 IKRHPFFSTIDW 262 (318)
T ss_pred HhCCCCcCCCCH
Confidence 999999988754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=293.38 Aligned_cols=207 Identities=27% Similarity=0.454 Sum_probs=165.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. +..++|+|||||+ |+|.+.+.. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 98 ~~~~hp~iv~~~~~~~-----~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHr 166 (370)
T cd05621 98 AFANSPWVVQLFCAFQ-----DDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHR 166 (370)
T ss_pred HhCCCCCEeeEEEEEE-----cCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 5679999999999984 4445999999998 477666643 358999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCC---CCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+|||++ .++.+||+|||+|........ .....||+.|+|||++.+. ..++.++|+||+||++|+|++|..
T Consensus 167 DLKp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~ 245 (370)
T cd05621 167 DVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245 (370)
T ss_pred CCCHHHEEEC-CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence 9999999999 578899999999986543221 2356789999999998643 237889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC--CCCHHH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALE 233 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~--R~t~~e 233 (296)
||.+.+....+.+++....... ++. ...++..+++++.+||+.++.+ |+|+.+
T Consensus 246 Pf~~~~~~~~~~~i~~~~~~~~---------------~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e 300 (370)
T cd05621 246 PFYADSLVGTYSKIMDHKNSLN---------------FPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEE 300 (370)
T ss_pred CCCCCCHHHHHHHHHhCCcccC---------------CCC----------cccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence 9999887777776654211110 110 1236899999999999865544 889999
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++||||+...+
T Consensus 301 ~l~hp~~~~~~~ 312 (370)
T cd05621 301 IKQHPFFKNDQW 312 (370)
T ss_pred HhcCcccCCCCc
Confidence 999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.98 Aligned_cols=208 Identities=30% Similarity=0.449 Sum_probs=161.9
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
.+ +||||+++++++. ....+|+||||++| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 60 ~l~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHr 129 (332)
T cd05614 60 HVRQSPFLVTLHYAFQ-----TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYR 129 (332)
T ss_pred hccCCCCcccEEEEEe-----cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEec
Confidence 45 5999999999884 34458899999995 6666554 34678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+...++.++||||+||++|+|++|..||.
T Consensus 130 Dlkp~Nili~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 130 DIKLENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred CCCHHHeEEC-CCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 9999999999 477899999999986533322 2345789999999999765558899999999999999999999997
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e 233 (296)
..........+.+... .. ...++..+++.+.++|.+||+.||++|+ ++++
T Consensus 209 ~~~~~~~~~~~~~~~~--------~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 263 (332)
T cd05614 209 LEGERNTQSEVSRRIL--------KC-----------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263 (332)
T ss_pred CCCCCCCHHHHHHHHh--------cC-----------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 5432211111111000 00 0012234789999999999999999999 8899
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||++..+.
T Consensus 264 ~l~h~~~~~~~~~ 276 (332)
T cd05614 264 IKEHPFFKGLDWE 276 (332)
T ss_pred HHcCCCcCCCCHH
Confidence 9999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=277.66 Aligned_cols=206 Identities=30% Similarity=0.464 Sum_probs=173.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~-l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+..+||.+..+.-.| +....+|+||||+.|+ |+- .++....+++..++.|..+|++||.|||+ ++||+
T Consensus 222 L~~~~HPFLt~LKYsF-----Qt~drlCFVMeyanGGeLf~----HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivY 291 (516)
T KOG0690|consen 222 LQNCRHPFLTSLKYSF-----QTQDRLCFVMEYANGGELFF----HLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVY 291 (516)
T ss_pred HHhccCcHHHHhhhhh-----ccCceEEEEEEEccCceEee----ehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeee
Confidence 3456899999987777 3444599999999964 332 23345679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||.+|+|++ .++.+||+|||+|+.-... ....+++|||.|.|||++.. ..|+.++|+|.+||++|||++|+.||.
T Consensus 292 RDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 292 RDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eechhhhheec-cCCceEeeecccchhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCccc
Confidence 99999999999 5888999999999876544 34567899999999999954 579999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e 233 (296)
..+.......|+- ++. .++..++++++.|+..+|.+||.+|.. +.|
T Consensus 370 n~dh~kLFeLIl~-----------------ed~------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakE 420 (516)
T KOG0690|consen 370 NKDHEKLFELILM-----------------EDL------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKE 420 (516)
T ss_pred ccchhHHHHHHHh-----------------hhc------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHH
Confidence 9988777766654 122 244679999999999999999999984 789
Q ss_pred HhcCCCcccccCCC
Q 022500 234 ACAHPFFDELREPN 247 (296)
Q Consensus 234 ~l~hp~f~~~~~~~ 247 (296)
+.+|+||..+.|..
T Consensus 421 i~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 421 IMRHRFFASVDWEA 434 (516)
T ss_pred HHhhhhhccCCHHH
Confidence 99999999998863
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=289.26 Aligned_cols=202 Identities=26% Similarity=0.478 Sum_probs=159.3
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++. +...+|+||||++| +|...+. ..+.+++..++.++.||+.||+|||+ +||+|||||
T Consensus 54 ~hp~Iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlk 123 (329)
T cd05588 54 NHPFLVGLHSCFQ-----TESRLFFVIEFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLK 123 (329)
T ss_pred CCCCCCceEEEEE-----cCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCC
Confidence 7999999999984 33458999999985 6655443 34679999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+||+++ .++.+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.....
T Consensus 124 p~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 201 (329)
T cd05588 124 LDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201 (329)
T ss_pred HHHeEEC-CCCCEEECcCccccccccCCCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccc
Confidence 9999998 478899999999875322 2233456789999999999754 589999999999999999999999963211
Q ss_pred --------HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC----
Q 022500 163 --------VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---- 230 (296)
Q Consensus 163 --------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---- 230 (296)
.+...+.+.. .. ..++..++.++.++|++||+.||.+|+|
T Consensus 202 ~~~~~~~~~~~~~~~~~~----------------~~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 253 (329)
T cd05588 202 SDNPDQNTEDYLFQVILE----------------KQ------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQ 253 (329)
T ss_pred cccccccchHHHHHHHHc----------------CC------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence 1111111110 00 0123457899999999999999999987
Q ss_pred --HHHHhcCCCcccccCC
Q 022500 231 --ALEACAHPFFDELREP 246 (296)
Q Consensus 231 --~~e~l~hp~f~~~~~~ 246 (296)
++++++||||..+.+.
T Consensus 254 ~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 254 TGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred CCHHHHhcCCCCCCCCHH
Confidence 7899999999887553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.39 Aligned_cols=209 Identities=29% Similarity=0.512 Sum_probs=175.7
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+.+-||+++-.| +++.++|+||||++| +|..++.. ..++++..+++|+.+|+.||.-+|++ |+||||||
T Consensus 133 ns~Wiv~LhyAF-----QD~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiK 202 (1317)
T KOG0612|consen 133 NSEWIVQLHYAF-----QDERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIK 202 (1317)
T ss_pred CcHHHHHHHHHh-----cCccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc-cceeccCC
Confidence 456788887777 788889999999995 66666654 34799999999999999999999996 99999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|+|||+| ..|.+||+|||.|-.+..++.. ...+|||.|+|||++.. .+.|+..+|+||+||++|||+.|..||
T Consensus 203 PDNvLld-~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 203 PDNVLLD-KSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred cceeEec-ccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 9999999 5888999999999888655433 45689999999999842 246899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC---HHHH
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEA 234 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---~~e~ 234 (296)
+..+..+.+.+|++.- ..+.+|.. ..+|++++|||.++++ +|+.|.+ ++++
T Consensus 282 YadslveTY~KIm~hk---------------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 282 YADSLVETYGKIMNHK---------------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDI 335 (1317)
T ss_pred hHHHHHHHHHHHhchh---------------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence 9999999999998741 12223310 2389999999999997 6899998 9999
Q ss_pred hcCCCcccccCCCCCC
Q 022500 235 CAHPFFDELREPNARL 250 (296)
Q Consensus 235 l~hp~f~~~~~~~~~~ 250 (296)
.+||||.++.|.+.+.
T Consensus 336 k~HpFF~g~~W~~iR~ 351 (1317)
T KOG0612|consen 336 KNHPFFEGIDWDNIRE 351 (1317)
T ss_pred HhCccccCCChhhhhh
Confidence 9999999999976543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=288.99 Aligned_cols=203 Identities=27% Similarity=0.442 Sum_probs=166.6
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.. ...+|+||||++| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 51 ~~~~h~~Iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHr 120 (325)
T cd05602 51 KNVKHPFLVGLHFSFQT-----ADKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS-LNIVYR 120 (325)
T ss_pred HhCCCCCCCceeEEEEc-----CCeEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 56899999999998843 3448999999996 6655554 34668899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+
T Consensus 121 Dlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 121 DLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred CCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCC
Confidence 9999999998 4778999999999754322 22345678999999999975 4589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH----HHh
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----EAC 235 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~----e~l 235 (296)
.+..+.+..+..... .+...+++.+.++|.+||+.||.+|+++. +++
T Consensus 199 ~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 199 RNTAEMYDNILNKPL-----------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCHHHHHHHHHhCCc-----------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 887776666543100 01134789999999999999999999875 899
Q ss_pred cCCCcccccC
Q 022500 236 AHPFFDELRE 245 (296)
Q Consensus 236 ~hp~f~~~~~ 245 (296)
+|+||..+.+
T Consensus 250 ~~~~~~~~~~ 259 (325)
T cd05602 250 NHIFFSPINW 259 (325)
T ss_pred cCcccCCCCH
Confidence 9999987755
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.67 Aligned_cols=207 Identities=29% Similarity=0.444 Sum_probs=163.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++.+. +...+|+|||||+ |+|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 55 l~~l~h~~iv~~~~~~~-----~~~~~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH 124 (376)
T cd05598 55 LAEADNEWVVKLYYSFQ-----DKDNLYFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHK-MGFIH 124 (376)
T ss_pred HHhCCCCCcceEEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEe
Confidence 35789999999999984 3445999999998 46766665 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC--------------------------------------------CCccc
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--------------------------------------------EANIS 115 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~--------------------------------------------~~~~~ 115 (296)
|||||+||+++ .++.+||+|||+|..+... .....
T Consensus 125 rDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (376)
T cd05598 125 RDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS 203 (376)
T ss_pred CCCCHHHEEEC-CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccc
Confidence 99999999999 5788999999997532100 00113
Q ss_pred eeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCC
Q 022500 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 195 (296)
Q Consensus 116 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (296)
.+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...... ...+
T Consensus 204 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~- 266 (376)
T cd05598 204 LVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP- 266 (376)
T ss_pred cCCCccccCHHHHcCC-CCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC-
Confidence 4789999999999654 5899999999999999999999999988776655544321000 0000
Q ss_pred CCCCCcccccCCCCCHHHHHHHHcccccCCCCCC---CHHHHhcCCCcccccC
Q 022500 196 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELRE 245 (296)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~---t~~e~l~hp~f~~~~~ 245 (296)
....+++++.++|.+|+ .+|.+|+ |+.++++||||+.+..
T Consensus 267 ---------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 267 ---------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred ---------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 11247899999999976 5999999 9999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=277.66 Aligned_cols=229 Identities=37% Similarity=0.718 Sum_probs=176.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++. +..+.|+||||++++|.+.+.. ....+++..++.++.|++.||.|||+ +||+||
T Consensus 57 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~ 127 (291)
T cd07844 57 LKDLKHANIVTLHDIIH-----TKKTLTLVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHR 127 (291)
T ss_pred HhhCCCcceeeEEEEEe-----cCCeEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecc
Confidence 46789999999999984 3445899999999988776653 23468999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++...... ......++..|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus 128 dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 128 DLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred cCCHHHEEEc-CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 57789999999987543221 112335678899999987655688999999999999999999999987
Q ss_pred CC-hHHHHHHHHHhcCCCCHHHHhhcCcC--CcCccCCCCCCCCcccccCCCCC--HHHHHHHHcccccCCCCCCCHHHH
Q 022500 160 EN-AVDQLVEIIKVLGTPTREEIRCMNPN--YTDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 160 ~~-~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.. ..+.+..+.+..+.+....+...... +.....+.....+..... ..++ .++.+++.+||+.+|++|||++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~ 285 (291)
T cd07844 207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEA 285 (291)
T ss_pred CccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHH
Confidence 76 56777778888888776665443221 222222211111111111 1244 889999999999999999999999
Q ss_pred hcCCCc
Q 022500 235 CAHPFF 240 (296)
Q Consensus 235 l~hp~f 240 (296)
++||||
T Consensus 286 l~~~~f 291 (291)
T cd07844 286 MKHPYF 291 (291)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.75 Aligned_cols=209 Identities=26% Similarity=0.458 Sum_probs=168.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. +...+|+||||++ |+|.+.+.. ....+++..++.++.||+.||+|||+ .||+||
T Consensus 56 ~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~ 126 (330)
T cd05601 56 SISNSPWIPQLQYAFQ-----DKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHR 126 (330)
T ss_pred HhCCCCCCcceeeEEe-----cCCeEEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcc
Confidence 5679999999999884 3445899999998 577766653 23579999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccC-----CCCCCchhHHHHHHHHHHHHHhC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g 153 (296)
||||+||+++ .++.+||+|||++......... ....||+.|+|||++.+ ...++.++||||+||++|+|++|
T Consensus 127 Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 205 (330)
T cd05601 127 DIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205 (330)
T ss_pred cCchHheEEC-CCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccC
Confidence 9999999999 5788999999999865433322 23468999999999853 34578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
..||.+.+....+..+.+.... ..++. ...+++++.+||.+||+ +|.+|+|+++
T Consensus 206 ~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~ 259 (330)
T cd05601 206 RSPFHEGTSAKTYNNIMNFQRF---------------LKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEG 259 (330)
T ss_pred CCCCCCCCHHHHHHHHHcCCCc---------------cCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence 9999988877766665542100 00110 12378999999999998 9999999999
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||+.+.+.
T Consensus 260 l~~h~~~~~~~~~ 272 (330)
T cd05601 260 LCCHPFFSKIDWN 272 (330)
T ss_pred HhCCCCcCCCCHH
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=278.53 Aligned_cols=235 Identities=37% Similarity=0.685 Sum_probs=180.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.. ..++|+||||+++++.+.+... ....+++..+..++.||+.||+|||+ +|++||
T Consensus 55 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~ 126 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHR 126 (294)
T ss_pred HHhccCCCEeeEEEEEec-----CCeEEEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCC
Confidence 357899999999999843 3458999999998877766531 23346888899999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++..++.+||+|||++....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+
T Consensus 127 dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred CCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998556679999999997653322 123446788999999987655688999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+.++....+.+....+.... +.+. ...+...... .......+++++.+++.+||+.+|++||++.++++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYK-SAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCHHHHHHHHHHHhCCCChhhccccccchhhh-hhcccCCCCC-HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 98888888888888877655543211 1110 0001000000 011223478899999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||.+++.
T Consensus 285 ~~~~~~~~ 292 (294)
T PLN00009 285 EYFKDLGD 292 (294)
T ss_pred chHhHHhc
Confidence 99998653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=285.18 Aligned_cols=228 Identities=28% Similarity=0.492 Sum_probs=164.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... .+++||||++| +|.+.+. ....+++..+..++.|++.||.|||+..+|+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH 127 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMH 127 (331)
T ss_pred HHHCCCCCCCeEEEEEEECC-----EEEEEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEc
Confidence 46789999999999985433 48899999995 7766654 34568999999999999999999998325999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++...... ......|++.|+|||++.+. .++.++|+||+||++|+|++|..||..
T Consensus 128 ~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 128 RDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred CCCChhhEEEc-CCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998 4778999999999765332 23345789999999999754 589999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHH----hhcCcCCc----Cc---cCCC------------CCCCCcccccCCCCCHHHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEI----RCMNPNYT----DF---RFPQ------------IKAHPWHKVFHKRMPPEAIDL 216 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~----~~~~~~~~----~~---~~~~------------~~~~~~~~~~~~~~~~~~~dl 216 (296)
.+..+... ++ +.+..... ....+... .. .... .............+++++++|
T Consensus 205 ~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (331)
T cd06649 205 PDAKELEA-IF---GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF 280 (331)
T ss_pred CCHHHHHH-Hh---cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHH
Confidence 76544322 22 11110000 00000000 00 0000 000000000112468899999
Q ss_pred HHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 217 ASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 217 l~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
|.+||++||++|||+.++++||||+...
T Consensus 281 i~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 281 VNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred HHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 9999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=287.85 Aligned_cols=204 Identities=26% Similarity=0.427 Sum_probs=165.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.. ...+|+||||++| +|...+. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 51 ~~~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~ 120 (321)
T cd05603 51 KNLKHPFLVGLHYSFQT-----AEKLYFVLDYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYR 120 (321)
T ss_pred HhCCCCCccceeeEEEc-----CCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 56899999999998843 3448999999995 6554443 34678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 121 Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 121 DLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred cCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCC
Confidence 9999999999 5788999999998753222 223345789999999998654 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH----HHHh
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEAC 235 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~----~e~l 235 (296)
.+.......+.... ..++...+.++.++|.+||+.||.+|+++ .+++
T Consensus 199 ~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~ 249 (321)
T cd05603 199 RDVSQMYDNILHKP-----------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIK 249 (321)
T ss_pred CCHHHHHHHHhcCC-----------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence 87666555544310 01223468899999999999999999875 5999
Q ss_pred cCCCcccccCC
Q 022500 236 AHPFFDELREP 246 (296)
Q Consensus 236 ~hp~f~~~~~~ 246 (296)
+|+||..+.+.
T Consensus 250 ~~~~~~~~~~~ 260 (321)
T cd05603 250 NHVFFSPINWD 260 (321)
T ss_pred CCCCcCCCCHH
Confidence 99999877653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=284.93 Aligned_cols=203 Identities=29% Similarity=0.472 Sum_probs=164.4
Q ss_pred CCCC-CCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 3 VMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 3 ~l~H-pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
.++| ++|+++++++.. ...+|+||||++| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 56 ~~~~~~~i~~~~~~~~~-----~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~ 125 (324)
T cd05587 56 LPGKPPFLTQLHSCFQT-----MDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYR 125 (324)
T ss_pred hcCCCCceeeeEEEEEc-----CCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 4555 568889888843 3348999999985 6655554 34668999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+|||++ .++.+||+|||++..... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 126 dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 126 DLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred CCCHHHeEEc-CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 9999999999 477899999999875322 2223345789999999999764 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH-----HHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~-----~e~ 234 (296)
.+..+.+..+.+.. ..++..+++++.+++++||+.||.+|++. .++
T Consensus 204 ~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (324)
T cd05587 204 EDEDELFQSIMEHN-----------------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDI 254 (324)
T ss_pred CCHHHHHHHHHcCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence 88777666654311 01223478999999999999999999976 899
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+.+.+.
T Consensus 255 ~~hp~~~~~~~~ 266 (324)
T cd05587 255 REHAFFRRIDWE 266 (324)
T ss_pred hcCCCcCCCCHH
Confidence 999999987653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=277.85 Aligned_cols=229 Identities=36% Similarity=0.694 Sum_probs=177.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++. +...+++||||+.++|...+.. .....+++..+..++.|++.||+|||+ .|++||
T Consensus 53 l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~ 124 (284)
T cd07860 53 LKELNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHR 124 (284)
T ss_pred HHhcCCCCCcchhhhcc-----cCCcEEEEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 35789999999999884 3345889999999887776653 234568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++ .++.+||+|||++........ .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus 125 ~l~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 125 DLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred CCCHHHEEEC-CCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999 577899999999876533222 22345688899999987655578999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+...++.+..+.+....+..... .+.. .++......... ....++++++++|.+||+.||++|||+.++++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 204 DSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP-SFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred CCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh-hcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 988888888888888876544322110 0000 111111111111 123478899999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 282 ~~f 284 (284)
T cd07860 282 PFF 284 (284)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=291.19 Aligned_cols=208 Identities=24% Similarity=0.422 Sum_probs=173.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|..++||+||++++.|+..+. ++|..|||+|+--+.+.- .-+..+.+.+++.+++|++.||.|||+ ++||||
T Consensus 83 La~CdHP~ivkLl~ayy~enk-----LwiliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHR 154 (1187)
T KOG0579|consen 83 LAECDHPVIVKLLSAYYFENK-----LWILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHR 154 (1187)
T ss_pred hhcCCChHHHHHHHHHhccCc-----eEEEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhh
Confidence 456899999999998876555 999999999876665432 245679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccc-cCCCccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||..|||+. -+|.++|+|||.+.... ......+++|||+|||||+... ...|++++||||||+.+.+|.-+.+
T Consensus 155 DLKAGNiL~T-ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 155 DLKAGNILLT-LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred hccccceEEE-ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 9999999999 57889999999975432 2234457899999999999742 4569999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|-..-+.+..+.+|.+.- +|+. .-+...+..+.||+++||.+||..||++++++
T Consensus 234 PHhelnpMRVllKiaKSe-PPTL-------------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 234 PHHELNPMRVLLKIAKSE-PPTL-------------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred CccccchHHHHHHHhhcC-CCcc-------------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 999999998888877631 1110 11234688999999999999999999999999
Q ss_pred cCCCcccc
Q 022500 236 AHPFFDEL 243 (296)
Q Consensus 236 ~hp~f~~~ 243 (296)
+||||.++
T Consensus 288 ~Hpfv~~~ 295 (1187)
T KOG0579|consen 288 KHPFVQNA 295 (1187)
T ss_pred hCcccccC
Confidence 99999854
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.36 Aligned_cols=202 Identities=26% Similarity=0.487 Sum_probs=158.7
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.+||||+++++++.. ...+|+||||++| +|...+. ....+++..++.++.||+.||+|||+ +||+||||
T Consensus 53 ~~hp~iv~~~~~~~~-----~~~~~lv~E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Di 122 (329)
T cd05618 53 SNHPFLVGLHSCFQT-----ESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDL 122 (329)
T ss_pred CCCCcCCceeeEEEe-----CCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCC
Confidence 489999999999844 3458999999995 5554443 34679999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
||+||+++ .++.+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||....
T Consensus 123 kp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (329)
T cd05618 123 KLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred CHHHEEEC-CCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCC
Confidence 99999999 477899999999875422 2223456789999999999754 58999999999999999999999995321
Q ss_pred --------hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC---
Q 022500 162 --------AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT--- 230 (296)
Q Consensus 162 --------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t--- 230 (296)
....+.+.+.. .. ..++..++..+.++|++||+.||++|+|
T Consensus 201 ~~~~~~~~~~~~~~~~i~~----------------~~------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~ 252 (329)
T cd05618 201 SSDNPDQNTEDYLFQVILE----------------KQ------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHP 252 (329)
T ss_pred CcCCcccccHHHHHHHHhc----------------CC------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCC
Confidence 11111111100 00 0133457899999999999999999998
Q ss_pred ---HHHHhcCCCcccccC
Q 022500 231 ---ALEACAHPFFDELRE 245 (296)
Q Consensus 231 ---~~e~l~hp~f~~~~~ 245 (296)
++++++||||+.+.+
T Consensus 253 ~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 253 QTGFADIQGHPFFRNVDW 270 (329)
T ss_pred CCCHHHHhcCCCCCCCCH
Confidence 589999999988755
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=274.65 Aligned_cols=229 Identities=33% Similarity=0.634 Sum_probs=173.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+++++||||+++++++.. ...+++||||+++++.+.+.. ....+++..++.++.|++.||+|||+ .|++||
T Consensus 54 l~~~~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~ 124 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRR-----KRKLHLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHR 124 (286)
T ss_pred HHhCCCCCEeeeeeEEee-----CCEEEEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceec
Confidence 357899999999999843 344889999999876554432 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+
T Consensus 125 dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 125 DVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred CCChhhEEEc-CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 47789999999998764433 223456788999999987655688999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCC-CCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+..+....+.+..+........... ..+.....+... ..+.. .....++..+.+||.+||+.+|++|||+.+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 88777777666655544332111110 001111111111 11111 112347899999999999999999999999999
Q ss_pred CCCc
Q 022500 237 HPFF 240 (296)
Q Consensus 237 hp~f 240 (296)
||||
T Consensus 283 ~~~f 286 (286)
T cd07847 283 HPYF 286 (286)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=292.32 Aligned_cols=207 Identities=28% Similarity=0.425 Sum_probs=165.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++.+. +..++|+||||++| +|.+.+. ....+++..++.++.|++.||+|||+ +||+||
T Consensus 56 ~~l~~~~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHr 125 (360)
T cd05627 56 VEADGAWVVKMFYSFQ-----DKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHR 125 (360)
T ss_pred HhCCCCCEeeEEEEEE-----cCCEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcc
Confidence 4679999999999884 44458999999985 6666554 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC------------------------------------CccceeecccccC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE------------------------------------ANISYICSRFYRA 124 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~------------------------------------~~~~~~~t~~y~a 124 (296)
||||+||+++ .++.+||+|||++....... .....+||+.|+|
T Consensus 126 DLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 204 (360)
T cd05627 126 DIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIA 204 (360)
T ss_pred CCCHHHEEEC-CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccC
Confidence 9999999998 57889999999987542110 0123578999999
Q ss_pred chhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccc
Q 022500 125 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 204 (296)
Q Consensus 125 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (296)
||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+...... ..++.
T Consensus 205 PE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~--------- 259 (360)
T cd05627 205 PEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKET---------------LVFPP--------- 259 (360)
T ss_pred HHHHcCC-CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCc---------------eecCC---------
Confidence 9999764 5899999999999999999999999988877776666531110 00110
Q ss_pred cCCCCCHHHHHHHHcccccCCCCCC---CHHHHhcCCCcccccCC
Q 022500 205 FHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP 246 (296)
Q Consensus 205 ~~~~~~~~~~dll~~~L~~~p~~R~---t~~e~l~hp~f~~~~~~ 246 (296)
...+++++++||.+|+ .||.+|+ +++++++||||+++.+.
T Consensus 260 -~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 260 -EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred -CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 0126899999999977 4999998 48999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=276.70 Aligned_cols=235 Identities=36% Similarity=0.650 Sum_probs=182.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.. ..+.|+||||+.|+|.+.+.. ....+++..+..++.||+.||.|||+ +|++|+
T Consensus 56 l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~ 126 (298)
T cd07841 56 LQELKHPNIIGLLDVFGH-----KSNINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHS-NWILHR 126 (298)
T ss_pred HhhcCCCCChhhhheeec-----CCEEEEEEcccCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeec
Confidence 457899999999999844 445899999997787777653 12369999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.++|.+
T Consensus 127 dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 127 DLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CCChhhEEEc-CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 9999999999 47889999999998664432 222345678899999986655688999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+.+.++....+.+....+......-...........+... .....+.++.++|.+||+.||++|||+.++++|||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 206 DSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred CccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 88888888888877777765543321110111111111111111 22346889999999999999999999999999999
Q ss_pred cccccCC
Q 022500 240 FDELREP 246 (296)
Q Consensus 240 f~~~~~~ 246 (296)
|++...+
T Consensus 285 ~~~~~~~ 291 (298)
T cd07841 285 FSNDPAP 291 (298)
T ss_pred ccCCCCC
Confidence 9986544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.50 Aligned_cols=248 Identities=35% Similarity=0.633 Sum_probs=189.0
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
+||||+++++...... .....+|+++||++++|.+.+. ....+++..++.++.||+.||+|||+ +|++||||||
T Consensus 60 ~h~~iv~~~~~~~~~~-~~~~~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp 133 (332)
T cd07857 60 GHKNITCLYDMDIVFP-GNFNELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKP 133 (332)
T ss_pred CCCChheeeeeeeecc-ccCCcEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCH
Confidence 5999999998754332 2234478999999988777665 34679999999999999999999999 7999999999
Q ss_pred CcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 85 QNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 85 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
+||+++ .++.+||+|||++........ .....+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+
T Consensus 134 ~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 134 GNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred HHeEEc-CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 999999 477899999999986543221 22356899999999886655689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCc-Cc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+....+..++..+|.+..+.+..+..... .+ .........+.. .....+..+.+|+.+||+.||++|||+.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 999999999999999888766554322110 00 001111111111 11236889999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCCCCCCCC
Q 022500 237 HPFFDELREPNARLPNGRPLPPLF 260 (296)
Q Consensus 237 hp~f~~~~~~~~~~~~~~~~~~~~ 260 (296)
||||++++++........+.++.|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~ 315 (332)
T cd07857 292 HPYLAIWHDPDDEPVCQKPFDFSF 315 (332)
T ss_pred ChhhhhhcCccccccccccccCCc
Confidence 999998877654443444443333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=279.80 Aligned_cols=236 Identities=37% Similarity=0.642 Sum_probs=176.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~-~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++... ....+|+||||+++++.+.+....... ..+++..++.++.|++.||.|||+ .+|+|
T Consensus 56 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h 131 (316)
T cd07842 56 LRELKHENVVSLVEVFLEH---ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLH 131 (316)
T ss_pred HHhcCCCCccceEEEEeCC---CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEee
Confidence 3568999999999998543 124588999999998887776443333 378999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC---CCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 80 RDLKPQNLLVDP---LTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 80 ~dlkp~Nill~~---~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
|||||+||+++. .++.+||+|||++........ .....+++.|+|||++.+...++.++|+||+||++|+|++
T Consensus 132 ~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 132 RDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred CCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999983 167899999999886533222 2234678899999998766668999999999999999999
Q ss_pred CCCCCCCCChH---------HHHHHHHHhcCCCCHHHHhhcC--cCCcCc----cCCCCCCCCcccccC--CCCCHHHHH
Q 022500 153 GQPLFPGENAV---------DQLVEIIKVLGTPTREEIRCMN--PNYTDF----RFPQIKAHPWHKVFH--KRMPPEAID 215 (296)
Q Consensus 153 g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~d 215 (296)
|.+||.+.... ..+..+++.++.+....+.... +.+... ............... ...+.++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (316)
T cd07842 212 LEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291 (316)
T ss_pred cCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHH
Confidence 99999876532 3566677777776665443221 111110 000000001111111 257889999
Q ss_pred HHHcccccCCCCCCCHHHHhcCCCc
Q 022500 216 LASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 216 ll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
++.+||+.||++|||+.|+++||||
T Consensus 292 ~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 292 LLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHhcCCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=283.23 Aligned_cols=201 Identities=28% Similarity=0.437 Sum_probs=165.7
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||+|+++++++.. ...+|+||||++ |+|...+. ....+++..+..++.||+.||+|||+ +||+|||||
T Consensus 59 ~~~~i~~~~~~~~~-----~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlk 128 (323)
T cd05616 59 KPPFLTQLHSCFQT-----MDRLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLK 128 (323)
T ss_pred CCCeEeeEEEEEec-----CCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCC
Confidence 68999999998843 345899999998 46655554 34678999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+|||++ .++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 129 p~Nill~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 129 LDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred HHHeEEC-CCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 9999999 5788999999999754322 22335578999999999965 4589999999999999999999999998887
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHHhcC
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAH 237 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~l~h 237 (296)
.+....+..... .++..+++++.+++.+||+.||.+|++ ..++++|
T Consensus 207 ~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 207 DELFQSIMEHNV-----------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHHHhCCC-----------------------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 777666654210 122347899999999999999999997 4899999
Q ss_pred CCcccccCC
Q 022500 238 PFFDELREP 246 (296)
Q Consensus 238 p~f~~~~~~ 246 (296)
|||+.+.+.
T Consensus 258 ~~~~~~~~~ 266 (323)
T cd05616 258 AFFRYIDWE 266 (323)
T ss_pred CCcCCCCHH
Confidence 999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=277.41 Aligned_cols=211 Identities=26% Similarity=0.389 Sum_probs=167.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++. ...++|+||||++| +|.+.+.. .....+++..+..++.|++.||+|||+ .|++|
T Consensus 54 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH 125 (285)
T cd05605 54 LEKVNSRFVVSLAYAYE-----TKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVY 125 (285)
T ss_pred HHhcCCCCEeeeeeeec-----CCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEe
Confidence 35689999999999884 33458999999985 66555442 223568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ +++.++|+|||++.............|++.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 126 ~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 126 RDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred cCCCHHHEEEC-CCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCC
Confidence 99999999998 4778999999999875444333455789999999999654 589999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+.......+....... ...++..++..+.+||.+||..||.+|+ +++++
T Consensus 204 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l 258 (285)
T cd05605 204 RKEKVKREEVERRVKED-------------------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV 258 (285)
T ss_pred CchhhHHHHHHHHhhhc-------------------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH
Confidence 76544333332211000 0012234789999999999999999999 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||....+.
T Consensus 259 ~~~~~~~~~~~~ 270 (285)
T cd05605 259 KAHPFFRTANFK 270 (285)
T ss_pred hcCcCccCCCHH
Confidence 999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=282.45 Aligned_cols=242 Identities=38% Similarity=0.724 Sum_probs=191.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++..........+|+||||++++|.+.+. ....+++..++.++.||+.||+|||+ .||+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~ 127 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHR 127 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 3568899999999988655433344689999999987776665 34579999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC----CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+|
T Consensus 128 dlkp~nili~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 128 DLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred CCCHHHEEEc-CCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence 9999999999 46889999999998765432 233456789999999997764689999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCc-CCcCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
|.+.+..+.+..+....+.+..+.+..... ....+ ..+.....++... ...++.++.++|.+||+++|.+|||+++
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 285 (330)
T cd07834 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADE 285 (330)
T ss_pred cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999999999999999999888776542211 11111 0111111222222 2347899999999999999999999999
Q ss_pred HhcCCCcccccCCCCC
Q 022500 234 ACAHPFFDELREPNAR 249 (296)
Q Consensus 234 ~l~hp~f~~~~~~~~~ 249 (296)
++.||||+++..+...
T Consensus 286 ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 286 ALAHPYLAQLHDPEDE 301 (330)
T ss_pred HHhCccHHhhcccccC
Confidence 9999999988765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=276.59 Aligned_cols=212 Identities=23% Similarity=0.383 Sum_probs=163.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++. +..++|+||||++| +|...+.. .....+++..+..++.|++.||+|||+ .||+|
T Consensus 47 l~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH 118 (277)
T cd05607 47 LEKVNSPFIVNLAYAFE-----SKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVY 118 (277)
T ss_pred HHhcCCCcEEEEEEEEe-----cCCeEEEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEE
Confidence 35789999999999884 34458999999985 66555542 223458899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.++|+|||++.............+++.|+|||++.+.. ++.++|+||+||++|+|++|..||.+
T Consensus 119 ~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 119 RDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred ccCChHhEEEc-CCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 47789999999998765444334457899999999997654 89999999999999999999999976
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH----HHHh
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEAC 235 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~----~e~l 235 (296)
.........+.+..- . ..... ....++++++++|++||++||.+|+++ ++++
T Consensus 197 ~~~~~~~~~~~~~~~----------~---~~~~~-----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 197 HKEKVAKEELKRRTL----------E---DEVKF-----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CcchhhHHHHHHHhh----------c---ccccc-----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 533211111111000 0 00000 012478999999999999999999999 7788
Q ss_pred cCCCcccccCC
Q 022500 236 AHPFFDELREP 246 (296)
Q Consensus 236 ~hp~f~~~~~~ 246 (296)
.||||+.+.++
T Consensus 253 ~h~~f~~~~~~ 263 (277)
T cd05607 253 KHEFFKTINFP 263 (277)
T ss_pred cChhhcCCCHH
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=289.20 Aligned_cols=203 Identities=28% Similarity=0.463 Sum_probs=168.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|.++++|||.++|+.|..... ++++||||.| ++.+.++ .+..+++..+..++++++.||.|||. ++.+|
T Consensus 65 Ls~~~~~~it~yygsyl~g~~-----LwiiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiH 134 (467)
T KOG0201|consen 65 LSQCDSPNITEYYGSYLKGTK-----LWIIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHS-EKKIH 134 (467)
T ss_pred HHhcCcchHHhhhhheeeccc-----HHHHHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhh-cceec
Confidence 357899999999999976555 8999999995 5555554 45556999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+.||++.. .+.+|++|||.+..+.... ...+++|||.|||||++.+ ..|+.++||||||++.+||++|.+|+.
T Consensus 135 rDIKaanil~s~-~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 135 RDIKAANILLSE-SGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred ccccccceeEec-cCcEEEEecceeeeeechhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 999999999995 5899999999998775443 3378899999999999974 469999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
...++..+..|-+. . ...+....++.+++||..||.+||+.||+|.++|+|+
T Consensus 213 ~~hPmrvlflIpk~------------------------~----PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 213 KLHPMRVLFLIPKS------------------------A----PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred ccCcceEEEeccCC------------------------C----CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 87764443333221 0 0112235799999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
|++..
T Consensus 265 FIk~a 269 (467)
T KOG0201|consen 265 FIKRA 269 (467)
T ss_pred HHHhc
Confidence 99874
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=291.40 Aligned_cols=229 Identities=24% Similarity=0.332 Sum_probs=165.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++|+|||||++++++... ...|+|||++.++|...+.. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 214 L~~L~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHr 284 (461)
T PHA03211 214 LRRLSHPAVLALLDVRVVG-----GLTCLVLPKYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHR 284 (461)
T ss_pred HHHCCCCCCCcEEEEEEEC-----CEEEEEEEccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEC
Confidence 4678999999999988543 34889999999988877653 23469999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|+|++|..++
T Consensus 285 DLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 285 DIKTENVLVN-GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cCCHHHEEEC-CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCc
Confidence 9999999998 477899999999976533221 1235689999999999764 5899999999999999999987554
Q ss_pred CCC-------ChHHHHHHHHHhcCCCCHHHH--------hhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccc
Q 022500 158 PGE-------NAVDQLVEIIKVLGTPTREEI--------RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222 (296)
Q Consensus 158 ~~~-------~~~~~~~~i~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 222 (296)
.+. ....++.++++..+....+.. ............+......|... ..++.++.+||.+||+
T Consensus 363 f~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 363 FSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALT 440 (461)
T ss_pred ccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcc
Confidence 322 123445555554333211100 00000000001111111222221 1367899999999999
Q ss_pred cCCCCCCCHHHHhcCCCccc
Q 022500 223 YSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 223 ~~p~~R~t~~e~l~hp~f~~ 242 (296)
+||.+|||+.|+|+||||+.
T Consensus 441 ~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 441 FDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cChhhCcCHHHHhhCcccCC
Confidence 99999999999999999974
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=287.90 Aligned_cols=207 Identities=27% Similarity=0.439 Sum_probs=164.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. +..++|+||||++| +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 98 ~~~~hp~iv~~~~~~~-----~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHr 166 (371)
T cd05622 98 AFANSPWVVQLFYAFQ-----DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHR 166 (371)
T ss_pred HhCCCCCCCeEEEEEE-----cCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeC
Confidence 5679999999999984 34458999999985 66666543 458999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCC---CCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++ .++.+||+|||++....... .....+||+.|+|||++.+. ..++.++||||+||++|+|++|..
T Consensus 167 DLkp~NIll~-~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 245 (371)
T cd05622 167 DVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (371)
T ss_pred CCCHHHEEEC-CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence 9999999999 57889999999998654322 12356789999999998643 237889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC--CCCHHH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALE 233 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~--R~t~~e 233 (296)
||.+.+......++........ ++ ....++++++++|.+||+.++.+ |+++++
T Consensus 246 Pf~~~~~~~~~~~i~~~~~~~~---------------~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~e 300 (371)
T cd05622 246 PFYADSLVGTYSKIMNHKNSLT---------------FP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEE 300 (371)
T ss_pred CCCCCCHHHHHHHHHcCCCccc---------------CC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHH
Confidence 9999888777776654211100 11 01247999999999999844433 789999
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++||||++..+
T Consensus 301 i~~h~~~~~~~~ 312 (371)
T cd05622 301 IKRHLFFKNDQW 312 (371)
T ss_pred HhcCcccCCCCh
Confidence 999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=288.07 Aligned_cols=198 Identities=27% Similarity=0.451 Sum_probs=166.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+||||+.+.+++.... ++|||||||. |-|...|+ .+.++.......|..+|+.|+.|||. +.|||
T Consensus 166 LRkLkH~NII~FkGVCtqsP-----cyCIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~-hKIIH 235 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSP-----CYCIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHL-HKIIH 235 (904)
T ss_pred HHhccCcceeeEeeeecCCc-----eeEEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHH-hhHhh
Confidence 57899999999999995444 4999999999 77777776 45678888899999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||.-|||++ .+..|||+|||.++.........++.||..|||||++... .+++|+||||+||++|||+||..||..
T Consensus 236 RDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 236 RDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hccCCCceEee-ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccc
Confidence 99999999999 5778999999999987666666789999999999999764 599999999999999999999999976
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
-+...++ --.|. ..+.-..+..++..++=||++||.-.|.+||+..+++.|
T Consensus 314 VdssAII----wGVGs-----------------------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 314 VDSSAII----WGVGS-----------------------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred cchheeE----EeccC-----------------------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 6543221 11111 111222445688899999999999999999999999988
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=282.73 Aligned_cols=211 Identities=26% Similarity=0.430 Sum_probs=167.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|+||+++++++. +...+|+||||+. |+|.+.+.. ....+++..++.++.||+.||+|||+ .||+||
T Consensus 56 ~~~~~~~i~~~~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHr 126 (332)
T cd05623 56 VNGDNQWITTLHYAFQ-----DENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHR 126 (332)
T ss_pred hhCCCCCEeeEEEEEe-----cCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 4678999999999884 3445899999998 577777653 24568999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
||||+||+++ .++.+||+|||++......... ....||+.|+|||++.+ ...++.++|+||+||++|+|++|.
T Consensus 127 Dlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~ 205 (332)
T cd05623 127 DIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205 (332)
T ss_pred CCCHHHEEEC-CCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCC
Confidence 9999999998 5788999999998765333221 23578999999999852 345789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC--CCCHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTAL 232 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~--R~t~~ 232 (296)
.||.+.+..+.+..+...... +.++. ....+++++++||++||+.++.+ |++++
T Consensus 206 ~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~ 261 (332)
T cd05623 206 TPFYAESLVETYGKIMNHKER---------------FQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIE 261 (332)
T ss_pred CCCCCCCHHHHHHHHhCCCcc---------------ccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHH
Confidence 999998877777666542110 00110 11247899999999999765554 68999
Q ss_pred HHhcCCCcccccCC
Q 022500 233 EACAHPFFDELREP 246 (296)
Q Consensus 233 e~l~hp~f~~~~~~ 246 (296)
++++||||..+.+.
T Consensus 262 ~~~~h~~f~~~~~~ 275 (332)
T cd05623 262 DFKQHPFFTGIDWD 275 (332)
T ss_pred HHhCCCCcCCCCHH
Confidence 99999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=272.81 Aligned_cols=230 Identities=37% Similarity=0.703 Sum_probs=181.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.... ..++||||++++|.+.+.... ....+++..+..++.|++.||.|||+ .|++||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~ 124 (284)
T cd07836 52 MKELKHENIVRLHDVIHTEN-----KLMLVFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHR 124 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCC-----cEEEEEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeC
Confidence 35689999999999985443 488999999998887775422 23568999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.++|+|||++........ .....++..|++||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus 125 dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 125 DLKPQNLLIN-KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred CCCHHHEEEC-CCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 577899999999975533221 22345688999999987655678999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+...++.+..+.|....+..+. ....+ ..+....... ..+....+..++++|.+||+.||.+||++.++++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 204 TNNEDQLLKIFRIMGTPTESTWPGIS-QLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CCcHHHHHHHHHHhCCCChhhHHHHh-cCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99888888888888888776654432 11111 1111111111 11223468899999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 282 ~~f 284 (284)
T cd07836 282 PWF 284 (284)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=274.26 Aligned_cols=225 Identities=30% Similarity=0.556 Sum_probs=176.0
Q ss_pred eeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEE
Q 022500 9 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88 (296)
Q Consensus 9 Iv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nil 88 (296)
+|++.++| +-..+.|||+|.++-++++.++. +.-.+++...++.+++|++.++++||+ .+++|.||||+|||
T Consensus 153 cv~m~~wF-----dyrghiCivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENIL 224 (415)
T KOG0671|consen 153 CVQMRDWF-----DYRGHICIVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENIL 224 (415)
T ss_pred EEeeehhh-----hccCceEEEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEE
Confidence 57777777 55566999999999999998874 344679999999999999999999999 59999999999999
Q ss_pred EcC-------------------CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHH
Q 022500 89 VDP-------------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 89 l~~-------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 149 (296)
+.+ .+..|+++|||.|+.. .+...+.+.|+.|+|||++++.+ ++.++||||+|||++|
T Consensus 225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVE 301 (415)
T ss_pred EeccceEEEeccCCccceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEE
Confidence 831 1335899999999854 33446678899999999999875 9999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc-CcCC-----cCccCCCCC---------CCCcccccCC--CCCHH
Q 022500 150 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-NPNY-----TDFRFPQIK---------AHPWHKVFHK--RMPPE 212 (296)
Q Consensus 150 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~---------~~~~~~~~~~--~~~~~ 212 (296)
+.+|..+|++.++.+.++.+-.++|..+...+... ...| .+|...... ..+....... .--.+
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 99999999999999999999999998777766544 2111 111000000 0111111111 11235
Q ss_pred HHHHHHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 213 AIDLASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 213 ~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
+.|||++||.+||.+|+|+.|+|.||||+.+.
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 88999999999999999999999999999754
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=281.56 Aligned_cols=202 Identities=25% Similarity=0.451 Sum_probs=159.7
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++.. ...+|+||||++| +|...+. ....+++..++.++.||+.||+|||+ +||+|||||
T Consensus 54 ~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlk 123 (327)
T cd05617 54 SNPFLVGLHSCFQT-----TSRLFLVIEYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLK 123 (327)
T ss_pred CCCCEeeEEEEEEe-----CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCC
Confidence 69999999999843 3458999999985 6655544 34579999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN- 161 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~- 161 (296)
|+||+++ .++.+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||....
T Consensus 124 p~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~ 201 (327)
T cd05617 124 LDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITD 201 (327)
T ss_pred HHHEEEe-CCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCC
Confidence 9999998 477899999999875322 2233456789999999999654 58999999999999999999999996432
Q ss_pred -----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC------
Q 022500 162 -----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ 230 (296)
Q Consensus 162 -----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t------ 230 (296)
..+.....+.. . ...++..++..+.++|++||+.||++|++
T Consensus 202 ~~~~~~~~~~~~~~~~----------------~------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 253 (327)
T cd05617 202 NPDMNTEDYLFQVILE----------------K------------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTG 253 (327)
T ss_pred CcccccHHHHHHHHHh----------------C------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCC
Confidence 11222222110 0 00123457899999999999999999998
Q ss_pred HHHHhcCCCcccccCC
Q 022500 231 ALEACAHPFFDELREP 246 (296)
Q Consensus 231 ~~e~l~hp~f~~~~~~ 246 (296)
++++++||||+.+.+.
T Consensus 254 ~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 254 FSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHHcCCCCCCCCHH
Confidence 5799999999988654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=274.62 Aligned_cols=235 Identities=28% Similarity=0.506 Sum_probs=175.3
Q ss_pred CCCCCCCCeeeeceeeeccCC---CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~---~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
|++++||||+++++++..... ......|+||||+++++.+.+.. ....+++..++.++.|++.||+|||+ +|+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i 140 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKI 140 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence 357899999999998754332 22345789999999987776653 33568999999999999999999999 799
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
+|+||||+||+++ .++.+||+|||++........ .....++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus 141 ~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t 219 (310)
T cd07865 141 LHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219 (310)
T ss_pred eccCCCHHHEEEC-CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh
Confidence 9999999999999 578899999999976533221 1234568889999998765557899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCCccccc-CCCCCHHHHHHHHcccccCCCCCC
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
|.+||.+.+.......+.+..|..+.+.+.... ..+.....+..........+ ....+..+.+||.+||+.||.+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~ 299 (310)
T cd07865 220 RSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299 (310)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc
Confidence 999999988877777777766665544332221 00111111111111111111 112467889999999999999999
Q ss_pred CHHHHhcCCCc
Q 022500 230 TALEACAHPFF 240 (296)
Q Consensus 230 t~~e~l~hp~f 240 (296)
|++++++||||
T Consensus 300 t~~e~l~h~~f 310 (310)
T cd07865 300 DADTALNHDFF 310 (310)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=279.96 Aligned_cols=239 Identities=30% Similarity=0.547 Sum_probs=177.3
Q ss_pred CCCCCCCCeeeeceeeeccCCC---------CcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSK---------NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 71 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~---------~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~L 71 (296)
|++++||||+++++++...... +...+|+||||++++|.+.+. ...+++..++.++.||+.||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~L 130 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYI 130 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 4578999999999887543321 123578999999988766554 24689999999999999999999
Q ss_pred HhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 72 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 72 H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
|+ .|++||||||+||+++..+..+|++|||.+........ .....++..|+|||.+.+...++.++|+||+||++
T Consensus 131 H~-~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (342)
T cd07854 131 HS-ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 209 (342)
T ss_pred Hh-CCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHH
Confidence 99 79999999999999986567799999999875422111 12235688999999876655688999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC--CCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 148 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 148 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
|+|++|..||.+.+..+....+.+....+................. ......+... ....++.++.+||.+||+.||
T Consensus 210 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP 288 (342)
T cd07854 210 AEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNP 288 (342)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCc
Confidence 9999999999998888887777766555444332221111000000 0001111111 223578999999999999999
Q ss_pred CCCCCHHHHhcCCCcccccCC
Q 022500 226 SLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 226 ~~R~t~~e~l~hp~f~~~~~~ 246 (296)
.+|||+.++++||||+.+..+
T Consensus 289 ~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 289 MDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred hhccCHHHHhCCCccccccCC
Confidence 999999999999999876443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=278.18 Aligned_cols=210 Identities=28% Similarity=0.392 Sum_probs=170.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~--~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
.+++.+.||.+--.|.+.. .+|+||..|+|+ .++-.+. .+..+++..++.|+.+|+.||++||+ .+||+
T Consensus 240 ~kV~s~FiVslaYAfeTkd-----~LClVLtlMNGG---DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVY 310 (591)
T KOG0986|consen 240 EKVSSPFIVSLAYAFETKD-----ALCLVLTLMNGG---DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVY 310 (591)
T ss_pred HHhccCcEEEEeeeecCCC-----ceEEEEEeecCC---ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceee
Confidence 4567889999976674433 399999999975 2222222 23479999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+||+|||+| +.|++.|+|+|+|..+..+......+||.+|||||++.+.. |+...|+||+||++|+|+.|+.||..
T Consensus 311 RDLKPeNILLD-d~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 311 RDLKPENILLD-DHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred ccCChhheeec-cCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhh
Confidence 99999999999 68889999999999998888888889999999999997654 99999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~ 234 (296)
......-.++-+..- .....+++.+|++++++++.+|++||.+|.. ++++
T Consensus 389 ~KeKvk~eEvdrr~~-------------------------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~ev 443 (591)
T KOG0986|consen 389 RKEKVKREEVDRRTL-------------------------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEV 443 (591)
T ss_pred hhhhhhHHHHHHHHh-------------------------cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchh
Confidence 654322222211100 0112244568999999999999999999984 7899
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
.+||||+++++..
T Consensus 444 k~HpfFk~lnw~r 456 (591)
T KOG0986|consen 444 KEHPFFKDLNWRR 456 (591)
T ss_pred hhCcccccCCHhH
Confidence 9999999998864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=283.86 Aligned_cols=207 Identities=25% Similarity=0.454 Sum_probs=184.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
-.++.|.||++|..| .+..++|++||-|-| .+...++ .++.|++..++.|+..++.|++|||+ +|||+|
T Consensus 475 ~~~~s~fIvrLYrTf-----rd~kyvYmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYR 544 (732)
T KOG0614|consen 475 MECRSDFIVRLYRTF-----RDSKYVYMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHR-KGIIYR 544 (732)
T ss_pred HhcCchHHHHHHHHh-----ccchhhhhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHh-cCceec
Confidence 346789999999999 888889999999985 6665555 56889999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+|++++ .++.+||.|||+|+.+..+....+++|||.|.|||++.+.+ .+.++|.||||+++|||++|.+||.+.
T Consensus 545 DLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 545 DLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred cCChhheeec-cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999 68899999999999999999999999999999999998764 899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHHh
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEAC 235 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~l 235 (296)
+++..++.|++-... + .+++.++..+.+||+++...+|.+|.. +.++.
T Consensus 623 dpmktYn~ILkGid~---------------i------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIk 675 (732)
T KOG0614|consen 623 DPMKTYNLILKGIDK---------------I------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIK 675 (732)
T ss_pred chHHHHHHHHhhhhh---------------h------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHH
Confidence 999999999874221 1 134568999999999999999999986 78999
Q ss_pred cCCCcccccCCC
Q 022500 236 AHPFFDELREPN 247 (296)
Q Consensus 236 ~hp~f~~~~~~~ 247 (296)
+|-||....|.-
T Consensus 676 kH~Wf~gfdweg 687 (732)
T KOG0614|consen 676 KHRWFEGFDWEG 687 (732)
T ss_pred hhhhhhcCChhh
Confidence 999999998863
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=273.39 Aligned_cols=229 Identities=40% Similarity=0.763 Sum_probs=183.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++... ...++|+||+++++.+.+.. ....+++..+..++.|++.||.|||+ .||+|+
T Consensus 52 l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~ 122 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS-HGILHR 122 (283)
T ss_pred HHHhcCCCcchHHHhhccC-----CCEEEEEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH-CCeeec
Confidence 3567899999999988543 44889999999988777664 23578999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+
T Consensus 123 dl~p~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 123 DLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred CcCHHHEEEC-CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 57789999999987664433 223356788899999987654689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+..+.+..+.+....+..... .+..+.++......... ....++.++.++|.+||+.||.+||++.++++|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 202 KSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 999999999988888887766554433 11222222222222211 223478999999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 281 ~~~ 283 (283)
T cd05118 281 PYF 283 (283)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=278.56 Aligned_cols=268 Identities=34% Similarity=0.630 Sum_probs=198.3
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++.+++..... .....+|+|+||++++|.+.+.. ..+++..+..++.|++.||.|||+ .||+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H 141 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIH 141 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 356899999999998754332 23345889999999888776653 569999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.++|+|||++...... .....++..|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus 142 ~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 142 RDLKPSNIAVN-EDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred CCCCHHHeEEC-CCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 4788999999999865332 33456788999999986644678999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCC-cCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNY-TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+....+..+.+..+.+....+....... ..+ ..+......+.. .....++++.++|.+||+.||++|||+.++++
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 98888888888888877765444332110 000 001111111111 12246899999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHH
Q 022500 237 HPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 283 (296)
Q Consensus 237 hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (296)
||||........ .+..+.++..-+..........+++.-++.
T Consensus 298 h~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (343)
T cd07851 298 HPYLAEYHDPED-----EPVAPPYDQSFESRDLTVDEWKELVYKEIM 339 (343)
T ss_pred CCCccccCCCcc-----cccccccCcchhhhhcCHHHHHHHhHHHHH
Confidence 999998755432 222344444434445555566666555443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.24 Aligned_cols=211 Identities=27% Similarity=0.430 Sum_probs=165.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. +..++|+||||++ |+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 56 ~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 126 (331)
T cd05597 56 VNGDRRWITNLHYAFQ-----DENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHR 126 (331)
T ss_pred HhCCCCCCCceEEEEe-----cCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEC
Confidence 4578999999999984 4445999999998 477666653 24568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
||||+||+++ .++.+||+|||++......... ....||+.|+|||++.+ ...++.++|+||+||++|+|++|.
T Consensus 127 dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~ 205 (331)
T cd05597 127 DIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205 (331)
T ss_pred CCCHHHEEEC-CCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCC
Confidence 9999999998 5788999999998765433221 23468999999999853 234788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC--CCCHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTAL 232 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~--R~t~~ 232 (296)
.||.+.+..+....+...... +..+. ....++++++++|++||+.++.+ |+++.
T Consensus 206 ~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~ 261 (331)
T cd05597 206 TPFYAESLVETYGKIMNHKEH---------------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQ 261 (331)
T ss_pred CCCCCCCHHHHHHHHHcCCCc---------------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999988777666665432110 00000 01237899999999999764443 78999
Q ss_pred HHhcCCCcccccCC
Q 022500 233 EACAHPFFDELREP 246 (296)
Q Consensus 233 e~l~hp~f~~~~~~ 246 (296)
++++||||....+.
T Consensus 262 ~~l~hp~~~~~~~~ 275 (331)
T cd05597 262 DFKDHPFFEGIDWD 275 (331)
T ss_pred HHhcCCCCCCCCHH
Confidence 99999999987654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=278.53 Aligned_cols=237 Identities=36% Similarity=0.729 Sum_probs=184.9
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+++ +||||+++++++.. .+...+|+||||++++|...+.. ..+++..++.++.|++.||.|||+ +||+||
T Consensus 61 ~~l~~h~ni~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~ 131 (337)
T cd07852 61 QELGDHPNIVKLLNVIKA---ENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHR 131 (337)
T ss_pred HHhcCCCCccceeeeecc---CCCceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 456 99999999998743 22345789999999987766653 267888999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
||||+||+++ .++.+||+|||++....... ......+++.|+|||.+.+...++.++|+||+|+++|+|++|+
T Consensus 132 dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~ 210 (337)
T cd07852 132 DLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210 (337)
T ss_pred CCCHHHEEEc-CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCC
Confidence 9999999999 57889999999997654322 2234568899999998866556889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCcc---CCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR---FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
.||.+....+...++....+.+..+.+..+...+.... ............. ..++.++.++|.+||+.||++|||+
T Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~ 289 (337)
T cd07852 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTA 289 (337)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCH
Confidence 99999988888888888888877665544332211110 1111111122222 2378999999999999999999999
Q ss_pred HHHhcCCCcccccCCCCC
Q 022500 232 LEACAHPFFDELREPNAR 249 (296)
Q Consensus 232 ~e~l~hp~f~~~~~~~~~ 249 (296)
.++++||||+........
T Consensus 290 ~~il~~~~~~~~~~~~~~ 307 (337)
T cd07852 290 EEALEHPYVAQFHNPSDE 307 (337)
T ss_pred HHHhhChhhhhhccCCCC
Confidence 999999999998665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=285.67 Aligned_cols=195 Identities=32% Similarity=0.483 Sum_probs=157.2
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.-+||||+++++.+ .+..+.|+|||.+.|+.. +.. ... .+.....+..|+.||+.|+.|||+ +||+||||
T Consensus 372 ~~~h~niv~~~~v~-----~~~~~~~~v~e~l~g~el--l~r-i~~-~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDL 441 (612)
T KOG0603|consen 372 VRDHPNIVKSHDVY-----EDGKEIYLVMELLDGGEL--LRR-IRS-KPEFCSEASQWAAELVSAVDYLHE-QGVVHRDL 441 (612)
T ss_pred hcCCCcceeeccee-----cCCceeeeeehhccccHH--HHH-HHh-cchhHHHHHHHHHHHHHHHHHHHh-cCeeecCC
Confidence 34799999999999 677779999999997432 221 112 223337788899999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
||+|||++.+.++++|+|||.++..... ..+.+-|..|.|||++. ...|+.++||||||+++|+|++|+.||.....
T Consensus 442 kp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 442 KPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred ChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 9999999535788999999999876443 33446688899999996 56799999999999999999999999987765
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
.. .|....+.++ +...+|.+++|||++||++||.+|+++++++.||||
T Consensus 519 ~~---ei~~~i~~~~---------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 519 GI---EIHTRIQMPK---------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hH---HHHHhhcCCc---------------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 52 2333222222 113489999999999999999999999999999999
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.50 Aligned_cols=206 Identities=29% Similarity=0.436 Sum_probs=176.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.|+|||||+++.+..+... +|+||||+.| .+++.+. .++++.+.+++.++.|+++|++|||+ ++|+|
T Consensus 109 mk~l~HPnIvkl~~v~~t~~~-----lylV~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivH 178 (596)
T KOG0586|consen 109 MKSLNHPNIVKLFSVIETEAT-----LYLVMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHS-KNIVH 178 (596)
T ss_pred HHhcCCcceeeeeeeeeecce-----eEEEEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhh-cceec
Confidence 678999999999999965554 9999999995 5555554 56888889999999999999999999 89999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||.+||+++ .+.++||+|||++..+.......+.+|++.|.|||++.+..+.++.+|+||+|+++|.|++|..||.|
T Consensus 179 rdLk~eNilL~-~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 179 RDLKAENILLD-ENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred cccchhhcccc-cccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 99999999999 57789999999999988777788999999999999999888788999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+.-.+.+.. .+ .++-.++.++.++|+++|..+|++|++.++++.|.|
T Consensus 258 ~~lk~Lr~rvl~g-----------------k~------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 258 QNLKELRPRVLRG-----------------KY------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred cccccccchheee-----------------ee------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 8754433322210 01 122348999999999999999999999999999999
Q ss_pred cccccCC
Q 022500 240 FDELREP 246 (296)
Q Consensus 240 f~~~~~~ 246 (296)
.......
T Consensus 309 ~n~~~~~ 315 (596)
T KOG0586|consen 309 RNDLLEA 315 (596)
T ss_pred cchhhhh
Confidence 9877655
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=274.29 Aligned_cols=202 Identities=30% Similarity=0.511 Sum_probs=173.5
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+-|.+++++.+|.+... +|+||||+.| +|..-+. +-+++.+..+..|+.+|+-||-+||+ +||++||||
T Consensus 408 kppFL~qlHScFQTmDR-----LyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLK 477 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLK 477 (683)
T ss_pred CCchHHHHHHHhhhhhh-----eeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeecc
Confidence 35788999999966655 9999999996 4433333 44778999999999999999999999 899999999
Q ss_pred CCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
.+||+++ ..+.+||+|||+|+...- .....+++|||.|+|||++. .+.|+.++|+||+||++|||+.|++||.|.+.
T Consensus 478 LDNvmLd-~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 478 LDNVMLD-SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ccceEec-cCCceEeeecccccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999999 578899999999986544 34456789999999999995 56799999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH-----HHHhcC
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAH 237 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~-----~e~l~h 237 (296)
.+..+.|.+. . ..+++++|.++.++++..|.++|.+|... .++..|
T Consensus 556 ~elF~aI~eh-----------------n------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H 606 (683)
T KOG0696|consen 556 DELFQAIMEH-----------------N------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREH 606 (683)
T ss_pred HHHHHHHHHc-----------------c------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhC
Confidence 9999999873 1 12456799999999999999999999864 589999
Q ss_pred CCcccccCCC
Q 022500 238 PFFDELREPN 247 (296)
Q Consensus 238 p~f~~~~~~~ 247 (296)
|||+.+.|..
T Consensus 607 ~FFR~iDWek 616 (683)
T KOG0696|consen 607 PFFRRIDWEK 616 (683)
T ss_pred cchhhccHHH
Confidence 9999998863
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=277.75 Aligned_cols=201 Identities=28% Similarity=0.463 Sum_probs=163.9
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+|++|+++++++.. ...+|+||||++| +|.+.+. ..+.+++..++.++.|++.||+|||+ +||+|||||
T Consensus 59 ~~~~i~~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDik 128 (323)
T cd05615 59 KPPFLTQLHSCFQT-----VDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLK 128 (323)
T ss_pred CCCchhheeeEEec-----CCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCC
Confidence 46788899988843 3348999999985 6655554 34679999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+||+++ .++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 129 p~Nill~-~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 129 LDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred HHHeEEC-CCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 9999999 57889999999987543222 2334568999999999965 4589999999999999999999999998887
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHHhcC
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAH 237 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~l~h 237 (296)
......+.... . .++..++.++.+++.+||+.||.+|++ ..++++|
T Consensus 207 ~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 207 DELFQSIMEHN-----------------V------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHHHHHHhCC-----------------C------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 76666665411 0 122347899999999999999999997 5799999
Q ss_pred CCcccccCC
Q 022500 238 PFFDELREP 246 (296)
Q Consensus 238 p~f~~~~~~ 246 (296)
|||+.+.+.
T Consensus 258 ~~f~~~~~~ 266 (323)
T cd05615 258 AFFRRIDWD 266 (323)
T ss_pred cccCCCCHH
Confidence 999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=276.26 Aligned_cols=230 Identities=37% Similarity=0.617 Sum_probs=179.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.. ..+.|+||||++|+|.+.+. ....+++..+..++.|++.||+|||+ .|++||
T Consensus 74 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~ 143 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVE-----GDFINLVMDIMASDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHK-WYFMHR 143 (335)
T ss_pred HHhCCCcceeeeeEEEec-----CCcEEEEEeccccCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecc
Confidence 357899999999999843 33588999999998877765 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC---------------CCccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
||+|+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+||
T Consensus 144 dl~~~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 222 (335)
T PTZ00024 144 DLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222 (335)
T ss_pred cccHHHeEEC-CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHH
Confidence 9999999999 5778999999998765311 11122345788999999876556799999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 146 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 146 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
++|+|++|.+||.+.+..+.+..+.+..+.+....+.... +.+..+.. ....... ......+.++.++|.+||+.
T Consensus 223 ~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 223 IFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTP--RKPKDLK-TIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCc--CCcccHH-HhCcCCChHHHHHHHHHcCC
Confidence 9999999999999999999898898888877765433221 11111100 0001111 11234688999999999999
Q ss_pred CCCCCCCHHHHhcCCCccccc
Q 022500 224 SPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 224 ~p~~R~t~~e~l~hp~f~~~~ 244 (296)
+|++|||+++++.||||+...
T Consensus 300 ~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 300 NPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred CchhccCHHHHhcCcccCCCC
Confidence 999999999999999998653
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.23 Aligned_cols=230 Identities=36% Similarity=0.669 Sum_probs=172.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++|+||+++++++.. ....|+||||+.+++.+.+.. ....+++..++.++.|++.||.|||+ .||+|+
T Consensus 57 l~~l~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~ 127 (291)
T cd07870 57 LKGLKHANIVLLHDIIHT-----KETLTFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHR 127 (291)
T ss_pred HHhcCCCCEeEEEEEEec-----CCeEEEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 356899999999999843 335889999999887766543 23557888899999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus 128 dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 128 DLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCChHHEEEc-CCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998 57889999999987543221 123345688999999987655688999999999999999999999976
Q ss_pred CC-hHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCCcccccC-CCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 160 EN-AVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 160 ~~-~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
.+ ..+.+.++....|.|......... +.+.....+............ -..+.++.+++.+||+.||++|||+.+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 207 VSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred chhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 54 446677777777777665443322 112111111111111111000 01367899999999999999999999999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
.||||
T Consensus 287 ~h~~~ 291 (291)
T cd07870 287 LHPYF 291 (291)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.92 Aligned_cols=235 Identities=20% Similarity=0.300 Sum_probs=167.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~-~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++... ...|+|+|++.+++.+.+.... ..........++.++.||+.||+|||+ +||+|
T Consensus 217 l~~l~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiH 290 (501)
T PHA03210 217 LGRLNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIH 290 (501)
T ss_pred HHhCCCCCcCcEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 4578999999999998543 3488999999988887664321 112334567788999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL- 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p- 156 (296)
|||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||+||++|+|++|..+
T Consensus 291 rDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 291 RDIKLENIFLN-CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCHHHEEEC-CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999 477899999999987644322 2345789999999999764 589999999999999999998754
Q ss_pred CCCC--ChHHHHHHHHHhcCCCCHHHHhhcCcCC---cCccCCCCCCCCccc-ccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 157 FPGE--NAVDQLVEIIKVLGTPTREEIRCMNPNY---TDFRFPQIKAHPWHK-VFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 157 f~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
+.+. .....+.+++...+.+..+........+ ....+.... ..... .....++.++.++|.+||++||.+|||
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps 447 (501)
T PHA03210 369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG 447 (501)
T ss_pred ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcC
Confidence 4322 3455666666655543322110000000 000000000 00000 011246788999999999999999999
Q ss_pred HHHHhcCCCccccc
Q 022500 231 ALEACAHPFFDELR 244 (296)
Q Consensus 231 ~~e~l~hp~f~~~~ 244 (296)
+.|+|+||||+...
T Consensus 448 a~elL~hp~f~~~~ 461 (501)
T PHA03210 448 AAELLALPLFSAEE 461 (501)
T ss_pred HHHHhhChhhhcCC
Confidence 99999999998754
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=280.67 Aligned_cols=206 Identities=26% Similarity=0.361 Sum_probs=155.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++. ....+|+||||++++.+ . .....++..+..++.||+.||+|||+ +||+||
T Consensus 126 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L---~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHr 192 (353)
T PLN00034 126 LRDVNHPNVVKCHDMFD-----HNGEIQVLLEFMDGGSL---E----GTHIADEQFLADVARQILSGIAYLHR-RHIVHR 192 (353)
T ss_pred HHhCCCCCcceeeeEec-----cCCeEEEEEecCCCCcc---c----ccccCCHHHHHHHHHHHHHHHHHHHH-CCEeec
Confidence 45789999999999984 34458999999996422 1 12345678889999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++ .++.+||+|||+++...... ......||..|+|||++.. ....+.++||||+||++|+|++|..
T Consensus 193 Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 193 DIKPSNLLIN-SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred CCCHHHEEEc-CCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence 9999999999 57889999999998654322 2234678999999998742 1234568999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||......+....+....... .......++.++++||.+||+.||++|||+.|++
T Consensus 272 pf~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell 326 (353)
T PLN00034 272 PFGVGRQGDWASLMCAICMSQ-------------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLL 326 (353)
T ss_pred CCCCCCCccHHHHHHHHhccC-------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 997433221111111100000 0011234789999999999999999999999999
Q ss_pred cCCCcccccC
Q 022500 236 AHPFFDELRE 245 (296)
Q Consensus 236 ~hp~f~~~~~ 245 (296)
+||||.....
T Consensus 327 ~hp~~~~~~~ 336 (353)
T PLN00034 327 QHPFILRAQP 336 (353)
T ss_pred cCcccccCCc
Confidence 9999987643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=269.79 Aligned_cols=228 Identities=35% Similarity=0.677 Sum_probs=177.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++||||+++++++.. ....|+||||++++|.+.+... ....+++..+..++.|++.||+|||+ ++++|||
T Consensus 53 ~~l~~~~iv~~~~~~~~-----~~~~~iv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~d 124 (283)
T cd07835 53 KELNHPNIVRLLDVVHS-----ENKLYLVFEFLDLDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRD 124 (283)
T ss_pred HhcCCCCccCHhheecc-----CCeEEEEEeccCcCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCC
Confidence 56799999999999843 3458999999998887776532 22468999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|+|+||+++. ++.++|+|||++........ .....++..|+|||++.+...++.++|+||+|+++|+|++|.+||.+.
T Consensus 125 l~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 125 LKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CCHHHEEEcC-CCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999995 78899999999975532221 123456888999998876555789999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+....+.++.+..+.+....+..... .+.. .++........ .....++.++.++|.+||+.||++|||+.++++||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 204 SEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP-TFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred CHHHHHHHHHHHhCCCChHHhhhhhhchhhhh-hcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 88888888888888877665432211 1100 01111111111 12235789999999999999999999999999999
Q ss_pred Cc
Q 022500 239 FF 240 (296)
Q Consensus 239 ~f 240 (296)
||
T Consensus 282 ~~ 283 (283)
T cd07835 282 YF 283 (283)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=272.82 Aligned_cols=234 Identities=31% Similarity=0.584 Sum_probs=178.4
Q ss_pred CCCCCCCCeeeeceeeeccCC---CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~---~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
|+.++||||+++++++..... .....+|+|+||+++++...+.. ....+++..++.++.|++.||.|||+ .|+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i 136 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHI 136 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 357899999999998764332 23446789999999887666553 34579999999999999999999999 699
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC------------ccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
+||||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+...++.++|+||+||
T Consensus 137 ~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 215 (311)
T cd07866 137 LHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC 215 (311)
T ss_pred ecCCCCHHHEEEC-CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHH
Confidence 9999999999999 578899999999975432211 123356888999999876556889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 146 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 146 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
++|+|++|.+||.+.+.......+....+.+....+.... +................. ....+++.+.++|.+||+.
T Consensus 216 il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~ 294 (311)
T cd07866 216 VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSL 294 (311)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHccc
Confidence 9999999999999999888888888887777655443221 111110000000111111 1124668899999999999
Q ss_pred CCCCCCCHHHHhcCCCc
Q 022500 224 SPSLRCTALEACAHPFF 240 (296)
Q Consensus 224 ~p~~R~t~~e~l~hp~f 240 (296)
||++|||+.+++.||||
T Consensus 295 ~p~~R~t~~ell~~~~f 311 (311)
T cd07866 295 DPYKRLTASDALEHPYF 311 (311)
T ss_pred CcccCcCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=253.61 Aligned_cols=232 Identities=33% Similarity=0.633 Sum_probs=186.9
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
-||||++++++..+..++. ..|++||++..-+..+- ..++...++.++.|++.||.|+|+ .||+|||+||
T Consensus 91 gg~NIi~L~DiV~Dp~Skt---paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKP 160 (338)
T KOG0668|consen 91 GGPNIIKLLDIVKDPESKT---PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKP 160 (338)
T ss_pred CCCCeeehhhhhcCccccC---chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCc
Confidence 3999999999986554433 45899999975444443 457788899999999999999999 5999999999
Q ss_pred CcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChH
Q 022500 85 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAV 163 (296)
Q Consensus 85 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~ 163 (296)
.|++++.....++|+|+|+|.....+..-...+.++.|-.||.+...+.|+.+-|+||+||+++.|+..+.| |.|.+..
T Consensus 161 hNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~ 240 (338)
T KOG0668|consen 161 HNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 240 (338)
T ss_pred ceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH
Confidence 999999877889999999999887776666778899999999999888899999999999999999998754 6888999
Q ss_pred HHHHHHHHhcCCCCHHHHh-h----cCcCCcCccCCCCCCCCcccccCC----CCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 164 DQLVEIIKVLGTPTREEIR-C----MNPNYTDFRFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 164 ~~~~~i~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
+++-+|.+.+|+.....+- + +.+.|.++ .......+|...++. -.++++.||+.++|.+|.++|+||.|+
T Consensus 241 DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 241 DQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred HHHHHHHHHhChHHHHHHHHHHccCCChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH
Confidence 9999999999986544321 1 23333332 222333444443332 257999999999999999999999999
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
+.||||....+..
T Consensus 320 m~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 320 MAHPYFAPVREAE 332 (338)
T ss_pred hcCchHHHHHHHh
Confidence 9999998876543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=267.19 Aligned_cols=201 Identities=27% Similarity=0.479 Sum_probs=161.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+|+||++| +|.+.+.. ...+++..++.++.|++.||.|||+ .|++|
T Consensus 58 l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H 127 (263)
T cd06625 58 LKNLQHERIVQYYGCLRD-----DETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVH 127 (263)
T ss_pred HHhCCCCCeeeeEEEEcc-----CCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 357899999999999843 3359999999985 66665543 3568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||+|+||+++ .++.++|+|||++......... ....++..|+|||.+.+. .++.++|+||+|+++|+|++|..
T Consensus 128 ~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~ 205 (263)
T cd06625 128 RDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKP 205 (263)
T ss_pred CCCCHHHEEEc-CCCCEEEeecccceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCC
Confidence 99999999998 5788999999998755332111 234578899999999764 48999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||...........+...... ..++..++..+.++|++||..+|.+|||+.+++
T Consensus 206 p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 206 PWAEFEAMAAIFKIATQPTN---------------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258 (263)
T ss_pred CccccchHHHHHHHhccCCC---------------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 99876655544433321100 112335789999999999999999999999999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
+||||
T Consensus 259 ~~~~~ 263 (263)
T cd06625 259 RHFFV 263 (263)
T ss_pred hCCCC
Confidence 99998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=275.81 Aligned_cols=233 Identities=20% Similarity=0.318 Sum_probs=162.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++++.... .+|+||||++ |+|.+.+... ....+++..++.++.|++.||+|||+ +||+|
T Consensus 53 l~~l~hpniv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH 124 (327)
T cd08227 53 SKLFNHPNIVPYRATFIADN-----ELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVH 124 (327)
T ss_pred HHhcCCCCeeeEEEEEEECC-----EEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEec
Confidence 35689999999999985433 4889999999 4666666532 23458999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--------ccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l 150 (296)
|||||+||+++ .++.++++||+.+........ .....++..|+|||++.+. ..++.++||||+||++|+|
T Consensus 125 ~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 203 (327)
T cd08227 125 RSVKASHILIS-VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203 (327)
T ss_pred CCCChhhEEEe-cCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHH
Confidence 99999999998 477899999987544321111 1123457789999998653 3588999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCC---------HHHHhhcC------cCCcCcc----CCCCCCCCcccccCCCCCH
Q 022500 151 LLGQPLFPGENAVDQLVEIIKVLGTPT---------REEIRCMN------PNYTDFR----FPQIKAHPWHKVFHKRMPP 211 (296)
Q Consensus 151 l~g~~pf~~~~~~~~~~~i~~~~~~~~---------~~~~~~~~------~~~~~~~----~~~~~~~~~~~~~~~~~~~ 211 (296)
++|..||.............. +... .+...... ..+.... ................+++
T Consensus 204 ~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (327)
T cd08227 204 ANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSP 281 (327)
T ss_pred HHCCCCCCCcchhHHHHHHhc--CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCH
Confidence 999999987654433332221 1110 01000000 0000000 0000000001112234688
Q ss_pred HHHHHHHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 212 EAIDLASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 212 ~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
++.+||.+||+.||++|||++++++||||+.+.
T Consensus 282 ~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 282 HFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred HHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 999999999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.35 Aligned_cols=230 Identities=35% Similarity=0.693 Sum_probs=179.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.. ....++||||+++++...+.. ....+++..+..++.|++.||.|||+ +|++||
T Consensus 54 l~~l~~~~i~~~~~~~~~-----~~~~~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~ 124 (288)
T cd07833 54 LRQLRHENIVNLKEAFRR-----KGRLYLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHR 124 (288)
T ss_pred HHhcCCCCeeehhheEEE-----CCEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 357899999999999854 334889999999876655442 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||+|+||+++ .++.+||+|||++....... ......++..|+|||++.+...++.++|+||+|+++|+|++|.+||.
T Consensus 125 dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 125 DIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred CCCHHHeEEC-CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999 57889999999988765433 23346778999999999766468999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCC-CCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
+.+..+.+..+....+........... ..+.....+. .....+....+..+++++.+||++||..+|++|||+++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 204 GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 888888777777766665554332221 1111111111 1111222234445689999999999999999999999999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
+||||
T Consensus 284 ~~~~f 288 (288)
T cd07833 284 QHPYF 288 (288)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=277.92 Aligned_cols=230 Identities=27% Similarity=0.452 Sum_probs=163.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... .++|+||||+.| +|.+.+. ..+.+++..+..++.|++.||.|||+..+|+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH 127 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 127 (333)
T ss_pred HHHCCCCcccceeEEEEEC-----CEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence 3578999999999998543 358999999985 7766665 34568999999999999999999997237999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++...... ......+++.|+|||++.+. .++.++|+||+||++|+|++|..||..
T Consensus 128 ~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 128 RDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred cCCChhhEEEc-CCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999998 4778999999998765322 22345689999999999654 589999999999999999999999987
Q ss_pred CChHHHHHHHHHh--cCCCCHHHHhhcCc-------CCcCccCCCC---------CCCCcccccCCCCCHHHHHHHHccc
Q 022500 160 ENAVDQLVEIIKV--LGTPTREEIRCMNP-------NYTDFRFPQI---------KAHPWHKVFHKRMPPEAIDLASRLL 221 (296)
Q Consensus 160 ~~~~~~~~~i~~~--~~~~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~dll~~~L 221 (296)
....... .++.. .+.+.......... .+..-..+.. .............+.++++||.+||
T Consensus 205 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 283 (333)
T cd06650 205 PDAKELE-LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCL 283 (333)
T ss_pred cchhHHH-HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhc
Confidence 6654332 22211 11111000000000 0000000000 0000000011236789999999999
Q ss_pred ccCCCCCCCHHHHhcCCCcccc
Q 022500 222 QYSPSLRCTALEACAHPFFDEL 243 (296)
Q Consensus 222 ~~~p~~R~t~~e~l~hp~f~~~ 243 (296)
++||++|||+.|+++||||+..
T Consensus 284 ~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 284 IKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCcccCcCHHHHhhCHHHhcC
Confidence 9999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=289.76 Aligned_cols=212 Identities=23% Similarity=0.340 Sum_probs=171.5
Q ss_pred CCCCCCCeeeeceeeeccCC---CCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 2 RVMDHPNVISLKHCFFSTTS---KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~---~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
..++|+||+++++.+..... .....+++||||++ |+|.+.+.........+++..+..++.|++.||.|||+ +||
T Consensus 86 ~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~I 164 (496)
T PTZ00283 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHM 164 (496)
T ss_pred hcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCE
Confidence 46789999999887753322 12235789999999 58888887655556679999999999999999999999 799
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccC---CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
+||||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|.
T Consensus 165 iHrDLKP~NILl~-~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 165 IHRDIKSANILLC-SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred ecCCCCHHHEEEe-CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999 4778999999999765322 122346789999999999764 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+.+..+..... ..++..+++++.+++.+||+.||.+||++.++
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~el 294 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRY----------------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 99998877666555443100 01223578999999999999999999999999
Q ss_pred hcCCCccccc
Q 022500 235 CAHPFFDELR 244 (296)
Q Consensus 235 l~hp~f~~~~ 244 (296)
++|||++.+.
T Consensus 295 l~~p~~~~~~ 304 (496)
T PTZ00283 295 LNMPICKLFI 304 (496)
T ss_pred HhCHHHHHhh
Confidence 9999987653
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=272.83 Aligned_cols=235 Identities=36% Similarity=0.671 Sum_probs=180.9
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++..... .....+|+|+||+.+++.... +..+++..+..++.|++.||+|||+ .|++|
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H 140 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIH 140 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 356899999999998864332 123347899999987654432 2468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||+++.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus 141 ~dlkp~NIll~-~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 141 RDLKPGNLAVN-EDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CCCCHHHEEEC-CCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 478899999999875422 223457788999999986655588999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCC-cCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNY-TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+....+..+....|.+............ ..+ ..+......+...+ ...++++.+||.+||+.||.+||++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 98888888888888877765544332110 000 01111111121111 236888999999999999999999999999
Q ss_pred CCCcccccCC
Q 022500 237 HPFFDELREP 246 (296)
Q Consensus 237 hp~f~~~~~~ 246 (296)
||||..+++.
T Consensus 297 h~~f~~~~~~ 306 (342)
T cd07879 297 HPYFDSFRDA 306 (342)
T ss_pred Ccchhhcccc
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=268.91 Aligned_cols=230 Identities=34% Similarity=0.658 Sum_probs=173.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++. +....|+|+||+++++.+.+. .....+++..+..++.|++.||.|||+ .|++|+
T Consensus 54 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~ 124 (286)
T cd07846 54 LKQLRHENLVNLIEVFR-----RKKRLYLVFEFVDHTVLDDLE---KYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHR 124 (286)
T ss_pred HHhcCCcchhhHHHhcc-----cCCeEEEEEecCCccHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 35689999999999983 444589999999986544433 234568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++ .++.++|+|||++........ .....++..|+|||++.+...++.++|+||+|+++|+|++|.+||.+
T Consensus 125 ~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 125 DIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred CCCHHHEEEC-CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999998 477899999999886543322 23456788999999987655578899999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcC--cCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+....+....+......-.... +.......+......-.......++..+.+|+.+||..+|.+||++.++++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 204 DSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 88878777777766554322111110 0011111111111111111233578999999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 284 ~~~ 286 (286)
T cd07846 284 EFF 286 (286)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=271.80 Aligned_cols=208 Identities=26% Similarity=0.421 Sum_probs=164.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++.+. +..++|+||||++| +|.+.+.. .....+++..+..++.|++.||.|||+ .||+|
T Consensus 54 l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH 125 (285)
T cd05630 54 LEKVNSRFVVSLAYAYE-----TKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVY 125 (285)
T ss_pred HHhCCCCCeeeeeEEEe-----cCCEEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEe
Confidence 35789999999999884 33458999999985 66666543 223458999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.++|+|||++.............|++.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 126 ~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 126 RDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred CCCCHHHEEEC-CCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 4778999999998765444333455789999999999654 589999999999999999999999987
Q ss_pred CChH---HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----H
Q 022500 160 ENAV---DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----A 231 (296)
Q Consensus 160 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~ 231 (296)
.... +....+... .....+..+++++.+|+++||+.||++|+| +
T Consensus 204 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 255 (285)
T cd05630 204 RKKKIKREEVERLVKE----------------------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGA 255 (285)
T ss_pred CCccchHHHHHhhhhh----------------------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCch
Confidence 5432 111111110 000122347889999999999999999999 9
Q ss_pred HHHhcCCCcccccCC
Q 022500 232 LEACAHPFFDELREP 246 (296)
Q Consensus 232 ~e~l~hp~f~~~~~~ 246 (296)
+|+++||||+...+.
T Consensus 256 ~~~~~h~~~~~~~~~ 270 (285)
T cd05630 256 REVKEHPLFKQINFK 270 (285)
T ss_pred HHHHcChhhhccCHH
Confidence 999999999886544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=258.96 Aligned_cols=205 Identities=26% Similarity=0.415 Sum_probs=171.4
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
+.|+||+++++|+.... ++|.||.++.=...+++. -.++++|..+-++...++.||.||.+.+||+|||+||
T Consensus 149 dcpyIV~c~GyFi~n~d-----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKP 220 (391)
T KOG0983|consen 149 DCPYIVQCFGYFITNTD-----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 220 (391)
T ss_pred CCCeeeeeeeEEeeCch-----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCc
Confidence 46999999999987665 778999998544444443 3467999999999999999999999877899999999
Q ss_pred CcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCC-C
Q 022500 85 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-N 161 (296)
Q Consensus 85 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~ 161 (296)
+|||+| ..+++|+||||++..+.+........|-+.|||||.+.- ...|+..+||||||+.++||.||+.||.+. .
T Consensus 221 SNILlD-e~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 221 SNILLD-ERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred cceEEc-cCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 999999 689999999999999888887778889999999999832 345889999999999999999999999985 4
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~ 241 (296)
+.+.+.++++... |... ...++|+++.+|+..||++|+++||.-.++|+|||+.
T Consensus 300 dFe~ltkvln~eP-P~L~-------------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 300 DFEVLTKVLNEEP-PLLP-------------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred cHHHHHHHHhcCC-CCCC-------------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 5677777776211 1100 1134799999999999999999999999999999998
Q ss_pred ccc
Q 022500 242 ELR 244 (296)
Q Consensus 242 ~~~ 244 (296)
.+.
T Consensus 354 ~ye 356 (391)
T KOG0983|consen 354 RYE 356 (391)
T ss_pred ecc
Confidence 764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=269.13 Aligned_cols=201 Identities=19% Similarity=0.195 Sum_probs=160.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... .+...+++||||++| +|.+.+. ....+++.....++.|++.||.|||+..+++|
T Consensus 72 l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~H 146 (283)
T PHA02988 72 LRRIDSNNILKIYGFIIDIV-DDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY 146 (283)
T ss_pred HHhcCCCCEEEEeeeEEecc-cCCCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 46789999999999886422 223458899999995 6666654 34678899999999999999999997238999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||+++..... .....++..|+|||++.+. ..++.++||||+||++|+|++|..||.
T Consensus 147 rdlkp~nill~-~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 147 KNLTSVSFLVT-ENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred CcCChhhEEEC-CCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 99999999999 5788999999998765322 2345678999999998652 458999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+.+..+....+......+. ++...++++.+|+.+||+.||.+|||+.++++
T Consensus 224 ~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLK---------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCHHHHHHHHHhcCCCCC---------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 8877666665543211111 11236889999999999999999999999985
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=299.48 Aligned_cols=215 Identities=28% Similarity=0.431 Sum_probs=169.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV----- 74 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~----- 74 (296)
|++|+|||||+++++|.... ...+||||||++ |+|.+.+.........+++..++.|+.||+.||.|||+.
T Consensus 66 L~~L~HPNIVrl~d~f~de~---~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~ 142 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKA---NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPN 142 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecC---CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccc
Confidence 35789999999999886432 235889999999 588888876555557799999999999999999999983
Q ss_pred -CCcccCCCCCCcEEEcCC----------------CCcEEEeeccCccccccCCCccceeecccccCchhccCC-CCCCc
Q 022500 75 -PRVCHRDLKPQNLLVDPL----------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTT 136 (296)
Q Consensus 75 -~~i~H~dlkp~Nill~~~----------------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 136 (296)
++|+||||||+|||++.. ...+||+|||++.............||+.|+|||++.+. ..++.
T Consensus 143 ~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~ 222 (1021)
T PTZ00266 143 GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD 222 (1021)
T ss_pred cCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCc
Confidence 139999999999999631 235899999999876444334456789999999998642 34789
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHH
Q 022500 137 SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 216 (296)
Q Consensus 137 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 216 (296)
++||||||||+|+|++|..||...+....+...+... +. . .....+.++.+|
T Consensus 223 KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~---------------l-----------pi~~~S~eL~dL 274 (1021)
T PTZ00266 223 KSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PD---------------L-----------PIKGKSKELNIL 274 (1021)
T ss_pred hhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CC---------------C-----------CcCCCCHHHHHH
Confidence 9999999999999999999998776555444433211 00 0 002358899999
Q ss_pred HHcccccCCCCCCCHHHHhcCCCcccccCC
Q 022500 217 ASRLLQYSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 217 l~~~L~~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
|.+||+.+|.+||++.++|.|||++.+..+
T Consensus 275 I~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 275 IKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred HHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 999999999999999999999999876543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=265.92 Aligned_cols=228 Identities=39% Similarity=0.716 Sum_probs=183.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++... ..+++|+||++++|.+.+... ...+++..+..++.|++.||+|||+ +||+|||
T Consensus 53 ~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~ 123 (282)
T cd07829 53 KELKHPNIVKLLDVIHTE-----RKLYLVFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRD 123 (282)
T ss_pred HhcCCCCHHHHHhhhhcC-----CceEEEecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCC
Confidence 567899999999998543 448899999999888877642 2569999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||+++++++|.+||.+.
T Consensus 124 l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 124 LKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred CChheEEEc-CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999 47889999999987654332 1223455778999999876556899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcC-CcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPN-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
...+.+.++.+..+.+....+...... +....++..........+ ..++.++.++|++||..||++||++.++++|||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 203 SEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 999999999998888888766544322 112223332222232222 235889999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
|
T Consensus 282 ~ 282 (282)
T cd07829 282 F 282 (282)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.37 Aligned_cols=209 Identities=26% Similarity=0.375 Sum_probs=164.2
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++..........+|+||||++| +|.+.+.........+++..++.++.|++.||+|||+ .|++|||||
T Consensus 77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlk 155 (291)
T cd06639 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVK 155 (291)
T ss_pred CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCC
Confidence 79999999999875443344568899999985 7777766544455678999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCC----CCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|+||+++ .++.+||+|||++....... ......++..|+|||.+.... .++.++|+||+||++|+|++|..||.
T Consensus 156 p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 156 GNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred HHHEEEc-CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 9999998 47789999999987654322 123346788999999975432 26789999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
.......+..+.+... + . ...+...+..+.++|.+||+.+|++||++.++++||
T Consensus 235 ~~~~~~~~~~~~~~~~-~------------------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 235 DMHPVKTLFKIPRNPP-P------------------T-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred CCcHHHHHHHHhcCCC-C------------------C-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 8766555444332100 0 0 001123577899999999999999999999999999
Q ss_pred Ccc
Q 022500 239 FFD 241 (296)
Q Consensus 239 ~f~ 241 (296)
||+
T Consensus 289 ~~~ 291 (291)
T cd06639 289 FIK 291 (291)
T ss_pred ccC
Confidence 994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.92 Aligned_cols=213 Identities=31% Similarity=0.519 Sum_probs=170.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++.+. +..+.|+||||+.| +|.+.+.. .....+++..++.++.|++.||+|||+ .|++|
T Consensus 55 l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H 126 (316)
T cd05574 55 LATLDHPFLPTLYASFQ-----TETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVY 126 (316)
T ss_pred HHhCCCCCchhheeeee-----cCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 35688999999999883 34458999999985 77666653 234578999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC------------------------------ccceeecccccCchhcc
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------------------------------NISYICSRFYRAPELIF 129 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~------------------------------~~~~~~t~~y~aPE~~~ 129 (296)
|||||+||+++ .++.++|+|||++........ ....+|+..|+|||++.
T Consensus 127 ~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 205 (316)
T cd05574 127 RDLKPENILLH-ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS 205 (316)
T ss_pred cCCChHHeEEc-CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc
Confidence 99999999999 477899999999875422110 11236788899999997
Q ss_pred CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCC
Q 022500 130 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM 209 (296)
Q Consensus 130 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (296)
+. .++.++|+||+|+++|+|++|..||.+.+....+..+.... ...+. ...+
T Consensus 206 ~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~ 257 (316)
T cd05574 206 GD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE-----------------VTFPG----------SPPV 257 (316)
T ss_pred CC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC-----------------ccCCC----------cccc
Confidence 64 48999999999999999999999998887766665544210 00000 0126
Q ss_pred CHHHHHHHHcccccCCCCCCC----HHHHhcCCCcccccCCCCCC
Q 022500 210 PPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARL 250 (296)
Q Consensus 210 ~~~~~dll~~~L~~~p~~R~t----~~e~l~hp~f~~~~~~~~~~ 250 (296)
+.++.++|.+||+.||++||| ++++++||||+...++....
T Consensus 258 ~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred CHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence 899999999999999999999 99999999999988876655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=277.08 Aligned_cols=211 Identities=25% Similarity=0.410 Sum_probs=165.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|+||+++++++. +..+.|+||||+. |+|.+.+.. ....+++..++.++.|++.||+|||+ +||+||
T Consensus 56 ~~~~~~~i~~l~~~~~-----~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHr 126 (331)
T cd05624 56 VNGDCQWITTLHYAFQ-----DENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHR 126 (331)
T ss_pred HhCCCCCEeeEEEEEE-----cCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeec
Confidence 4578999999999984 4445899999998 477666653 24578999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCC----CCCCchhHHHHHHHHHHHHHhCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~ 154 (296)
||||+||+++ .++.+||+|||++......... ....||+.|+|||++.+. ..++.++|+||+||++|+|++|.
T Consensus 127 Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~ 205 (331)
T cd05624 127 DIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205 (331)
T ss_pred cCchHHEEEc-CCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCC
Confidence 9999999998 5778999999999765433221 234689999999998542 34788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC--CCCHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTAL 232 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~--R~t~~ 232 (296)
.||.+.+..+.+..+....... .++. ....++++++++|.+||+.++++ |++++
T Consensus 206 ~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~ 261 (331)
T cd05624 206 TPFYAESLVETYGKIMNHEERF---------------QFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIE 261 (331)
T ss_pred CCccCCCHHHHHHHHHcCCCcc---------------cCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHH
Confidence 9999888776666655421110 0000 01236899999999999976654 56899
Q ss_pred HHhcCCCcccccCC
Q 022500 233 EACAHPFFDELREP 246 (296)
Q Consensus 233 e~l~hp~f~~~~~~ 246 (296)
++++||||+.+.+.
T Consensus 262 ~~~~h~~f~~~~~~ 275 (331)
T cd05624 262 DFKKHAFFEGIDWE 275 (331)
T ss_pred HHhcCCCcCCCCHH
Confidence 99999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.09 Aligned_cols=231 Identities=31% Similarity=0.603 Sum_probs=178.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++.... ....++|+||++++|.+.+.. ....+++..+..++.|++.||+|||+ .|++|+|
T Consensus 53 ~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~d 125 (287)
T cd07840 53 QKLRHPNIVRLKEIVTSKG---KGSIYMVFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRD 125 (287)
T ss_pred HhccCCCeeeheeeEecCC---CCcEEEEeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecc
Confidence 5678999999999885431 245889999999887766653 23578999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|+|+||+++ .++.+||+|||++....... ......++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+
T Consensus 126 l~p~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 126 IKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred CcHHHeEEc-CCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999 57889999999998664432 123345688899999887655689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcC--CcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+....+..+.+..+.+....+...... .................+...+++.+.+++++||+.||++||++.++++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 205 STELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9888888888887777766554332211 11110111001111112222248999999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 285 ~~~ 287 (287)
T cd07840 285 EYF 287 (287)
T ss_pred cCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=268.61 Aligned_cols=209 Identities=27% Similarity=0.423 Sum_probs=165.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~-~i~H~ 80 (296)
+.++||||+++++++.... ..|+||||++|+|.+.+.........+++..+..++.|++.||+|||+ + +++||
T Consensus 55 ~~~~~~~iv~~~~~~~~~~-----~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~ 128 (283)
T cd06617 55 RSVDCPYTVTFYGALFREG-----DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHR 128 (283)
T ss_pred HHcCCCCeeeeeEEEecCC-----cEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecC
Confidence 4578999999999985433 488999999998888877655455679999999999999999999998 6 99999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCC---CCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++ .++.+||+|||++.............++..|+|||.+.+. ..++.++|+||+||++|+|++|..||
T Consensus 129 dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 129 DVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred CCCHHHEEEC-CCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence 9999999998 4778999999999866443333345678899999988542 33688999999999999999999999
Q ss_pred CCC-ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGE-NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
... ...+.+..+..... + .. ....+++++.++|.+||..+|.+||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~-~---------------~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 208 DSWKTPFQQLKQVVEEPS-P---------------QL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CccccCHHHHHHHHhcCC-C---------------CC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 643 22233333322100 0 00 01236889999999999999999999999999
Q ss_pred CCCccccc
Q 022500 237 HPFFDELR 244 (296)
Q Consensus 237 hp~f~~~~ 244 (296)
||||....
T Consensus 261 ~~~~~~~~ 268 (283)
T cd06617 261 HPFFELHL 268 (283)
T ss_pred Cchhhhcc
Confidence 99998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=286.68 Aligned_cols=207 Identities=29% Similarity=0.516 Sum_probs=169.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~--~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
++|+|.|||++.+.+ ..+.++-|.||-++| +|.++++. .-+++ ++..+..|..||+.||+|||+ +.||
T Consensus 627 ~~LrHkNIVrYLGs~-----senGf~kIFMEqVPGGSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHe-n~IV 697 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSV-----SENGFFKIFMEQVPGGSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHE-NKIV 697 (1226)
T ss_pred HHHhhHhHHHHhhcc-----CCCCeEEEEeecCCCCcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhh-ccee
Confidence 578999999999987 555578899999995 77777765 33566 899999999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhcc-CCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIF-GATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||.+|+|++.-.|.+||+|||.++.+..-. ...++.||..|||||++- |.+.|+.++||||+||.+.||.||++|
T Consensus 698 HRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP 777 (1226)
T KOG4279|consen 698 HRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP 777 (1226)
T ss_pred eccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence 999999999999888999999999998764433 345678999999999994 456699999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|........ .+++. | -| .....++..++.+++.||.+|+..+|.+||+|.++|.
T Consensus 778 F~ElgspqA--AMFkV-G------------my-----------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 778 FVELGSPQA--AMFKV-G------------MY-----------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eeecCChhH--hhhhh-c------------ce-----------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 976543221 12221 0 00 0112245668999999999999999999999999999
Q ss_pred CCCcccc
Q 022500 237 HPFFDEL 243 (296)
Q Consensus 237 hp~f~~~ 243 (296)
.||++.-
T Consensus 832 DpFlq~~ 838 (1226)
T KOG4279|consen 832 DPFLQHN 838 (1226)
T ss_pred CcccccC
Confidence 9999764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=276.28 Aligned_cols=197 Identities=27% Similarity=0.385 Sum_probs=163.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|+|||++++++.... .+||||||+. |+|.++++. ..+..++......++.||+.|++||++ +++||
T Consensus 255 Mk~L~H~~lV~l~gV~~~~~-----piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IH 326 (468)
T KOG0197|consen 255 MKKLRHEKLVKLYGVCTKQE-----PIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIH 326 (468)
T ss_pred HHhCcccCeEEEEEEEecCC-----ceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 68899999999999995433 3899999999 899998886 356778999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccce--eecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY--ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~--~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||-..|||++ ++..+||+|||+|+...++.-.... --..-|.|||.+.. ..++.+|||||+||++|||+| |+.|
T Consensus 327 RDLAARNiLV~-~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~p 404 (468)
T KOG0197|consen 327 RDLAARNILVD-EDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVP 404 (468)
T ss_pred hhhhhhheeec-cCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCC
Confidence 99999999999 5789999999999954333221111 11446999999964 469999999999999999998 8899
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|.+.+..+.+..+-+-. +++ -|..+++++-+++..||..+|++|||.+.+.
T Consensus 405 y~~msn~ev~~~le~Gy------------------Rlp----------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 405 YPGMSNEEVLELLERGY------------------RLP----------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCHHHHHHHHhccC------------------cCC----------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999988887765521 122 1245899999999999999999999998664
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=274.86 Aligned_cols=203 Identities=27% Similarity=0.452 Sum_probs=157.2
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
.|-+||++|++-+. +.++|+||||=+.+|...|+.. ...++...++.|+.|++.|+.++|. +||||.||||
T Consensus 418 g~~~IIqL~DYEv~-----d~~lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKP 488 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVT-----DGYLYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKP 488 (677)
T ss_pred CCceEEEEeeeecc-----CceEEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCc
Confidence 58899999998743 5569999999999999998863 2334445899999999999999999 7999999999
Q ss_pred CcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCC----------CCCCchhHHHHHHHHHHHHH
Q 022500 85 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 85 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll 151 (296)
.|+|+- +|.+||+|||+|..+..+.. ..+.+||+.||+||.+... -..+.++||||||||+|+|+
T Consensus 489 ANFLlV--kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 489 ANFLLV--KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred ccEEEE--eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 999997 57899999999998765543 2457999999999998431 12567999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 152 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
.|++||.... ..++++..... |. ..+.++... -..++.++++.||++||.+|||+
T Consensus 567 YgktPf~~~~--n~~aKl~aI~~-P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si 621 (677)
T KOG0596|consen 567 YGKTPFGQII--NQIAKLHAITD-PN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSI 621 (677)
T ss_pred hcCCchHHHH--HHHHHHHhhcC-CC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCc
Confidence 9999995432 22333322211 10 112222211 12239999999999999999999
Q ss_pred HHHhcCCCcccc
Q 022500 232 LEACAHPFFDEL 243 (296)
Q Consensus 232 ~e~l~hp~f~~~ 243 (296)
.|+|+|||+.-.
T Consensus 622 ~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 622 PELLQHPFLQIQ 633 (677)
T ss_pred HHHhcCcccccc
Confidence 999999999863
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.69 Aligned_cols=205 Identities=29% Similarity=0.512 Sum_probs=165.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++.+.. ...+|+|+||++ ++|.+.+.. ...+++..+..++.|++.||+|||+ +|++|+
T Consensus 48 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~ 117 (262)
T cd05572 48 EECNHPFIVKLYRTFKD-----KKYIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYR 117 (262)
T ss_pred HhCCCCCEeeeeeeEEc-----CCccEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccC
Confidence 56899999999998843 344889999998 477666653 3568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||+|+||+++ .++.++|+|||++.............+++.|++||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 118 dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 118 DLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred CCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 9999999999 477899999999987654433344567889999999865 45889999999999999999999999877
Q ss_pred C--hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHH
Q 022500 161 N--AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALE 233 (296)
Q Consensus 161 ~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e 233 (296)
. ..+....+...... ..++...++++.++|.+||+.||++|++ +.|
T Consensus 196 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~ 248 (262)
T cd05572 196 DEDPMEIYNDILKGNGK---------------------------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKD 248 (262)
T ss_pred CCCHHHHHHHHhccCCC---------------------------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHH
Confidence 6 44444433321000 0112335889999999999999999999 999
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++||||++..+
T Consensus 249 l~~~~~~~~~~~ 260 (262)
T cd05572 249 IKKHKWFNGFDW 260 (262)
T ss_pred HhcChhhhCCCC
Confidence 999999998755
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=283.09 Aligned_cols=203 Identities=30% Similarity=0.460 Sum_probs=174.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+++.|||+|.+.+||.-... .|||||||-|+-.+++.. ..+++.+.++..|..+.+.||.|||+ .+.|||
T Consensus 80 L~~l~HPntieYkgCyLre~T-----aWLVMEYClGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHR 150 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHT-----AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNRIHR 150 (948)
T ss_pred HHhccCCCcccccceeeccch-----HHHHHHHHhccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHH-hhHHhh
Confidence 467899999999999976555 889999999988787765 34679999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||..|||++ +.+.|||+|||.|.... ...+++|||+|||||++. +.+.|+-++||||||+...||.-+++|+.
T Consensus 151 DiKAGNILLs-e~g~VKLaDFGSAsi~~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 151 DIKAGNILLS-EPGLVKLADFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred hccccceEec-CCCeeeeccccchhhcC---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 9999999999 58899999999987543 346789999999999984 34569999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+.+..+..|...- .|+ .+ ....|..++.|+.+||++-|.+|||.+++|.|+
T Consensus 227 nMNAMSALYHIAQNe-sPt------------------Lq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 227 NMNAMSALYHIAQNE-SPT------------------LQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CchHHHHHHHHHhcC-CCC------------------CC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 999999998887631 111 11 123588999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
|...-
T Consensus 280 fv~R~ 284 (948)
T KOG0577|consen 280 FVLRE 284 (948)
T ss_pred hhccC
Confidence 99754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=265.87 Aligned_cols=229 Identities=40% Similarity=0.723 Sum_probs=181.3
Q ss_pred CCCC-CCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++ ||||+++++++.. ....|+||||++|++.+.+... ....+++..+..++.|++.||.|||+ +|++|+
T Consensus 52 ~~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~ 123 (283)
T cd07830 52 RKLNEHPNIVKLKEVFRE-----NDELYFVFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHK-HGFFHR 123 (283)
T ss_pred HhccCCCCchhHHHHhhc-----CCcEEEEEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccC
Confidence 3566 9999999999854 3348899999988887777642 12468999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||+|+||+++ .++.++|+|||.+.............++..|+|||++.+...++.++|+||+|+++++|++|.+||++.
T Consensus 124 dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 124 DLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred CCChhhEEEc-CCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 9999999999 478899999999987654444445678889999999866556889999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCc--CccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYT--DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
...+.+.++...++.+....+........ ....+..........++ ..+.++.++|++||+.||++|||+.|++.||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~ 281 (283)
T cd07830 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHP 281 (283)
T ss_pred ChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence 98899999998888887665433211111 11111111111222222 2378999999999999999999999999999
Q ss_pred Cc
Q 022500 239 FF 240 (296)
Q Consensus 239 ~f 240 (296)
||
T Consensus 282 ~~ 283 (283)
T cd07830 282 YF 283 (283)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=263.39 Aligned_cols=204 Identities=33% Similarity=0.525 Sum_probs=163.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++.+||||+++++++.. ...+|+|+||++| +|.+.+. ....+++..+..++.|++.||.|||+ .|++||
T Consensus 52 ~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~ 121 (260)
T cd05611 52 IQGESPYVAKLYYSFQS-----KDYLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHR 121 (260)
T ss_pred hcCCCCCeeeeeeeEEc-----CCeEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 35689999999999843 3458999999985 6665554 33568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||+|+||+++ .++.+||+|||++..... .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.
T Consensus 122 dl~p~nil~~-~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 122 DIKPENLLID-QTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred CCCHHHeEEC-CCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999 477899999999875432 23446788999999987654 899999999999999999999999887
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC---HHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---~~e~l~h 237 (296)
+.......+..... .+.......+++++.++|.+||+.||++||+ ++|+++|
T Consensus 197 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 197 TPDAVFDNILSRRI-------------------------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHHHHHHHhccc-------------------------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 76655544432100 0011112247899999999999999999995 5799999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+++.+
T Consensus 252 ~~~~~~~~ 259 (260)
T cd05611 252 PFFKSINW 259 (260)
T ss_pred hHhhcCCC
Confidence 99988765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=263.79 Aligned_cols=232 Identities=36% Similarity=0.637 Sum_probs=178.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++||||+++++++..........++++|||++++|.+.+... ....+++..++.++.|++.||.|||+ .+++|+|
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~ 132 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRD 132 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecc
Confidence 34579999999999876554455568899999998887766542 22358999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|+|+||+++. ++.+||+|||.+.............++..|+|||.+.+. .++.++|+||+||++|+|++|.+||.+..
T Consensus 133 l~~~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 133 LKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred CChhhEEEcc-CCCEEEeccCcceeccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 9999999994 688999999999876444333445678899999999764 48899999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
..+.+.++....+.+....+..... .....++....... ......+++.+.++|.+||+.||++||++.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVS-LPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcc-cchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 8888888887766554433211100 00001111111111 11122467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=265.99 Aligned_cols=234 Identities=29% Similarity=0.521 Sum_probs=178.0
Q ss_pred CCCCCCCCeeeeceeeeccCC-----CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-----KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 75 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-----~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~ 75 (296)
+++++||||+++++++..... .+..++|+|+||+++++...+.. ....+++..++.++.|++.||+|||+ .
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~ 135 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-K 135 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence 356899999999998854331 12236889999999987766653 23568999999999999999999999 6
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
||+||||||+||+++ .++.+||+|||++........ .....++..|+|||.+.+...++.++|+||+||++++|++|
T Consensus 136 ~i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g 214 (302)
T cd07864 136 NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214 (302)
T ss_pred CeecCCCCHHHEEEC-CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 999999999999999 578899999999976543321 12235577899999886555578999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
.+||...+..+.+..+.+..+.+....++.... .+............+ ......++..+.++|.+||+.||++|||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 293 (302)
T cd07864 215 KPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRL-REEFSFIPTPALDLLDHMLTLDPSKRCTA 293 (302)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccch-hhhcCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999998888888888888777776655433211 111100000000111 11223478999999999999999999999
Q ss_pred HHHhcCCCc
Q 022500 232 LEACAHPFF 240 (296)
Q Consensus 232 ~e~l~hp~f 240 (296)
.+++.||||
T Consensus 294 ~~il~~~~~ 302 (302)
T cd07864 294 EEALNSPWL 302 (302)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.33 Aligned_cols=205 Identities=26% Similarity=0.365 Sum_probs=161.0
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
..+||||+++++.+... ..+|+||||++| +|.+.+. ..+.+++..+..++.|++.||+|||+ +||+|||
T Consensus 53 ~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~d 122 (279)
T cd05633 53 TGDCPFIVCMTYAFHTP-----DKLCFILDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRD 122 (279)
T ss_pred hCCCCcEeEEEEEEecC-----CeEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCC
Confidence 35799999999988543 348899999995 5555443 34679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|||+||+++ .++.++|+|||++...... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||....
T Consensus 123 ikp~Nil~~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 123 LKPANILLD-EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CCHHHEEEC-CCCCEEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 999999998 5778999999998755332 22345689999999998644558899999999999999999999997653
Q ss_pred hH--HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 162 AV--DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 162 ~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.. ..+...... ....++..++.++.++|.+||..||++|+ |+.++
T Consensus 201 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~ 252 (279)
T cd05633 201 TKDKHEIDRMTLT----------------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEV 252 (279)
T ss_pred CcCHHHHHHHhhc----------------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 21 111111100 00112345789999999999999999999 69999
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
++||||+.+.+..
T Consensus 253 ~~h~~~~~~~~~~ 265 (279)
T cd05633 253 KEHVFFKGIDWQQ 265 (279)
T ss_pred HhCccccCCCHhH
Confidence 9999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=265.17 Aligned_cols=206 Identities=25% Similarity=0.401 Sum_probs=162.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ...|+|+||+++ +|...+.. ....+++..+..++.|++.||.|||+ .|++||
T Consensus 57 ~~l~h~~ii~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~ 127 (282)
T cd06643 57 ASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHR 127 (282)
T ss_pred HHCCCCCeeeEEEEEeeC-----CEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeec
Confidence 568999999999988543 348899999996 44333332 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhcc----CCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++ .++.+||+|||++....... ......+++.|+|||++. ....++.++|+||+||++|+|++|.+
T Consensus 128 dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~ 206 (282)
T cd06643 128 DLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206 (282)
T ss_pred CCCcccEEEc-cCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCC
Confidence 9999999998 57789999999987643322 123456788999999974 22347789999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||...+..+....+....... ...+..++.++.+||.+||+.||.+||++++++
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 207 PHHELNPMRVLLKIAKSEPPT--------------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CccccCHHHHHHHHhhcCCCC--------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 998877666655554321100 001224688999999999999999999999999
Q ss_pred cCCCcccc
Q 022500 236 AHPFFDEL 243 (296)
Q Consensus 236 ~hp~f~~~ 243 (296)
+||||+..
T Consensus 261 ~~~~~~~~ 268 (282)
T cd06643 261 QHPFVTVN 268 (282)
T ss_pred cCCCEecc
Confidence 99999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=263.03 Aligned_cols=237 Identities=34% Similarity=0.569 Sum_probs=187.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
..++|.||+...++.....-.--..+|+++|++..+|..++- ....++.+.++.+++||+.||+|||+ .+|.|||
T Consensus 107 cfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRD 181 (449)
T KOG0664|consen 107 SSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT-ANILHRD 181 (449)
T ss_pred HhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh-cchhhcc
Confidence 456899999999887543322122367899999887766554 45779999999999999999999999 6999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||.|+|++ .+..+||||||+++....+.. .+..+.|.+|+|||++.|.+.|+.++||||+|||+.|++-++..|..
T Consensus 182 IKPGNLLVN-SNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 182 IKPGNLLVN-SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred CCCccEEec-cCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 999999999 588899999999986544332 23346689999999999998999999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCC---cccccC--CCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP---WHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.+..+++..|.+.+|+|+.+.++.-++.-..-........+ .--.+. ..-..+..+++.++|.+||++|.+.+++
T Consensus 261 q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 261 AGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred cChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 99999999999999999999887554432222111111111 011111 1335678999999999999999999999
Q ss_pred hcCCCccccc
Q 022500 235 CAHPFFDELR 244 (296)
Q Consensus 235 l~hp~f~~~~ 244 (296)
+.|++..+.+
T Consensus 341 ~~~~~~~e~R 350 (449)
T KOG0664|consen 341 LQHRYLEEGR 350 (449)
T ss_pred cccccccccc
Confidence 9999998765
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=265.67 Aligned_cols=206 Identities=28% Similarity=0.455 Sum_probs=170.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++.|+||++|+.|+.... ++||||||+ |+..++++. .++++++.++..+++.-+.||+|||.+ .-+|
T Consensus 82 MQQC~S~yVVKYYGSYFK~sD-----LWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIH 152 (502)
T KOG0574|consen 82 MQQCKSKYVVKYYGSYFKHSD-----LWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIH 152 (502)
T ss_pred HHHcCCchhhhhhhhhccCCc-----eEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHH
Confidence 568899999999999876555 999999999 788887774 568899999999999999999999996 7889
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||..|||++ .++..||+|||.|..+... ....+.+|||.|||||++..- .|+.++||||||+...||..|++||.
T Consensus 153 RDIKAGNILLN-T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 153 RDIKAGNILLN-TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred hhcccccEEEc-ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcc
Confidence 99999999999 5788999999999876443 234678999999999999654 59999999999999999999999997
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
.-.++..+..|-. .|+ |.++ .+...|.++-||+++||.++|++|-|+.++++||
T Consensus 231 DIHPMRAIFMIPT---~PP----------------PTF~-------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 231 DIHPMRAIFMIPT---KPP----------------PTFK-------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred cccccceeEeccC---CCC----------------CCCC-------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 7665544332211 000 0000 1123688999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
|.++.
T Consensus 285 FiknA 289 (502)
T KOG0574|consen 285 FIKNA 289 (502)
T ss_pred hhcCC
Confidence 99865
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=266.47 Aligned_cols=211 Identities=26% Similarity=0.394 Sum_probs=167.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++.+.. ....|+||||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ .||+|
T Consensus 54 l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH 125 (285)
T cd05632 54 LEKVNSQFVVNLAYAYET-----KDALCLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVY 125 (285)
T ss_pred HHHcCCcCceeEEEEEec-----CCEEEEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 457899999999988843 3358999999995 55554442 223469999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++.............|+..|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 126 ~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 126 RDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred cCCCHHHEEEC-CCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99999999998 4678999999998765433333456789999999999654 589999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~ 234 (296)
.........+.+...... ..+...+++++.+|+.+||+.||++|+| +.++
T Consensus 204 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l 258 (285)
T cd05632 204 RKEKVKREEVDRRVLETE-------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEV 258 (285)
T ss_pred CCHHHHHHHHHHhhhccc-------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHH
Confidence 765544444332111000 0122347889999999999999999999 8899
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++|+||+.....
T Consensus 259 ~~~~~~~~~~~~ 270 (285)
T cd05632 259 KRHPFFRNMNFK 270 (285)
T ss_pred HcChhhhcCCHH
Confidence 999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=262.49 Aligned_cols=205 Identities=26% Similarity=0.382 Sum_probs=159.5
Q ss_pred CCCCeeeeceeeeccCCC-CcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 5 DHPNVISLKHCFFSTTSK-NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~-~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
+||||+++++++...... ....+|+||||+++ +|.+.+.. .....+++..+..++.|++.||+|||+ ++|+||||
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl 137 (272)
T cd06637 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDI 137 (272)
T ss_pred CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCC
Confidence 799999999998654322 23458899999985 77666653 123568999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||+||+++ .++.+||+|||++....... ......|++.|+|||++.+ ...++.++|+||+||++|+|++|..||
T Consensus 138 ~~~nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~ 216 (272)
T cd06637 138 KGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216 (272)
T ss_pred CHHHEEEC-CCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999999 57789999999997653322 2234568899999999853 234788999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
...........+.... ........++.++.+|+.+||..||.+|||+.++++|
T Consensus 217 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 217 CDMHPMRALFLIPRNP---------------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cccCHHHHHHHHhcCC---------------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 7665443333221100 0000112468899999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 270 ~~~ 272 (272)
T cd06637 270 PFI 272 (272)
T ss_pred CCC
Confidence 998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=270.18 Aligned_cols=235 Identities=20% Similarity=0.275 Sum_probs=165.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ...|++|||++ |++.+.+... ....+++..++.++.|++.||+|||+ ++|+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH 124 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIH 124 (314)
T ss_pred HHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 3578999999999998543 34889999999 4666666532 23458899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--------ccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l 150 (296)
|||||+||+++ .++.+|++|||.+........ .....++..|+|||++.+. ..++.++|+||+||++|+|
T Consensus 125 ~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el 203 (314)
T cd08216 125 RSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203 (314)
T ss_pred CCCCcceEEEe-cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHH
Confidence 99999999999 578899999999875532211 1233567789999998643 3488999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHH----HHhhcCcCCcCc---cCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 151 LLGQPLFPGENAVDQLVEIIKVLGTPTRE----EIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 151 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
++|..||.............. +..... ............ .................++.++.+|+.+||+.
T Consensus 204 ~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 281 (314)
T cd08216 204 ANGHVPFKDMPATQMLLEKVR--GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281 (314)
T ss_pred HhCCCCCCCCCHHHHHHHHHh--ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhc
Confidence 999999987654443322211 111000 000000000000 00000011111122234567899999999999
Q ss_pred CCCCCCCHHHHhcCCCcccccCC
Q 022500 224 SPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 224 ~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
||++|||+.++++||||+.+++.
T Consensus 282 ~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 282 DPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred CCCcCcCHHHHhcCchHhhhccc
Confidence 99999999999999999987644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=264.96 Aligned_cols=209 Identities=25% Similarity=0.435 Sum_probs=162.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~-l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++.+... ..+|+||||++|+ +...+.. ....+++..+..++.|++.||.|||+ .|++|
T Consensus 63 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H 133 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWD-----GKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIH 133 (292)
T ss_pred HHhCCCCcEeeeEEEEEeC-----CeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeee
Confidence 3578999999999988533 3489999999964 4333332 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+ ...++.++|+||+||++|+|++|.
T Consensus 134 ~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 212 (292)
T cd06644 134 RDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212 (292)
T ss_pred cCCCcceEEEc-CCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCC
Confidence 99999999998 47789999999987543222 2234567889999999842 234678999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
+||...+......++.... .+. ...+..++.++.++|++||..||++||+++++
T Consensus 213 ~p~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 266 (292)
T cd06644 213 PPHHELNPMRVLLKIAKSE-PPT-------------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266 (292)
T ss_pred CCCccccHHHHHHHHhcCC-Ccc-------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 9998776554444432210 000 00123468899999999999999999999999
Q ss_pred hcCCCcccccC
Q 022500 235 CAHPFFDELRE 245 (296)
Q Consensus 235 l~hp~f~~~~~ 245 (296)
++||||..+..
T Consensus 267 l~~~~~~~~~~ 277 (292)
T cd06644 267 LEHPFVSSVTS 277 (292)
T ss_pred hcCcccccccc
Confidence 99999987654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=266.70 Aligned_cols=203 Identities=32% Similarity=0.534 Sum_probs=167.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++ ++|.+.+.. ...+++..+..++.|++.||.|||+ +|++|
T Consensus 55 l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H 124 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQD-----DSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVY 124 (290)
T ss_pred HHhCCCCCccceeeEEEc-----CCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEec
Confidence 457899999999999843 345899999996 677666653 4679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+|+||+++ .++.+||+|||++...... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||..
T Consensus 125 ~dl~p~nili~-~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 125 RDLKPENLLLD-SDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred CCCCHHHEEEC-CCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998 4778999999999876443 3345678999999998654 588999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+.......+... .+ .++..+++.+.++|.+||+.||.+|+ +++++
T Consensus 201 ~~~~~~~~~~~~~--~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l 251 (290)
T cd05580 201 DNPIQIYEKILEG--KV---------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI 251 (290)
T ss_pred CCHHHHHHHHhcC--Cc---------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHH
Confidence 7755555444321 00 12234689999999999999999999 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+.+.+.
T Consensus 252 ~~~~~~~~~~~~ 263 (290)
T cd05580 252 KNHPWFAGIDWI 263 (290)
T ss_pred HcCcccccCCHH
Confidence 999999987754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=271.35 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=152.8
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh---------------------------------
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS--------------------------------- 47 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~--------------------------------- 47 (296)
.+ +|||||++++++... ...+++||||++ |+|.+.+.....
T Consensus 66 ~l~~h~niv~~~~~~~~~----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (338)
T cd05102 66 HIGNHLNVVNLLGACTKP----NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQ 141 (338)
T ss_pred HhccCcceeeEEeEecCC----CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccccccc
Confidence 45 899999999987432 224789999999 588777754211
Q ss_pred -------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeecc
Q 022500 48 -------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 102 (296)
Q Consensus 48 -------------------------~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 102 (296)
....+++..+..++.||+.||+|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~-~~~~~kl~DfG 219 (338)
T cd05102 142 ASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLS-ENNVVKICDFG 219 (338)
T ss_pred CCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEc-CCCcEEEeecc
Confidence 02347888899999999999999999 7999999999999998 47789999999
Q ss_pred CccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 022500 103 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 178 (296)
Q Consensus 103 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 178 (296)
+++....... .....+++.|+|||++.+. .++.++||||+||++|+|++ |..||.+....+.+...+.....+
T Consensus 220 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-- 296 (338)
T cd05102 220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-- 296 (338)
T ss_pred cccccccCcchhcccCCCCCccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--
Confidence 9986533221 1223456789999998654 58999999999999999997 999998765443333322210000
Q ss_pred HHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
..+...++++.+++.+||+.||.+|||+.++++
T Consensus 297 -------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -------------------------RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=266.42 Aligned_cols=206 Identities=35% Similarity=0.575 Sum_probs=163.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+++||||+.+ +|.+.+. ....+++..+..++.|++.||.+||+ +|++|+
T Consensus 53 ~~l~~~~i~~~~~~~~~-----~~~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~ 122 (260)
T PF00069_consen 53 RRLRHPNIVQILDVFQD-----DNYLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHR 122 (260)
T ss_dssp HHHTBTTBCHEEEEEEE-----SSEEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEES
T ss_pred ccccccccccccccccc-----ccccccccccccccccccccc----cccccccccccccccccccccccccc-cccccc
Confidence 35689999999999954 4448899999997 8877776 34678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCcccc-ccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.++|+|||.+... ..........+++.|+|||++.....++.++|+||+|+++|+|++|..||..
T Consensus 123 dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 123 DIKPENILLD-ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp SBSGGGEEES-TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred cccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999 6888999999999753 2223334567899999999986345689999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
....+....+.+........... .....++++.++|.+||+.||++|||+.++++|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 202 SNSDDQLEIIEKILKRPLPSSSQ----------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp SSHHHHHHHHHHHHHTHHHHHTT----------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred ccchhhhhhhhhccccccccccc----------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 74444444333322111111100 00112479999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
|
T Consensus 260 ~ 260 (260)
T PF00069_consen 260 F 260 (260)
T ss_dssp G
T ss_pred C
Confidence 8
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=263.41 Aligned_cols=207 Identities=27% Similarity=0.427 Sum_probs=163.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++.+.. ...+|+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+|
T Consensus 56 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h 126 (280)
T cd06611 56 LSECKHPNIVGLYEAYFY-----ENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIH 126 (280)
T ss_pred HHhCCCCceeEEEEEEec-----CCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 357899999999999853 3348999999996 66555543 23569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.. ...++.++|+||+|+++|+|++|.
T Consensus 127 ~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~ 205 (280)
T cd06611 127 RDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205 (280)
T ss_pred CCCChhhEEEC-CCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCC
Confidence 99999999998 57889999999987543322 2234567899999999742 234678999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+.......+.... .+. ...+..++.++.++|.+||+.+|++||++.++
T Consensus 206 ~p~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 259 (280)
T cd06611 206 PPHHELNPMRVLLKILKSE-PPT-------------------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259 (280)
T ss_pred CCcccCCHHHHHHHHhcCC-CCC-------------------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 9998877655544433210 000 00112468899999999999999999999999
Q ss_pred hcCCCcccc
Q 022500 235 CAHPFFDEL 243 (296)
Q Consensus 235 l~hp~f~~~ 243 (296)
++||||++.
T Consensus 260 l~~~~~~~~ 268 (280)
T cd06611 260 LKHPFVSDQ 268 (280)
T ss_pred hcChhhccc
Confidence 999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=305.51 Aligned_cols=206 Identities=28% Similarity=0.477 Sum_probs=169.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
..|+|||||++|++-..... ++|.||||+| +|.+.+.+ +...++...+.|..|++.|+.|||+ .|||||
T Consensus 1289 E~lnHpNlV~YyGVEvHRek-----v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHR 1358 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREK-----VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHR 1358 (1509)
T ss_pred HhccCccccccCceeecHHH-----HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceec
Confidence 45799999999998765554 7799999995 66666553 4557888999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-----CccceeecccccCchhccCCC--CCCchhHHHHHHHHHHHHHhC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-----ANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g 153 (296)
||||+||+++ .++.+|++|||.|..+.... ......||+.|||||++.+.. +...+.||||+||++.||+||
T Consensus 1359 DIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1359 DIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred CCCccceeee-cCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence 9999999999 57899999999998775542 234678999999999997643 366799999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
+.||...+..-++.--+....+|. +|..+|++.+|||..||+.||++|+++.+
T Consensus 1438 krPW~~~dne~aIMy~V~~gh~Pq---------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1438 KRPWAELDNEWAIMYHVAAGHKPQ---------------------------IPERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred CCchhhccchhHHHhHHhccCCCC---------------------------CchhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence 999988776655444444333322 34458999999999999999999999999
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++|.|=+.-.+
T Consensus 1491 lle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1491 LLEHAFGKSCTD 1502 (1509)
T ss_pred HHHhhccccccc
Confidence 999998876443
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=263.95 Aligned_cols=212 Identities=29% Similarity=0.410 Sum_probs=165.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++| +|.+.+... ....+++..+..++.|++.||.|||+ +|++|
T Consensus 47 l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H 118 (277)
T cd05577 47 LEKVSSRFIVSLAYAFET-----KDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVY 118 (277)
T ss_pred HHhCCCCCEeeeeeEEec-----CCeEEEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 457899999999998843 3448999999995 666555432 22368999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+|+||+++ .++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+||++|+|++|..||.+
T Consensus 119 ~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 119 RDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 99999999999 47789999999987654433334456788999999986644 88999999999999999999999977
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.........+.+..- ......+..+++++.++|++||+.||++|+ ++.++
T Consensus 197 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 197 RKEKVEKEELKRRTL-------------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred CcccccHHHHHhccc-------------------------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 654221111111000 000112234789999999999999999999 89999
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
++||||+++.+..
T Consensus 252 l~h~~~~~~~~~~ 264 (277)
T cd05577 252 REHPLFKDLNWRR 264 (277)
T ss_pred HhChhhhcCChhh
Confidence 9999999887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=270.24 Aligned_cols=237 Identities=35% Similarity=0.617 Sum_probs=181.6
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++..... ......|+++++++++|.+.+.. ..+++..++.++.|++.||+|||+ .||+|
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH 143 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIH 143 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 356899999999998754322 22334789999998887665542 458999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++..... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus 144 ~dlkp~NIll~-~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 144 RDLKPSNLAVN-EDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cCCChHHEEEc-CCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 477899999999876432 233457789999999987655688999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc---cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+....+..+....+.+.......+....... ..+......+.. .....++++.++|.+||+.||.+|+++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 88888888888877777666554332211000 001111111111 11236889999999999999999999999999
Q ss_pred CCCcccccCCC
Q 022500 237 HPFFDELREPN 247 (296)
Q Consensus 237 hp~f~~~~~~~ 247 (296)
||||+++..+.
T Consensus 300 h~~f~~~~~~~ 310 (345)
T cd07877 300 HAYFAQYHDPD 310 (345)
T ss_pred ChhhhhcCCCC
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=288.40 Aligned_cols=201 Identities=26% Similarity=0.430 Sum_probs=159.4
Q ss_pred CCCCC-CCCeeeece-eeeccCCCC-cceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022500 1 MRVMD-HPNVISLKH-CFFSTTSKN-ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 76 (296)
Q Consensus 1 l~~l~-HpnIv~l~~-~~~~~~~~~-~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~ 76 (296)
||+|. |+|||.+++ ........+ ...+.|.||||. |+|.+++..++..+ |++.++.+|++|++.|+.+||. ..
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~-~~ 164 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHY-LK 164 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhc-CC
Confidence 57777 999999999 444333333 466889999999 69999998876643 9999999999999999999999 47
Q ss_pred --cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----------cceeecccccCchhc--cCCCCCCchhHHHH
Q 022500 77 --VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----------ISYICSRFYRAPELI--FGATEYTTSIDIWS 142 (296)
Q Consensus 77 --i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~t~~y~aPE~~--~~~~~~~~~~Diws 142 (296)
|||||||-||||++ .++..||||||.|......... ....-|+.|+|||++ .....+++|+||||
T Consensus 165 pPiIHRDLKiENvLls-~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA 243 (738)
T KOG1989|consen 165 PPIIHRDLKIENVLLS-ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA 243 (738)
T ss_pred CccchhhhhhhheEEc-CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence 99999999999999 5788999999999755333211 123559999999998 22345899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccc
Q 022500 143 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222 (296)
Q Consensus 143 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 222 (296)
|||++|-|+....||.+.....+ ++ ..|.+|.. ..++..+++||+.||+
T Consensus 244 LGclLYkLCy~t~PFe~sg~laI----ln-----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~ 292 (738)
T KOG1989|consen 244 LGCLLYKLCYFTTPFEESGKLAI----LN-----------------GNYSFPPF----------PNYSDRLKDLIRTMLQ 292 (738)
T ss_pred HHHHHHHHHHhCCCcCcCcceeE----Ee-----------------ccccCCCC----------ccHHHHHHHHHHHHhc
Confidence 99999999999999977643322 11 12233321 2378999999999999
Q ss_pred cCCCCCCCHHHHhc
Q 022500 223 YSPSLRCTALEACA 236 (296)
Q Consensus 223 ~~p~~R~t~~e~l~ 236 (296)
.||.+||++.+++.
T Consensus 293 ~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 293 PNPDERPNIYQVLE 306 (738)
T ss_pred cCcccCCCHHHHHH
Confidence 99999999988765
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=264.17 Aligned_cols=210 Identities=27% Similarity=0.391 Sum_probs=163.6
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
.+ +||||+++++++......+...+++||||++| +|.+.+.........+++..+..++.|++.||.|||+ .+++||
T Consensus 70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 148 (286)
T cd06638 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHR 148 (286)
T ss_pred HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCcccc
Confidence 44 79999999998865544455668999999984 7777776544455678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++. ++.+||+|||++....... ......|++.|+|||++.+ ...++.++|+||+||++|+|++|..
T Consensus 149 dlkp~nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 149 DVKGNNILLTT-EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred CCCHHhEEECC-CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 99999999994 6779999999987654322 2234568899999998743 2347889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||........+..+... .+ + ....+...+.++.++|.+||+.||++|||+.|++
T Consensus 228 p~~~~~~~~~~~~~~~~--~~-----------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 228 PLADLHPMRALFKIPRN--PP-----------------P-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred CCCCCchhHHHhhcccc--CC-----------------C-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 99876554433222110 00 0 0001123578899999999999999999999999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
+|+||
T Consensus 282 ~~~~~ 286 (286)
T cd06638 282 QHVFI 286 (286)
T ss_pred hcccC
Confidence 99997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=267.79 Aligned_cols=237 Identities=36% Similarity=0.691 Sum_probs=180.9
Q ss_pred CCCCCCCCeeeeceeeeccCCC-CcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~-~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++...... ....+++||||++++|...+. ...+++..++.++.|++.||+|||+ .||+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H 141 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIH 141 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 4678999999999988644321 223468999999877766554 2568999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.++|+|||++..... ......+++.|+|||.+.+...++.++|+||+||++|++++|..||.+
T Consensus 142 ~dlkp~Nill~-~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 142 RDLKPGNLAVN-EDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred CCCCHHHEEEc-CCCCEEEeeccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 477899999999986533 223456788999999987644588999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCc-Cc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+....+..+++..+.+.......+..... .+ ..+......+ ......+++++.++|.+||+.||++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 888888888887766665443332221100 00 0011111111 1122457889999999999999999999999999
Q ss_pred CCCcccccCCC
Q 022500 237 HPFFDELREPN 247 (296)
Q Consensus 237 hp~f~~~~~~~ 247 (296)
||||+..+...
T Consensus 298 ~~~~~~~~~~~ 308 (343)
T cd07880 298 HPYFEEFHDPE 308 (343)
T ss_pred CccHhhhcCcc
Confidence 99999886643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.81 Aligned_cols=203 Identities=26% Similarity=0.442 Sum_probs=162.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++.+.. ....+|+||||+++ +|.+.+... ....+++..+..++.|++.||.+||+ +|++|
T Consensus 53 l~~l~~~~i~~~~~~~~~----~~~~~~lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H 125 (257)
T cd08223 53 LSQLKHPNIVAYRESWEG----EDGLLYIVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILH 125 (257)
T ss_pred HHhCCCCCeeeeeeeecC----CCCEEEEEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 357899999999887632 23357899999984 776666542 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.++|+|||++........ .....+++.|+|||++.+. .++.++|+||+|+++++|++|..||.
T Consensus 126 ~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 126 RDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred cCCCchhEEEe-cCCcEEEecccceEEecccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 99999999998 577899999999976543222 2344678899999998654 58899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+.......+..... + ..+..+++++.+++.+||+.||++|||+.++++||
T Consensus 204 ~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 255 (257)
T cd08223 204 AKDMNSLVYRIIEGKL-------------------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255 (257)
T ss_pred CCCHHHHHHHHHhcCC-------------------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 8776555544433110 0 01134789999999999999999999999999999
Q ss_pred Cc
Q 022500 239 FF 240 (296)
Q Consensus 239 ~f 240 (296)
||
T Consensus 256 ~~ 257 (257)
T cd08223 256 YI 257 (257)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=266.98 Aligned_cols=208 Identities=26% Similarity=0.443 Sum_probs=163.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++.+.. ..+.|+||||+++ +|.+.+. .+.+++..+..++.||+.||.|||+ +||+|
T Consensus 73 l~~l~h~~ii~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH 141 (292)
T cd06658 73 MRDYHHENVVDMYNSYLV-----GDELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIH 141 (292)
T ss_pred HHhCCCCcHHHHHHheec-----CCeEEEEEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEee
Confidence 356899999999998843 3348999999996 4444332 2468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.
T Consensus 142 ~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 142 RDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred cCCCHHHEEEc-CCCCEEEccCcchhhcccccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 46789999999987543222 22345688999999998653 58899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+....+..+........ + .....+..+.+++.+||..||.+|||+.++++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~----------------~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 220 NEPPLQAMRRIRDNLPPRV----------------K----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred CCCHHHHHHHHHhcCCCcc----------------c----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 8776555444332111000 0 0123688999999999999999999999999999
Q ss_pred CcccccCCC
Q 022500 239 FFDELREPN 247 (296)
Q Consensus 239 ~f~~~~~~~ 247 (296)
||+....+.
T Consensus 274 ~~~~~~~~~ 282 (292)
T cd06658 274 FLKLAGPPS 282 (292)
T ss_pred hhhccCCcc
Confidence 999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=264.46 Aligned_cols=212 Identities=25% Similarity=0.381 Sum_probs=160.9
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~-~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++... ...+++|||+++++.+..... ......+++..+..++.|++.||+|||+..+++|||||
T Consensus 61 ~~~~iv~~~~~~~~~-----~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk 135 (288)
T cd06616 61 DCPYIVKFYGALFRE-----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVK 135 (288)
T ss_pred CCCCEeeeeeEEecC-----CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCC
Confidence 499999999988543 337899999997665544321 22346799999999999999999999972399999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|+||+++ .++.+||+|||++.............+++.|+|||++.+. ..++.++|+||+||++|+|++|..||....
T Consensus 136 p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 136 PSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred HHHEEEc-cCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 9999998 4778999999999765544333445678899999998654 358899999999999999999999997654
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~ 241 (296)
. ....+.+...... +. ........++.++.+||++||+.||++|||++++++||||+
T Consensus 215 ~--~~~~~~~~~~~~~----------------~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 215 S--VFDQLTQVVKGDP----------------PI-----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred h--HHHHHhhhcCCCC----------------Cc-----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 1 1222221110000 00 00011124789999999999999999999999999999998
Q ss_pred cccC
Q 022500 242 ELRE 245 (296)
Q Consensus 242 ~~~~ 245 (296)
...+
T Consensus 272 ~~~~ 275 (288)
T cd06616 272 DYEE 275 (288)
T ss_pred chhh
Confidence 7543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=263.32 Aligned_cols=205 Identities=26% Similarity=0.382 Sum_probs=161.9
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
..+||||+++++++.. ...+|+||||+.| +|.+.+. ..+.+++..++.++.|++.||+|||+ .+++|||
T Consensus 53 ~~~~~~i~~~~~~~~~-----~~~~~~v~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~d 122 (278)
T cd05606 53 TGDCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRD 122 (278)
T ss_pred hCCCCcEeeeeeeeec-----CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCC
Confidence 3579999999998843 3458899999996 5544443 44679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|||+||+++ .++.+||+|||++...... ......|+..|+|||++.+...++.++|+||+||++|+|++|..||.+..
T Consensus 123 i~p~nili~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 123 LKPANILLD-EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred CCHHHEEEC-CCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 999999998 4778999999998765332 23345789999999998655458899999999999999999999997763
Q ss_pred hHHH--HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 162 AVDQ--LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 162 ~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.... ....... ....++...+.++.+++.+||..+|.+|+ ++.++
T Consensus 201 ~~~~~~~~~~~~~----------------------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~l 252 (278)
T cd05606 201 TKDKHEIDRMTLT----------------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 252 (278)
T ss_pred ccchHHHHHHhhc----------------------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHH
Confidence 2211 1111100 00112234689999999999999999999 99999
Q ss_pred hcCCCcccccCCC
Q 022500 235 CAHPFFDELREPN 247 (296)
Q Consensus 235 l~hp~f~~~~~~~ 247 (296)
++||||+...+..
T Consensus 253 l~~~~~~~~~~~~ 265 (278)
T cd05606 253 KEHPFFRSLDWQM 265 (278)
T ss_pred HhCccccCCCchH
Confidence 9999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=275.96 Aligned_cols=204 Identities=26% Similarity=0.432 Sum_probs=166.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--c
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--V 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i 77 (296)
|+.|+|||||++|+.|.+..+ ..+.+|+|++. |+|..+++ ..+..+...++.|++||+.||.|||+ +. |
T Consensus 95 LKsL~H~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs-~~PPI 166 (632)
T KOG0584|consen 95 LKSLKHPNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHS-QDPPI 166 (632)
T ss_pred HccCCCCceeeeeeheecCCC---ceeeeeeecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhc-CCCCc
Confidence 578999999999999976554 45779999999 66655555 55778999999999999999999999 45 9
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
+|||||-+||++++..|.|||+|+|+|...... .....+|||.|||||++. ..|+..+||||||.++.||+|+..||
T Consensus 167 IHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPY 243 (632)
T KOG0584|consen 167 IHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPY 243 (632)
T ss_pred cccccccceEEEcCCcCceeecchhHHHHhhcc-ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCCh
Confidence 999999999999988899999999999865433 334589999999999985 46999999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
..-....++++-+-. |..+ .. +.+--+++.++||.+||.. .++|+|+.|+|+|
T Consensus 244 sEC~n~AQIYKKV~S-GiKP-~s------------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 244 SECTNPAQIYKKVTS-GIKP-AA------------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhhCCHHHHHHHHHc-CCCH-HH------------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 765544444433322 2111 11 1122378999999999999 9999999999999
Q ss_pred CCccc
Q 022500 238 PFFDE 242 (296)
Q Consensus 238 p~f~~ 242 (296)
|||..
T Consensus 297 ~Ff~~ 301 (632)
T KOG0584|consen 297 PFFDE 301 (632)
T ss_pred hhhcc
Confidence 99986
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=261.79 Aligned_cols=200 Identities=32% Similarity=0.533 Sum_probs=159.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ..+.++||||+++ +|.+.+. ..+.+++..++.++.|++.||+|||+ +|++|
T Consensus 60 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH 129 (267)
T cd06628 60 LKELQHENIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN-RGIIH 129 (267)
T ss_pred HHhcCCCCeeeEEEEEEe-----CCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh-cCccc
Confidence 356899999999998843 3348899999985 6666554 34668999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
|||+|+||+++ .++.++|+|||.++....... .....++..|+|||.+.+. .++.++|+||+||++|+|++
T Consensus 130 ~di~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~ 207 (267)
T cd06628 130 RDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLT 207 (267)
T ss_pred ccCCHHHEEEc-CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhh
Confidence 99999999998 578899999999886642211 1123578889999998654 58899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||.+.+....+..+.... ...++..++.++.++|++||+.||.+||++.
T Consensus 208 g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 208 GKHPFPDCTQLQAIFKIGENA----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred CCCCCCCccHHHHHHHHhccC----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHH
Confidence 999998766544433322210 0012234789999999999999999999999
Q ss_pred HHhcCCCc
Q 022500 233 EACAHPFF 240 (296)
Q Consensus 233 e~l~hp~f 240 (296)
++++||||
T Consensus 260 ~il~~~~~ 267 (267)
T cd06628 260 ELLKHPFL 267 (267)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=262.64 Aligned_cols=205 Identities=27% Similarity=0.389 Sum_probs=159.8
Q ss_pred CCCCeeeeceeeeccCC-CCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 5 DHPNVISLKHCFFSTTS-KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
+||||+++++++..... ....++|++|||+++ +|.+.+... ....+++..+..++.||+.||.|||+ .||+||||
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl 147 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDI 147 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCC
Confidence 79999999998864322 234568899999985 777666542 34568899999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||+||+++ .++.++|+|||++....... ......+++.|+|||.+.. ...++.++|+||+||++|+|++|..||
T Consensus 148 ~~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 226 (282)
T cd06636 148 KGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226 (282)
T ss_pred CHHHEEEC-CCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence 99999999 57789999999987653221 2234568899999999852 234788999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
...........+.+... .......++.++.+||++||..||.+|||+.|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 227 CDMHPMRALFLIPRNPP---------------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred cccCHHhhhhhHhhCCC---------------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 77654443332221100 000112478899999999999999999999999999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 280 ~~~ 282 (282)
T cd06636 280 PFI 282 (282)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=265.98 Aligned_cols=233 Identities=37% Similarity=0.729 Sum_probs=180.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.... ...|+|+||++++|...+. ...+++..+..++.|++.||+|||+ .||+||
T Consensus 63 l~~l~hpniv~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~ 132 (328)
T cd07856 63 LKHLRHENIISLSDIFISPL----EDIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHR 132 (328)
T ss_pred HHhcCCCCeeeEeeeEecCC----CcEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 35789999999999885422 2378999999888766554 2457888899999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||+|+||+++ .++.++|+|||.+..... ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.
T Consensus 133 dl~p~Nili~-~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 133 DLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred CCCHHHEeEC-CCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998 577899999999875422 2234567889999999866456899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcC-CcCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
........+.+.+|.++.+........ -..+ ..+.....+.... ...++.++.++|++||+.+|++|||+++++.|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 210 DHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEK-FKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHH-cCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 888888888888888876554432110 0000 0111111111111 13478899999999999999999999999999
Q ss_pred CCcccccCCC
Q 022500 238 PFFDELREPN 247 (296)
Q Consensus 238 p~f~~~~~~~ 247 (296)
|||.....+.
T Consensus 289 ~~~~~~~~~~ 298 (328)
T cd07856 289 PYLAPYHDPT 298 (328)
T ss_pred CccccccCCc
Confidence 9998776653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=260.92 Aligned_cols=210 Identities=28% Similarity=0.408 Sum_probs=164.0
Q ss_pred CC-CCCCeeeeceeeeccCC-CCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 3 VM-DHPNVISLKHCFFSTTS-KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++ +||||+++++++..... .....+|+||||+++ +|.+.+......+..+++..++.++.|++.||+|||+ .|++|
T Consensus 58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H 136 (275)
T cd06608 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIH 136 (275)
T ss_pred HhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCccc
Confidence 45 79999999999865443 345568899999995 6666665544345779999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
+||+|+||+++ .++.+||+|||++....... ......++..|+|||++.. ...++.++|+||+||++|+|++|.
T Consensus 137 ~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~ 215 (275)
T cd06608 137 RDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215 (275)
T ss_pred CCCCHHHEEEc-cCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCC
Confidence 99999999999 47789999999987653322 2234567889999998743 234678899999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||...........+.+... +. ...+...+.++.+||.+||..||++|||+.++
T Consensus 216 ~p~~~~~~~~~~~~~~~~~~-------------------~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 216 PPLCDMHPMRALFKIPRNPP-------------------PT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred CCccccchHHHHHHhhccCC-------------------CC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 99987665555544432100 00 00112367899999999999999999999999
Q ss_pred hcCCCc
Q 022500 235 CAHPFF 240 (296)
Q Consensus 235 l~hp~f 240 (296)
++|||+
T Consensus 270 l~~~~~ 275 (275)
T cd06608 270 LEHPFI 275 (275)
T ss_pred hcCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.73 Aligned_cols=202 Identities=27% Similarity=0.399 Sum_probs=163.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. ....|+||||++| +|.+.+... ....+++..+..++.|++.||.|||+ +|++|
T Consensus 53 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h 124 (256)
T cd08529 53 LAKLDSSYIIRYYESFLD-----KGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILH 124 (256)
T ss_pred HHhcCCCCeehheeeecc-----CCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 357899999999998843 3458999999984 777766542 24578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||||+||+++ .++.++|+|||++........ .....+++.|+|||++.+. .++.++|+||+||++++|++|..||.
T Consensus 125 ~dl~~~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 125 RDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred CCCCcceEEEe-CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCC
Confidence 99999999999 477899999999886544322 2234678899999998654 48899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+.......+.+.... .++..++.++.+++.+||+.+|++||++.++++||
T Consensus 203 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 203 ANNQGALILKIIRGVFP----------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred CCCHHHHHHHHHcCCCC----------------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 88766555544331100 01124688999999999999999999999999999
Q ss_pred Cc
Q 022500 239 FF 240 (296)
Q Consensus 239 ~f 240 (296)
|+
T Consensus 255 ~~ 256 (256)
T cd08529 255 SL 256 (256)
T ss_pred CC
Confidence 95
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=264.08 Aligned_cols=212 Identities=26% Similarity=0.471 Sum_probs=162.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++.+.. ...+|+||||++| +|...+.. ......+++..++.++.|++.||.|||+..|++||
T Consensus 54 ~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~ 127 (286)
T cd06622 54 HKAVSPYIVDFYGAFFI-----EGAVYMCMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR 127 (286)
T ss_pred HhcCCCcHHhhhhheec-----CCeEEEEEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeC
Confidence 56899999999998843 3458999999996 55555442 11234789999999999999999999962499999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCC-----CCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++. ++.+||+|||++...... ......+++.|+|||.+.+.. .++.++|+||+||++|+|++|..
T Consensus 128 dl~p~nil~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 205 (286)
T cd06622 128 DVKPTNVLVNG-NGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205 (286)
T ss_pred CCCHHHEEECC-CCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence 99999999994 788999999998765332 223446788999999985422 25789999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||...........+........ ..++..+++++.+||.+||+.+|++||++.+++
T Consensus 206 pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 260 (286)
T cd06622 206 PYPPETYANIFAQLSAIVDGDP-------------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260 (286)
T ss_pred CCCCcchhhHHHHHHHHhhcCC-------------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 9977654443333222111000 012234789999999999999999999999999
Q ss_pred cCCCcccccCC
Q 022500 236 AHPFFDELREP 246 (296)
Q Consensus 236 ~hp~f~~~~~~ 246 (296)
+||||...+..
T Consensus 261 ~~~~~~~~~~~ 271 (286)
T cd06622 261 EHPWLVKYKNA 271 (286)
T ss_pred cChhhhhccCC
Confidence 99999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.96 Aligned_cols=205 Identities=27% Similarity=0.485 Sum_probs=163.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++.+.. ...+|+|+||+.| +|.+.+. ...+++..+..++.|++.||.|||+ .|++|
T Consensus 70 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H 138 (296)
T cd06655 70 MKELKNPNIVNFLDSFLV-----GDELFVVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIH 138 (296)
T ss_pred HHhcCCCceeeeeeeEec-----CceEEEEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 356899999999999843 3348999999985 5554443 2458999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus 139 ~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 139 RDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred CCCCHHHEEEC-CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 578899999999876543322 2234678899999998654 58899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+.......+... +.+. ...+..+++.+.++|++||..||++|||+.++++||
T Consensus 217 ~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 217 NENPLRALYLIATN-GTPE-------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred CCCHHHHHHHHHhc-CCcc-------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 88765554433221 1100 001234788999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||+...
T Consensus 271 ~~~~~~ 276 (296)
T cd06655 271 FLKLAK 276 (296)
T ss_pred Hhhhcc
Confidence 998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.70 Aligned_cols=203 Identities=30% Similarity=0.458 Sum_probs=165.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++.+. ....+++||||++| +|.+.+... ....+++..+..++.|++.||+|||+ +|++|
T Consensus 53 l~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h 124 (256)
T cd08220 53 LKLLSHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILH 124 (256)
T ss_pred HhhCCCCchhheeeeEe-----cCCEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 46789999999999884 33458899999985 777776542 23458999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
+||+|+||+++..+..+||+|||.+.............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+
T Consensus 125 ~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred CCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCccc
Confidence 9999999999865667899999999876544444445678899999998654 588999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+.......+...... .++..+++++.+++.+||..||++|||+.++++|||
T Consensus 204 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 204 ANLPALVLKIMSGTFA----------------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI 255 (256)
T ss_pred CchHHHHHHHHhcCCC----------------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence 7766555444331100 012347889999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
|
T Consensus 256 ~ 256 (256)
T cd08220 256 C 256 (256)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=260.37 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=157.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++.+.. ...+|+||||+++ +|.+.+. ..+.+++..++.++.|++.||+|||+ .|++|+
T Consensus 61 ~~l~h~~ii~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 130 (267)
T cd06645 61 KDCKHSNIVAYFGSYLR-----RDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHR 130 (267)
T ss_pred HhCCCCCeeeEEEEEEe-----CCEEEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 56799999999998843 3348899999995 6666554 34679999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++ .++.++|+|||++....... ......|++.|+|||++. ....++.++|+||+||++|+|++|..||
T Consensus 131 dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~ 209 (267)
T cd06645 131 DIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred CCCHHHEEEC-CCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCc
Confidence 9999999998 57789999999987553322 223457899999999874 2334788999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
...........+.... ...+.. . ....++..+.++|.+||+.+|++|||++++++|
T Consensus 210 ~~~~~~~~~~~~~~~~-----------------~~~~~~-----~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 210 FDLHPMRALFLMTKSN-----------------FQPPKL-----K--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccchhhHHhhhccC-----------------CCCCcc-----c--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 7665443333222110 000000 0 001367889999999999999999999999999
Q ss_pred CC
Q 022500 238 PF 239 (296)
Q Consensus 238 p~ 239 (296)
||
T Consensus 266 ~~ 267 (267)
T cd06645 266 PF 267 (267)
T ss_pred CC
Confidence 98
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=256.87 Aligned_cols=202 Identities=28% Similarity=0.462 Sum_probs=160.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... .++|+++||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ .+++||
T Consensus 53 ~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~ 123 (256)
T cd06612 53 KQCDSPYIVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHR 123 (256)
T ss_pred HhCCCCcEeeeeeeeecC-----CcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccC
Confidence 567999999999998543 448999999995 66665542 34568999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++ .++.++|+|||++....... ......++..|+|||++.+. .++.++|+||+|+++|+|++|..||..
T Consensus 124 dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 124 DIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred CCCcceEEEC-CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 47789999999998664432 22334578899999998654 589999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.........+.... .+. ...+..++.++.++|.+||+.||.+|||+.++++|||
T Consensus 202 ~~~~~~~~~~~~~~-------------------~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 202 IHPMRAIFMIPNKP-------------------PPT-------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred cchhhhhhhhccCC-------------------CCC-------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 65543332211100 000 0011236789999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
|
T Consensus 256 ~ 256 (256)
T cd06612 256 I 256 (256)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.70 Aligned_cols=202 Identities=27% Similarity=0.439 Sum_probs=160.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++++.. ...+|+|+||++| +|.+.+. ....+++..+..++.|++.||+|||+ .+++|
T Consensus 56 l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H 125 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLD-----DNTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVH 125 (265)
T ss_pred HHhcCCCCEeeEeeEeec-----CCeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 357899999999999843 3458999999985 6655554 34568999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+||++|+|++
T Consensus 126 ~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~ 203 (265)
T cd06631 126 RDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMAT 203 (265)
T ss_pred CCcCHHhEEEC-CCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHh
Confidence 99999999998 57889999999987542211 1123457889999999865 458899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||...+.......+....+. ....+..++.++.++|++||..+|.+||++.
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 257 (265)
T cd06631 204 GKPPLASMDRLAAMFYIGAHRGL--------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSAL 257 (265)
T ss_pred CCCccccCChHHHHHHhhhccCC--------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHH
Confidence 99999876655443333221110 0012235789999999999999999999999
Q ss_pred HHhcCCCc
Q 022500 233 EACAHPFF 240 (296)
Q Consensus 233 e~l~hp~f 240 (296)
++++||||
T Consensus 258 ~~l~~~~~ 265 (265)
T cd06631 258 QLLRHDFL 265 (265)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=257.27 Aligned_cols=206 Identities=26% Similarity=0.439 Sum_probs=166.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-----hC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-----TV 74 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH-----~~ 74 (296)
|++++||||+++++++... ....+|++|||++ ++|.+.+.........+++..+..++.||+.||.||| +
T Consensus 53 l~~l~~~~i~~~~~~~~~~---~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~- 128 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDR---SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG- 128 (265)
T ss_pred HHhcCCCccceeeeeeecC---CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-
Confidence 4578999999999977532 2334789999998 5787777765555678999999999999999999999 8
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
.+++|+||||+||+++ .++.+||+|||++........ .....+++.|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus 129 ~~i~h~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g 206 (265)
T cd08217 129 NTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCAL 206 (265)
T ss_pred CcceecCCCHHHEEEe-cCCCEEEecccccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHC
Confidence 6999999999999999 578899999999987654432 3345789999999998654 488999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
..||...+..+....+.... . ..++...+.++.+++.+||+.+|.+|||+.+
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 207 SPPFTARNQLQLASKIKEGK-------------------F---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred CCcccCcCHHHHHHHHhcCC-------------------C---------CCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 99998877544433332210 0 0122347889999999999999999999999
Q ss_pred HhcCCCc
Q 022500 234 ACAHPFF 240 (296)
Q Consensus 234 ~l~hp~f 240 (296)
+++|||+
T Consensus 259 il~~~~~ 265 (265)
T cd08217 259 LLQLPLI 265 (265)
T ss_pred HhhCCCC
Confidence 9999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.95 Aligned_cols=204 Identities=26% Similarity=0.444 Sum_probs=161.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++.+... ...|+||||+.| +|.+.+.. ..+++..+..++.|++.||.|||+ .||+|
T Consensus 71 l~~~~h~~v~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H 139 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIH 139 (296)
T ss_pred HHhCCCCCEeeEEEEEEeC-----CEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 3567999999999988543 348999999985 66665542 458899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++........ .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 140 ~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~ 217 (296)
T cd06654 140 RDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (296)
T ss_pred CCCCHHHEEEc-CCCCEEECccccchhccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 577899999999876533222 223467889999999865 457899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+.......+... +.+. ...+..++..+.+++.+||..+|++|||+.++++||
T Consensus 218 ~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 218 NENPLRALYLIATN-GTPE-------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred CCCHHHhHHHHhcC-CCCC-------------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 77654433322210 1100 001234788999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||...
T Consensus 272 ~~~~~ 276 (296)
T cd06654 272 FLKIA 276 (296)
T ss_pred hhhcc
Confidence 99864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.38 Aligned_cols=198 Identities=28% Similarity=0.436 Sum_probs=156.3
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++.+... ..+|+||||++ ++|.+.+.. ...+++..++.++.|++.||.|||+ .|++|||||
T Consensus 67 ~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~ 136 (267)
T PHA03390 67 DNPNFIKLYYSVTTL-----KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIK 136 (267)
T ss_pred cCCCEEEEEEEEecC-----CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCC
Confidence 699999999998543 35899999998 577766653 3479999999999999999999999 699999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 163 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 163 (296)
|+||+++..++.++|+|||++...... ....++..|+|||++.+. .++.++|+||+|+++|+|++|..||......
T Consensus 137 p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 137 LENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred HHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 999999854438999999998765322 234678899999999654 5899999999999999999999999865433
Q ss_pred HH-HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-HHHHhcCCCcc
Q 022500 164 DQ-LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFD 241 (296)
Q Consensus 164 ~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-~~e~l~hp~f~ 241 (296)
.. ...+...... .......+++.+.+||.+||+.||.+|++ ++++++||||+
T Consensus 213 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 213 ELDLESLLKRQQK--------------------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hhhHHHHHHhhcc--------------------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 21 1111111000 00112247999999999999999999996 59999999997
Q ss_pred c
Q 022500 242 E 242 (296)
Q Consensus 242 ~ 242 (296)
.
T Consensus 267 ~ 267 (267)
T PHA03390 267 I 267 (267)
T ss_pred C
Confidence 3
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.03 Aligned_cols=202 Identities=27% Similarity=0.413 Sum_probs=163.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ..+|+|+||+++ +|.+.+.. ..+++..+..++.|++.||.|||+ ++++||
T Consensus 54 ~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~ 122 (274)
T cd06609 54 SQCRSPYITKYYGSFLKG-----SKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHR 122 (274)
T ss_pred HHcCCCCeeeeeEEEEEC-----CeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 567899999999988533 458999999985 66655542 378999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++ .++.++|+|||++...... .......+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+
T Consensus 123 dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 123 DIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred CCCHHHEEEC-CCCCEEEcccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999999 4788999999999876543 2233456788999999997654 89999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCC-CCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
.+.......+..... ..... .+++++.+++.+||..+|++|||++++++||
T Consensus 201 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 201 LHPMRVLFLIPKNNP----------------------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred CchHHHHHHhhhcCC----------------------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 765544433322100 00111 2688999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||.+..
T Consensus 253 ~~~~~~ 258 (274)
T cd06609 253 FIKKAK 258 (274)
T ss_pred hhcCCC
Confidence 998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=264.44 Aligned_cols=230 Identities=28% Similarity=0.469 Sum_probs=162.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ..++|+||||++| +|.+.+.. ...+++..++.++.|++.||.|||+..+++|
T Consensus 53 l~~l~h~~iv~~~~~~~~-----~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H 123 (308)
T cd06615 53 LHECNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMH 123 (308)
T ss_pred HHhCCCCCCCeEEEEEee-----CCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEE
Confidence 356899999999999843 3358999999985 66666553 3678999999999999999999997238999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++...... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||..
T Consensus 124 ~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 124 RDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred CCCChHHEEEe-cCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998 4778999999998765332 22345788999999998654 588999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCH-HHH-hhcCcCCcC-cc-C------CCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTR-EEI-RCMNPNYTD-FR-F------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~-~~~-~~~~~~~~~-~~-~------~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
.+.... ..+......... ... ......... .. . ...........-...++.++++|+.+||..||++||
T Consensus 201 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 279 (308)
T cd06615 201 PDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279 (308)
T ss_pred cchhhH-HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc
Confidence 664332 222221110000 000 000000000 00 0 000000000001113678999999999999999999
Q ss_pred CHHHHhcCCCcccc
Q 022500 230 TALEACAHPFFDEL 243 (296)
Q Consensus 230 t~~e~l~hp~f~~~ 243 (296)
|+.++++||||.+.
T Consensus 280 t~~~ll~~~~~~~~ 293 (308)
T cd06615 280 DLKELTKHPFIKRA 293 (308)
T ss_pred CHHHHhcChhhhhc
Confidence 99999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=253.32 Aligned_cols=211 Identities=26% Similarity=0.420 Sum_probs=159.7
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
.|+||++++++| +++..+|||||-+.| .|+.-+. .+.-|++.++..++.+|+.||.|||. +||.|||+|
T Consensus 134 gh~nilqLiefF-----Edd~~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlK 203 (463)
T KOG0607|consen 134 GHKNILQLIEFF-----EDDTRFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLK 203 (463)
T ss_pred CCccHHHHHHHh-----cccceEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCC
Confidence 599999999999 444459999999996 5444333 45679999999999999999999999 899999999
Q ss_pred CCcEEEcCCC--CcEEEeeccCccccccC--------CCccceeecccccCchhcc----CCCCCCchhHHHHHHHHHHH
Q 022500 84 PQNLLVDPLT--HQVKICDFGSAKQLIAG--------EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 84 p~Nill~~~~--~~vkl~Dfg~a~~~~~~--------~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ 149 (296)
|+|||...-+ .-||||||.+...+... ....+.+|+-.|||||+.. ....|+.+.|.||||||+|.
T Consensus 204 PENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYI 283 (463)
T KOG0607|consen 204 PENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYI 283 (463)
T ss_pred ccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHH
Confidence 9999985322 25899999887643211 1224567888999999962 23458999999999999999
Q ss_pred HHhCCCCCCCCChH-----------HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHH
Q 022500 150 LLLGQPLFPGENAV-----------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 218 (296)
Q Consensus 150 ll~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 218 (296)
|++|.+||.|.=.. .-.+.+++.. .+ ..+.+|+ . -+..+|.+++|+++
T Consensus 284 mLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI--------QE-----GkYeFPd---k-----dWahIS~eakdlis 342 (463)
T KOG0607|consen 284 MLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI--------QE-----GKYEFPD---K-----DWAHISSEAKDLIS 342 (463)
T ss_pred HHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH--------hc-----cCCcCCh---h-----hhHHhhHHHHHHHH
Confidence 99999999875211 1122222211 11 1112222 1 12458999999999
Q ss_pred cccccCCCCCCCHHHHhcCCCcccccCC
Q 022500 219 RLLQYSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 219 ~~L~~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
++|..++.+|.++..+++|||+......
T Consensus 343 nLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 343 NLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHhccHHhhhhhhhccCCccccccchh
Confidence 9999999999999999999999987554
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=262.80 Aligned_cols=206 Identities=25% Similarity=0.479 Sum_probs=157.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++.+... ...++||||++++..... ..+++..+..++.|++.||.|||+ .||+|+
T Consensus 53 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 119 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVE-----NRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHR 119 (279)
T ss_pred HHhCCCCCeeeEEEEEEEC-----CEEEEEEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeC
Confidence 3578999999999998543 348899999997533222 347888999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.++|+|||++...... ......++..|+|||++.+. .++.++|+||+||++|+|++|..||...
T Consensus 120 dlkp~Nill~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 120 DVKPSNMLVN-TRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCCHHHEEEC-CCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 9999999999 4788999999999765432 23345789999999999654 5899999999999999999999999653
Q ss_pred ChHHH---HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQ---LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
..... .....+...... .+ .......++++++++.+||+.||.+||+++++++|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~---------------~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 197 QKNQGSLMPLQLLQCIVDED---------------PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cccccccchHHHHHHHhccC---------------CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 21110 001111000000 00 00112368899999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||.....
T Consensus 254 ~~~~~~~~ 261 (279)
T cd06619 254 PFIVQYND 261 (279)
T ss_pred cccccccC
Confidence 99987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=259.89 Aligned_cols=206 Identities=29% Similarity=0.523 Sum_probs=160.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++. +...+++|+||+.| +|.+.+. ....+++..+..++.|++.||.|||+ +|++|
T Consensus 57 l~~l~h~~iv~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H 126 (268)
T cd06630 57 MARLNHPHIIRMLGATC-----EDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE-NQIIH 126 (268)
T ss_pred HHHcCCCceehhhceec-----cCCeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 35689999999999984 34458899999995 6666554 34578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
+||+|+||+++..+..+||+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++|+|++|.
T Consensus 127 ~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 205 (268)
T cd06630 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAK 205 (268)
T ss_pred CCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCC
Confidence 999999999985555799999999876643211 1234578899999998654 5889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||...........+.+.... .....++..+++++.+++.+||..+|++|||+.++
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 206 PPWNAEKHSNHLALIFKIASA------------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred CCCCCCCCcchHHHHHHHhcc------------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 999765433322222221000 00011223478999999999999999999999999
Q ss_pred hcCCCcc
Q 022500 235 CAHPFFD 241 (296)
Q Consensus 235 l~hp~f~ 241 (296)
++||||+
T Consensus 262 l~~~~~~ 268 (268)
T cd06630 262 LKHPVFR 268 (268)
T ss_pred hcCcccC
Confidence 9999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.10 Aligned_cols=209 Identities=28% Similarity=0.405 Sum_probs=163.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++.+.. ....|+|||+++| +|.+.+... .....+++..+..++.|++.||.|||+ .|++|
T Consensus 53 l~~l~~~~i~~~~~~~~~-----~~~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h 125 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVV-----GDELWLVMPYLSGGSLLDIMKSS-YPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIH 125 (267)
T ss_pred HHhcCCCCEEEEEEEEee-----CCEEEEEEeccCCCcHHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 357899999999998843 3348899999985 666665532 112568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc-----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||+|+||+++. ++.++|+|||++......... ....++..|+|||.+.....++.++|+||+||++|+|++|.
T Consensus 126 ~~l~p~ni~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~ 204 (267)
T cd06610 126 RDIKAGNILLGE-DGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204 (267)
T ss_pred CCCCHHhEEEcC-CCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC
Confidence 999999999994 678999999998766443222 23467889999999876546889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||...+....+.++.... .+ . .+. ......+++++.+++.+||+.||++|||+.++
T Consensus 205 ~p~~~~~~~~~~~~~~~~~-~~----------~-----~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 261 (267)
T cd06610 205 APYSKYPPMKVLMLTLQND-PP----------S-----LET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261 (267)
T ss_pred CCccccChhhhHHHHhcCC-CC----------C-----cCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9998776655554443310 00 0 000 00013478999999999999999999999999
Q ss_pred hcCCCc
Q 022500 235 CAHPFF 240 (296)
Q Consensus 235 l~hp~f 240 (296)
++||||
T Consensus 262 l~~p~~ 267 (267)
T cd06610 262 LKHKFF 267 (267)
T ss_pred hhCCCC
Confidence 999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=254.81 Aligned_cols=202 Identities=35% Similarity=0.540 Sum_probs=161.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. ...+|+|+||++| +|.+.+. ....+++..+..++.|++.||+|||+ .|++|
T Consensus 56 l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 125 (258)
T cd06632 56 LSKLQHPNIVQYLGTERE-----EDNLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVH 125 (258)
T ss_pred HHhcCCCCchheeeeEec-----CCeEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 356799999999998743 3448899999985 6665554 34568999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
+||+|+||+++ .++.+||+|||++.............++..|++||.+.....++.++|+||+||++|+|++|..||..
T Consensus 126 ~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 126 RDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred CCCCHHHEEEC-CCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 99999999998 47789999999988664443334566788999999986543488999999999999999999999977
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.........+......+ .++..+++++.+++++||+.+|.+||++.+++.|||
T Consensus 205 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 205 LEGVAAVFKIGRSKELP---------------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred CcHHHHHHHHHhcccCC---------------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 66444443332211100 122347899999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
+
T Consensus 258 ~ 258 (258)
T cd06632 258 V 258 (258)
T ss_pred C
Confidence 6
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=257.08 Aligned_cols=203 Identities=28% Similarity=0.471 Sum_probs=157.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ....+++++||+++ +|.+.+. ....+++..+..++.|++.||+|||+ .+++|
T Consensus 58 l~~l~h~~i~~~~~~~~~~---~~~~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H 129 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDR---AEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS-NMIVH 129 (266)
T ss_pred HHHcCCCCeeeEEEEEEcC---CCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3568999999999987532 22357899999985 6666654 33568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC----CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.+||+|||++....... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus 130 ~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~ 207 (266)
T cd06651 130 RDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKP 207 (266)
T ss_pred CCCCHHHEEEC-CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCC
Confidence 99999999998 47789999999987543211 11234578889999999664 58899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||...........+...... ..++..+++.+.+++ +||..+|++||+++|++
T Consensus 208 pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 208 PWAEYEAMAAIFKIATQPTN---------------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred CccccchHHHHHHHhcCCCC---------------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 99876554444332211000 012234688899999 67778999999999999
Q ss_pred cCCCcc
Q 022500 236 AHPFFD 241 (296)
Q Consensus 236 ~hp~f~ 241 (296)
+||||+
T Consensus 260 ~hp~~~ 265 (266)
T cd06651 260 RHPFAQ 265 (266)
T ss_pred cCcccc
Confidence 999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=272.48 Aligned_cols=207 Identities=29% Similarity=0.479 Sum_probs=163.4
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.-+++.||+||-.| +++..+|+||||++| ++..+|. ..+.|.|..+++|+.++.+|+++.|.+ |+||||
T Consensus 685 EADn~WVVrLyySF-----QDkdnLYFVMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm-GFIHRD 754 (1034)
T KOG0608|consen 685 EADNEWVVRLYYSF-----QDKDNLYFVMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM-GFIHRD 754 (1034)
T ss_pred hcCCcceEEEEEEe-----ccCCceEEEEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc-cceecc
Confidence 34688999999888 555669999999995 6555554 458899999999999999999999996 999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccc---------cCC----------------------------------Cccceee
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLI---------AGE----------------------------------ANISYIC 118 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~---------~~~----------------------------------~~~~~~~ 118 (296)
|||+|||+| .+|.+||+|||+|..+. .+. .....+|
T Consensus 755 iKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvg 833 (1034)
T KOG0608|consen 755 IKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVG 833 (1034)
T ss_pred cCccceEEc-cCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcC
Confidence 999999999 57889999999995320 000 0013489
Q ss_pred cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCC
Q 022500 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKA 198 (296)
Q Consensus 119 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (296)
|+.|+|||++.. ..|+...|+||.|||+|+|+.|++||......+...++++. .++..
T Consensus 834 t~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw-------------~~~l~-------- 891 (1034)
T KOG0608|consen 834 TPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW-------------RNFLH-------- 891 (1034)
T ss_pred CCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh-------------hhccc--------
Confidence 999999999975 45999999999999999999999999888766655554431 11111
Q ss_pred CCcccccCCCCCHHHHHHHHcccccCCCCCCC---HHHHhcCCCcccccCCC
Q 022500 199 HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPN 247 (296)
Q Consensus 199 ~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---~~e~l~hp~f~~~~~~~ 247 (296)
......+++++.++|.++. .+++.|+. ++++..||||+.+....
T Consensus 892 ----~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 892 ----IPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred ----cccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHh
Confidence 1122468999999999865 47888984 67899999999987654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=254.14 Aligned_cols=202 Identities=31% Similarity=0.495 Sum_probs=164.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++++.. ...+++||||++ ++|.+.+... ....+++..+..++.|++.||.|||+ .|++|
T Consensus 53 l~~~~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h 124 (256)
T cd08221 53 LSLLQHPNIIAYYNHFMD-----DNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILH 124 (256)
T ss_pred HHhCCCCCeeEEEeEEec-----CCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 467899999999999954 345889999998 4777766532 24568999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||+|+||+++ .++.+||+|||++....... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.
T Consensus 125 ~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 125 RDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred cCCChHhEEEe-CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 99999999999 47789999999987653332 22345678999999998654 47899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+....+....+... .... ....++.++.+++.+||..+|.+||++.++++||
T Consensus 203 ~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 203 ATNPLNLVVKIVQG--NYTP--------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCHHHHHHHHHcC--CCCC--------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 87776666655431 1000 0124688999999999999999999999999999
Q ss_pred Cc
Q 022500 239 FF 240 (296)
Q Consensus 239 ~f 240 (296)
|+
T Consensus 255 ~l 256 (256)
T cd08221 255 LL 256 (256)
T ss_pred CC
Confidence 86
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.31 Aligned_cols=236 Identities=20% Similarity=0.294 Sum_probs=163.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.. ..++|+|+||+.+ ++.+.+.... ...+++..++.++.|++.||+|||+ +|++||
T Consensus 54 ~~l~h~niv~~~~~~~~-----~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHr 125 (328)
T cd08226 54 HFFRHPNIMTSWTVFTT-----GSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHR 125 (328)
T ss_pred HhCCCCCcceEeeeEec-----CCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 45899999999999854 3348899999994 7776666432 2458999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc--------cceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--------ISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll 151 (296)
||||+||+++ .++.++++||+.+......... ....++..|+|||++.+. ..++.++|+||+||++|+|+
T Consensus 126 Dlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~ 204 (328)
T cd08226 126 NIKASHILIS-GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204 (328)
T ss_pred CCCHHHEEEe-CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999998 4778999999865432211110 112235669999998653 34789999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCHH---------HHhhcCcCCcC----ccC-----CCCCCCCcccccCCCCCHHH
Q 022500 152 LGQPLFPGENAVDQLVEIIKVLGTPTRE---------EIRCMNPNYTD----FRF-----PQIKAHPWHKVFHKRMPPEA 213 (296)
Q Consensus 152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------~~~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~ 213 (296)
+|..||.+..........+......... ........+.. ... .......+........++++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (328)
T cd08226 205 TGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF 284 (328)
T ss_pred hCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHH
Confidence 9999998877655544443321110000 00000000000 000 00000011111223467889
Q ss_pred HHHHHcccccCCCCCCCHHHHhcCCCcccccCC
Q 022500 214 IDLASRLLQYSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 214 ~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
.+||++||+.||.+|||++++++||||+.+...
T Consensus 285 ~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 285 QNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 999999999999999999999999999887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=274.08 Aligned_cols=207 Identities=30% Similarity=0.540 Sum_probs=173.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|..++||.||.+...|.+... +++|||.+.|++++.+-. ...+++++...+.++.||+.||+|||- ++|+|+
T Consensus 617 Lq~l~HPGiV~le~M~ET~er-----vFVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHC 688 (888)
T KOG4236|consen 617 LQNLHHPGIVNLECMFETPER-----VFVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHC 688 (888)
T ss_pred HHhcCCCCeeEEEEeecCCce-----EEEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeec
Confidence 457899999999999865554 889999999998887753 466889999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCC--CcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLT--HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+|||+...+ ..+||||||+|+.+.+..-..+.+|||.|.|||++... .|...-|+||+|||+|.-++|..||.
T Consensus 689 DLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 689 DLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred cCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCC
Confidence 9999999997433 37999999999998777777889999999999999765 59999999999999999999999997
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
...+. -.+|-+ ..+.+ ...+| +.+++++.|||.++|++.=++|.+++..+.||
T Consensus 768 EdEdI--ndQIQN-----------------AaFMy---Pp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 768 EDEDI--NDQIQN-----------------AAFMY---PPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred Cccch--hHHhhc-----------------ccccc---CCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 65322 112211 11112 22344 34899999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
|++++
T Consensus 821 Wlq~y 825 (888)
T KOG4236|consen 821 WLQDY 825 (888)
T ss_pred hhhcc
Confidence 99875
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=261.49 Aligned_cols=206 Identities=27% Similarity=0.459 Sum_probs=161.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. ..+.|+||||++| +|.+.+.. ..+++..+..++.|++.||.|||+ .|++|
T Consensus 70 l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H 138 (297)
T cd06656 70 MRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIH 138 (297)
T ss_pred HHhCCCCCEeeEEEEEec-----CCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 356899999999999843 3358899999985 66555532 458899999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||.
T Consensus 139 ~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 139 RDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred CCCCHHHEEEC-CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 578899999999876533322 223467889999999865 458899999999999999999999997
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+.......+.. .+.+. ...+..++..+.+|+.+||..||.+||++.++++||
T Consensus 217 ~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 217 NENPLRALYLIAT-NGTPE-------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred CCCcchheeeecc-CCCCC-------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 7654332221111 01110 001234788999999999999999999999999999
Q ss_pred CcccccC
Q 022500 239 FFDELRE 245 (296)
Q Consensus 239 ~f~~~~~ 245 (296)
||+..+.
T Consensus 271 ~~~~~~~ 277 (297)
T cd06656 271 FLKLAKP 277 (297)
T ss_pred hhccccc
Confidence 9987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=255.99 Aligned_cols=205 Identities=27% Similarity=0.396 Sum_probs=160.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|++|||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ .|++|
T Consensus 54 l~~~~h~~i~~~~~~~~~-----~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h 124 (262)
T cd06613 54 LKECRHPNIVAYFGSYLR-----RDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIH 124 (262)
T ss_pred HHhCCCCChhceEEEEEe-----CCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCcee
Confidence 457899999999998844 3348999999996 55544442 23679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
+||+|+||+++ .++.+||+|||++....... ......++..|+|||.+.+. ..++.++|+||+|+++|+|++|.+|
T Consensus 125 ~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p 203 (262)
T cd06613 125 RDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203 (262)
T ss_pred cCCChhhEEEC-CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999 57889999999987654322 22345678899999998643 2578899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+.......+....-.+. . .......+.++.+++.+||..+|.+|||+.+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~-----------------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 204 MFDLHPMRALFLISKSNFPPP-----------------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCCCHHHHHHHHHhccCCCc-----------------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 988776555443322100000 0 0011235788999999999999999999999999
Q ss_pred CCC
Q 022500 237 HPF 239 (296)
Q Consensus 237 hp~ 239 (296)
|+|
T Consensus 260 ~~~ 262 (262)
T cd06613 260 HPF 262 (262)
T ss_pred CCC
Confidence 998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=260.69 Aligned_cols=208 Identities=31% Similarity=0.472 Sum_probs=162.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++.+. ...++|+||||++| +|.+.+. ..+.+++..+..++.|++.||+|||+ .|++|
T Consensus 55 l~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 124 (305)
T cd05609 55 LTFAENPFVVSMFCSFE-----TKRHLCMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHN-YGIVH 124 (305)
T ss_pred HHhCCCCCeeeeEEEEe-----cCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 35689999999999884 33458999999996 6666654 34578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC----------------CccceeecccccCchhccCCCCCCchhHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSA 143 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 143 (296)
|||||+||+++ .++.+||+|||+++...... ......++..|+|||.+.+ ..++.++|+||+
T Consensus 125 ~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl 202 (305)
T cd05609 125 RDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAM 202 (305)
T ss_pred cCCchHHEEEC-CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHH
Confidence 99999999998 57889999999986321000 0112356788999999865 458999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 144 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 144 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
||++|+|++|..||.+....+....+...... .+. ....++.++.++|.+||+.
T Consensus 203 G~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~ 256 (305)
T cd05609 203 GIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----------------WPE---------GDEALPADAQDLISRLLRQ 256 (305)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----------------CCC---------ccccCCHHHHHHHHHHhcc
Confidence 99999999999999887766555554431100 000 0013688999999999999
Q ss_pred CCCCCCC---HHHHhcCCCcccccCC
Q 022500 224 SPSLRCT---ALEACAHPFFDELREP 246 (296)
Q Consensus 224 ~p~~R~t---~~e~l~hp~f~~~~~~ 246 (296)
||++||+ +.++++||||...++.
T Consensus 257 ~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 257 NPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred ChhhccCccCHHHHHhCccccCCCHH
Confidence 9999998 7899999999776543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=259.94 Aligned_cols=207 Identities=27% Similarity=0.481 Sum_probs=163.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... ...|+|+||+++ +|...+. ...+++..+..++.|++.||.|||+ +|++|
T Consensus 72 l~~l~hp~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH 140 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIH 140 (297)
T ss_pred HHhCCCCchhhhhhheeeC-----CeEEEEEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 3568999999999988543 348899999995 5544433 2568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++....... ......++..|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 141 ~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 141 RDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred CCCCHHHeEEc-cCCcEEEeechhHhhcccccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 57889999999987553322 22345688999999999654 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+..+.+..+... +. .. ......++..+.++|++||+.+|.+||++.++++||
T Consensus 219 ~~~~~~~~~~~~~~---~~-----------~~------------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 219 SDSPVQAMKRLRDS---PP-----------PK------------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCCHHHHHHHHhcc---CC-----------CC------------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 87766555433221 00 00 001123688999999999999999999999999999
Q ss_pred CcccccCC
Q 022500 239 FFDELREP 246 (296)
Q Consensus 239 ~f~~~~~~ 246 (296)
||.....+
T Consensus 273 ~~~~~~~~ 280 (297)
T cd06659 273 FLLQTGLP 280 (297)
T ss_pred hhccCCCc
Confidence 99876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=256.92 Aligned_cols=215 Identities=26% Similarity=0.458 Sum_probs=162.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ....+|+||||++| +|.+.+.........+++..+..++.||+.||.|||+ .|++|
T Consensus 53 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H 128 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDE---SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIH 128 (287)
T ss_pred HHhCCCCCeeeeeeEEEcc---CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 4678999999999988542 23347899999985 7777666544455678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
+||+|+||+++ .++.++|+|||++....... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||..
T Consensus 129 ~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (287)
T cd06621 129 RDIKPSNILLT-RKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPP 205 (287)
T ss_pred CCCCHHHEEEe-cCCeEEEeeccccccccccc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 99999999998 47789999999987553322 123456888999999865 4589999999999999999999999976
Q ss_pred CCh-----HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 160 ENA-----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 160 ~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
... .+....+... .... .+.. .......++.+.++|.+||..||++|||+.|+
T Consensus 206 ~~~~~~~~~~~~~~~~~~----~~~~------------~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei 263 (287)
T cd06621 206 EGEPPLGPIELLSYIVNM----PNPE------------LKDE------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM 263 (287)
T ss_pred ccCCCCChHHHHHHHhcC----Cchh------------hccC------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHH
Confidence 622 2222111110 0000 0000 00001246789999999999999999999999
Q ss_pred hcCCCccccc
Q 022500 235 CAHPFFDELR 244 (296)
Q Consensus 235 l~hp~f~~~~ 244 (296)
+.||||+...
T Consensus 264 l~~~~~~~~~ 273 (287)
T cd06621 264 LEHPWIKAQM 273 (287)
T ss_pred HhCccccccc
Confidence 9999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=260.22 Aligned_cols=202 Identities=28% Similarity=0.436 Sum_probs=162.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++||||+++++++.... ..|+|+||+.|++.+.+.. ....+++..+..++.|++.||.|||+ .|++|||
T Consensus 70 ~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~d 140 (307)
T cd06607 70 QQLRHPNTIEYKGCYLREH-----TAWLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRD 140 (307)
T ss_pred HhCCCCCEEEEEEEEEeCC-----eEEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecC
Confidence 5689999999999985433 3889999999988776653 23568999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|+|+||+++ .++.++|+|||++...... ....+++.|+|||++.+ ...++.++||||+|+++|+|++|.+||.+
T Consensus 141 l~p~nIl~~-~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 141 IKAGNILLT-EPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred CCcccEEEC-CCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 999999999 5788999999998754322 34567889999998742 34578899999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+.......+... ..+. ......+.++.++|.+||+.||.+||++.+++.|||
T Consensus 217 ~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 217 MNAMSALYHIAQN-DSPT--------------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ccHHHHHHHHhcC-CCCC--------------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 7765554433221 0000 001235788999999999999999999999999999
Q ss_pred cccc
Q 022500 240 FDEL 243 (296)
Q Consensus 240 f~~~ 243 (296)
|..-
T Consensus 270 ~~~~ 273 (307)
T cd06607 270 VLRE 273 (307)
T ss_pred hccc
Confidence 9863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=256.63 Aligned_cols=205 Identities=26% Similarity=0.473 Sum_probs=163.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ...|+|+||+.| +|.+.+.. .++++..+..++.|++.||+|||+ +|++||
T Consensus 71 ~~~~h~~vv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~ 139 (285)
T cd06648 71 RDYQHPNIVEMYSSYLVG-----DELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHR 139 (285)
T ss_pred HHcCCCChheEEEEEEcC-----CeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 567999999999988533 348899999985 66655542 568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus 140 dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 140 DIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred CCChhhEEEc-CCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 9999999999 57889999999887543322 12335688999999998654 488999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+.......+... ..+. . .....++..+.+++++||+.+|++|||+.++++|||
T Consensus 218 ~~~~~~~~~~~~~-~~~~---------------~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 218 EPPLQAMKRIRDN-LPPK---------------L----------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred CCHHHHHHHHHhc-CCCC---------------C----------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 7766555544321 0000 0 001236889999999999999999999999999999
Q ss_pred cccccC
Q 022500 240 FDELRE 245 (296)
Q Consensus 240 f~~~~~ 245 (296)
|+..+.
T Consensus 272 ~~~~~~ 277 (285)
T cd06648 272 LAKAGP 277 (285)
T ss_pred cccCCC
Confidence 998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.98 Aligned_cols=204 Identities=25% Similarity=0.367 Sum_probs=156.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++.+... ..+|+||||+++ +|.+.+. ....+++..+..++.|++.||+|||+ .||+|
T Consensus 60 l~~~~h~~ii~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H 129 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSR-----EKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS-KGKMH 129 (267)
T ss_pred HHhcCCCCeeeeeEEEEeC-----CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 3568999999999988533 348899999995 6665554 34578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++ .++.+||+|||++....... ......+++.|+|||.+.+ ...++.++|+||+||++|+|++|..|
T Consensus 130 ~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p 208 (267)
T cd06646 130 RDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208 (267)
T ss_pred cCCCHHHEEEC-CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99999999998 57789999999998654322 2234567889999998742 33477899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|......+....+... .+..+.. .....++..+.+||++||+.+|++|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~-----------------~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 209 MFDLHPMRALFLMSKS-----------------NFQPPKL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred ccccchhhhheeeecC-----------------CCCCCCC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 9665433222211110 0000000 011246889999999999999999999999999
Q ss_pred CCC
Q 022500 237 HPF 239 (296)
Q Consensus 237 hp~ 239 (296)
|+|
T Consensus 265 ~l~ 267 (267)
T cd06646 265 HLF 267 (267)
T ss_pred CCC
Confidence 987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=253.83 Aligned_cols=204 Identities=28% Similarity=0.466 Sum_probs=156.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~--~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
++++||||+++++++.. ....++|+||+++ +|.+.+... ...+ ++..+..++.||+.||+|||+ +||+
T Consensus 60 ~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~ 130 (268)
T cd06624 60 SYLKHRNIVQYLGSDSE-----NGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIV 130 (268)
T ss_pred HhcCCCCeeeeeeeecc-----CCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEe
Confidence 56899999999998843 3458899999984 777666532 2334 788899999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||||+||+++...+.++|+|||.+........ .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..|
T Consensus 131 h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p 210 (268)
T cd06624 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210 (268)
T ss_pred ecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999985567899999999876533222 2234578899999998542 3478999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|................. ....++..+++++.+++.+||+.+|++|||+.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 211 FIELGEPQAAMFKVGMFK--------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CccccChhhhHhhhhhhc--------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 975432211110000000 001123457889999999999999999999999999
Q ss_pred CCCc
Q 022500 237 HPFF 240 (296)
Q Consensus 237 hp~f 240 (296)
||||
T Consensus 265 ~~~~ 268 (268)
T cd06624 265 DPFL 268 (268)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=253.42 Aligned_cols=206 Identities=33% Similarity=0.542 Sum_probs=159.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. ...+++||||+.| +|.+.+.. .+.+++..++.++.|++.||.|||+ +|++|
T Consensus 62 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H 131 (272)
T cd06629 62 LKDLDHLNIVQYLGFETT-----EEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILH 131 (272)
T ss_pred HHhcCCCCcceEEEEecc-----CCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeee
Confidence 457899999999998743 3348899999985 66666553 3678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||+|+||+++ .++.++++|||++....... ......++..|+|||.+.+.. .++.++|+||+|+++|++++|..
T Consensus 132 ~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 210 (272)
T cd06629 132 RDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210 (272)
T ss_pred cCCChhhEEEc-CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence 99999999999 57889999999987643221 122345788999999986543 47899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||......+....+...... ..........++.+++++|.+||..+|++|||+++++
T Consensus 211 p~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 211 PWSDEEAIAAMFKLGNKRSA-----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267 (272)
T ss_pred CCcCcchHHHHHHhhccccC-----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 99766544433322211000 0001112234789999999999999999999999999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
+||||
T Consensus 268 ~~~~~ 272 (272)
T cd06629 268 QHPFI 272 (272)
T ss_pred hCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=254.29 Aligned_cols=205 Identities=33% Similarity=0.557 Sum_probs=163.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++.+. .....|+|+||+.| +|.+.+.. ...+++..+..++.|++.||.|||+ +|++||
T Consensus 48 ~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~ 117 (265)
T cd05579 48 SQAQSPYVVKLYYSFQ-----GKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHR 117 (265)
T ss_pred HhCCCcchhHHHHhee-----cCcEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecC
Confidence 5678999999998874 34458999999985 76666653 3478999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC---------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
||+|+||+++ .++.++|+|||++....... ......++..|+|||...+. .++.++|+||+|+++|+++
T Consensus 118 di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~ 195 (265)
T cd05579 118 DLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFL 195 (265)
T ss_pred CCCHHHeEEc-CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHH
Confidence 9999999999 47789999999987543321 11234568889999998654 4889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 152 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
+|..||......+....+... .. ..+. ...++..+.+++.+||+.+|.+|||+
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~--~~---------------~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (265)
T cd05579 196 VGIPPFHGETPEEIFQNILNG--KI---------------EWPE----------DVEVSDEAIDLISKLLVPDPEKRLGA 248 (265)
T ss_pred hCCCCCCCCCHHHHHHHHhcC--Cc---------------CCCc----------cccCCHHHHHHHHHHhcCCHhhcCCC
Confidence 999999888766655544331 00 0000 01148899999999999999999999
Q ss_pred ---HHHhcCCCcccccC
Q 022500 232 ---LEACAHPFFDELRE 245 (296)
Q Consensus 232 ---~e~l~hp~f~~~~~ 245 (296)
.++++||||+++.|
T Consensus 249 ~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 249 KSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ccHHHHhcCccccCCCC
Confidence 99999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=255.26 Aligned_cols=203 Identities=27% Similarity=0.416 Sum_probs=161.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++.. ..++|+||||++| +|.+.+. ...+++..+..++.|++.||+|||+ .+++|
T Consensus 56 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH 124 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLK-----GTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIH 124 (277)
T ss_pred HHhCCCCCEeeEEEEEEE-----CCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccC
Confidence 356899999999999843 3458999999985 6665554 2468899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||+|+||+++ .++.++++|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus 125 ~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 125 RDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cCCChhhEEEc-CCCCEEEcccccceeccCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999 577899999999976543322 2234578889999998654 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..........+... .. ..+...++..+.+++.+||+.+|++||++.++++||
T Consensus 203 ~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 203 DMHPMRVLFLIPKN-NP---------------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CcChHhHhhhhhcC-CC---------------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 77654433322110 00 011223678899999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||....
T Consensus 255 ~~~~~~ 260 (277)
T cd06640 255 FIVKNA 260 (277)
T ss_pred Hhhhcc
Confidence 997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=251.89 Aligned_cols=202 Identities=25% Similarity=0.404 Sum_probs=163.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++. +..+.|+|+||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ +|++|
T Consensus 53 l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h 124 (256)
T cd08218 53 LSNMKHPNIVQYQESFE-----ENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILH 124 (256)
T ss_pred HHhCCCCCeeeeEeeec-----CCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 46789999999999883 34458999999985 77666653 123457899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||+|+||+++ .++.++++|||++........ .....+++.|+|||++.+. .++.++|+||+||++++|++|..||.
T Consensus 125 ~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 125 RDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred CCCCHHHEEEc-CCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCcc
Confidence 99999999998 477899999999976533221 1234578889999998654 48889999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+..+....+....- . ..+..++.++.++|.+||+.+|.+||++.++++||
T Consensus 203 ~~~~~~~~~~~~~~~~--~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 203 AGNMKNLVLKIIRGSY--P--------------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred CCCHHHHHHHHhcCCC--C--------------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence 8777666655543100 0 01234788999999999999999999999999999
Q ss_pred Cc
Q 022500 239 FF 240 (296)
Q Consensus 239 ~f 240 (296)
||
T Consensus 255 ~~ 256 (256)
T cd08218 255 FI 256 (256)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=257.48 Aligned_cols=203 Identities=29% Similarity=0.448 Sum_probs=163.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++... ...|+||||+.|++.+.+.. ....+++..+..++.|++.||.|||+ +|++||
T Consensus 75 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~ 145 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKE-----HTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHR 145 (313)
T ss_pred HHhCCCCCCccEEEEEEeC-----CEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 3568999999999998543 34889999999988777653 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||+|+||+++ .++.+||+|||++.... ......++..|+|||++.+ ...++.++|+||+||++|+|++|..||.
T Consensus 146 dl~p~nili~-~~~~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 146 DIKAGNILLT-EPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred CCChhhEEEC-CCCCEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999998 47789999999986432 2234567889999999842 2457889999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+.......+.... .+. .....++..+++|+.+||+.+|.+||++.+++.||
T Consensus 222 ~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 222 NMNAMSALYHIAQND-SPT--------------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred CCChHHHHHHHHhcC-CCC--------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 877666555443210 000 01123577899999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||...
T Consensus 275 ~~~~~ 279 (313)
T cd06633 275 FVRRD 279 (313)
T ss_pred ccCCC
Confidence 99864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=254.70 Aligned_cols=202 Identities=31% Similarity=0.579 Sum_probs=160.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCH 79 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~-~~~i~H 79 (296)
++++||||+++++.+... ..+++|+||++ ++|.+.+... ...+++..+..++.|++.||.|||+ . |++|
T Consensus 54 ~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H 124 (265)
T cd06605 54 HKCNSPYIVGFYGAFYNN-----GDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH-KIIH 124 (265)
T ss_pred HHCCCCchhhhheeeecC-----CEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC-Ceec
Confidence 567899999999988543 45899999999 5777666532 2678999999999999999999999 6 9999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
+||||+||+++. ++.++|+|||.+........ ....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..
T Consensus 125 ~dl~~~ni~~~~-~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~ 201 (265)
T cd06605 125 RDVKPSNILVNS-RGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPP 201 (265)
T ss_pred CCCCHHHEEECC-CCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 999999999994 77899999999876543222 226778899999998664 589999999999999999999999976
Q ss_pred CC-----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCC-CCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 160 EN-----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 160 ~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
.+ ..+....+... +. + ..+. .++++++++|.+||..||.+|||+.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~---~~----------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (265)
T cd06605 202 ENDPPDGIFELLQYIVNE---PP----------------P---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253 (265)
T ss_pred cccccccHHHHHHHHhcC---CC----------------C---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHH
Confidence 52 22222222210 00 0 0111 16889999999999999999999999
Q ss_pred HhcCCCcccc
Q 022500 234 ACAHPFFDEL 243 (296)
Q Consensus 234 ~l~hp~f~~~ 243 (296)
++.||||+.+
T Consensus 254 ll~~~~~~~~ 263 (265)
T cd06605 254 LLEHPFIKKY 263 (265)
T ss_pred HhhCchhhcc
Confidence 9999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=254.73 Aligned_cols=200 Identities=27% Similarity=0.461 Sum_probs=161.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++ .+...+|+|+||+.| +|.+.+.. ...+++..+..++.|++.||.|||+ +|++|
T Consensus 54 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h 123 (258)
T cd05578 54 LQELNHPFLVNLWYSF-----QDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIH 123 (258)
T ss_pred HHhCCCCChHHHHHhh-----cCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 3578999999999988 344458999999985 66555543 3578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
+||+|+||+++ .++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..
T Consensus 124 ~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 124 RDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred cCCCHHHeEEc-CCCCEEEeecccccccCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 99999999999 5788999999998876544333455678899999998654 489999999999999999999999987
Q ss_pred CCh--HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH--HHHh
Q 022500 160 ENA--VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA--LEAC 235 (296)
Q Consensus 160 ~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~--~e~l 235 (296)
.+. .+.+...... . ....+..++.++.++|.+||+.||.+|+++ .|++
T Consensus 202 ~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 202 HSRTIRDQIRAKQET-A---------------------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CCccHHHHHHHHhcc-c---------------------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 764 2222211110 0 011223468999999999999999999999 9999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
+||||
T Consensus 254 ~~~~~ 258 (258)
T cd05578 254 NHPYF 258 (258)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.84 Aligned_cols=203 Identities=29% Similarity=0.485 Sum_probs=158.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ....+|+||||++| +|.+.+. ....+++..+..++.|++.||+|||+ ++++|
T Consensus 58 l~~l~h~~i~~~~~~~~~~---~~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H 129 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDP---MERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS-NMIVH 129 (265)
T ss_pred HHhcCCCCeeeEEeEeccC---CCceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 3568999999999987432 12357899999985 6666554 33568899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC----CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
+||||+||+++ .++.++|+|||++....... ......++..|+|||++.+. .++.++|+||+||++|+|++|..
T Consensus 130 ~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~ 207 (265)
T cd06652 130 RDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKP 207 (265)
T ss_pred CCCCHHHEEec-CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCC
Confidence 99999999998 57889999999987543211 12234578899999998654 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||..........++... +. ....+..++..+.++|++|+. +|++||++++++
T Consensus 208 p~~~~~~~~~~~~~~~~---~~------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il 259 (265)
T cd06652 208 PWAEFEAMAAIFKIATQ---PT------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELL 259 (265)
T ss_pred CCCccchHHHHHHHhcC---CC------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHh
Confidence 99876544444333211 00 001223468899999999995 999999999999
Q ss_pred cCCCcc
Q 022500 236 AHPFFD 241 (296)
Q Consensus 236 ~hp~f~ 241 (296)
+|||+.
T Consensus 260 ~~~~~~ 265 (265)
T cd06652 260 RHTFVH 265 (265)
T ss_pred cCcccC
Confidence 999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=257.15 Aligned_cols=203 Identities=28% Similarity=0.429 Sum_probs=160.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++++.. ...+|+||||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +|++|
T Consensus 56 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH 124 (277)
T cd06642 56 LSQCDSPYITRYYGSYLK-----GTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIH 124 (277)
T ss_pred HHcCCCCccHhhhccccc-----CCceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeec
Confidence 357899999999998843 3448999999995 6555443 2568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||+|+||+++ .++.++++|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus 125 ~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 125 RDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cCCChheEEEe-CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999998 478899999999976543322 1234578889999998654 58899999999999999999999997
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..........+... . ........+.++.++|.+||+.+|.+|||+.++++||
T Consensus 203 ~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 203 DLHPMRVLFLIPKN-S---------------------------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ccchhhHHhhhhcC-C---------------------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 65543333221110 0 0011234678999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||....
T Consensus 255 ~~~~~~ 260 (277)
T cd06642 255 FITRYT 260 (277)
T ss_pred HHHHHh
Confidence 998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=255.08 Aligned_cols=201 Identities=23% Similarity=0.306 Sum_probs=158.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a 67 (296)
|++++||||+++++++... ...|++|||++ |+|.+.+..... ....+++..+..++.|++.|
T Consensus 62 l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~a 136 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAG 136 (283)
T ss_pred HHhcCCcccceEEEEEcCC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHH
Confidence 3568999999999988433 34889999998 577777754211 01458889999999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|.|||+ +|++||||||+||+++ .++.+||+|||++....... ......+++.|+|||.+.+. .++.++|+||+|
T Consensus 137 l~~lH~-~~i~H~dlkp~Nil~~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG 213 (283)
T cd05048 137 MEYLSS-HHFVHRDLAARNCLVG-EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFG 213 (283)
T ss_pred HHHHHh-CCeeccccccceEEEc-CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHH
Confidence 999999 7999999999999998 47789999999997653322 12234567889999998654 589999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
|++|+|++ |..||.+.+..+....+.+.... ..+..+++++.+|+.+||+.
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~ 265 (283)
T cd05048 214 VVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL----------------------------PCPEDCPARVYALMIECWNE 265 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccC
Confidence 99999998 99999888776655444321000 01234789999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 022500 224 SPSLRCTALEACAH 237 (296)
Q Consensus 224 ~p~~R~t~~e~l~h 237 (296)
||.+||++.+++++
T Consensus 266 ~p~~Rp~~~~i~~~ 279 (283)
T cd05048 266 IPARRPRFKDIHTR 279 (283)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=252.73 Aligned_cols=197 Identities=17% Similarity=0.213 Sum_probs=153.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ...|+||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +|++|
T Consensus 60 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH 130 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRG-----NTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVH 130 (266)
T ss_pred HhcCCCCCcCeEEEEEecC-----CCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEee
Confidence 4578999999999988533 348899999996 55555543 23578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCcc--ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+|++|||.+.......... ...++..|+|||++.+ ..++.++||||+||++|++++ |..|
T Consensus 131 ~dikp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p 208 (266)
T cd05064 131 KGLAAHKVLVN-SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred ccccHhhEEEc-CCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCC
Confidence 99999999998 47789999999876542221111 1234568999999865 458999999999999999775 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+.+..+.+.... ..+..++..+.+++.+||+.+|.+||+++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 209 YWDMSGQDVIKAVEDGFRL----------------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred cCcCCHHHHHHHHHCCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9888776655544321100 012346889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=265.01 Aligned_cols=200 Identities=22% Similarity=0.337 Sum_probs=153.2
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh--------------------------------
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------------------- 47 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-------------------------------- 47 (296)
+.+ +|||||++++++... ..+|+|||||. |+|.+.+.....
T Consensus 96 ~~l~~h~nIv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (374)
T cd05106 96 SHLGQHKNIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSD 170 (374)
T ss_pred HhhccCCceeeEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccc
Confidence 456 899999999988433 34889999999 587777653210
Q ss_pred ----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCC
Q 022500 48 ----------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 93 (296)
Q Consensus 48 ----------------------------------~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~ 93 (296)
...++++..++.++.||+.||.|||+ +||+||||||+||+++ .+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~-~~ 248 (374)
T cd05106 171 SGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLT-DG 248 (374)
T ss_pred ccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEe-CC
Confidence 11347888999999999999999999 7999999999999999 57
Q ss_pred CcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022500 94 HQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 169 (296)
Q Consensus 94 ~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 169 (296)
+.+||+|||+++........ ....++..|+|||++.+ ..++.++||||+||++|+|++ |..||...........+
T Consensus 249 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~ 327 (374)
T cd05106 249 RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327 (374)
T ss_pred CeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH
Confidence 88999999999765432211 11234567999999865 458999999999999999997 99999876544444333
Q ss_pred HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 170 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+.....+ ..+...++++.+++.+||+.||.+|||+.++++
T Consensus 328 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 328 VKRGYQM---------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcccCc---------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3311000 011236889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=253.37 Aligned_cols=209 Identities=25% Similarity=0.327 Sum_probs=161.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHT 73 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~------~~~~~~~~~~~~~~qil~aL~~LH~ 73 (296)
|+.++||||+++++++... ...|+||||+. |+|.+.+...... ...++...+..++.|++.||.|||+
T Consensus 63 l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA 137 (288)
T ss_pred HHhCCCCCeeeEEEEEcCC-----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3568999999999987433 34789999998 6888777653211 2345677889999999999999999
Q ss_pred CCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 74 ~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
++|+||||||+||+++ .++.++|+|||+++....... .....++..|+|||.+.+. .++.++|+||+||++|+|
T Consensus 138 -~~i~H~dikp~nili~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el 214 (288)
T cd05061 138 -KKFVHRDLAARNCMVA-HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred -CCCcCCCCChheEEEc-CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHH
Confidence 7999999999999999 578899999999875533221 1122346679999998654 589999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 151 LL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 151 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
++ |..||.+....+....+... +.+ ..+...++.+.+++.+||+.||++||
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRP 266 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCc
Confidence 98 78899887766555444321 000 01123678999999999999999999
Q ss_pred CHHHHhc------CCCcccccC
Q 022500 230 TALEACA------HPFFDELRE 245 (296)
Q Consensus 230 t~~e~l~------hp~f~~~~~ 245 (296)
|+.++++ ||||+++.+
T Consensus 267 s~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 267 TFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CHHHHHHHHHhhcCCCCCCCCC
Confidence 9999886 999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=255.58 Aligned_cols=207 Identities=20% Similarity=0.255 Sum_probs=153.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh---------------cCCCCCHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS---------------ANQRMPLIYVKLYTYQI 64 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~---------------~~~~~~~~~~~~~~~qi 64 (296)
|++++||||+++++++.... ..|+||||++ |+|.+.+..... ....+++..+..++.||
T Consensus 73 l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 147 (304)
T cd05096 73 LSRLKDPNIIRLLGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQI 147 (304)
T ss_pred HhhcCCCCeeEEEEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHH
Confidence 45789999999999985433 3889999998 577777654211 11346778899999999
Q ss_pred HHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHH
Q 022500 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIW 141 (296)
Q Consensus 65 l~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 141 (296)
+.||.|||+ .||+||||||+||+++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++|||
T Consensus 148 ~~al~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~ 224 (304)
T cd05096 148 ASGMKYLSS-LNFVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVW 224 (304)
T ss_pred HHHHHHHHH-CCccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhH
Confidence 999999999 7999999999999999 578899999999986533221 1123447789999998654 589999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHc
Q 022500 142 SAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 219 (296)
Q Consensus 142 slG~il~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 219 (296)
|+||++|+|++ +..||.+.+..+....+........ .. .....+..+++.+.+|+.+
T Consensus 225 slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------~~--------------~~~~~~~~~~~~~~~li~~ 283 (304)
T cd05096 225 AFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQG-------RQ--------------VYLFRPPPCPQGLYELMLQ 283 (304)
T ss_pred HHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcc-------cc--------------ccccCCCCCCHHHHHHHHH
Confidence 99999999986 5678877665554443322110000 00 0000122468899999999
Q ss_pred ccccCCCCCCCHHHHhc
Q 022500 220 LLQYSPSLRCTALEACA 236 (296)
Q Consensus 220 ~L~~~p~~R~t~~e~l~ 236 (296)
||+.||.+|||+.++.+
T Consensus 284 cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 284 CWSRDCRERPSFSDIHA 300 (304)
T ss_pred HccCCchhCcCHHHHHH
Confidence 99999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.26 Aligned_cols=206 Identities=27% Similarity=0.460 Sum_probs=162.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++.+.. ..+.|+||||+++ +|.+.+. ...+++..++.++.|++.||+|||+ .|++|
T Consensus 71 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH 139 (292)
T cd06657 71 MRDYQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIH 139 (292)
T ss_pred HHhcCCcchhheeeEEEe-----CCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 356899999999999843 3458899999996 5444332 2468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||+|+||+++ .++.++|+|||++........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.
T Consensus 140 ~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 140 RDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred CCCCHHHEEEC-CCCCEEEcccccceecccccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999 477899999999876543321 233567889999998854 458899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+....+....+..... + . . .....++..+.+++.+||+.||.+||++.++++||
T Consensus 218 ~~~~~~~~~~~~~~~~-~----------~-----~----------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~ 271 (292)
T cd06657 218 NEPPLKAMKMIRDNLP-P----------K-----L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 271 (292)
T ss_pred CCCHHHHHHHHHhhCC-c----------c-----c----------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcCh
Confidence 8766555443322100 0 0 0 00123688999999999999999999999999999
Q ss_pred CcccccC
Q 022500 239 FFDELRE 245 (296)
Q Consensus 239 ~f~~~~~ 245 (296)
||.....
T Consensus 272 ~~~~~~~ 278 (292)
T cd06657 272 FLAKAGP 278 (292)
T ss_pred HHhccCC
Confidence 9998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=250.38 Aligned_cols=203 Identities=27% Similarity=0.407 Sum_probs=161.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++.+. .....|+|+||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ .+++|
T Consensus 53 l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H 124 (257)
T cd08225 53 LAKMKHPNIVTFFASFQ-----ENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD-RKILH 124 (257)
T ss_pred HHhCCCCChhhhhheec-----cCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 35689999999999884 33458999999985 77666653 123457999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc-cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||||+||+++.++..+|++|||.+......... ....+++.|+|||++.+. .++.++|+||+|+++++|++|..||.
T Consensus 125 ~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred ccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999854456799999998765433221 234578899999998654 58899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+....+....- .......+.++.++|.+||..+|++|||+.++++||
T Consensus 204 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 204 GNNLHQLVLKICQGYF----------------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred CccHHHHHHHHhcccC----------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 7766555544332100 001124688999999999999999999999999999
Q ss_pred Cc
Q 022500 239 FF 240 (296)
Q Consensus 239 ~f 240 (296)
||
T Consensus 256 ~~ 257 (257)
T cd08225 256 FL 257 (257)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.55 Aligned_cols=202 Identities=25% Similarity=0.482 Sum_probs=162.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.... ..++|+||+++ +|...+..+......+++..++.++.|++.||.|||+ .|++|+
T Consensus 57 ~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~ 130 (260)
T cd08222 57 SKLDHPAIVKFHASFLERD-----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHR 130 (260)
T ss_pred HhCCCCcHHHHHHHHhcCC-----ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCcccc
Confidence 5689999999999885433 38899999985 7777776555556779999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++ ++.++|+|||++........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+
T Consensus 131 ~l~~~nili~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 131 DLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCChhheEee--cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999997 35699999999876543322 223457888999999854 4578899999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.........+... .. ...+..++.++.++|.+||..||++||++.++++|||
T Consensus 208 ~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 208 QNFLSVVLRIVEG--PT--------------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred ccHHHHHHHHHcC--CC--------------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 6655544443321 00 0012346889999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
|
T Consensus 260 ~ 260 (260)
T cd08222 260 I 260 (260)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=255.54 Aligned_cols=202 Identities=29% Similarity=0.422 Sum_probs=163.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.... ..|+||||+.|++.+.+.. ....+++..+..++.|++.||.|||+ +||+||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~ 149 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREH-----TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHR 149 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCC-----eEEEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccC
Confidence 35689999999999985433 3889999999988776653 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||+|+||+++ .++.+||+|||++..... .....+++.|+|||.+.+ ...++.++|+||+||++|+|++|..||.
T Consensus 150 dL~p~Nil~~-~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 150 DIKAGNILLT-EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CCCcccEEEC-CCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999998 477899999999865432 234567889999999742 2347889999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+.......+......+. .....++.+.+++.+||+.+|.+||++.++++|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 226 NMNAMSALYHIAQNESPTL---------------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CccHHHHHHHHHhccCCCC---------------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 8776666555544211000 0123678899999999999999999999999999
Q ss_pred Cccc
Q 022500 239 FFDE 242 (296)
Q Consensus 239 ~f~~ 242 (296)
|+..
T Consensus 279 ~~~~ 282 (317)
T cd06635 279 FVLR 282 (317)
T ss_pred hhhc
Confidence 9965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=253.92 Aligned_cols=200 Identities=23% Similarity=0.304 Sum_probs=156.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAY 70 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~---------~~~~~~~~~~~~~~~~qil~aL~~ 70 (296)
|++++||||+++++++.. ...+++||||++ ++|.+.+.... .....+++..+..++.|++.||+|
T Consensus 61 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~ 135 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVY 135 (288)
T ss_pred HHhCCCCCcceEEEEEec-----CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999998843 334889999998 57777665321 112358999999999999999999
Q ss_pred HHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 71 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 71 LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
||+ +|++||||||+||+++ .++.+||+|||++........ .....++..|+|||++.+ ..++.++|+||+||++
T Consensus 136 lH~-~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il 212 (288)
T cd05093 136 LAS-QHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVL 212 (288)
T ss_pred HHh-CCeeecccCcceEEEc-cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHH
Confidence 999 7999999999999998 578899999999986533221 112334678999999865 4589999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 148 AELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 148 ~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|+|++ |.+||.+....+....+...... ..+...+.++.+|+.+||+.||.
T Consensus 213 ~~l~t~g~~p~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~ 264 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNEVIECITQGRVL----------------------------QRPRTCPKEVYDLMLGCWQREPH 264 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHccCChh
Confidence 99998 89999887766655554431000 01124688999999999999999
Q ss_pred CCCCHHHHhc
Q 022500 227 LRCTALEACA 236 (296)
Q Consensus 227 ~R~t~~e~l~ 236 (296)
+|||+.++++
T Consensus 265 ~Rpt~~~v~~ 274 (288)
T cd05093 265 MRLNIKEIHS 274 (288)
T ss_pred hCCCHHHHHH
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=256.19 Aligned_cols=203 Identities=27% Similarity=0.417 Sum_probs=162.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++... ...++||||+.|++.+.+.. ....+++..+..++.|++.||.|||+ ++++||
T Consensus 69 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~ 139 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHR 139 (308)
T ss_pred HHhCCCCCcccEEEEEEcC-----CeeEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 3568999999999998543 34889999999987766653 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||+|+||+++ .++.++|+|||++...... ....+++.|+|||.+.+ ...++.++||||+||++|+|++|..||.
T Consensus 140 dl~p~nil~~-~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 140 DVKAGNILLS-EPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred CCCHHhEEEC-CCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 9999999998 4788999999998754322 24467889999999742 2347889999999999999999999997
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+..+....+..... +. ......+..+.++|++||+.+|.+||+++++++||
T Consensus 216 ~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 216 NMNAMSALYHIAQNES-PA--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cccHHHHHHHHhhcCC-CC--------------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 7665554444332100 00 01123688899999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
|+...
T Consensus 269 ~~~~~ 273 (308)
T cd06634 269 FVLRE 273 (308)
T ss_pred ccccc
Confidence 99874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=236.88 Aligned_cols=209 Identities=25% Similarity=0.353 Sum_probs=162.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--cc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VC 78 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i~ 78 (296)
++++||||++++++............||+++|.. |+|.+.+......+..+++..+..|+.+|+.||++||+ .. ..
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yA 151 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYA 151 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCccc
Confidence 5789999999999887665556667899999998 78999998877777789999999999999999999999 68 99
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCC----------ccceeecccccCchhccC--CCCCCchhHHHHHHHH
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----------NISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCV 146 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----------~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i 146 (296)
||||||.|||++ +.+.+++.|||.+....-.-. -....+|..|+|||.+.- ....+.++|||||||+
T Consensus 152 H~DiKP~NILls-~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCt 230 (302)
T KOG2345|consen 152 HRDIKPANILLS-DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCT 230 (302)
T ss_pred ccCCCcceeEec-CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHH
Confidence 999999999999 478899999999875421111 123467899999999832 2236899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 147 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 147 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
+|.|+.|..||.. +.+..|.... ...-..+.+|. ...+|+.+.++|++||++||.
T Consensus 231 LYa~mf~~sPfe~---------~~~~GgSlaL------Av~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~ 285 (302)
T KOG2345|consen 231 LYAMMFGESPFER---------IYQQGGSLAL------AVQNAQISIPN----------SSRYSEALHQLIKSMLQVDPN 285 (302)
T ss_pred HHHHHHcCCcchH---------HhhcCCeEEE------eeeccccccCC----------CCCccHHHHHHHHHHhcCCcc
Confidence 9999999999942 2222111110 00001111221 123799999999999999999
Q ss_pred CCCCHHHHhcC
Q 022500 227 LRCTALEACAH 237 (296)
Q Consensus 227 ~R~t~~e~l~h 237 (296)
+||++.+++.+
T Consensus 286 qRP~i~~ll~~ 296 (302)
T KOG2345|consen 286 QRPTIPELLSK 296 (302)
T ss_pred cCCCHHHHHHH
Confidence 99999999863
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=251.62 Aligned_cols=200 Identities=23% Similarity=0.308 Sum_probs=158.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh----------hcCCCCCHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS----------SANQRMPLIYVKLYTYQIFRGLA 69 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~----------~~~~~~~~~~~~~~~~qil~aL~ 69 (296)
|+.++||||+++++++... ...|+||||++ ++|.+.+.... .....+++..+..++.|++.||+
T Consensus 62 l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 136 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMV 136 (280)
T ss_pred HHhcCCCCchheeeEEecC-----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHH
Confidence 3568999999999998544 34899999998 57777775421 12345789999999999999999
Q ss_pred HHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHH
Q 022500 70 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 146 (296)
Q Consensus 70 ~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 146 (296)
|||+ +|++||||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++||||+||+
T Consensus 137 ~lH~-~~i~h~dlkp~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i 213 (280)
T cd05049 137 YLAS-QHFVHRDLATRNCLVG-YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVV 213 (280)
T ss_pred HHhh-CCeeccccccceEEEc-CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHH
Confidence 9999 7999999999999999 47889999999987543222 12233457789999998654 58999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 147 LAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 147 l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
+|+|++ |..||.+.+..+....+..... ...+...+..+.+++.+||+.||
T Consensus 214 l~e~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p 265 (280)
T cd05049 214 LWEIFTYGKQPWYGLSNEEVIECITQGRL----------------------------LQRPRTCPSEVYDIMLGCWKRDP 265 (280)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCc
Confidence 999998 9999988776665554432100 00112478899999999999999
Q ss_pred CCCCCHHHHhc
Q 022500 226 SLRCTALEACA 236 (296)
Q Consensus 226 ~~R~t~~e~l~ 236 (296)
.+|||+.|+++
T Consensus 266 ~~Rp~~~eil~ 276 (280)
T cd05049 266 QQRINIKDIHE 276 (280)
T ss_pred ccCCCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=247.65 Aligned_cols=198 Identities=18% Similarity=0.292 Sum_probs=155.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ..+|+||||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+ .|++|
T Consensus 53 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 123 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQ-----RPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIH 123 (256)
T ss_pred HhcCCCCCeeeEEEEEccC-----CCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 4678999999999988432 347899999985 66666543 23368999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
+||||+||+++ .++.+||+|||.++........ ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus 124 ~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p 201 (256)
T cd05113 124 RDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMP 201 (256)
T ss_pred cccCcceEEEc-CCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCC
Confidence 99999999998 4778999999998765332211 122345679999998654 48999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|......+....+.+.... ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 202 YERFNNSETVEKVSQGLRL----------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred cCcCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9877765555544331100 011235789999999999999999999999986
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
+
T Consensus 254 ~ 254 (256)
T cd05113 254 S 254 (256)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=251.03 Aligned_cols=201 Identities=22% Similarity=0.305 Sum_probs=155.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHT 73 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~------~~~~~~~~~~~~~~qil~aL~~LH~ 73 (296)
++.++||||+++++++. .....++||||++ |+|.+.+...... ...++...+..++.|++.||.|||+
T Consensus 63 l~~l~~~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (277)
T cd05062 63 MKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA 137 (277)
T ss_pred HHhCCCCCeeeEEEEEc-----CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35689999999999883 3334889999999 5777776542111 1235778899999999999999999
Q ss_pred CCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 74 ~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
.|++||||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .++.++|+||+||++|+|
T Consensus 138 -~~~vH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el 214 (277)
T cd05062 138 -NKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 214 (277)
T ss_pred -CCcccCCcchheEEEc-CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHH
Confidence 7999999999999999 578899999999875533221 1122446789999998654 589999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 151 LL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 151 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
++ |..||.+....+....+... +.+ ..+...+..+.+++.+||+.||++||
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05062 215 ATLAEQPYQGMSNEQVLRFVMEG-GLL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRP 266 (277)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 98 78999887766555444321 000 01234688999999999999999999
Q ss_pred CHHHHhcC
Q 022500 230 TALEACAH 237 (296)
Q Consensus 230 t~~e~l~h 237 (296)
|+.|++++
T Consensus 267 s~~e~l~~ 274 (277)
T cd05062 267 SFLEIISS 274 (277)
T ss_pred CHHHHHHH
Confidence 99999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=254.17 Aligned_cols=199 Identities=21% Similarity=0.283 Sum_probs=153.4
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHH
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~aL 68 (296)
++ +||||+++++++.. ...+|+||||++ ++|.+.+..... ....+++..++.++.|++.||
T Consensus 58 ~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 132 (297)
T cd05089 58 KLGHHPNIINLLGACEN-----RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGM 132 (297)
T ss_pred hhcCCCchhheEEEEcc-----CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHH
Confidence 45 79999999998843 334889999998 577777754211 113588999999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
+|||+ +|++||||||+||+++ .++.+||+|||++..............+..|+|||++.+. .++.++||||+||++|
T Consensus 133 ~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ 209 (297)
T cd05089 133 QYLSE-KQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLW 209 (297)
T ss_pred HHHHH-CCcccCcCCcceEEEC-CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHH
Confidence 99999 7999999999999998 4778999999998643221111112224569999998654 5899999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC
Q 022500 149 ELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 149 ~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~ 227 (296)
+|++ |..||.+....+....+...... ..+..++.++.+|+.+||+.+|.+
T Consensus 210 el~t~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~ 261 (297)
T cd05089 210 EIVSLGGTPYCGMTCAELYEKLPQGYRM----------------------------EKPRNCDDEVYELMRQCWRDRPYE 261 (297)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhh
Confidence 9997 99999888766655544321100 012347899999999999999999
Q ss_pred CCCHHHHhcC
Q 022500 228 RCTALEACAH 237 (296)
Q Consensus 228 R~t~~e~l~h 237 (296)
|||++++++.
T Consensus 262 Rp~~~~i~~~ 271 (297)
T cd05089 262 RPPFAQISVQ 271 (297)
T ss_pred CcCHHHHHHH
Confidence 9999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=247.59 Aligned_cols=203 Identities=30% Similarity=0.463 Sum_probs=165.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|||++++.+.+... ...++|+||+++ +|.+.+.........+++..+..++.|++.||.|||+ +|++|+
T Consensus 54 ~~l~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~ 127 (258)
T cd08215 54 KKLNHPNIIKYYESFEEK-----GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHR 127 (258)
T ss_pred HhcCCCChhheEEEEecC-----CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecc
Confidence 567899999999988543 458899999985 7777776543335779999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||..
T Consensus 128 dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~ 205 (258)
T cd08215 128 DIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEG 205 (258)
T ss_pred cCChHHeEEc-CCCcEEECCccceeecccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999 47889999999997654432 22345678899999998654 488999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+....+..... ..++..++.++.+++.+||..+|++|||+.++++|||
T Consensus 206 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 206 ENLLELALKILKGQY----------------------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred CcHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 775554444332110 0012247889999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
|
T Consensus 258 ~ 258 (258)
T cd08215 258 I 258 (258)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=246.08 Aligned_cols=203 Identities=29% Similarity=0.438 Sum_probs=164.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... ...|+|+||+++ +|.+.+.........+++..+..++.|++.||+|||+ .|++|
T Consensus 53 l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h 126 (256)
T cd08530 53 LASVNHPNIISYKEAFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILH 126 (256)
T ss_pred HHhCCCCCchhhhhhhccC-----CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCccc
Confidence 3578999999999998543 448899999985 7777776544445678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
+||+|+||+++. ++.+||+|||++...... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||..
T Consensus 127 ~~l~~~ni~~~~-~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~ 203 (256)
T cd08530 127 RDLKSANILLVA-NDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEA 203 (256)
T ss_pred CCCCcceEEEec-CCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999994 778999999999766443 33345678899999998654 588899999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+....+..... + ..+...+.++++++.+||+.+|.+|||+.++++||+
T Consensus 204 ~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 204 RSMQDLRYKVQRGKY-------------------P---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred CCHHHHHHHHhcCCC-------------------C---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 876554443322100 0 011246889999999999999999999999999998
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
+
T Consensus 256 ~ 256 (256)
T cd08530 256 V 256 (256)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=247.20 Aligned_cols=197 Identities=20% Similarity=0.295 Sum_probs=155.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++ |+|.+.+.. ..+.+++..+..++.|++.||+|||+ +|++|
T Consensus 53 l~~l~h~~i~~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 123 (256)
T cd05114 53 MMKLSHPKLVQLYGVCTQ-----QKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIH 123 (256)
T ss_pred HHHCCCCCceeEEEEEcc-----CCCEEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 467899999999998843 334889999998 567666543 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCcc--ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||.++......... ...++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..|
T Consensus 124 ~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p 201 (256)
T cd05114 124 RDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMP 201 (256)
T ss_pred cccCcceEEEc-CCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCC
Confidence 99999999998 57789999999987653322211 2234567999999865 458999999999999999999 8999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|...+..+.+..+.+.... ..+...+.++.+++.+||+.+|++||+++++++
T Consensus 202 ~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 202 FEKKSNYEVVEMISRGFRL----------------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCHHHHHHHHHCCCCC----------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9888776666655431000 011235788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=247.81 Aligned_cols=194 Identities=17% Similarity=0.204 Sum_probs=149.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.... ..++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 53 l~~~~h~~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH 123 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGD-----ESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTH 123 (258)
T ss_pred HHhCCCCChhheeeEEEeCC-----CcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 35789999999999985433 37899999985 66666543 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCC-------cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 80 RDLKPQNLLVDPLTH-------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 80 ~dlkp~Nill~~~~~-------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
|||||+||+++.++. .++++|||++...... ....++..|+|||++.+...++.++|+||+||++|+|++
T Consensus 124 ~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 200 (258)
T cd05078 124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200 (258)
T ss_pred CCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc
Confidence 999999999974332 2799999998754322 234678889999999765568899999999999999999
Q ss_pred CC-CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 GQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|. +||...+...... .... . ..++...+.++.+++.+||+.||++|||+
T Consensus 201 g~~~~~~~~~~~~~~~-~~~~-----------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 250 (258)
T cd05078 201 GGDKPLSALDSQKKLQ-FYED-----------------R------------HQLPAPKWTELANLINQCMDYEPDFRPSF 250 (258)
T ss_pred CCCCChhhccHHHHHH-HHHc-----------------c------------ccCCCCCcHHHHHHHHHHhccChhhCCCH
Confidence 85 6665554433222 1110 0 00122356789999999999999999999
Q ss_pred HHHhc
Q 022500 232 LEACA 236 (296)
Q Consensus 232 ~e~l~ 236 (296)
+++++
T Consensus 251 ~~il~ 255 (258)
T cd05078 251 RAIIR 255 (258)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=254.31 Aligned_cols=206 Identities=27% Similarity=0.428 Sum_probs=159.5
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
..||||+++++++.. ...+|+||||+++.+...+.. ....+++..+..++.|++.||+|||+..||+||||+
T Consensus 71 ~~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~ 142 (296)
T cd06618 71 HDCPYIVKCYGYFIT-----DSDVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVK 142 (296)
T ss_pred cCCCchHhhheeeec-----CCeEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCc
Confidence 369999999999854 334899999999877666554 235789999999999999999999972399999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|+||+++ .++.+||+|||++.............++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||...
T Consensus 143 p~nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 143 PSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred HHHEEEc-CCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999998 5788999999998765443333344577889999998643 23788999999999999999999999764
Q ss_pred Ch-HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 161 NA-VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 161 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.. .+.+..++.... + . .+ ....++.++.+|+.+||..||.+||++++++.|||
T Consensus 222 ~~~~~~~~~~~~~~~-~-------------~--~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 222 KTEFEVLTKILQEEP-P-------------S--LP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred hhHHHHHHHHhcCCC-C-------------C--CC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 32 233333322100 0 0 00 00136889999999999999999999999999999
Q ss_pred ccccc
Q 022500 240 FDELR 244 (296)
Q Consensus 240 f~~~~ 244 (296)
|....
T Consensus 276 ~~~~~ 280 (296)
T cd06618 276 IRRYE 280 (296)
T ss_pred hhccc
Confidence 98654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=249.35 Aligned_cols=190 Identities=27% Similarity=0.363 Sum_probs=150.1
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
..||||+++++++.. ...+|+||||++| +|.+.+.. ...+++..+..++.|++.||+|||+ .||+||||
T Consensus 42 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl 111 (237)
T cd05576 42 HCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDL 111 (237)
T ss_pred cCCCceeehhhheec-----CCeEEEEEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCC
Confidence 469999999998843 3458899999995 77666653 3458999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
||+||+++ .++.++++|||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..|+.....
T Consensus 112 kp~Nil~~-~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~ 187 (237)
T cd05576 112 NPNNILLD-DRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPS 187 (237)
T ss_pred CHHHEEEc-CCCCEEEecccchhccccc--cccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence 99999999 4778999999987655332 223455778999998854 4588999999999999999999987743211
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH-----HHHhcC
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAH 237 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~-----~e~l~h 237 (296)
. +. .... ..++..+++.++++|.+||+.||++|+++ +++++|
T Consensus 188 ~-----~~----------------~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 188 G-----IN----------------THTT------------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred h-----cc----------------cccc------------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 0 00 0000 01223478999999999999999999985 899999
Q ss_pred CCc
Q 022500 238 PFF 240 (296)
Q Consensus 238 p~f 240 (296)
|||
T Consensus 235 ~~~ 237 (237)
T cd05576 235 PFF 237 (237)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=246.78 Aligned_cols=200 Identities=27% Similarity=0.375 Sum_probs=160.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVP 75 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~-----~~~~~~~~~~~~~~qil~aL~~LH~~~ 75 (296)
+.++|+||+++++++.. ...+++||||++ ++|.+.+...... ...+++..+..++.|++.||+|||+ +
T Consensus 51 ~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~ 124 (262)
T cd00192 51 KKLGHPNVVRLLGVCTE-----EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-K 124 (262)
T ss_pred hhcCCCChheeeeeecC-----CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-C
Confidence 56789999999998854 344889999996 6877777653211 3679999999999999999999999 7
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
|++||||||+||+++ .++.+||+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++
T Consensus 125 ~i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~ 202 (262)
T cd00192 125 KFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFT 202 (262)
T ss_pred CcccCccCcceEEEC-CCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHh
Confidence 999999999999999 46889999999998765432 22344568889999998654 58999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 -GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|..||.+....+....+.... ....+..+++++.+++.+||+.||++|||+
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 254 (262)
T cd00192 203 LGATPYPGLSNEEVLEYLRKGY----------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTF 254 (262)
T ss_pred cCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCccCChHHHHHHHHHccCCcccCcCH
Confidence 699998887665555443310 001223468999999999999999999999
Q ss_pred HHHhcC
Q 022500 232 LEACAH 237 (296)
Q Consensus 232 ~e~l~h 237 (296)
.+++++
T Consensus 255 ~~l~~~ 260 (262)
T cd00192 255 SELVER 260 (262)
T ss_pred HHHHHh
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=249.80 Aligned_cols=201 Identities=26% Similarity=0.436 Sum_probs=158.3
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
.||||+++++++.. ....|+||||++| +|.+.+.. ..+++..+..++.|++.||.|||+ .|++|+||+
T Consensus 60 ~~~~vi~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~ 128 (277)
T cd06917 60 QPPNITKYYGSYLK-----GPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIK 128 (277)
T ss_pred CCCCeeeEeeeeee-----CCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcC
Confidence 59999999998843 3348899999986 66555432 368999999999999999999999 699999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+||+++. ++.++|+|||++........ .....|+..|+|||.+.+...++.++|+||+||++|+|++|..||.+...
T Consensus 129 p~ni~i~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 129 AANILVTN-TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred HHHEEEcC-CCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999994 78899999999986644332 23446888999999986655578999999999999999999999977654
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
......+... . .+. ......+.++.+++.+||+.||++||++.+++.||||++
T Consensus 208 ~~~~~~~~~~-~------------------~~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 208 FRAMMLIPKS-K------------------PPR--------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred hhhhhccccC-C------------------CCC--------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 3322211110 0 000 001126789999999999999999999999999999976
Q ss_pred cc
Q 022500 243 LR 244 (296)
Q Consensus 243 ~~ 244 (296)
..
T Consensus 261 ~~ 262 (277)
T cd06917 261 HS 262 (277)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=261.27 Aligned_cols=200 Identities=23% Similarity=0.344 Sum_probs=152.3
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh--------------------------------
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------------------- 47 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-------------------------------- 47 (296)
+.+ +|||||++++++.. ....++|||||+ |+|.+.+.....
T Consensus 93 ~~l~~HpnIv~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (375)
T cd05104 93 SYLGNHINIVNLLGACTV-----GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNE 167 (375)
T ss_pred HHhcCCcceeeeeeeecc-----CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhh
Confidence 345 89999999998843 334889999999 577777653210
Q ss_pred ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEE
Q 022500 48 ---------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88 (296)
Q Consensus 48 ---------------------------------------~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nil 88 (296)
....+++..+..++.||+.||+|||+ +||+||||||+||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil 246 (375)
T cd05104 168 YMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNIL 246 (375)
T ss_pred hhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEE
Confidence 11257888999999999999999999 79999999999999
Q ss_pred EcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 022500 89 VDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 164 (296)
Q Consensus 89 l~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 164 (296)
++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++|+||+||++|+|++ |..||.+.....
T Consensus 247 l~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 247 LT-HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred EE-CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 98 4778999999999865432211 122345679999999654 58999999999999999998 889998765444
Q ss_pred HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 165 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 165 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
...+.+.....+ ..+...+.++.+|+.+||+.||++|||+.++++
T Consensus 325 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 325 KFYKMIKEGYRM---------------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHHHHHhCccC---------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 433333210000 011235789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=247.53 Aligned_cols=203 Identities=32% Similarity=0.502 Sum_probs=162.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCH 79 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~-~~~i~H 79 (296)
++++||||+++++++... ..+++||||++ ++|.+.+.. ...+++..+..++.|++.||+|||+ . |++|
T Consensus 54 ~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H 123 (264)
T cd06623 54 RSCESPYVVKCYGAFYKE-----GEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIH 123 (264)
T ss_pred HhcCCCCeeeEEEEEccC-----CeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCcc
Confidence 467899999999998543 44899999999 576666653 3678999999999999999999999 7 9999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc-cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||+|+||+++ .++.++|+|||.+......... ....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.
T Consensus 124 ~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~ 201 (264)
T cd06623 124 RDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFL 201 (264)
T ss_pred CCCCHHHEEEC-CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999 4788999999999876443332 245678899999998654 58899999999999999999999997
Q ss_pred CCC---hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCC-CCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 159 GEN---AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 159 ~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
..+ ..+....+... .. ...... ++..+.++|.+||..+|++|||+.++
T Consensus 202 ~~~~~~~~~~~~~~~~~---~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 253 (264)
T cd06623 202 PPGQPSFFELMQAICDG---PP-------------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAEL 253 (264)
T ss_pred cccccCHHHHHHHHhcC---CC-------------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 774 22222222210 00 001122 68899999999999999999999999
Q ss_pred hcCCCccccc
Q 022500 235 CAHPFFDELR 244 (296)
Q Consensus 235 l~hp~f~~~~ 244 (296)
++||||+.++
T Consensus 254 l~~~~~~~~~ 263 (264)
T cd06623 254 LQHPFIKKAD 263 (264)
T ss_pred HhCHHHHhcc
Confidence 9999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=247.65 Aligned_cols=193 Identities=16% Similarity=0.209 Sum_probs=147.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.... ..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+ +||+||
T Consensus 59 ~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 129 (262)
T cd05077 59 RQVSHKHIVLLYGVCVRDV-----ENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED-KDLVHG 129 (262)
T ss_pred HhCCCCCEeeEEEEEecCC-----CCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECC
Confidence 5689999999999885433 37899999996 44433332 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCC-------cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH-h
Q 022500 81 DLKPQNLLVDPLTH-------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-L 152 (296)
Q Consensus 81 dlkp~Nill~~~~~-------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~ 152 (296)
||||+||+++. ++ .++++|||++...... ....++..|+|||.+.+...++.++||||+||++|+|+ .
T Consensus 130 dlkp~Nill~~-~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 130 NVCTKNILLAR-EGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCCcccEEEec-CCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 99999999974 33 2899999998754322 23457888999999865556899999999999999998 5
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||.+....+.. ..... .+. .....+.++.+||.+||+.||.+||++.
T Consensus 206 ~~~p~~~~~~~~~~-~~~~~--------------~~~---------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~ 255 (262)
T cd05077 206 GEIPLKDKTLAEKE-RFYEG--------------QCM---------------LVTPSCKELADLMTHCMNYDPNQRPFFR 255 (262)
T ss_pred CCCCCCCcchhHHH-HHHhc--------------Ccc---------------CCCCChHHHHHHHHHHcCCChhhCcCHH
Confidence 88888765433221 11110 000 0112467899999999999999999999
Q ss_pred HHhcC
Q 022500 233 EACAH 237 (296)
Q Consensus 233 e~l~h 237 (296)
+++++
T Consensus 256 ~il~~ 260 (262)
T cd05077 256 AIMRD 260 (262)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=251.42 Aligned_cols=200 Identities=23% Similarity=0.300 Sum_probs=156.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~~~~qil~a 67 (296)
+++++||||+++++++.. ....++||||++ ++|.+.+.... ...+.+++..+..++.||+.|
T Consensus 61 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 135 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 135 (291)
T ss_pred HhcCCCCCcceEEEEEcc-----CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHH
Confidence 357899999999998843 334889999998 57777765421 112458999999999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|+|||+ +||+||||||+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|
T Consensus 136 l~~lH~-~~i~H~dlkp~Nil~~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG 212 (291)
T cd05094 136 MVYLAS-QHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFG 212 (291)
T ss_pred HHHHHh-CCeeecccCcceEEEc-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHH
Confidence 999999 7999999999999999 477899999999976533221 1234557889999998654 589999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
|++|+|++ |..||...+..+....+... .. . ..+...+..+.+++.+||+.
T Consensus 213 ~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~-----------------~---------~~~~~~~~~~~~li~~~l~~ 264 (291)
T cd05094 213 VILWEIFTYGKQPWFQLSNTEVIECITQG--RV-----------------L---------ERPRVCPKEVYDIMLGCWQR 264 (291)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHhCC--CC-----------------C---------CCCccCCHHHHHHHHHHccc
Confidence 99999998 99999877765544433221 00 0 01123688999999999999
Q ss_pred CCCCCCCHHHHhc
Q 022500 224 SPSLRCTALEACA 236 (296)
Q Consensus 224 ~p~~R~t~~e~l~ 236 (296)
||.+|||+.++++
T Consensus 265 ~P~~Rpt~~~v~~ 277 (291)
T cd05094 265 EPQQRLNIKEIYK 277 (291)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=262.55 Aligned_cols=226 Identities=33% Similarity=0.551 Sum_probs=181.4
Q ss_pred CeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcE
Q 022500 8 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 87 (296)
Q Consensus 8 nIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Ni 87 (296)
|+++++..| ....++|||+|-+.-+|.+.++.|... ..+....++.|+.|++.||..|-. .||+|.||||+||
T Consensus 495 Hclrl~r~F-----~hknHLClVFE~LslNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 495 HCLRLFRHF-----KHKNHLCLVFEPLSLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNI 567 (752)
T ss_pred HHHHHHHHh-----hhcceeEEEehhhhchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccce
Confidence 567777777 555679999999999999999987554 558899999999999999999999 6999999999999
Q ss_pred EEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022500 88 LVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 167 (296)
Q Consensus 88 ll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 167 (296)
|++.....+||||||.|.....++ .+.++.+..|+|||++.|.. |+...|+||+||.+|||.||+..|+|.+...++.
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred EeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 999878889999999998765443 45677889999999999865 9999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHhhcCc---CC---cCc---c------------CCCCCC-CCccccc------CC---CCCHHHHHH
Q 022500 168 EIIKVLGTPTREEIRCMNP---NY---TDF---R------------FPQIKA-HPWHKVF------HK---RMPPEAIDL 216 (296)
Q Consensus 168 ~i~~~~~~~~~~~~~~~~~---~~---~~~---~------------~~~~~~-~~~~~~~------~~---~~~~~~~dl 216 (296)
..+.+-|..+...+....- -| .++ . +..... ..+...+ +. ..-.+++||
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 9999999988887764321 00 000 0 000000 1111111 11 122478999
Q ss_pred HHcccccCCCCCCCHHHHhcCCCccc
Q 022500 217 ASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 217 l~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
|.+||..||++|.|+.++|+||||..
T Consensus 726 Ldkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHhccChhhcCCHHHHhcCCcccC
Confidence 99999999999999999999999963
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=247.69 Aligned_cols=195 Identities=19% Similarity=0.256 Sum_probs=149.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++.... ..++||||+++ +|...+.. ..+.+++..+..++.|++.||+|||+ +||+|
T Consensus 70 ~~~l~h~niv~~~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH 140 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGS-----ENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVH 140 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCC-----ceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccC
Confidence 45789999999999985433 47899999996 44444432 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCC------CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH-h
Q 022500 80 RDLKPQNLLVDPL------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-L 152 (296)
Q Consensus 80 ~dlkp~Nill~~~------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~ 152 (296)
|||||+||+++.. ...+|++|||++...... ....++..|+|||.+.+...++.++|+||+||++|+++ +
T Consensus 141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~ 217 (274)
T cd05076 141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217 (274)
T ss_pred CCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999732 124899999988654322 23356788999999866556899999999999999985 6
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||.+....+... ..... . ..+...++++.++|.+||+.+|++|||+.
T Consensus 218 g~~p~~~~~~~~~~~-~~~~~-----------------~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~ 267 (274)
T cd05076 218 GEVPLKERTPSEKER-FYEKK-----------------H------------RLPEPSCKELATLISQCLTYEPTQRPSFR 267 (274)
T ss_pred CCCCccccChHHHHH-HHHhc-----------------c------------CCCCCCChHHHHHHHHHcccChhhCcCHH
Confidence 899997765443322 11100 0 01122467899999999999999999999
Q ss_pred HHhcC
Q 022500 233 EACAH 237 (296)
Q Consensus 233 e~l~h 237 (296)
+++++
T Consensus 268 ~il~~ 272 (274)
T cd05076 268 TILRD 272 (274)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=245.53 Aligned_cols=197 Identities=22% Similarity=0.308 Sum_probs=150.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++|
T Consensus 47 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H 117 (252)
T cd05084 47 LKQYSHPNIVRLIGVCTQ-----KQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIH 117 (252)
T ss_pred HHhCCCCCcceEEEEEcC-----CCCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 467899999999998843 3348899999985 66655542 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCcc---ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+||+++ .++.+||+|||++.......... ....+..|+|||.+.+. .++.++|+||+||++|+|++ |..
T Consensus 118 ~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~ 195 (252)
T cd05084 118 RDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAV 195 (252)
T ss_pred cccchheEEEc-CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999998 57789999999987543221110 11224569999998654 48999999999999999997 888
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||...........+.... . ...+...+..+.+++.+||+.+|++|||+.+++
T Consensus 196 p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 247 (252)
T cd05084 196 PYANLSNQQTREAIEQGV-R---------------------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVH 247 (252)
T ss_pred CccccCHHHHHHHHHcCC-C---------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 987665544333322210 0 001234688999999999999999999999987
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 248 ~ 248 (252)
T cd05084 248 Q 248 (252)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=247.62 Aligned_cols=198 Identities=27% Similarity=0.441 Sum_probs=158.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++.+. +..++|+||||+++ ++.+.+.. .....+++..+..++.|++.||.|||+ +|++|+
T Consensus 53 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~ 124 (255)
T cd08219 53 AKMKHPNIVAFKESFE-----ADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHR 124 (255)
T ss_pred HhCCCCCcceEEEEEE-----ECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccC
Confidence 5689999999999984 33458999999984 67666553 134568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.++++|||.+........ .....+++.|+|||++.+. .++.++|+||+|+++|+|++|..||..
T Consensus 125 dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 125 DIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred CCCcceEEEC-CCCcEEEcccCcceeecccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCC
Confidence 9999999998 577899999999876543222 2345678899999998654 589999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.......+....- ...+..++..+.++|.+||+.||++|||+.+++.-
T Consensus 203 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 203 NSWKNLILKVCQGSY----------------------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCHHHHHHHHhcCCC----------------------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 776555544432100 00123468899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=245.20 Aligned_cols=199 Identities=35% Similarity=0.612 Sum_probs=162.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++.+ .+....|+||||++ ++|.+.+.. ...+++..+..++.|++.||.|||+ .+++|
T Consensus 47 l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H 116 (250)
T cd05123 47 LSRINHPFIVKLHYAF-----QTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIY 116 (250)
T ss_pred HHHcCCCcHHHHHHHe-----ecCCeeEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcee
Confidence 3568899999999988 34445899999995 677666653 3468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||+|+||+++ .++.++|+|||++...... .......++..|+|||.+.+. ..+.++|+||+|+++|++++|..||.
T Consensus 117 ~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 117 RDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred cCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999999999 4778999999998765433 223345678899999998654 47899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH---HHHh
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEAC 235 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~---~e~l 235 (296)
..+.......+.. +. . .++..++..+.+++++||..||++||++ ++++
T Consensus 195 ~~~~~~~~~~~~~--~~---------------~------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 195 AEDRKEIYEKILK--DP---------------L------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred CCCHHHHHHHHhc--CC---------------C------------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence 7776444444432 00 0 1223468899999999999999999999 9999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
+||||
T Consensus 246 ~~~~f 250 (250)
T cd05123 246 AHPFF 250 (250)
T ss_pred hCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=252.58 Aligned_cols=205 Identities=27% Similarity=0.471 Sum_probs=160.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++.+.... ..|+|+||+++ +|.+.+.. ..+++..+..++.|++.||.|||+ +|++|
T Consensus 70 l~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H 138 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIH 138 (293)
T ss_pred HhhcCCCCeeehhheeeeCC-----cEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEee
Confidence 35689999999999885433 48899999985 66555542 457889999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.++|+|||++........ .....+++.|++||.+.+ ..++.++|+||+||++|++++|..||.
T Consensus 139 ~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 139 RDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred ccCCHHHEEEc-CCCCEEEccCcceecccccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 477899999998875533322 223467888999999865 458899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+....+..+.. .+.+. ...+..++..+.++|++||+.+|++||++.+++.||
T Consensus 217 ~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 217 NENPLRALYLIAT-NGTPE-------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCChhhheeehhc-CCCCC-------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 7765433322211 00000 001123678999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||+..+
T Consensus 271 ~~~~~~ 276 (293)
T cd06647 271 FLKIAK 276 (293)
T ss_pred HHhcCc
Confidence 998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=248.64 Aligned_cols=206 Identities=21% Similarity=0.265 Sum_probs=156.1
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCc-ccHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVP-ESMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPR 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~-g~l~~~l~~~~--~~~~~~~~~~~~~~~~qil~aL~~LH~~~~ 76 (296)
|+.++||||+++++++..... ......+++|||+. |+|.+.+.... .....+++..+..++.|++.||+|||+ +|
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ 132 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KS 132 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence 357899999999997653321 12234779999998 57766553211 123458999999999999999999999 79
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 152 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~- 152 (296)
|+||||||+||+++ .++.+||+|||+++....... .....+++.|++||.+.+ ..++.++|+||+||++|+|++
T Consensus 133 i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 133 FIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred eeccccchhheEEc-CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcC
Confidence 99999999999998 577899999999986543321 112235678999999865 458999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||.+....+....+.+... + ..+..++..+.++|.+||+.||++|||+.
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 262 (272)
T cd05075 211 GQTPYPGVENSEIYDYLRQGNR-L---------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFE 262 (272)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC-C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence 7899988766555444332100 0 01124678899999999999999999999
Q ss_pred HHhcC
Q 022500 233 EACAH 237 (296)
Q Consensus 233 e~l~h 237 (296)
+++++
T Consensus 263 ~l~~~ 267 (272)
T cd05075 263 TLRCE 267 (272)
T ss_pred HHHHH
Confidence 99753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=250.77 Aligned_cols=210 Identities=29% Similarity=0.500 Sum_probs=157.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++.+... ..+|+||||+++ +|.+.+. ..+.+++..++.++.|++.||.|||+..+++||
T Consensus 58 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~ 128 (284)
T cd06620 58 HECRSPYIVSFYGAFLNE-----NNICMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128 (284)
T ss_pred HHcCCCCcceEeeeEecC-----CEEEEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 467999999999998543 458999999995 5554443 345789999999999999999999962489999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.++|+|||++...... ......++..|+|||++.+. .++.++|+||+||++|++++|..||...
T Consensus 129 dl~p~nil~~-~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 129 DIKPSNILVN-SRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred CCCHHHEEEC-CCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 9999999998 5778999999998754322 22345788999999998654 5889999999999999999999999865
Q ss_pred ChHHH----HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 161 NAVDQ----LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 161 ~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
...+. ...+... ....... . .+. .....++.++.+|+.+||+.||.+|||++|+++
T Consensus 206 ~~~~~~~~~~~~~~~~--------~~~~~~~-~---~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 206 NIDDDGQDDPMGILDL--------LQQIVQE-P---PPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred chhhhhhhhhhHHHHH--------HHHHhhc-c---CCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 54211 0000000 0000000 0 000 000126788999999999999999999999999
Q ss_pred CCCcccc
Q 022500 237 HPFFDEL 243 (296)
Q Consensus 237 hp~f~~~ 243 (296)
|+||...
T Consensus 266 ~~~~~~~ 272 (284)
T cd06620 266 MPPFIQA 272 (284)
T ss_pred Ccccccc
Confidence 9999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=255.00 Aligned_cols=200 Identities=22% Similarity=0.283 Sum_probs=153.1
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a 67 (296)
+++ +||||+++++++.. ...+|+||||++ |+|.+.+..... ....+++..++.++.|++.|
T Consensus 62 ~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 136 (303)
T cd05088 62 CKLGHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 136 (303)
T ss_pred HHhcCCCCcceEEEEECC-----CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHH
Confidence 356 89999999999843 344889999998 577777654221 12368899999999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
|+|||+ +|++||||||+||+++ .++.+||+|||++..............+..|+|||.+.+ ..++.++||||+||++
T Consensus 137 l~~LH~-~gi~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il 213 (303)
T cd05088 137 MDYLSQ-KQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLL 213 (303)
T ss_pred HHHHHh-CCccccccchheEEec-CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHH
Confidence 999999 7999999999999998 477899999999864321111111223567999998855 4588999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 148 AELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 148 ~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|+|++ |..||.+.+..+....+.... . ...+...++++.+|+.+||+.+|+
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~~l~~~p~ 265 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQGY----------------R------------LEKPLNCDDEVYDLMRQCWREKPY 265 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcCC----------------c------------CCCCCCCCHHHHHHHHHHcCCChh
Confidence 99998 999998776655443332100 0 001123678999999999999999
Q ss_pred CCCCHHHHhcC
Q 022500 227 LRCTALEACAH 237 (296)
Q Consensus 227 ~R~t~~e~l~h 237 (296)
+||++++++++
T Consensus 266 ~Rp~~~~il~~ 276 (303)
T cd05088 266 ERPSFAQILVS 276 (303)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=248.10 Aligned_cols=206 Identities=21% Similarity=0.277 Sum_probs=158.3
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCc-ccHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVP-ESMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPR 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~-g~l~~~l~~~~~--~~~~~~~~~~~~~~~qil~aL~~LH~~~~ 76 (296)
|+.++||||+++++++..... .+....++++||+. |+|...+..... ....+++..+..++.|++.||.|||+ ++
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~ 133 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RN 133 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence 356899999999998764433 23345789999999 577766644321 23468999999999999999999999 79
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 152 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~- 152 (296)
++||||||+||+++ .++.+||+|||+++........ ....++..|+|||.+.+ ..++.++|+||+||++|+|++
T Consensus 134 i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 134 FIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred eeccccchheEEEC-CCCeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhC
Confidence 99999999999998 5778999999999865433211 11234567999999854 458999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||.+....+....+.... . ...+...+.++.+++.+||+.||++|||+.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 263 (273)
T cd05035 212 GQTPYPGVENHEIYDYLRHGN-R---------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFT 263 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCC-C---------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 889998877655544443210 0 001234788999999999999999999999
Q ss_pred HHhcC
Q 022500 233 EACAH 237 (296)
Q Consensus 233 e~l~h 237 (296)
+++++
T Consensus 264 e~~~~ 268 (273)
T cd05035 264 KLREV 268 (273)
T ss_pred HHHHH
Confidence 99763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=245.82 Aligned_cols=204 Identities=29% Similarity=0.513 Sum_probs=157.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|+||+++++.+.. ...+++|+||+++ +|.+.+. ....+++..+..++.|++.||+|||+ .|++|
T Consensus 53 ~~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H 122 (264)
T cd06626 53 LELLKHPNLVKYYGVEVH-----REKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVH 122 (264)
T ss_pred HHhCCCCChhheeeeEec-----CCEEEEEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 357899999999998743 3348899999995 6655554 34568899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc-----cceeecccccCchhccCCC--CCCchhHHHHHHHHHHHHHh
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~ 152 (296)
+||+|+||+++. ++.+||+|||++......... ....+++.|+|||.+.+.. .++.++|+||+|+++|++++
T Consensus 123 ~dl~~~nil~~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 123 RDIKPANIFLDH-NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred CCCCHHHEEECC-CCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh
Confidence 999999999994 788999999998865433221 1245688999999986532 37889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||.+................+. .+. ...+++.+.++|.+||+.+|.+|||+.
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPP---------------IPD----------SLQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCC---------------CCc----------ccccCHHHHHHHHHHccCCcccCCCHH
Confidence 9999976643322222221100000 000 113588999999999999999999999
Q ss_pred HHhcCCCc
Q 022500 233 EACAHPFF 240 (296)
Q Consensus 233 e~l~hp~f 240 (296)
+++.|||+
T Consensus 257 ~i~~~~~~ 264 (264)
T cd06626 257 ELLQHPFV 264 (264)
T ss_pred HHhcCCCC
Confidence 99999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=246.56 Aligned_cols=198 Identities=22% Similarity=0.353 Sum_probs=154.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... ..+++||||++ ++|.+.+... ....+++..++.++.|++.||+|||+ +|++|
T Consensus 56 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H 127 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIH 127 (263)
T ss_pred HHhCCCCChhheEEEEcCC-----CCcEEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEee
Confidence 3578999999999988433 34889999998 5776666531 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||++......... ....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..|
T Consensus 128 ~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p 205 (263)
T cd05052 128 RDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP 205 (263)
T ss_pred cccCcceEEEc-CCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 99999999998 5788999999999765432211 11223567999999865 458899999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.... ....+..++.++.+++.+||+.||++|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 206 YPGIDLSQVYELLEKGY----------------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCHHHHHHHHHCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 98877655444432210 00122357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=246.27 Aligned_cols=195 Identities=25% Similarity=0.311 Sum_probs=152.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++. +. ..++||||+++ +|.+.+. ....+++..+..++.|++.||+|||+ +|++|
T Consensus 50 l~~l~h~~i~~~~~~~~-----~~-~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H 118 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-----AE-SWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE-TNFVH 118 (257)
T ss_pred HHhCCCCCcceEEEEEc-----CC-CcEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEee
Confidence 35689999999998762 11 26799999995 6666654 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+||+|||++......... ....++..|+|||.+.+ ..++.++|+||+||++|+|++ |.
T Consensus 119 ~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~ 196 (257)
T cd05116 119 RDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQ 196 (257)
T ss_pred cccchhhEEEc-CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCC
Confidence 99999999999 4778999999999865433221 11233578999998854 458899999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+.+. ..+ ..+..+++++.++|.+||+.||++||+++++
T Consensus 197 ~p~~~~~~~~~~~~i~~~-~~~---------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i 248 (257)
T cd05116 197 KPYKGMKGNEVTQMIESG-ERM---------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248 (257)
T ss_pred CCCCCCCHHHHHHHHHCC-CCC---------------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence 999887766555444321 000 0123478999999999999999999999988
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
.+
T Consensus 249 ~~ 250 (257)
T cd05116 249 EL 250 (257)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=247.89 Aligned_cols=200 Identities=25% Similarity=0.324 Sum_probs=156.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHT 73 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------~~~~~~~~~~~~~~~qil~aL~~LH~ 73 (296)
|+.++||||+++++++... ...|+||||++ |+|.+.+..... ....+++..+..++.|++.||.|||+
T Consensus 63 l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 137 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTG-----QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA 137 (277)
T ss_pred HHhCCCCceeEEEEEEcCC-----CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3568999999999998433 44889999998 587777754321 12347888999999999999999999
Q ss_pred CCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 74 ~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
++++||||||+||+++ .++.+||+|||+++....... .....++..|+|||.+.+. .++.++|+||+||++|++
T Consensus 138 -~~i~H~di~p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el 214 (277)
T cd05032 138 -KKFVHRDLAARNCMVA-EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred -CCccccccChheEEEc-CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHh
Confidence 7999999999999999 578899999999876543221 1233457789999998654 589999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 151 LL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 151 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
++ |..||.+.+..+....+.. .+.+ ..+...+.++.+++.+||+.+|++||
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVID-GGHL---------------------------DLPENCPDKLLELMRMCWQYNPKMRP 266 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhc-CCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCC
Confidence 98 9999988776655444331 1100 01233688999999999999999999
Q ss_pred CHHHHhc
Q 022500 230 TALEACA 236 (296)
Q Consensus 230 t~~e~l~ 236 (296)
|+.++++
T Consensus 267 t~~~l~~ 273 (277)
T cd05032 267 TFLEIVS 273 (277)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=245.77 Aligned_cols=198 Identities=25% Similarity=0.333 Sum_probs=155.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++++.. ....++||||+. ++|.+.+... ....+++..+..++.|++.||+|||+ .+++|
T Consensus 55 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H 126 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTK-----EEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIH 126 (261)
T ss_pred HHhCCCCCeeeEEEEEcC-----CCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 357899999999998743 334889999998 5777766532 34568889999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus 127 ~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p 204 (261)
T cd05072 127 RDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIP 204 (261)
T ss_pred cccchhhEEec-CCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCC
Confidence 99999999999 578899999999986543221 1123346679999998654 58899999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....+....+.+.... .....++.++.+++.+||..+|++|||++++.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 205 YPGMSNSDVMSALQRGYRM----------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9887766655544321100 011236889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=248.25 Aligned_cols=199 Identities=22% Similarity=0.291 Sum_probs=151.9
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a 67 (296)
+++ +||||+++++++... ..+|+||||+. |+|.+.+..... ....+++..++.++.|++.|
T Consensus 50 ~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a 124 (270)
T cd05047 50 CKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 124 (270)
T ss_pred HhhccCCCeeeEEEEEecC-----CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHH
Confidence 356 799999999998433 34889999998 578777754221 12357899999999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
|+|||+ +|++||||||+||+++ .++.+|++|||++..............+..|+|||++.+ ..++.++|+||+||++
T Consensus 125 l~~lH~-~~i~H~dikp~nili~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il 201 (270)
T cd05047 125 MDYLSQ-KQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLL 201 (270)
T ss_pred HHHHHH-CCEeecccccceEEEc-CCCeEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHH
Confidence 999999 7999999999999999 578899999999864321111111223567999999854 4589999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 148 AELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 148 ~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|+|++ |..||.+.+..+....+.... . . ..+..++.++.+++.+||..||.
T Consensus 202 ~el~~~g~~pf~~~~~~~~~~~~~~~~----------------~--~----------~~~~~~~~~~~~li~~~l~~~p~ 253 (270)
T cd05047 202 WEIVSLGGTPYCGMTCAELYEKLPQGY----------------R--L----------EKPLNCDDEVYDLMRQCWREKPY 253 (270)
T ss_pred HHHHcCCCCCccccCHHHHHHHHhCCC----------------C--C----------CCCCcCCHHHHHHHHHHcccChh
Confidence 99997 999998776555444332210 0 0 01123678999999999999999
Q ss_pred CCCCHHHHhc
Q 022500 227 LRCTALEACA 236 (296)
Q Consensus 227 ~R~t~~e~l~ 236 (296)
+|||+.++++
T Consensus 254 ~Rps~~~il~ 263 (270)
T cd05047 254 ERPSFAQILV 263 (270)
T ss_pred hCCCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.68 Aligned_cols=202 Identities=28% Similarity=0.444 Sum_probs=160.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++.+.. ...+|+||||+++ +|.+.+. ...+++..+..++.|++.|+.|||+ +|++|
T Consensus 56 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h 124 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLK-----DTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIH 124 (277)
T ss_pred HHhcCCCCEeEEEEEEEe-----CCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeec
Confidence 357899999999999843 3348899999996 5555443 2468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus 125 ~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred CCCCHHhEEEC-CCCCEEEeecccceecccchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999998 577899999999876543221 2234678889999998653 57889999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..........+... +.+ .+...++.++.+++.+||..+|.+||++.++++||
T Consensus 203 ~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 203 ELHPMKVLFLIPKN-NPP---------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred ccchHHHHHHHhcC-CCC---------------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 76654444332210 000 01234688999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||...
T Consensus 255 ~~~~~ 259 (277)
T cd06641 255 FIVRF 259 (277)
T ss_pred HHhhh
Confidence 99874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=254.93 Aligned_cols=202 Identities=25% Similarity=0.365 Sum_probs=153.9
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhh--------------------------------
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS-------------------------------- 47 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~-------------------------------- 47 (296)
+++ +||||+++++++... ...++++|||+.+ +|.+.+.....
T Consensus 65 ~~l~~h~niv~~~~~~~~~----~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (337)
T cd05054 65 IHIGHHLNVVNLLGACTKP----GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQ 140 (337)
T ss_pred HhhccCcchhheeeeEecC----CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccc
Confidence 345 799999999987533 2348899999994 77766643211
Q ss_pred -------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeecc
Q 022500 48 -------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 102 (296)
Q Consensus 48 -------------------------~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 102 (296)
....+++..+..++.||+.||+|||+ +||+||||||+||+++ .++.++|+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~-~~~~vkL~DfG 218 (337)
T cd05054 141 SSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLS-ENNVVKICDFG 218 (337)
T ss_pred cccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEe-CCCcEEEeccc
Confidence 02368899999999999999999999 7999999999999999 47789999999
Q ss_pred CccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCH
Q 022500 103 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 178 (296)
Q Consensus 103 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 178 (296)
++..+..... .....++..|+|||++.+. .++.++||||+||++|+|++ |..||.+....+.+...+...-.+
T Consensus 219 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-- 295 (337)
T cd05054 219 LARDIYKDPDYVRKGDARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-- 295 (337)
T ss_pred cchhcccCcchhhccCCCCCccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--
Confidence 9986533221 1223446789999998664 58999999999999999998 999998755444333332210000
Q ss_pred HHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
..+...++++.+++.+||+.+|++||++.++++|
T Consensus 296 -------------------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 -------------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0122467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=248.55 Aligned_cols=199 Identities=22% Similarity=0.277 Sum_probs=155.6
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHH
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~------------~~~~~~~~~~~~~~~~qil~aL 68 (296)
++++||||+++++++.... ..++++||+.+ +|.+.+.... .....+++..+..++.|++.||
T Consensus 63 ~~l~h~~iv~~~~~~~~~~-----~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL 137 (283)
T cd05091 63 SRLQHPNIVCLLGVVTKEQ-----PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137 (283)
T ss_pred hcCCCCCcCeEEEEEcCCC-----ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 5689999999999885433 38899999984 6666653210 1124588889999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
+|||+ +||+||||||+||+++ .++.+||+|||+++....... .....+++.|+|||.+.+. .++.++|+||+||
T Consensus 138 ~~lH~-~gi~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~ 214 (283)
T cd05091 138 EFLSS-HHVVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGV 214 (283)
T ss_pred HHHHH-cCccccccchhheEec-CCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHH
Confidence 99999 7999999999999998 477899999999886533221 1223456789999998654 4899999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 146 VLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 146 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
++|+|++ |..||.+....+....+.+.... ..+..++..+.+++.+||+.+
T Consensus 215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~ 266 (283)
T cd05091 215 VLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEF 266 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCC
Confidence 9999998 88899887776665555432110 012347889999999999999
Q ss_pred CCCCCCHHHHhc
Q 022500 225 PSLRCTALEACA 236 (296)
Q Consensus 225 p~~R~t~~e~l~ 236 (296)
|.+||++.++++
T Consensus 267 p~~RP~~~~i~~ 278 (283)
T cd05091 267 PSRRPRFKDIHS 278 (283)
T ss_pred cccCCCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=250.86 Aligned_cols=209 Identities=26% Similarity=0.445 Sum_probs=160.7
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++ +||||+++++++. ....+|+||||+++ +|.+.+. ....+++..+..++.|++.||.|||+ .|++|
T Consensus 59 ~~l~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H 128 (290)
T cd05613 59 EHIRQSPFLVTLHYAFQ-----TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK-LGIIY 128 (290)
T ss_pred HhcccCCChhceeeEee-----cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 345 6999999998883 34458899999995 6666554 34568899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||+|+||+++ .++.+||+|||++....... ......++..|+|||.+.+. ..++.++|+||+|+++|+|++|..|
T Consensus 129 ~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p 207 (290)
T cd05613 129 RDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207 (290)
T ss_pred cCCCHHHeEEC-CCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence 99999999999 47889999999987653322 12245678899999998642 2467899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CH
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TA 231 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~ 231 (296)
|...........+.+..... ....+..+++.+.+++++||+.||++|+ ++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~ 262 (290)
T cd05613 208 FTVDGEKNSQAEISRRILKS-------------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDA 262 (290)
T ss_pred CCcCCccccHHHHHHHhhcc-------------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence 97543322222222210000 0001234788999999999999999997 88
Q ss_pred HHHhcCCCcccccCC
Q 022500 232 LEACAHPFFDELREP 246 (296)
Q Consensus 232 ~e~l~hp~f~~~~~~ 246 (296)
++++.||||....+.
T Consensus 263 ~~l~~~~~~~~~~~~ 277 (290)
T cd05613 263 DEIKKHPFFQKINWD 277 (290)
T ss_pred HHHHcCcccccCCHH
Confidence 999999999988754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=247.44 Aligned_cols=202 Identities=19% Similarity=0.288 Sum_probs=154.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPR 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~---~~~~~~~~~~~~~~~qil~aL~~LH~~~~ 76 (296)
++.++||||+++++++.... ..++||||+. ++|.+.+..... ....+++..+..++.||+.||+|||+ ++
T Consensus 63 l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ 136 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERL-----PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NH 136 (277)
T ss_pred HHhCCCCCEeeEEEEEccCC-----CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence 35789999999999885433 3789999997 577777764321 11358999999999999999999999 79
Q ss_pred cccCCCCCCcEEEcCC--CCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 77 VCHRDLKPQNLLVDPL--THQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 77 i~H~dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
++||||||+||+++.. ...+||+|||+++....... ......+..|+|||++.+. .++.++||||+||++|+|+
T Consensus 137 ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 137 FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHH
Confidence 9999999999999743 23689999999986532211 1122335679999999654 5899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 152 L-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 152 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
+ |..||.+.+..+....+... +.+ ..+..++..+.+++.+||+.+|++|||
T Consensus 216 ~~g~~pf~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps 267 (277)
T cd05036 216 SLGYMPYPGRTNQEVMEFVTGG-GRL---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPN 267 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 7 99999887766544433221 000 012347889999999999999999999
Q ss_pred HHHHhcC
Q 022500 231 ALEACAH 237 (296)
Q Consensus 231 ~~e~l~h 237 (296)
+.++++|
T Consensus 268 ~~~vl~~ 274 (277)
T cd05036 268 FATILER 274 (277)
T ss_pred HHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=244.30 Aligned_cols=197 Identities=18% Similarity=0.282 Sum_probs=154.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++. ...+.|+||||++| +|.+.+.. ....+++..+..++.|++.||.|||+ +|++|
T Consensus 53 l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H 123 (256)
T cd05059 53 MMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIH 123 (256)
T ss_pred HHhCCCCCEEEEEEEEc-----CCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 35789999999999874 33458899999985 67666653 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||+++........ ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |..|
T Consensus 124 ~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p 201 (256)
T cd05059 124 RDLAARNCLVG-EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMP 201 (256)
T ss_pred ccccHhhEEEC-CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCC
Confidence 99999999999 5788999999998765332211 111234579999998654 58999999999999999998 7999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+..... ...+...+.++.+++.+||+.+|++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 202 YERFSNSEVVESVSAGYR----------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred CCCCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 987766655544332100 0012236889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=245.37 Aligned_cols=202 Identities=26% Similarity=0.411 Sum_probs=156.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... ..+++|+||+++ +|.+.+.........+++..+..++.|++.||.|||+ +|++|
T Consensus 56 l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H 129 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIED-----NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMH 129 (267)
T ss_pred HHhCCCcceeeeeeeEEEC-----CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeC
Confidence 3678999999999988543 348899999995 7776666544445668999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.
T Consensus 130 ~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 130 RDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCCCHHHEEEc-CCCCEEECccccceeccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 99999999998 477899999999876543222 1234678899999998654 48899999999999999999999996
Q ss_pred CCCh-HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENA-VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.... ...+...+...+.++ ......+..+.+++.+||+.+|++||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 208 GDKMNLFSLCQKIEQCDYPP--------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred cccccHHHHHHHHhcCCCCC--------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 6532 122222222111111 011236788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=244.70 Aligned_cols=202 Identities=27% Similarity=0.489 Sum_probs=158.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ....+++|+||++| +|.+.+. ..+.+++..++.++.|++.||.|||+ +|++|
T Consensus 58 l~~l~h~~i~~~~~~~~~~---~~~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H 129 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDP---EEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS-NMIVH 129 (264)
T ss_pred HHHcCCCCcceEEEEEEcC---CCCEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 3568999999999987432 22347899999985 6665554 33568899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC----CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
+||||+||+++ .++.++|+|||+++..... .......++..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus 130 ~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~ 207 (264)
T cd06653 130 RDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKP 207 (264)
T ss_pred CCCCHHHEEEc-CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCC
Confidence 99999999998 4778999999999865321 111234678899999998664 48899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||..........++.. .+. ...++..+++.+.++|.+||+ +|.+||++.+++
T Consensus 208 p~~~~~~~~~~~~~~~---~~~------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 208 PWAEYEAMAAIFKIAT---QPT------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCCccCHHHHHHHHHc---CCC------------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 9987655544433321 111 111334588999999999999 579999999999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
.|||.
T Consensus 260 ~~~~~ 264 (264)
T cd06653 260 RHPFV 264 (264)
T ss_pred cCCCC
Confidence 99984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=248.28 Aligned_cols=208 Identities=29% Similarity=0.479 Sum_probs=164.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++.+... ...|+|+||++ ++|.+.+... ...++...+..++.|++.||.|||+ .|++|
T Consensus 69 l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H 139 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVG-----DELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS-QNVIH 139 (286)
T ss_pred HHHCCCCCeeEEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3578999999999998544 34889999999 5777777642 1379999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus 140 ~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~ 217 (286)
T cd06614 140 RDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYL 217 (286)
T ss_pred CCCChhhEEEc-CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCC
Confidence 99999999999 577899999999865433221 1234567889999998654 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+.......+... +.+.. .....++.++.++|.+||+.+|.+|||+.++++||
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 218 REPPLRALFLITTK-GIPPL-------------------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CCCHHHHHHHHHhc-CCCCC-------------------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 77665544443321 10000 00122678999999999999999999999999999
Q ss_pred CcccccC
Q 022500 239 FFDELRE 245 (296)
Q Consensus 239 ~f~~~~~ 245 (296)
||+...+
T Consensus 272 ~~~~~~~ 278 (286)
T cd06614 272 FLKKACP 278 (286)
T ss_pred HhhccCc
Confidence 9998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.74 Aligned_cols=197 Identities=25% Similarity=0.341 Sum_probs=153.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... ..++|+||+. |+|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 63 l~~l~h~niv~~~g~~~~~------~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH 132 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVH 132 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC------CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeec
Confidence 4678999999999988532 1568999998 577777663 23468889999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCcc---ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+||+++ .++.+||+|||+++......... ...++..|+|||.+.+. .++.++||||+||++|+|++ |..
T Consensus 133 ~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~ 210 (316)
T cd05108 133 RDLAARNVLVK-TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSK 210 (316)
T ss_pred cccchhheEec-CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCC
Confidence 99999999998 57789999999998764433221 12235679999998654 58999999999999999997 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+....+. ..++.....+ + .+...+.++.+++.+||..||.+||++.+++
T Consensus 211 p~~~~~~~~~-~~~~~~~~~~-----------------~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~ 262 (316)
T cd05108 211 PYDGIPASEI-SSILEKGERL-----------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELI 262 (316)
T ss_pred CCCCCCHHHH-HHHHhCCCCC-----------------C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9987665443 2333211100 0 1123678899999999999999999999998
Q ss_pred cC
Q 022500 236 AH 237 (296)
Q Consensus 236 ~h 237 (296)
.+
T Consensus 263 ~~ 264 (316)
T cd05108 263 IE 264 (316)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=247.88 Aligned_cols=201 Identities=22% Similarity=0.325 Sum_probs=155.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh-------------cCCCCCHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------ANQRMPLIYVKLYTYQIFR 66 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-------------~~~~~~~~~~~~~~~qil~ 66 (296)
|+.++||||+++++++.... ..|+||||+. ++|.+.+..... ....+++..+..++.|++.
T Consensus 61 l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 135 (283)
T cd05090 61 MAELHHPNIVCLLGVVTQEQ-----PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135 (283)
T ss_pred HhhCCCCCeeeEEEEEecCC-----ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence 46789999999999884433 3889999998 477666642110 1234788899999999999
Q ss_pred HHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHH
Q 022500 67 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSA 143 (296)
Q Consensus 67 aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 143 (296)
||+|||+ +|++||||||+||+++ .++.+||+|||+++....... .....++..|+|||.+.+. .++.++|+||+
T Consensus 136 al~~lH~-~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~sl 212 (283)
T cd05090 136 GMEYLSS-HFFVHKDLAARNILIG-EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSF 212 (283)
T ss_pred HHHHHHh-cCeehhccccceEEEc-CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHH
Confidence 9999999 7999999999999999 477899999999986533221 2233456679999998654 58999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccc
Q 022500 144 GCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222 (296)
Q Consensus 144 G~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 222 (296)
||++|+|++ |..||.+.+..+....+... ..+ ..+..+++.+.+++.+||+
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~ 264 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQ 264 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcc
Confidence 999999998 99999887655444433221 000 0123478899999999999
Q ss_pred cCCCCCCCHHHHhcC
Q 022500 223 YSPSLRCTALEACAH 237 (296)
Q Consensus 223 ~~p~~R~t~~e~l~h 237 (296)
.||.+||++.+++++
T Consensus 265 ~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 265 EGPSRRPRFKDIHTR 279 (283)
T ss_pred cCcccCcCHHHHHHH
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=241.20 Aligned_cols=202 Identities=30% Similarity=0.496 Sum_probs=160.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++... ...++++||++ ++|.+.+.. ....+++..+..++.|++.||.+||+ +|++|
T Consensus 51 l~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h 121 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKK-----DELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS-NGIIH 121 (253)
T ss_pred HHhCCCCCEeEEEEEEecC-----CeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc-CCEec
Confidence 3568899999999988544 34889999999 466655543 22578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+|+||+++ .++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..
T Consensus 122 ~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 199 (253)
T cd05122 122 RDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSE 199 (253)
T ss_pred CCCCHHHEEEc-cCCeEEEeeccccccccccccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 4788999999999876544323456778899999998654 488999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+.......+.. ...+. .+ ....++..+.++|.+||+.||++|||+.++++|||
T Consensus 200 ~~~~~~~~~~~~-~~~~~---------------~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 200 LPPMKALFKIAT-NGPPG---------------LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CchHHHHHHHHh-cCCCC---------------cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 755444433222 00000 00 00114789999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=250.65 Aligned_cols=200 Identities=24% Similarity=0.362 Sum_probs=155.2
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHH
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~~~~qil~a 67 (296)
+++ +||||+++++++... ..++++|||+. |+|...+.... .....+++..+..++.|++.|
T Consensus 70 ~~l~~h~~i~~~~~~~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 144 (293)
T cd05053 70 KMIGKHKNIINLLGVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARG 144 (293)
T ss_pred HhhcCCCCeeeEEEEEcCC-----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHH
Confidence 355 799999999988433 34889999998 57777765421 234568999999999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|+|||+ +||+||||||+||+++ .++.+||+|||+++....... .....++..|+|||++.+ ..++.++||||+|
T Consensus 145 l~~LH~-~~ivH~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG 221 (293)
T cd05053 145 MEFLAS-KKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221 (293)
T ss_pred HHHHHH-CCccccccceeeEEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehh
Confidence 999999 7999999999999998 578899999999986543221 111223567999999865 4589999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
|++|++++ |..||.+....+....+..... . ..+...+.++.+|+.+||..
T Consensus 222 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~li~~~l~~ 273 (293)
T cd05053 222 VLLWEIFTLGGSPYPGIPVEELFKLLKEGYR----------------M------------EKPQNCTQELYHLMRDCWHE 273 (293)
T ss_pred hHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc----------------C------------CCCCCCCHHHHHHHHHHccc
Confidence 99999997 9999988776555443322100 0 01123688999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 022500 224 SPSLRCTALEACAH 237 (296)
Q Consensus 224 ~p~~R~t~~e~l~h 237 (296)
||.+|||+.+++++
T Consensus 274 ~p~~Rps~~eil~~ 287 (293)
T cd05053 274 VPSQRPTFKQLVED 287 (293)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=242.82 Aligned_cols=203 Identities=34% Similarity=0.527 Sum_probs=160.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++.+.... ...+++|+||++ ++|.+.+.. ...+++..+..++.|++.||+|||+ .|++|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h 124 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEE---KNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVH 124 (260)
T ss_pred HHHcCCCCEeeEEEEEecCC---CCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 35789999999999885431 145889999996 566655553 3479999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
+||+|+||+++. ++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++++|++|..|
T Consensus 125 ~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p 202 (260)
T cd06606 125 RDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPP 202 (260)
T ss_pred cCCCHHHEEEcC-CCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999994 78899999999987655432 3445678899999998654 489999999999999999999999
Q ss_pred CCCCCh-HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 157 FPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 157 f~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|..... ......+... .....++...+..+.++|.+||+.||.+||++.+++
T Consensus 203 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 203 WSELGNPMAALYKIGSS---------------------------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred CCCCCchHHHHHhcccc---------------------------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 987762 2111111100 000112334689999999999999999999999999
Q ss_pred cCCCc
Q 022500 236 AHPFF 240 (296)
Q Consensus 236 ~hp~f 240 (296)
+||||
T Consensus 256 ~~~~~ 260 (260)
T cd06606 256 QHPFL 260 (260)
T ss_pred hCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=243.24 Aligned_cols=196 Identities=23% Similarity=0.277 Sum_probs=152.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++|
T Consensus 49 l~~l~h~~ii~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 118 (257)
T cd05115 49 MHQLDNPYIVRMIGVCEA------EALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVH 118 (257)
T ss_pred HHhcCCCCeEEEEEEEcC------CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeee
Confidence 467899999999998631 137899999985 66655542 34578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+||+|||++......... ....++..|+|||.+.+. .++.++|+||+||++|++++ |.
T Consensus 119 ~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~ 196 (257)
T cd05115 119 RDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQ 196 (257)
T ss_pred cccchheEEEc-CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCC
Confidence 99999999998 5778999999999755333221 111225679999998654 48899999999999999996 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+....+....+.+. ..+ ..+...++++.+++.+||..||++||++.++
T Consensus 197 ~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 197 KPYKKMKGPEVMSFIEQG-KRL---------------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred CCcCcCCHHHHHHHHHCC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999887766554433221 000 0123468999999999999999999999988
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
.+
T Consensus 249 ~~ 250 (257)
T cd05115 249 EE 250 (257)
T ss_pred HH
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=246.88 Aligned_cols=198 Identities=34% Similarity=0.611 Sum_probs=160.5
Q ss_pred CCCC-CCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++++ ||||+++++++.. ...+++||||++ ++|.+.+.. ...+++..+..++.|++.||.|||+ .|++|
T Consensus 56 ~~l~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H 125 (280)
T cd05581 56 TRLNGHPGIIKLYYTFQD-----EENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIH 125 (280)
T ss_pred HhcccCCCchhHHHHhcC-----CceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 4566 9999999998843 334889999996 677766653 3579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC---------------------ccceeecccccCchhccCCCCCCchh
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---------------------NISYICSRFYRAPELIFGATEYTTSI 138 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~ 138 (296)
+||+|+||+++ .++.++++|||++........ .....++..|+|||+..+. .++.++
T Consensus 126 ~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~ 203 (280)
T cd05581 126 RDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSS 203 (280)
T ss_pred cCCCHHHeEEC-CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhh
Confidence 99999999998 477899999999876533221 1223567889999998654 488999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHH
Q 022500 139 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 218 (296)
Q Consensus 139 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 218 (296)
|+||+|++++++++|..||...+....+..+... . ..++..+++.+.++|.
T Consensus 204 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~~li~ 254 (280)
T cd05581 204 DLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-----------------E------------YSFPPNFPPDAKDLIE 254 (280)
T ss_pred hHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-----------------C------------CCCCCccCHHHHHHHH
Confidence 9999999999999999999888765554444321 0 0122346899999999
Q ss_pred cccccCCCCCCCH----HHHhcCCCc
Q 022500 219 RLLQYSPSLRCTA----LEACAHPFF 240 (296)
Q Consensus 219 ~~L~~~p~~R~t~----~e~l~hp~f 240 (296)
+||+.+|++|||+ .++++||||
T Consensus 255 ~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 255 KLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 9999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=241.26 Aligned_cols=198 Identities=25% Similarity=0.341 Sum_probs=157.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++.+.. ..+++||||++ ++|.+.+.... ...+++..+..++.|++.||+|||+ +|++|
T Consensus 50 l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H 120 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLES-KRFIH 120 (257)
T ss_pred HhhcCCCCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 467899999999998854 34889999998 57777766421 1468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++. ++.+||+|||++......... ....++..|+|||.+.+. .++.++|+||+||++|+|++ |.
T Consensus 121 ~di~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~ 198 (257)
T cd05040 121 RDLAARNILLAS-DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGE 198 (257)
T ss_pred cccCcccEEEec-CCEEEeccccccccccccccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCC
Confidence 999999999994 688999999999876432211 123456789999998654 58999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||...+..+....+...... . ..+...+..+.+++.+||+.+|++|||+.++
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~---------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 199 EPWAGLSGSQILKKIDKEGER---------------L------------ERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred CCCCCCCHHHHHHHHHhcCCc---------------C------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 999877766655554321000 0 0112368899999999999999999999998
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 252 ~~ 253 (257)
T cd05040 252 RE 253 (257)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=244.07 Aligned_cols=204 Identities=21% Similarity=0.298 Sum_probs=152.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~-~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+.++||||+++++.+... ..+|+||||++ |+|.+.+...... ....++..++.++.||+.||+|||+ +||+|
T Consensus 50 ~~l~h~nii~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH 123 (269)
T cd05042 50 RELNHPNVLQCLGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIH 123 (269)
T ss_pred HhCCCCCcceEEEEECCC-----CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEec
Confidence 568999999999988433 34889999998 5777777643211 2335678889999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccC------CCCCCchhHHHHHHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l 150 (296)
|||||+||+++ .++.+||+|||++........ .....++..|+|||++.. ...++.++|+||+||++|+|
T Consensus 124 ~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 202 (269)
T cd05042 124 SDLALRNCQLT-ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202 (269)
T ss_pred ccccHhheEec-CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHH
Confidence 99999999999 578899999999875432211 122344667999998742 23468899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 151 LL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 151 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
++ |..||......+.+..++...... .+. ......+++.+.+++..|+ .||++||
T Consensus 203 ~~~~~~p~~~~~~~~~~~~~~~~~~~~----------------~~~-------~~~~~~~~~~~~~~~~~~~-~dp~~Rp 258 (269)
T cd05042 203 FTAADQPYPDLSDEQVLKQVVREQDIK----------------LPK-------PQLDLKYSDRWYEVMQFCW-LDPETRP 258 (269)
T ss_pred HhCCCCCCCcCCHHHHHHHHhhccCcc----------------CCC-------CcccccCCHHHHHHHHHHh-cCccccc
Confidence 99 788998777666555544321110 000 0122347888999999998 5999999
Q ss_pred CHHHHhc
Q 022500 230 TALEACA 236 (296)
Q Consensus 230 t~~e~l~ 236 (296)
|++++++
T Consensus 259 t~~~v~~ 265 (269)
T cd05042 259 TAEEVHE 265 (269)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=241.66 Aligned_cols=197 Identities=21% Similarity=0.312 Sum_probs=154.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++++... ....|+||||++ ++|.+.+... ....+++..+..++.|++.||+|||+ +|++|
T Consensus 53 l~~l~~~~i~~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 125 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEE----KGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVH 125 (256)
T ss_pred HHhCCCCCeeeEEEEEEcC----CCceEEEEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 4678999999999876432 223789999998 4777766531 23458899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++....... ....++..|+|||++.+ ..++.++|+||+||++|+|++ |..||.
T Consensus 126 ~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 126 RDLAARNVLVS-EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred cccchheEEEc-CCCcEEecCCccceeccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999998 57889999999987543322 22334567999999865 458899999999999999997 999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
..+..+....+.+.. ....+..+++.+.+++.+||+.+|++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 202 RIPLKDVVPRVEKGY----------------------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCHHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 776555444332210 00122347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=247.73 Aligned_cols=198 Identities=25% Similarity=0.383 Sum_probs=154.1
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++ +||||+++++++... ..+|+||||+. |+|.+.+... ....+++..+..++.|++.||+|||+ ++++|
T Consensus 93 ~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH 164 (302)
T cd05055 93 SHLGNHENIVNLLGACTIG-----GPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS-KNCIH 164 (302)
T ss_pred HhccCCCCcceEEEEEecC-----CceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeh
Confidence 456 799999999988433 34889999998 5777666531 22348999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
+||||+||+++ .++.++++|||++........ .....++..|+|||.+.+. .++.++||||+||++|+|++ |..
T Consensus 165 ~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~ 242 (302)
T cd05055 165 RDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSN 242 (302)
T ss_pred hhhccceEEEc-CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCC
Confidence 99999999998 577899999999986543321 1123456789999998654 48999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+....+...+....... ...+...++++.+++.+||..+|++|||+.+++
T Consensus 243 p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell 295 (302)
T cd05055 243 PYPGMPVDSKFYKLIKEGYR---------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295 (302)
T ss_pred CcCCCCchHHHHHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 99877655544443321000 001123688999999999999999999999997
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 296 ~ 296 (302)
T cd05055 296 Q 296 (302)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=246.10 Aligned_cols=200 Identities=24% Similarity=0.331 Sum_probs=155.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-----------~~~~~~~~~~~~~~~qil~aL 68 (296)
++.++||||+++++++... ...++||||+. ++|.+.+..... ....+++..+..++.|++.||
T Consensus 61 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al 135 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135 (280)
T ss_pred HhcCCCCCCceEEEEEecC-----CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHH
Confidence 3578999999999988433 34889999998 577776654211 113578999999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
+|||+ .|++||||||+||+++ +++.+||+|||++........ .....+++.|+|||.+.+. .++.++|+||+||
T Consensus 136 ~~LH~-~~i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ 212 (280)
T cd05092 136 VYLAS-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGV 212 (280)
T ss_pred HHHHH-CCeecccccHhhEEEc-CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHH
Confidence 99999 7999999999999998 578899999999875533221 1223446789999998654 4899999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 146 VLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 146 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
++|+|++ |.+||......+....+..... ...+..+++.+.++|.+||+.|
T Consensus 213 il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~ 264 (280)
T cd05092 213 VLWEIFTYGKQPWYQLSNTEAIECITQGRE----------------------------LERPRTCPPEVYAIMQGCWQRE 264 (280)
T ss_pred HHHHHHcCCCCCCccCCHHHHHHHHHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCC
Confidence 9999998 8999987766655544432100 0012347889999999999999
Q ss_pred CCCCCCHHHHhc
Q 022500 225 PSLRCTALEACA 236 (296)
Q Consensus 225 p~~R~t~~e~l~ 236 (296)
|.+||++.++++
T Consensus 265 P~~Rp~~~~l~~ 276 (280)
T cd05092 265 PQQRMVIKDIHS 276 (280)
T ss_pred hhhCCCHHHHHH
Confidence 999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=243.24 Aligned_cols=198 Identities=23% Similarity=0.306 Sum_probs=157.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. ....++||||+++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|
T Consensus 56 l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h 127 (261)
T cd05148 56 LKRLRHKHLISLFAVCSV-----GEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIH 127 (261)
T ss_pred HhcCCCcchhheeeeEec-----CCCeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 467899999999998843 3348899999985 877777642 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
|||||+||+++ .++.+||+|||.+........ .....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||
T Consensus 128 ~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~ 205 (261)
T cd05148 128 RDLAARNILVG-EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPY 205 (261)
T ss_pred cccCcceEEEc-CCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999 577899999999976532211 112234667999999865 458899999999999999998 89999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+.+..+.+..+...... ..+...++.+.+++.+||+.||++|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 206 PGMNNHEVYDQITAGYRM----------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CcCCHHHHHHHHHhCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 888766666555431110 012347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=242.42 Aligned_cols=205 Identities=20% Similarity=0.265 Sum_probs=153.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++.+.. ....|+||||++ |+|.+.+..........++..++.++.||+.||+|||+ .+++|
T Consensus 49 ~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H 122 (268)
T cd05086 49 YRILQHPNILQCLGQCVE-----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLH 122 (268)
T ss_pred HhccCCcchhheEEEecC-----CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 356899999999998843 334889999999 57777776432233456778889999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCC------CCCCchhHHHHHHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l 150 (296)
|||||+||+++ .++.+||+|||++....... ......++..|+|||++.+. ..++.++|+||+||++|+|
T Consensus 123 ~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (268)
T cd05086 123 SDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201 (268)
T ss_pred cCCccceEEEc-CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHH
Confidence 99999999998 47789999999986432211 12234678899999987421 2356789999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 151 LL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 151 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
++ |..||...+..+.+..+++..... . +...+...+++.+.+++..|+ .+|.+||
T Consensus 202 ~~~~~~p~~~~~~~~~~~~~~~~~~~~----------------~-------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp 257 (268)
T cd05086 202 FENAAQPYSHLSDREVLNHVIKDQQVK----------------L-------FKPQLELPYSERWYEVLQFCW-LSPEKRA 257 (268)
T ss_pred HhCCCCCCCCCCHHHHHHHHHhhcccc----------------c-------CCCccCCCCcHHHHHHHHHHh-hCcccCC
Confidence 97 567887777766666554321100 0 001112236788999999999 6899999
Q ss_pred CHHHHhc
Q 022500 230 TALEACA 236 (296)
Q Consensus 230 t~~e~l~ 236 (296)
++.++++
T Consensus 258 ~~~~i~~ 264 (268)
T cd05086 258 TAEEVHR 264 (268)
T ss_pred CHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=242.93 Aligned_cols=198 Identities=24% Similarity=0.320 Sum_probs=154.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ...|+||||+. ++|.+.+... ....+++..+..++.|++.||.|||+ +|++|
T Consensus 55 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 126 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLE-----EPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIH 126 (261)
T ss_pred HHHCCCCCccceeEEEecC-----CCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3568999999999987433 34889999996 6777766542 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||++......... .....+..|+|||.+.+ ..++.++|+||+|+++|+|++ |..|
T Consensus 127 ~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p 204 (261)
T cd05068 127 RDLAARNVLVG-ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMP 204 (261)
T ss_pred ccCCcceEEEc-CCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCC
Confidence 99999999999 4778999999999866432211 11122357999999865 458999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+.......+.+....+ .+...+..+.+++.+||+.+|.+||++.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 205 YPGMTNAEVLQQVDQGYRMP----------------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 98877665555443311100 11236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=256.08 Aligned_cols=156 Identities=28% Similarity=0.425 Sum_probs=122.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchh
Q 022500 51 RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPEL 127 (296)
Q Consensus 51 ~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~ 127 (296)
.+++..+..++.|++.||+|||+ ++|+||||||+||+++ .++.+||+|||+++....... .....+++.|+|||.
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 310 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES 310 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhh
Confidence 47888899999999999999999 7999999999999999 477899999999976533221 223456778999999
Q ss_pred ccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccC
Q 022500 128 IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 206 (296)
Q Consensus 128 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (296)
+.+. .++.++||||+||++|+|++ |..||.+..........+.....+ ..+
T Consensus 311 ~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 362 (400)
T cd05105 311 IFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM---------------------------AKP 362 (400)
T ss_pred hcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC---------------------------CCC
Confidence 8654 58999999999999999997 899998765443333332210000 011
Q ss_pred CCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 207 KRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 207 ~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
..++.++.+++.+||+.||++|||+.++.+
T Consensus 363 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 363 DHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 347889999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=246.90 Aligned_cols=200 Identities=24% Similarity=0.349 Sum_probs=153.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh--------------------cCCCCCHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS--------------------ANQRMPLIYVKL 59 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~--------------------~~~~~~~~~~~~ 59 (296)
|+.++||||+++++.+... ...++|+||+. |+|.+.+..... ....+++..+..
T Consensus 57 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 131 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLIS 131 (290)
T ss_pred HhhCCCCCEeeEEEEEecC-----CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHH
Confidence 3578999999999988433 33789999999 577766653211 123578899999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCc
Q 022500 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTT 136 (296)
Q Consensus 60 ~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~ 136 (296)
++.|++.||+|||+ .+++||||||+||+++ +++.+||+|||+++....... .....++..|+|||.+.+ ..++.
T Consensus 132 i~~~i~~~l~~LH~-~~ivH~dikp~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~ 208 (290)
T cd05045 132 FAWQISRGMQYLAE-MKLVHRDLAARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTT 208 (290)
T ss_pred HHHHHHHHHHHHHH-CCeehhhhhhheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcch
Confidence 99999999999999 7999999999999998 577899999999976533221 112234668999999865 45899
Q ss_pred hhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHH
Q 022500 137 SIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 215 (296)
Q Consensus 137 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 215 (296)
++|+||+|+++|+|++ |..||.+....+....+.+... ...+..++.++.+
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~ 260 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------------------MERPENCSEEMYN 260 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC----------------------------CCCCCCCCHHHHH
Confidence 9999999999999998 9999987765544433221100 0012347889999
Q ss_pred HHHcccccCCCCCCCHHHHhc
Q 022500 216 LASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 216 ll~~~L~~~p~~R~t~~e~l~ 236 (296)
++.+||+.+|++||++.++++
T Consensus 261 ~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 261 LMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=241.17 Aligned_cols=204 Identities=25% Similarity=0.472 Sum_probs=164.3
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
-+||.+|-++.+|.+.+ .+++|.||++|+ +++.+ .+...+++++.++.|..+|+.||.|||+ +||++||||
T Consensus 308 sn~pflvglhscfqtes-----rlffvieyv~gg--dlmfh-mqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlk 378 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTES-----RLFFVIEYVNGG--DLMFH-MQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLK 378 (593)
T ss_pred cCCCeEEehhhhhcccc-----eEEEEEEEecCc--ceeee-hhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeecc
Confidence 37999999999995444 499999999974 12222 2234679999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC---
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG--- 159 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--- 159 (296)
.+|+|++ ..+.+||+|+|+|+.... .....+++|||.|+|||++.|. .|+..+|+|++||+++||+.|+.||.-
T Consensus 379 ldnvlld-aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm 456 (593)
T KOG0695|consen 379 LDNVLLD-AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGM 456 (593)
T ss_pred ccceEEc-cCCceeecccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecC
Confidence 9999999 578899999999986543 3445678999999999999875 599999999999999999999999942
Q ss_pred ----CChHHHHHHH-HHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC----
Q 022500 160 ----ENAVDQLVEI-IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---- 230 (296)
Q Consensus 160 ----~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---- 230 (296)
.+.++-+.++ ++. ...++.++|-.+..+++..|++||.+|..
T Consensus 457 ~n~d~ntedylfqvilek-----------------------------qiriprslsvkas~vlkgflnkdp~erlgc~~~ 507 (593)
T KOG0695|consen 457 DNPDMNTEDYLFQVILEK-----------------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQ 507 (593)
T ss_pred CCcccchhHHHHHHHhhh-----------------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCcc
Confidence 1222322222 221 12245668889999999999999999974
Q ss_pred --HHHHhcCCCcccccCCC
Q 022500 231 --ALEACAHPFFDELREPN 247 (296)
Q Consensus 231 --~~e~l~hp~f~~~~~~~ 247 (296)
..++..|+||+.+.|..
T Consensus 508 ~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 508 TGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred cchhhhhcchhhhhCCHHH
Confidence 68999999999998763
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=243.23 Aligned_cols=198 Identities=24% Similarity=0.325 Sum_probs=154.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++.+... ...++||||+++ +|.+.+.. ..+.+++..+..++.|++.||+|||+ +||+|
T Consensus 59 l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H 129 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKS-----RPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVH 129 (266)
T ss_pred HHhCCCCCcceEeEEEecC-----CceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 3578999999999988433 348899999985 66666543 23578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc-c--ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+||+++ .++.++|+|||++......... . ...++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..
T Consensus 130 ~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~ 207 (266)
T cd05033 130 RDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGER 207 (266)
T ss_pred CCCCcceEEEc-CCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCC
Confidence 99999999999 4778999999999876422211 1 1223567999999865 458999999999999999997 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||......+....+.+....+ .+...++.+.+++.+||+.+|++||++.+++
T Consensus 208 p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~ 259 (266)
T cd05033 208 PYWDMSNQDVIKAVEDGYRLP----------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIV 259 (266)
T ss_pred CCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 997776555544443211000 1123688999999999999999999999998
Q ss_pred cC
Q 022500 236 AH 237 (296)
Q Consensus 236 ~h 237 (296)
++
T Consensus 260 ~~ 261 (266)
T cd05033 260 ST 261 (266)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=242.36 Aligned_cols=200 Identities=24% Similarity=0.341 Sum_probs=155.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPR 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~---~~~~~~~~~~~~~~~qil~aL~~LH~~~~ 76 (296)
|+.++||||+++++++.... ..++||||++ ++|.+.+..... ....+++..+..++.|++.||+|||+ ++
T Consensus 53 l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~ 126 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNE-----PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MH 126 (269)
T ss_pred HHhcCCCCeeeEeeeecCCC-----CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CC
Confidence 46789999999999885333 4889999998 587777764322 22447889999999999999999999 79
Q ss_pred cccCCCCCCcEEEcCCCC-----cEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 77 VCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~-----~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
++|+||||+||+++. +. .++++|||++........ .....++..|+|||.+.+. .++.++|+||+||++|
T Consensus 127 i~H~dl~p~nil~~~-~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ 204 (269)
T cd05044 127 FIHRDLAARNCLVSE-KGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMW 204 (269)
T ss_pred cccCCCChheEEEec-CCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHH
Confidence 999999999999984 44 799999999976533211 1123456789999998654 5899999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC
Q 022500 149 ELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 149 ~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~ 227 (296)
+|++ |..||...+..+....+... +.+ ..+..+++.+.++|.+||+.+|.+
T Consensus 205 ellt~g~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~ 256 (269)
T cd05044 205 EILTLGQQPYPALNNQEVLQHVTAG-GRL---------------------------QKPENCPDKIYQLMTNCWAQDPSE 256 (269)
T ss_pred HHHHcCCCCCcccCHHHHHHHHhcC-Ccc---------------------------CCcccchHHHHHHHHHHcCCCccc
Confidence 9998 99999877765544433210 000 012346889999999999999999
Q ss_pred CCCHHHHhc
Q 022500 228 RCTALEACA 236 (296)
Q Consensus 228 R~t~~e~l~ 236 (296)
||+++++++
T Consensus 257 Rp~~~~i~~ 265 (269)
T cd05044 257 RPTFDRIQE 265 (269)
T ss_pred CCCHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=243.95 Aligned_cols=200 Identities=28% Similarity=0.440 Sum_probs=155.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ..++++|||++| +|.+.+.........+++..+..++.|++.||.|||+ +|++|+
T Consensus 57 ~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~ 130 (267)
T cd08229 57 KQLNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHR 130 (267)
T ss_pred HHccCCchhhhhheeEeC-----CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 568999999999998543 348899999995 7777776544445678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+
T Consensus 131 dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 131 DIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCCHHHEEEc-CCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999998 477899999999876543222 2234678899999998654 588999999999999999999999976
Q ss_pred CChH--HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAV--DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.... .....+... . .+. ......++++.+++.+||+.||.+|||+.++++
T Consensus 209 ~~~~~~~~~~~~~~~-~------------------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 209 DKMNLYSLCKKIEQC-D------------------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ccchHHHHhhhhhcC-C------------------CCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 5421 111111110 0 000 011236889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=243.55 Aligned_cols=195 Identities=21% Similarity=0.287 Sum_probs=151.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.. . ..++++||+. |+|.+.+.. ....+++..+..++.||+.||+|||+ +|++||
T Consensus 64 ~~l~h~~iv~~~~~~~~-----~-~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~ 133 (279)
T cd05111 64 GSLDHAYIVRLLGICPG-----A-SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHR 133 (279)
T ss_pred hcCCCCCcceEEEEECC-----C-ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecc
Confidence 57899999999998632 1 2668999998 687777653 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
||||+||+++ .++.+||+|||+++........ ....++..|+|||.+.+. .++.++|+||+||++|++++ |..|
T Consensus 134 dlkp~nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p 211 (279)
T cd05111 134 NLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEP 211 (279)
T ss_pred ccCcceEEEc-CCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999998 5788999999999865433221 123456789999998654 58999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....... .+++....+. .+...+.++.+++.+||..||.+|||+.|+++
T Consensus 212 ~~~~~~~~~~-~~~~~~~~~~---------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 212 YAGMRPHEVP-DLLEKGERLA---------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCCHHHHH-HHHHCCCcCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9877654332 2222111100 01225678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=240.49 Aligned_cols=199 Identities=32% Similarity=0.561 Sum_probs=161.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... ..+++||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ .|++||
T Consensus 54 ~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 123 (254)
T cd06627 54 KNLKHPNIVKYIGSIETS-----DSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHR 123 (254)
T ss_pred HhCCCCCccEEEEEEEeC-----CEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccC
Confidence 568999999999988433 448899999986 66655543 3678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||+|+||+++. ++.++|+|||.+........ .....++..|+|||...+. .++.++|+||+|+++|+|++|..||..
T Consensus 124 dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 124 DIKAANILTTK-DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred CCCHHHEEECC-CCCEEEeccccceecCCCcccccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999994 78899999999986644332 2334678899999998654 488999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+.......+... . ...++..+++.+.+++.+||..+|++|||+.+++.|||
T Consensus 202 ~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 253 (254)
T cd06627 202 LNPMAALFRIVQD-D---------------------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW 253 (254)
T ss_pred ccHHHHHHHHhcc-C---------------------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence 7654444333210 0 00122347899999999999999999999999999999
Q ss_pred c
Q 022500 240 F 240 (296)
Q Consensus 240 f 240 (296)
|
T Consensus 254 ~ 254 (254)
T cd06627 254 I 254 (254)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=240.47 Aligned_cols=198 Identities=23% Similarity=0.356 Sum_probs=150.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.... ...++||||+. |+|.+.+.. .....++..+..++.|++.||.|||+ .+++|
T Consensus 50 l~~l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 121 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSE----GSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVH 121 (262)
T ss_pred HccCCCCCcceEEEEeecCC----CCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 46789999999999764322 23679999999 577666653 23446777888999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG- 153 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g- 153 (296)
|||||+||+++ .++.+||+|||+++....... .....++..|+|||.+.+. .++.++||||+||++|+|++|
T Consensus 122 ~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 122 RDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred cccCcceEEEc-CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCC
Confidence 99999999999 477899999999975532211 1123346789999998654 589999999999999999994
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
.+||...+..+....+... ..+ ..+..+++.+.+++.+||..+|++||++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 251 (262)
T cd05058 200 APPYPDVDSFDITVYLLQG-RRL---------------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSE 251 (262)
T ss_pred CCCCCCCCHHHHHHHHhcC-CCC---------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 6777766655544333221 000 011235789999999999999999999999
Q ss_pred Hhc
Q 022500 234 ACA 236 (296)
Q Consensus 234 ~l~ 236 (296)
+++
T Consensus 252 il~ 254 (262)
T cd05058 252 LVS 254 (262)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=247.37 Aligned_cols=209 Identities=29% Similarity=0.450 Sum_probs=158.6
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++ +||||+++++.+. ....+|+||||+++ +|.+.+. ....+++..++.++.|++.||.|||+ .|++|
T Consensus 59 ~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H 128 (288)
T cd05583 59 EAVRRCPFLVTLHYAFQ-----TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ-LGIIY 128 (288)
T ss_pred HhccCCcchhhhheeee-----cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 345 6999999998883 33458899999985 6655554 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+.. ..+.++|+||+|+++|+|++|..|
T Consensus 129 ~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p 207 (288)
T cd05583 129 RDIKLENILLD-SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207 (288)
T ss_pred cCCCHHHeEEC-CCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence 99999999998 467899999999876543322 12345788999999985432 368899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC---HHH
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALE 233 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t---~~e 233 (296)
|...+.......+.+..-. . ....+..++.++.++|.+||+.||++||| +.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~-----------~--------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~ 262 (288)
T cd05583 208 FTVDGEQNSQSEISRRILK-----------S--------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADE 262 (288)
T ss_pred cccCcccchHHHHHHHHHc-----------c--------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHH
Confidence 9654322222222111000 0 00012347889999999999999999998 567
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||+.+.+.
T Consensus 263 ~l~~~~~~~~~~~ 275 (288)
T cd05583 263 IKNHPFFQGIDWD 275 (288)
T ss_pred HhcCcccccCCHH
Confidence 8999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=239.10 Aligned_cols=197 Identities=24% Similarity=0.359 Sum_probs=152.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... ..++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++|
T Consensus 46 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H 116 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQ-----PIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIH 116 (250)
T ss_pred HHhCCCCCcCeEEEEEecCC-----ccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 35689999999999884433 38899999984 66655542 33568899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||++......... ....++..|+|||++.+ ..++.++|+||+|+++|++++ |..|
T Consensus 117 ~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p 194 (250)
T cd05085 117 RDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCP 194 (250)
T ss_pred cccChheEEEc-CCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCC
Confidence 99999999998 5778999999998754322111 11233567999999865 458899999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.........+..... ...+..++.++.+++.+||+.+|++||++.++++
T Consensus 195 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 195 YPGMTNQQAREQVEKGYR----------------------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 988765554443322100 0012346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=245.17 Aligned_cols=207 Identities=20% Similarity=0.248 Sum_probs=156.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIH 72 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-------~~~~~~~~~~~~~~~qil~aL~~LH 72 (296)
|++++||||+++++++... ...++||||+. ++|.+.+..... ....+++..+..++.|++.||.|||
T Consensus 73 l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH 147 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE 147 (296)
T ss_pred HHhcCCCCEeEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3578999999999988433 34889999998 577777654321 1126899999999999999999999
Q ss_pred hCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHH
Q 022500 73 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 73 ~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 149 (296)
+ .|++||||||+||+++ .++.++|+|||+++....... .....+++.|+|||.+.+. .++.++||||+||++|+
T Consensus 148 ~-~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~e 224 (296)
T cd05051 148 S-LNFVHRDLATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWE 224 (296)
T ss_pred H-cCccccccchhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHH
Confidence 9 7999999999999999 468899999999876533221 1233457789999998654 58999999999999999
Q ss_pred HHh--CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC
Q 022500 150 LLL--GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 150 ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~ 227 (296)
|++ |..||...+..+.+..+......... ......+...+.++.+++.+||+.||.+
T Consensus 225 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~ 283 (296)
T cd05051 225 ILTLCREQPYEHLTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEED 283 (296)
T ss_pred HHhcCCCCCCCCcChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhc
Confidence 998 67888776665555444332110000 0000011236789999999999999999
Q ss_pred CCCHHHHhc
Q 022500 228 RCTALEACA 236 (296)
Q Consensus 228 R~t~~e~l~ 236 (296)
|||+.++++
T Consensus 284 Rpt~~el~~ 292 (296)
T cd05051 284 RPTFREIHL 292 (296)
T ss_pred CCCHHHHHH
Confidence 999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=248.01 Aligned_cols=199 Identities=24% Similarity=0.343 Sum_probs=153.9
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a 67 (296)
+++ +||||+++++++.. ...+|+||||+. |+|.+.+..... ....+++..+..++.|++.|
T Consensus 72 ~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 146 (314)
T cd05099 72 KLIGKHKNIINLLGVCTQ-----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARG 146 (314)
T ss_pred HhccCCCCeeeEEEEEcc-----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHH
Confidence 345 69999999998843 334889999998 577777765321 12458899999999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|.|||+ +|++||||||+||+++ .++.+||+|||+++....... .....++..|+|||.+.+ ..++.++|+||+|
T Consensus 147 L~~lH~-~gi~H~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG 223 (314)
T cd05099 147 MEYLES-RRCIHRDLAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 223 (314)
T ss_pred HHHHHH-CCeeeccccceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHH
Confidence 999999 7999999999999998 477899999999986532211 111123457999999865 4589999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
|++|+|++ |..||.+....+....+..... ...+..++.++.+++.+||..
T Consensus 224 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~ 275 (314)
T cd05099 224 ILMWEIFTLGGSPYPGIPVEELFKLLREGHR----------------------------MDKPSNCTHELYMLMRECWHA 275 (314)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence 99999999 8899988776655544432100 001234688999999999999
Q ss_pred CCCCCCCHHHHhc
Q 022500 224 SPSLRCTALEACA 236 (296)
Q Consensus 224 ~p~~R~t~~e~l~ 236 (296)
||.+|||+.++++
T Consensus 276 ~p~~Rps~~~ll~ 288 (314)
T cd05099 276 VPTQRPTFKQLVE 288 (314)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=240.65 Aligned_cols=195 Identities=27% Similarity=0.368 Sum_probs=152.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ...++||||++ |+|.+.+. ....+++..+..++.|++.||+|||+ .+++|
T Consensus 50 l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H 118 (257)
T cd05060 50 MAQLDHPCIVRLIGVCKG------EPLMLVMELAPLGPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLES-KHFVH 118 (257)
T ss_pred HHhcCCCCeeeEEEEEcC------CceEEEEEeCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhh-cCeec
Confidence 467899999999997631 13689999998 57766665 33578999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCcc----ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+||+|||+++......... ...++..|+|||.+.+. .++.++|+||+|+++|+|++ |.
T Consensus 119 ~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~ 196 (257)
T cd05060 119 RDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGA 196 (257)
T ss_pred cCcccceEEEc-CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCC
Confidence 99999999998 57889999999998664332211 11224579999998654 58999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||...+..+....+... .. ...+...+..+++++.+||..+|.+||++.++
T Consensus 197 ~p~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 197 KPYGEMKGAEVIAMLESG-ER---------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred CCcccCCHHHHHHHHHcC-Cc---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 999877765544433221 00 00123468899999999999999999999998
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 249 ~~ 250 (257)
T cd05060 249 ES 250 (257)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=240.74 Aligned_cols=197 Identities=21% Similarity=0.285 Sum_probs=154.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++.+++... ...|+||||+++ +|.+.+.. ..+.+++..+..++.|++.||+|||+ .|++|
T Consensus 60 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H 130 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKF-----KPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVH 130 (268)
T ss_pred HhcCCCCCeeEEEEEEccC-----CCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 4678999999999988433 348899999995 66555543 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCcc----ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+|++|||++.......... ....+..|+|||++.+. .++.++|+||+||++|+|++ |.
T Consensus 131 ~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~ 208 (268)
T cd05063 131 RDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGE 208 (268)
T ss_pred cccchhhEEEc-CCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999 57789999999987654322111 11224569999998654 58999999999999999997 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||...+..+....+......+ .....+.++.+++.+||+.+|.+||++.++
T Consensus 209 ~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 209 RPYWDMSNHEVMKAINDGFRLP----------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred CCCCcCCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 9998877666555554311110 012367899999999999999999999999
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 261 ~~ 262 (268)
T cd05063 261 VN 262 (268)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=240.78 Aligned_cols=205 Identities=20% Similarity=0.230 Sum_probs=150.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
+++++||||+++++++.. ...+++||||++ |+|.+.+..... .....++..++.++.|++.||+|||+ .+++
T Consensus 49 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~ 122 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTE-----VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFI 122 (269)
T ss_pred HHhCCCCCEeeEEEEEcC-----CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEe
Confidence 357899999999998843 334789999999 577777754322 22356777888999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCC------CCCCchhHHHHHHHHHHH
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ 149 (296)
||||||+||+++ .++.+||+|||++........ .....++..|+|||++.+. ..++.++|+||+|+++|+
T Consensus 123 H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 201 (269)
T cd05087 123 HSDLALRNCLLT-ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201 (269)
T ss_pred ccccCcceEEEc-CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHH
Confidence 999999999999 477899999999875432211 1223457789999998532 135789999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCC
Q 022500 150 LLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228 (296)
Q Consensus 150 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R 228 (296)
|++ |..||......+........... ..+ ........++.+.+++++|+ .+|++|
T Consensus 202 l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~R 257 (269)
T cd05087 202 LFELGSQPYRHLSDEQVLTYTVREQQL----------------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQR 257 (269)
T ss_pred HHhCCCCCCCCCChHHHHHHHhhcccC----------------CCC-------CCccCCCCChHHHHHHHHHh-cCcccC
Confidence 996 99999876655543332221000 000 00111236788999999998 689999
Q ss_pred CCHHHHhc
Q 022500 229 CTALEACA 236 (296)
Q Consensus 229 ~t~~e~l~ 236 (296)
||+++++.
T Consensus 258 pt~~~l~~ 265 (269)
T cd05087 258 PSAEEVHL 265 (269)
T ss_pred CCHHHHHH
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=265.32 Aligned_cols=214 Identities=21% Similarity=0.272 Sum_probs=143.7
Q ss_pred CcceEEEEeccCcc-cHHHHHHHhhh----------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 022500 23 NELFLNLVMEYVPE-SMYRVLKHYSS----------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 85 (296)
Q Consensus 23 ~~~~~~lv~E~~~g-~l~~~l~~~~~----------------~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~ 85 (296)
....+++|+||+++ +|.+.+..... .........+..++.||+.||+|||+ ++|+||||||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~ 284 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQ 284 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHH
Confidence 44458899999994 67766653110 01112344577899999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEeeccCccccccC--CCccceeecccccCchhccCCC---------------------CCCchhHHHH
Q 022500 86 NLLVDPLTHQVKICDFGSAKQLIAG--EANISYICSRFYRAPELIFGAT---------------------EYTTSIDIWS 142 (296)
Q Consensus 86 Nill~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diws 142 (296)
|||++..++.+||+|||+|+..... .......+++.|+|||.+.... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 9999855678999999999765322 2234567899999999763221 2345679999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccc
Q 022500 143 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222 (296)
Q Consensus 143 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 222 (296)
+||++|+|+++..+ ..+....+.+++...+............... +... ......+..+..+.|||.+||+
T Consensus 365 lGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~----~~~~---~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 365 AGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAWRKLVEPRAS----PDLR---RGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHHHHhhccccc----hhhh---hhhhhccccchHHHHHHHHHcc
Confidence 99999999986654 4444455555555444332211111111000 0000 0000112235567899999999
Q ss_pred cCCCCCCCHHHHhcCCCcccccCC
Q 022500 223 YSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 223 ~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
+||++|||+.++|+||||+.....
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred CCcccCCCHHHHhCCcCcCCCCcc
Confidence 999999999999999999876543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=246.83 Aligned_cols=199 Identities=24% Similarity=0.343 Sum_probs=154.6
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a 67 (296)
+.+ +||||+++++++... ...|+||||++ |+|.+.+..... ....++...+..++.||+.|
T Consensus 75 ~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 149 (304)
T cd05101 75 KMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG 149 (304)
T ss_pred HhhccCCCchheeEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHH
Confidence 345 799999999988433 34889999998 577777764211 12357888899999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|.|||+ +|++||||||+||+++ .++.+||+|||+++....... .....+++.|+|||++.+ ..++.++||||+|
T Consensus 150 l~~LH~-~givH~dlkp~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG 226 (304)
T cd05101 150 MEYLAS-QKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 226 (304)
T ss_pred HHHHHH-CCeeecccccceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHH
Confidence 999999 7999999999999998 577899999999986543221 112234678999999865 4589999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
+++|+|++ |..||.+....+....+.... . ...+...+.++.+|+.+||..
T Consensus 227 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~ 278 (304)
T cd05101 227 VLMWEIFTLGGSPYPGIPVEELFKLLKEGH-R---------------------------MDKPANCTNELYMMMRDCWHA 278 (304)
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHccc
Confidence 99999998 788998877665554432210 0 001124688999999999999
Q ss_pred CCCCCCCHHHHhc
Q 022500 224 SPSLRCTALEACA 236 (296)
Q Consensus 224 ~p~~R~t~~e~l~ 236 (296)
+|.+|||+.++++
T Consensus 279 ~p~~Rps~~e~l~ 291 (304)
T cd05101 279 IPSHRPTFKQLVE 291 (304)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=240.27 Aligned_cols=216 Identities=25% Similarity=0.363 Sum_probs=172.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~-~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.-+-||||++|+..+..+. .+|-||+++-++..+.+ .+......++|..+-.+....+.||.||...-.|+||
T Consensus 118 ks~~cp~IVkfyGa~F~EGd-----cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHR 192 (361)
T KOG1006|consen 118 KSSNCPNIVKFYGALFSEGD-----CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHR 192 (361)
T ss_pred hhcCCcHHHHHhhhhhcCCc-----eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhc
Confidence 44467999999999977665 88999999987766543 3445567899999999999999999999985589999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCC-CCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|+||+|||++ ..|.+||||||+|..+...-..+...|-+.|||||.+..... |+.+||+||||+.+||+.||..|+.+
T Consensus 193 DvKPSNILld-r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 193 DVKPSNILLD-RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred cCChhheEEe-cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 9999999999 578899999999988876655566678888999999954433 89999999999999999999999977
Q ss_pred CC-hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 160 EN-AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 160 ~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
-+ ..+++..++. |.|+.- ..... .-..+..+..||.-||.+|-++||..++++++|
T Consensus 272 w~svfeql~~Vv~--gdpp~l-----~~~~~----------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 272 WDSVFEQLCQVVI--GDPPIL-----LFDKE----------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred HHHHHHHHHHHHc--CCCCee-----cCccc----------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 54 3455555443 222210 00000 013688999999999999999999999999999
Q ss_pred CcccccCC
Q 022500 239 FFDELREP 246 (296)
Q Consensus 239 ~f~~~~~~ 246 (296)
|++.+...
T Consensus 329 fyr~y~~~ 336 (361)
T KOG1006|consen 329 FYRMYAVE 336 (361)
T ss_pred hhhhhhhc
Confidence 99876543
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=241.90 Aligned_cols=197 Identities=24% Similarity=0.307 Sum_probs=154.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ....|+||||++| +|.+.+.. ..+.+++..+..++.|++.||+|||+ .|++|
T Consensus 59 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h 129 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTK-----SKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVH 129 (267)
T ss_pred HHhCCCCCcceEEEEEec-----CCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEee
Confidence 356899999999998843 3348899999985 66666543 23568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCcc----ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.++++|||++.......... ...++..|+|||.+.+. .++.++|+||+||++|++++ |.
T Consensus 130 ~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 130 RDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred hhhchhcEEEC-CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCC
Confidence 99999999998 47789999999998664332211 11224579999999654 58999999999999999886 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+.+....+ .+..+++.+.+++.+||+.+|.+||++.++
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 208 RPYWEMSNQDVIKAIEEGYRLP----------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred CCcccCCHHHHHHHHhCCCcCC----------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence 9998877665555443311100 112368899999999999999999999998
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 260 ~~ 261 (267)
T cd05066 260 VS 261 (267)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=240.18 Aligned_cols=197 Identities=25% Similarity=0.335 Sum_probs=154.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...|++|||+++ +|.+.+.. .....+++..++.++.|++.||+|||+ +|++|
T Consensus 55 l~~l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H 125 (260)
T cd05070 55 MKKLRHDKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIH 125 (260)
T ss_pred HHhcCCCceEEEEeEECC------CCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 467899999999987621 126799999985 77766653 223568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.++|+|||++......... ....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |.+|
T Consensus 126 ~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p 203 (260)
T cd05070 126 RDLRSANILVG-DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred CCCccceEEEe-CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999 4778999999999765332211 12234567999999865 458899999999999999999 8999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+...... ..+...+..+.+++.+||..+|++|||+.++.+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 204 YPGMNNREVLEQVERGYRM----------------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9887766665554331100 012346889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=240.04 Aligned_cols=200 Identities=24% Similarity=0.399 Sum_probs=159.7
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.++||||+++++++.. ....++||||++| +|.+.+.........+++..+..++.|++.||.|||+..+++|+|
T Consensus 65 ~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~d 139 (269)
T cd08528 65 QLRHPNIVRYYKTFLE-----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRD 139 (269)
T ss_pred cCCCCCeeeEEeeEcc-----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecC
Confidence 5789999999998843 3458999999985 777776554445567999999999999999999999524799999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|+|+||+++ .++.+||+|||.+.............++..|++||.+.+. .++.++|+||+|+++|+|++|.+||....
T Consensus 140 l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 140 LTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred CCHHHEEEC-CCCcEEEecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 999999998 4778999999999865544333455678899999999754 48999999999999999999999998776
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.......+.+....+. .....++++.+++.+||+.||++||++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 218 MLSLATKIVEAVYEPL---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHHHHHhhccCCcC---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 5554444433111100 01236889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=238.09 Aligned_cols=196 Identities=25% Similarity=0.355 Sum_probs=154.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|+||+++++++... ...|+||||++ ++|.+.+... ....+++..+..++.|++.||.|||+ +|++|
T Consensus 54 l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H 125 (256)
T cd05039 54 MTTLRHPNLVQLLGVVLQG-----NPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVH 125 (256)
T ss_pred HHhcCCcceeeeEEEEcCC-----CCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 3578999999999998543 33889999999 5877766532 22368999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||.++...... .....+..|+|||.+.+. .++.++|+||+|+++|++++ |..||.
T Consensus 126 ~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 126 RDLAARNVLVS-EDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred hhcccceEEEe-CCCCEEEccccccccccccc--ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999998 57889999999998763221 123345679999998654 58899999999999999997 999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.....+....+.+. .. ...+...++++.++|.+||..+|++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 202 RIPLKDVVPHVEKG-YR---------------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCHHHHHHHHhcC-CC---------------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 77655443333221 00 0112346899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=242.77 Aligned_cols=195 Identities=22% Similarity=0.278 Sum_probs=151.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ..++++||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ +||+||
T Consensus 64 ~~~~~~~i~~~~~~~~~~------~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~ 133 (279)
T cd05109 64 AGVGSPYVCRLLGICLTS------TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHR 133 (279)
T ss_pred HhcCCCCCceEEEEEcCC------CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 467899999999987432 2568999998 677766653 24568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
||||+||+++ +++.+||+|||+++........ ....+++.|+|||.+.+. .++.++||||+||++|+|++ |..|
T Consensus 134 dlkp~Nil~~-~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p 211 (279)
T cd05109 134 DLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ccccceEEEc-CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999999998 4677999999999866433221 112335679999998654 58999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.......... .+.....+. .+...+.++.+++.+||+.||++||++.++++
T Consensus 212 ~~~~~~~~~~~-~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 212 YDGIPAREIPD-LLEKGERLP---------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCCCCHHHHHH-HHHCCCcCC---------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 97765444333 232111110 11236889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=239.81 Aligned_cols=196 Identities=26% Similarity=0.335 Sum_probs=152.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++.+.. ...|+||||+++ +|.+.+... ....+++..+..++.|++.||+|||+ ++++||
T Consensus 56 ~~l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~ 126 (262)
T cd05071 56 KKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHR 126 (262)
T ss_pred HhCCCCCcceEEEEECC------CCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 56899999999987621 126799999994 777666532 23457899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
||||+||+++ .++.++|+|||.+......... ....++..|+|||...+. .++.++|+||+||++|+|++ |..||
T Consensus 127 dl~p~Nill~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~ 204 (262)
T cd05071 127 DLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPY 204 (262)
T ss_pred ccCcccEEEc-CCCcEEeccCCceeeccccccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999 4778999999999765432211 123456679999988644 58999999999999999999 88899
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+....+....+......+ ....++..+.+++.+||+.||++||++.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 205 PGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCChHHHHHHHhcCCCCC----------------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8877665555443211000 11236889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=244.23 Aligned_cols=197 Identities=27% Similarity=0.387 Sum_probs=151.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++..... +++|+||+. |+|.+.+... ....++...+..++.||+.||.|||+ ++++|+
T Consensus 56 ~~l~h~ni~~~~g~~~~~~~-----~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~ 127 (259)
T PF07714_consen 56 RKLRHPNIVKLYGFCIENEP-----LFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHG 127 (259)
T ss_dssp HTHSBTTBE-EEEEEESSSS-----EEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEES
T ss_pred cccccccccccccccccccc-----cccccccccccccccccccc--cccccccccccccccccccccccccc-cccccc
Confidence 46799999999999973333 889999998 6888888752 24678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
+|+++||+++ .++.+||+|||++........ .........|+|||.+.+. .++.++||||+|+++||+++ |..|
T Consensus 128 ~l~~~nill~-~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p 205 (259)
T PF07714_consen 128 NLSPSNILLD-SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFP 205 (259)
T ss_dssp T-SGGGEEEE-TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGT
T ss_pred cccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccc
Confidence 9999999999 478999999999986622211 1233457789999998654 48999999999999999999 6899
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|...+..+....+.+. .. ...+..++..+.++|.+||..||.+|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 206 FSDYDNEEIIEKLKQG-QR---------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TTTSCHHHHHHHHHTT-EE---------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccccc-cc---------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9888777666665331 00 0122347899999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=238.88 Aligned_cols=197 Identities=25% Similarity=0.311 Sum_probs=154.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++. + ...|+||||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ .|++|
T Consensus 55 l~~l~h~~i~~~~~~~~-----~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H 125 (260)
T cd05069 55 MKKLRHDKLVPLYAVVS-----E-EPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIH 125 (260)
T ss_pred HHhCCCCCeeeEEEEEc-----C-CCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEee
Confidence 35789999999998762 1 126799999985 787777542 23457899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ +++.++|+|||++........ .....++..|+|||...+ ..++.++|+||+|+++|+|++ |..|
T Consensus 126 ~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p 203 (260)
T cd05069 126 RDLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP 203 (260)
T ss_pred cccCcceEEEc-CCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999 578899999999976533221 112345677999998865 458999999999999999999 8999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....+....+.+... + ..+...+..+.+++++||+.||.+||+++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 204 YPGMVNREVLEQVERGYR-M---------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCHHHHHHHHHcCCC-C---------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 988776665554433100 0 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=240.53 Aligned_cols=197 Identities=23% Similarity=0.335 Sum_probs=152.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++.. ...+++||||+++ +|.+.+.. ..+.+++..++.++.|++.||+|||+ +|++|
T Consensus 59 l~~l~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H 129 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTK-----SRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVH 129 (269)
T ss_pred HHhCCCcCcceEEEEECC-----CCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEee
Confidence 357899999999998843 3348899999985 66655543 24568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccce---e---ecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---I---CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 152 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~---~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~- 152 (296)
|||||+||+++ .++.+||+|||++............ . .+..|+|||.+.+ ..++.++|+||+||++|++++
T Consensus 130 ~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~ 207 (269)
T cd05065 130 RDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSY 207 (269)
T ss_pred cccChheEEEc-CCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcC
Confidence 99999999998 4778999999998765332221111 1 1346999999865 458999999999999999886
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||...+..+....+......+ .+..++..+.+++.+||+.+|.+||++.
T Consensus 208 g~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (269)
T cd05065 208 GERPYWDMSNQDVINAIEQDYRLP----------------------------PPMDCPTALHQLMLDCWQKDRNARPKFG 259 (269)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCC----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999998877665554443211100 1123678899999999999999999999
Q ss_pred HHhc
Q 022500 233 EACA 236 (296)
Q Consensus 233 e~l~ 236 (296)
+++.
T Consensus 260 ~i~~ 263 (269)
T cd05065 260 QIVS 263 (269)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=246.27 Aligned_cols=198 Identities=23% Similarity=0.335 Sum_probs=152.2
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHH
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~aL 68 (296)
.+ +||||+++++++... ...|+||||++ |+|.+.+..... ....++...++.++.|++.||
T Consensus 79 ~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 153 (307)
T cd05098 79 MIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGM 153 (307)
T ss_pred HhcCCCCEeeEEEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHH
Confidence 45 799999999988433 34889999998 588777764211 123588899999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
+|||+ +|++||||||+||+++ .++.+||+|||++......... ....+++.|+|||.+.+. .++.++|+||+||
T Consensus 154 ~~lH~-~gi~H~dlkp~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~ 230 (307)
T cd05098 154 EYLAS-KKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGV 230 (307)
T ss_pred HHHHH-CCcccccccHHheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHH
Confidence 99999 7999999999999999 4678999999998765332111 112234679999998654 5899999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 146 VLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 146 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
++|+|++ |..||.+....+....+... .. ...+...+.++.+++.+||..+
T Consensus 231 ~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~ 282 (307)
T cd05098 231 LLWEIFTLGGSPYPGVPVEELFKLLKEG-HR---------------------------MDKPSNCTNELYMMMRDCWHAV 282 (307)
T ss_pred HHHHHHcCCCCCCCcCCHHHHHHHHHcC-CC---------------------------CCCCCcCCHHHHHHHHHHcccC
Confidence 9999998 88899776654443332210 00 0112346889999999999999
Q ss_pred CCCCCCHHHHhc
Q 022500 225 PSLRCTALEACA 236 (296)
Q Consensus 225 p~~R~t~~e~l~ 236 (296)
|++|||+.++++
T Consensus 283 p~~Rps~~evl~ 294 (307)
T cd05098 283 PSQRPTFKQLVE 294 (307)
T ss_pred hhhCcCHHHHHH
Confidence 999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=241.80 Aligned_cols=211 Identities=27% Similarity=0.356 Sum_probs=151.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... +...+|+||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ +||+|
T Consensus 60 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H 130 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQ---GGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIH 130 (283)
T ss_pred HHhCCCCCEeeEEEEEecC---CCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 4578999999999987432 23347899999995 66555542 459999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.+||+|||+++....... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..
T Consensus 131 ~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~ 208 (283)
T cd05080 131 RDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCD 208 (283)
T ss_pred cccChheEEEc-CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCC
Confidence 99999999998 467899999999986543221 1122346679999998653 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHh-cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 156 LFPGENAVDQLVEIIKV-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
||...... +..+... .+......+..... .......+...+.++.+++.+||+.+|++|||++++
T Consensus 209 p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i 274 (283)
T cd05080 209 SKQSPPKK--FEEMIGPKQGQMTVVRLIELLE------------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274 (283)
T ss_pred CCCCCcch--hhhhhcccccccchhhhhhhhh------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 98654321 1111110 00000000000000 000011234578899999999999999999999999
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 275 ~~ 276 (283)
T cd05080 275 IP 276 (283)
T ss_pred HH
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=238.29 Aligned_cols=192 Identities=19% Similarity=0.212 Sum_probs=147.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. . ..++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 55 l~~l~h~~i~~~~~~~~~-~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H 124 (259)
T cd05037 55 MSQLSHKHLVKLYGVCVR-D-----ENIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLED-KKLVH 124 (259)
T ss_pred HHcCCCcchhheeeEEec-C-----CcEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhh-CCeec
Confidence 467899999999998754 2 26799999995 66665553 22268999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCC-------cEEEeeccCccccccCCCccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTH-------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 80 ~dlkp~Nill~~~~~-------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll 151 (296)
|||||+||+++. ++ .+||+|||++..... .....++..|+|||++.+. ..++.++|+||+||++|+|+
T Consensus 125 ~dlkp~Nill~~-~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 125 GNVCGKNILVAR-YGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred ccCccceEEEec-CccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999999984 44 699999999986543 2234567789999998664 35889999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 152 L-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 152 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
+ |..||...+..+....... . ...+......+.+++.+||+.+|.+|||
T Consensus 201 ~~~~~p~~~~~~~~~~~~~~~-~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt 250 (259)
T cd05037 201 SNGEEPLSTLSSSEKERFYQD-Q-----------------------------HRLPMPDCAELANLINQCWTYDPTKRPS 250 (259)
T ss_pred hCCCCCcccCCchhHHHHHhc-C-----------------------------CCCCCCCchHHHHHHHHHhccChhhCCC
Confidence 9 5777866543222111110 0 0001112378999999999999999999
Q ss_pred HHHHhc
Q 022500 231 ALEACA 236 (296)
Q Consensus 231 ~~e~l~ 236 (296)
+.++++
T Consensus 251 ~~~il~ 256 (259)
T cd05037 251 FRAILR 256 (259)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=237.03 Aligned_cols=197 Identities=25% Similarity=0.367 Sum_probs=152.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++.... ..++||||++| +|.+.+.. ....+++..+..++.|++.||.|||+ ++++|
T Consensus 46 l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h 116 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQ-----PIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIH 116 (251)
T ss_pred HHhCCCCCeEEEEEEEecCC-----CeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeh
Confidence 35789999999999885433 48899999985 66665543 23468899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+||+++ .++.+||+|||++......... .....+..|+|||.+.+. .++.++|+||+||++|+|++ |..
T Consensus 117 ~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~ 194 (251)
T cd05041 117 RDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDT 194 (251)
T ss_pred hhcCcceEEEc-CCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCC
Confidence 99999999998 5778999999999765321111 112235569999998654 58999999999999999999 789
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.........+...... ..+..++.++.+++.+||+.+|.+|||+.|++
T Consensus 195 p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell 246 (251)
T cd05041 195 PYPGMSNQQTRERIESGYRM----------------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY 246 (251)
T ss_pred CCccCCHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 99777654444333221000 01234688999999999999999999999998
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 247 ~ 247 (251)
T cd05041 247 N 247 (251)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=238.80 Aligned_cols=198 Identities=26% Similarity=0.351 Sum_probs=156.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ....++||||+++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|
T Consensus 55 l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h 126 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSE-----EEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIH 126 (261)
T ss_pred HhhCCCCCEeeeeeeeec-----CCceEEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 357899999999998743 2348899999985 777666531 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
+||||+||+++ .++.+||+|||++......... ....++..|+|||.+.+. .++.++|+||+||++|++++ |..|
T Consensus 127 ~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p 204 (261)
T cd05034 127 RDLAARNILVG-ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVP 204 (261)
T ss_pred CCcchheEEEc-CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999 4788999999998765432111 122335679999998654 58999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+....+..+......+ .+...+.++.+++.+||+.+|++||+++++.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 205 YPGMTNREVLEQVERGYRMP----------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 98887766666554321110 11235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=236.88 Aligned_cols=197 Identities=19% Similarity=0.299 Sum_probs=153.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++++||||+++++++.. ....|+||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ .+++|
T Consensus 53 l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h 123 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTE-----RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIH 123 (256)
T ss_pred HHhCCCCCeeeEEEEEcc-----CCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 357899999999998843 3348899999995 55555542 23568899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++|+|++ |..|
T Consensus 124 ~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p 201 (256)
T cd05112 124 RDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTP 201 (256)
T ss_pred cccccceEEEc-CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999998 577899999999875533221 1122345689999998654 58899999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|......+....+.+.. ....+...+..+.+|+.+||+.+|++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 202 YENRSNSEVVETINAGF----------------------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred CCcCCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 98877665555442210 00011235789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=237.91 Aligned_cols=201 Identities=29% Similarity=0.458 Sum_probs=155.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++++... ...++||||++ |+|...+.........+++..+..++.|++.||.|||+ .|++|
T Consensus 56 l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h 129 (267)
T cd08224 56 LKQLDHPNVIKYLASFIEN-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMH 129 (267)
T ss_pred HHhCCCCCeeeeeeeeecC-----CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 3578999999999998543 34889999999 48877776544445668999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||+|+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus 130 ~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 130 RDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCcChhhEEEC-CCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 99999999998 477899999999876543322 2335678899999998654 58899999999999999999999996
Q ss_pred CCCh--HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENA--VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.... .+....+.... .+. ......+.++.++|.+||..+|++|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~-------------------~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 208 GDKMNLYSLCKKIEKCD-------------------YPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cCCccHHHHHhhhhcCC-------------------CCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5531 11111111100 000 001146789999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=239.78 Aligned_cols=196 Identities=29% Similarity=0.403 Sum_probs=153.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. . ..|+||||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ .|++|
T Consensus 61 l~~~~h~~i~~~~~~~~~-----~-~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H 130 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-----N-PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVH 130 (270)
T ss_pred HHhCCCCchhceeEEEcC-----C-CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 357899999999998742 1 2579999998 577776653 23458999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||+++........ ....++..|+|||.+.+ ..++.++|+||+|+++|++++ |..|
T Consensus 131 ~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p 208 (270)
T cd05056 131 RDIAARNVLVS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKP 208 (270)
T ss_pred cccChheEEEe-cCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCC
Confidence 99999999999 4778999999998765433211 11223467999999865 458999999999999999986 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.+.... ..+..++.++.+++.+|+..+|++|||+.+++.
T Consensus 209 f~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 209 FQGVKNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCCCCHHHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9888766655444321000 012347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=242.16 Aligned_cols=200 Identities=25% Similarity=0.316 Sum_probs=154.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh------------------hcCCCCCHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS------------------SANQRMPLIYVKLYT 61 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~------------------~~~~~~~~~~~~~~~ 61 (296)
|++++||||+++++++.. ...+|+||||++ |+|.+.+.... .....+++..+..++
T Consensus 62 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 136 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIA 136 (288)
T ss_pred HHhcCCCchheEEEEEcC-----CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHH
Confidence 356899999999998843 334789999999 57777775421 112347888899999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchh
Q 022500 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSI 138 (296)
Q Consensus 62 ~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 138 (296)
.|++.||.|||+ ++++||||||+||+++ .++.++|+|||++........ ......+..|+|||.+.+. .++.++
T Consensus 137 ~~i~~aL~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 213 (288)
T cd05050 137 KQVAAGMAYLSE-RKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTES 213 (288)
T ss_pred HHHHHHHHHHHh-CCeecccccHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchh
Confidence 999999999999 7999999999999998 578899999999875432211 1223346679999998654 589999
Q ss_pred HHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHH
Q 022500 139 DIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 217 (296)
Q Consensus 139 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 217 (296)
|+||+||++|+|++ |..||.+.+..+....+...... ..+..++.++.+|+
T Consensus 214 Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li 265 (288)
T cd05050 214 DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL----------------------------SCPDNCPLELYNLM 265 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHH
Confidence 99999999999997 88899887766655444321000 01123688999999
Q ss_pred HcccccCCCCCCCHHHHhc
Q 022500 218 SRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 218 ~~~L~~~p~~R~t~~e~l~ 236 (296)
.+||+.+|++|||+.|+++
T Consensus 266 ~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 266 RLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=247.42 Aligned_cols=200 Identities=23% Similarity=0.328 Sum_probs=154.9
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHH
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~~~~qil~a 67 (296)
+++ +||||+++++++... ..+++++||++ |+|.+.+.... .....++...+..++.|++.|
T Consensus 72 ~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 146 (334)
T cd05100 72 KMIGKHKNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARG 146 (334)
T ss_pred HhhcCCCCeeeeeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHH
Confidence 456 799999999988433 34889999998 57777776421 122357888899999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|.|||+ +|++||||||+||+++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++|+||+|
T Consensus 147 l~~LH~-~givH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG 223 (334)
T cd05100 147 MEYLAS-QKCIHRDLAARNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFG 223 (334)
T ss_pred HHHHHH-CCeeccccccceEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHH
Confidence 999999 7999999999999998 4778999999999765332211 112234679999998654 589999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
|++|+|++ |..||.+.+..+....+..... ...+...+.++.+++.+||+.
T Consensus 224 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~ 275 (334)
T cd05100 224 VLLWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHA 275 (334)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHccc
Confidence 99999998 8899988876665544432100 001234688999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 022500 224 SPSLRCTALEACAH 237 (296)
Q Consensus 224 ~p~~R~t~~e~l~h 237 (296)
+|.+|||+.+++++
T Consensus 276 ~p~~Rps~~ell~~ 289 (334)
T cd05100 276 VPSQRPTFKQLVED 289 (334)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=237.82 Aligned_cols=197 Identities=25% Similarity=0.352 Sum_probs=154.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...|+||||+. ++|.+.+.. ..+..+++..+..++.|++.||+|||+ .|++|
T Consensus 55 l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H 125 (260)
T cd05067 55 MKQLQHPRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIH 125 (260)
T ss_pred HHhcCCcCeeeEEEEEcc------CCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeec
Confidence 467899999999987621 13789999998 577776653 234568999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+|+++|++++ |..|
T Consensus 126 ~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p 203 (260)
T cd05067 126 RDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIP 203 (260)
T ss_pred ccccHHhEEEc-CCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCC
Confidence 99999999999 577899999999976542221 112344678999999865 458899999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+......+ .+...+.++.+++.+||+.+|++|||++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 204 YPGMTNPEVIQNLERGYRMP----------------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCChHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 98877665554443211100 11336889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=241.27 Aligned_cols=207 Identities=21% Similarity=0.267 Sum_probs=153.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhh--------cCCCCCHHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS--------ANQRMPLIYVKLYTYQIFRGLAYI 71 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~--------~~~~~~~~~~~~~~~qil~aL~~L 71 (296)
|++++||||+++++++... ...++||||+.+ +|.+.+..... ....+++..+..++.|++.||+||
T Consensus 71 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 145 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145 (295)
T ss_pred HHhCCCCCcCeEEEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH
Confidence 4678999999999998533 348899999995 77776643210 112468888999999999999999
Q ss_pred HhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 72 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 72 H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
|+ +|++||||||+||+++ .++.+||+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|
T Consensus 146 H~-~~i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~ 222 (295)
T cd05097 146 AS-LNFVHRDLATRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLW 222 (295)
T ss_pred Hh-cCeeccccChhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHH
Confidence 99 7999999999999998 577899999999976533221 1122346789999998654 5899999999999999
Q ss_pred HHHh--CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 149 ELLL--GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 149 ~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
+|++ |..||...+..+....+.+...... ...+ ...+...++.+.+|+.+||+.||.
T Consensus 223 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 223 EMFTLCKEQPYSLLSDEQVIENTGEFFRNQG-------RQIY--------------LSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred HHHHcCCCCCCcccChHHHHHHHHHhhhhcc-------cccc--------------CCCCCCCCHHHHHHHHHHcCCCch
Confidence 9988 6678887766555544332110000 0000 001123688999999999999999
Q ss_pred CCCCHHHHhc
Q 022500 227 LRCTALEACA 236 (296)
Q Consensus 227 ~R~t~~e~l~ 236 (296)
+|||++++++
T Consensus 282 ~RPs~~~i~~ 291 (295)
T cd05097 282 DRPTFNKIHH 291 (295)
T ss_pred hCcCHHHHHH
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=238.41 Aligned_cols=201 Identities=21% Similarity=0.286 Sum_probs=154.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTV 74 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~-----~~~~~~~~~~~~~~qil~aL~~LH~~ 74 (296)
|++++||||+++++++. +....|+||||++ |+|.+.+...... ...+++..+..++.|++.||+|||+
T Consensus 62 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~- 135 (275)
T cd05046 62 FRKLSHKNVVRLLGLCR-----EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN- 135 (275)
T ss_pred HHhcCCcceeeeEEEEC-----CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-
Confidence 35789999999999873 3344889999999 5777776643211 1268999999999999999999999
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
+||+||||||+||+++ .++.++++|||++....... ......++..|+|||.+.+. .++.++|+||+|+++|++++
T Consensus 136 ~~i~H~dlkp~Nili~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~ 213 (275)
T cd05046 136 ARFVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFT 213 (275)
T ss_pred cCcccCcCccceEEEe-CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHh
Confidence 7999999999999998 47789999999987543221 12234567789999998654 47899999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 -GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|..||.+......+..+... .... ..+..++..+.+++.+||+.+|++|||+
T Consensus 214 ~~~~p~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~ 266 (275)
T cd05046 214 QGELPFYGLSDEEVLNRLQAG-----------------KLEL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSF 266 (275)
T ss_pred CCCCCccccchHHHHHHHHcC-----------------CcCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 78899776655444433210 0000 0123478899999999999999999999
Q ss_pred HHHhc
Q 022500 232 LEACA 236 (296)
Q Consensus 232 ~e~l~ 236 (296)
.++++
T Consensus 267 ~~~l~ 271 (275)
T cd05046 267 SELVS 271 (275)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=241.51 Aligned_cols=207 Identities=21% Similarity=0.276 Sum_probs=152.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA-------NQRMPLIYVKLYTYQIFRGLAYIH 72 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~-------~~~~~~~~~~~~~~qil~aL~~LH 72 (296)
|+.++||||+++++++.... ..|+||||+. |+|.+.+...... ...+++..+..++.|++.||+|||
T Consensus 73 l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 147 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS 147 (296)
T ss_pred HHhCCCCCcceEEEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 35789999999999885433 3889999998 5777776543211 134778889999999999999999
Q ss_pred hCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHH
Q 022500 73 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 73 ~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 149 (296)
+ .|++||||||+||+++ .++.++|+|||++........ .....++..|++||...+. .++.++|+||+||++|+
T Consensus 148 ~-~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~e 224 (296)
T cd05095 148 S-LNFVHRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWE 224 (296)
T ss_pred H-CCeecccCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHH
Confidence 9 7999999999999998 477899999999986533221 1122335679999987654 58999999999999999
Q ss_pred HHh--CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC
Q 022500 150 LLL--GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 150 ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~ 227 (296)
|++ |..||...+..+......+.. ... ...... ..+..+++.+.+|+.+||+.||.+
T Consensus 225 l~~~~~~~p~~~~~~~~~~~~~~~~~--------~~~---~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~ 283 (296)
T cd05095 225 ILTLCKEQPYSQLSDEQVIENTGEFF--------RDQ---GRQVYL----------PKPALCPDSLYKLMLSCWRRNAKE 283 (296)
T ss_pred HHHhCCCCCccccChHHHHHHHHHHH--------hhc---cccccC----------CCCCCCCHHHHHHHHHHcCCCccc
Confidence 998 778887766554443322110 000 000000 011236789999999999999999
Q ss_pred CCCHHHHhc
Q 022500 228 RCTALEACA 236 (296)
Q Consensus 228 R~t~~e~l~ 236 (296)
||++.++.+
T Consensus 284 Rp~~~~i~~ 292 (296)
T cd05095 284 RPSFQEIHA 292 (296)
T ss_pred CCCHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=240.10 Aligned_cols=201 Identities=19% Similarity=0.261 Sum_probs=155.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA----NQRMPLIYVKLYTYQIFRGLAYIHTVP 75 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~----~~~~~~~~~~~~~~qil~aL~~LH~~~ 75 (296)
|+.++||||+++++++... ....++++||++ ++|.+.+...... ...+++..+..++.|++.||+|||+ +
T Consensus 62 l~~l~h~ni~~~~~~~~~~----~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~ 136 (280)
T cd05043 62 LYGLSHQNILPILHVCIED----GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-R 136 (280)
T ss_pred HHhCCCCCCCeEEEEEecC----CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence 3578999999999987533 223779999998 6777776543221 1468999999999999999999999 7
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
+++||||||+||+++ .++.+||+|||+++.+...... ....++..|+|||++.+. .++.++||||+||++|++++
T Consensus 137 ~i~H~di~p~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~ 214 (280)
T cd05043 137 GVIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMT 214 (280)
T ss_pred CEeecccCHhhEEEc-CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhc
Confidence 999999999999998 5788999999999865332211 123346679999998654 58999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 -GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|..||...+..+....+.... . .. ....+++++.+++.+||+.||++|||+
T Consensus 215 ~g~~p~~~~~~~~~~~~~~~~~-~-----------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~ 266 (280)
T cd05043 215 LGQTPYVEIDPFEMAAYLKDGY-R-----------------LA----------QPINCPDELFAVMACCWALDPEERPSF 266 (280)
T ss_pred CCCCCcCcCCHHHHHHHHHcCC-C-----------------CC----------CCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 999998876655443332210 0 00 112367899999999999999999999
Q ss_pred HHHhc
Q 022500 232 LEACA 236 (296)
Q Consensus 232 ~e~l~ 236 (296)
.++++
T Consensus 267 ~~~~~ 271 (280)
T cd05043 267 SQLVQ 271 (280)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=242.06 Aligned_cols=206 Identities=18% Similarity=0.169 Sum_probs=151.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++|+||++++++..... ....+.++++|++..++.+.+.. ....++..++.++.|++.||+|||+ ++|+|||
T Consensus 78 ~~~~h~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrD 151 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGD 151 (294)
T ss_pred ccCCCCCCCcEEEeeeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 3578999999998764332 22335678999988776665543 2346788899999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC--------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
|||+|||++ .++.++|+|||+|+...... ......||+.|+|||++.+. .++.++||||+||++|+|++|
T Consensus 152 iKp~Nill~-~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 152 IKPENIMVD-GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCHHHEEEc-CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhC
Confidence 999999998 46789999999998653221 11234689999999998654 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
..||.+...........+. +.+..+.. + .......++++.++++.|+..+|++||+.++
T Consensus 230 ~~P~~~~~~~~~~~~~~~~------~~~~~~~~-------~--------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~ 288 (294)
T PHA02882 230 KLPWKGFGHNGNLIHAAKC------DFIKRLHE-------G--------KIKIKNANKFIYDFIECVTKLSYEEKPDYDA 288 (294)
T ss_pred CCCCCccccchHHHHHhHH------HHHHHhhh-------h--------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence 9999877432222211110 00000000 0 0001235789999999999999999999999
Q ss_pred Hhc
Q 022500 234 ACA 236 (296)
Q Consensus 234 ~l~ 236 (296)
+++
T Consensus 289 l~~ 291 (294)
T PHA02882 289 LIK 291 (294)
T ss_pred HHH
Confidence 875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=254.07 Aligned_cols=203 Identities=26% Similarity=0.350 Sum_probs=162.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++||+...... ++||||+|.| +|.+.++. ..+.++..+...++.+.+.||+|||+ ++++|
T Consensus 215 Mr~l~H~NVVr~yGVa~~~~P-----l~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IH 285 (474)
T KOG0194|consen 215 MRQLNHPNVVRFYGVAVLEEP-----LMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHS-KNCIH 285 (474)
T ss_pred HHhCCCCCEEEEEEEEcCCCc-----cEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcc
Confidence 678999999999999865554 8999999995 77777764 23369999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccce-eecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
|||-..|+|++ .++.+||+|||+++........... --...|+|||.+... .|+.++||||+||++||+++ |..||
T Consensus 286 RDIAARNcL~~-~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 286 RDIAARNCLYS-KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred hhHhHHHheec-CCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCC
Confidence 99999999999 4677899999998764311111111 124679999999654 69999999999999999998 78899
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
++....+...+|+...-+ ...+...+.+...++.+|+..||++|+|+.++.+
T Consensus 364 ~g~~~~~v~~kI~~~~~r---------------------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~- 415 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYR---------------------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK- 415 (474)
T ss_pred CCCCHHHHHHHHHhcCcc---------------------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH-
Confidence 999998888887542111 1122346888999999999999999999998865
Q ss_pred CCcccc
Q 022500 238 PFFDEL 243 (296)
Q Consensus 238 p~f~~~ 243 (296)
++..+
T Consensus 416 -~l~~~ 420 (474)
T KOG0194|consen 416 -KLEAL 420 (474)
T ss_pred -HHHHH
Confidence 44443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=242.60 Aligned_cols=234 Identities=29% Similarity=0.475 Sum_probs=180.0
Q ss_pred CCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCc
Q 022500 7 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 86 (296)
Q Consensus 7 pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~N 86 (296)
.+||+|++.|.-.+ .+..++|+|+|+++.+|+..++.. ...-++...++.|++||+.||.|||...||||.||||+|
T Consensus 142 ~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred ceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 47999999997666 678899999999999999988864 335588999999999999999999997899999999999
Q ss_pred EEEcC---------------------------------------------------------------------------
Q 022500 87 LLVDP--------------------------------------------------------------------------- 91 (296)
Q Consensus 87 ill~~--------------------------------------------------------------------------- 91 (296)
||+..
T Consensus 219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~ 298 (590)
T KOG1290|consen 219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP 298 (590)
T ss_pred eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence 99820
Q ss_pred ---------------------------------------C----------------------------------------
Q 022500 92 ---------------------------------------L---------------------------------------- 92 (296)
Q Consensus 92 ---------------------------------------~---------------------------------------- 92 (296)
.
T Consensus 299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~ 378 (590)
T KOG1290|consen 299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP 378 (590)
T ss_pred cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence 0
Q ss_pred -----------CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-
Q 022500 93 -----------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE- 160 (296)
Q Consensus 93 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~- 160 (296)
+.+|||+|||.|.+. ....+..+.|+.|+|||++.|.. |+..+||||++|++|||+||..+|...
T Consensus 379 ~v~p~~~~~~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 379 LVNPDIPLPECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred ccCCCCCCCccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 003577777777654 22334567899999999999864 999999999999999999999998543
Q ss_pred -----ChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCc-----cCCCCCCCCcccc------cCCCCCHHHHHHHHcccc
Q 022500 161 -----NAVDQLVEIIKVLGTPTREEIRCMNP--NYTDF-----RFPQIKAHPWHKV------FHKRMPPEAIDLASRLLQ 222 (296)
Q Consensus 161 -----~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~------~~~~~~~~~~dll~~~L~ 222 (296)
.+.+.++.|++.+|..+......... .|-+. .+...+..++... ++..-..++.|||.-||+
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 36789999999999988776644321 11100 1112222222221 222334678999999999
Q ss_pred cCCCCCCCHHHHhcCCCcccccCC
Q 022500 223 YSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 223 ~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
++|++|+||.++|+|||+.....+
T Consensus 536 f~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cCccccccHHHHhcCccccCCCCC
Confidence 999999999999999999976543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=265.92 Aligned_cols=93 Identities=27% Similarity=0.413 Sum_probs=79.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. ...++|+||||+. ++|.+.+.. .+.+++..++.++.||+.||.|||. +||+||
T Consensus 59 ~~l~hp~Iv~~~~~~~-----~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHr 128 (669)
T cd05610 59 ALSKSPFIVHLYYSLQ-----SANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHR 128 (669)
T ss_pred HhcCCCCcCeEEEEEE-----ECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeC
Confidence 5679999999998874 3345899999997 477666653 3568899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
||||+|||++ .++.+||+|||+++
T Consensus 129 DLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 129 DLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred CccHHHEEEc-CCCCEEEEeCCCCc
Confidence 9999999998 57889999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=234.94 Aligned_cols=197 Identities=28% Similarity=0.395 Sum_probs=154.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ...|++|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ .|++||
T Consensus 56 ~~l~~~~i~~~~~~~~~~-----~~~~~i~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~ 127 (258)
T smart00219 56 RKLDHPNIVKLLGVCTEE-----EPLMIVMEYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLES-KNFIHR 127 (258)
T ss_pred HhcCCCchheEEEEEcCC-----CeeEEEEeccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhc-CCeeec
Confidence 467999999999988543 348899999985 776666532 11228999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCcc--ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
||||+||+++ .++.++|+|||++.......... ...+++.|+|||.+.+ ..++.++|+||+|+++++|++ |.+||
T Consensus 128 dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~ 205 (258)
T smart00219 128 DLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY 205 (258)
T ss_pred ccccceEEEc-cCCeEEEcccCCceecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999 47789999999998664432211 1235688999999854 458999999999999999998 78999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+.+.......+..... ...+...+.++.+++.+||..||++|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 206 PGMSNEEVLEYLKKGYR----------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCHHHHHHHHhcCCC----------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 88766655554432100 0011236889999999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=265.56 Aligned_cols=202 Identities=22% Similarity=0.303 Sum_probs=150.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA-------NQRMPLIYVKLYTYQIFRGLAYIH 72 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~-------~~~~~~~~~~~~~~qil~aL~~LH 72 (296)
|++++||||+++++++.. ....|+||||++| +|.+.+...... ....+...+..++.||+.||+|||
T Consensus 56 Ls~L~HPNIVkl~~v~~d-----~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH 130 (932)
T PRK13184 56 AADLIHPGIVPVYSICSD-----GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH 130 (932)
T ss_pred HHhCCCcCcCeEEEEEee-----CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999998843 3348899999995 777776542211 234566778899999999999999
Q ss_pred hCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC-------------------CccceeecccccCchhccCCCC
Q 022500 73 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-------------------ANISYICSRFYRAPELIFGATE 133 (296)
Q Consensus 73 ~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~ 133 (296)
+ +||+||||||+||+++ .++.+||+|||+++...... .....+||+.|+|||++.+. .
T Consensus 131 s-~GIIHRDLKPeNILLd-~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~ 207 (932)
T PRK13184 131 S-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-P 207 (932)
T ss_pred H-CCccccCCchheEEEc-CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-C
Confidence 9 7999999999999999 47789999999997651110 01124689999999998764 5
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHH
Q 022500 134 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA 213 (296)
Q Consensus 134 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (296)
++.++||||+||++|+|++|..||.+.+....... .....|. . .. ....+++.+
T Consensus 208 ~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~--~-----------------~~-----p~~~iP~~L 261 (932)
T PRK13184 208 ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPI--E-----------------VA-----PYREIPPFL 261 (932)
T ss_pred CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChh--h-----------------cc-----ccccCCHHH
Confidence 89999999999999999999999987554332211 0000000 0 00 012478899
Q ss_pred HHHHHcccccCCCCCCCHHHHhc
Q 022500 214 IDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 214 ~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+++.+||+.||++|++..+.+.
T Consensus 262 ~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 262 SQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999987665543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=237.72 Aligned_cols=196 Identities=26% Similarity=0.330 Sum_probs=153.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...++||||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ +|++|
T Consensus 63 l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H 132 (279)
T cd05057 63 MASVDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVH 132 (279)
T ss_pred HHhCCCCCcceEEEEEec------CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEe
Confidence 357899999999998854 23789999998 577666653 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccc---eeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+||+++ .++.+||+|||+++.......... ..++..|+|||.+.. ..++.++|+||+||++|++++ |..
T Consensus 133 ~di~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~ 210 (279)
T cd05057 133 RDLAARNVLVK-TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred cccCcceEEEc-CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCC
Confidence 99999999998 577899999999986543322111 122467999998854 458899999999999999998 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+....+....+.+. ... ..+...+.++.+++.+||..||.+|||+.+++
T Consensus 211 p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 211 PYEGIPAVEIPDLLEKG-ERL---------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred CCCCCCHHHHHHHHhCC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 99887665544433321 000 01123578899999999999999999999987
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 263 ~ 263 (279)
T cd05057 263 N 263 (279)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=260.10 Aligned_cols=210 Identities=29% Similarity=0.412 Sum_probs=174.8
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.-+|||++.+|++|.-........++||||||+ |+..++++... +.++.|..+..|++.++.||.+||. +.++|||
T Consensus 72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRD 148 (953)
T KOG0587|consen 72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRD 148 (953)
T ss_pred ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeec
Confidence 458999999999998655555666999999999 58888888765 7889999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCC----CCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||-.|||++ .++.|||+|||.+...... ....+.+|||.|||||++... ..|+..+|+||||++..||.-|.+|
T Consensus 149 ikG~NiLLT-~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP 227 (953)
T KOG0587|consen 149 IKGQNVLLT-ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP 227 (953)
T ss_pred ccCceEEEe-ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC
Confidence 999999999 5788999999999876543 344678999999999999543 2367899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+....++..+..|-+. |++. -..++..++++.|||..||.+|..+||+..++++
T Consensus 228 l~DmHPmraLF~IpRN---PPPk-----------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 228 LCDMHPMRALFLIPRN---PPPK-----------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccCcchhhhhccCCCC---CCcc-----------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 9988877766555431 1100 0012346899999999999999999999999999
Q ss_pred CCCccc
Q 022500 237 HPFFDE 242 (296)
Q Consensus 237 hp~f~~ 242 (296)
|||+++
T Consensus 282 hpFi~e 287 (953)
T KOG0587|consen 282 HPFITE 287 (953)
T ss_pred CCcccc
Confidence 999974
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=234.30 Aligned_cols=195 Identities=21% Similarity=0.331 Sum_probs=152.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... ..|+||||+. ++|.+.+... ....+++..+..++.|++.||.|||+ +|++|
T Consensus 53 l~~~~~~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H 123 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN------GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVH 123 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC------CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 3578999999999987421 1679999998 5877777642 23458899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++...... ......+..|+|||.+.+ ..++.++|+||+||++|+|++ |..||.
T Consensus 124 ~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 124 RDLAARNILVS-EDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred cccCcceEEEc-CCCcEEECCCccceecccc--CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 99999999998 4778999999998754321 122234567999999865 458999999999999999997 999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+.+..+....+.+.. . . .....++..+.+++.+||+.+|.+||++++++.
T Consensus 200 ~~~~~~~~~~~~~~~-~-----------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 200 KMSLKEVKECVEKGY-R-----------------M----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCHHHHHHHHhCCC-C-----------------C----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 877655443332210 0 0 011346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=247.24 Aligned_cols=156 Identities=25% Similarity=0.376 Sum_probs=123.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchh
Q 022500 51 RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPEL 127 (296)
Q Consensus 51 ~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~ 127 (296)
.+++..+..++.||+.||+|||+ ++++||||||+||+++ .++.+||+|||+++...... ......+++.|+|||.
T Consensus 235 ~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 312 (401)
T cd05107 235 ALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES 312 (401)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence 46777889999999999999999 7999999999999998 47789999999997643221 1223456788999999
Q ss_pred ccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccC
Q 022500 128 IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 206 (296)
Q Consensus 128 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (296)
+.+. .++.++|+||+||++|+|++ |..||......+.....+...-.+ ..+
T Consensus 313 ~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~---------------------------~~p 364 (401)
T cd05107 313 IFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM---------------------------AKP 364 (401)
T ss_pred hcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC---------------------------CCC
Confidence 8654 58999999999999999998 889998766555444333210000 012
Q ss_pred CCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 207 KRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 207 ~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
..++.++.+++.+||..+|.+||+++++++
T Consensus 365 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 365 AHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=235.08 Aligned_cols=197 Identities=24% Similarity=0.354 Sum_probs=154.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|+||+++++++.. ...+++|||++ ++|.+.+... ....+++..+..++.|++.||.|||+ .|++|
T Consensus 55 l~~l~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H 125 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIH 125 (260)
T ss_pred HHhcCCCCcceEEEEEcC------CCeEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 457899999999988743 23789999998 5777776542 24567888999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||.+........ .....++..|+|||++.+ ..++.++|+||+||++|++++ |..|
T Consensus 126 ~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p 203 (260)
T cd05073 126 RDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIP 203 (260)
T ss_pred cccCcceEEEc-CCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCC
Confidence 99999999998 578899999999876533221 112234567999999865 458899999999999999998 8999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+...... ......+.++.+++.+||+.+|++||++.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 204 YPGMSNPEVIRALERGYRM----------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCCCHHHHHHHHhCCCCC----------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9887765555443321100 011346889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=240.59 Aligned_cols=196 Identities=23% Similarity=0.321 Sum_probs=151.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++++... ..++++||++ |+|.+.+.. ....+++..+..++.|++.||.|||+ +||+|
T Consensus 63 ~~~l~h~niv~~~~~~~~~------~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH 132 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVH 132 (303)
T ss_pred HHhCCCCCcccEEEEEcCC------CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeec
Confidence 3578999999999987532 1468999999 577766653 23468899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+||+++ .++.+||+|||+++........ ....++..|+|||.+.+ ..++.++||||+||++|+|++ |..
T Consensus 133 ~dikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~ 210 (303)
T cd05110 133 RDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGK 210 (303)
T ss_pred cccccceeeec-CCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999998 4678999999999865432221 12334678999999865 458999999999999999997 889
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+....+. ..++.....+. .+...+.++.+++.+||..+|++||++.+++
T Consensus 211 p~~~~~~~~~-~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~ 262 (303)
T cd05110 211 PYDGIPTREI-PDLLEKGERLP---------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELA 262 (303)
T ss_pred CCCCCCHHHH-HHHHHCCCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9977654333 22322111000 0123578899999999999999999999987
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 263 ~ 263 (303)
T cd05110 263 A 263 (303)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=256.91 Aligned_cols=199 Identities=24% Similarity=0.325 Sum_probs=162.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------cC----CCCCHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------AN----QRMPLIYVKLYTYQIFRGLA 69 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------~~----~~~~~~~~~~~~~qil~aL~ 69 (296)
|..|+|||||++++++.. +..+|+|+|||. |||-++|+.... .+ .+++..+...++.||+.|++
T Consensus 543 la~l~H~nIVrLlGVC~~-----~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~ 617 (774)
T KOG1026|consen 543 LAELQHPNIVRLLGVCRE-----GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGME 617 (774)
T ss_pred HHhccCCCeEEEEEEEcc-----CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHH
Confidence 457899999999999943 334899999999 899998875331 12 23889999999999999999
Q ss_pred HHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHH
Q 022500 70 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 146 (296)
Q Consensus 70 ~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 146 (296)
||-+ +.+|||||-..|+|++ .+..|||+|||+++.+.+.+- .....-...|||||.|. .++++.+|||||+||+
T Consensus 618 YLs~-~~FVHRDLATRNCLVg-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVv 694 (774)
T KOG1026|consen 618 YLSS-HHFVHRDLATRNCLVG-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVV 694 (774)
T ss_pred HHHh-Ccccccchhhhhceec-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhh
Confidence 9999 6999999999999999 578999999999997644321 11233466899999996 4579999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 147 LAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 147 l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
+||+++ |..||.+....+.+..|-+.-- + .-++..+.++-+|+..||+.+|
T Consensus 695 LWEIFsyG~QPy~glSn~EVIe~i~~g~l----------------L------------~~Pe~CP~~vY~LM~~CW~~~P 746 (774)
T KOG1026|consen 695 LWEIFSYGKQPYYGLSNQEVIECIRAGQL----------------L------------SCPENCPTEVYSLMLECWNENP 746 (774)
T ss_pred hhhhhccccCcccccchHHHHHHHHcCCc----------------c------------cCCCCCCHHHHHHHHHHhhcCc
Confidence 999997 8899999999888877654100 0 0124589999999999999999
Q ss_pred CCCCCHHHHh
Q 022500 226 SLRCTALEAC 235 (296)
Q Consensus 226 ~~R~t~~e~l 235 (296)
++||++.||-
T Consensus 747 ~~RPsF~eI~ 756 (774)
T KOG1026|consen 747 KRRPSFKEIH 756 (774)
T ss_pred ccCCCHHHHH
Confidence 9999999873
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=236.51 Aligned_cols=214 Identities=27% Similarity=0.348 Sum_probs=149.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++...+ ...+++||||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ +|++|
T Consensus 59 l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H 131 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAG---RRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVH 131 (284)
T ss_pred HHhCCCCCeeEEEEEEccCC---CCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCcee
Confidence 35789999999999775332 234789999998 577766653 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.+||+|||++......... ....++..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus 132 ~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~ 209 (284)
T cd05081 132 RDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSD 209 (284)
T ss_pred ccCCHhhEEEC-CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCC
Confidence 99999999998 4778999999999865432211 111224459999998654 58999999999999999999887
Q ss_pred CCCCCChHHHHHHHHHhc-CCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 156 LFPGENAVDQLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
++...... ....+-... +......+...... .. .......++.++.+|+.+||..+|++|||+.++
T Consensus 210 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05081 210 KSCSPPAE-FMRMMGNDKQGQMIVYHLIELLKN--NG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276 (284)
T ss_pred cCCCcchh-hhhhcccccccccchHHHHHHHhc--CC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 66443211 111100000 00000000000000 00 000123478899999999999999999999999
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 277 ~~ 278 (284)
T cd05081 277 AL 278 (284)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=257.61 Aligned_cols=158 Identities=27% Similarity=0.357 Sum_probs=131.0
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
||+|+|||||++.++-.+... --...-.+|||||. |+|+..+....+ ...+++.+++.++..+..||.|||+ +||+
T Consensus 65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrE-n~Iv 142 (732)
T KOG4250|consen 65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRE-NGIV 142 (732)
T ss_pred HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHH-cCce
Confidence 578999999999987533220 00222569999999 588777765433 3459999999999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCC-C--cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 79 HRDLKPQNLLVDPLT-H--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 79 H~dlkp~Nill~~~~-~--~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||||+||++.... + .-||+|||.|+....+....+.+||+.|.+||++.....|+..+|.||+||++|+++||..
T Consensus 143 HRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l 222 (732)
T KOG4250|consen 143 HRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL 222 (732)
T ss_pred eccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence 999999999985322 2 4699999999999888888999999999999999655679999999999999999999999
Q ss_pred CCCCC
Q 022500 156 LFPGE 160 (296)
Q Consensus 156 pf~~~ 160 (296)
||-..
T Consensus 223 PF~p~ 227 (732)
T KOG4250|consen 223 PFIPF 227 (732)
T ss_pred CCCcC
Confidence 99544
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=243.34 Aligned_cols=202 Identities=25% Similarity=0.366 Sum_probs=150.5
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh--------------------------------
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------------------- 47 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-------------------------------- 47 (296)
+++ +||||+++++++.... ..+++|||||+ |+|.+.+.....
T Consensus 65 ~~l~~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (343)
T cd05103 65 IHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDS 140 (343)
T ss_pred HhccCCccHhhhcceeecCC----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccc
Confidence 345 6899999999875322 24789999999 577776653210
Q ss_pred -------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcE
Q 022500 48 -------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 96 (296)
Q Consensus 48 -------------------------------~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~v 96 (296)
....+++..+..++.|++.||+|||+ +||+||||||+||+++ .++.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~-~~~~~ 218 (343)
T cd05103 141 ITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLS-ENNVV 218 (343)
T ss_pred cccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEc-CCCcE
Confidence 01246788889999999999999999 7999999999999998 57889
Q ss_pred EEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022500 97 KICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 172 (296)
Q Consensus 97 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 172 (296)
||+|||++........ .....++..|+|||.+.+. .++.++|+||+|+++|+|++ |..||.+..........+..
T Consensus 219 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 297 (343)
T cd05103 219 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297 (343)
T ss_pred EEEecccccccccCcchhhcCCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc
Confidence 9999999976532211 1122345679999998654 58999999999999999997 89999776543333222221
Q ss_pred cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
...+ ..+...++++.+++.+||+.||++|||+.++++|
T Consensus 298 ~~~~---------------------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 298 GTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred cCCC---------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 0112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=258.94 Aligned_cols=203 Identities=32% Similarity=0.440 Sum_probs=152.9
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
+|||||++|+.- ++..++||..|.|..+|.++++..........-...+.++.|++.||++||++ +|+||||||
T Consensus 561 ~H~NviRyyc~E-----~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkP 634 (903)
T KOG1027|consen 561 EHPNVIRYYCSE-----QDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKP 634 (903)
T ss_pred CCCceEEEEeec-----cCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCC
Confidence 699999998865 67778999999999999998875211111112144678899999999999995 999999999
Q ss_pred CcEEEcC----CCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-CC
Q 022500 85 QNLLVDP----LTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QP 155 (296)
Q Consensus 85 ~Nill~~----~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~ 155 (296)
.|||++. ....++|+|||+|+....+... .+..||-+|+|||++.+.. -..++||||+||++|+.++| ..
T Consensus 635 QNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~H 713 (903)
T KOG1027|consen 635 QNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSH 713 (903)
T ss_pred ceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCcc
Confidence 9999974 2247899999999987655432 3456799999999997643 57799999999999999987 78
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||...- +.-..|+.. +++-.... .....++.|||.+||.++|..||+|.++|
T Consensus 714 pFGd~~--~R~~NIl~~--------------~~~L~~L~------------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 714 PFGDSL--ERQANILTG--------------NYTLVHLE------------PLPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred CCCchH--HhhhhhhcC--------------ccceeeec------------cCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 985432 222234331 11100000 01122899999999999999999999999
Q ss_pred cCCCccc
Q 022500 236 AHPFFDE 242 (296)
Q Consensus 236 ~hp~f~~ 242 (296)
.||||-.
T Consensus 766 ~HPlFW~ 772 (903)
T KOG1027|consen 766 NHPLFWD 772 (903)
T ss_pred CCCccCC
Confidence 9999954
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=236.07 Aligned_cols=209 Identities=26% Similarity=0.397 Sum_probs=149.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... +....++||||++| +|.+.+.. ....+++..+..++.|++.||+|||+ +|++|
T Consensus 60 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H 132 (284)
T cd05079 60 LRNLYHENIVKYKGICTED---GGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVH 132 (284)
T ss_pred HHhCCCCCeeeeeeEEecC---CCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 3578999999999987542 12347899999984 66665542 23458999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.++|+|||++......... ....++..|+|||.+.+. .++.++|+||+||++|+|+++..
T Consensus 133 ~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~ 210 (284)
T cd05079 133 RDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCD 210 (284)
T ss_pred cccchheEEEc-CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCC
Confidence 99999999998 4778999999999865433221 223456679999998654 58899999999999999999876
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHH-----HHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTRE-----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
|+..... .. .+..+....+ ........ .....+..++..+.+|+.+||+.||.+|||
T Consensus 211 ~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 272 (284)
T cd05079 211 SESSPMT--LF---LKMIGPTHGQMTVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTT 272 (284)
T ss_pred CCccccc--hh---hhhcccccccccHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcC
Confidence 6533211 11 1111110000 00000000 000112347899999999999999999999
Q ss_pred HHHHhc
Q 022500 231 ALEACA 236 (296)
Q Consensus 231 ~~e~l~ 236 (296)
+.++++
T Consensus 273 ~~~il~ 278 (284)
T cd05079 273 FQNLIE 278 (284)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=241.06 Aligned_cols=207 Identities=27% Similarity=0.437 Sum_probs=159.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCH 79 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~-l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~-~~i~H 79 (296)
+.|+||-||++|++|.-. ...+|-|+|||+|+ |.-+++ .+..+++.+++.|+.||+.||.||.+. ..|+|
T Consensus 522 KeLDHpRIVKlYDyfslD----tdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEikpPIIH 593 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLD----TDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIH 593 (775)
T ss_pred hccCcceeeeeeeeeeec----cccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeee
Confidence 578999999999998532 22388999999984 443444 567899999999999999999999973 34999
Q ss_pred CCCCCCcEEEcC--CCCcEEEeeccCccccccCCCc--------cceeecccccCchhcc-C--CCCCCchhHHHHHHHH
Q 022500 80 RDLKPQNLLVDP--LTHQVKICDFGSAKQLIAGEAN--------ISYICSRFYRAPELIF-G--ATEYTTSIDIWSAGCV 146 (296)
Q Consensus 80 ~dlkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~-~--~~~~~~~~DiwslG~i 146 (296)
-||||.|||+-. ..+.+||+|||+++.+...... ....||.||.+||.+. + ...++.++||||+|||
T Consensus 594 YDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVI 673 (775)
T KOG1151|consen 594 YDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVI 673 (775)
T ss_pred eccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehh
Confidence 999999999852 2357999999999977543221 2346899999999983 2 3457899999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHH--HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 147 LAELLLGQPLFPGENAV-DQLV--EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 147 l~~ll~g~~pf~~~~~~-~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
+|.++.|+.||..+-.. +++. -|++. ..+.+|.. ..+++++++||++||++
T Consensus 674 FyQClYGrKPFGhnqsQQdILqeNTIlkA----------------tEVqFP~K----------PvVsseAkaFIRRCLaY 727 (775)
T KOG1151|consen 674 FYQCLYGRKPFGHNQSQQDILQENTILKA----------------TEVQFPPK----------PVVSSEAKAFIRRCLAY 727 (775)
T ss_pred hhhhhccCCCCCCchhHHHHHhhhchhcc----------------eeccCCCC----------CccCHHHHHHHHHHHHh
Confidence 99999999999665322 2211 12211 11122211 13799999999999999
Q ss_pred CCCCCCCHHHHhcCCCccc
Q 022500 224 SPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 224 ~p~~R~t~~e~l~hp~f~~ 242 (296)
.-++|..+.++-.||+|..
T Consensus 728 RKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 728 RKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhhhhhhHHHHccCccccc
Confidence 9999999999999999965
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=233.05 Aligned_cols=205 Identities=21% Similarity=0.331 Sum_probs=154.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCc-ceEEEEeccCc-ccHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNE-LFLNLVMEYVP-ESMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPR 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~-~~~~lv~E~~~-g~l~~~l~~~~--~~~~~~~~~~~~~~~~qil~aL~~LH~~~~ 76 (296)
|++++||||+++++++......+. ...++++||+. |+|...+.... .....+++..+..++.|++.||+|||+ +|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~ 133 (273)
T cd05074 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KN 133 (273)
T ss_pred HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence 467899999999998865433322 23578999998 56655543211 112357889999999999999999999 79
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 152 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~- 152 (296)
|+||||||+||+++ .++.+|++|||+++....... .....+++.|++||.+.+. .++.++|+||+||++|+|++
T Consensus 134 i~H~dikp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 134 FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred EeecccchhhEEEc-CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhC
Confidence 99999999999998 577899999999886533221 1223445779999998654 58899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|.+||.+.+..+....+... .. .. .....+..+.+++.+||+.+|++||++.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~-~~---------------~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~ 263 (273)
T cd05074 212 GQTPYAGVENSEIYNYLIKG-NR---------------LK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQ 263 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcC-Cc---------------CC------------CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 88999877665544443321 00 00 0123678999999999999999999999
Q ss_pred HHhc
Q 022500 233 EACA 236 (296)
Q Consensus 233 e~l~ 236 (296)
++++
T Consensus 264 ~~~~ 267 (273)
T cd05074 264 HLRD 267 (273)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=272.21 Aligned_cols=208 Identities=17% Similarity=0.170 Sum_probs=150.1
Q ss_pred CCCCC-CCeeeeceeeeccCC--CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 2 RVMDH-PNVISLKHCFFSTTS--KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 2 ~~l~H-pnIv~l~~~~~~~~~--~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
+.++| +||+++++.|..... .....++.++|+++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCee
Confidence 56778 799999998732221 12234678999999998888763 34569999999999999999999999 7999
Q ss_pred cCCCCCCcEEEcC------------------CCCcEEEeeccCccccccCC-----------------Cccceeeccccc
Q 022500 79 HRDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIAGE-----------------ANISYICSRFYR 123 (296)
Q Consensus 79 H~dlkp~Nill~~------------------~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~ 123 (296)
||||||+|||++. .++.+|++|||+++...... .....+||++|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999952 23456677777765321100 001245789999
Q ss_pred CchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCccc
Q 022500 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 203 (296)
Q Consensus 124 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (296)
|||++.+. .++.++||||+||++|||++|.+|+.... .....+... ..+. .
T Consensus 183 APE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-~~~~-~------------------------ 233 (793)
T PLN00181 183 SPEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-VLPP-Q------------------------ 233 (793)
T ss_pred ChhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-hcCh-h------------------------
Confidence 99998765 58999999999999999999988875322 111111110 0000 0
Q ss_pred ccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 204 VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 204 ~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
. ..-.+...+++.+||+.||.+||++.|+++||||....
T Consensus 234 -~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 -I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred -h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 0 00144567899999999999999999999999998753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=261.27 Aligned_cols=200 Identities=21% Similarity=0.377 Sum_probs=162.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPR 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~---~~~~~~~~~~~~~~~qil~aL~~LH~~~~ 76 (296)
|+.++|||||+++++.++.+. .+|++|||+ |+|..+++.-.. ....++......++.||+.|++||++ ++
T Consensus 749 m~~f~HpNiv~liGv~l~~~~-----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~ 822 (1025)
T KOG1095|consen 749 MSKFDHPNIVSLIGVCLDSGP-----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KH 822 (1025)
T ss_pred HhcCCCcceeeEEEeecCCCC-----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CC
Confidence 678999999999999987554 789999999 588888875311 13468899999999999999999999 79
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cce-eecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISY-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 152 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~- 152 (296)
+|||||...|+|++. ...+||+|||+|+.+...+-. ... .-...|||||.+.. ..++.++|||||||++||+++
T Consensus 823 fvHRDLAaRNCLL~~-~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifsl 900 (1025)
T KOG1095|consen 823 FVHRDLAARNCLLDE-RRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSL 900 (1025)
T ss_pred CcCcchhhhheeecc-cCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhC
Confidence 999999999999995 688999999999955332211 111 22457999999976 469999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|..||++.+..+.+...++.. +.. .+..++..+-+++..||+.+|++||+..
T Consensus 901 G~~PY~~~~n~~v~~~~~~gg-RL~---------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 901 GATPYPSRSNFEVLLDVLEGG-RLD---------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred CCCCCCCcchHHHHHHHHhCC-ccC---------------------------CCCCCChHHHHHHHHHccCChhhCccHH
Confidence 889999999888776555421 111 1234788888999999999999999999
Q ss_pred HHhc
Q 022500 233 EACA 236 (296)
Q Consensus 233 e~l~ 236 (296)
.+++
T Consensus 953 ~i~~ 956 (1025)
T KOG1095|consen 953 TIVE 956 (1025)
T ss_pred HHHh
Confidence 8886
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.60 Aligned_cols=213 Identities=25% Similarity=0.305 Sum_probs=150.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAYIHTVP--R 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~-~~~~~~~~~~~~qil~aL~~LH~~~--~ 76 (296)
|.+++|||+|++++|+...+. ..+||+||++ |+|.+.+.. ... .+++....+|+.+++.||+|||... .
T Consensus 125 ls~l~H~Nlv~LlGyC~e~~~----~~~LVYEym~nGsL~d~L~~---~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~ 197 (361)
T KOG1187|consen 125 LSRLRHPNLVKLLGYCLEGGE----HRLLVYEYMPNGSLEDHLHG---KKGEPLDWETRLKIALGAARGLAYLHEGCPPP 197 (361)
T ss_pred HhcCCCcCcccEEEEEecCCc----eEEEEEEccCCCCHHHHhCC---CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCC
Confidence 457899999999999964442 3779999999 688777654 222 8899999999999999999999943 2
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCcccccc-CCCccce-eecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISY-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|+|||||++|||+| .+.+.||+|||+|+.... .....+. .||.+|++||++.. ...+.++||||+||++.|+++|+
T Consensus 198 iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr 275 (361)
T KOG1187|consen 198 IIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGR 275 (361)
T ss_pred EecCCCCHHHeeEC-CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCC
Confidence 99999999999999 689999999999976544 3222233 79999999999964 45899999999999999999999
Q ss_pred CCCCCCC---hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCC-CCCHHHHHHHHcccccCCCCCCC
Q 022500 155 PLFPGEN---AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 155 ~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dll~~~L~~~p~~R~t 230 (296)
.+..... ......-........ ....+.-+...... ... ..-..+..+..+|++.+|.+||+
T Consensus 276 ~~~d~~~~~~~~~l~~w~~~~~~~~----------~~~eiiD~~l~~~~----~~~~~~~~~~~~~a~~C~~~~~~~RP~ 341 (361)
T KOG1187|consen 276 KAVDQSRPRGELSLVEWAKPLLEEG----------KLREIVDPRLKEGE----YPDEKEVKKLAELALRCLRPDPKERPT 341 (361)
T ss_pred cccCCCCCcccccHHHHHHHHHHCc----------chhheeCCCccCCC----CChHHHHHHHHHHHHHHcCcCCCcCcC
Confidence 8776432 111111111111110 11111111100000 000 01223667789999999999999
Q ss_pred HHHHhc
Q 022500 231 ALEACA 236 (296)
Q Consensus 231 ~~e~l~ 236 (296)
+.++.+
T Consensus 342 m~~Vv~ 347 (361)
T KOG1187|consen 342 MSQVVK 347 (361)
T ss_pred HHHHHH
Confidence 998743
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=233.84 Aligned_cols=229 Identities=30% Similarity=0.521 Sum_probs=168.5
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
-+.||+++.+++ ..+....+|+||++..-+..+. ..++..+++.|++.++.||+++|. +||+||||||
T Consensus 93 G~~ni~~~~~~~-----rnnd~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKp 160 (418)
T KOG1167|consen 93 GSDNIIKLNGCF-----RNNDQVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKP 160 (418)
T ss_pred cchhhhcchhhh-----ccCCeeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCc
Confidence 367999999988 4455588999999974333333 236788999999999999999999 7999999999
Q ss_pred CcEEEcCCCCcEEEeeccCccccc-----------------c--C--------------------------CCccceeec
Q 022500 85 QNLLVDPLTHQVKICDFGSAKQLI-----------------A--G--------------------------EANISYICS 119 (296)
Q Consensus 85 ~Nill~~~~~~vkl~Dfg~a~~~~-----------------~--~--------------------------~~~~~~~~t 119 (296)
+|+|++...+.-.|+|||+|.... . . ...-...||
T Consensus 161 sNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT 240 (418)
T KOG1167|consen 161 SNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGT 240 (418)
T ss_pred cccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCC
Confidence 999999888888999999986210 0 0 000135789
Q ss_pred ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCHHHHhhcCc------------
Q 022500 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNP------------ 186 (296)
Q Consensus 120 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~------------ 186 (296)
++|+|||++...+..+.++||||.|||+..++++..|| ...++.+.+.+|+..+|.-.-........
T Consensus 241 ~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~ 320 (418)
T KOG1167|consen 241 PGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPT 320 (418)
T ss_pred CCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccc
Confidence 99999999988888899999999999999999999776 45566777777777666533222221111
Q ss_pred ------CCcCccCCCCC---C-CCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccC
Q 022500 187 ------NYTDFRFPQIK---A-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 187 ------~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~ 245 (296)
.|......... . ..+.....+..+..+.||+.+||..||.+|+||+++|+||||.....
T Consensus 321 ~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 321 IPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred cHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 12211101100 0 01222333345678999999999999999999999999999996543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=224.55 Aligned_cols=202 Identities=38% Similarity=0.654 Sum_probs=159.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++|+||+++++++... ...++++||+++ +|.+.+.. ...++...+..++.+++.++.+||+ .+++|+
T Consensus 42 ~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~ 111 (244)
T smart00220 42 KKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHR 111 (244)
T ss_pred HhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecC
Confidence 467999999999988543 348899999997 77766653 2338899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||+|+||+++. ++.++++|||.+.............++..|++||.+.+ ..++.++|+||+|++++++++|..||...
T Consensus 112 ~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 112 DLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred CcCHHHeEECC-CCcEEEccccceeeeccccccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999994 67899999999987655434455677889999999864 45788999999999999999999999874
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
...+.....+....... ......++.++.+++.+||..+|++||++.++++||||
T Consensus 190 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 190 DQLLELFKKIGKPKPPF-------------------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CcHHHHHHHHhccCCCC-------------------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 43333333222100000 00001167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=244.24 Aligned_cols=195 Identities=31% Similarity=0.454 Sum_probs=156.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||++++++.... .+||||++. |.|..+++. ....++......|.+||+.||.|||+ +.+||
T Consensus 445 MrnfdHphIikLIGv~~e~P------~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVH 514 (974)
T KOG4257|consen 445 MRNFDHPHIIKLIGVCVEQP------MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVH 514 (974)
T ss_pred HHhCCCcchhheeeeeeccc------eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhh
Confidence 68899999999999984322 789999999 777777764 45678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceee--cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||-..|||+.+ ...|||+|||+++.+.....-+...| ..-|||||.+. -+.++.++|||-|||++||++. |..|
T Consensus 515 RDIAaRNiLVsS-p~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkP 592 (974)
T KOG4257|consen 515 RDIAARNILVSS-PQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKP 592 (974)
T ss_pred hhhhhhheeecC-cceeeecccchhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCc
Confidence 999999999994 67899999999998765443322233 44699999984 3459999999999999999885 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|.|-...+.+-.|.+- .++ ..+..+++.+-.|+.+||+++|.+||+..++.
T Consensus 593 fqgvkNsDVI~~iEnG-eRl---------------------------P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 593 FQGVKNSDVIGHIENG-ERL---------------------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred cccccccceEEEecCC-CCC---------------------------CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 9987665554433221 000 02345889999999999999999999976653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=244.21 Aligned_cols=201 Identities=21% Similarity=0.303 Sum_probs=152.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+|+=+|.||+=+.+++.... +.||+.+|+| +|+..+.. ...+|+....+.|++||+.|+.|||. ++|||
T Consensus 442 lkkTRH~NIlLFMG~~~~p~------~AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHA-K~IIH 511 (678)
T KOG0193|consen 442 LKKTRHENILLFMGACMNPP------LAIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHA-KNIIH 511 (678)
T ss_pred HhhcchhhheeeehhhcCCc------eeeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhh
Confidence 35668999999999985333 3699999998 66655553 34679999999999999999999999 89999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCcccccc--C-CCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIA--G-EANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~--~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
||||..||++. ++++|||+|||++..-.. . .......|...|||||++.. ...|+..+||||+|+++|||++|.
T Consensus 512 rDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~ 590 (678)
T KOG0193|consen 512 RDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE 590 (678)
T ss_pred hhccccceEEc-cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence 99999999999 468999999999864211 1 11223456778999999954 345899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.......++..+=+-.+.|..-. .....++++++|+..||.+++++||+..+|
T Consensus 591 lPysi~~~dqIifmVGrG~l~pd~s~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i 646 (678)
T KOG0193|consen 591 LPYSIQNRDQIIFMVGRGYLMPDLSK------------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQL 646 (678)
T ss_pred CCcCCCChhheEEEecccccCccchh------------------------hhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence 99984443332222211111111110 112367799999999999999999999888
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
|.
T Consensus 647 l~ 648 (678)
T KOG0193|consen 647 LS 648 (678)
T ss_pred HH
Confidence 75
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=228.45 Aligned_cols=213 Identities=26% Similarity=0.351 Sum_probs=150.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++||||+++++++... +..+.++||||++ ++|.+.+.. ....+++..+..++.|++.||+|||+ +|++|
T Consensus 60 l~~l~~~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H 132 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKP---GGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIH 132 (284)
T ss_pred HHhCCCCChheEEeeeecC---CCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 3578999999999877432 2345889999998 577766653 22358999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.++|+|||.+......... ....++..|++||.+.+. .++.++|+||+|+++++|++|..
T Consensus 133 ~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~ 210 (284)
T cd05038 133 RDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGD 210 (284)
T ss_pred CCCCHHhEEEc-CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCC
Confidence 99999999999 4788999999999876432211 112335569999998654 58899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhc-CCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 156 LFPGENAVDQLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
|+........ .+.... +......+......... ...+...+.++.+++.+||..+|++|||+.++
T Consensus 211 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05038 211 PSQSPPAEFL--RMIGIAQGQMIVTRLLELLKEGER------------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276 (284)
T ss_pred Ccccccchhc--cccccccccccHHHHHHHHHcCCc------------CCCCccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 8865432110 000000 00000000000000000 00112367889999999999999999999999
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 277 ~~ 278 (284)
T cd05038 277 IL 278 (284)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=233.29 Aligned_cols=195 Identities=23% Similarity=0.399 Sum_probs=157.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||+|++.+++... ..+|||+|||. |+|+++++.. .+..++.-....++.||.+|++||.. +++||
T Consensus 317 MKeikHpNLVqLLGVCT~E-----pPFYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEk-knFIH 388 (1157)
T KOG4278|consen 317 MKEIKHPNLVQLLGVCTHE-----PPFYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEK-KNFIH 388 (1157)
T ss_pred HHhhcCccHHHHhhhhccC-----CCeEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHH-hhhhh
Confidence 6889999999999998433 33889999998 8999999875 34567888889999999999999999 89999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceee---cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||-..|+|+. .++.||++|||+++.+..+ .-+...| ..-|.|||.+. ...++.++|||+|||++||+.| |..
T Consensus 389 RDLAARNCLVg-EnhiVKvADFGLsRlMtgD-TYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMs 465 (1157)
T KOG4278|consen 389 RDLAARNCLVG-ENHIVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMS 465 (1157)
T ss_pred hhhhhhhcccc-ccceEEeeccchhhhhcCC-ceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCC
Confidence 99999999999 5788999999999977433 1122223 45699999985 4568999999999999999997 789
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
||+|-+....+. +++. .+.+. -+.++++..-+|++.||+++|++||+..|+
T Consensus 466 PYPGidlSqVY~-LLEk-----------------gyRM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 466 PYPGIDLSQVYG-LLEK-----------------GYRMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCccHHHHHH-HHhc-----------------ccccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 999987655444 3331 11111 234689999999999999999999999876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=235.49 Aligned_cols=216 Identities=22% Similarity=0.280 Sum_probs=141.9
Q ss_pred eeeeceeeeccCC---CCcceEEEEeccCc-ccHHHHHHHhh-----------h---------cCCCCCHHHHHHHHHHH
Q 022500 9 VISLKHCFFSTTS---KNELFLNLVMEYVP-ESMYRVLKHYS-----------S---------ANQRMPLIYVKLYTYQI 64 (296)
Q Consensus 9 Iv~l~~~~~~~~~---~~~~~~~lv~E~~~-g~l~~~l~~~~-----------~---------~~~~~~~~~~~~~~~qi 64 (296)
++++++++..... ......+||+||++ ++|.+.+.... . ....+++..++.++.|+
T Consensus 239 ~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql 318 (507)
T PLN03224 239 CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV 318 (507)
T ss_pred hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHH
Confidence 3566666543211 12334789999999 47777665311 0 11234677899999999
Q ss_pred HHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccc--eeecccccCchhccCCCC---------
Q 022500 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAPELIFGATE--------- 133 (296)
Q Consensus 65 l~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~t~~y~aPE~~~~~~~--------- 133 (296)
+.||.|||+ .+|+||||||+||+++ .++.+||+|||++........... ..+++.|+|||.+.....
T Consensus 319 ~~aL~~lH~-~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~ 396 (507)
T PLN03224 319 LTGLRKLHR-IGIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAM 396 (507)
T ss_pred HHHHHHHHH-CCeecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhh
Confidence 999999999 7999999999999999 467899999999976543322222 234789999999853211
Q ss_pred ----------C--CchhHHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCC
Q 022500 134 ----------Y--TTSIDIWSAGCVLAELLLGQP-LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP 200 (296)
Q Consensus 134 ----------~--~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (296)
+ ..+.|+||+||++++|++|.. ||.+....... .+.... ....+.... ...
T Consensus 397 ~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~~-~~~~~r~~~------------~~~ 460 (507)
T PLN03224 397 AALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYDN-DLNRWRMYK------------GQK 460 (507)
T ss_pred hhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhccc-hHHHHHhhc------------ccC
Confidence 1 134799999999999999875 66443211110 000000 000011000 000
Q ss_pred cccccCCCCCHHHHHHHHcccccCC---CCCCCHHHHhcCCCccc
Q 022500 201 WHKVFHKRMPPEAIDLASRLLQYSP---SLRCTALEACAHPFFDE 242 (296)
Q Consensus 201 ~~~~~~~~~~~~~~dll~~~L~~~p---~~R~t~~e~l~hp~f~~ 242 (296)
+.-......++.++||+.+||+.+| .+|+|++|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0111224478999999999999876 68999999999999963
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=203.36 Aligned_cols=165 Identities=25% Similarity=0.442 Sum_probs=140.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+....|.+|.+|+.++..+. ++|.||.++.+|..+.++....++.++|..+-+++..++.||.|||+.-.++||
T Consensus 99 ~r~~~CPf~V~FyGa~~regd-----vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHR 173 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGD-----VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHR 173 (282)
T ss_pred ccCCCCCeEEEeehhhhcccc-----EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhc
Confidence 355678999999998865554 899999999999888888888899999999999999999999999995579999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC---CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|+||+|||++ ..+++|+||||.+..+.+.-..+...|-..|||||.+.. ...|+.++||||||+.+.||.+++.||
T Consensus 174 DvKPsNiLIn-~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY 252 (282)
T KOG0984|consen 174 DVKPSNILIN-YDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY 252 (282)
T ss_pred cCCcceEEEc-cCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence 9999999999 588999999999987765544443566677999999832 235899999999999999999999999
Q ss_pred CC-CChHHHHHHHHH
Q 022500 158 PG-ENAVDQLVEIIK 171 (296)
Q Consensus 158 ~~-~~~~~~~~~i~~ 171 (296)
.. .++.+++.++++
T Consensus 253 ~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 253 ESWGTPFQQLKQVVE 267 (282)
T ss_pred cccCCHHHHHHHHhc
Confidence 65 466777777776
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=241.38 Aligned_cols=197 Identities=23% Similarity=0.353 Sum_probs=166.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|-+++||||++|.++..... -+.||+|||+ |+|..+|+. .++.|+..+...+++.|+.|++||-++ |.||
T Consensus 684 MGQFdHPNIIrLEGVVTks~-----PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm-~YVH 754 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSK-----PVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM-NYVH 754 (996)
T ss_pred cccCCCCcEEEEEEEEecCc-----eeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc-Cchh
Confidence 67899999999999884333 3889999999 788888875 457799999999999999999999996 9999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-cccee-e--cccccCchhccCCCCCCchhHHHHHHHHHHHHH-hCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYI-C--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~-~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~ 154 (296)
|||...|||++ .+-.+|++|||+++.+.++.. ..+.. | ...|.|||.+. .++++.+|||||+|++|||.+ .|.
T Consensus 755 RDLAARNILVN-snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 755 RDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred hhhhhhheeec-cceEEEeccccceeecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCC
Confidence 99999999999 578899999999998755542 22222 2 45799999996 456999999999999999876 599
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||...+..+.+..|.+....|++ ..++..+-.|+..||++|-.+||+.++|
T Consensus 833 RPYWdmSNQdVIkaIe~gyRLPpP----------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qi 884 (996)
T KOG0196|consen 833 RPYWDMSNQDVIKAIEQGYRLPPP----------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQI 884 (996)
T ss_pred CcccccchHHHHHHHHhccCCCCC----------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHH
Confidence 999999999999888875554442 2478899999999999999999999998
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 885 V~ 886 (996)
T KOG0196|consen 885 VS 886 (996)
T ss_pred HH
Confidence 76
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=240.87 Aligned_cols=186 Identities=32% Similarity=0.453 Sum_probs=137.1
Q ss_pred cceEEEEeccCcccHHHHHHHhhhcCCCC-CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeecc
Q 022500 24 ELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 102 (296)
Q Consensus 24 ~~~~~lv~E~~~g~l~~~l~~~~~~~~~~-~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 102 (296)
..++||-||||+.++.+.+.+ .+... ....+..+++||+.||.|+|+ +|||||||||.||+++ ..+.|||+|||
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~---~N~~~~~~d~~wrLFreIlEGLaYIH~-~giIHRDLKP~NIFLd-~~~~VKIGDFG 742 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIR---RNHFNSQRDEAWRLFREILEGLAYIHD-QGIIHRDLKPRNIFLD-SRNSVKIGDFG 742 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHH---hcccchhhHHHHHHHHHHHHHHHHHHh-CceeeccCCcceeEEc-CCCCeeecccc
Confidence 367999999999765554443 22222 477889999999999999999 6999999999999999 57789999999
Q ss_pred Cccccc-------------------cCCCccceeecccccCchhccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 103 SAKQLI-------------------AGEANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 103 ~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
+|.... +....++.+||-.|+|||++.+.. .|+.|+|+||||+|++||+.. |...
T Consensus 743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts- 818 (1351)
T KOG1035|consen 743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTS- 818 (1351)
T ss_pred cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCch-
Confidence 997611 011235679999999999997655 699999999999999999974 5433
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~ 241 (296)
++....+.+. ..+. +|.. ..+...--+.-..+|+.||+.||.+||||.|+|++.||-
T Consensus 819 -MERa~iL~~L-R~g~---------------iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 819 -MERASILTNL-RKGS---------------IPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred -HHHHHHHHhc-ccCC---------------CCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 2322222221 1111 1100 011122234567899999999999999999999999996
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=231.51 Aligned_cols=201 Identities=23% Similarity=0.347 Sum_probs=162.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|.+|+|||+|+||++..+.. +.+|||+++ |+|.+-|.. .....|.......|+.||+.|+.||.+ +++||
T Consensus 165 M~~L~H~hliRLyGvVl~qp------~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvH 235 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLDQP------AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVH 235 (1039)
T ss_pred HHhccCcceeEEeeeeccch------hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhh
Confidence 56799999999999986422 559999999 788888876 345678889999999999999999999 89999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceee----cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||-..|+|+.. ...|||+|||+.+.+..++....... ...|.|||.+.. ..++.++|+|++||.+|||++ |.
T Consensus 236 RDLAARNlllas-prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGE 313 (1039)
T KOG0199|consen 236 RDLAARNLLLAS-PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGE 313 (1039)
T ss_pred hhhhhhhheecc-cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCC
Confidence 999999999984 67899999999998766554332111 346999999965 469999999999999999998 67
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.|.....++.+|-+. .. . ..++.+++++-++++.||+.+|.+|||...|
T Consensus 314 ePW~G~~g~qIL~~iD~~-er-----------------L----------pRPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 314 EPWVGCRGIQILKNIDAG-ER-----------------L----------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CCCCCCCHHHHHHhcccc-cc-----------------C----------CCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 999999988777765421 00 0 0224578999999999999999999999888
Q ss_pred hcCCCc
Q 022500 235 CAHPFF 240 (296)
Q Consensus 235 l~hp~f 240 (296)
.+.-+.
T Consensus 366 r~~~~l 371 (1039)
T KOG0199|consen 366 REDLVL 371 (1039)
T ss_pred HHhHHH
Confidence 654333
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=203.48 Aligned_cols=167 Identities=20% Similarity=0.167 Sum_probs=124.8
Q ss_pred ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccc
Q 022500 36 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 115 (296)
Q Consensus 36 g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~ 115 (296)
|+|.+.+.. .+..+++..++.++.|++.||+|||+ ++ ||+||+++ .++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~-~~~~~~~--fG~~~~~~~~----~ 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLT-WDGLLKL--DGSVAFKTPE----Q 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEc-Cccceee--ccceEeeccc----c
Confidence 567776653 24569999999999999999999999 57 99999998 5777888 9998765332 2
Q ss_pred eeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhcCcCCcCccCC
Q 022500 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 194 (296)
Q Consensus 116 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (296)
..||+.|+|||++.+. .++.++||||+||++|+|++|..||...... ..+..+..........
T Consensus 64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------- 127 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR--------------- 127 (176)
T ss_pred CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence 3678999999999764 5899999999999999999999999765432 2222222211100000
Q ss_pred CCCCCCcccccCCCCCH--HHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 195 QIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 195 ~~~~~~~~~~~~~~~~~--~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
. ......++. ++.++|.+||..||.+||++.++++|+|+..
T Consensus 128 -~------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 -D------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -c------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0 000011233 6999999999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=226.13 Aligned_cols=205 Identities=21% Similarity=0.282 Sum_probs=157.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|.+|+|||||.+.+++..... +|+++||++ |+|.+++..... ..........++.||++|++||.+. ++||
T Consensus 589 LsqLkhPNIveLvGVC~~DeP-----icmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~-nfVH 660 (807)
T KOG1094|consen 589 LSRLKHPNIVELLGVCVQDDP-----LCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL-NFVH 660 (807)
T ss_pred HhccCCCCeeEEEeeeecCCc-----hHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh-chhh
Confidence 568999999999999976554 889999999 787777764322 2234445667999999999999995 9999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH--hCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL--LGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~ 154 (296)
||+.+.|+|++ .+.++||+|||+++.+.+.+- ....+-...|||+|.+.. ++++.++|+|++|+.+||++ +..
T Consensus 661 rd~a~rNcLv~-~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e 738 (807)
T KOG1094|consen 661 RDLATRNCLVD-GEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCRE 738 (807)
T ss_pred ccccccceeec-CcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhh
Confidence 99999999999 588999999999997655432 223344678999999975 46999999999999999976 578
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||....+...+.+.-..+..+....+ -..+.-++..+-+++.+||.++-++||+.+++
T Consensus 739 ~Py~~lt~e~vven~~~~~~~~~~~~~---------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 739 QPYSQLTDEQVVENAGEFFRDQGRQVV---------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred CchhhhhHHHHHHhhhhhcCCCCccee---------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 999877776665554433222221110 11223478888999999999999999999998
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
-.
T Consensus 798 h~ 799 (807)
T KOG1094|consen 798 HL 799 (807)
T ss_pred HH
Confidence 43
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=248.81 Aligned_cols=206 Identities=22% Similarity=0.311 Sum_probs=140.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH---TVPR 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH---~~~~ 76 (296)
|++++|||||++++++.... ..|+||||++ |+|.+.++ .+++..+..++.|++.||+||| + .+
T Consensus 737 l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ 803 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEK-----GAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PA 803 (968)
T ss_pred HhhCCCCCcceEEEEEEcCC-----CCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CC
Confidence 46789999999999985433 3789999998 57766664 2788899999999999999999 6 59
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|+||||||+||+++. +...++. +|....... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.|
T Consensus 804 iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 804 VVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred eecCCCCHHhEEECC-CCceEEE-ecccccccc---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCC
Confidence 999999999999984 5556654 555443211 123467899999999865 4589999999999999999999999
Q ss_pred CCCCChH-HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 157 FPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 157 f~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|...... .......+..-... .. ..+.-+..... . ........++.+++.+||+.||++|||+.|++
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~~~~-~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDC--HL-------DMWIDPSIRGD-V--SVNQNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCcc--ch-------hheeCccccCC-C--CccHHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 8543110 01111111000000 00 00000000000 0 00001234678999999999999999999998
Q ss_pred cC
Q 022500 236 AH 237 (296)
Q Consensus 236 ~h 237 (296)
+.
T Consensus 946 ~~ 947 (968)
T PLN00113 946 KT 947 (968)
T ss_pred HH
Confidence 63
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=225.26 Aligned_cols=197 Identities=26% Similarity=0.390 Sum_probs=153.4
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh---hc-------C--CCCCHHHHHHHHHHHHHHHHH
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS---SA-------N--QRMPLIYVKLYTYQIFRGLAY 70 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~---~~-------~--~~~~~~~~~~~~~qil~aL~~ 70 (296)
.+||||+.+.+++.. ...+++|+|||. |+|..+++... .- . ..++......+++||+.|++|
T Consensus 359 g~H~niv~llG~~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~ 433 (609)
T KOG0200|consen 359 GKHPNIVNLLGACTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEY 433 (609)
T ss_pred cCCcchhhheeeecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHH
Confidence 379999999998854 334889999999 89999888644 00 1 238899999999999999999
Q ss_pred HHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceee--cccccCchhccCCCCCCchhHHHHHHHH
Q 022500 71 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC--SRFYRAPELIFGATEYTTSIDIWSAGCV 146 (296)
Q Consensus 71 LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~i 146 (296)
|++ .+++||||-..|||+. .+..+||+|||+|+........ ....+ ...|||||.+.. ..|+.++||||+|++
T Consensus 434 L~~-~~~vHRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~ 510 (609)
T KOG0200|consen 434 LAS-VPCVHRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGIL 510 (609)
T ss_pred Hhh-CCccchhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHH
Confidence 999 7999999999999999 4778999999999865433221 11122 334999999976 569999999999999
Q ss_pred HHHHHh-CCCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 147 LAELLL-GQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 147 l~~ll~-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
+||+++ |..||++-. ..+.+ +.++...+.. .+...++++-++++.||+.+
T Consensus 511 L~EifsLG~~PYp~~~~~~~l~-~~l~~G~r~~---------------------------~P~~c~~eiY~iM~~CW~~~ 562 (609)
T KOG0200|consen 511 LWEIFTLGGTPYPGIPPTEELL-EFLKEGNRME---------------------------QPEHCSDEIYDLMKSCWNAD 562 (609)
T ss_pred HHHHhhCCCCCCCCCCcHHHHH-HHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHhCCC
Confidence 999997 789998854 33333 3333211111 22347899999999999999
Q ss_pred CCCCCCHHHHhc
Q 022500 225 PSLRCTALEACA 236 (296)
Q Consensus 225 p~~R~t~~e~l~ 236 (296)
|++||+..++.+
T Consensus 563 p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 563 PEDRPTFSECVE 574 (609)
T ss_pred cccCCCHHHHHH
Confidence 999999988765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-29 Score=222.67 Aligned_cols=208 Identities=25% Similarity=0.367 Sum_probs=166.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+..+|||||.+++-|..... +++.||||+|+-++.+.+ -.+++++.++..+.++.+.||+|||+ .|-+||
T Consensus 66 ~~dc~h~nivay~gsylr~dk-----lwicMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs-~gk~hR 136 (829)
T KOG0576|consen 66 LRDCRHPNIVAYFGSYLRRDK-----LWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS-QGKIHR 136 (829)
T ss_pred eecCCCcChHHHHhhhhhhcC-----cEEEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc-CCcccc
Confidence 467899999999999876554 899999999643333332 45889999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||-.||+++ +.+.+|+.|||.+..+... .+..+++|||+|||||+.. ....|...+|+|++|+...|+.--++|.
T Consensus 137 diKGanillt-d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 137 DIKGANILLT-DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred cccccceeec-ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 9999999999 5788999999998776443 3456889999999999962 2345899999999999999998888887
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
..--.+..+..+-+..-.|+ ... -....++.+.+|++.+|.+||++|||++.+|.|
T Consensus 216 fdlhpmr~l~LmTkS~~qpp--------------~lk----------Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 216 FDLHPMRALFLMTKSGFQPP--------------TLK----------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cccchHHHHHHhhccCCCCC--------------ccc----------CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 66666666555444322111 111 112468899999999999999999999999999
Q ss_pred CCccc
Q 022500 238 PFFDE 242 (296)
Q Consensus 238 p~f~~ 242 (296)
||...
T Consensus 272 ~fvs~ 276 (829)
T KOG0576|consen 272 PFVSQ 276 (829)
T ss_pred eeecc
Confidence 99964
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=217.41 Aligned_cols=142 Identities=26% Similarity=0.416 Sum_probs=126.7
Q ss_pred CCCeeeeceeeeccCCCCcceEEEEeccCc-c-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVP-E-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 6 HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
|+||+|+.++| ++..++||+||--+ | +|++++. ....++|.+++.|+.|++.|+++||+ .||+|||||
T Consensus 628 H~NIlKlLdfF-----Eddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdik 697 (772)
T KOG1152|consen 628 HENILKLLDFF-----EDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIK 697 (772)
T ss_pred ccchhhhhhee-----ecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccc-cCceecccc
Confidence 99999999999 77777999999998 4 7777776 46789999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
-+|+.++ .+|.+||+|||.|... .+.....++||..|.|||++.|..+.+...|||++|+++|.++....||+.
T Consensus 698 denvivd-~~g~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 698 DENVIVD-SNGFVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cccEEEe-cCCeEEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999 5788999999998754 344556789999999999998887779999999999999999999988863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=228.76 Aligned_cols=213 Identities=25% Similarity=0.381 Sum_probs=161.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.|.||||+.....+..... .+-+||||+++|+..+.. .+.+....+..++.|++.|++|||+ .||.|||
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~-----~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~Giahrd 445 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDG-----ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRD 445 (601)
T ss_pred ccccCCchhhhHHHHhhccc-----chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceecc
Confidence 36899999888777643322 334499999988777663 3578888999999999999999999 5999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
+|++|+++. .++.+||+|||.+......-. ....+|+..|+|||++.+........||||+|+++..|.+|+.|
T Consensus 446 lK~enll~~-~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~ 524 (601)
T KOG0590|consen 446 LKLENLLVT-ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP 524 (601)
T ss_pred CccccEEEe-cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence 999999999 477999999999876543222 34678899999999998776556789999999999999999999
Q ss_pred CCCCChHHHHH-HHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 157 FPGENAVDQLV-EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 157 f~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|......+... ... +.. +.....-...+...++...+.+|.+||+.||.+|.|+++|+
T Consensus 525 Wk~a~~~~~~~~~~~-----------------~~~----~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 525 WKVAKKSDNSFKTNN-----------------YSD----QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred cccccccccchhhhc-----------------ccc----ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 96654332211 000 000 00000001112234788999999999999999999999999
Q ss_pred cCCCcccccCC
Q 022500 236 AHPFFDELREP 246 (296)
Q Consensus 236 ~hp~f~~~~~~ 246 (296)
+.+||+.+.-.
T Consensus 584 ~d~W~~~i~~c 594 (601)
T KOG0590|consen 584 NDEWIRSIECC 594 (601)
T ss_pred hChHhhhcceE
Confidence 99999987543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=202.58 Aligned_cols=216 Identities=27% Similarity=0.312 Sum_probs=153.3
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-------
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------- 74 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~------- 74 (296)
-|+|+||+++++.-.-.+ .+...++||+||.+ |+|.++|+. ..+++....+++..++.||+|||+.
T Consensus 260 ~m~h~nIl~Fi~~ekr~t-~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~ 333 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGT-ADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHH 333 (534)
T ss_pred CccchhHHHhhchhccCC-ccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCC
Confidence 479999999987643222 33556899999999 899998875 5689999999999999999999973
Q ss_pred -CCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCC-----chhHHHHHHH
Q 022500 75 -PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYT-----TSIDIWSAGC 145 (296)
Q Consensus 75 -~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~ 145 (296)
..|+|||||..|||+. ++.++-|+|||+|..+..... ....+||..|||||++.|.-++. .+.||||+|.
T Consensus 334 Kp~IaHRDlkSkNVLvK-~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL 412 (534)
T KOG3653|consen 334 KPPIAHRDLKSKNVLVK-NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL 412 (534)
T ss_pred CCccccccccccceEEc-cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence 4699999999999998 588999999999987765433 23578999999999997765555 4699999999
Q ss_pred HHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHHHhhcCcCC-cCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 146 VLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIRCMNPNY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 146 il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
++|||+++-.-+. +..+.=++.-=.+....|+.+++....-.- .+-.++ ..|.. ...-..+++.+..||..
T Consensus 413 VLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p----~~W~~---h~~~~~l~et~EeCWDh 485 (534)
T KOG3653|consen 413 VLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP----DAWRK---HAGMAVLCETIEECWDH 485 (534)
T ss_pred HHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCCh----hhhhc---CccHHHHHHHHHHHcCC
Confidence 9999998653332 221111111111223445555544332110 000000 11111 12345688999999999
Q ss_pred CCCCCCCHH
Q 022500 224 SPSLRCTAL 232 (296)
Q Consensus 224 ~p~~R~t~~ 232 (296)
|++.|+|+.
T Consensus 486 DaeARLTA~ 494 (534)
T KOG3653|consen 486 DAEARLTAG 494 (534)
T ss_pred chhhhhhhH
Confidence 999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=193.60 Aligned_cols=203 Identities=23% Similarity=0.294 Sum_probs=143.8
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
.|.||+..|++-+++.+ ++++++||++ |+|.+.+.. ..+-|...+.++.|+++||.|||+ +++||||||
T Consensus 79 ~H~hIi~tY~vaFqt~d----~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK 148 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSD----AYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLK 148 (378)
T ss_pred cchhhhHHHHHHhhcCc----eEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccc
Confidence 58999999997664433 5789999999 787766543 447888899999999999999999 899999999
Q ss_pred CCcEEEc-CCCCcEEEeeccCccccccCCCccceeecccccCchhccCC----CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 84 PQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 84 p~Nill~-~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
.+|||+- .+...||+||||..+....- ....-.+..|.+||+.... -...+.+|+|.+|+++|.+++|.+||+
T Consensus 149 ~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 149 AENILIFDADFYRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred cceEEEecCCccEEEeeecccccccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 9999984 33458999999998754221 1112235568899987322 225678999999999999999999997
Q ss_pred CCChHHH-HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC---CHHHH
Q 022500 159 GENAVDQ-LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEA 234 (296)
Q Consensus 159 ~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~---t~~e~ 234 (296)
.....+. +.+.++-.+... + ......+.+++.+..+.++-|..+|.+|. ++..-
T Consensus 227 ka~~~d~~Y~~~~~w~~rk~----------------~------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 227 KASIMDKPYWEWEQWLKRKN----------------P------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hhhccCchHHHHHHHhcccC----------------c------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 5432221 111111111100 0 00011234799999999999999999994 45444
Q ss_pred hcCCCcc
Q 022500 235 CAHPFFD 241 (296)
Q Consensus 235 l~hp~f~ 241 (296)
...-|..
T Consensus 285 rk~~w~E 291 (378)
T KOG1345|consen 285 RKCLWKE 291 (378)
T ss_pred HHHHHHH
Confidence 5555553
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=197.55 Aligned_cols=210 Identities=23% Similarity=0.269 Sum_probs=147.4
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-------
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------- 74 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~------- 74 (296)
.|+|+||+.+++.=..+. ..-..++||++|.+ |+|+++|.. ..++...+.+++..+++||++||..
T Consensus 261 mLRHENILgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgK 334 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGK 334 (513)
T ss_pred HhccchhhhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCC
Confidence 479999999987543222 33445999999999 899999874 6789999999999999999999962
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccccccC-----CCccceeecccccCchhccCCCCCC-----chhHHHHHH
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYT-----TSIDIWSAG 144 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG 144 (296)
..|.|||||..|||+. +++.+-|+|+|+|...... ......+||..|||||++...-+.. ..+||||+|
T Consensus 335 PaIAHRDlKSKNILVK-kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafg 413 (513)
T KOG2052|consen 335 PAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFG 413 (513)
T ss_pred chhhccccccccEEEc-cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHH
Confidence 3599999999999999 5889999999999765443 2235679999999999995432211 369999999
Q ss_pred HHHHHHHhC----------CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHH
Q 022500 145 CVLAELLLG----------QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 214 (296)
Q Consensus 145 ~il~~ll~g----------~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (296)
+++||++.+ ++||.+-.+. .|..+++.+. .+.-.........|.. ...-..+.
T Consensus 414 LVlWEiarRc~~ggi~eey~~Pyyd~Vp~-----------DPs~eeMrkV---VCv~~~RP~ipnrW~s---~~~l~~m~ 476 (513)
T KOG2052|consen 414 LVLWEIARRCESGGIVEEYQLPYYDVVPS-----------DPSFEEMRKV---VCVQKLRPNIPNRWKS---DPALRVMA 476 (513)
T ss_pred HHHHHHHHHhhcCCEehhhcCCcccCCCC-----------CCCHHHHhcc---eeecccCCCCCccccc---CHHHHHHH
Confidence 999999853 4666543211 1122222111 1111111111111211 01123466
Q ss_pred HHHHcccccCCCCCCCHHHHhc
Q 022500 215 DLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 215 dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+++.||..||.-|.||..+.+
T Consensus 477 klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 477 KLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred HHHHHhhcCCchhhhHHHHHHH
Confidence 8899999999999999987754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=208.34 Aligned_cols=196 Identities=27% Similarity=0.366 Sum_probs=156.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|..|+|||++++.+++..+. +-||++|++ |.|.+.++. .+..+-......|.+||+.|+.|||. ++++|
T Consensus 752 masldHpnl~RLLgvc~~s~------~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVH 821 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLST------LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVH 821 (1177)
T ss_pred HhcCCCchHHHHhhhcccch------HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhh
Confidence 57899999999999986544 459999999 788888775 45678889999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceee---cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||-..|||+.. -..+||.|||+++...........-+ .+-|||-|.+.. ..|+.++||||+||.+||++| |..
T Consensus 822 rdLaaRNVLVks-P~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~ 899 (1177)
T KOG1025|consen 822 RDLAARNVLVKS-PNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAK 899 (1177)
T ss_pred hhhhhhheeecC-CCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCC
Confidence 999999999984 56799999999997766554433322 456899999864 569999999999999999997 889
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|+.+....++- .+++...+ ... +...+-+.--++.+||..|+..||++.++-
T Consensus 900 Py~gi~~~eI~-dlle~geR---------------Lsq------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 900 PYDGIPAEEIP-DLLEKGER---------------LSQ------------PPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred ccCCCCHHHhh-HHHhcccc---------------CCC------------CCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 99887655443 33332111 111 123678889999999999999999998875
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 952 ~ 952 (1177)
T KOG1025|consen 952 E 952 (1177)
T ss_pred H
Confidence 4
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-25 Score=178.17 Aligned_cols=169 Identities=36% Similarity=0.580 Sum_probs=139.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++.++|++|+++++++... ...++++|+++ ++|.+.+... ...++...+..++.+++.++++||+ .|++|
T Consensus 45 ~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H 115 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIH 115 (215)
T ss_pred HHhcCCCCeeeEeeeeecC-----CeEEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 3567899999999988543 34889999999 5777666531 1468899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
+||+|.||+++..++.++|+|||.+....... ......+...|++||.+.....++.+.|+|++|++++++
T Consensus 116 ~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------- 187 (215)
T cd00180 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------- 187 (215)
T ss_pred cCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------
Confidence 99999999999425789999999997654332 123355678899999986543688999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..+.+++.+|++.||.+||++.++++|+
T Consensus 188 ----------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2456899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=197.65 Aligned_cols=191 Identities=27% Similarity=0.423 Sum_probs=159.5
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~-l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||.+|++.-.+.+... +|+++++..|+ ++. .......+.+...+.+...++.|++++|+ .+|+|||+|
T Consensus 55 ~~~f~v~lhyafqt~~k-----l~l~ld~~rgg~lft----~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k 124 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGK-----LYLILDFLRGGDLFT----RLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYK 124 (612)
T ss_pred CCCceeeeeeeeccccc-----hhHhhhhcccchhhh----ccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhccc
Confidence 48999999888855444 88999999974 332 23455678899999999999999999999 599999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 163 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 163 (296)
++||+++ .+|.+++.|||+++.....+.. +||..|||||++. .....+|+||+|+++++|++|..||.+
T Consensus 125 ~enilld-~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~---- 193 (612)
T KOG0603|consen 125 LENVLLL-LEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG---- 193 (612)
T ss_pred ccceeec-ccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----
Confidence 9999999 4788999999999876554433 8999999999986 367899999999999999999999988
Q ss_pred HHHHHHHHh-cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHHhcC
Q 022500 164 DQLVEIIKV-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAH 237 (296)
Q Consensus 164 ~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~l~h 237 (296)
+....|.+. .+ ++..++..+++++.+++..+|.+|.. ++|+++|
T Consensus 194 ~~~~~Il~~~~~------------------------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 194 DTMKRILKAELE------------------------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred HHHHHHhhhccC------------------------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 556666552 11 23457899999999999999999985 4799999
Q ss_pred CCcccccCC
Q 022500 238 PFFDELREP 246 (296)
Q Consensus 238 p~f~~~~~~ 246 (296)
+||..+.|.
T Consensus 244 ~f~~~i~~~ 252 (612)
T KOG0603|consen 244 EFFQSIDWN 252 (612)
T ss_pred chheeeeHh
Confidence 999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=173.89 Aligned_cols=158 Identities=32% Similarity=0.529 Sum_probs=127.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~-~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+.++|+||+++++.+... ...++++|++++ +|.+.+.. ... +++..+..++.+++.++.+||+ .+++|
T Consensus 52 ~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h 121 (225)
T smart00221 52 KKLKHPNIVKLYGVFEDP-----EPLYLVMEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVH 121 (225)
T ss_pred HhCCCCChhhheeeeecC-----CceEEEEeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 457899999999987543 338899999997 77766653 223 8899999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
+|++|.||+++. ++.++|+|||.+....... ......++..|++||.+.+...++.++|+|++|+++++|++|..||
T Consensus 122 ~di~~~ni~v~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf 200 (225)
T smart00221 122 RDLKPENILLGM-DGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF 200 (225)
T ss_pred CCCCHHHEEEcC-CCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence 999999999994 6889999999988764432 2344567888999998843445788999999999999999999999
Q ss_pred CC-CChH-HHHHHHH
Q 022500 158 PG-ENAV-DQLVEII 170 (296)
Q Consensus 158 ~~-~~~~-~~~~~i~ 170 (296)
.+ .+.. .....+.
T Consensus 201 ~~~~~~~~~~~~~~~ 215 (225)
T smart00221 201 SGEGEFTSLLSDVWS 215 (225)
T ss_pred cccchhHHHHHHHHh
Confidence 87 4444 4444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=177.92 Aligned_cols=199 Identities=22% Similarity=0.322 Sum_probs=145.0
Q ss_pred CCCCeeeeceeeeccC----------------------CCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHH
Q 022500 5 DHPNVISLKHCFFSTT----------------------SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 62 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~----------------------~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~ 62 (296)
+|||||++...|+++- -.....+|+||..+..+|.+++.. ...+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 7999999998875431 123456899999999888777763 3466777888999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCCcEEEcCC---CCcEEEeeccCccccccCC-------CccceeecccccCchhccCCC
Q 022500 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQLIAGE-------ANISYICSRFYRAPELIFGAT 132 (296)
Q Consensus 63 qil~aL~~LH~~~~i~H~dlkp~Nill~~~---~~~vkl~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~ 132 (296)
|++.|+.|||. +||.|||+|.+|||+.-+ -..+.++|||.|-.-.... ......|.-..||||+.....
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 799999999999998422 2368899999885422211 122345666789999984322
Q ss_pred CC-----CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCC
Q 022500 133 EY-----TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 207 (296)
Q Consensus 133 ~~-----~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (296)
.. -.++|.|++|.+.||++....||++...+..-.+- |.+-..| .++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~------------------Yqe~qLP---------alp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT------------------YQESQLP---------ALPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh------------------hhhhhCC---------CCcc
Confidence 21 24799999999999999999999986543211110 1111111 1445
Q ss_pred CCCHHHHHHHHcccccCCCCCCCH---HHHhc
Q 022500 208 RMPPEAIDLASRLLQYSPSLRCTA---LEACA 236 (296)
Q Consensus 208 ~~~~~~~dll~~~L~~~p~~R~t~---~e~l~ 236 (296)
.+++.+++++..+|+.||++|+++ +.+++
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 689999999999999999999985 45554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=174.64 Aligned_cols=199 Identities=18% Similarity=0.222 Sum_probs=154.5
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA----NQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~----~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
-..|||+.++.++..... ...++++.+.+ |+|..++...... ...++-.+...++.|+..|++|||+ .||
T Consensus 343 ~~sH~nll~V~~V~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~V 417 (563)
T KOG1024|consen 343 GASHPNLLSVLGVSIEDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGV 417 (563)
T ss_pred cCcCCCccceeEEEeecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCc
Confidence 357999999999876433 22557788888 7887777643322 2346667788899999999999999 799
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-C
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-G 153 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g 153 (296)
+|.||-..|++++ +.-++||+|=.+++.+....-. ........||+||.+... .|+.++|+||+||++|||++ |
T Consensus 418 iHkDiAaRNCvId-d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg 495 (563)
T KOG1024|consen 418 IHKDIAARNCVID-DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLG 495 (563)
T ss_pred ccchhhhhcceeh-hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcC
Confidence 9999999999999 5678999999999876543321 112335679999999764 59999999999999999997 8
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
+.|+..-++.++...+.+.. +.. -+-.++.++..++.-||+..|++||+.++
T Consensus 496 ~~PyaeIDPfEm~~ylkdGy------------------Rla----------QP~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 496 KLPYAEIDPFEMEHYLKDGY------------------RLA----------QPFNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred CCCccccCHHHHHHHHhccc------------------eec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 89998888888776655410 010 12358999999999999999999999998
Q ss_pred Hhc
Q 022500 234 ACA 236 (296)
Q Consensus 234 ~l~ 236 (296)
+..
T Consensus 548 lv~ 550 (563)
T KOG1024|consen 548 LVI 550 (563)
T ss_pred HHH
Confidence 764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-21 Score=166.01 Aligned_cols=217 Identities=33% Similarity=0.470 Sum_probs=158.3
Q ss_pred CCCCCC-CeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVMDHP-NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l~Hp-nIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+.+.|+ +|+++++.+.... ..+++++++.+ ++.+.+...... ..++...+..++.|++.++.|+|+ .+++|
T Consensus 52 ~~~~~~~~i~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~h 124 (384)
T COG0515 52 ASLNHPPNIVKLYDFFQDEG-----SLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIH 124 (384)
T ss_pred HHccCCcceeeEEEEEecCC-----EEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 356777 7999999983322 27899999996 544333321100 278999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-------CccceeecccccCchhccCC--CCCCchhHHHHHHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-------ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l 150 (296)
||+||+||+++.....++++|||.+....... ......++..|++||.+.+. ..+....|+||+|++++++
T Consensus 125 rd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~ 204 (384)
T COG0515 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204 (384)
T ss_pred cCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHH
Confidence 99999999999533369999999997554332 23567889999999999763 4688999999999999999
Q ss_pred HhCCCCCCCCCh---HHHHHHHHHhcCCC-CHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 151 LLGQPLFPGENA---VDQLVEIIKVLGTP-TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 151 l~g~~pf~~~~~---~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
++|..||..... .......+.....+ ..... . ............+++.+++..+|.
T Consensus 205 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~--------~~~~~~~~~~~~~~~~~~~~~~~~ 264 (384)
T COG0515 205 LTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL------------S--------PSNPELISKAASDLLKKLLAKDPK 264 (384)
T ss_pred HhCCCCCCCCCccccHHHHHHHHHhcCCccccccc------------C--------ccccchhhHHHHHHHHHHHhcCch
Confidence 999999877764 33444444332222 00000 0 000011246889999999999999
Q ss_pred CCCCHHHHhcCCCcccccC
Q 022500 227 LRCTALEACAHPFFDELRE 245 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~~ 245 (296)
.|.+..+...+++......
T Consensus 265 ~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 265 NRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred hcCCHHHHhhchHhhCccc
Confidence 9999999888877765443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=189.58 Aligned_cols=155 Identities=32% Similarity=0.494 Sum_probs=127.3
Q ss_pred HHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC----------------CccceeecccccCch
Q 022500 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----------------ANISYICSRFYRAPE 126 (296)
Q Consensus 63 qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----------------~~~~~~~t~~y~aPE 126 (296)
+++.+++|||+ -||+|||+||+|.++. .-+.+|++|||+++...... ..+..+|||.|+|||
T Consensus 151 dmvla~Eylh~-ygivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 151 DMVLAVEYLHS-YGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhhHHhHhhcc-CCeecCCCCCCcceee-ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 34789999999 6999999999999999 47789999999987432110 012458899999999
Q ss_pred hccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccC
Q 022500 127 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 206 (296)
Q Consensus 127 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (296)
++.. +.|+..+|+|++|+|+|+.+.|..||.++..++.+...+.....-+. . .
T Consensus 229 Vilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE-------------------------~-d 281 (1205)
T KOG0606|consen 229 VILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-------------------------E-D 281 (1205)
T ss_pred hhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc-------------------------c-C
Confidence 9975 45999999999999999999999999999999998888764222111 1 1
Q ss_pred CCCCHHHHHHHHcccccCCCCCC---CHHHHhcCCCcccccCC
Q 022500 207 KRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP 246 (296)
Q Consensus 207 ~~~~~~~~dll~~~L~~~p~~R~---t~~e~l~hp~f~~~~~~ 246 (296)
..+.++++|+|.++|+.+|..|. ++.++.+|+||+.+.|.
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 24789999999999999999996 45689999999998776
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=183.07 Aligned_cols=194 Identities=29% Similarity=0.478 Sum_probs=138.7
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.++|||++.+.-+. ......|||-+|+..+|++-+.. +.-+...+.+.|+.|++.||.-+|. .||+||||
T Consensus 77 l~~~pn~lPfqk~~-----~t~kAAylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDI 146 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVL-----VTDKAAYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDI 146 (1431)
T ss_pred hhcCCcccchHHHH-----HhhHHHHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCcccccc
Confidence 46899999887664 33344779999999988877653 4557888999999999999999999 69999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCC---ccc-eee----cccccCchhccCCC----------CCCchhHHHHHH
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NIS-YIC----SRFYRAPELIFGAT----------EYTTSIDIWSAG 144 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~-~~~----t~~y~aPE~~~~~~----------~~~~~~DiwslG 144 (296)
|.+|||+++-+ .+.|+||..-+...-.+. ..+ +.. ...|.|||.+.... ..+++-||||+|
T Consensus 147 KsENILiTSWN-W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G 225 (1431)
T KOG1240|consen 147 KSENILITSWN-WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG 225 (1431)
T ss_pred ccceEEEeeec-hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence 99999999644 489999987654321111 111 112 33699999984311 156789999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHH-hcC-CCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIK-VLG-TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 221 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 221 (296)
|+++||++ |++||.- .++++ ..| ....+.. +..--+...+.+|..|+
T Consensus 226 CViaELf~Eg~PlF~L-------SQL~aYr~~~~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi 275 (1431)
T KOG1240|consen 226 CVIAELFLEGRPLFTL-------SQLLAYRSGNADDPEQL-----------------------LEKIEDVSLRNLILSMI 275 (1431)
T ss_pred HHHHHHHhcCCCcccH-------HHHHhHhccCccCHHHH-----------------------HHhCcCccHHHHHHHHH
Confidence 99999997 6888831 11111 001 1111111 11112457899999999
Q ss_pred ccCCCCCCCHHHHhcC
Q 022500 222 QYSPSLRCTALEACAH 237 (296)
Q Consensus 222 ~~~p~~R~t~~e~l~h 237 (296)
+.||++|.+|++.|+-
T Consensus 276 ~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 276 QRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCchhccCHHHHHHh
Confidence 9999999999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=168.61 Aligned_cols=204 Identities=26% Similarity=0.396 Sum_probs=152.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc-c
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-C 78 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i-~ 78 (296)
|+.+.|.|+.++++..+.... .++|.+||+ |+|.+.+.. ....++......++++|+.||+|+|.. .| .
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~-----~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPE-----MIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS-PIGY 71 (484)
T ss_pred CcccchhhhhhheeeEecCCc-----eEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence 789999999999999976643 889999999 898888875 456788889999999999999999994 65 9
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccC---CCccceeecccccCchhccCCC--C----CCchhHHHHHHHHHHH
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGAT--E----YTTSIDIWSAGCVLAE 149 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~--~----~~~~~DiwslG~il~~ 149 (296)
|+.++..|++++ ..+.+|++|||+....... ..........-|.|||.+.+.. . .+.+.|+||+|++++|
T Consensus 72 hg~l~s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 72 HGALKSSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeccccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 999999999999 6899999999998765321 1111222345689999996531 1 3667999999999999
Q ss_pred HHhCCCCCCCCCh----HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 150 LLLGQPLFPGENA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 150 ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
+++...||..... .+.+..+.+....+..+.+.. .....++...++++||..+|
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~----------------------~~e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL----------------------LNELPPELLLLVARCWEEIP 208 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh----------------------hhhcchHHHHHHHHhcccCh
Confidence 9999999977432 233333222011111111100 01356689999999999999
Q ss_pred CCCCCHHHHhc
Q 022500 226 SLRCTALEACA 236 (296)
Q Consensus 226 ~~R~t~~e~l~ 236 (296)
.+||+++.+..
T Consensus 209 ~~rPs~~~i~~ 219 (484)
T KOG1023|consen 209 EKRPSIEQIRS 219 (484)
T ss_pred hhCccHHHHHh
Confidence 99999988753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-19 Score=155.30 Aligned_cols=198 Identities=19% Similarity=0.158 Sum_probs=144.6
Q ss_pred CCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCc
Q 022500 7 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 86 (296)
Q Consensus 7 pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~N 86 (296)
+++.++++... ....+-|+||+.++.+|.++.+... ...++..++..++.|++.+|++||+ .|++||||||+|
T Consensus 80 ~~~~~~~~~G~----~~~~~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N 152 (322)
T KOG1164|consen 80 SHFPKLLDHGR----STEDFNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPEN 152 (322)
T ss_pred CCCCEEEEecc----CCCceeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHH
Confidence 46666666552 2444578999999999988776543 5789999999999999999999999 799999999999
Q ss_pred EEEcCCC----CcEEEeeccCcc--ccccCC--------C-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 87 LLVDPLT----HQVKICDFGSAK--QLIAGE--------A-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 87 ill~~~~----~~vkl~Dfg~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
+++.... ..+.+.|||+|+ ...... . .....||..|.++.+..+. ..+.+.|+||++.++.++.
T Consensus 153 ~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~ 231 (322)
T KOG1164|consen 153 FVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELL 231 (322)
T ss_pred eeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHh
Confidence 9997433 569999999998 321111 0 1234589999999988664 5899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 152 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
.|..||.+........++.+...... ... .....+.++.++...+-..+...+|..
T Consensus 232 ~g~LPW~~~~~~~~~~~~~~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 232 KGSLPWEALEMTDLKSKFEKDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDY 287 (322)
T ss_pred cCCCCCccccccchHHHHHHHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCH
Confidence 99999977654333333222100000 000 112245677788877777899999988
Q ss_pred HHHhc
Q 022500 232 LEACA 236 (296)
Q Consensus 232 ~e~l~ 236 (296)
..+..
T Consensus 288 ~~~~~ 292 (322)
T KOG1164|consen 288 EKLAE 292 (322)
T ss_pred HHHHH
Confidence 76654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=165.85 Aligned_cols=179 Identities=30% Similarity=0.444 Sum_probs=129.5
Q ss_pred cceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeecc
Q 022500 24 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 102 (296)
Q Consensus 24 ~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 102 (296)
..++||.|++|. ++|.+-+.. .......+......++.|+..|++| +|.+|||+||.||.+. .+..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~-~d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFS-DDDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccc-cchhhhhhhhh
Confidence 446899999999 455554442 2234557788899999999999999 4899999999999998 46789999999
Q ss_pred CccccccCC-------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcC
Q 022500 103 SAKQLIAGE-------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLG 174 (296)
Q Consensus 103 ~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~ 174 (296)
+........ ..+..+||.+||+||.+.+. .|+.++||||||+|++|++.- ...|...... ..++. |
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~----~d~r~-g 475 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERIATL----TDIRD-G 475 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHHHhh----hhhhc-C
Confidence 988765554 34567899999999999875 599999999999999999982 2222111100 01110 0
Q ss_pred CCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
..++. +.. -.++-.+|+.+||...|.+||++.+.--|+|.
T Consensus 476 ~ip~~-------------------------~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 476 IIPPE-------------------------FLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCChH-------------------------Hhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 00000 000 13455699999999999999988777666664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.6e-20 Score=154.23 Aligned_cols=165 Identities=25% Similarity=0.291 Sum_probs=106.3
Q ss_pred EEEEeccCcccHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccC
Q 022500 27 LNLVMEYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103 (296)
Q Consensus 27 ~~lv~E~~~g~l~~~l~~~~~~~~~---~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 103 (296)
.+++|+-+.++|.+.+......... +.......+..|++..+++||+ .|++|+||+|+|++++. +|.++|+||+.
T Consensus 114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi~~~nfll~~-~G~v~Lg~F~~ 191 (288)
T PF14531_consen 114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDIKPENFLLDQ-DGGVFLGDFSS 191 (288)
T ss_dssp EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEE-T-TS-EEE--GGG
T ss_pred hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecccceeeEEEcC-CCCEEEcChHH
Confidence 5789999999988876643333222 2222334445899999999999 69999999999999994 78899999988
Q ss_pred ccccccCCCccceeecccccCchhccCC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 022500 104 AKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176 (296)
Q Consensus 104 a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 176 (296)
.......... ...+..|.+||..... ..++.+.|.|++|+++|.|+||..||.........
T Consensus 192 ~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~---------- 259 (288)
T PF14531_consen 192 LVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP---------- 259 (288)
T ss_dssp EEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS----------
T ss_pred HeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc----------
Confidence 7654322111 2335779999987432 23788999999999999999999999765321100
Q ss_pred CHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCC
Q 022500 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228 (296)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R 228 (296)
++.+. ....+++..++||.++|++||.+|
T Consensus 260 -------------~~~f~----------~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 260 -------------EWDFS----------RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -------------GGGGT----------TSS---HHHHHHHHHHT-SSGGGS
T ss_pred -------------cccch----------hcCCcCHHHHHHHHHHccCCcccC
Confidence 00011 112479999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=140.56 Aligned_cols=193 Identities=20% Similarity=0.283 Sum_probs=144.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.+.||||..+.+.+-+.. .+.++..|++ |+|+..+.. ..+...+..++.+++..++.|+.|||++..++-
T Consensus 241 lrifshpnilpvlgacnspp-----nlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~ip 313 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPP-----NLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIP 313 (448)
T ss_pred eeeecCCchhhhhhhccCCC-----CceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchhhh
Confidence 46678999999999985444 4889999999 888888764 234557888899999999999999999755554
Q ss_pred C-CCCCCcEEEcCCCCcEEEe--eccCccccccCCCccceeecccccCchhccCCCCC--CchhHHHHHHHHHHHHHhCC
Q 022500 80 R-DLKPQNLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFYRAPELIFGATEY--TTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~-dlkp~Nill~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwslG~il~~ll~g~ 154 (296)
| -|....++++ .+-+.+|. |--++.. .......|.|++||.+...+.. -.++|+||+++++||+.|+.
T Consensus 314 r~~lns~hvmid-edltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tre 386 (448)
T KOG0195|consen 314 RFYLNSKHVMID-EDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTRE 386 (448)
T ss_pred hhhcccceEEec-chhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccc
Confidence 4 5677788888 34444443 4333221 1234558899999999653322 35799999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||..-++++.-.+|.-. -+...++.+++.....|++-|+..||.+||..+.+
T Consensus 387 vpfadlspmecgmkiale---------------------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 387 VPFADLSPMECGMKIALE---------------------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred cccccCCchhhhhhhhhc---------------------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 999888877765554321 11223456789999999999999999999988755
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.5e-18 Score=140.17 Aligned_cols=156 Identities=20% Similarity=0.281 Sum_probs=124.8
Q ss_pred CCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCc
Q 022500 7 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 86 (296)
Q Consensus 7 pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~N 86 (296)
++|...|-+. +...+-.||+|+++.+|.+++.-+ +.+|+..++..++.|++.-++|+|+ +.+|.|||||+|
T Consensus 84 ~GIP~vYYFG-----qeG~~NiLVidLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdN 154 (449)
T KOG1165|consen 84 EGIPQVYYFG-----QEGKYNILVIDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDN 154 (449)
T ss_pred CCCCceeeec-----cccchhhhhhhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccc
Confidence 5566554332 455556699999999998887753 4569999999999999999999999 799999999999
Q ss_pred EEEcC----CCCcEEEeeccCccccccCCC--------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 87 LLVDP----LTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 87 ill~~----~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
+|+.. +...|.++|||+|+...+.+. .++-.||-.||+--...|. .-+...|+=|+|-++.+.+.|.
T Consensus 155 FLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 155 FLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred eeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCC
Confidence 99952 234689999999998755433 2355789999998888775 4789999999999999999999
Q ss_pred CCCCCC---ChHHHHHHHHHh
Q 022500 155 PLFPGE---NAVDQLVEIIKV 172 (296)
Q Consensus 155 ~pf~~~---~~~~~~~~i~~~ 172 (296)
.||+|- +..+.+.+|-+.
T Consensus 234 LPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 234 LPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred CccccccCcchHHHHHHhccc
Confidence 999885 455666666443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.7e-19 Score=163.42 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=156.5
Q ss_pred CCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCC
Q 022500 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAYIH-TVPRVCHRDL 82 (296)
Q Consensus 6 HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~-~~~~~~~~~~~~qil~aL~~LH-~~~~i~H~dl 82 (296)
|+|++++++.. .+..+.+++++|..| +++..+. ..+. ..+...+..++.|+..++.|+| . .++.|||+
T Consensus 80 h~n~~~~~~~~-----~~~~~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~i 150 (601)
T KOG0590|consen 80 HSNTVHMIEPS-----SSPRSYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDI 150 (601)
T ss_pred cccccccCCcc-----CCCcccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCC
Confidence 99999999987 444458899999885 5554442 1222 4666778899999999999999 8 79999999
Q ss_pred CCCcEEEcCCCC-cEEEeeccCcccccc-CCC---ccceee-cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 83 KPQNLLVDPLTH-QVKICDFGSAKQLIA-GEA---NISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 83 kp~Nill~~~~~-~vkl~Dfg~a~~~~~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||+|.+++. .+ .+++.|||+|..... ... ....+| ++.|+|||...+....++..|+||+|+++..+++|..|
T Consensus 151 kP~n~~l~~-s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 151 KPSNSLLDE-SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred CCccchhcc-CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence 999999994 55 899999999987755 322 234577 99999999998766678999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+........ .|..|.... .......+..++....+++.+++..+|..|.+.+++..
T Consensus 230 ~~~~~~~~~---------------------~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 230 WDFPSRKDG---------------------RYSSWKSNK---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccccccc---------------------cceeecccc---cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 866543321 111111000 11112233568999999999999999999999999999
Q ss_pred CCCccc
Q 022500 237 HPFFDE 242 (296)
Q Consensus 237 hp~f~~ 242 (296)
+||+..
T Consensus 286 d~~~~~ 291 (601)
T KOG0590|consen 286 DNWLSS 291 (601)
T ss_pred cccccc
Confidence 999988
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-18 Score=150.15 Aligned_cols=108 Identities=19% Similarity=0.210 Sum_probs=79.1
Q ss_pred CCCCCCCCeee-eceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVIS-LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~-l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|+||+. +++. + ..||||||++|+.+..+. . .. ...++.|++.||.|||+ +||+|
T Consensus 75 L~~L~h~~iv~~l~~~----~-----~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~-~gIiH 134 (365)
T PRK09188 75 LKTVRGIGVVPQLLAT----G-----KDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHR-AGITH 134 (365)
T ss_pred HHhccCCCCCcEEEEc----C-----CcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHH-CCCee
Confidence 46789999985 5432 1 267999999974332211 1 11 14678999999999999 79999
Q ss_pred CCC-CCCcEEEcCCCCcEEEeeccCccccccCCC---------ccceeecccccCchhcc
Q 022500 80 RDL-KPQNLLVDPLTHQVKICDFGSAKQLIAGEA---------NISYICSRFYRAPELIF 129 (296)
Q Consensus 80 ~dl-kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---------~~~~~~t~~y~aPE~~~ 129 (296)
||| ||+|||++ .++.+||+|||+|+....... ..+..+++.|.|||.+.
T Consensus 135 rDL~KP~NILv~-~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 135 NDLAKPQNWLMG-PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CCCCCcceEEEc-CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999 99999998 467899999999986543321 13446678899999883
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=132.23 Aligned_cols=139 Identities=23% Similarity=0.339 Sum_probs=110.4
Q ss_pred CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcC--CCCcEEEe
Q 022500 22 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKIC 99 (296)
Q Consensus 22 ~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~ 99 (296)
.+..+-.+|||.++.+|.+++.-+ ...++..++.-++-|++.-++|+|. ++++||||||+|+|..- ....+.++
T Consensus 81 ~e~~ynvlVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 81 TEKDYNVLVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred cccccceeeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEE
Confidence 444556799999999988777643 2458999999999999999999999 79999999999999742 33468999
Q ss_pred eccCccccccCCC--------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 022500 100 DFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 165 (296)
Q Consensus 100 Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 165 (296)
|||+|+...+... ...-.||..|.+--...+. ..+...|+-|+|.++.+...|..||++......
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 9999987644322 2345788889887666543 367889999999999999999999998754433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=132.62 Aligned_cols=140 Identities=19% Similarity=0.091 Sum_probs=99.6
Q ss_pred CCCCC-CCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+ |++|++++++. . .|++|||+.|..+... . +.. ...++.|++.+|+++|+ +||+|
T Consensus 55 L~~L~~~~~vP~ll~~~-----~----~~lvmeyI~G~~L~~~---~------~~~-~~~~~~qi~~~L~~lH~-~GIvH 114 (218)
T PRK12274 55 LRQLDGLPRTPRLLHWD-----G----RHLDRSYLAGAAMYQR---P------PRG-DLAYFRAARRLLQQLHR-CGVAH 114 (218)
T ss_pred HHhcCCCCCCCEEEEEc-----C----EEEEEeeecCccHHhh---h------hhh-hHHHHHHHHHHHHHHHH-CcCcc
Confidence 35674 47899988752 1 5799999998532211 0 011 13477899999999999 79999
Q ss_pred CCC-CCCcEEEcCCCCcEEEeeccCccccccCCCc--------------cceeecccccCchhccCCCCCC-chhHHHHH
Q 022500 80 RDL-KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--------------ISYICSRFYRAPELIFGATEYT-TSIDIWSA 143 (296)
Q Consensus 80 ~dl-kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--------------~~~~~t~~y~aPE~~~~~~~~~-~~~Diwsl 143 (296)
||| ||+||+++ .++.++|+|||+|......... .-...++.|++|+...-....+ ...++++.
T Consensus 115 rDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~ 193 (218)
T PRK12274 115 NDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFAT 193 (218)
T ss_pred CCCCCcceEEEc-CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHh
Confidence 999 79999998 4678999999999854332210 0112467788887653332334 56789999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 022500 144 GCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 144 G~il~~ll~g~~pf~~~~ 161 (296)
|+.+|.++|+..+..+++
T Consensus 194 g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 194 GKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHhccCCccccC
Confidence 999999999998876654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-17 Score=132.98 Aligned_cols=123 Identities=14% Similarity=0.182 Sum_probs=86.1
Q ss_pred CCCCCCCeeeeceeeeccCCCC---cceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKN---ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~---~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
.++.||+|..+.+++....... ....+|||||++| +|.+.. .+++. .+.+++.+|..+|. .|+
T Consensus 90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~~----~~~~i~~~l~~lH~-~gi 156 (232)
T PRK10359 90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISED----VKAKIKASIESLHQ-HGM 156 (232)
T ss_pred HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh--------hccHH----HHHHHHHHHHHHHH-cCC
Confidence 4578999999998875432111 1236799999998 443321 13332 45699999999999 799
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
+|||+||+||++++ ++ ++|+|||.+........... .... ..|+.++|+||+|+.+....
T Consensus 157 ~H~Dikp~Nili~~-~g-i~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 157 VSGDPHKGNFIVSK-NG-LRIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccCCCChHHEEEeC-CC-EEEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence 99999999999984 56 99999998865432211110 2222 34668899999999877554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-15 Score=122.85 Aligned_cols=92 Identities=15% Similarity=0.204 Sum_probs=68.0
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc---ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCcccC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL-AYIHTVPRVCHR 80 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~---g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL-~~LH~~~~i~H~ 80 (296)
+||||+++++++.+..+. ...+.+|+||++ |+|.+.++. ..+++. ..++.|++.++ +|||+ ++|+||
T Consensus 59 ~h~nIvr~yg~~et~~g~-g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~Ivhr 129 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGT-GYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTM 129 (210)
T ss_pred CCcccceeeEEEEeCCCC-eEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeec
Confidence 689999999998654321 222447999955 587777753 236655 35688888888 99999 799999
Q ss_pred CCCCCcEEEcC---CCCcEEEeeccCcc
Q 022500 81 DLKPQNLLVDP---LTHQVKICDFGSAK 105 (296)
Q Consensus 81 dlkp~Nill~~---~~~~vkl~Dfg~a~ 105 (296)
||||+||+++. .+..++|+|++.+.
T Consensus 130 DlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 130 ELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred CCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 99999999973 23479999954443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-16 Score=124.69 Aligned_cols=74 Identities=19% Similarity=0.270 Sum_probs=60.6
Q ss_pred EEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 28 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 28 ~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~L-H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
+|||||++|+...... .....+++..+..++.|++.+|.++ |+ .||+||||||+||+++ ++.++|+|||+|..
T Consensus 93 ~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NIli~--~~~v~LiDFG~a~~ 166 (190)
T cd05147 93 VLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNLLYH--DGKLYIIDVSQSVE 166 (190)
T ss_pred EEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEE--CCcEEEEEcccccc
Confidence 6999999975322111 1235789999999999999999999 68 6999999999999998 36799999999974
Q ss_pred c
Q 022500 107 L 107 (296)
Q Consensus 107 ~ 107 (296)
.
T Consensus 167 ~ 167 (190)
T cd05147 167 H 167 (190)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.8e-15 Score=140.88 Aligned_cols=192 Identities=28% Similarity=0.407 Sum_probs=148.7
Q ss_pred EEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 27 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 27 ~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
++||++|++| ++...+. ..+..++.-++.++..+..+++|||+ ..+.|||++|.|++.. ..+..++.|||...
T Consensus 879 ~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~-~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIA-YDGHRPLTDFGTLS 952 (1205)
T ss_pred cchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhc-ccCCcccCcccccc
Confidence 7799999985 5555544 34567777788899999999999999 5799999999999998 57778999998432
Q ss_pred cccc------------------------------C--CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 106 QLIA------------------------------G--EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 106 ~~~~------------------------------~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
.... . .......+|+.|.+||...+.. .+..+|+|+.|+++++.++|
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcC
Confidence 1100 0 0112346799999999998754 78999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH-
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL- 232 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~- 232 (296)
.+||........+..|.+..- +|.. -+...+.++++++.+.|..+|.+|.++.
T Consensus 1032 ~pp~na~tpq~~f~ni~~~~~-------------------------~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRDI-------------------------PWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred CCCCCCcchhhhhhccccCCC-------------------------CCCC-CccccChhhhhhhhhhhccCchhccCccc
Confidence 999999888777766654211 1110 1234788999999999999999999876
Q ss_pred --HHhcCCCcccccCCCCCCC
Q 022500 233 --EACAHPFFDELREPNARLP 251 (296)
Q Consensus 233 --e~l~hp~f~~~~~~~~~~~ 251 (296)
++-.||||+...|.+....
T Consensus 1086 ~~e~k~~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1086 AAEVKGHPFFQDVDWENLALQ 1106 (1205)
T ss_pred ccccccCCccCCCCccccccc
Confidence 8899999999988754433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.3e-14 Score=139.05 Aligned_cols=122 Identities=22% Similarity=0.381 Sum_probs=103.1
Q ss_pred EEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEc------CCCCcEEEe
Q 022500 27 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD------PLTHQVKIC 99 (296)
Q Consensus 27 ~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~------~~~~~vkl~ 99 (296)
-+||+||.+ |+|++++. ..+.+++..+..+..|++.-++.||. .+|||+||||+|++|. .....++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEE
Confidence 459999999 88887776 56789999999999999999999999 6999999999999983 123459999
Q ss_pred eccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 100 DFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 100 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||.+..+.--. ......+|-.+-++|...|+ .+++.+|.|.++.+++.|+.|.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence 999997654322 33455678889999999775 5999999999999999999997
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-14 Score=117.64 Aligned_cols=74 Identities=19% Similarity=0.163 Sum_probs=61.0
Q ss_pred EEEEeccCccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCcEEEcCCCCcEEEeeccCc
Q 022500 27 LNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 104 (296)
Q Consensus 27 ~~lv~E~~~g~-l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~-~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 104 (296)
.||||||++|+ +..... ....++...+..++.|++.++.++|+ . ||+||||||+||+++ ++.++|+|||+|
T Consensus 92 ~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~--~~~~~liDFG~a 164 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH--DGKPYIIDVSQA 164 (190)
T ss_pred CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE--CCCEEEEEcccc
Confidence 36999999975 222211 22467888999999999999999998 6 999999999999998 567999999999
Q ss_pred ccc
Q 022500 105 KQL 107 (296)
Q Consensus 105 ~~~ 107 (296)
...
T Consensus 165 ~~~ 167 (190)
T cd05145 165 VEL 167 (190)
T ss_pred eec
Confidence 765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-14 Score=121.05 Aligned_cols=207 Identities=19% Similarity=0.217 Sum_probs=143.6
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHR 80 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~-~~i~H~ 80 (296)
++.|.|||+++.++.+....+.....+++||++ |++.+.|+.-......+.....++|+.||++||.|||+. --|+|+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 467999999999987666556666789999999 888888887666677889999999999999999999994 238999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCcc--ccc--cCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAK--QLI--AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~--~~~--~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
++..+.|++. .++-+|+.--.-.. ... .... .....+-++|.+||.=.. .+.+.++|||++|....+|..+..
T Consensus 203 nlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 203 NLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred Ccchhheeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHhee
Confidence 9999999998 46666665211111 000 0000 112234678899986532 346788999999999999988763
Q ss_pred C-CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 156 L-FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 156 p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
- -.+.+..+.-..+.+. +...-..--++++.+||+-.|..||++.++
T Consensus 281 q~tnseS~~~~ee~ia~~--------------------------------i~~len~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANV--------------------------------IIGLENGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred ccCCCcceeehhhhhhhh--------------------------------eeeccCccccCcCcccccCCCCCCcchhhh
Confidence 2 2222211111111110 000011223578999999999999999999
Q ss_pred hcCCCcccc
Q 022500 235 CAHPFFDEL 243 (296)
Q Consensus 235 l~hp~f~~~ 243 (296)
+.||..-++
T Consensus 329 lfHpllfeV 337 (458)
T KOG1266|consen 329 LFHPLLFEV 337 (458)
T ss_pred hcCceeeec
Confidence 999987554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-12 Score=118.72 Aligned_cols=136 Identities=25% Similarity=0.338 Sum_probs=101.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
||.|+||||+++++.+...+ .+|||+|.+-. |...++. +....+...+.||+.||.|||.-++++|+
T Consensus 63 lKtlRHP~Il~yL~t~e~~~-----~~ylvTErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHg 129 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEG-----TLYLVTERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHG 129 (690)
T ss_pred hhhccCchhhhhhhhhcccC-----ceEEEeecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeec
Confidence 68899999999999985444 49999999984 2234443 33667888899999999999854789999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
+|.-+.|+++ ..|..||++|.++........ .....---.|..|+.+.. . .-..|.|-|||++++++.|
T Consensus 130 Nv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s--~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 130 NVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-S--EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-c--ccchhhhhHHHHHHHHhCc
Confidence 9999999999 578899999998865432221 111111223666765421 1 1457999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.5e-13 Score=118.56 Aligned_cols=198 Identities=23% Similarity=0.229 Sum_probs=148.5
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCcccC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR----GLAYIHTVPRVCHR 80 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~----aL~~LH~~~~i~H~ 80 (296)
.|+|.|+.+..+. +...+++-+|+|+.++...... ...-++...+..++.+... ||..+|+ .+++|-
T Consensus 176 ~~~~~v~~~~~~e-----~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~ 246 (524)
T KOG0601|consen 176 SHENPVRDSPAWE-----GSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHD 246 (524)
T ss_pred ccccccccCcccc-----cCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Cccccc
Confidence 5889999877774 4444889999999765554432 3344788889999999999 9999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCcc------ceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI------SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|+||+||....+....+++|||+...+.+..... ...+..-|++||...+ -++..+|++++|.++.+..++.
T Consensus 247 ~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 247 DLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGS 324 (524)
T ss_pred ccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhc
Confidence 9999999998533779999999998876554221 1245667999999854 4899999999999999999987
Q ss_pred CCCCCC--ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 155 PLFPGE--NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 155 ~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
.+...+ +...++.. .....++....+.++...+..|+..+|..|+++.
T Consensus 325 ~~~~~g~~~~W~~~r~------------------------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 325 HLPSVGKNSSWSQLRQ------------------------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred ccccCCCCCCcccccc------------------------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 655433 21111111 0112223334566777799999999999999999
Q ss_pred HHhcCCCcccc
Q 022500 233 EACAHPFFDEL 243 (296)
Q Consensus 233 e~l~hp~f~~~ 243 (296)
.+++|++....
T Consensus 375 ~~~~l~~i~s~ 385 (524)
T KOG0601|consen 375 ILTALNVIHSK 385 (524)
T ss_pred HHhccccccch
Confidence 99999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-12 Score=121.67 Aligned_cols=86 Identities=21% Similarity=0.230 Sum_probs=68.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|++|+..+.+..... ..++||||++| +|.+.+. ....++.|++.+|.+||+ .|++||
T Consensus 391 ~~l~~~~i~~p~~~~~~~~-----~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHr 452 (535)
T PRK09605 391 SEARRAGVPTPVIYDVDPE-----EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHG 452 (535)
T ss_pred HhhcccCCCeeEEEEEeCC-----CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccC
Confidence 4678999887766554322 25799999996 5554443 246788999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCcccc
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQL 107 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~ 107 (296)
||||+||+++ ++.++|+|||+++..
T Consensus 453 Dlkp~NILl~--~~~~~liDFGla~~~ 477 (535)
T PRK09605 453 DLTTSNFIVR--DDRLYLIDFGLGKYS 477 (535)
T ss_pred CCChHHEEEE--CCcEEEEeCcccccC
Confidence 9999999995 567999999999753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.1e-12 Score=108.02 Aligned_cols=92 Identities=16% Similarity=0.182 Sum_probs=65.5
Q ss_pred CCCCCCe--eeeceeeeccCCCCcceEEEEeccCcc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 3 VMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 3 ~l~HpnI--v~l~~~~~~~~~~~~~~~~lv~E~~~g--~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
.|+|++| ++.+++...... .....++|||+++| +|.+.+.. ..+++.. +.|++.+|.+||+ +||+
T Consensus 96 ~L~~~gi~vP~pl~~~~~~~~-~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~ 164 (239)
T PRK01723 96 QLYEAGLPVPRPIAARVVRHG-LFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVY 164 (239)
T ss_pred HHHhCCCCCceeEeeeeeecC-cceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCC
Confidence 4667664 556555432211 11123599999996 56555432 3455543 5689999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
||||||+|||++. ++.++|+|||.+..
T Consensus 165 HrDlkp~NILv~~-~~~v~LIDfg~~~~ 191 (239)
T PRK01723 165 HADLNAHNILLDP-DGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCchhEEEcC-CCCEEEEECCCccc
Confidence 9999999999984 56899999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.8e-12 Score=106.56 Aligned_cols=88 Identities=20% Similarity=0.301 Sum_probs=67.9
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.+.|+||.....++.... ..++||||++| +|.+.+.. .. . ....++.+++.+|.++|+ .|++|||
T Consensus 55 ~l~~~~i~~p~~~~~~~~-----~~~lv~e~~~G~~L~~~~~~----~~---~-~~~~i~~~i~~~l~~lH~-~~i~H~D 120 (211)
T PRK14879 55 RARKAGVNVPAVYFVDPE-----NFIIVMEYIEGEPLKDLINS----NG---M-EELELSREIGRLVGKLHS-AGIIHGD 120 (211)
T ss_pred HHHHCCCCCCeEEEEeCC-----CCEEEEEEeCCcCHHHHHHh----cc---H-HHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 456777766655553332 26799999986 66555542 11 1 678899999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccc
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
++|+||+++ ++.++++|||.+..
T Consensus 121 l~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 121 LTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcccEEEE--CCCEEEEECCcccC
Confidence 999999998 56799999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-12 Score=108.23 Aligned_cols=75 Identities=20% Similarity=0.150 Sum_probs=59.6
Q ss_pred EEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-cccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 27 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 27 ~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~-i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.++||||++|+..... ......+....+..++.|++.+|.+||+ .| ++||||||+||+++ ++.++|+|||.|.
T Consensus 123 ~~lV~E~~~g~~L~~~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp~NIli~--~~~i~LiDFg~a~ 196 (237)
T smart00090 123 NVLVMEFIGGDGLPAP---RLKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSEYNILVH--DGKVVIIDVSQSV 196 (237)
T ss_pred ceEEEEEecCCccccc---ccccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCChhhEEEE--CCCEEEEEChhhh
Confidence 4699999998432211 1123456666788999999999999999 79 99999999999998 5679999999987
Q ss_pred cc
Q 022500 106 QL 107 (296)
Q Consensus 106 ~~ 107 (296)
..
T Consensus 197 ~~ 198 (237)
T smart00090 197 EL 198 (237)
T ss_pred cc
Confidence 43
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.8e-12 Score=103.61 Aligned_cols=66 Identities=26% Similarity=0.435 Sum_probs=54.0
Q ss_pred EEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 27 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 27 ~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.++||||++| +|.+.+.. ... .++.|++.+|.+||+ .|++|||++|+||+++ ++.++++|||++.
T Consensus 72 ~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~ 137 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGK 137 (199)
T ss_pred CEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCc
Confidence 5699999986 55444332 110 688999999999999 6999999999999998 5679999999987
Q ss_pred c
Q 022500 106 Q 106 (296)
Q Consensus 106 ~ 106 (296)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 5
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-12 Score=118.75 Aligned_cols=160 Identities=19% Similarity=0.299 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC--------ccce--eecccccCchhcc
Q 022500 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--------NISY--ICSRFYRAPELIF 129 (296)
Q Consensus 60 ~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~--~~t~~y~aPE~~~ 129 (296)
=+.++..|+.|+|...++||++|.|++|.++ .++.+||+.|+++........ .... .-...|.|||++.
T Consensus 104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhhcccchhhhhccCcceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455679999999988999999999999999 588899999999865433111 0111 2245699999997
Q ss_pred CCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCC
Q 022500 130 GATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 208 (296)
Q Consensus 130 ~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (296)
+ .-.+.++|++|+||++|.+. .|...+.+.+.......-....+... ......
T Consensus 183 ~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~-------------------------~~~s~~ 236 (700)
T KOG2137|consen 183 G-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA-------------------------FGYSNN 236 (700)
T ss_pred c-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc-------------------------cccccc
Confidence 6 44789999999999999999 55565655433222211111111000 012246
Q ss_pred CCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccCC
Q 022500 209 MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 209 ~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
+++++++=|.++|..++..||++.+++..|||.+..-.
T Consensus 237 ~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~ 274 (700)
T KOG2137|consen 237 LPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK 274 (700)
T ss_pred CcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence 89999999999999999999999999999999876543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.1e-11 Score=96.98 Aligned_cols=70 Identities=21% Similarity=0.219 Sum_probs=55.8
Q ss_pred EEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 27 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 27 ~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.++||||++|.....+.. ......++.+++.++.++|+ .||+||||||+||+++ .++.++|+|||.+..
T Consensus 106 ~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Nill~-~~~~~~liDfg~~~~ 174 (198)
T cd05144 106 HAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNILVD-DDEKIYIIDWPQMVS 174 (198)
T ss_pred ceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccEEEc-CCCcEEEEECCcccc
Confidence 479999999742222211 02356788999999999999 7999999999999998 478899999999965
Q ss_pred c
Q 022500 107 L 107 (296)
Q Consensus 107 ~ 107 (296)
.
T Consensus 175 ~ 175 (198)
T cd05144 175 T 175 (198)
T ss_pred C
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.5e-10 Score=91.02 Aligned_cols=73 Identities=26% Similarity=0.225 Sum_probs=56.4
Q ss_pred EEEEeccCcccH-H-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCc
Q 022500 27 LNLVMEYVPESM-Y-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 104 (296)
Q Consensus 27 ~~lv~E~~~g~l-~-~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 104 (296)
.++||||++|+. . ..+.... .. ..++.++.+++.++.++|...||+||||||+||+++ ++.++++|||.+
T Consensus 90 ~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--~~~~~liDfg~a 161 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--DGKVYIIDVPQA 161 (187)
T ss_pred CEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--CCcEEEEECccc
Confidence 579999999721 1 1222211 11 567889999999999999823999999999999998 667999999999
Q ss_pred ccc
Q 022500 105 KQL 107 (296)
Q Consensus 105 ~~~ 107 (296)
...
T Consensus 162 ~~~ 164 (187)
T cd05119 162 VEI 164 (187)
T ss_pred ccc
Confidence 754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.5e-09 Score=93.19 Aligned_cols=134 Identities=23% Similarity=0.356 Sum_probs=100.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc--cHHHHHHHh-----------hhcCCCCCHHHHHHHHHHHHHHH
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHY-----------SSANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g--~l~~~l~~~-----------~~~~~~~~~~~~~~~~~qil~aL 68 (296)
+++.|+|||++.++|... .-+...+++|++|.++ +|.+....- ...+...++..+..|+.|+..||
T Consensus 328 kkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL 406 (655)
T KOG3741|consen 328 KKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL 406 (655)
T ss_pred HHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence 578999999999999733 3566679999999994 665543211 12234578899999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
.++|+ .|+.-+-|.|.+|++.+ +.+++|..-|..-....+. . |.+.+ ..+-|.=.+|.+++
T Consensus 407 ~sIHs-sGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~~d~-----------~--~~le~----~Qq~D~~~lG~ll~ 467 (655)
T KOG3741|consen 407 YSIHS-SGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQEDP-----------T--EPLES----QQQNDLRDLGLLLL 467 (655)
T ss_pred HHHHh-cCceeecccHhHeEeeC-cceEEEecccceeeecCCC-----------C--cchhH----HhhhhHHHHHHHHH
Confidence 99999 69999999999999994 5578888777655443332 0 11211 24568899999999
Q ss_pred HHHhCCC
Q 022500 149 ELLLGQP 155 (296)
Q Consensus 149 ~ll~g~~ 155 (296)
.|.||..
T Consensus 468 aLAt~~~ 474 (655)
T KOG3741|consen 468 ALATGTE 474 (655)
T ss_pred HHhhccc
Confidence 9999963
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.00 E-value=4e-10 Score=86.80 Aligned_cols=84 Identities=25% Similarity=0.230 Sum_probs=63.8
Q ss_pred CCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCCCCC
Q 022500 7 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKP 84 (296)
Q Consensus 7 pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~--~~i~H~dlkp 84 (296)
.++.+++..+... ...+++|||++|..... ++......++.+++.+++++|.. .+++|+|++|
T Consensus 53 ~~~p~~~~~~~~~-----~~~~~v~e~~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~ 117 (155)
T cd05120 53 LPVPKVLASGESD-----GWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHP 117 (155)
T ss_pred CCCCeEEEEcCCC-----CccEEEEEecCCeeccc----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCc
Confidence 4777777665322 34789999999742211 14455677889999999999984 1699999999
Q ss_pred CcEEEcCCCCcEEEeeccCccc
Q 022500 85 QNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 85 ~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
+||+++. .+.++++|||.+..
T Consensus 118 ~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 118 GNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred ceEEEEC-CcEEEEEecccccC
Confidence 9999994 67899999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-09 Score=87.45 Aligned_cols=73 Identities=21% Similarity=0.253 Sum_probs=56.9
Q ss_pred EEEEeccCccc-HH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCCcEEEcCCCCcEEEeeccC
Q 022500 27 LNLVMEYVPES-MY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103 (296)
Q Consensus 27 ~~lv~E~~~g~-l~-~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~L-H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 103 (296)
-+|||||++++ +. ..++ +..++...+..++.|++.+|..| |. .|++|+||++.||+++ ++.+.|+|||.
T Consensus 99 ~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHGDLs~~NIL~~--~~~v~iIDF~q 170 (197)
T cd05146 99 HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHADLSEYNMLWH--DGKVWFIDVSQ 170 (197)
T ss_pred CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEE--CCcEEEEECCC
Confidence 45999999863 21 1222 23455666778889999999999 88 6999999999999997 35699999998
Q ss_pred cccc
Q 022500 104 AKQL 107 (296)
Q Consensus 104 a~~~ 107 (296)
+...
T Consensus 171 av~~ 174 (197)
T cd05146 171 SVEP 174 (197)
T ss_pred ceeC
Confidence 8654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.6e-10 Score=100.43 Aligned_cols=195 Identities=19% Similarity=0.193 Sum_probs=132.6
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
.|.+++..+..|..... .|+-.|||+|.....-. .-...+++...+....|++.++.++|+ ..++|+|+||
T Consensus 324 ~~~~~~g~~~~W~~~r~-----~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~p 394 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQ-----GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKP 394 (524)
T ss_pred cccccCCCCCCcccccc-----ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccc
Confidence 57888888777754333 56899999863322222 122457788889999999999999999 6999999999
Q ss_pred CcEEEcCCCCcEEEeeccCccccccCCCccceeeccccc-CchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 022500 85 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 163 (296)
Q Consensus 85 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 163 (296)
+||++...++..++.|||....+.-. .......-.+. .+|++.....+..+.|++|+|.-+.+.++|.+.-......
T Consensus 395 sni~i~~~~~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~ 472 (524)
T KOG0601|consen 395 SNILISNDGFFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS 472 (524)
T ss_pred cceeeccchhhhhcccccccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc
Confidence 99999843477899999988642111 11122223333 3555555566889999999999999999987543322211
Q ss_pred HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 164 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
..|.. | ..+ .......++..+.+.+...++..|+.+-++..|.=|..
T Consensus 473 ---~~i~~--~-----------------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 ---LTIRS--G-----------------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---eeeec--c-----------------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00000 0 000 00123477888999999999999999998887765543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.5e-07 Score=82.43 Aligned_cols=192 Identities=18% Similarity=0.210 Sum_probs=122.2
Q ss_pred EEEEeccCcc--cHHHHHH--HhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeecc
Q 022500 27 LNLVMEYVPE--SMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 102 (296)
Q Consensus 27 ~~lv~E~~~g--~l~~~l~--~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 102 (296)
.-+.|..+.| ....++. +..+.-..+++..+.+..+.++.+..-||. .|.+-+|++++|+|++ +++.|.|.|-.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVs-d~~~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVS-DDSKVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeee-cCceEEEEccc
Confidence 5678888886 3333321 222233457889999999999999999999 6999999999999999 57788888754
Q ss_pred CccccccCCCccceeecccccCchhcc-C---CCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCC
Q 022500 103 SAKQLIAGEANISYICSRFYRAPELIF-G---ATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPT 177 (296)
Q Consensus 103 ~a~~~~~~~~~~~~~~t~~y~aPE~~~-~---~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~ 177 (296)
.-....++....-.+|...|.+||.-. + ...-+...|.|.||+++++++.| +.||.|--. +.. -+.|-
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~------~~~-ap~p~ 235 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL------ISD-APNPL 235 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc------cCC-CCCcc
Confidence 322222333334457889999999853 1 12246789999999999999987 899976421 000 01111
Q ss_pred HHHHhhcCcCCcC----ccCCCCCCCCcccccCCCCCHHHHHHHHcccccC--CCCCCCHH
Q 022500 178 REEIRCMNPNYTD----FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS--PSLRCTAL 232 (296)
Q Consensus 178 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~--p~~R~t~~ 232 (296)
...+....-.|.. -..+.....+| .-++++...+..+|++.- +.-|||++
T Consensus 236 E~~Ia~g~f~ya~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 236 ETDIAHGRFAYASDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhhhhcceeeechhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1122111111110 01111122222 237889999999999753 56899864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2e-08 Score=78.70 Aligned_cols=66 Identities=21% Similarity=0.350 Sum_probs=49.1
Q ss_pred EEEEeccCcccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 27 LNLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 27 ~~lv~E~~~g~l~~-~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
..|+|||++|.+.. .+. .. .. .++..+=.-+.-||. +||+|+||.++||+++ ++.+.++|||++.
T Consensus 74 ~~I~me~I~G~~lkd~l~----~~---~~----~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~--~~~i~~IDfGLg~ 139 (204)
T COG3642 74 GLIVMEYIEGELLKDALE----EA---RP----DLLREVGRLVGKLHK-AGIVHGDLTTSNIILS--GGRIYFIDFGLGE 139 (204)
T ss_pred CEEEEEEeCChhHHHHHH----hc---ch----HHHHHHHHHHHHHHh-cCeecCCCccceEEEe--CCcEEEEECCccc
Confidence 34999999996433 333 22 22 344555556677999 7999999999999998 3459999999987
Q ss_pred c
Q 022500 106 Q 106 (296)
Q Consensus 106 ~ 106 (296)
.
T Consensus 140 ~ 140 (204)
T COG3642 140 F 140 (204)
T ss_pred c
Confidence 4
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.3e-08 Score=83.14 Aligned_cols=77 Identities=12% Similarity=0.127 Sum_probs=62.3
Q ss_pred eEEEEeccCcc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcC------CCCcEE
Q 022500 26 FLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------LTHQVK 97 (296)
Q Consensus 26 ~~~lv~E~~~g--~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~------~~~~vk 97 (296)
.-+||||+++| +|.+.+.... ....+......++.++...+.-||. +||+|+|+++.|||++. .+..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEE
Confidence 35699999997 5666665322 2445677788999999999999999 79999999999999973 245799
Q ss_pred EeeccCcc
Q 022500 98 ICDFGSAK 105 (296)
Q Consensus 98 l~Dfg~a~ 105 (296)
++||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999885
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.73 E-value=3e-08 Score=90.17 Aligned_cols=73 Identities=22% Similarity=0.282 Sum_probs=51.8
Q ss_pred EEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCc
Q 022500 27 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR-GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 104 (296)
Q Consensus 27 ~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~-aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 104 (296)
-+|||||++| ++.+.... . . ...+ ...++.+++. .+..+|. .|++|+|+||.||+++ .++.++++|||++
T Consensus 233 ~vLvmE~i~G~~L~~~~~~-~-~-~~~~---~~~ia~~~~~~~l~ql~~-~g~~H~D~hPgNilv~-~~g~i~liDfG~~ 304 (437)
T TIGR01982 233 RVLTMEWIDGIPLSDIAAL-D-E-AGLD---RKALAENLARSFLNQVLR-DGFFHADLHPGNIFVL-KDGKIIALDFGIV 304 (437)
T ss_pred ceEEEEeECCcccccHHHH-H-h-cCCC---HHHHHHHHHHHHHHHHHh-CCceeCCCCcccEEEC-CCCcEEEEeCCCe
Confidence 4699999997 44433321 1 1 1122 2345555554 4678899 7999999999999998 4778999999998
Q ss_pred ccc
Q 022500 105 KQL 107 (296)
Q Consensus 105 ~~~ 107 (296)
..+
T Consensus 305 ~~l 307 (437)
T TIGR01982 305 GRL 307 (437)
T ss_pred eEC
Confidence 765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.5e-08 Score=75.00 Aligned_cols=78 Identities=17% Similarity=0.198 Sum_probs=56.9
Q ss_pred EEEEeccCcc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcE--EEeecc
Q 022500 27 LNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV--KICDFG 102 (296)
Q Consensus 27 ~~lv~E~~~g--~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~v--kl~Dfg 102 (296)
-.|+|||++| .+.+++..... ..........++.+|-..+.-||. ++|+|+||..+||++.+.+..+ .++|||
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEeec
Confidence 3489999998 55555543221 112222236788888889999999 7999999999999997655544 899999
Q ss_pred Ccccc
Q 022500 103 SAKQL 107 (296)
Q Consensus 103 ~a~~~ 107 (296)
++...
T Consensus 162 ls~~s 166 (229)
T KOG3087|consen 162 LSSVS 166 (229)
T ss_pred chhcc
Confidence 98643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.2e-07 Score=77.53 Aligned_cols=77 Identities=22% Similarity=0.323 Sum_probs=61.6
Q ss_pred ceEEEEeccCcc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCC--CcEEEee
Q 022500 25 LFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICD 100 (296)
Q Consensus 25 ~~~~lv~E~~~g--~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~--~~vkl~D 100 (296)
...+||+|+++| +|.+.+.. ....+......++.++...+.-||. +||+|+|+++.|||++..+ ..+.++|
T Consensus 90 ~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lID 164 (206)
T PF06293_consen 90 YRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLIAKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLID 164 (206)
T ss_pred eeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHHHHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEc
Confidence 346799999997 55555553 2226667788999999999999999 7999999999999998533 2689999
Q ss_pred ccCccc
Q 022500 101 FGSAKQ 106 (296)
Q Consensus 101 fg~a~~ 106 (296)
|+.++.
T Consensus 165 ld~~~~ 170 (206)
T PF06293_consen 165 LDRMRF 170 (206)
T ss_pred chhcee
Confidence 998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.2e-08 Score=89.10 Aligned_cols=72 Identities=24% Similarity=0.299 Sum_probs=50.8
Q ss_pred EEEEeccCcc-cHHHHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCC----cEEE
Q 022500 27 LNLVMEYVPE-SMYRVLKHYSSAN---QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVKI 98 (296)
Q Consensus 27 ~~lv~E~~~g-~l~~~l~~~~~~~---~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~----~vkl 98 (296)
-+|||||++| .+.+. ......+ ..+.+..+..++.|++ . .|++|+|+||+||+++. ++ .+++
T Consensus 236 ~VLvmE~i~G~~l~d~-~~l~~~g~d~~~la~~~v~~~~~Qif-------~-~GffHaDpHPGNIlv~~-~g~~~~~i~l 305 (537)
T PRK04750 236 TVMVMERMYGIPVSDV-AALRAAGTDMKLLAERGVEVFFTQVF-------R-DGFFHADMHPGNIFVSY-DPPENPRYIA 305 (537)
T ss_pred ceEEEeeecCccHHhH-HHHHhcCCCHHHHHHHHHHHHHHHHH-------h-CCeeeCCCChHHeEEec-CCCCCCeEEE
Confidence 4599999997 44332 1111111 1355666666777765 3 59999999999999984 44 8999
Q ss_pred eeccCccccc
Q 022500 99 CDFGSAKQLI 108 (296)
Q Consensus 99 ~Dfg~a~~~~ 108 (296)
+|||++..+.
T Consensus 306 lDFGivg~l~ 315 (537)
T PRK04750 306 LDFGIVGSLN 315 (537)
T ss_pred EecceEEECC
Confidence 9999997653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.56 E-value=9e-08 Score=75.57 Aligned_cols=64 Identities=25% Similarity=0.351 Sum_probs=48.7
Q ss_pred EEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc-----ccCCCCCCcEEEcCCCCcEEEeecc
Q 022500 28 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-----CHRDLKPQNLLVDPLTHQVKICDFG 102 (296)
Q Consensus 28 ~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i-----~H~dlkp~Nill~~~~~~vkl~Dfg 102 (296)
++||||++|...... . .....++.+++.+|..||. .++ +|+|++|.||+++ ++.++++|||
T Consensus 67 ~lv~e~i~G~~l~~~-------~----~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~ 132 (170)
T cd05151 67 VLITEFIEGSELLTE-------D----FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWE 132 (170)
T ss_pred eEEEEecCCCccccc-------c----ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEecc
Confidence 589999998421110 0 1123456799999999999 575 9999999999998 4569999999
Q ss_pred Ccc
Q 022500 103 SAK 105 (296)
Q Consensus 103 ~a~ 105 (296)
.+.
T Consensus 133 ~a~ 135 (170)
T cd05151 133 YAG 135 (170)
T ss_pred ccc
Confidence 876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-07 Score=76.00 Aligned_cols=72 Identities=31% Similarity=0.377 Sum_probs=47.4
Q ss_pred EEEeccCc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCc
Q 022500 28 NLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY-IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 104 (296)
Q Consensus 28 ~lv~E~~~--g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~-LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 104 (296)
+|||||++ |.....+... .++......++.+++..+.. +|. .||+|+|+.+.||+++. + .+.++|||.+
T Consensus 82 ~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~-~~~iIDf~qa 153 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G-KVYIIDFGQA 153 (188)
T ss_dssp EEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T-CEEE--GTTE
T ss_pred EEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c-eEEEEecCcc
Confidence 49999999 6433334331 11133456778888886555 578 69999999999999984 3 7999999988
Q ss_pred ccc
Q 022500 105 KQL 107 (296)
Q Consensus 105 ~~~ 107 (296)
...
T Consensus 154 v~~ 156 (188)
T PF01163_consen 154 VDS 156 (188)
T ss_dssp EET
T ss_pred eec
Confidence 654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7e-07 Score=86.95 Aligned_cols=197 Identities=22% Similarity=0.302 Sum_probs=131.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
....|+|++.++.+.......+ .-+.+..|+|+. ++...+. .-+..+...++.+..+++.||.|+|+ ....|.
T Consensus 237 ~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~-~~l~~v 310 (1351)
T KOG1035|consen 237 SKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS-LSLEHV 310 (1351)
T ss_pred HhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH-hcccee
Confidence 4568999999988775443322 224456678875 5444444 34678899999999999999999999 555554
Q ss_pred CCCCCc---EEEcCCCCcEEEe--eccCccccccCCCccceeecccccCchhccCCCCCCc--hhHHHHHHHHHHHHHhC
Q 022500 81 DLKPQN---LLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT--SIDIWSAGCVLAELLLG 153 (296)
Q Consensus 81 dlkp~N---ill~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~--~~DiwslG~il~~ll~g 153 (296)
-+..+. -..+ ..+.+.++ ||+.+..............+..+.++|..... ..+. ..|+|.+|.....+..|
T Consensus 311 ~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 311 VLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred EEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccc-cchhhhhhHHHHHHHHHhhhhhc
Confidence 443331 1122 23345555 88888776655555555667778888877432 2333 36999999999999888
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
..+-.-.. ....++ .........+.+.+|+..++++|+++.+
T Consensus 389 ~~i~~~~~---~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 389 EDISEKSA---VPVSLL-----------------------------------DVLSTSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred Cccccccc---chhhhh-----------------------------------ccccchhhhhhhhhhcchhhhhccchhh
Confidence 74421110 000000 0011126789999999999999999999
Q ss_pred HhcCCCccccc
Q 022500 234 ACAHPFFDELR 244 (296)
Q Consensus 234 ~l~hp~f~~~~ 244 (296)
++.|+|.+.-.
T Consensus 431 ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 431 LLTHPFLRFPT 441 (1351)
T ss_pred hhhchhccccc
Confidence 99999997643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.7e-06 Score=68.40 Aligned_cols=64 Identities=22% Similarity=0.371 Sum_probs=47.6
Q ss_pred EEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 27 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 27 ~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|||++| .|.+.. .+++. +...+..++.-+|. .|++|+|.+|.|++++ ++.++++||+..+
T Consensus 118 ~~ll~EYIeG~~l~d~~--------~i~e~----~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~--~~~i~iID~~~k~ 182 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIE--------DIDED----LAEKIVEAIKQLHK-HGFYHGDPHPGNFLVS--NNGIRIIDTQGKR 182 (229)
T ss_pred EEEEEEEecCeecccch--------hcCHH----HHHHHHHHHHHHHH-cCCccCCCCcCcEEEE--CCcEEEEECcccc
Confidence 5589999998 332221 13332 34567778999999 6999999999999998 3449999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1e-07 Score=87.31 Aligned_cols=201 Identities=20% Similarity=0.215 Sum_probs=128.9
Q ss_pred CCCCCCC-eeeeceeeeccCCCCcceEEEEeccCccc--HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 2 RVMDHPN-VISLKHCFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 2 ~~l~Hpn-Iv~l~~~~~~~~~~~~~~~~lv~E~~~g~--l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
.+++||| .+..++-+ +.+.+..+++++++++ ...... .....+..-+.....+.-+.+++++|+. .=+
T Consensus 288 dK~n~P~~~v~~~~d~-----~~E~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~ 358 (829)
T KOG0576|consen 288 DKVNNPNPVVRYLEDY-----DGEDYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS-YKV 358 (829)
T ss_pred HHccCCCCcccccccC-----CcccccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc-ccc
Confidence 4678999 55444433 5566688999999954 111110 0112233334555666678899999993 557
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|+| ||+.+ +...|..||+....+.......+..+++.++|||+..+. .+....|.|++|+-..++.-|.+|-.
T Consensus 359 ~~d----~~l~s--~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 359 HRD----NILGS--EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred Ccc----ccccc--ccccccccccCCcccCcccccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCC
Confidence 888 88887 356899999998877665556778899999999988654 48899999999987667777776654
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
..- ..... .|..+ ..... .....|...+ -.++...|+...|..|.+.-.++.|.
T Consensus 432 ~P~--~~~~~----~g~~p-----------~s~~L--~~~~aw~~~~-------~~~~~~~~~~g~P~~pkv~mgacfsK 485 (829)
T KOG0576|consen 432 SPP--AVLPM----IGNGP-----------NSPML--TDKSAWSPVF-------HRDFPAPCLNGLPPTPKVHMGACFSK 485 (829)
T ss_pred CCc--cccCC----CCCCC-----------Ccccc--chhhhcCccc-------ccCCcccccCCCCCCCcchhhHHHHH
Confidence 310 00000 00000 00000 0001111111 12688899999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
+|....
T Consensus 486 vfngCp 491 (829)
T KOG0576|consen 486 VFNGCP 491 (829)
T ss_pred HhccCc
Confidence 997653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.1e-05 Score=63.79 Aligned_cols=80 Identities=13% Similarity=0.023 Sum_probs=63.0
Q ss_pred cceEEEEeccCcc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCc--EEEe
Q 022500 24 ELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKIC 99 (296)
Q Consensus 24 ~~~~~lv~E~~~g--~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~--vkl~ 99 (296)
...-+||+|-++| +|.+.+... .-.+.+......++.++...+.-||. .|+.|+|+.+.||+++. .+. ++++
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~-~g~~~v~lI 172 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKT-EGKAEAGFL 172 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecC-CCCeeEEEE
Confidence 3446799999995 766655431 12356777888999999999999999 79999999999999973 345 9999
Q ss_pred eccCcccc
Q 022500 100 DFGSAKQL 107 (296)
Q Consensus 100 Dfg~a~~~ 107 (296)
||.-++..
T Consensus 173 DlEk~r~~ 180 (216)
T PRK09902 173 DLEKSRRR 180 (216)
T ss_pred Ehhccchh
Confidence 99987643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.85 E-value=5.2e-05 Score=62.30 Aligned_cols=31 Identities=26% Similarity=0.364 Sum_probs=25.4
Q ss_pred CcccCCCCCCcEEEcCC-CCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~-~~~vkl~Dfg~a~~ 106 (296)
.++|+|++|.||+++.+ ++.+.|+||+.+..
T Consensus 175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred EEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 46999999999999853 45578999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.82 E-value=3.3e-05 Score=69.82 Aligned_cols=93 Identities=20% Similarity=0.275 Sum_probs=68.0
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHH
Q 022500 136 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 215 (296)
Q Consensus 136 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 215 (296)
+++||||+|.++.++..|...+..-...+.+..+.+..-.+..-..-.+ ...+.-.++....+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~-----------------e~~~~~~~d~~~~~ 172 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAM-----------------EHLIQLLADKKRLP 172 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHH-----------------HHHHHHhhhHhHHH
Confidence 4999999999999999999888877777776666554322221111100 00122246788999
Q ss_pred HHHcccccCCCCCCCHHHHhcCCCcccccC
Q 022500 216 LASRLLQYSPSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 216 ll~~~L~~~p~~R~t~~e~l~hp~f~~~~~ 245 (296)
+..+|+-..|..||...++.+++-|.+...
T Consensus 173 ~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 173 LLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HhccCCccccccccchhHHhcCccHHHHHh
Confidence 999999999999999999999999987643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.2e-05 Score=80.59 Aligned_cols=151 Identities=15% Similarity=0.025 Sum_probs=109.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC----
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---- 76 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~---- 76 (296)
+...|++++..+.-..+..+ ...|.+++||. |.++..+-.-..+...++...+.....+.+.+..-+|+..+
T Consensus 1284 ~~~~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T 1360 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNT 1360 (2724)
T ss_pred hhhhceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCcc
Confidence 34578888877665543332 22558999999 68888776655555666666666556665777777776422
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCcc-ccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~-~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
.+|+++|+-|.++. .+.++|+.++|+.+ ...........++++.|+.|++.. .-.++.++|+|..|+-+|..-.|..
T Consensus 1361 ~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred chhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhcccH
Confidence 58999999999998 47789999999998 222222334567889999999774 3457888999999999999988887
Q ss_pred CC
Q 022500 156 LF 157 (296)
Q Consensus 156 pf 157 (296)
+|
T Consensus 1439 ~f 1440 (2724)
T KOG1826|consen 1439 YF 1440 (2724)
T ss_pred HH
Confidence 76
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=9.1e-05 Score=68.30 Aligned_cols=74 Identities=19% Similarity=0.241 Sum_probs=47.9
Q ss_pred EEEEeccCcc---cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcC---CCCcEEEee
Q 022500 27 LNLVMEYVPE---SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICD 100 (296)
Q Consensus 27 ~~lv~E~~~g---~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~---~~~~vkl~D 100 (296)
-.|+||||+| +-.+.++. ..++...+...+.+...- .-++ .|++|.|-+|.||++.+ .+..+.+.|
T Consensus 277 RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~-qIf~--~GffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 277 RVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLE-QIFK--TGFFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred eEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHH-HHHh--cCCccCCCCCCcEEEecCCCCCccEEEEc
Confidence 3499999997 22234432 234444444333333321 2222 48999999999999983 366899999
Q ss_pred ccCccccc
Q 022500 101 FGSAKQLI 108 (296)
Q Consensus 101 fg~a~~~~ 108 (296)
||+...+.
T Consensus 349 hGl~~~is 356 (538)
T KOG1235|consen 349 HGLYAVIS 356 (538)
T ss_pred cccccccc
Confidence 99987653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0001 Score=68.04 Aligned_cols=74 Identities=24% Similarity=0.401 Sum_probs=48.0
Q ss_pred EEEEeccCcc-cHHHH--HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccC
Q 022500 27 LNLVMEYVPE-SMYRV--LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103 (296)
Q Consensus 27 ~~lv~E~~~g-~l~~~--l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 103 (296)
-.|+|||++| .+.+. ++........+....++.++.|++. .|++|.|.+|.||+++ .++.+.+.|||+
T Consensus 241 ~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~--------dgffHaDpHpGNi~v~-~~g~i~~lDfGi 311 (517)
T COG0661 241 RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR--------DGFFHADPHPGNILVR-SDGRIVLLDFGI 311 (517)
T ss_pred cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh--------cCccccCCCccceEEe-cCCcEEEEcCcc
Confidence 3499999998 44343 3321111112333334444444433 5999999999999999 478899999999
Q ss_pred cccccc
Q 022500 104 AKQLIA 109 (296)
Q Consensus 104 a~~~~~ 109 (296)
...+..
T Consensus 312 ~g~l~~ 317 (517)
T COG0661 312 VGRLDP 317 (517)
T ss_pred eecCCH
Confidence 876543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00026 Score=59.22 Aligned_cols=70 Identities=21% Similarity=0.264 Sum_probs=48.5
Q ss_pred EEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCcccc
Q 022500 28 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 107 (296)
Q Consensus 28 ~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 107 (296)
.+||||++|-. +.. -+++...+..++..|+.-+.-+=. .|++|+|+++=||+++ .++.+.++||--+...
T Consensus 183 aVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNIlV~-~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 183 AVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNILVT-EDGDIVVIDWPQAVPI 252 (304)
T ss_pred eeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheEEEe-cCCCEEEEeCcccccC
Confidence 49999999832 111 111233344555666655555556 5999999999999999 4778999999877643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00059 Score=54.85 Aligned_cols=94 Identities=18% Similarity=0.127 Sum_probs=67.5
Q ss_pred CCCC-CCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcc
Q 022500 3 VMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVC 78 (296)
Q Consensus 3 ~l~H-pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~--~~i~ 78 (296)
.+++ +++.+++|.+ . -.+|+||.+. ++... ......--..++....+++.+++..+++++.. ..+.
T Consensus 15 ~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 15 LLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred HcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 4454 5899999877 2 2368999994 43211 00001113468888999999999999999972 2367
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCcccc
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQL 107 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 107 (296)
-.|++++|+-++ +++++|++|...+...
T Consensus 85 lcDv~~~nfgv~-~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVN-DDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEe-CCCcEEEEechhcchh
Confidence 789999999999 5788999999887543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0014 Score=54.33 Aligned_cols=74 Identities=22% Similarity=0.211 Sum_probs=54.1
Q ss_pred EEEEeccCcccH--HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCc
Q 022500 27 LNLVMEYVPESM--YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 104 (296)
Q Consensus 27 ~~lv~E~~~g~l--~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 104 (296)
-.|||||++... .-.|+ +..+...++..+..+++..+.-|=...++||+||+.=|||+. ++.+.|+|+|-|
T Consensus 141 nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--~~~p~iID~~Qa 213 (268)
T COG1718 141 NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--DGEPYIIDVSQA 213 (268)
T ss_pred CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE--CCeEEEEECccc
Confidence 349999998431 00111 223333367888889998888776635999999999999998 567999999988
Q ss_pred ccc
Q 022500 105 KQL 107 (296)
Q Consensus 105 ~~~ 107 (296)
...
T Consensus 214 V~~ 216 (268)
T COG1718 214 VTI 216 (268)
T ss_pred ccc
Confidence 654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0089 Score=52.42 Aligned_cols=106 Identities=17% Similarity=0.201 Sum_probs=70.7
Q ss_pred CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeec
Q 022500 22 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 101 (296)
Q Consensus 22 ~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 101 (296)
.+..++|++|++-++.+.. + .....+++..++++.+.-+.-+...=..-|||+..+||+++ .|+|.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI-I-------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 4566789999999876421 1 22456778889999888777776622478999999999998 678999999
Q ss_pred cCccccccCCCccceeecccccCchhccCCCCCCchhHHHHH
Q 022500 102 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSA 143 (296)
Q Consensus 102 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 143 (296)
-+|+....... +-....--|..+.|. -+..-+||-+
T Consensus 366 klsRl~~~q~~----isy~rldhp~lF~G~--dd~QFeIYrl 401 (488)
T COG5072 366 KLSRLSYSQGI----ISYNRLDHPDLFNGV--DDYQFEIYRL 401 (488)
T ss_pred eeeecccCCce----eeccccCchhhhcCc--cceeeeHHHH
Confidence 99984322221 111122344445443 2555666653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.017 Score=47.97 Aligned_cols=28 Identities=21% Similarity=0.258 Sum_probs=24.3
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.++|+|+.|.||+++. ++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~-~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSG-KG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcC-CC-cEEEechhcC
Confidence 5789999999999984 55 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.021 Score=46.29 Aligned_cols=90 Identities=18% Similarity=0.291 Sum_probs=59.9
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCc---ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~---g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
..+.+|.++++...+..+ +-+|+|.+. |+....+..+... +.++. .++.. +-.-.+||-. .+|+.+
T Consensus 74 ~~~~~i~r~~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~---L~~f~~~l~~-~~Iv~~ 142 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLG-----LGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQA---LDEFKRYLLD-HHIVIR 142 (199)
T ss_pred CcccccccEeEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHH---HHHHHHHHHH-cCCeec
Confidence 357789999998855444 668888775 5656666666543 44665 33333 3344567777 699999
Q ss_pred CCCCCcEEEcCCC--C-cEEEee-ccCc
Q 022500 81 DLKPQNLLVDPLT--H-QVKICD-FGSA 104 (296)
Q Consensus 81 dlkp~Nill~~~~--~-~vkl~D-fg~a 104 (296)
|++|.||++...+ . .+.|+| ||..
T Consensus 143 dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 143 DLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 9999999995322 2 577777 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.052 Score=44.53 Aligned_cols=64 Identities=17% Similarity=0.172 Sum_probs=43.5
Q ss_pred CcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCcEEEcCCCCcEEEeec
Q 022500 23 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDF 101 (296)
Q Consensus 23 ~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~-~~~i~H~dlkp~Nill~~~~~~vkl~Df 101 (296)
+...+-++.|+|..- ..... .++..=+.+|.-.|+ ..+.+|+|..|+||+-+ ..|.+||.|=
T Consensus 125 n~~~yGvIlE~Cy~~------------~i~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D-~~G~lKlVDP 187 (308)
T PF07387_consen 125 NNYKYGVILERCYKI------------KINFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCD-KFGYLKLVDP 187 (308)
T ss_pred CCceeEEEEeeccCc------------ccchh----HHHHHhHHHHHHhhccCCCeecCCCChhheeec-CCCCEEecCh
Confidence 444477999999731 00111 112222567888884 25789999999999999 5788999996
Q ss_pred cC
Q 022500 102 GS 103 (296)
Q Consensus 102 g~ 103 (296)
+.
T Consensus 188 ~~ 189 (308)
T PF07387_consen 188 VC 189 (308)
T ss_pred hh
Confidence 64
|
The function of this family is unknown. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.035 Score=55.11 Aligned_cols=31 Identities=23% Similarity=0.426 Sum_probs=25.0
Q ss_pred CcccCCCCCCcEEEcCCCC-cEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~-~vkl~Dfg~a~~ 106 (296)
.++|+|++++|+++++.+. .+-|.||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 4999999999999985333 357999999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.042 Score=44.46 Aligned_cols=80 Identities=21% Similarity=0.372 Sum_probs=53.3
Q ss_pred CCCCCCCe--eeeceeeeccC-C------------CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHH
Q 022500 2 RVMDHPNV--ISLKHCFFSTT-S------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 66 (296)
Q Consensus 2 ~~l~HpnI--v~l~~~~~~~~-~------------~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~ 66 (296)
+...+.++ |+++++..-.. . ......-||.||+...- .++... +.+|++
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~ 175 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLR 175 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHH
Confidence 34556677 88888764321 0 11122457888887531 233333 347778
Q ss_pred HHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCc
Q 022500 67 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 104 (296)
Q Consensus 67 aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 104 (296)
-+..+|. .||+-+|+++.|.. ++ ||+|||.+
T Consensus 176 dl~~~~k-~gI~~~Dv~~~ny~----~G--~lvDfs~~ 206 (207)
T PF13095_consen 176 DLKILHK-LGIVPRDVKPRNYR----GG--KLVDFSSS 206 (207)
T ss_pred HHHHHHH-CCeeeccCcccccc----CC--EEEecccC
Confidence 8888999 69999999999985 33 89999975
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.044 Score=45.46 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=26.2
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
+++|+|+.+.||+++..++.+.++||..|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 6899999999999984245799999998853
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.024 Score=49.53 Aligned_cols=30 Identities=30% Similarity=0.230 Sum_probs=25.2
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|+|+.|+||+++ .+...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~-~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFE-GDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence 4899999999999998 34445799999875
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.048 Score=47.54 Aligned_cols=78 Identities=21% Similarity=0.225 Sum_probs=44.6
Q ss_pred EEeccCcccHHHHH-HHhhhcCCCCCHHHHHHHHHHHHHHH--H-HHHhCCCcccCCCCCCcEEEcCCCC----------
Q 022500 29 LVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGL--A-YIHTVPRVCHRDLKPQNLLVDPLTH---------- 94 (296)
Q Consensus 29 lv~E~~~g~l~~~l-~~~~~~~~~~~~~~~~~~~~qil~aL--~-~LH~~~~i~H~dlkp~Nill~~~~~---------- 94 (296)
||+.++-++-.+.- ..+...+-..-...++.++.||+.-. - -|-...+.+|-||||+|||+-+...
T Consensus 248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~ 327 (434)
T PF05445_consen 248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN 327 (434)
T ss_pred EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE
Confidence 78887765322211 11111222334456788888886533 1 1221147899999999999853221
Q ss_pred -------cEEEeeccCccc
Q 022500 95 -------QVKICDFGSAKQ 106 (296)
Q Consensus 95 -------~vkl~Dfg~a~~ 106 (296)
.++|.||.+|+.
T Consensus 328 ~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 328 YVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred EEecccceeeecccCHHHh
Confidence 356677777653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.041 Score=45.82 Aligned_cols=30 Identities=40% Similarity=0.543 Sum_probs=24.5
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|+|+.++||+++ .+...-|+||+.|.
T Consensus 164 ~~l~HGD~~~~Nvlv~-~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQ-DGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEE-CCCEEEEEeCcccC
Confidence 3589999999999998 34445699999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.077 Score=45.91 Aligned_cols=30 Identities=33% Similarity=0.531 Sum_probs=25.7
Q ss_pred CcccCCCCCCcEEEcCC---CCcEEEeeccCcc
Q 022500 76 RVCHRDLKPQNLLVDPL---THQVKICDFGSAK 105 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~---~~~vkl~Dfg~a~ 105 (296)
.++|+|+.+.||+++.+ .+.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 68999999999999842 3679999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.13 Score=44.72 Aligned_cols=29 Identities=28% Similarity=0.558 Sum_probs=24.9
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|+|+.+.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 47899999999999984 458999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.032 Score=45.84 Aligned_cols=31 Identities=45% Similarity=0.743 Sum_probs=21.1
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
..++|+|+.|.||+++..++.+-|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3699999999999998445666799999775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.098 Score=45.46 Aligned_cols=30 Identities=37% Similarity=0.385 Sum_probs=25.6
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|+|+++.||+++. ++.+.++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 58999999999999984 5556899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.063 Score=42.95 Aligned_cols=28 Identities=21% Similarity=0.357 Sum_probs=24.1
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.+|+|+.|+|++++. ++ ++++||+.|..
T Consensus 79 p~H~D~~~~N~~~~~-~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSA-SG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEEC-CC-EEEEeCCcccC
Confidence 599999999999983 45 99999999864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.041 Score=44.96 Aligned_cols=31 Identities=39% Similarity=0.668 Sum_probs=20.7
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.++|+|+.+.||+++..++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 5799999999999933577899999999863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.65 E-value=0.054 Score=46.68 Aligned_cols=30 Identities=33% Similarity=0.304 Sum_probs=25.3
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 37999999999999984 5556899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.11 Score=46.06 Aligned_cols=31 Identities=32% Similarity=0.579 Sum_probs=26.5
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.++|+|+++.||+++..++.+.++||..|..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999985456799999998863
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.26 Score=42.99 Aligned_cols=64 Identities=22% Similarity=0.215 Sum_probs=38.1
Q ss_pred EEEeccCcccHHHHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcccCCCCCCcEEEcC
Q 022500 28 NLVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLAYIHT---VPRVCHRDLKPQNLLVDP 91 (296)
Q Consensus 28 ~lv~E~~~g~l~~~l~-~~~~~~~~~~~~~~~~~~~qil~aL~~LH~---~~~i~H~dlkp~Nill~~ 91 (296)
.||+.++-++-.+.-. .....+-..-...++.++.||+.-.-.+=+ ..+.+|-||||+|||+-+
T Consensus 251 IIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 251 IIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred EEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 3788877643222111 111222233455688889998765423311 147899999999999853
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.16 Score=43.23 Aligned_cols=52 Identities=23% Similarity=0.275 Sum_probs=37.7
Q ss_pred HHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 54 LIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 54 ~~~~~~~~~qil~aL~~LH~~-~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
...++..+..+-.++.-.+.. .-++|+|+.|+|++.++ .+.++|+||..|..
T Consensus 131 ~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~-~~~l~LIDWEyAg~ 183 (269)
T COG0510 131 NHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTD-KGGLFLIDWEYAGL 183 (269)
T ss_pred hHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcC-CCcEEEEecccCCC
Confidence 334455555566666666651 14899999999999993 57799999998864
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.31 E-value=0.14 Score=44.90 Aligned_cols=29 Identities=38% Similarity=0.544 Sum_probs=24.4
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
+||+|+.|+||+++..+..+.++||+-|.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999533248899999875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=93.00 E-value=0.086 Score=44.04 Aligned_cols=29 Identities=31% Similarity=0.400 Sum_probs=24.8
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.++|+|+.|.||+++. +..+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~-~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDP-GKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeC-CcEEEEEEccccc
Confidence 4899999999999994 5567899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=92.97 E-value=0.095 Score=45.56 Aligned_cols=68 Identities=16% Similarity=0.211 Sum_probs=47.2
Q ss_pred EEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 27 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 27 ~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
=++|||++.| .|.+. . ...+ +..+...++.-+.-|-. +|+||+|..-=||++. +++.++++||--+.
T Consensus 183 H~Vvmelv~g~Pl~~v-~------~v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNimv~-dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 183 HCVVMELVDGYPLRQV-R------HVED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFNIMVK-DDDKIVVIDFPQMV 250 (465)
T ss_pred eeeHHHhhcccceeee-e------ecCC---hHHHHHHHHHHHHHHHH-cCceecccchheeEEe-cCCCEEEeechHhh
Confidence 4589999987 32211 1 1112 23344555556667888 7999999999999998 47779999997654
Q ss_pred c
Q 022500 106 Q 106 (296)
Q Consensus 106 ~ 106 (296)
.
T Consensus 251 S 251 (465)
T KOG2268|consen 251 S 251 (465)
T ss_pred c
Confidence 3
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.26 Score=39.77 Aligned_cols=31 Identities=23% Similarity=0.278 Sum_probs=25.3
Q ss_pred CCcccCCCCCCcEEEcCCC-C---cEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLT-H---QVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~-~---~vkl~Dfg~a~ 105 (296)
..++|||+.+.|+++..++ + .+.++||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4689999999999997432 2 58999999885
|
subfamily of choline kinases |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=92.69 E-value=0.089 Score=44.39 Aligned_cols=29 Identities=31% Similarity=0.472 Sum_probs=24.8
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.++|+|+.|.||+++. ++ +.++||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeC-CC-CEEEeccccCc
Confidence 4899999999999984 44 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.03 E-value=0.12 Score=44.18 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=24.6
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.++|+|++|.||+++..+..+-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999984233356999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.93 E-value=0.13 Score=45.34 Aligned_cols=30 Identities=23% Similarity=0.340 Sum_probs=25.9
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
++|+|+.+.||+++..++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 699999999999975556799999998853
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.89 E-value=0.31 Score=43.22 Aligned_cols=74 Identities=20% Similarity=0.185 Sum_probs=54.6
Q ss_pred EEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 28 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 28 ~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.|||+|++++- ...-.-.+..++...++.+-.|++.-+.-|=...++||.||.-=|+|+. ++.+.|+|.+-+..
T Consensus 240 VLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh--dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 240 VLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH--DGKLYIIDVSQSVE 313 (520)
T ss_pred eEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE--CCEEEEEEcccccc
Confidence 48999999421 1100112456777788888888888777765547999999999999997 67899999887653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.71 E-value=0.31 Score=42.39 Aligned_cols=30 Identities=23% Similarity=0.283 Sum_probs=26.0
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|+|+.++|+++++ ++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDE-TRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcC-CCCEEEEEhhhcc
Confidence 37999999999999984 5678999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.40 E-value=0.56 Score=41.19 Aligned_cols=28 Identities=25% Similarity=0.267 Sum_probs=23.8
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|+|+.++||+++ + .+.++||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence 4789999999999995 3 47899999875
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.32 E-value=0.58 Score=47.46 Aligned_cols=32 Identities=19% Similarity=0.262 Sum_probs=25.4
Q ss_pred CCcccCCCCCCcEEEcCCC-C---cEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLT-H---QVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~-~---~vkl~Dfg~a~~ 106 (296)
.++||+|++++||+++.+. + ..-|+|||-+..
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 5899999999999998532 2 247999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.95 E-value=0.46 Score=41.41 Aligned_cols=31 Identities=32% Similarity=0.594 Sum_probs=26.2
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
..++|+|+.+.|+++++. .-+-++||+++..
T Consensus 198 ~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPG-RPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCC-CeeEEEecccccc
Confidence 358999999999999964 4489999999864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.88 E-value=0.83 Score=46.54 Aligned_cols=32 Identities=34% Similarity=0.540 Sum_probs=25.2
Q ss_pred CCcccCCCCCCcEEEcCCCC-cE-EEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLTH-QV-KICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~-~v-kl~Dfg~a~~ 106 (296)
.++||+|+++.||+++.+.. .+ -|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 47999999999999985321 34 4999998864
|
|
| >KOG1234 consensus ABC (ATP binding cassette) 1 protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.05 E-value=0.83 Score=38.82 Aligned_cols=71 Identities=18% Similarity=0.275 Sum_probs=48.4
Q ss_pred EEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHH-HHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCcccc
Q 022500 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF-RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 107 (296)
Q Consensus 29 lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil-~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 107 (296)
+.||+..|- .+. .-..++....-.|..+++ ..|+-+-. -.+...|=+-+|++++....++.|.|||.++..
T Consensus 164 lt~el~~G~---pid----~~~~~sQ~~rn~i~~~~l~lcLrEif~-f~fMQTDPNWsNFly~~~tk~i~LlDFGAsr~y 235 (363)
T KOG1234|consen 164 LTLELGQGL---PID----KTAKLSQETRNYIGYKLLELCLREIFE-FRFMQTDPNWSNFLYNGRTKKIELLDFGASREY 235 (363)
T ss_pred hhhhhhcCc---cch----hhhcccHHHHHHHHHHHHHHHHHHHHH-HhhhcCCCCHHHhccCCCcceEEEEeccccccc
Confidence 677777762 111 112355555555555554 34666666 367788999999999988889999999999865
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=86.90 E-value=0.36 Score=41.57 Aligned_cols=30 Identities=30% Similarity=0.477 Sum_probs=24.5
Q ss_pred CcccCCCCCCcEEEcCCCC----cEEEeeccCcc
Q 022500 76 RVCHRDLKPQNLLVDPLTH----QVKICDFGSAK 105 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~----~vkl~Dfg~a~ 105 (296)
-++|||++..||++..++. .++++||..++
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeecccccc
Confidence 3899999999999964322 68999999875
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=86.75 E-value=0.54 Score=42.47 Aligned_cols=30 Identities=23% Similarity=0.259 Sum_probs=25.3
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
..++|||+.+.||++.. ..++++||.+|..
T Consensus 223 ~~l~HgDl~~gni~~~~--~~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTE--EETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeC--CCcEEEecccccc
Confidence 46899999999999973 3599999998763
|
|
| >cd05164 PIKKc Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases | Back alignment and domain information |
|---|
Probab=85.48 E-value=4 Score=33.70 Aligned_cols=72 Identities=28% Similarity=0.309 Sum_probs=43.3
Q ss_pred EeccCcc--cHHHHHHHhhhcCCCCC--HHHH-HHHHHHHH--HHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeecc
Q 022500 30 VMEYVPE--SMYRVLKHYSSANQRMP--LIYV-KLYTYQIF--RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 102 (296)
Q Consensus 30 v~E~~~g--~l~~~l~~~~~~~~~~~--~~~~-~~~~~qil--~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 102 (296)
+.|++++ ++...++.+......-+ +..+ +.++.+++ +.+.|+=. =+|-.|+||+++..+|.+.-+|||
T Consensus 84 liE~v~~~~sl~~~l~~~~~~~~~~~~~~~~~r~~F~~SlA~~s~~~Yvlg-----lgDRh~~NIli~~~tG~v~hIDf~ 158 (222)
T cd05164 84 LIEWVEGTTTLKPVLKKWFWLQFPDPEQWFAARKNYTRSTAVMSIVGYILG-----LGDRHLDNILIDRETGEVVHIDFG 158 (222)
T ss_pred eEEEcCCcchHHHHHHHHHHHHCcCHHHHHHHHHHHHHHHHHHHHHHHHhc-----cCCCCCceEEEECCCCcEEEEccH
Confidence 3577775 66666665543322211 1122 33333332 33445433 379999999999768888889999
Q ss_pred Cccc
Q 022500 103 SAKQ 106 (296)
Q Consensus 103 ~a~~ 106 (296)
.+..
T Consensus 159 ~~~~ 162 (222)
T cd05164 159 CIFE 162 (222)
T ss_pred Hhhc
Confidence 8753
|
Members include ATM (Ataxia telangiectasia mutated), ATR (Ataxia telangiectasia and Rad3-related), TOR (Target of rapamycin), SMG-1 (Suppressor of morphogenetic effect on genitalia-1), and DNA-PK (DNA-dependent protein kinase). PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). They show strong preference for phosphorylating serine/threonine residues followed by a glutamine and are also referred to as (S/T)-Q-directed kinases. They all contain a FATC (FRAP, ATM and TRRAP, C-terminal) d |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 296 | ||||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-116 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-116 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-116 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-116 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-116 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-116 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-116 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-116 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-116 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-116 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-115 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-115 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-115 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-115 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-115 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-115 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-115 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-115 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-115 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-114 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-114 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-109 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-76 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-68 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-42 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-41 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-41 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-40 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-40 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-40 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-40 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-40 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-40 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-40 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-40 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-40 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-40 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-40 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-40 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-40 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-40 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-40 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-40 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-40 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-40 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-40 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-39 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-38 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-38 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-37 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-37 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-37 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-37 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-37 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-37 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-36 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-36 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-36 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-36 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-36 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-36 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-36 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-36 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-36 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-36 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-36 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-36 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-36 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-36 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-36 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-36 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-36 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-36 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-36 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-36 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-36 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-36 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-36 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-36 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-36 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-36 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-36 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-35 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-35 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-35 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-35 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-35 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-35 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-35 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-35 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-35 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-35 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-35 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-35 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-35 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-35 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-35 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-35 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-35 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-35 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-34 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-34 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-34 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-34 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-34 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-34 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-34 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-34 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-34 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-34 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-34 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-34 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-34 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-33 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-33 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-33 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-33 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-33 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-33 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-33 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-33 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-33 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-33 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-33 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-33 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-33 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-33 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-33 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-33 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-33 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-33 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-33 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-33 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-33 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-33 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-33 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-33 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-33 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-33 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-33 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-33 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-33 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-33 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-33 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-33 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-33 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-33 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-33 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-33 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-33 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-33 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-33 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-33 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-33 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-33 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-33 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-33 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-32 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-32 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-32 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-32 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-32 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-32 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-32 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-32 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-31 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-31 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-31 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-31 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-30 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-30 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-30 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-30 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-29 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-29 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-29 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-29 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-29 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-29 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-29 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-29 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-29 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-29 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-29 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-29 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-29 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-29 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-29 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-29 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-29 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-29 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-29 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-29 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-29 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-29 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-29 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-29 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-29 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-29 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-29 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-29 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-29 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-29 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-29 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-28 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-28 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-28 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-28 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-28 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-28 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-28 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-28 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-28 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-28 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-28 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-28 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-28 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-28 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-28 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-28 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-28 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-28 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-28 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-28 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-28 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-28 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-27 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-27 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-27 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-27 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-26 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-26 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-24 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-24 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-24 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-24 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-24 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-23 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-23 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-23 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-23 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-22 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-21 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-21 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-21 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-20 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-17 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-16 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-14 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-14 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-14 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-09 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-04 |
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 517 bits (1334), Expect = 0.0
Identities = 193/297 (64%), Positives = 239/297 (80%), Gaps = 2/297 (0%)
Query: 1 MRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
MR +DH N++ L++ F+S+ K +E++LNLV++YVPE++YRV +HYS A Q +P+IYVKL
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL+ GE N+SYICS
Sbjct: 161 YMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T LEACAH F
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 240 FDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 296
FDELR+PN +LPNGR P LFNF + ++P L LIP H + Q + A
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATA 396
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 516 bits (1330), Expect = 0.0
Identities = 180/290 (62%), Positives = 231/290 (79%), Gaps = 2/290 (0%)
Query: 1 MRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
MR++ HPNV+ LK F+S K +E+FLNLV+EYVPE++YR +HY+ Q MP++ +KL
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y YQ+ R LAYIH++ +CHRD+KPQNLL+DP + +K+ DFGSAK LIAGE N+SYICS
Sbjct: 146 YMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLFPGE+ +DQLVEIIKVLGTP+RE
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+I+ MNPNY + +FPQI+ HP+ KVF R PP+AIDL SRLL+Y+PS R TA+EA HPF
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324
Query: 240 FDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLN 289
FDELR AR+PNGR LPPLFN+ +E P+L+++L+P H + +L
Sbjct: 325 FDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSR 374
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 488 bits (1259), Expect = e-175
Identities = 126/287 (43%), Positives = 183/287 (63%), Gaps = 8/287 (2%)
Query: 1 MRVMDHPNVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
+ V+ HPN++ L+ F++ + +++LN+VMEYVP++++R ++Y P I +K
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 59 LYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
++ +Q+ R + +H VCHRD+KP N+LV+ +K+CDFGSAK+L E N++YI
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
CSR+YRAPELIFG YTT++DIWS GC+ AE++LG+P+F G+N+ QL EI++VLG P+
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEA 234
RE +R +NP++TD K PW VF + EA DL S LLQY P R EA
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
Query: 235 CAHPFFDELREPNARLPNGRPLPP-LFNF-KQELSGASPELVNKLIP 279
HP+FDEL +P +LPN + LP LF F E+ S KL+
Sbjct: 313 LCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVR 359
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 473 bits (1220), Expect = e-169
Identities = 140/328 (42%), Positives = 206/328 (62%), Gaps = 44/328 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSK---------------------------------NELFL 27
M+V+DH N+I L F++T + +L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 28 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 87
N++MEYVP+++++VLK + + + +P+ + +Y YQ+FR + +IH++ +CHRD+KPQNL
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNL 172
Query: 88 LVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147
LV+ + +K+CDFGSAK+LI E +++YICSRFYRAPEL+ GATEYT SID+WS GCV
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 148 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 207
EL+LG+PLF GE ++DQLV II+++GTPT+E++ MNP+YT+ RFP +KA W K+ +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 208 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPLPP 258
P AIDL ++L+Y P LR EA AHPFFD LR N+ P+G + +P
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQ 352
Query: 259 LFNF-KQELSGASPELVNKLIPDHVKRQ 285
LFNF ELS ++N+++P +
Sbjct: 353 LFNFSPYELSIIPGNVLNRILPKNFSPN 380
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 2e-85
Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 16/268 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN+++L F K L L V EY ++ L Y + +P VK
Sbjct: 56 LKQLKHPNLVNLLEVF---RRKRRLHL--VFEYCDHTVLHELDRY---QRGVPEHLVKSI 107
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICS 119
T+Q + + + H HRD+KP+N+L+ +K+CDFG A+ L + + +
Sbjct: 108 TWQTLQAVNFCHKH-NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVAT 165
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YR+PEL+ G T+Y +D+W+ GCV AELL G PL+PG++ VDQL I K LG
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225
Query: 180 --EIRCMNPNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
++ N ++ + P + P F + A+ L L P+ R T +
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLH 284
Query: 237 HPFFDELREPNARLPNGRPLPPLFNFKQ 264
HP+F+ +RE L P + Q
Sbjct: 285 HPYFENIREIE-DLAKEHDKPAENLYFQ 311
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 6e-83
Identities = 86/271 (31%), Positives = 143/271 (52%), Gaps = 20/271 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N+++L + S L LV EY+ + + + L + + VKL+
Sbjct: 54 LKDLKHANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDC---GNIINMHNVKLF 105
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---I 117
+Q+ RGLAY H +V HRDLKPQNLL++ ++K+ DFG A+ +Y +
Sbjct: 106 LFQLLRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAK--SIPTKTYDNEV 161
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ +YR P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 178 RE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
E I + + +P+ +A R+ + DL ++LLQ+ R +A +A
Sbjct: 222 EETWPGILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 235 CAHPFFDELREPNARLPNGRPLPPLFNFKQE 265
HPFF L E +LP+ + L + +
Sbjct: 280 MKHPFFLSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-82
Identities = 78/250 (31%), Positives = 129/250 (51%), Gaps = 15/250 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N+++L K +L V E+V ++ L+ + + V+ Y
Sbjct: 78 LKQLRHENLVNLLEVC---KKKKRWYL--VFEFVDHTILDDLELF---PNGLDYQVVQKY 129
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICS 119
+QI G+ + H+ + HRD+KP+N+LV + VK+CDFG A+ L GE + +
Sbjct: 130 LFQIINGIGFCHSH-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVAT 187
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPEL+ G +Y ++D+W+ GC++ E+ +G+PLFPG++ +DQL I+ LG
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247
Query: 180 --EIRCMNPNYTDFRFPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
E+ NP + R P+IK P + + ++ IDLA + L P R E
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306
Query: 237 HPFFDELREP 246
H FF
Sbjct: 307 HDFFQMDGFA 316
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-80
Identities = 87/249 (34%), Positives = 139/249 (55%), Gaps = 20/249 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN++SL S L LV E++ + + +VL + +K+Y
Sbjct: 73 LKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIY 124
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---I 117
YQ+ RG+A+ H R+ HRDLKPQNLL++ +K+ DFG A+ G SY +
Sbjct: 125 LYQLLRGVAHCHQH-RILHRDLKPQNLLINS-DGALKLADFGLARAF--GIPVRSYTHEV 180
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ +YRAP+++ G+ +Y+TS+DIWS GC+ AE++ G+PLFPG DQL +I +LGTP
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240
Query: 178 RE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+++ + P + F + PW + E IDL S +L + P+ R +A +A
Sbjct: 241 PREWPQVQEL-PLWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDA 298
Query: 235 CAHPFFDEL 243
HP+F +L
Sbjct: 299 MNHPYFKDL 307
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-80
Identities = 71/262 (27%), Positives = 128/262 (48%), Gaps = 22/262 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQR 51
+R +DH N++ + + S+ + +V EY+ + VL+
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GP 116
Query: 52 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 111
+ + +L+ YQ+ RGL YIH+ V HRDLKP NL ++ +KI DFG A+ +
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 112 ANIS----YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 167
++ + +++YR+P L+ YT +ID+W+AGC+ AE+L G+ LF G + ++Q+
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 168 EIIKVLGTPTREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225
I++ + E+ + + + P ++ + EA+D ++L +SP
Sbjct: 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSP 294
Query: 226 SLRCTALEACAHPFFDELREPN 247
R TA EA +HP+ P
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPM 316
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 4e-80
Identities = 81/272 (29%), Positives = 136/272 (50%), Gaps = 17/272 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVK 58
+ HPN++ L+ F L LV E + + +V+ QR+ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+ Y I GL +H V HRDL P N+L+ + + ICDF A++ A Y+
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
R+YRAPEL+ +T +D+WSAGCV+AE+ + LF G +QL +I++V+GTP
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 179 EEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
E++ + +Y + A W V P A+DL +++L+++P R + +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 235 CAHPFFDELREPNARLPNGRPLPPLFNFKQEL 266
HP+F+ L +P L G F+F + +
Sbjct: 315 LRHPYFESLFDPL-DLTEGLSER--FHFDESV 343
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 7e-80
Identities = 89/294 (30%), Positives = 154/294 (52%), Gaps = 25/294 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ H N+I++ + + +N + ++ E + ++RV+ Q + +++ +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYF 117
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----- 115
YQ R + +H V HRDLKP NLL++ +K+CDFG A+ + A+ S
Sbjct: 118 IYQTLRAVKVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 116 ------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
++ +R+YRAPE++ + +Y+ ++D+WS GC+LAEL L +P+FPG + QL+ I
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 170 IKVLGTPTREEI--RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225
++GTP + +P ++ P A P K+F + + P+ IDL R+L + P
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDP 294
Query: 226 SLRCTALEACAHPFFDELREPNARLPNGRPLPPL-FNFKQELSGASPELVNKLI 278
+ R TA EA HP+ +PN P G P+PP F F + + + KLI
Sbjct: 295 AKRITAKEALEHPYLQTYHDPN-DEPEGEPIPPSFFEFDHYKEALTTKDLKKLI 347
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 8e-80
Identities = 84/249 (33%), Positives = 133/249 (53%), Gaps = 21/249 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N++ L + L LV E++ + + ++L + + K +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSF 105
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---I 117
Q+ G+AY H RV HRDLKPQNLL++ ++KI DFG A+ G Y I
Sbjct: 106 LLQLLNGIAYCHDR-RVLHRDLKPQNLLINR-EGELKIADFGLARAF--GIPVRKYTHEI 161
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ +YRAP+++ G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 178 RE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+ + + P Y F + PW K + IDL S++L+ P+ R TA +A
Sbjct: 222 SKNWPNVTEL-PKYDPN-FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQA 278
Query: 235 CAHPFFDEL 243
H +F E
Sbjct: 279 LEHAYFKEN 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-79
Identities = 88/264 (33%), Positives = 133/264 (50%), Gaps = 24/264 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN+I L F ++ ++LV +++ + ++K + + ++K Y
Sbjct: 66 LQELSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAY 117
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---I 117
+GL Y+H + HRDLKP NLL+D +K+ DFG AK G N +Y +
Sbjct: 118 MLMTLQGLEYLHQH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYTHQV 173
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+R+YRAPEL+FGA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233
Query: 178 REEI---RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
EE C P+Y F P H +F + +DL L ++P R TA +A
Sbjct: 234 -EEQWPDMCSLPDYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 235 CAHPFFDELREPNARLPNGRPLPP 258
+F P P P
Sbjct: 290 LKMKYFSNR--PGPTPGCQLPRPN 311
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 2e-79
Identities = 82/268 (30%), Positives = 129/268 (48%), Gaps = 35/268 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N+I LK + L L + EY LK Y N + + +K +
Sbjct: 87 LKELQHRNIIELKSVI---HHNHRLHL--IFEY----AENDLKKYMDKNPDVSMRVIKSF 137
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIAGEANISY 116
YQ+ G+ + H+ R HRDLKPQNLL+ +KI DFG A+ G +
Sbjct: 138 LYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQF 194
Query: 117 ---ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
I + +YR PE++ G+ Y+TS+DIWS C+ AE+L+ PLFPG++ +DQL +I +VL
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 174 GTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
G P + + P++ FP+ + +V + E +DL + +L+ P R +
Sbjct: 255 GLPDDTTWPGVTAL-PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312
Query: 231 ALEACAHPFFDELREPNARLPNGRPLPP 258
A A HP+F P
Sbjct: 313 AKNALEHPYFSHN-----------DFDP 329
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 5e-79
Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
PN+I+L S+ LV E+V + ++ L Q + ++ Y Y+I
Sbjct: 89 GGPNIITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEI 139
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 124
+ L Y H++ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++
Sbjct: 140 LKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 125 PELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 183
PEL+ Y S+D+WS GC+LA ++ +P F G + DQLV I KVLGT +
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258
Query: 184 -----MNPNYTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEA 234
++P + D + W + H + PEA+D +LL+Y R TA EA
Sbjct: 259 KYNIELDPRFND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317
Query: 235 CAHPFFDELREP 246
HP+F + +
Sbjct: 318 MEHPYFYTVVKD 329
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 5e-78
Identities = 86/254 (33%), Positives = 146/254 (57%), Gaps = 15/254 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ H N+I + + T + + +V + + +Y++LK Q + ++ +
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYF 133
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----Y 116
YQI RGL YIH+ V HRDLKP NLL++ T +KICDFG A+ + Y
Sbjct: 134 LYQILRGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ +R+YRAPE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 177 TREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
++E++ C+ N ++ P PW+++F +A+DL ++L ++P R +
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 234 ACAHPFFDELREPN 247
A AHP+ ++ +P+
Sbjct: 311 ALAHPYLEQYYDPS 324
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 2e-77
Identities = 85/275 (30%), Positives = 134/275 (48%), Gaps = 22/275 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ +HPNV+ L + + E L LV E+V + + L +P +K
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 125
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---I 117
+Q+ RGL ++H+ RV HRDLKPQN+LV + Q+K+ DFG A+ ++ +
Sbjct: 126 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLAR---IYSFQMALTSVV 180
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ +YRAPE++ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 178 REEIRCMNPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
E+ P F A P K + DL + L ++P+ R +A A
Sbjct: 240 EEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 235 CAHPFFDELREPNARLPNGRPLPPLFNFKQELSGA 269
+HP+F +L L P EL+ A
Sbjct: 295 LSHPYFQDLERCKENLD---SHLPPSQNTSELNTA 326
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 4e-77
Identities = 84/282 (29%), Positives = 147/282 (52%), Gaps = 19/282 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ M H NVI L F + ++ LVM ++ + +++K ++++ ++
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQF 132
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ +GL YIH + HRDLKP NL V+ ++KI DFG A+Q A Y+ +
Sbjct: 133 LVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQ--ADSEMTGYVVT 188
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 180 EIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
++ + + ++ P+++ + + P A++L ++L R TA EA A
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALA 307
Query: 237 HPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 278
HP+F+ L + P ++ + + + ++
Sbjct: 308 HPYFESLHDTED-----EPQVQKYDDSFDDVDRTLDEWKRVT 344
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 9e-77
Identities = 85/251 (33%), Positives = 135/251 (53%), Gaps = 15/251 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ M H NVI L F +S + LVM ++ + +++ + ++
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQY 130
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ +GL YIH+ V HRDLKP NL V+ ++KI DFG A+ A Y+ +
Sbjct: 131 LVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVT 186
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 180 EIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
++ + + + PQ + ++F R P+A DL ++L+ R TA +A
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALT 305
Query: 237 HPFFDELREPN 247
HPFF+ R+P
Sbjct: 306 HPFFEPFRDPE 316
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 3e-76
Identities = 88/282 (31%), Positives = 143/282 (50%), Gaps = 19/282 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ M H NVI L F S E + LV + + ++K Q++ +V+
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQF 136
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQI RGL YIH+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +
Sbjct: 137 LIYQILRGLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVAT 192
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 180 EIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
++ + + + ++ Q+ + VF P A+DL ++L R TA +A A
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALA 311
Query: 237 HPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 278
H +F + +P+ P+ ++ E + L
Sbjct: 312 HAYFAQYHDPDD-----EPVADPYDQSLESRDLLIDEWKSLT 348
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-76
Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 28/272 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVK 58
M+ + H N++ L + L LV E++ + + + + N + + L VK
Sbjct: 57 MKELKHENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-- 116
+ +Q+ +GLA+ H ++ HRDLKPQNLL++ Q+K+ DFG A+ G ++
Sbjct: 112 YFQWQLLQGLAFCHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARAF--GIPVNTFSS 167
Query: 117 -ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
+ + +YRAP+++ G+ Y+TSIDIWS GC+LAE++ G+PLFPG N +QL I ++GT
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227
Query: 176 PTREEIRCMNPNYTDF-----RFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPS 226
P E + P+ T Q +V + +D LLQ +P
Sbjct: 228 PN-ESLW---PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 227 LRCTALEACAHPFFDELREPNARLPNGRPLPP 258
+R +A +A HP+F E A + R
Sbjct: 284 MRLSAKQALHHPWFAEYYHH-ASMGGSRSHHH 314
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 8e-76
Identities = 84/253 (33%), Positives = 131/253 (51%), Gaps = 22/253 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N++ L S L LV E+ + + + S N + VK +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSF 106
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---I 117
+Q+ +GL + H+ V HRDLKPQNLL++ ++K+ +FG A+ G Y +
Sbjct: 107 LFQLLKGLGFCHSR-NVLHRDLKPQNLLINR-NGELKLANFGLARAF--GIPVRCYSAEV 162
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 176
+ +YR P+++FGA Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTP
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 177 TRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
T E + + P+Y + V ++ DL LL+ +P R +A E
Sbjct: 223 TEEQWPSMTKL-PDYKPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 234 ACAHPFFDELREP 246
A HP+F + P
Sbjct: 280 ALQHPYFSDFCPP 292
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 1e-75
Identities = 71/249 (28%), Positives = 117/249 (46%), Gaps = 19/249 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ +HPNV+ L ++ + E+ + LV E+V + + L + +P +K
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDL 125
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---I 117
Q RGL ++H + HRDLKP+N+LV VK+ DFG A+ ++ +
Sbjct: 126 MRQFLRGLDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLAR---IYSYQMALTPVV 180
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ +YRAPE++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P
Sbjct: 181 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 178 REEIRCMNPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
++ P FP P V M L +L ++P R +A A
Sbjct: 240 EDDW----PRDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 235 CAHPFFDEL 243
H + +
Sbjct: 295 LQHSYLHKD 303
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 3e-75
Identities = 79/282 (28%), Positives = 139/282 (49%), Gaps = 25/282 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
M+ ++H N+I L + F S E + +VME + ++ +V++ + +
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSY 131
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +
Sbjct: 132 LLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVT 189
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E
Sbjct: 190 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248
Query: 180 EIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMP-----------PEAIDLASRLLQYSPS 226
++ + P + P+ + + K+F + +A DL S++L S
Sbjct: 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308
Query: 227 LRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF-KQELS 267
R + EA HP+ + +P+ P P ++E +
Sbjct: 309 KRISVDEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 232 bits (592), Expect = 2e-73
Identities = 78/279 (27%), Positives = 142/279 (50%), Gaps = 26/279 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
M+ ++H N+ISL + F + E + LVME + ++ +V++ + +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSY 168
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +
Sbjct: 169 LLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVT 226
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E
Sbjct: 227 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285
Query: 180 EIRCMNPNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPS 226
++ + P ++ P+ + K+F +K +A DL S++L P+
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 227 LRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQE 265
R + +A HP+ + +P P P +++ + +
Sbjct: 346 KRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQLD 381
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-72
Identities = 84/329 (25%), Positives = 134/329 (40%), Gaps = 69/329 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ ++H +V+ + + L +V+E ++ + + +++K
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR----TPVYLTELHIKTL 161
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----- 115
Y + G+ Y+H+ + HRDLKP N LV+ VK+CDFG A+ + E S
Sbjct: 162 LYNLLVGVKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 116 -----------------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 153 -----------GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEI 181
PLFPG + DQL I +LGTP+ E+I
Sbjct: 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI 339
Query: 182 RCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ + + FP+ + + F +AI L R+L ++P+ R T E AHP
Sbjct: 340 EALEKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHP 398
Query: 239 FFDELREPNARLPNGRPLPPLFNFKQELS 267
FF E+R + FN +
Sbjct: 399 FFKEVRIAEVETNATEKVRLPFNDWMNMD 427
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-72
Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 22/271 (8%)
Query: 1 MRVMDHPNVISLK---HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIY 56
++++ H NV++L S ++ + + LV ++ L S+ + L
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSE 125
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ--LIAGEANI 114
+K + GL YIH ++ HRD+K N+L+ +K+ DFG A+ L
Sbjct: 126 IKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPN 183
Query: 115 SY---ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
Y + + +YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I +
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 172 VLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSL 227
+ G+ T E + Y + + P A+DL +LL P+
Sbjct: 244 LCGSITPEVWPNVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 228 RCTALEACAHPFFDELREPNARLPNGRPLPP 258
R + +A H FF +P G
Sbjct: 303 RIDSDDALNHDFFWS--DPMPSDLKGMLSTH 331
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-70
Identities = 74/303 (24%), Positives = 139/303 (45%), Gaps = 50/303 (16%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
H N+++L + + + +++L V +Y+ ++ V++ + ++ + YQ+
Sbjct: 67 GHENIVNLLNVLRAD-NDRDVYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQL 118
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--------- 115
+ + Y+H+ + HRD+KP N+L++ VK+ DFG ++ + +
Sbjct: 119 IKVIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 116 -------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162
Y+ +R+YRAPE++ G+T+YT ID+WS GC+L E+L G+P+FPG +
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 163 VDQLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMP--------- 210
++QL II V+ P+ E++ + +P +
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 211 ------PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQ 264
EA+DL +LLQ++P+ R +A +A HPF PN + N
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNV 356
Query: 265 ELS 267
+ S
Sbjct: 357 KHS 359
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-70
Identities = 82/302 (27%), Positives = 134/302 (44%), Gaps = 36/302 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLI 55
+R + HPNVISL+ F S + + L+ +Y ++ ++K + ++ ++P
Sbjct: 72 LRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEA 112
VK YQI G+ Y+H V HRDLKP N+LV +VKI D G A+ +
Sbjct: 129 MVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 113 NISYICSR----FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----- 163
++ + +YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 164 ----DQLVEIIKVLGTPTRE---------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 210
DQL I V+G P + E + ++ + + + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 211 PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGAS 270
+A L +LL P R T+ +A P+F E +P + ++ L+
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEE 365
Query: 271 PE 272
P+
Sbjct: 366 PD 367
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 3e-69
Identities = 79/323 (24%), Positives = 136/323 (42%), Gaps = 65/323 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
+ + +I L +EL++ V+E + ++ K + ++K
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFK----TPIFLTEEHIK 132
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--- 115
Y + G +IH + HRDLKP N L++ VK+CDFG A+ + + +
Sbjct: 133 TILYNLLLGENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVND 190
Query: 116 --------------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ- 154
++ +R+YRAPELI YT SIDIWS GC+ AELL
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 155 ----------PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NP 186
PLFPG ++ DQL I ++GTPT ++++ + P
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP 310
Query: 187 NYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 244
+ FP K + + + + I+L +L+++P+ R T +A HP+ ++R
Sbjct: 311 EVIKYIKLFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369
Query: 245 EPNARLPNGRPLPPLFNFKQELS 267
+ + + + F+ LS
Sbjct: 370 KKKLENFSTKKIILPFDDWMVLS 392
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-55
Identities = 82/281 (29%), Positives = 131/281 (46%), Gaps = 45/281 (16%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
+ NVI + F T +N + + E + ++Y ++K + Q L V+ + + I
Sbjct: 157 NTMNVIHMLENF---TFRNHICM--TFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSI 209
Query: 65 FRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 123
+ L +H R+ H DLKP+N LL +K+ DFGS+ + +YI SRFYR
Sbjct: 210 LQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRFYR 266
Query: 124 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR- 182
APE+I GA Y ID+WS GC+LAELL G PL PGE+ DQL +I++LG P+++ +
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 183 ----------CMNPNYTDF---------------RFPQIKAHPWHKVFHKRMPPEA---- 213
P Y R +++ P + + +
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 214 IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 254
+D + L++ P++R T +A HP+ R + P G
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWL---RRRLPKPPTGE 423
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 9e-55
Identities = 72/278 (25%), Positives = 121/278 (43%), Gaps = 30/278 (10%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 63
M +++ L F+ N + + +V E + E++ ++K Y ++ +PLIYVK + Q
Sbjct: 83 MGANHILKLLD-HFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQ 139
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYIC 118
+ GL Y+H + H D+KP+N+L++ + +KI D G+A E + I
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQ 197
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKV 172
+R YR+PE++ GA + DIWS C++ EL+ G LF + D + +II++
Sbjct: 198 TREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 173 LGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLASR 219
LG +R N ++K P V ++ E D S
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316
Query: 220 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP 257
+LQ P R A HP+ + R L
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-54
Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 44/272 (16%)
Query: 8 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 67
+ + F + + V E + S Y +K L +++ YQI +
Sbjct: 78 RCVQMLEWF---EHHGHICI--VFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKS 130
Query: 68 LAYIHTVPRVCHRDLKPQN-LLVD-----------------PLTHQVKICDFGSAKQLIA 109
+ ++H+ ++ H DLKP+N L V + +K+ DFGSA
Sbjct: 131 VNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYD 187
Query: 110 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
E + + + +R YRAPE+I ++ D+WS GC+L E LG +FP ++ + L +
Sbjct: 188 DEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246
Query: 170 IKVLGTPTREEIR-CMNPNY-TDFRFPQIKAHPWHKVFHKRMPP-------------EAI 214
++LG + I+ Y R + + + P
Sbjct: 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306
Query: 215 DLASRLLQYSPSLRCTALEACAHPFFDELREP 246
DL ++L+Y P+ R T EA HPFFD L++
Sbjct: 307 DLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-54
Identities = 79/275 (28%), Positives = 122/275 (44%), Gaps = 47/275 (17%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
++ LK F +N L L V E + ++Y +L++ + + + L + + Q+
Sbjct: 114 MKYYIVHLKRHF---MFRNHLCL--VFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQM 166
Query: 65 FRGLAYIHTV-PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 122
L ++ T + H DLKP+N LL +P +KI DFGS+ Q G+ YI SRFY
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRFY 224
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
R+PE++ G Y +ID+WS GC+L E+ G+PLF G N VDQ+ +I++VLG P +
Sbjct: 225 RSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283
Query: 183 -----------CMNPNYTDFRFPQIKAH---PWHKVFH-----KRMPPEA---------- 213
+ + + K P + H + P
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343
Query: 214 ------IDLASRLLQYSPSLRCTALEACAHPFFDE 242
DL R+L Y P R A H FF +
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-53
Identities = 65/281 (23%), Positives = 105/281 (37%), Gaps = 44/281 (15%)
Query: 8 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 67
+ + F + + E + ++ + LK + Q PL +V+ YQ+
Sbjct: 83 LCVLMSDWF---NFHGHMCI--AFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHA 135
Query: 68 LAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------QVKICDFGSAKQLIA 109
L ++H ++ H DLKP+N L V+ +++ DFGSA
Sbjct: 136 LRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFD 192
Query: 110 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
E + + + +R YR PE+I + D+WS GC+L E G LF + LV +
Sbjct: 193 HEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251
Query: 170 IKVLGTPTREEIRCM---------NPNYTDFRFPQIKAHPWHKVFHKRMPPEA------I 214
K+LG I + + K M ++
Sbjct: 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311
Query: 215 DLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 255
DL R+L++ P+ R T EA HPFF L R
Sbjct: 312 DLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 52/278 (18%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
++ N++ F + + L + E + S+Y ++ + + +KLY +I
Sbjct: 94 NNNNIVKYHGKF---MYYDHMCL--IFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEI 146
Query: 65 FRGLAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------------QVKICD 100
+ L Y+ + + H DLKP+N LL DP +K+ D
Sbjct: 147 LKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 101 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160
FG A + + S I +R YRAPE+I + S D+WS GCVLAEL G LF
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 161 NAVDQLVEIIKVLGTPTREEIR---------CMNPNYTDFRFPQIKAHPWHKVFHKRMPP 211
++ L + ++ + + +N + +P+ + K+ P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 212 EA--------IDLASRLLQYSPSLRCTALEACAHPFFD 241
D +LQ P+LR + E H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 61/309 (19%), Positives = 106/309 (34%), Gaps = 55/309 (17%)
Query: 1 MRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
+ + + +I L + ++ +VME + LK + + K
Sbjct: 108 LNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERK 158
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 115
Y + + IH + H DLKP N L+ +K+ DFG A Q+ ++ S
Sbjct: 159 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 116 YICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVD 164
+ + Y PE I ++ + D+WS GC+L + G+ F N +
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 165 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224
+L II +PN+ FP I + D+ L+
Sbjct: 276 KLHAII--------------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRD 308
Query: 225 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284
P R + E AHP+ P ++ G + Q + SP + K +
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEH 368
Query: 285 QLGLNFLHP 293
G +
Sbjct: 369 YSGGESHNS 377
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-46
Identities = 56/269 (20%), Positives = 96/269 (35%), Gaps = 55/269 (20%)
Query: 1 MRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
+ + + +I L + ++ +VME + LK + + K
Sbjct: 80 LNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERK 130
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 115
Y + + IH + H DLKP N L+ +K+ DFG A Q+ ++ S
Sbjct: 131 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 116 YICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVD 164
+ + Y PE I ++ + D+WS GC+L + G+ F N +
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247
Query: 165 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224
+L II +PN+ FP I + D+ L+
Sbjct: 248 KLHAII--------------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRD 280
Query: 225 PSLRCTALEACAHPFFDELREPNARLPNG 253
P R + E AHP+ P ++ G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-46
Identities = 61/309 (19%), Positives = 106/309 (34%), Gaps = 55/309 (17%)
Query: 1 MRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
+ + + +I L + ++ +VME + LK + + K
Sbjct: 61 LNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERK 111
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 115
Y + + IH + H DLKP N L+ +K+ DFG A Q+ ++ S
Sbjct: 112 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 116 YICSRFYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVD 164
+ + Y PE I ++ + D+WS GC+L + G+ F N +
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228
Query: 165 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224
+L II +PN+ FP I + D+ L+
Sbjct: 229 KLHAII--------------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRD 261
Query: 225 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284
P R + E AHP+ P ++ G + Q + SP + K +
Sbjct: 262 PKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEH 321
Query: 285 QLGLNFLHP 293
G +
Sbjct: 322 YSGGESHNS 330
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-45
Identities = 41/256 (16%), Positives = 75/256 (29%), Gaps = 26/256 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ V P L N L L E ++ L ++ + +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
T Q+ R A + + + H P NL + P ++ + D + + G +
Sbjct: 200 TAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSALWK--VGTRGPASSVPV 255
Query: 121 FYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
Y E + +T +++ W G + + F + L P +
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+P L R L + R LEA P
Sbjct: 316 --------------------SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355
Query: 240 FDELR-EPNARLPNGR 254
F +L+ E ++ L G+
Sbjct: 356 FLQLQNEISSSLSTGQ 371
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-43
Identities = 53/246 (21%), Positives = 84/246 (34%), Gaps = 45/246 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+V HP + L+ + L L E S+ + + + +P V Y
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGI-----LYLQTELCGPSLQQHCEAW---GASLPEAQVWGY 162
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
LA++H+ + H D+KP N+ + P + K+ DFG +L A
Sbjct: 163 LRDTLLALAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDP 220
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y APEL+ Y T+ D++S G + E+ L G QL +
Sbjct: 221 RYMAPELL--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL--------- 269
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
F + E + +L+ P LR TA A P
Sbjct: 270 ---------------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
Query: 241 DELREP 246
R+P
Sbjct: 309 ---RQP 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-42
Identities = 51/261 (19%), Positives = 86/261 (32%), Gaps = 44/261 (16%)
Query: 1 MRVMDHPNVISLKHCFF-STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 58
R+ +HPN++ L +K+E +L ++ + +++ ++ + +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWL--LLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK----------QLI 108
I RGL IH HRDLKP N+L+ Q + D GS Q +
Sbjct: 138 WLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 109 AGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 166
+ + C+ YRAPEL D+WS GCVL ++ G+ +
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
Query: 167 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226
V + V PQ R L + ++ P
Sbjct: 256 VALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTVDPH 289
Query: 227 LRCTALEACAHPFFDELREPN 247
R + + P
Sbjct: 290 QRPHIPLLLSQLEALQPPAPG 310
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-41
Identities = 53/266 (19%), Positives = 108/266 (40%), Gaps = 29/266 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----ESMYRVLKHYSSANQRMPLI 55
+ + + ++ + T+ +E+++ + EY+ + + +P+
Sbjct: 97 ITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 115
+K + +YIH +CHRD+KP N+L+D +VK+ DFG ++ ++ + S
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIKGS 210
Query: 116 YIC-SRFYRAPELIFGATEY-TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
+ + PE + Y +DIWS G L + F + ++ +L I+
Sbjct: 211 --RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR-- 266
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
+ I P + F + + + E ID L+ +P+ R T+ +
Sbjct: 267 ----TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319
Query: 234 ACAHPFF-----DELREPNARLPNGR 254
A H + ++LRE + L R
Sbjct: 320 ALKHEWLADTNIEDLREFSKELYKKR 345
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 55/248 (22%), Positives = 95/248 (38%), Gaps = 48/248 (19%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQ 63
+HPNVI K+ F + +E ++ V + + P+ ++ Q
Sbjct: 76 EHPNVIRYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----Q 126
Query: 64 IFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLIAGEANISY--- 116
GLA++H++ + HRDLKP N+L+ + I DFG K+L G + S
Sbjct: 127 TTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 117 IC-SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 172
+ + + APE++ + T ++DI+SAGCV ++ G F
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------- 234
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
+ + + P K A +L +++ P R +A
Sbjct: 235 -----QRQANILLGAC-SLDCLH----PE-----KHEDVIARELIEKMIAMDPQKRPSAK 279
Query: 233 EACAHPFF 240
HPFF
Sbjct: 280 HVLKHPFF 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-41
Identities = 59/248 (23%), Positives = 93/248 (37%), Gaps = 39/248 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+R + HPN++ T+ L +VMEY + V+ + Q + +V
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 60 YTYQIFRGLAYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 115
Q+ L H V HRDLKP N+ +D VK+ DFG A+ L +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAK 174
Query: 116 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+ +Y +PE + Y DIWS GC+L EL P F + +L I+
Sbjct: 175 TFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR--- 229
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+ +F +I R E ++ +R+L R + E
Sbjct: 230 ---------------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEI 265
Query: 235 CAHPFFDE 242
+P E
Sbjct: 266 LENPLILE 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 57/267 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKH--YSSANQRMPLIYV 57
DHPNVI +C +T + FL + +E ++ V +
Sbjct: 63 TESDDHPNVIRY-YCSETT----DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD------------PLTHQVKICDFGSAK 105
QI G+A++H++ ++ HRDLKPQN+LV ++ I DFG K
Sbjct: 118 ISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 106 QLIAGEANISYICSRF-----YRAPELIFGATE------YTTSIDIWSAGCVLAELL-LG 153
+L +G+++ + +RAPEL+ + T SIDI+S GCV +L G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA 213
+ F + + II+ F ++K + EA
Sbjct: 237 KHPFGDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEA 272
Query: 214 IDLASRLLQYSPSLRCTALEACAHPFF 240
DL S+++ + P R TA++ HP F
Sbjct: 273 TDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 57/264 (21%), Positives = 91/264 (34%), Gaps = 56/264 (21%)
Query: 1 MRVMDHPNVISLKHCF--------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQR 51
+ ++H V+ + T K + L + MEY ++Y ++ + QR
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 52 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 111
QI L+YIH+ + HRDLKP N+ +D + VKI DFG AK +
Sbjct: 116 D---EYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSL 170
Query: 112 ANISYICSR---------------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156
+ Y A E++ G Y ID++S G + E++ P
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPF 228
Query: 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 216
G V I+K L + FP P F +
Sbjct: 229 STGME----RVNILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKI 263
Query: 217 ASRLLQYSPSLRCTALEACAHPFF 240
L+ + P+ R A +
Sbjct: 264 IRLLIDHDPNKRPGARTLLNSGWL 287
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 45/251 (17%), Positives = 94/251 (37%), Gaps = 16/251 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ ++H N++ L TT+++ L+ME+ P S+Y VL+ S+A +P +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLI 116
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISY 116
+ G+ ++ + HR++KP N++ K+ DFG+A++L E +S
Sbjct: 117 VLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 117 ICSRFYRAPELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
+ Y P++ A +Y ++D+WS G G F + E+
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 170 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229
+ + T + P + + + + +L+
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
Query: 230 TALEACAHPFF 240
+ A
Sbjct: 296 GFDQFFAETSD 306
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-38
Identities = 64/266 (24%), Positives = 104/266 (39%), Gaps = 43/266 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
R + H +V+ F + +F+ V+E S+ + K + + +
Sbjct: 69 HRSLAHQHVVGFHGFF---EDNDFVFV--VLELCRRRSLLELHK----RRKALTEPEARY 119
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C
Sbjct: 120 YLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 178 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------ 230
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
++ P + P A L ++LQ P+ R T E
Sbjct: 231 -----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDE 267
Query: 239 FFDELREPNARLPNGRPLPPLFNFKQ 264
FF P +PP F+
Sbjct: 268 FFTSGYIPARLPITCLTIPPRFSIAP 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 47/271 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
++++DHPN++ L F +++ LVME E ++ ++
Sbjct: 90 LKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------D 137
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANI 114
+ Q+ G+ Y+H + HRDLKP+NLL++ +KI DFG + +
Sbjct: 138 AAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+ + +Y APE++ +Y D+WS G +L LL G P F G+ DQ EI+
Sbjct: 197 ERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL---- 246
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
++ + W V A DL ++LQ+ R +A +A
Sbjct: 247 ----RKVEKGKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQA 289
Query: 235 CAHPFFDELREPNARLPNGRPLPPLF-NFKQ 264
HP+ E+ L N ++
Sbjct: 290 LEHPWIKEMCSKKESGIELPSLANAIENMRK 320
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 63/259 (24%), Positives = 104/259 (40%), Gaps = 46/259 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVK 58
+ + H N++ + + S+N F+ + ME VP S+ +L+ + I
Sbjct: 73 HKHLKHKNIVQ----YLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--G 125
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYI 117
YT QI GL Y+H ++ HRD+K N+L++ + +KI DFG++K+L ++
Sbjct: 126 FYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184
Query: 118 CSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ Y APE+I Y + DIWS GC + E+ G+P F +L E +
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM--- 235
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTAL 232
F+ K HP +P EA + + P R A
Sbjct: 236 --------------FKVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACAN 274
Query: 233 EACAHPFFDELREPNARLP 251
+ F + P
Sbjct: 275 DLLVDEFLKVSSKKKKTQP 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 46/270 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
++ +DHPN++ L F +++ + LV E E ++ +S
Sbjct: 80 LKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------D 127
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANI 114
Q+ G+ Y+H ++ HRDLKP+NLL++ + ++I DFG + A +
Sbjct: 128 AARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
I + +Y APE++ G Y D+WS G +L LL G P F G N D L ++ K
Sbjct: 187 DKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--- 241
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+ F W KV A DL ++L Y PS+R +A +A
Sbjct: 242 --------------GKYTFE---LPQWKKV-----SESAKDLIRKMLTYVPSMRISARDA 279
Query: 235 CAHPFFDELREPNARLPNGRPLPPLFNFKQ 264
H + + + + N +Q
Sbjct: 280 LDHEWIQTYTKEQISVDVPSLDNAILNIRQ 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 67/271 (24%), Positives = 108/271 (39%), Gaps = 47/271 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
++ +DHPN++ L ++ +V E E ++K +S
Sbjct: 75 LKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------D 122
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANI 114
Q+F G+ Y+H + HRDLKP+N+L++ +KI DFG +
Sbjct: 123 AARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
I + +Y APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 182 DRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--- 236
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+ F W + +A DL ++L + PSLR TA +
Sbjct: 237 --------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274
Query: 235 CAHPFFDELREPNARLPNGRPLPPLF-NFKQ 264
HP+ + + + L N +Q
Sbjct: 275 LEHPWIQKYSSETPTISDLPSLESAMTNIRQ 305
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-38
Identities = 51/244 (20%), Positives = 96/244 (39%), Gaps = 36/244 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ + HPN++ + ST + + LV E + ++ LK + + M + ++
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRS 133
Query: 60 YTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+ QI +GL ++HT P + HRDLK N+ + T VKI D G A A A + I
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIG 192
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ + APE+ +Y S+D+++ G + E+ + + Q+ + T
Sbjct: 193 TPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------TS 244
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
PE ++ ++ + R + + H
Sbjct: 245 GVKPASFDKVAI--------------------PEVKEIIEGCIRQNKDERYSIKDLLNHA 284
Query: 239 FFDE 242
FF E
Sbjct: 285 FFQE 288
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-38
Identities = 52/262 (19%), Positives = 89/262 (33%), Gaps = 49/262 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ +I ++ + FL M+ ++ VL +SS ++ +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
T Q+ R LA +H + H L+P ++++D V + F + A + SR
Sbjct: 212 TLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRD---GARVVSSVSR 266
Query: 121 FYRAPELI----------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ PEL T T S D W+ G V+ + + A+
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG------ 320
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
E I FR K +P L L+Y R
Sbjct: 321 ------GSEWI---------FRSC------------KNIPQPVRALLEGFLRYPKEDRLL 353
Query: 231 ALEACAHPFFDELREP-NARLP 251
L+A P +++LR +A LP
Sbjct: 354 PLQAMETPEYEQLRTELSAALP 375
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 46/270 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
++ +DHPN+I L F +++ + LV E+ E +++ +
Sbjct: 100 LKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC-------D 147
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANI 114
QI G+ Y+H + HRD+KP+N+L++ +KI DFG +
Sbjct: 148 AANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+ + +Y APE++ +Y D+WS G ++ LL G P F G+N DQ +II
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+++ + + W + EA +L +L Y + RCTA EA
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299
Query: 235 CAHPFFDELREPNARLPNGRPLPPLFNFKQ 264
+ + + L N ++
Sbjct: 300 LNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-38
Identities = 64/267 (23%), Positives = 104/267 (38%), Gaps = 43/267 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
R + H +V+ F + +F+ V+E S+ + K + + +
Sbjct: 95 HRSLAHQHVVGFHGFF---EDNDFVFV--VLELCRRRSLLELHK----RRKALTEPEARY 145
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C
Sbjct: 146 YLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 204 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------ 256
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
++ P + P A L ++LQ P+ R T E
Sbjct: 257 -----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDE 293
Query: 239 FFDELREPNARLPNGRPLPPLFNFKQE 265
FF P +PP F+
Sbjct: 294 FFTSGYIPARLPITCLTIPPRFSIAPS 320
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-38
Identities = 60/242 (24%), Positives = 102/242 (42%), Gaps = 42/242 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ HP+++ L + F N ++L V+E M R LK + + +
Sbjct: 65 HCQLKHPSILELYNYF---EDSNYVYL--VLEMCHNGEMNRYLK---NRVKPFSENEARH 116
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
+ +QI G+ Y+H+ + HRDL NLL+ +KI DFG A QL +C
Sbjct: 117 FMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCG 174
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y +PE+ + + D+WS GC+ LL+G+P F + + L +++
Sbjct: 175 TPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------ 227
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
D+ P + + EA DL +LL+ +P+ R + HP
Sbjct: 228 -----------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 239 FF 240
F
Sbjct: 265 FM 266
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-38
Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 37/242 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ ++HPNVI F LN+V+E + R++KH+ + +P V
Sbjct: 86 LKQLNHPNVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYIC 118
Y Q+ L ++H+ RV HRD+KP N+ + T VK+ D G + + S +
Sbjct: 141 YFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPT 177
+ +Y +PE I Y DIWS GC+L E+ Q F G+ + L + I
Sbjct: 199 TPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI------- 250
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
+C +P + + E L + + P R
Sbjct: 251 ---EQC--------DYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
Query: 238 PF 239
Sbjct: 292 AK 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-38
Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 45/254 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ HPN++ L F ++L ++EY P ++YR L+ +
Sbjct: 63 QSHLRHPNILRLYGYFHD---ATRVYL--ILEYAPLGTVYRELQK----LSKFDEQRTAT 113
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y ++ L+Y H+ RV HRD+KP+NLL+ ++KI DFG + + +C
Sbjct: 114 YITELANALSYCHS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCG 169
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y PE+I G + +D+WS G + E L+G+P F + I +V
Sbjct: 170 TLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------ 222
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+F FP + + A DL SRLL+++PS R E HP
Sbjct: 223 -----------EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHP 259
Query: 239 FFDELREPNARLPN 252
+ + N
Sbjct: 260 WITANSSKPSNCQN 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 48/246 (19%), Positives = 82/246 (33%), Gaps = 44/246 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ P ++ L +N+ ME + S+ +++K +P
Sbjct: 104 CAGLSSPRIVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQMG----CLPEDRALY 154
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y Q GL Y+HT R+ H D+K N+L+ + +CDFG A L S +
Sbjct: 155 YLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 120 R------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
+ APE++ G +DIWS+ C++ +L G + ++I
Sbjct: 214 DYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-E 271
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
P +I P L+ P R +A+E
Sbjct: 272 PPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAME 306
Query: 234 ACAHPF 239
Sbjct: 307 LRRKVG 312
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 44/249 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ ++HP +I +K+ F + +V+E + E +V+ + +R+ K
Sbjct: 194 LKKLNHPCIIKIKNFFDAED------YYIVLELMEGGELFDKVVGN-----KRLKEATCK 242
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISY 116
LY YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L +
Sbjct: 243 LYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT 300
Query: 117 IC-SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
+C + Y APE++ Y ++D WS G +L L G P F L + I
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-S 359
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
G + F W +V +A+DL +LL P R T E
Sbjct: 360 G---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEE 396
Query: 234 ACAHPFFDE 242
A HP+ +
Sbjct: 397 ALRHPWLQD 405
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 46/252 (18%), Positives = 87/252 (34%), Gaps = 50/252 (19%)
Query: 1 MRVMDHPNVISLKHCF-----------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA 48
+ +DH N++ C+ +++ L + ME+ + ++ + ++
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-- 115
Query: 49 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 108
+++ + QI +G+ YIH+ ++ +RDLKP N+ + T QVKI DFG L
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLK 173
Query: 109 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 168
+ Y +PE I +Y +D+++ G +LAELL +
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTD 230
Query: 169 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228
+ + + L +LL P R
Sbjct: 231 LRD-------------------------------GIISDIFDKKEKTLLQKLLSKKPEDR 259
Query: 229 CTALEACAHPFF 240
E
Sbjct: 260 PNTSEILRTLTV 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 51/247 (20%), Positives = 91/247 (36%), Gaps = 40/247 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ M HPN++ + F S L +VM+Y +++ + +
Sbjct: 77 LANMKHPNIVQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQK--GVLFQEDQILD 129
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
+ QI L ++H ++ HRD+K QN+ + V++ DFG A+ L +
Sbjct: 130 WFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVELARACIG 187
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ +Y +PE+ Y DIW+ GCVL EL + F + + LV I
Sbjct: 188 TPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------S 239
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
++ +Y + L S+L + +P R +
Sbjct: 240 GSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKG 278
Query: 239 FFDELRE 245
F + E
Sbjct: 279 FIAKRIE 285
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 64/294 (21%), Positives = 109/294 (37%), Gaps = 75/294 (25%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
M+ + HPN+ L + ++E ++ LVME + ++ + + + VK
Sbjct: 82 MKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 59 L-----------------------------------YTYQIFRGLAYIHTVPRVCHRDLK 83
QIF L Y+H +CHRD+K
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIK 195
Query: 84 PQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYIC-----SRFYRAPELIFGATE-YTT 136
P+N L + ++K+ DFG +K+ Y + ++ APE++ E Y
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 137 SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 196
D WSAG +L LL+G FPG N D + +++ F
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE-- 296
Query: 197 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 250
++ + P A DL S LL + R A+ A HP+ + + ++
Sbjct: 297 -NPNYNVL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 67/276 (24%), Positives = 106/276 (38%), Gaps = 48/276 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
++ ++HP +I +K+ FF +V+E + E +V+ A +
Sbjct: 69 LKKLNHPCIIKIKN-FFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCK----- 117
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANI 114
LY YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L +
Sbjct: 118 --LYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-M 173
Query: 115 SYIC-SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
+C + Y APE++ Y ++D WS G +L L G P F L + I
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
Query: 172 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231
G + F W +V +A+DL +LL P R T
Sbjct: 234 -SG---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTT 269
Query: 232 LEACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 267
EA HP+ + Q L+
Sbjct: 270 EEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-36
Identities = 58/248 (23%), Positives = 101/248 (40%), Gaps = 45/248 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ HPN++ + + +F + + L++E+ P +Y+ L+ + R
Sbjct: 68 QSHLRHPNILRM-YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSAT 118
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
+ ++ L Y H +V HRD+KP+NLL+ ++KI DFG + + C
Sbjct: 119 FMEELADALHYCHE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CG 174
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y PE+I G + +D+W AG + E L+G P F + + I+ V
Sbjct: 175 TLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------ 227
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
D +FP P+ + + DL S+LL+Y P R HP
Sbjct: 228 -----------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 239 FFDELREP 246
+
Sbjct: 265 WVKANSRR 272
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-36
Identities = 38/243 (15%), Positives = 87/243 (35%), Gaps = 18/243 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ ++H N++ L TT+++ L+ME+ P + + ++ +P
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFL 115
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANIS 115
+ + G+ ++ + HR++KP N++ K+ DFG+A++L E +S
Sbjct: 116 IVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 116 YICSRFYRAPELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 168
+ Y P++ A +Y ++D+WS G G F + E
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 169 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228
++ + T + P + + + + +L+
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
Query: 229 CTA 231
Sbjct: 295 WGF 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 50/268 (18%), Positives = 97/268 (36%), Gaps = 55/268 (20%)
Query: 1 MRVMDHPNVISLKHCFF-------STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRM 52
+ ++HP ++ + + S +++L + M+ E++ + + +R
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER- 115
Query: 53 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 112
QI + ++H+ + HRDLKP N+ VK+ DFG + E
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEE 173
Query: 113 NISYICSR-------------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159
+ + Y +PE I G Y+ +DI+S G +L ELL P F
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FST 229
Query: 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 219
+ + + ++ + +FP + + P +
Sbjct: 230 QMERVRTLTDVR------------------NLKFPPL---------FTQKYPCEYVMVQD 262
Query: 220 LLQYSPSLRCTALEACAHPFFDELREPN 247
+L SP R A+ + F++L P
Sbjct: 263 MLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 67/249 (26%), Positives = 105/249 (42%), Gaps = 48/249 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
M+ +DHPN+I L F ++ + LVME E RV+ + +
Sbjct: 60 MKSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------D 107
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANI 114
+ +AY H + V HRDLKP+N L + +K+ DFG A + G+ +
Sbjct: 108 AARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MM 165
Query: 115 SYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
+ +Y +P+++ G Y D WSAG ++ LL G P F + +++I +
Sbjct: 166 RTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG- 222
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
F FP W V P+A L RLL SP R T+L+
Sbjct: 223 ----------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQ 258
Query: 234 ACAHPFFDE 242
A H +F++
Sbjct: 259 ALEHEWFEK 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 67/252 (26%), Positives = 102/252 (40%), Gaps = 50/252 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
+V HPN+I LK + + F LV + + E + + S R
Sbjct: 78 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR----- 127
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
+ + +H + + HRDLKP+N+L+D +K+ DFG + QL GE +
Sbjct: 128 --KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LRE 182
Query: 117 IC-SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+C + Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
+++F + W DL SR L P R T
Sbjct: 243 SG-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYT 277
Query: 231 ALEACAHPFFDE 242
A EA AHPFF +
Sbjct: 278 AEEALAHPFFQQ 289
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 51/252 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--------ESMYRVLKHYSSANQRM 52
++ +DHPN+I + F ++ + +VME S K S
Sbjct: 74 LKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG---- 124
Query: 53 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAG 110
YV Q+ LAY H+ V H+DLKP+N+L + +KI DFG A+ +
Sbjct: 125 ---YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 111 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
E + + + Y APE+ + T DIWSAG V+ LL G F G + + +
Sbjct: 181 EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT 238
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
+ + + P+A+DL ++L P R +
Sbjct: 239 YK-----------------EPNYAV---ECRP------LTPQAVDLLKQMLTKDPERRPS 272
Query: 231 ALEACAHPFFDE 242
A + H +F +
Sbjct: 273 AAQVLHHEWFKQ 284
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 66/290 (22%), Positives = 107/290 (36%), Gaps = 42/290 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
M + HP +I+L F K E+ L ++E++ E R+ ++ V
Sbjct: 102 MNQLHHPKLINLHDAF---EDKYEMVL--ILEFLSGGELFDRIAAEDYKMSEA----EVI 152
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYI 117
Y Q GL ++H + H D+KP+N++ VKI DFG A +L E
Sbjct: 153 NYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ + APE I D+W+ G + LL G F GE+ ++ L + +
Sbjct: 212 ATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----- 265
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
D+ F + V PEA D LLQ P R T +A H
Sbjct: 266 ------------DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305
Query: 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLG 287
P+ L+ ++ L + P +Q++ +
Sbjct: 306 PW---LKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFS 352
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 64/248 (25%), Positives = 102/248 (41%), Gaps = 46/248 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
++ +DHPN++ L ++ +V E E ++K +S
Sbjct: 75 LKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------D 122
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANI 114
Q+F G+ Y+H + HRDLKP+N+L++ +KI DFG +
Sbjct: 123 AARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
I + +Y APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 182 DRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--- 236
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+ F W + +A DL ++L + PSLR TA +
Sbjct: 237 --------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274
Query: 235 CAHPFFDE 242
HP+ +
Sbjct: 275 LEHPWIQK 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 59/266 (22%), Positives = 107/266 (40%), Gaps = 28/266 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKL 59
+ + P ++ F+S +++ ME++ S+ +VLK R+P +
Sbjct: 85 LHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGK 135
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ + +GL Y+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGT 193
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R Y +PE + G Y+ DIWS G L E+ +G+ P +A + + + E
Sbjct: 194 RSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVF---------------HKRMPPEAIDLASRLLQYS 224
+ + P +F E D ++ L +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312
Query: 225 PSLRCTALEACAHPFFDELREPNARL 250
P+ R + H F
Sbjct: 313 PAERADLKQLMVHAFIKRSDAEEVDF 338
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-35
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 35/243 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR +D P ++ F + + ME + S+ + K Q +P +
Sbjct: 60 MRTVDCPFTVTFYGALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
I + L ++H+ V HRD+KP N+L++ QVK+CDFG + L+ A +
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCK 173
Query: 121 FYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
Y APE I Y+ DIWS G + EL + + + Q ++ + V
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS- 231
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
PQ+ A + E +D S+ L+ + R T E H
Sbjct: 232 ----------------PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQH 267
Query: 238 PFF 240
PFF
Sbjct: 268 PFF 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-35
Identities = 60/272 (22%), Positives = 101/272 (37%), Gaps = 49/272 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
+R + H NVI+L + ++ ++ L ++E V E + + S
Sbjct: 69 LRQVLHHNVITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE------- 116
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEAN 113
+ QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G
Sbjct: 117 ATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174
Query: 114 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
I + + APE I D+WS G + LL G F G+ + L I V
Sbjct: 175 FKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
+ F + A D +LL R T
Sbjct: 234 -----------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQ 268
Query: 233 EACAHPFFDELREPNARLPNGRPLPPLFNFKQ 264
EA HP+ + + + L NF++
Sbjct: 269 EALRHPWITP-VDNQQAMVRRESVVNLENFRK 299
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 63/281 (22%), Positives = 106/281 (37%), Gaps = 51/281 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY-- 56
++ HP+++ L + ++ L +V E++ + + ++K + Y
Sbjct: 80 CHMLKHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSE 129
Query: 57 --VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGE 111
Y QI L Y H + HRD+KP +L+ + + VK+ FG A QL
Sbjct: 130 AVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESG 187
Query: 112 ANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ + APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 188 LVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI 244
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
++ W + A DL R+L P+ R T
Sbjct: 245 I----------------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERIT 280
Query: 231 ALEACAHPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 269
EA HP+ E ++ + L FN +++L GA
Sbjct: 281 VYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 62/257 (24%), Positives = 101/257 (39%), Gaps = 48/257 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
+R + HPN+I+L F +K ++ L ++E V E + + +
Sbjct: 62 LREIRHPNIITLHDIF---ENKTDVVL--ILELVSGGELFDFLAEKESLTEDE------- 109
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEAN 113
+ QI G+ Y+H+ R+ H DLKP+N+++ + ++K+ DFG A ++ AG
Sbjct: 110 ATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE- 167
Query: 114 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
I + + APE I D+WS G + LL G F GE + L I V
Sbjct: 168 FKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
++ F + A D RLL P R T
Sbjct: 227 -----------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIA 261
Query: 233 EACAHPFFDELREPNAR 249
++ H + +R N R
Sbjct: 262 QSLEHSWIKAIRRRNVR 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 67/268 (25%), Positives = 105/268 (39%), Gaps = 45/268 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
R + HPN++ L + E F LV + V E ++ YS A+
Sbjct: 82 CRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----- 131
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEANI 114
QI +AY H+ + HR+LKP+NLL+ VK+ DFG A ++ EA
Sbjct: 132 --HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+ + Y +PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 189 GFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-- 245
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+ +P + W V PEA L +L +P R TA +A
Sbjct: 246 ---------------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQA 282
Query: 235 CAHPFFDELREPNARLPNGRPLPPLFNF 262
P+ + + + L F
Sbjct: 283 LKVPWICNRERVASAIHRQDTVDCLKKF 310
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 12/253 (4%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLN-LVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 58
M+ ++HPNV+S + L L MEY + + L + + + ++
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIR 124
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISY 116
I L Y+H R+ HRDLKP+N+++ P + KI D G AK+L GE +
Sbjct: 125 TLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ + Y APEL+ +YT ++D WS G + E + G F Q ++
Sbjct: 184 VGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EK 239
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+ E I + +F + P H + + +L + R T +
Sbjct: 240 SNEHIVVYDDLTGAVKFSSVLPTPNH--LSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297
Query: 237 HPFFDELREPNAR 249
F L +
Sbjct: 298 VGCFQALDSILSL 310
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 61/272 (22%), Positives = 103/272 (37%), Gaps = 49/272 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
+R + HPN+I+L + ++ ++ L ++E V E + + S
Sbjct: 69 LRQVLHPNIITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE------- 116
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEAN 113
+ QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G
Sbjct: 117 ATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174
Query: 114 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
I + + APE I D+WS G + LL G F G+ + L I V
Sbjct: 175 FKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
+ F + + A D +LL R T
Sbjct: 234 -----------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQ 268
Query: 233 EACAHPFFDELREPNARLPNGRPLPPLFNFKQ 264
EA HP+ + + + L NFK+
Sbjct: 269 EALRHPWITP-VDTQQAMVRRESVVNLENFKK 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 65/247 (26%), Positives = 99/247 (40%), Gaps = 47/247 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
R + HPN++ L + E F LV + V E ++ YS A+
Sbjct: 59 CRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----- 108
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEANI 114
QI +AY H+ + HR+LKP+NLL+ VK+ DFG A ++ EA
Sbjct: 109 --HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-W 164
Query: 115 SYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
+ Y +PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 165 HGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG- 222
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
+ +P + W V PEA L +L +P R TA +
Sbjct: 223 ----------------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQ 258
Query: 234 ACAHPFF 240
A P+
Sbjct: 259 ALKVPWI 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 46/270 (17%), Positives = 86/270 (31%), Gaps = 52/270 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ +I ++ + FL M+ ++ VL +SS ++ +
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
T Q+ R LA +H + H L+P ++++D V + F G + +S R
Sbjct: 217 TLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLV--RDGASAVS-PIGR 271
Query: 121 FYRAPELI---------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
+ PE T T + D W+ G + + + A+
Sbjct: 272 GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----- 326
Query: 172 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRC 229
+F K +P L L+Y R
Sbjct: 327 ------------------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRL 356
Query: 230 TALEACAHPFFDELRE-PNARLPNGRPLPP 258
L+A P +++LR +A LP +
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 67/269 (24%), Positives = 105/269 (39%), Gaps = 46/269 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
R++ HPN++ L E L+ + V E ++ +YS A
Sbjct: 64 CRLLKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------D 111
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANI 114
QI + + H + V HR+LKP+NLL L VK+ DFG A ++ +
Sbjct: 112 ASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 115 SYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
+ Y +PE + Y +D+W+ G +L LL+G P F E+ +I
Sbjct: 171 FGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA-- 227
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
+ FP + W V PEA DL +++L +PS R TA E
Sbjct: 228 ---------------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAE 264
Query: 234 ACAHPFFDELREPNARLPNGRPLPPLFNF 262
A HP+ + + + L F
Sbjct: 265 ALKHPWISHRSTVASCMHRQETVDCLKKF 293
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 61/272 (22%), Positives = 106/272 (38%), Gaps = 49/272 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
++ + HPNVI+L + +K ++ L ++E V E + + +
Sbjct: 68 LKEIQHPNVITLHEVY---ENKTDVIL--ILELVAGGELFDFLAEKESLTEEE------- 115
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEAN 113
+ QI G+ Y+H++ ++ H DLKP+N+++ + ++KI DFG A ++ G
Sbjct: 116 ATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 114 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
I + + APE I D+WS G + LL G F G+ + L + V
Sbjct: 174 FKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232
NY +F + A D RLL P R T
Sbjct: 233 --------------NY-EFEDE-----YFSNT-----SALAKDFIRRLLVKDPKKRMTIQ 267
Query: 233 EACAHPFFDELREPNARLPNGRPLPPLFNFKQ 264
++ HP+ ++ L + FK+
Sbjct: 268 DSLQHPWIKP-KDTQQALSRKASAVNMEKFKK 298
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 50/250 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
+V HP++I+L + S++ F+ LV + + E + + S R
Sbjct: 154 RQVAGHPHIITLIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEKETR----- 203
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
+ ++++H + HRDLKP+N+L+D Q+++ DFG + L GE +
Sbjct: 204 --SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEK-LRE 258
Query: 117 IC-SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+C + Y APE++ + + Y +D+W+ G +L LL G P F + L I+
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
+ ++F + W DL SRLLQ P R T
Sbjct: 319 EG-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLT 353
Query: 231 ALEACAHPFF 240
A +A HPFF
Sbjct: 354 AEQALQHPFF 363
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 38/271 (14%), Positives = 72/271 (26%), Gaps = 73/271 (26%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ H +V+ + + + EY S+ + +K
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------------------LTHQVKICDF 101
Q+ RGL YIH+ + H D+KP N+ + KI D
Sbjct: 120 LLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 102 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161
G ++ + + A E++ + DI++ + +PL
Sbjct: 179 GHVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN-- 233
Query: 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP-------EAI 214
WH++ R+P E
Sbjct: 234 ------------------------------------GDQWHEIRQGRLPRIPQVLSQEFT 257
Query: 215 DLASRLLQYSPSLRCTALEACAHPFFDELRE 245
+L ++ P R +A+ H
Sbjct: 258 ELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-34
Identities = 63/291 (21%), Positives = 95/291 (32%), Gaps = 59/291 (20%)
Query: 2 RVMDHPNVISLKHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY 56
++ HPN++ S T + E L + E + LK + +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLL--LTELCKGQLVEFLKK-MESRGPLSCDT 137
Query: 57 VKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG----- 110
V YQ R + ++H P + HRDLK +NLL+ +K+CDFGSA +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSW 196
Query: 111 --------EANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160
E I+ + YR PE+I + DIW+ GC+L L Q F
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
Query: 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 220
+ R +N Y P H L +
Sbjct: 257 AKL------------------RIVNGKY---SIPP----------HDTQYTVFHSLIRAM 285
Query: 221 LQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASP 271
LQ +P R + E E+ P P+ L A+
Sbjct: 286 LQVNPEERLSIAEVVHQLQ--EIAAARNVNPK-SPITELLEQNGGYGSATL 333
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 63/249 (25%), Positives = 98/249 (39%), Gaps = 46/249 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
+R HPN+I+LK + + ++ +V E + E + ++L+ +S
Sbjct: 70 LRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---- 120
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEAN 113
+ I + + Y+H V HRDLKP N+L ++ICDFG AKQL A
Sbjct: 121 ---VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 114 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
+ C + + APE + Y + DIWS G +L +L G F + ++
Sbjct: 177 LMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235
Query: 173 L-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231
G F W+ V A DL S++L P R TA
Sbjct: 236 GSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTA 272
Query: 232 LEACAHPFF 240
HP+
Sbjct: 273 ALVLRHPWI 281
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 61/296 (20%), Positives = 110/296 (37%), Gaps = 43/296 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
M V+ HP +++L F + ++ E++ E +V ++ ++ + Y++
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 262
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYI 117
Q+ +GL ++H H DLKP+N++ ++++K+ DFG L ++
Sbjct: 263 ----QVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ + APE+ G D+WS G + LL G F GEN + T
Sbjct: 318 GTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------T 364
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
++ + N D F I + D +LL P+ R T +A H
Sbjct: 365 LRNVKSCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEH 411
Query: 238 PFFDELREPNARLPNGR-PLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLH 292
P+ L NA + + P + + L P H
Sbjct: 412 PW---LTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 464
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 64/270 (23%), Positives = 105/270 (38%), Gaps = 43/270 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R + H NVI L ++ K ++++ VMEY M +L +R P+ Y
Sbjct: 60 LRRLRHKNVIQLVDVLYNEE-KQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGY 114
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC- 118
Q+ GL Y+H+ + H+D+KP NLL+ +KI G + +
Sbjct: 115 FCQLIDGLEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 119 -SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
S ++ PE+ G ++ +DIWSAG L + G F G+N + +L E I
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIG----- 226
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+ P P DL +L+Y P+ R + +
Sbjct: 227 -----------KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 237 HPFFDELREPNARLPNGRPLPPLFNFKQEL 266
H +F + P P+PP + K
Sbjct: 264 HSWFRKKHPPAEAPV---PIPPSPDTKDRW 290
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 43/276 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPL 54
+ P+++ + + + L ++ME + R + ++
Sbjct: 76 WQASGGPHIVCILD-VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER------ 128
Query: 55 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA 112
I + ++H+ + HRD+KP+NLL +K+ DFG AK+
Sbjct: 129 -EAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185
Query: 113 NISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
+ C + +Y APE + G +Y S D+WS G ++ LL G P F + +
Sbjct: 186 -LQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243
Query: 172 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231
R Y F P W +V +A L LL+ P+ R T
Sbjct: 244 ----------RIRLGQY-GFPNP-----EWSEV-----SEDAKQLIRLLLKTDPTERLTI 282
Query: 232 LEACAHPFFDELRE-PNARLPNGRPLPPLFNFKQEL 266
+ HP+ ++ P L R L + E+
Sbjct: 283 TQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEV 318
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 47/253 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK---HYSSANQRMPLI 55
+ + H N++ L F S EL + + E++ + R+ +
Sbjct: 55 LNIARHRNILHLHESF---ESMEELVM--IFEFISGLDIFERINTSAFELNERE------ 103
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANI 114
+ Y +Q+ L ++H+ + H D++P+N++ + +KI +FG A+QL G+ N
Sbjct: 104 -IVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NF 160
Query: 115 SYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
+ + Y APE + +T+ D+WS G ++ LL G F E +Q +II
Sbjct: 161 RLLFTAPEYYAPE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--- 212
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
E I + + F +I EA+D RLL R TA E
Sbjct: 213 -----ENIMNAEYTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASE 254
Query: 234 ACAHPFFDELREP 246
A HP+ + E
Sbjct: 255 ALQHPWLKQKIER 267
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 61/257 (23%), Positives = 103/257 (40%), Gaps = 48/257 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
++ + H N+++L+ + S +L VM+ V E R+L+ Y+ +
Sbjct: 60 LKKIKHENIVTLEDIY---ESTTHYYL--VMQLVSGGELFDRILERGVYTEKDAS----- 109
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANI 114
L Q+ + Y+H + HRDLKP+NLL ++ I DFG +K + +
Sbjct: 110 --LVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIM 164
Query: 115 SYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
S C + Y APE + Y+ ++D WS G + LL G P F E +I +
Sbjct: 165 STACGTPGYVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG- 222
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
+ F + W + A D LL+ P+ R T +
Sbjct: 223 ----------------YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEK 258
Query: 234 ACAHPFFDELREPNARL 250
A +HP+ D + +
Sbjct: 259 ALSHPWIDGNTALHRDI 275
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-33
Identities = 56/245 (22%), Positives = 97/245 (39%), Gaps = 43/245 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ +DHPNV+ L +++ L++ V E V M + + +
Sbjct: 90 LKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGPVMEVP------TLKPLSEDQAR 140
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y + +G+ Y+H ++ HRD+KP NLLV +KI DFG + + +A +S
Sbjct: 141 FYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 119 -SRFYRAPELIFGAT-EYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
+ + APE + ++ ++D+W+ G L + GQ F E + L IK
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLHSKIK---- 253
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
FP + + DL +R+L +P R E
Sbjct: 254 ------------SQALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
Query: 236 AHPFF 240
HP+
Sbjct: 292 LHPWV 296
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 67/256 (26%), Positives = 110/256 (42%), Gaps = 41/256 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
M +DH N+I L F SKN++ L VMEYV E R++ + + ++++K
Sbjct: 140 MNQLDHANLIQLYDAF---ESKNDIVL--VMEYVDGGELFDRIIDESYNLTELDTILFMK 194
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYI 117
QI G+ ++H + + H DLKP+N+L V+ Q+KI DFG A++ E +
Sbjct: 195 ----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVN 248
Query: 118 C-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ + APE + + D+WS G + LL G F G+N + L I+
Sbjct: 249 FGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC---- 303
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+ D + + EA + S+LL S R +A EA
Sbjct: 304 ----------RW-DLEDE-----EFQDI-----SEEAKEFISKLLIKEKSWRISASEALK 342
Query: 237 HPFFDELREPNARLPN 252
HP+ + + +
Sbjct: 343 HPWLSDHKLHSRLSAQ 358
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 66/263 (25%), Positives = 104/263 (39%), Gaps = 40/263 (15%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 57
HPN++ L F ++L LVME + E R+ K H+S
Sbjct: 61 LCEGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY----- 110
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANIS 115
++ ++++H V V HRDLKP+NLL D + ++KI DFG A+ +
Sbjct: 111 --IMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 116 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
C + Y APE + Y S D+WS G +L +L GQ F + ++++
Sbjct: 168 TPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM- 225
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
++I+ DF F W V EA DL LL P+ R
Sbjct: 226 ----KKIKKG-----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGL 268
Query: 235 CAHPFFDELRE-PNARLPNGRPL 256
+ + + + + L L
Sbjct: 269 RYNEWLQDGSQLSSNPLMTPDIL 291
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 61/278 (21%), Positives = 106/278 (38%), Gaps = 46/278 (16%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
+ ++SL + F T + L LVM + + Y + + N YT
Sbjct: 242 VHSRFIVSLAYAF-ETKTD----LCLVMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYT 295
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 120
QI GL ++H + +RDLKP+N+L+D + V+I D G A +L AG+ +
Sbjct: 296 AQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+ APEL+ G EY S+D ++ G L E++ + F +E
Sbjct: 354 GFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE------------KVENKE 400
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEAC 235
+ ++ + + P + D LLQ P R +
Sbjct: 401 L-----------KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447
Query: 236 AHPFFDELREPN-ARLPNGRPLPPLFNFKQELSGASPE 272
HP F ++ + +L G PP + + + +
Sbjct: 448 THPLFRDI---SWRQLEAGMLTPPFVPDSRTVYAKNIQ 482
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-32
Identities = 74/290 (25%), Positives = 117/290 (40%), Gaps = 59/290 (20%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
++ V+SL + + T L LV+ + + + + Y P Y
Sbjct: 241 VNSRFVVSLAYAY-ETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYA 292
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
+I GL +H R+ +RDLKP+N+L+D H ++I D G A + G+ + +
Sbjct: 293 AEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 122 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 181
Y APE++ YT S D W+ GC+L E++ GQ F REE+
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK------------KIKREEV 397
Query: 182 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 236
+K P + + +R P+A L S+LL P+ R +A E
Sbjct: 398 -----------ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 237 HPFFDELREPN-ARLPNGRPLPP------------LFNFKQELSGASPEL 273
HP F +L N RL G PP + + +Q + EL
Sbjct: 445 HPLFKKL---NFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVEL 491
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 57/247 (23%), Positives = 94/247 (38%), Gaps = 41/247 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPL 54
R P+++ + + L +VME + R + ++
Sbjct: 109 WRASQCPHIVRI-VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER------ 161
Query: 55 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGE 111
I + Y+H++ + HRD+KP+NLL P +K+ DFG AK+ +
Sbjct: 162 -EASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTSHN 218
Query: 112 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
+ + + +Y APE + G +Y S D+WS G ++ LL G P F + + +
Sbjct: 219 SLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
Query: 172 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231
R Y +F P W +V E L LL+ P+ R T
Sbjct: 278 ----------RIRMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTI 316
Query: 232 LEACAHP 238
E HP
Sbjct: 317 TEFMNHP 323
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 64/254 (25%), Positives = 98/254 (38%), Gaps = 33/254 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKL 59
MR D P ++ F + ME + S + K+ YS + +P +
Sbjct: 75 MRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
T + L ++ ++ HRD+KP N+L+D + +K+CDFG + QL+ A
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 120 RFYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
R Y APE I + Y D+WS G L EL G+ +P N+V + + V G P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP 247
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
PQ+ + F P I+ + L S R E
Sbjct: 248 -----------------PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLK 285
Query: 237 HPFFDELREPNARL 250
HPF E +
Sbjct: 286 HPFILMYEERAVEV 299
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 68/245 (27%), Positives = 100/245 (40%), Gaps = 46/245 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIY 56
+ + HPN+I LK F + E+ L V+E V E R+++ +YS +
Sbjct: 102 LLRLSHPNIIKLKEIF---ETPTEISL--VLELVTGGELFDRIVEKGYYSERDAA----- 151
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANI 114
QI +AY+H + HRDLKP+NLL P +KI DFG +K + +
Sbjct: 152 --DAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-M 207
Query: 115 SYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
+C + Y APE I Y +D+WS G + LL G F E + I
Sbjct: 208 KTVCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL-- 264
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
C ++ F + W +V A DL +L+ P R T +
Sbjct: 265 --------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQ 302
Query: 234 ACAHP 238
A HP
Sbjct: 303 ALQHP 307
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 58/261 (22%), Positives = 99/261 (37%), Gaps = 50/261 (19%)
Query: 1 MRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMP 53
+ + P VI+L + + +E+ L ++EY + + + S +
Sbjct: 82 LELAKSCPRVINLHEVY---ENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSEND---- 132
Query: 54 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQLIAGE 111
V QI G+ Y+H + H DLKPQN+L+ + +KI DFG ++++
Sbjct: 133 ---VIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 112 ANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ I + Y APE I TT+ D+W+ G + LL F GE+ + + I
Sbjct: 189 E-LREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
+V + + + V A D LL +P R T
Sbjct: 247 QV-----------------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPT 281
Query: 231 ALEACAHPFFDELREPNARLP 251
A +H + + N P
Sbjct: 282 AEICLSHSWLQQWDFENLFHP 302
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 68/245 (27%), Positives = 105/245 (42%), Gaps = 49/245 (20%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
HP + +LK+ F T + L VMEY E + + S + + Y
Sbjct: 205 SRHPFLTALKYSF-QTHDR----LCFVMEYANGGELFFHL-----SRERVFSEDRARFYG 254
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 120
+I L Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C +
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y APE++ +Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 314 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL--------- 362
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEAC 235
+ RFP + + PEA L S LL+ P R A E
Sbjct: 363 -------MEEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM 403
Query: 236 AHPFF 240
H FF
Sbjct: 404 QHRFF 408
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 62/280 (22%), Positives = 101/280 (36%), Gaps = 72/280 (25%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
+V E + + + + + Q +PL VK Q+ +GL Y+HT R+ H D+KP+N+L
Sbjct: 122 MVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 89 V------------------------------------------------DPLTHQVKICD 100
+ + +VKI D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 101 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160
G+A + I +R YR+ E++ G+ Y T DIWS C+ EL G LF
Sbjct: 240 LGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 161 NA------VDQLVEIIKVLGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHK 207
+ D + II++LG R+ I ++K +V +
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 208 RMP------PEAIDLASRLLQYSPSLRCTALEACAHPFFD 241
+ D +L+ P R TA E HP+ +
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 67/265 (25%), Positives = 109/265 (41%), Gaps = 47/265 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
M++++HPN++ L ++ L+L +MEY E + Y A+ RM +
Sbjct: 68 MKILNHPNIVKLFEVI---ETEKTLYL--IMEYASGGE-----VFDYLVAHGRMKEKEAR 117
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI + Y H R+ HRDLK +NLL+D +KI DFG + + G + C
Sbjct: 118 SKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK-LDAFC 174
Query: 119 -SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ Y APEL G +Y +D+WS G +L L+ G F G+N + +L E +
Sbjct: 175 GAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL----- 227
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
+R P + M + +L R L +P R T +
Sbjct: 228 -----------RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMK 264
Query: 237 HPFFDELREPNARLPNGRPLPPLFN 261
+ + E + P P + +
Sbjct: 265 DRWINAGHEEDELKPFVEPELDISD 289
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 61/244 (25%), Positives = 97/244 (39%), Gaps = 39/244 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
R + HPN++ K + L + +MEY E L R +
Sbjct: 70 HRSLRHPNIVRFKEVI---LTPTHLAI--IMEYASGGE-----LYERICNAGRFSEDEAR 119
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYI 117
+ Q+ G++Y H++ ++CHRDLK +N L+D ++KICDFG +K + S +
Sbjct: 120 FFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 118 CSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ Y APE++ EY D+WS G L +L+G F
Sbjct: 179 GTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRK 229
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
T + I + + P R+ PE L SR+ P+ R + E
Sbjct: 230 TIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKT 274
Query: 237 HPFF 240
H +F
Sbjct: 275 HSWF 278
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 61/263 (23%), Positives = 91/263 (34%), Gaps = 53/263 (20%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 57
+ H NV+ L F + E LV E + + + K H++ +
Sbjct: 66 QCQGHRNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV----- 115
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEA 112
+ L ++H + HRDLKP+N+L H VKICDF +
Sbjct: 116 --VVQDVASALDFLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 113 NISYICSR--------FYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160
Y APE++ A+ Y D+WS G +L LL G P F G
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229
Query: 161 NAVDQLVEIIKVLGTPTR---EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 217
D + + E I+ + FP W + A DL
Sbjct: 230 CGSDCGWDRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLI 276
Query: 218 SRLLQYSPSLRCTALEACAHPFF 240
S+LL R +A + HP+
Sbjct: 277 SKLLVRDAKQRLSAAQVLQHPWV 299
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-30
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 47/247 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++++H NV+ N +L +EY E L + MP +
Sbjct: 59 NKMLNHENVVKFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQ 108
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISY 116
+ +Q+ G+ Y+H + + HRD+KP+NLL+D +KI DFG A ++
Sbjct: 109 RFFHQLMAGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNK 166
Query: 117 IC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVL 173
+C + Y APEL+ E+ +D+WS G VL +L G+ P ++ + + +
Sbjct: 167 MCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-- 223
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
PW K + + L ++L +PS R T +
Sbjct: 224 ---------------KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPD 258
Query: 234 ACAHPFF 240
++
Sbjct: 259 IKKDRWY 265
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-30
Identities = 67/244 (27%), Positives = 95/244 (38%), Gaps = 47/244 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
+++ HP++I L ++ + F+ VMEYV E L Y + R+ + +
Sbjct: 65 LKLFRHPHIIKLYQVI---STPTDFFM--VMEYVSGGE-----LFDYICKHGRVEEMEAR 114
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYI 117
QI + Y H V HRDLKP+N+L+D KI DFG S S
Sbjct: 115 RLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLRTS-- 170
Query: 118 C-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
C S Y APE+I G +DIWS G +L LL G F E+ V L + I+
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIR----- 224
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
F P + + L +LQ P R T +
Sbjct: 225 -----------GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKDIRE 261
Query: 237 HPFF 240
H +F
Sbjct: 262 HEWF 265
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-30
Identities = 65/245 (26%), Positives = 106/245 (43%), Gaps = 50/245 (20%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
HP + +LK+ F T + L VMEY E + + + + + Y
Sbjct: 62 TRHPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRE-----RVFTEERARFYG 111
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 120
+I L Y+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C +
Sbjct: 112 AEIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTP 169
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y APE++ +Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 170 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL--------- 218
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEAC 235
+ RFP + + PEA L + LL+ P R A E
Sbjct: 219 -------MEEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 236 AHPFF 240
H FF
Sbjct: 260 EHRFF 264
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 58/246 (23%), Positives = 94/246 (38%), Gaps = 46/246 (18%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTY 62
D P ++ + + F + ++L +++ + + Y + +H ++ Y
Sbjct: 250 DCPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAA 299
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 122
+I GL ++H V +RDLKP N+L+D H V+I D G A + + + + + Y
Sbjct: 300 EIILGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGY 356
Query: 123 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 182
APE++ Y +S D +S GC+L +LL G F D + EI
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI- 402
Query: 183 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAH 237
PE L LLQ + R C A E
Sbjct: 403 ----------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450
Query: 238 PFFDEL 243
PFF L
Sbjct: 451 PFFRSL 456
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-30
Identities = 52/255 (20%), Positives = 85/255 (33%), Gaps = 40/255 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ D P ++ F + T + + ME + K +P +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTD-----VFIAMELMGTC---AEKLKKRMQGPIPERILGKM 129
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
T I + L Y+ V HRD+KP N+L+D Q+K+CDFG + +L+ +A
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCA 188
Query: 121 FYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGT 175
Y APE I +Y D+WS G L EL GQ + + L ++++
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EE 246
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
P P + H + L R +
Sbjct: 247 P-----------------PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
Query: 236 AHPFFDELREPNARL 250
H F +
Sbjct: 283 EHSFIKRYETLEVDV 297
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-30
Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 45/263 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++++H NV+ N +L +EY E L + MP +
Sbjct: 59 NKMLNHENVVKFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQ 108
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISY 116
+ +Q+ G+ Y+H + + HRD+KP+NLL+D +KI DFG A ++
Sbjct: 109 RFFHQLMAGVVYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNK 166
Query: 117 IC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+C + Y APEL+ E+ +D+WS G VL +L G+ + DQ + +
Sbjct: 167 MCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYS 219
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
++ PW K + + L ++L +PS R T +
Sbjct: 220 DWKEKKTYLN---------------PWKK-----IDSAPLALLHKILVENPSARITIPDI 259
Query: 235 CAHPFFDELREPNARLPNGRPLP 257
++++ + A+ P
Sbjct: 260 KKDRWYNKPLKKGAKRPRVTSGG 282
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 44/242 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++++ HP++I L T+ ++ + V+EY ++ Y +RM + +
Sbjct: 63 LKLLRHPHIIKLYDVI---TTPTDIVM--VIEYAGGELF----DYIVEKKRMTEDEGRRF 113
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC- 118
QI + Y H ++ HRDLKP+NLL+D VKI DFG S S C
Sbjct: 114 FQQIICAIEYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTS--CG 169
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
S Y APE+I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN------- 221
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ P + + P A L R++ P R T E P
Sbjct: 222 ---------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDP 260
Query: 239 FF 240
+F
Sbjct: 261 WF 262
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 62/253 (24%), Positives = 99/253 (39%), Gaps = 57/253 (22%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
+DHP + L F +++ L + Y E L Y + YT
Sbjct: 87 LDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYT 136
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
+I L Y+H + HRDLKP+N+L++ H ++I DFG+AK L + F
Sbjct: 137 AEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQAR--ANSF 192
Query: 122 -----YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
Y +PEL+ S D+W+ GC++ +L+ G P F N + + I
Sbjct: 193 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----- 245
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ 230
++ FP ++ P+A DL +LL + R
Sbjct: 246 -----------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEG 282
Query: 231 ALEACAHPFFDEL 243
AHPFF+ +
Sbjct: 283 YGPLKAHPFFESV 295
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 46/243 (18%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL 59
+HP + + F T L VMEY+ + MY + + L
Sbjct: 73 LAWEHPFLTHMFCTF-QTKEN----LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATF 122
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y +I GL ++H+ + +RDLK N+L+D H +KI DFG K+ + G+A + C
Sbjct: 123 YAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCG 180
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ G +Y S+D WS G +L E+L+GQ F G++ ++L I+
Sbjct: 181 TPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR------- 231
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAH 237
+ +P + + EA DL +L P R H
Sbjct: 232 ---------MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270
Query: 238 PFF 240
P F
Sbjct: 271 PLF 273
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 48/243 (19%), Positives = 94/243 (38%), Gaps = 48/243 (19%)
Query: 15 CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 73
S +++L + M+ E++ + S R + + ++ QI + ++H+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS 182
Query: 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------AGEANISYICSR 120
+ HRDLKP N+ VK+ DFG + A + + ++
Sbjct: 183 -KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y +PE I G Y+ +DI+S G +L ELL E ++++ +
Sbjct: 241 LYMSPEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM-------ERVRII-----TD 285
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
+R + +FP + + P+ + +L SP+ R A + + F
Sbjct: 286 VR-------NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIF 329
Query: 241 DEL 243
+ L
Sbjct: 330 ENL 332
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 63/266 (23%), Positives = 98/266 (36%), Gaps = 60/266 (22%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
+ D + L F +N L+L VMEY + + S +R+P +
Sbjct: 115 LVNGDRRWITQLHFAF---QDENYLYL--VMEYYVGGDLLT----LLSKFGERIPAEMAR 165
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y +I + +H + HRD+KP N+L+D H +++ DFGS +L A S +
Sbjct: 166 FYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLV- 222
Query: 119 SRF-----YRAPELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 167
Y +PE++ G Y D W+ G E+ GQ F ++ +
Sbjct: 223 --AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETY 279
Query: 168 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227
I ++ P + +P EA D RLL P
Sbjct: 280 GKI-------------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPET 315
Query: 228 R---CTALEACAHPFF-----DELRE 245
R A + HPFF D LR+
Sbjct: 316 RLGRGGAGDFRTHPFFFGLDWDGLRD 341
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 58/249 (23%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
+ HP ++ L + F T K L L++EY+ E ++ + Y
Sbjct: 78 VKHPFIVDLIYAF-QTGGK----LYLILEYLSGGELFMQLERE-----GIFMEDTACFYL 127
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 121
+I L ++H + +RDLKP+N++++ H VK+ DFG K+ I F
Sbjct: 128 AEISMALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTV----THTF 181
Query: 122 -----YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
Y APE++ + + ++D WS G ++ ++L G P F GEN + ++ I
Sbjct: 182 CGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------ 233
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTA 231
+ ++ P + EA DL +LL+ + + R A
Sbjct: 234 LKCKL----------NLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDA 271
Query: 232 LEACAHPFF 240
E AHPFF
Sbjct: 272 GEVQAHPFF 280
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 60/248 (24%), Positives = 97/248 (39%), Gaps = 51/248 (20%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL 59
+HP + L CF + + LF VME+V + M+ + K +R +
Sbjct: 79 LARNHPFLTQLFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARF 128
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y +I L ++H + +RDLK N+L+D H K+ DFG K+ I + C
Sbjct: 129 YAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCG 186
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ Y ++D W+ G +L E+L G F EN D L E I
Sbjct: 187 TPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL------- 237
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTAL 232
+ +P + +A + + +P++R
Sbjct: 238 ---------NDEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEH 276
Query: 233 EACAHPFF 240
HPFF
Sbjct: 277 AILRHPFF 284
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 65/247 (26%), Positives = 97/247 (39%), Gaps = 50/247 (20%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL 59
P + L CF T + L VMEYV + MY + + R +
Sbjct: 76 LPGKPPFLTQLHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVF 125
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y +I GL ++ + + +RDLK N+++D H +KI DFG K+ I C
Sbjct: 126 YAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCG 183
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE+I Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 184 TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM------- 234
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALE 233
+ +P K M EA+ + L+ P R +
Sbjct: 235 ---------EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
Query: 234 ACAHPFF 240
H FF
Sbjct: 274 IKEHAFF 280
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 54/263 (20%), Positives = 91/263 (34%), Gaps = 51/263 (19%)
Query: 1 MRVMDH--PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 58
++ + VI L F + L ++E L + + + +
Sbjct: 100 LKKVSSGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELAR 152
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+ +Q+ + + H V HRD+K +N+L+D ++K+ DFGS L +
Sbjct: 153 SFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD 209
Query: 119 -SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+R Y PE I Y S +WS G +L +++ G F + EII+
Sbjct: 210 GTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR----- 257
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
F +R+ E L L PS R T E
Sbjct: 258 ------------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
Query: 237 HPFFDELREPNARLP-NGRPLPP 258
HP+ ++ P + L P
Sbjct: 294 HPWMQDVLLPQETAEIHLHSLSP 316
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-28
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 50/245 (20%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 61
++HP ++ L + F T K L L+++++ + R+ K VK Y
Sbjct: 83 VNHPFIVKLHYAF-QTEGK----LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYL 132
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 120
++ L ++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C +
Sbjct: 133 AELALALDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y APE++ +T S D WS G ++ E+L G F G++ + + +I
Sbjct: 191 EYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL--------- 239
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEAC 235
PQ + PEA L L + +P+ R E
Sbjct: 240 -------KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK 280
Query: 236 AHPFF 240
H FF
Sbjct: 281 RHSFF 285
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 55/253 (21%), Positives = 86/253 (33%), Gaps = 74/253 (29%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
R P+++ + + L +VME + E R+ A
Sbjct: 65 WRASQCPHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---------- 113
Query: 59 LYT--------YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAK 105
+T I + Y+H++ + HRD+KP+NLL T + +K+ DFG AK
Sbjct: 114 -FTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFGFAK 168
Query: 106 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 165
+ + Y S D+WS G ++ LL G P F + +
Sbjct: 169 ETTGEK----------------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206
Query: 166 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225
+ R Y +F P W +V E L LL+ P
Sbjct: 207 SPGMKT----------RIRMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEP 245
Query: 226 SLRCTALEACAHP 238
+ R T E HP
Sbjct: 246 TQRMTITEFMNHP 258
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 70/244 (28%), Positives = 99/244 (40%), Gaps = 47/244 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
+++ HP++I L ++ +++F+ VMEYV E L Y N R+ +
Sbjct: 70 LKLFRHPHIIKLYQVI---STPSDIFM--VMEYVSGGE-----LFDYICKNGRLDEKESR 119
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYI 117
QI G+ Y H V HRDLKP+N+L+D KI DFG S S
Sbjct: 120 RLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLRTS-- 175
Query: 118 C-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
C S Y APE+I G +DIWS+G +L LL G F ++ V L + I
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC----- 229
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
F P + + P I L +LQ P R T +
Sbjct: 230 -----------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKDIRE 266
Query: 237 HPFF 240
H +F
Sbjct: 267 HEWF 270
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-28
Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 49/246 (19%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL 59
+ + HP ++ L F T K L V++Y+ E Y + + + +
Sbjct: 94 KNVKHPFLVGLHFSF-QTADK----LYFVLDYINGGELFYHLQRE-----RCFLEPRARF 143
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y +I L Y+H++ + +RDLKP+N+L+D H + + DFG K+ I + S C
Sbjct: 144 YAAEIASALGYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCG 201
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ Y ++D W G VL E+L G P F N ++ + I
Sbjct: 202 TPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL------- 252
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----CTALEA 234
+ + A L LLQ + R +E
Sbjct: 253 ---------NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291
Query: 235 CAHPFF 240
+H FF
Sbjct: 292 KSHVFF 297
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 61/264 (23%), Positives = 101/264 (38%), Gaps = 58/264 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
+ D + +L + F +++ L LVM+Y + + S R+P +
Sbjct: 128 LVNGDSKWITTLHYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMAR 178
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y ++ + +H + HRD+KP N+L+D H +++ DFGS +L+ S +
Sbjct: 179 FYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSV- 235
Query: 119 SRF-----YRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 169
Y +PE++ G Y D WS G + E+L G+ F E+ + +
Sbjct: 236 --AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGK 292
Query: 170 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229
I MN F+FP + A DL RL+ S R
Sbjct: 293 I-------------MNHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRL 328
Query: 230 T---ALEACAHPFF-----DELRE 245
+ HPFF D +R
Sbjct: 329 GQNGIEDFKKHPFFSGIDWDNIRN 352
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 28/261 (10%), Positives = 74/261 (28%), Gaps = 57/261 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ + +N L V E + + + ++ + MP V
Sbjct: 121 LKPSMQHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----------VKICDFGSAKQLI 108
+ ++ + +H + H D+KP N ++ + + + D G + +
Sbjct: 176 SFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 109 AGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVD 164
+ + ++ E++ + ID + + +L G + E
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 165 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224
+ + + R P + W++ FH +L
Sbjct: 294 KPEGLFR--------------------RLPHL--DMWNEFFHV------------MLNIP 319
Query: 225 PSLRCTALEACAHPFFDELRE 245
+L+ ++
Sbjct: 320 DCHHLPSLDLLRQKLKKVFQQ 340
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-27
Identities = 65/247 (26%), Positives = 97/247 (39%), Gaps = 50/247 (20%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL 59
P + L CF T + L VMEYV + MY + + R +
Sbjct: 397 LPGKPPFLTQLHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVF 446
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y +I GL ++ + + +RDLK N+++D H +KI DFG K+ I C
Sbjct: 447 YAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCG 504
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE+I Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 505 TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------ME 556
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALE 233
+ +P K M EA+ + L+ P R +
Sbjct: 557 HNV----------AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 594
Query: 234 ACAHPFF 240
H FF
Sbjct: 595 IKEHAFF 601
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 53/252 (21%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL 59
+ P +++L + F T +K L+L+++Y+ E + + +R V++
Sbjct: 114 HIRQSPFLVTLHYAF-QTETK----LHLILDYINGGELFTHLSQR-----ERFTEHEVQI 163
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y +I L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E
Sbjct: 164 YVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETER---AY 218
Query: 120 RF-----YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 173
F Y AP+++ G + ++D WS G ++ ELL G F + + EI
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--- 275
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----- 228
I ++ +PQ M A DL RLL P R
Sbjct: 276 -----RRIL-----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGP 313
Query: 229 CTALEACAHPFF 240
A E H FF
Sbjct: 314 RDADEIKEHLFF 325
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 61/256 (23%), Positives = 100/256 (39%), Gaps = 55/256 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
M + P V+ L + F +++ +L +VMEY+P + + ++ N +P + +
Sbjct: 123 MAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWAR 171
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
YT ++ L IH++ HRD+KP N+L+D H +K+ DFG+ ++
Sbjct: 172 FYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDT- 228
Query: 119 SRF-----YRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
Y +PE++ G Y D WS G L E+L+G F ++ V
Sbjct: 229 --AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------ 280
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
T +I MN FP + EA +L L +R
Sbjct: 281 ------TYSKI--MNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLG 320
Query: 231 ---ALEACAHPFFDEL 243
E H FF
Sbjct: 321 RNGVEEIKRHLFFKND 336
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 42/248 (16%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL 59
+ +HP ++ L CF T S+ L V+EYV + M+ + + +++P + +
Sbjct: 65 QASNHPFLVGLHSCF-QTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARF 114
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y+ +I L Y+H + +RDLK N+L+D H +K+ D+G K+ + S C
Sbjct: 115 YSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ G +Y S+D W+ G ++ E++ G+ F + D + T
Sbjct: 173 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTE 224
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTAL 232
+ + F I + + +A + L P R
Sbjct: 225 DYL-----------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271
Query: 233 EACAHPFF 240
+ HPFF
Sbjct: 272 DIQGHPFF 279
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 54/250 (21%), Positives = 101/250 (40%), Gaps = 47/250 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
M+ ++HP +++L + F +F+ V++ + + Y + + N VK
Sbjct: 69 MQGLEHPFLVNLWYSF-QDEED--MFM--VVDLLLGGDLRYHLQQ-----NVHFKEETVK 118
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
L+ ++ L Y+ R+ HRD+KP N+L+D H V I DF A L +
Sbjct: 119 LFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAG 176
Query: 119 SRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLG 174
++ Y APE+ Y+ ++D WS G ELL G+ + ++ ++V +
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--- 233
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
T +P E + L +LL+ +P R + L
Sbjct: 234 -------------TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSD 268
Query: 235 -CAHPFFDEL 243
P+ +++
Sbjct: 269 VQNFPYMNDI 278
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 53/242 (21%), Positives = 91/242 (37%), Gaps = 48/242 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ ++H N+I + F +N+ F LVME + L + + R+
Sbjct: 83 LSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLD--LFAFIDRHPRLDEPLASYI 135
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 119
Q+ + Y+ + HRD+K +N+++ +K+ DFGSA L G+ C +
Sbjct: 136 FRQLVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGT 192
Query: 120 RFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
Y APE++ G Y +++WS G L L+ + F +L E ++
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
P + E + L S LLQ P R T + P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276
Query: 239 FF 240
+
Sbjct: 277 WV 278
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 59/248 (23%), Positives = 105/248 (42%), Gaps = 42/248 (16%)
Query: 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL 59
+ +HP ++ L CF T S+ L V+EYV + M+ + + +++P + +
Sbjct: 108 QASNHPFLVGLHSCF-QTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARF 157
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC- 118
Y+ +I L Y+H + +RDLK N+L+D H +K+ D+G K+ + S C
Sbjct: 158 YSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ G +Y S+D W+ G ++ E++ G+ F + D + T
Sbjct: 216 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTE 267
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC- 235
+ + F I + + +A + L P R C
Sbjct: 268 DYL-----------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA 314
Query: 236 ---AHPFF 240
HPFF
Sbjct: 315 DIQGHPFF 322
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 57/256 (22%), Positives = 90/256 (35%), Gaps = 48/256 (18%)
Query: 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 65
HP VI L +F T LV+E + L Y + + + + Q+
Sbjct: 97 HPGVIRL-LDWFETQEG----FMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFFGQVV 149
Query: 66 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRA 124
+ + H+ V HRD+K +N+L+D K+ DFGS L + +R Y
Sbjct: 150 AAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSP 206
Query: 125 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 183
PE I +Y +WS G +L +++ G F + EI++
Sbjct: 207 PEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA----------- 248
Query: 184 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 243
+ FP + P+ L R L PS R + E P+
Sbjct: 249 ------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290
Query: 244 REPNARLPNGRPLPPL 259
E P+ PL
Sbjct: 291 AEDVPLNPSKGGPAPL 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ ++HPN++ + + LVMEY S+Y VL H + +
Sbjct: 55 LSRVNHPNIVK----LYGACLNP---VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMS 106
Query: 60 YTYQIFRGLAYIH--TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
+ Q +G+AY+H + HRDLKP NLL+ +KICDFG+A + +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNK 164
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 168
S + APE+ G + Y+ D++S G +L E++ + F +
Sbjct: 165 GSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 53/251 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVK 58
++ ++ P ++ L+ F K+ L +VMEYV E + + R + +
Sbjct: 95 LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHAR 144
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
Y QI Y+H++ + +RDLKP+NLL+D + +++ DFG AK++ + +C
Sbjct: 145 FYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLC 199
Query: 119 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ APE+I Y ++D W+ G ++ E+ G P F + Q+ E I
Sbjct: 200 GTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV------ 251
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----- 232
RFP + DL LLQ + R L
Sbjct: 252 ----------SGKVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 233 EACAHPFFDEL 243
+ H +F
Sbjct: 290 DIKNHKWFATT 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 37/166 (22%), Positives = 64/166 (38%), Gaps = 19/166 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M ++HPN++ + +VME+VP +Y L +
Sbjct: 77 MSNLNHPNIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLR 126
Query: 60 YTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANI 114
I G+ Y+ P + HRDL+ N+ + K+ DFG ++ + +
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVS 184
Query: 115 SYICSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 159
+ + + APE I E YT D +S +L +L G+ F
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ HPN+I+L+ N L LVME+ + RVL +R+P +
Sbjct: 60 FAMLKHPNIIALRGV--CLKEPN---LCLVMEFARGGPLNRVLS-----GKRIPPDILVN 109
Query: 60 YTYQIFRGLAYIH--TVPRVCHRDLKPQNLLVD-------PLTHQVKICDFGSAKQLIAG 110
+ QI RG+ Y+H + + HRDLK N+L+ +KI DFG A+
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHR 168
Query: 111 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159
+S + + APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 11/162 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ + HPN++ + T L + V EY+ S+YR+L H S A +++
Sbjct: 88 MKRLRHPNIVLFMG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLS 141
Query: 60 YTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYI 117
Y + +G+ Y+H P + HR+LK NLLVD + VK+CDFG ++ + + S
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159
+ + APE++ D++S G +L EL Q +
Sbjct: 201 GTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-24
Identities = 65/254 (25%), Positives = 100/254 (39%), Gaps = 67/254 (26%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTY 62
HP +I + F ++ + ++M+Y+ E + K +QR P K Y
Sbjct: 64 THPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAA 113
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--------EANI 114
++ L Y+H+ + +RDLKP+N+L+D H +KI DFG AK + +
Sbjct: 114 EVCLALEYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--- 168
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
Y APE++ Y SID WS G ++ E+L G F N + E I
Sbjct: 169 -------YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL--- 216
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-- 232
+ RFP + DL SRL+ S R L
Sbjct: 217 -------------NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQN 251
Query: 233 ---EACAHPFFDEL 243
+ HP+F E+
Sbjct: 252 GTEDVKNHPWFKEV 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-24
Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 17/176 (9%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+R H N++ F ++ +L + V ++ S+Y L ++ + + +
Sbjct: 74 LRKTRHVNILL----FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLID 124
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Q RG+ Y+H + HRDLK N+ + + VKI DFG A + + +
Sbjct: 125 IARQTARGMDYLHA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 120 RF---YRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ APE+I Y+ D+++ G VL EL+ GQ + N DQ++E++
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 4e-23
Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 29/171 (16%)
Query: 1 MRVMDHPNVIS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYV 57
+M H N++ + T S +L+L + +Y S+Y LK + A + L Y
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY- 141
Query: 58 KLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 110
GL ++HT P + HRDLK +N+LV I D G A + I+
Sbjct: 142 -----SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISD 195
Query: 111 EANISYICS-----RFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 151
+ + + Y PE++ + + D++S G +L E+
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-23
Identities = 33/163 (20%), Positives = 64/163 (39%), Gaps = 14/163 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+R+ HPNV+ + S L+ ++P S+Y VL + N +
Sbjct: 61 LRIFSHPNVLPVLGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVK 115
Query: 60 YTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+ + RG+A++HT+ P + L +++++D +I + +
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA- 173
Query: 119 SRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPG 159
+ APE + S D+WS +L EL+ + F
Sbjct: 174 ---WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 9e-23
Identities = 55/252 (21%), Positives = 97/252 (38%), Gaps = 34/252 (13%)
Query: 1 MRVMDHPNVIS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYV 57
+ M H N++ + T+ +L+L + + + S+ LK S N+ +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET 129
Query: 58 KLYTYQIFRGLAYIHT---------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 108
+ RGLAY+H P + HRD+K +N+L+ I DFG A +
Sbjct: 130 ------MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKFE 182
Query: 109 AG--EANISYIC-SRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161
AG + +R Y APE++ GA + ID+++ G VL EL G
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 221
L ++ P+ E+++ + P ++ + W K M +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQ--EVVVHKKKRPVLRDY-WQKHAGMAM---LCETIEECW 296
Query: 222 QYSPSLRCTALE 233
+ R +A
Sbjct: 297 DHDAEARLSAGC 308
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 40/171 (23%), Positives = 68/171 (39%), Gaps = 29/171 (16%)
Query: 1 MRVMDHPNVIS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYV 57
++ H N++ + S S +L+L + Y S+Y L+ + + ++
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL- 112
Query: 58 KLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 110
I GLA++H P + HRDLK +N+LV Q I D G A
Sbjct: 113 -----SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQS 166
Query: 111 EANISYICS-----RFYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 151
+ + + Y APE++ + +DIW+ G VL E+
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 1e-22
Identities = 47/294 (15%), Positives = 95/294 (32%), Gaps = 41/294 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ +HPN++ + F + L +V ++ S ++ + M + +
Sbjct: 80 SKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMNELAIAY 132
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--------GE 111
+ + L YIH + HR +K ++L+ + +V + S +I+ +
Sbjct: 133 ILQGVLKALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 112 ANISYICSRFYRAPELIF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ + +PE++ Y DI+S G EL G F A L+E +
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 171 K-----------------VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA 213
+ ++ + T +H+ P
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 214 IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 267
+ LQ +P R +A H FF + LP L ++
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFK-----QIKRRASEALPELLRPVTPIT 359
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-22
Identities = 38/171 (22%), Positives = 67/171 (39%), Gaps = 29/171 (16%)
Query: 1 MRVMDHPNVIS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYV 57
++ H N++ + + +L+L V +Y S++ L Y+ + + L
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL- 146
Query: 58 KLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 110
GLA++H P + HRDLK +N+LV I D G A + +
Sbjct: 147 -----STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSA 200
Query: 111 EANISYICS-----RFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 151
I + + Y APE++ + E DI++ G V E+
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 32/201 (15%)
Query: 4 MDHPNVISLKHCFFSTTSKNELFLN-LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYT 61
+ HP+++ + F T ++ + +VMEYV +S+ R Q++P+ Y
Sbjct: 136 VVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYL 188
Query: 62 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISY 116
+I L+Y+H++ V + DLKP+N+++ Q+K+ D G+ ++ + G
Sbjct: 189 LEILPALSYLHSIGLV-YNDLKPENIMLTE--EQLKLIDLGAVSRINSFGYLYGTPG--- 242
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
++APE++ T + DI++ G LA L L P G VD L E VL T
Sbjct: 243 -----FQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTY 294
Query: 177 TR-EEI--RCMNPNYTDFRFP 194
+ R ++P+ RF
Sbjct: 295 DSYGRLLRRAIDPDPRQ-RFT 314
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 62/252 (24%), Positives = 97/252 (38%), Gaps = 39/252 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI---- 55
M HPN++S F K+EL+L VM+ + S+ ++KH + + +
Sbjct: 67 MSQCHHPNIVSYYTSFVV---KDELWL--VMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121
Query: 56 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 115
+ ++ GL Y+H HRD+K N+L+ V+I DFG + L A +I+
Sbjct: 122 TIATILREVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFL-ATGGDIT 178
Query: 116 YICSR-------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 168
R + APE++ Y DIWS G EL G + + L+
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 169 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228
++ N P ++ K K+ + S LQ P R
Sbjct: 239 TLQ-------------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
Query: 229 CTALEACAHPFF 240
TA E H FF
Sbjct: 280 PTAAELLRHKFF 291
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
+VMEYV L+ M + L + H + HRD+KP N++
Sbjct: 93 IVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIM 148
Query: 89 VDPLTHQVKICDFGSAKQLIAGEANISY----ICSRFYRAPELIFGATEYTTSIDIWSAG 144
+ T+ VK+ DFG A+ + +++ I + Y +PE G + S D++S G
Sbjct: 149 ISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLG 206
Query: 145 CVLAELLLGQPLFPGENAV 163
CVL E+L G+P F G++ V
Sbjct: 207 CVLYEVLTGEPPFTGDSPV 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-22
Identities = 49/139 (35%), Positives = 74/139 (53%), Gaps = 12/139 (8%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
LVMEY+ L Y ++ + + +T QI G+ + H + R+ HRD+KPQN+L
Sbjct: 88 LVMEYIEG---PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNIL 143
Query: 89 VDPLTHQVKICDFGSAKQLIAGEANISY----ICSRFYRAPELIFGATEYTTSIDIWSAG 144
+D +KI DFG AK E +++ + + Y +PE G + DI+S G
Sbjct: 144 IDS-NKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIG 199
Query: 145 CVLAELLLGQPLFPGENAV 163
VL E+L+G+P F GE AV
Sbjct: 200 IVLYEMLVGEPPFNGETAV 218
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-22
Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 46/244 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN I + C+ ++ +L VMEY S +L+ + + + + +
Sbjct: 108 LQKLRHPNTIQYRGCYLR---EHTAWL--VMEYCLGSASDLLEVH---KKPLQEVEIAAV 159
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC 118
T+ +GLAY+H+ + HRD+K N+L L+ VK+ DFGSA + AN S++
Sbjct: 160 THGALQGLAYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIM--APAN-SFVG 212
Query: 119 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ ++ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----- 267
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
P +++ W + F + LQ P R T+
Sbjct: 268 -------NES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLK 305
Query: 237 HPFF 240
H F
Sbjct: 306 HRFV 309
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 44/257 (17%)
Query: 5 DHPNVISLKHCFFSTTSKNELF-LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 62
H N+ + F L LVME+ S+ ++K ++ + ++
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICR 136
Query: 63 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYIC 118
+I RGL+++H +V HRD+K QN+L LT +VK+ DFG + QL G N ++I
Sbjct: 137 EILRGLSHLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIG 191
Query: 119 SRFYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+ ++ APE+I Y D+WS G E+ G P + + L I +
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--- 248
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
NP P++K+ W K F L + S R +
Sbjct: 249 ----------NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQL 284
Query: 235 CAHPFFDELREPNARLP 251
HPF +
Sbjct: 285 MKHPFIRDQPNERQVRI 301
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 41/197 (20%), Positives = 75/197 (38%), Gaps = 32/197 (16%)
Query: 1 MRVMDHPNVISLK-HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 58
R H NV+ C S L + + ++Y V++ A + + +
Sbjct: 83 YRQTRHENVVLFMGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTR 133
Query: 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
+I +G+ Y+H + H+DLK +N+ D +V I DFG +A
Sbjct: 134 QIAQEIVKGMGYLHAKGIL-HKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDK 190
Query: 119 SRF------YRAPELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVD 164
R + APE+I + ++ D+++ G + EL + F + A
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-- 248
Query: 165 QLVEIIKVLGTPTREEI 181
II +GT + +
Sbjct: 249 --EAIIWQMGTGMKPNL 263
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-21
Identities = 62/245 (25%), Positives = 96/245 (39%), Gaps = 45/245 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ D P+V+ +F +L++ VMEY S+ +++ N+ + +
Sbjct: 78 MQQCDSPHVVKYYGSYFK---NTDLWI--VMEYCGAGSVSDIIR---LRNKTLTEDEIAT 129
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANIS 115
+GL Y+H + R HRD+K N+L L K+ DFG A QL + N +
Sbjct: 130 ILQSTLKGLEYLHFM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-T 184
Query: 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
I + F+ APE+I Y DIWS G E+ G+P + + + + I
Sbjct: 185 VIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PP 242
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
PT + W F D + L SP R TA +
Sbjct: 243 PTFRK-----------------PELWSDNFT--------DFVKQCLVKSPEQRATATQLL 277
Query: 236 AHPFF 240
HPF
Sbjct: 278 QHPFV 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 56/242 (23%), Positives = 101/242 (41%), Gaps = 41/242 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
MR +PN+++ + +EL++ VMEY+ S+ V+ M +
Sbjct: 71 MRENKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVT-----ETCMDEGQIAA 120
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYIC 118
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ + +
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ ++ APE++ Y +DIWS G + E++ G+P + EN + L I GTP
Sbjct: 179 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL 236
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ +F D +R L+ R +A E H
Sbjct: 237 QN-----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQ 271
Query: 239 FF 240
F
Sbjct: 272 FL 273
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 62/253 (24%), Positives = 97/253 (38%), Gaps = 45/253 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ D P V + T L ++MEY+ S +L+ + +
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDLLE-----PGPLDETQIAT 123
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--GEANISYI 117
+I +GL Y+H+ + HRD+K N+L+ +VK+ DFG A QL + N +++
Sbjct: 124 ILREILKGLDYLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFV 180
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ F+ APE+I + Y + DIWS G EL G+P + + L I K PT
Sbjct: 181 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPT 238
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
E + K + L PS R TA E H
Sbjct: 239 LEG-------------------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKH 271
Query: 238 PFFDELREPNARL 250
F + + L
Sbjct: 272 KFILRNAKKTSYL 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 41/242 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
MR H NV+ + + EL++ +ME++ ++ ++ R+ +
Sbjct: 96 MRDYQHFNVVEMYKSYLV---GEELWV--LMEFLQGGALTDIVSQ-----VRLNEEQIAT 145
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYIC 118
+ + LAY+H V HRD+K ++L+ L +VK+ DFG Q+ S +
Sbjct: 146 VCEAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVG 203
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ ++ APE+I + Y T +DIWS G ++ E++ G+P + ++ V + + P
Sbjct: 204 TPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKL 261
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ +H V D R+L P R TA E HP
Sbjct: 262 KN-----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHP 296
Query: 239 FF 240
F
Sbjct: 297 FL 298
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-20
Identities = 53/249 (21%), Positives = 103/249 (41%), Gaps = 48/249 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ DHP ++ L ++ +L++ ++E+ P ++ ++ ++ + +++
Sbjct: 70 LATCDHPYIVKLLGAYYH---DGKLWI--MIEFCPGGAVDAIMLE---LDRGLTEPQIQV 121
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANIS 115
Q+ L ++H+ R+ HRDLK N+L +T +++ DFG + + + + + S
Sbjct: 122 VCRQMLEALNFLHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRD-S 176
Query: 116 YICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 171
+I + ++ APE++ T Y DIWS G L E+ +P N + L++I K
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236
Query: 172 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231
PT W F D L +P R +A
Sbjct: 237 S-DPPTLLT-----------------PSKWSVEFR--------DFLKIALDKNPETRPSA 270
Query: 232 LEACAHPFF 240
+ HPF
Sbjct: 271 AQLLEHPFV 279
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 7e-20
Identities = 61/261 (23%), Positives = 102/261 (39%), Gaps = 43/261 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
+ +M+H N+ T+ + LVMEY P S+ + L ++S +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL---- 116
Query: 60 YTYQIFRGLAYIHT--------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 111
+ + RGLAY+HT P + HRDL +N+LV I DFG + +L
Sbjct: 117 -AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNR 174
Query: 112 ---------ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QP 155
A IS + + Y APE++ GA +D+++ G + E+ +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 156 LFPGENAVD-QLVEIIKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVFHKRMPP 211
LFPGE+ + Q+ +V PT E+++ R P+ W + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE----KQR-PKFPEA-WKE--NSLAVR 286
Query: 212 EAIDLASRLLQYSPSLRCTAL 232
+ R TA
Sbjct: 287 SLKETIEDCWDQDAEARLTAQ 307
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 31/185 (16%)
Query: 1 MRVMDHPNVISLKHCFF--STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYV 57
MR ++HPNV+ F K LN + EY+ ++ ++K S + + P
Sbjct: 61 MRCLEHPNVLK----FIGVLYKDKR---LNFITEYIKGGTLRGIIK---SMDSQYPWSQR 110
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
+ I G+AY+H++ + HRDL N LV V + DFG A+ ++ + +
Sbjct: 111 VSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGL 168
Query: 118 CSRFYR---------------APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162
S APE+I G Y +D++S G VL E++ P
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227
Query: 163 VDQLV 167
Sbjct: 228 RTMDF 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-19
Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 12/138 (8%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
+ M + L + QI L H HRD+KP+N+L
Sbjct: 111 VDMRLING---VDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENIL 166
Query: 89 VDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAG 144
V + DFG A + + + + + +Y APE + T DI++
Sbjct: 167 VSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALT 222
Query: 145 CVLAELLLGQPLFPGENA 162
CVL E L G P + G+
Sbjct: 223 CVLYECLTGSPPYQGDQL 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-15
Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 20/159 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
++ + H N++ K ++ L+MEY+P Y L+ Y ++ R+ I +
Sbjct: 65 LKSLQHDNIVKYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQ 118
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YT QI +G+ Y+ T R HRDL +N+LV+ ++VKI DFG K L + +
Sbjct: 119 YTSQICKGMEYLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEFFKV 173
Query: 120 R-------FYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+ F+ APE + ++++ + D+WS G VL EL
Sbjct: 174 KEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 20/159 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
++ + H N++ K ++ L+MEY+P Y L+ Y ++ R+ I +
Sbjct: 96 LKSLQHDNIVKYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQ 149
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YT QI +G+ Y+ T R HRDL +N+LV+ ++VKI DFG K L + Y
Sbjct: 150 YTSQICKGMEYLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEYYKV 204
Query: 120 R-------FYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+ F+ APE + ++++ + D+WS G VL EL
Sbjct: 205 KEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 54/177 (30%), Positives = 76/177 (42%), Gaps = 21/177 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+R + H ++I K C L LVMEYVP L+ Y + + L + L+
Sbjct: 87 LRTLYHEHIIKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLF 139
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
QI G+AY+H HRDL +N+L+D VKI DFG AK + Y R
Sbjct: 140 AQQICEGMAYLHAQ-HYIHRDLAARNVLLDN-DRLVKIGDFGLAKAV---PEGHEYYRVR 194
Query: 121 -------FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 169
F+ APE + + + D+WS G L ELL +L+ I
Sbjct: 195 EDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 20/159 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKL 59
+R + H N++ K T L+ME++P LK Y N ++ L
Sbjct: 77 LRNLYHENIVKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLK 130
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y QI +G+ Y+ + + HRDL +N+LV+ HQVKI DFG K + E + Y
Sbjct: 131 YAVQICKGMDYLGSR-QYVHRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTV 185
Query: 120 R-------FYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
+ F+ APE + + + + D+WS G L ELL
Sbjct: 186 KDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
++ + ++ + + ++ L LVMEY+P L+ + ++ R+ + L
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLL 131
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y+ QI +G+ Y+ + R HRDL +N+LV+ VKI DFG AK L + Y
Sbjct: 132 YSSQICKGMEYLGSR-RCVHRDLAARNILVES-EAHVKIADFGLAKLL---PLDKDYYVV 186
Query: 120 R-------FYRAPELIFGATEYTTSIDIWSAGCVLAELL 151
R F+ APE + ++ D+WS G VL EL
Sbjct: 187 REPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 38/176 (21%), Positives = 69/176 (39%), Gaps = 30/176 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M+ HPNVI L +S+ +++ ++ ++ L + + L
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 60 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 117
+ I G+ Y+ HRDL +N ++ V + DFG +K++ +G+
Sbjct: 150 LKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD------ 201
Query: 118 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+YR A E L YT+ D+W+ G + E+ G +PG
Sbjct: 202 ---YYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 37/177 (20%), Positives = 67/177 (37%), Gaps = 31/177 (17%)
Query: 1 MRVMDHPNVISLKH-CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 58
M+ DHP+V L S +++ ++ ++ L L
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 59 L--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
L + I G+ Y+ + HRDL +N ++ V + DFG ++++ +G+
Sbjct: 139 LVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD----- 191
Query: 117 ICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+YR A E L YT D+W+ G + E++ GQ + G
Sbjct: 192 ----YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 21/176 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
M +D+P+V L + + L + + +P + L Y ++ + Y+
Sbjct: 71 MASVDNPHVCRL----LGICLTSTVQL--ITQLMP---FGCLLDYVREHKDNIGSQYLLN 121
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ QI +G+ Y+ R+ HRDL +N+LV VKI DFG AK L A E
Sbjct: 122 WCVQIAKGMNYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 120 RF---YRAPE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 168
+ + A E ++ YT D+WS G + EL+ G + G A + ++E
Sbjct: 180 KVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 2e-13
Identities = 36/229 (15%), Positives = 72/229 (31%), Gaps = 36/229 (15%)
Query: 21 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80
++LF+ L E+ + ++ SS K +Q+ LA R HR
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHR 186
Query: 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDI 140
DL N+L+ T K+ + K L +YT S
Sbjct: 187 DLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLE 232
Query: 141 WSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-------NYTDFRF 193
V ++ + + LF G+ D +I +++ +P +Y +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 194 PQIKAHPW--HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
+ + K++ + + +L +S +A +
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-13
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M+ + H ++ L ++ S+ +++ V EY+ L + L +L
Sbjct: 233 MKKLRHEKLVQL----YAVVSEEPIYI--VTEYMS---KGSLLDFLKGETGKYLRLPQLV 283
Query: 60 -YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI G+AY+ + HRDL+ N+LV K+ DFG A+ LI +
Sbjct: 284 DMAAQIASGMAYVERM-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQG 340
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
++F + APE +T D+WS G +L EL G+ +PG
Sbjct: 341 AKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 41/175 (23%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
+ +DH +++ L + L LV +Y+P L + ++ + +
Sbjct: 69 IGSLDHAHIVRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLN 119
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ QI +G+ Y+ + HR+L +N+L+ QV++ DFG A L + + Y +
Sbjct: 120 WGVQIAKGMYYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDKQLLYSEA 177
Query: 120 RF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 168
+ + A E I YT D+WS G + EL+ G + G + L+E
Sbjct: 178 KTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M+ + H ++ L ++ S+ +++ V EY+ L + L +L
Sbjct: 316 MKKLRHEKLVQL----YAVVSEEPIYI--VTEYMS---KGSLLDFLKGETGKYLRLPQLV 366
Query: 60 -YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI G+AY+ + HRDL+ N+LV K+ DFG A+ LI +
Sbjct: 367 DMAAQIASGMAYVERM-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQG 423
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
++F + APE +T D+WS G +L EL G+ +PG
Sbjct: 424 AKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
M +D+P+V L TS + L+ + +P + L Y ++ + Y+
Sbjct: 71 MASVDNPHVCRLLGI--CLTST----VQLITQLMP---FGCLLDYVREHKDNIGSQYLLN 121
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ QI +G+ Y+ R+ HRDL +N+LV VKI DFG AK L A E
Sbjct: 122 WCVQIAKGMNYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 120 RF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 168
+ + A E I YT D+WS G + EL+ G + G A + ++E
Sbjct: 180 KVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 31/194 (15%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLK 43
++V+ +H N+++L + L ++ EY +
Sbjct: 77 LKVLSYLGNHMNIVNLLGA----CTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 44 HYSSANQRMPLIYVKLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 101
+ + L L + YQ+ +G+A++ + HRDL +N+L+ KICDF
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDF 189
Query: 102 GSAKQLIAGEANISYICSRF-YR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLF 157
G A+ + + +R + APE IF YT D+WS G L EL LG +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPY 248
Query: 158 PGENAVDQLVEIIK 171
PG + ++IK
Sbjct: 249 PGMPVDSKFYKMIK 262
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 5e-12
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 37/174 (21%)
Query: 66 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 121
G+ ++H + HRD+K N+L+D KI DFG A+ + + + + SR
Sbjct: 144 NGINFLHENHHI-HRDIKSANILLDE-AFTAKISDFGLAR--ASEKFAQTVMTSRIVGTT 199
Query: 122 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------LVEIIKVLG 174
Y APE + G E T DI+S G VL E++ G P AVD+ L++I + +
Sbjct: 200 AYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP------AVDEHREPQLLLDIKEEIE 251
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228
+ ++ D ++ +AS+ L + R
Sbjct: 252 DEEKTIEDYIDKKMNDADSTSVE--------------AMYSVASQCLHEKKNKR 291
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-12
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 23/166 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M + H N++ L + + L +V EY+ L Y + R L L
Sbjct: 68 MTQLRHSNLVQL----LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLL 120
Query: 60 -YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
++ + + Y+ HRDL +N+LV + K+ DFG K+ + +
Sbjct: 121 KFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT----- 173
Query: 119 SRF-YR--APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ + APE L +++T D+WS G +L E+ G+ +P
Sbjct: 174 GKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-12
Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 18/165 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M+ + HPN++ L ++ F ++ E++ Y L Y R + V L
Sbjct: 270 MKEIKHPNLVQL----LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLL 321
Query: 60 -YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI + Y+ HR+L +N LV H VK+ DFG + +L+ G+ ++
Sbjct: 322 YMATQISSAMEYLEKK-NFIHRNLAARNCLVGE-NHLVKVADFGLS-RLMTGDTYTAHAG 378
Query: 119 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
++F + APE + ++ D+W+ G +L E+ G +PG
Sbjct: 379 AKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 25/168 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M+ +D+P ++ + L VME L Y N+ + +
Sbjct: 72 MQQLDNPYIVRM----IGICEAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIEL 122
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+Q+ G+ Y+ HRDL +N+L+ H KI DFG +K L A E +Y ++
Sbjct: 123 VHQVSMGMKYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADE---NYYKAQ 177
Query: 121 FYR-------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ APE + + ++++ D+WS G ++ E GQ + G
Sbjct: 178 THGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M+ + H ++ L + +K ++ ++ E++ L + +++ KL
Sbjct: 237 MKTLQHDKLVKL----HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLI 287
Query: 60 -YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
++ QI G+A+I HRDL+ N+LV + KI DFG A ++I +
Sbjct: 288 DFSAQIAEGMAFIEQR-NYIHRDLRAANILVSA-SLVCKIADFGLA-RVIEDNEYTAREG 344
Query: 119 SRF---YRAPE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
++F + APE + FG +T D+WS G +L E++ G+ +PG
Sbjct: 345 AKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 23/166 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M + H N++ L + + L +V EY+ L Y + R L L
Sbjct: 240 MTQLRHSNLVQL----LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLL 292
Query: 60 -YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
++ + + Y+ HRDL +N+LV + K+ DFG K+ + +
Sbjct: 293 KFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT----- 345
Query: 119 SRF-YR--APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ + APE L +++T D+WS G +L E+ G+ +P
Sbjct: 346 GKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIY 56
MR ++HPNV++L E ++++ Y+ + L + + QR P LI
Sbjct: 76 MRGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQFIRSPQRNPTVKDLIS 128
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
+ Q+ RG+ Y+ + HRDL +N ++D + VK+ DFG A+ ++ E Y
Sbjct: 129 ---FGLQVARGMEYLAEQ-KFVHRDLAARNCMLDE-SFTVKVADFGLARDILDRE----Y 179
Query: 117 ICSRFYR---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ +R A E L +TT D+WS G +L ELL G P +
Sbjct: 180 YSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 18/165 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
++ HPN++ L ++ + +VME V L+ + R+ + +
Sbjct: 166 LKQYSHPNIVRL----IGVCTQKQPIY-IVMELVQGGDFLTFLR---TEGARLRVKTLLQ 217
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
G+ Y+ + + HRDL +N LV + +KI DFG +++ G S
Sbjct: 218 MVGDAAAGMEYLESKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLR 275
Query: 120 RF-YR--APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ + APE L +G Y++ D+WS G +L E LG +P
Sbjct: 276 QVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 21/166 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M+ + H ++ L ++ ++ ++ ++ EY+ L + + L KL
Sbjct: 62 MKQLQHQRLVRL----YAVVTQEPIY--IITEYMENG---SLVDFLKTPSGIKLTINKLL 112
Query: 60 -YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI G+A+I HRDL+ N+LV T KI DFG A +LI +
Sbjct: 113 DMAAQIAEGMAFIEER-NYIHRDLRAANILVSD-TLSCKIADFGLA-RLIEDNEYTAREG 169
Query: 119 SRF-YR--APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
++F + APE + +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 20/166 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M+ + HPN++ L ++ F ++ E++ Y L Y R + V L
Sbjct: 63 MKEIKHPNLVQL----LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLL 114
Query: 60 -YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 118
QI + Y+ HRDL +N LV H VK+ DFG ++ L+ G+ ++
Sbjct: 115 YMATQISSAMEYLEKK-NFIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAG 171
Query: 119 SRF---YRAPE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
++F + APE L + +++ D+W+ G +L E+ G +PG
Sbjct: 172 AKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-11
Identities = 26/233 (11%), Positives = 52/233 (22%), Gaps = 64/233 (27%)
Query: 29 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 87
+V E++ S+ V + + H V P +
Sbjct: 108 VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRV 160
Query: 88 LVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147
V V + DI G L
Sbjct: 161 RVSI-DGDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASL 192
Query: 148 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 207
LL+ + P L + E ++ +
Sbjct: 193 YALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD-------------------- 231
Query: 208 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 260
+P + +A+R +Q +R + + +++ A L P+
Sbjct: 232 -IPFQISAVAARSVQGDGGIRSASTLL------NLMQQATAVADRTEVLGPID 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 26/169 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M +D+P ++ L L L VME +++ L + +P+ V
Sbjct: 390 MHQLDNPYIVRL----IGVCQAEALML--VMEMAGGGPLHKFLV---GKREEIPVSNVAE 440
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+Q+ G+ Y+ HR+L +N+L+ H KI DFG +K L A + SY +
Sbjct: 441 LLHQVSMGMKYLEEK-NFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTA 495
Query: 120 RFYR-------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
R APE + F ++++ D+WS G + E L GQ +
Sbjct: 496 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 7/116 (6%)
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ + + +
Sbjct: 198 YSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 120 RF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 171
R + APE IF YT D+WS G +L E+ LG +PG ++ +K
Sbjct: 256 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 56/209 (26%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVP------------------ESM 38
+++M H N+++L T ++L + EY E
Sbjct: 99 LKMMTQLGSHENIVNLLGA---CTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 39 YRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 96
Y K L + L + YQ+ +G+ ++ HRDL +N+LV V
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVV 211
Query: 97 KICDFGSAKQLIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAG 144
KICDFG A+ +++ Y APE +F YT D+WS G
Sbjct: 212 KICDFGLARDIMSDSN---------YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYG 261
Query: 145 CVLAEL--LLGQPLFPGENAVDQLVEIIK 171
+L E+ L P +PG ++I+
Sbjct: 262 ILLWEIFSLGVNP-YPGIPVDANFYKLIQ 289
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 40/192 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK----HYSSANQRMPLI 55
M+ + +V+ L S+ + L ++ME + + L+ ++ P
Sbjct: 82 MKEFNCHHVVRLLGV----VSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 56 YVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 113
K+ +I G+AY++ V HRDL +N +V VKI DFG + + +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD-- 192
Query: 114 ISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+YR +PE L G +TT D+WS G VL E+ L + + G
Sbjct: 193 -------YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQG 243
Query: 160 ENAVDQLVEIIK 171
+ +Q++ +
Sbjct: 244 LS-NEQVLRFVM 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 46/200 (23%), Positives = 80/200 (40%), Gaps = 47/200 (23%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVP---------ESMYRVLKHYSS 47
+++M H N+++L + L ++ EY + +
Sbjct: 100 LKIMSHLGQHENIVNLLGA----CTHGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 48 ANQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105
A L ++ Q+ +G+A++ + HRD+ +N+L+ H KI DFG A+
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLAR 212
Query: 106 QLIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-L 152
++ N S Y APE IF YT D+WS G +L E+ L
Sbjct: 213 DIM----NDSN-----YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSL 262
Query: 153 G-QPLFPGENAVDQLVEIIK 171
G P +PG + +++K
Sbjct: 263 GLNP-YPGILVNSKFYKLVK 281
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 45/201 (22%), Positives = 82/201 (40%), Gaps = 46/201 (22%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLK 43
++++ H NV++L T L + ++E+ E + +
Sbjct: 81 LKILIHIGHHLNVVNLLGA--CTKPGGPLMV--IVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 44 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103
+ L ++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGL 194
Query: 104 AKQLIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL 151
A+ + Y APE IF YT D+WS G +L E+
Sbjct: 195 ARDIY----KDPD-----YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 244
Query: 152 -LGQPLFPGENAVDQLVEIIK 171
LG +PG ++ +K
Sbjct: 245 SLGASPYPGVKIDEEFCRRLK 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
MR DHP+++ L ++N +++ +ME L+ + + + L + L
Sbjct: 445 MRQFDHPHIVKL----IGVITENPVWI--IMELCT---LGELRSFLQVRKFSLDLASLIL 495
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y YQ+ LAY+ + V HRD+ +N+LV VK+ DFG ++ + + +Y +
Sbjct: 496 YAYQLSTALAYLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM----EDSTYYKA 549
Query: 120 RFYR------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ APE + F +T++ D+W G + E+L G F G
Sbjct: 550 SKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 37/176 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL- 59
M+ HPNV+SL S+ +V+ Y+ + L+++ P + +
Sbjct: 80 MKDFSHPNVLSLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG 132
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ Q+ +G+ Y+ + + HRDL +N ++D VK+ DFG A+ + E
Sbjct: 133 FGLQVAKGMKYLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE-------- 182
Query: 120 RFYR--------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+Y A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 183 -YYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 44/168 (26%), Positives = 66/168 (39%), Gaps = 24/168 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
M +DH N+I L + + + V E P L +Q L +
Sbjct: 75 MHSLDHRNLIRL----YGVVLTPPMKM--VTELAP---LGSLLDRLRKHQGHFLLGTLSR 125
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y Q+ G+ Y+ + R HRDL +NLL+ VKI DFG + L + Y+
Sbjct: 126 YAVQVAEGMGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDD--HYVMQ 181
Query: 120 RFYR------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ APE L ++ + D W G L E+ GQ + G
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 45/169 (26%), Positives = 71/169 (42%), Gaps = 26/169 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKL 59
M +D+P ++ L L L VME L + + +P+ V
Sbjct: 64 MHQLDNPYIVRL----IGVCQAEALML--VMEMAG---GGPLHKFLVGKREEIPVSNVAE 114
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+Q+ G+ Y+ HRDL +N+L+ H KI DFG +K L A + SY +
Sbjct: 115 LLHQVSMGMKYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTA 169
Query: 120 RFYR-------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
R APE + F ++++ D+WS G + E L GQ +
Sbjct: 170 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-10
Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 25/168 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M + HP ++ + SK +V EY+ + L+ + + L+
Sbjct: 57 MMKLSHPKLVKF----YGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKGLEPSQLLE--- 108
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y + G+A++ + + HRDL +N LVD VK+ DFG + ++ + Y+ S
Sbjct: 109 MCYDVCEGMAFLESH-QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ----YVSS 162
Query: 120 RFYR------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ APE + +Y++ D+W+ G ++ E+ LG+ +
Sbjct: 163 VGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 66 RGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 121
RGLAY+H P++ HRD+K N+L+D + + DFG AK + + +++ +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTAVRG 197
Query: 122 ---YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 154
+ APE L G + + D++ G +L EL+ GQ
Sbjct: 198 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 26/174 (14%), Positives = 58/174 (33%), Gaps = 33/174 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M + H +++ + + + LV E+V S+ LK + + +
Sbjct: 66 MSKLSHKHLVLN----YGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCINILWKLE--- 117
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-------VKICDFGSAKQLIAGEA 112
Q+ + ++ + H ++ +N+L+ + +K+ D G + ++ +
Sbjct: 118 VAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD- 175
Query: 113 NISYICSRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ PE I + D WS G L E+ G
Sbjct: 176 --------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 19/165 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M + HP ++ L + + LV E++ + L+ L+
Sbjct: 57 MMKLSHPKLVQL----YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG--- 108
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ G+AY+ V HRDL +N LV +K+ DFG + + + S +
Sbjct: 109 MCLDVCEGMAYLEEA-CVIHRDLAARNCLVGE-NQVIKVSDFGMTR-FVLDDQYTSSTGT 165
Query: 120 RF---YRAPE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+F + +PE F Y++ D+WS G ++ E+ G+ +
Sbjct: 166 KFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 33/174 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIY 56
M+ HPNV+SL S+ +V+ Y+ + L+++ P LI
Sbjct: 144 MKDFSHPNVLSLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG 196
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
+ Q+ +G+ ++ + + HRDL +N ++D VK+ DFG A+ + E +
Sbjct: 197 ---FGLQVAKGMKFLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----F 247
Query: 117 ICSRFYR---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 21/167 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M DHPN+I L ++ L + +V EY+ S+ L+ + M L+
Sbjct: 104 MGQFDHPNIIRL----EGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVG--- 155
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ G+ Y+ + HRDL +N+LVD K+ DFG ++ ++ + + +Y +
Sbjct: 156 MLRGVGAGMRYLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSR-VLEDDPDAAYTTT 212
Query: 120 --RF-YR--APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ R APE + F ++++ D+WS G V+ E+L G+ +
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
MR DHP+++ L ++N ++ ++ME L+ + + + L + L
Sbjct: 70 MRQFDHPHIVKL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLIL 120
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y YQ+ LAY+ + R HRD+ +N+LV VK+ DFG ++ +
Sbjct: 121 YAYQLSTALAYLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST-------- 170
Query: 120 RFYR-----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+Y+ APE + F +T++ D+W G + E+L G F G
Sbjct: 171 -YYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 33/154 (21%), Positives = 53/154 (34%), Gaps = 23/154 (14%)
Query: 14 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 73
+ T K + +VME + L+ S N V ++ L YIH
Sbjct: 114 YGSGLTEFKGRSYRFMVMERLGID----LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE 169
Query: 74 VPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 132
V H D+K NLL+ QV + D+G + + + Y + G
Sbjct: 170 NEYV-HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTI 224
Query: 133 EYTTSI------------DIWSAGCVLAELLLGQ 154
E+ TS+ D+ G + L G+
Sbjct: 225 EF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 39/167 (23%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M H N+I L SK + + ++ EY+ ++ + L+ + L+
Sbjct: 100 MGQFSHHNIIRL----EGVISKYKPMM-IITEYMENGALDKFLREKDGEFSVLQLVG--- 151
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
I G+ Y+ + HRDL +N+LV+ K+ DFG ++ ++ + +Y S
Sbjct: 152 MLRGIAAGMKYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEATYTTS 208
Query: 120 --RF-YR--APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+ R APE + + +T++ D+WS G V+ E++ G+ +
Sbjct: 209 GGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 40/168 (23%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M DHPN+I L +K++ + +V EY+ S+ L+ + + + L+
Sbjct: 100 MGQFDHPNIIRL----EGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQFTVIQLVG--- 151
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
I G+ Y+ + HRDL +N+L++ K+ DFG + L + + +
Sbjct: 152 MLRGIASGMKYLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVL--EDDPEAAYTT 207
Query: 120 RFYR------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
R + +PE + + ++T++ D+WS G VL E++ G+ +
Sbjct: 208 RGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKL 59
M+ +DHP+++ L + + ++ME P Y L HY N+ + ++ + L
Sbjct: 67 MKNLDHPHIVKL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVL 117
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y+ QI + +AY+ ++ HRD+ +N+LV VK+ DFG ++ + + Y +
Sbjct: 118 YSLQICKAMAYLESI-NCVHRDIAVRNILVAS-PECVKLGDFGLSRYIEDED----YYKA 171
Query: 120 RFYR------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
R +PE + F +TT+ D+W + E+L G+ F
Sbjct: 172 SVTRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 5e-09
Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 54/206 (26%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-------------------ESMYRV 41
++ ++HP+VI L + L L++EY S
Sbjct: 80 LKQVNHPHVIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 42 LKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 99
L L + +QI +G+ Y+ + ++ HRDL +N+LV ++KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKIS 192
Query: 100 DFGSAKQLIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVL 147
DFG ++ + Y A E +F YTT D+WS G +L
Sbjct: 193 DFGLSRDVY----EEDS-----YVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLL 242
Query: 148 AELL-LG-QPLFPGENAVDQLVEIIK 171
E++ LG P +PG ++L ++K
Sbjct: 243 WEIVTLGGNP-YPGIP-PERLFNLLK 266
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 48/201 (23%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHY 45
M +M H N+I+L +++ +++EY +
Sbjct: 125 MEMMKMIGKHKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 46 SSANQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103
S N L L YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGL 237
Query: 104 AKQLIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL 151
A+ + + +Y+ APE +F YT D+WS G +L E+
Sbjct: 238 ARDIHHID---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIF 287
Query: 152 -LGQPLFPGENAVDQLVEIIK 171
LG +PG V++L +++K
Sbjct: 288 TLGGSPYPGVP-VEELFKLLK 307
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 6e-09
Identities = 40/199 (20%), Positives = 76/199 (38%), Gaps = 48/199 (24%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSAN 49
+ + H +++ + + +V EY+ +L
Sbjct: 71 LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 50 QRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 107
+ L ++ QI G+ Y+ + HRDL +N LV VKI DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183
Query: 108 IAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 153
+ + +YR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 154 -QPLFPGENAVDQLVEIIK 171
QP + + +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 36/179 (20%), Positives = 64/179 (35%), Gaps = 37/179 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVK 58
+ +H N++ + ++ +++E + + L + +Q L +
Sbjct: 128 ISKFNHQNIVRCIGV----SLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 59 L--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI 114
L I G Y+ HRD+ +N L+ KI DFG A+ +
Sbjct: 183 LLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--- 238
Query: 115 SYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+YR PE + G +T+ D WS G +L E+ LG +P
Sbjct: 239 ------YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 47/198 (23%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP----------ESMYRVLKHYSSANQ 50
+ ++ H +++ ++ L +V EY+ L
Sbjct: 97 LTMLQHQHIVRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 51 RMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 108
PL +L Q+ G+ Y+ + HRDL +N LV VKI DFG ++ +
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIY 209
Query: 109 AGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG- 153
+ + +YR PE +++ ++TT D+WS G VL E+ G
Sbjct: 210 STD---------YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGK 258
Query: 154 QPLFPGENAVDQLVEIIK 171
QP + + + ++ I
Sbjct: 259 QP-WYQLS-NTEAIDCIT 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-09
Identities = 37/179 (20%), Positives = 64/179 (35%), Gaps = 37/179 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVK 58
+ +H N++ + ++ ++ME + + L + +Q L +
Sbjct: 87 ISKFNHQNIVRCIGV----SLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 59 L--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI 114
L I G Y+ HRD+ +N L+ KI DFG A+ +
Sbjct: 142 LLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--- 197
Query: 115 SYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+YR PE + G +T+ D WS G +L E+ LG +P
Sbjct: 198 ------YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 9e-09
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 44/170 (25%)
Query: 6 HPNVISL-KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPL-------IY 56
HP+++SL C +NE+ L + +Y+ ++ R L Y S M + I
Sbjct: 94 HPHLVSLIGFC----DERNEMIL--IYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEIC 145
Query: 57 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116
+ RGL Y+HT + HRD+K N+L+D KI DFG +K E + ++
Sbjct: 146 I-----GAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK--KGTELDQTH 196
Query: 117 ICSRF-----YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 155
+ + Y P EY T D++S G VL E+L +
Sbjct: 197 LSTVVKGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 48/201 (23%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHY 45
M +M H N+I+L +++ +++EY + +
Sbjct: 137 MEMMKMIGKHKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 46 SSANQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103
+ + + L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGL 249
Query: 104 AKQLIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL 151
A+ + NI Y Y+ APE +F YT D+WS G ++ E+
Sbjct: 250 ARDIN----NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIF 299
Query: 152 -LGQPLFPGENAVDQLVEIIK 171
LG +PG V++L +++K
Sbjct: 300 TLGGSPYPGIP-VEELFKLLK 319
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 36/165 (21%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M + H ++ L + +K ++ EY+ + L+ Q L+
Sbjct: 73 MMNLSHEKLVQL----YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE--- 124
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
+ + Y+ + + HRDL +N LV+ VK+ DFG ++ + + S + S
Sbjct: 125 MCKDVCEAMEYLESK-QFLHRDLAARNCLVND-QGVVKVSDFGLSR-YVLDDEYTSSVGS 181
Query: 120 RF-YR--APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 159
+F R PE L++ ++++ DIW+ G ++ E+ LG+ +
Sbjct: 182 KFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 43/187 (22%), Positives = 71/187 (37%), Gaps = 47/187 (25%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSAN 49
+ HPNV+ L +K++ ++ Y V
Sbjct: 66 RARLQHPNVVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 50 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 107
+ L QI G+ Y+ + V H+DL +N+LV VKI D G +++
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREV 178
Query: 108 IAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 153
A + +Y+ APE +++G +++ DIWS G VL E+ G
Sbjct: 179 YAAD---------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYG 227
Query: 154 -QPLFPG 159
QP + G
Sbjct: 228 LQP-YCG 233
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 26/139 (18%), Positives = 49/139 (35%), Gaps = 21/139 (15%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
LV+ + S+ L + V ++ L ++H V H ++ +N+
Sbjct: 135 LVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYV-HGNVTAENIF 191
Query: 89 VDPLT-HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI--------- 138
VDP QV + +G A + +++Y G E+ S+
Sbjct: 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPS 246
Query: 139 ---DIWSAGCVLAELLLGQ 154
D+ S G + + L G
Sbjct: 247 RRSDLQSLGYCMLKWLYGF 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 47/189 (24%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHY 45
M +M H N+I+L +++ +++EY + +
Sbjct: 91 MEMMKMIGKHKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 46 SSANQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103
+ + + L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGL 203
Query: 104 AKQLIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL 151
A+ + NI Y Y+ APE +F YT D+WS G ++ E+
Sbjct: 204 ARDI----NNIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIF 253
Query: 152 -LGQPLFPG 159
LG +PG
Sbjct: 254 TLGGSPYPG 262
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-08
Identities = 44/207 (21%), Positives = 80/207 (38%), Gaps = 56/207 (27%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSS 47
M D+PN++ L + + L+ EY+ P ++ + S
Sbjct: 104 MAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 48 ANQRMPLIYVKLYT--------YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 99
R+ + Q+ G+AY+ + HRDL +N LV VKI
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKIA 216
Query: 100 DFGSAKQLIAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCV 146
DFG ++ + + + +Y+ PE + + YTT D+W+ G V
Sbjct: 217 DFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVV 265
Query: 147 LAELL-LG-QPLFPGENAVDQLVEIIK 171
L E+ G QP + G ++++ ++
Sbjct: 266 LWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 31/147 (21%), Positives = 52/147 (35%), Gaps = 35/147 (23%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
LV++ + S+ +L ++ + V + Q+ + IH V +RD+KP N L
Sbjct: 83 LVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLV-YRDIKPDNFL 138
Query: 89 V----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIFGATEYTTSI- 138
+ + + + DFG K Y YR + + G Y SI
Sbjct: 139 IGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYREKKNLSGTARY-MSIN 188
Query: 139 -----------DIWSAGCVLAELLLGQ 154
D+ + G V L G
Sbjct: 189 THLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 32/154 (20%), Positives = 54/154 (35%), Gaps = 22/154 (14%)
Query: 14 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 73
+ + ++M+ + K Y + +R V + +I L YIH
Sbjct: 114 WGSGLHDKNGKSYRFMIMDRFGSDLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIHE 170
Query: 74 VPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 132
V H D+K NLL++ QV + D+G A + + +Y G
Sbjct: 171 HEYV-HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTI 225
Query: 133 EYTTSI------------DIWSAGCVLAELLLGQ 154
E+ TSI D+ G + + L G
Sbjct: 226 EF-TSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 52/190 (27%)
Query: 1 MRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHY 45
+ V+ HPN+I+L + L+L +EY P +
Sbjct: 76 LEVLCKLGHHPNIINLLGA---CEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 46 SSANQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103
+ + L +L + + RG+ Y+ + HRDL +N+LV + KI DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGL 188
Query: 104 AKQLIAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAEL 150
++ Y A E L + YTT+ D+WS G +L E+
Sbjct: 189 SR-------GQEV-----YVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEI 234
Query: 151 L-LGQPLFPG 159
+ LG + G
Sbjct: 235 VSLGGTPYCG 244
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 3e-06
Identities = 65/361 (18%), Positives = 110/361 (30%), Gaps = 114/361 (31%)
Query: 2 RVMDH----PNVIS-LKHCFFSTTSKNELFLNLVMEYVPESM---YRVLKHYSSANQRMP 53
+DH + +S F++ SK E +V ++V E + Y+ L QR P
Sbjct: 49 EEIDHIIMSKDAVSGTLRLFWTLLSKQE---EMVQKFVEEVLRINYKFLMSPIKTEQRQP 105
Query: 54 LIYVKLYTYQ---IFRGLAYI--HTVPRV--------CHRDLKP-QNLLVDPLTHQVKIC 99
+ ++Y Q ++ + V R+ +L+P +N+L+ V
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI----DGVL-- 159
Query: 100 DFGSAKQLIAGEA------------NISYICSRFYRAPELIF-----------------G 130
GS K +A + I ++ + +PE +
Sbjct: 160 --GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 131 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-----VEII-------KVLGTPTR 178
+ I S L LL +P EN + L + K+L T TR
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPY---ENCLLVLLNVQNAKAWNAFNLSCKILLT-TR 273
Query: 179 EEIRCMNPNYTDFRFPQIKAHP----WHKVFHKRMPPEAIDLASRLLQYSPS-LRCTALE 233
TDF H P E L + L P L E
Sbjct: 274 ------FKQVTDFLSAATTTHISLDHHSMTLT---PDEVKSLLLKYLDCRPQDLP---RE 321
Query: 234 ACA-HPFF-----DELREPNARLPNGRPLPPLFNFKQ----ELSGASPELVNKLIPDHVK 283
+P + +R+ A N+K +L+ +N L P +
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWD---------NWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 284 R 284
+
Sbjct: 373 K 373
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 36/140 (25%), Positives = 60/140 (42%), Gaps = 23/140 (16%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
LVM+ + S+ + ++++ L V + Q+ + ++H+ HRD+KP N L
Sbjct: 80 LVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFL 135
Query: 89 V--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI-------- 138
+ +QV I DFG AK+ + +I YR + + G Y S+
Sbjct: 136 MGLGRRANQVYIIDFGLAKKYRDTSTH-QHIP---YRENKNLTGTARY-ASVNTHLGIEQ 190
Query: 139 ----DIWSAGCVLAELLLGQ 154
D+ S G VL L G
Sbjct: 191 SRRDDLESLGYVLMYFLRGS 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 8e-06
Identities = 31/147 (21%), Positives = 56/147 (38%), Gaps = 35/147 (23%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
+V+E + S+ + ++ L V + Q+ + Y+H+ + +RD+KP+N L
Sbjct: 82 MVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFL 137
Query: 89 V----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIFGATEYTTSI- 138
+ + + I DF AK+ YI YR + + G Y SI
Sbjct: 138 IGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYREHKSLTGTARY-MSIN 187
Query: 139 -----------DIWSAGCVLAELLLGQ 154
D+ + G + L G
Sbjct: 188 THLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 39/140 (27%), Positives = 58/140 (41%), Gaps = 23/140 (16%)
Query: 29 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88
+VME + S+ + +++ L V L Q+ + YIH+ HRD+KP N L
Sbjct: 82 MVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFL 137
Query: 89 V--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI-------- 138
+ + V I DFG AK+ + +I YR + + G Y SI
Sbjct: 138 MGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTGTARY-ASINTHLGIEQ 192
Query: 139 ----DIWSAGCVLAELLLGQ 154
D+ S G VL LG
Sbjct: 193 SRRDDLESLGYVLMYFNLGS 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.63 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.12 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.47 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.44 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.15 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.93 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.94 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 95.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.99 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.75 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.58 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 89.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 89.48 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 87.89 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 87.67 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 82.61 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=400.35 Aligned_cols=272 Identities=33% Similarity=0.637 Sum_probs=213.1
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.|+|||||++++++..... .+...+|||||||+|+|++.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~-~~iiH 181 (398)
T 4b99_A 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIH 181 (398)
T ss_dssp HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBC
T ss_pred HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcC
Confidence 457899999999998864321 2345689999999999887775 45789999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-----CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+|||++ .++.+||+|||+|+.+... ....+.+||++|+|||++.+...++.++||||+|||+|+|++|.
T Consensus 182 RDlKP~NIl~~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~ 260 (398)
T 4b99_A 182 RDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260 (398)
T ss_dssp CCCCGGGEEEC-TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred CCcCccccccC-CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCC
Confidence 99999999999 5788999999999865432 22346789999999999988777899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC---ccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
+||.+.+..+++..|++..|.|+...+......... ...+.....+|...+ ..++++++|||.+||++||.+|+|+
T Consensus 261 ~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta 339 (398)
T 4b99_A 261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISA 339 (398)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCH
Confidence 999999999999999999999987665433211100 012333333444433 3589999999999999999999999
Q ss_pred HHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHH
Q 022500 232 LEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 283 (296)
Q Consensus 232 ~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (296)
+|+|+||||++..++.... ...+.+.+..+....+.+.+++++.+++.
T Consensus 340 ~e~L~Hp~f~~~~~p~~~p----~~~~~~~~~~~~~~~~~~~~k~~i~~ei~ 387 (398)
T 4b99_A 340 AAALRHPFLAKYHDPDDEP----DCAPPFDFAFDREALTRERIKEAIVAEIE 387 (398)
T ss_dssp HHHTTSGGGTTTCCGGGSC----CCSSCCCCHHHHSCCCHHHHHHHHHHHHH
T ss_pred HHHhcCHhhCcCCCCcccc----CCCCCCCCccchhhcCHHHHHHHHHHHHH
Confidence 9999999999987654322 22344555555566677777777766554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-57 Score=386.50 Aligned_cols=207 Identities=30% Similarity=0.538 Sum_probs=178.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||+++++|. +...+|||||||+| +|.+.+.. .+.+++..++.|+.||+.||+|||+ +||+|
T Consensus 86 l~~l~HpnIv~l~~~~~-----~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiH 155 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQ-----DDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIH 155 (311)
T ss_dssp HTTCCCTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEE-----eCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Confidence 57899999999999994 44459999999994 88887764 3679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+|||++ .++.+||+|||+|+.+.... ...+.+||+.|||||++.+. .|+.++||||+||++|+|++|.+|
T Consensus 156 RDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~P 233 (311)
T 4aw0_A 156 RDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPP 233 (311)
T ss_dssp SCCSGGGEEEC-TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHeEEc-CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999 57889999999998764322 23567899999999999764 599999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH---
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE--- 233 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e--- 233 (296)
|.+.+..+.+.+|.+. .+. ++..++++++|||.+||++||++|+|++|
T Consensus 234 F~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 234 FRAGNEGLIFAKIIKL-----------------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp SCCSSHHHHHHHHHHT-----------------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCCCCHHHHHHHHHcC-----------------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 9999988888888762 111 23458999999999999999999999887
Q ss_pred ---HhcCCCcccccCCCC
Q 022500 234 ---ACAHPFFDELREPNA 248 (296)
Q Consensus 234 ---~l~hp~f~~~~~~~~ 248 (296)
+++||||+++.|...
T Consensus 285 ~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 285 YGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHHHHTSGGGTTCCCTTG
T ss_pred CHHHHCCCCcCCCCHHHh
Confidence 589999999987653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=380.79 Aligned_cols=202 Identities=28% Similarity=0.449 Sum_probs=164.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++|||||++++++.+ ...+|||||||+|+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||
T Consensus 67 l~~l~HpnIv~~~~~~~~-----~~~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHR 136 (275)
T 3hyh_A 67 LRLLRHPHIIKLYDVIKS-----KDEIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHR 136 (275)
T ss_dssp HHHCCCTTBCCEEEEEEC-----SSEEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred HHHCCCCCCCeEEEEEEE-----CCEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 457899999999999944 445999999999998887763 4679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+|||++ .++.+||+|||+|+.........+.+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.
T Consensus 137 DiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 137 DLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp CCCTTTEEEC-TTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCChHHeEEC-CCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999 578899999999987665555567899999999999987665678999999999999999999999998
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
+..+.+..+.+.. + .++..+|+++++||.+||++||++|||++|+++||||
T Consensus 216 ~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 216 SIPVLFKNISNGV-----------------Y------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp SHHHHHHHHHHTC-----------------C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred CHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 8877777665521 0 1224589999999999999999999999999999999
Q ss_pred cc
Q 022500 241 DE 242 (296)
Q Consensus 241 ~~ 242 (296)
+.
T Consensus 267 k~ 268 (275)
T 3hyh_A 267 KV 268 (275)
T ss_dssp HT
T ss_pred cc
Confidence 73
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=384.72 Aligned_cols=205 Identities=27% Similarity=0.449 Sum_probs=173.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||+++++|... ..+|||||||+| +|.+.+.. +.+++..++.|+.||+.||+|||+ +||+|
T Consensus 125 l~~l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiH 193 (346)
T 4fih_A 125 MRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIH 193 (346)
T ss_dssp HHHCCCTTBCCEEEEEEET-----TEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 4578999999999999544 349999999995 77776653 569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+|+..... ....+.+||+.|||||++.+ ..|+.++||||+||++|+|++|.+||.
T Consensus 194 RDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 194 RDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp CCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCHHHEEEC-CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999 5788999999999876543 33456789999999999965 459999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..|.+...... .....+|++++|||.+||++||++|||++|+++||
T Consensus 272 ~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 272 NEPPLKAMKMIRDNLPPRL--------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp TSCHHHHHHHHHHSSCCCC--------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CcCHHHHHHHHHcCCCCCC--------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 9998888877765211000 01124799999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||++..
T Consensus 326 ~~~~~~ 331 (346)
T 4fih_A 326 FLAKAG 331 (346)
T ss_dssp GGGGCC
T ss_pred hhcCCC
Confidence 998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=377.72 Aligned_cols=205 Identities=27% Similarity=0.433 Sum_probs=175.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||++++++.+ ...+|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+|
T Consensus 80 l~~l~HpnIv~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiH 149 (304)
T 3ubd_A 80 LVEVNHPFIVKLHYAFQT-----EGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIY 149 (304)
T ss_dssp CCCCCCTTEECEEEEEEE-----TTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHHCCCCCCCeEEEEEEE-----CCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcC
Confidence 678999999999999954 344999999999 588877764 3679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+|+..... ....+.+||+.|||||++.+. .|+.++||||+||++|+|++|.+||.
T Consensus 150 RDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 150 RDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp SSCCGGGEEEC-TTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHeEEc-CCCCEEecccccceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCC
Confidence 99999999999 5788999999999865433 334567899999999999764 59999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e 233 (296)
+.+..+.+.+|.+.. . .++..+|+++++||++||++||++|+| ++|
T Consensus 228 ~~~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~e 278 (304)
T 3ubd_A 228 GKDRKETMTMILKAK-----------------L------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278 (304)
T ss_dssp CSSHHHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHH
T ss_pred CcCHHHHHHHHHcCC-----------------C------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHH
Confidence 999988888887621 0 022458999999999999999999998 589
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||++++|.
T Consensus 279 il~Hp~f~~idw~ 291 (304)
T 3ubd_A 279 IKRHSFFSTIDWN 291 (304)
T ss_dssp HHTSGGGTTCCHH
T ss_pred HHcCccccCCCHH
Confidence 9999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=387.51 Aligned_cols=284 Identities=63% Similarity=1.152 Sum_probs=256.4
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||++++++..... .+..++|+||||+++++.+.+..+......+++..++.++.||+.||+|||+ +||+|
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH 164 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICH 164 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccC
Confidence 457899999999999876554 5667789999999999888887776677889999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++..++.+||+|||+|+............||+.|+|||++.+...++.++||||+||++|+|++|.+||.+
T Consensus 165 rDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998557889999999998776666666788999999999997766799999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+++..+++.+|.|..+.+..+.+.+....++.....++...+...+++++.+||.+||++||.+|||+.|+++|||
T Consensus 245 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 99999999999999999999999999888888888888888888888889999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHhh
Q 022500 240 FDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 285 (296)
Q Consensus 240 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (296)
|+++++.....+..+.+++.+++..+.....++++.+++|++....
T Consensus 325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (394)
T 4e7w_A 325 FDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAE 370 (394)
T ss_dssp GSTTTSSCCCCTTSSCCCCSCCCCHHHHHTCGGGHHHHSCGGGCSS
T ss_pred hhhhccccccCCCCCCCCCcCCCCHHHhhcCHHHHHhhccHhhhhh
Confidence 9999998877778888899999998888888899999999887443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-55 Score=372.77 Aligned_cols=207 Identities=25% Similarity=0.386 Sum_probs=169.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--c
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--V 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i 77 (296)
|++|+|||||+++++|.... .+..++|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +| |
T Consensus 79 l~~l~HpnIV~~~~~~~~~~-~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~I 152 (290)
T 3fpq_A 79 LKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPI 152 (290)
T ss_dssp HHTCCCTTBCCEEEEEEEEE-TTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCC
T ss_pred HHhCCCCCCCcEEEEEeecc-CCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCE
Confidence 46799999999999986533 33456899999999 588877764 3679999999999999999999999 68 9
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
+||||||+|||++..++.+||+|||+|+.. ......+.+||+.|||||++.+ .|+.++||||+||++|+|++|.+||
T Consensus 153 iHRDlKp~NILl~~~~g~vKl~DFGla~~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf 229 (290)
T 3fpq_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CCCCCCGGGEEESSTTSCEEECCTTGGGGC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EecccChhheeEECCCCCEEEEeCcCCEeC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999855678999999999754 3334456789999999999864 5999999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+....+.+.+.....| ..++...++++++||.+||+.||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 230 SECQNAAQIYRRVTSGVKP--------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTCSSHHHHHHHHTTTCCC--------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCcHHHHHHHHHcCCCC--------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 8776655554443321111 01223478999999999999999999999999999
Q ss_pred CCccc
Q 022500 238 PFFDE 242 (296)
Q Consensus 238 p~f~~ 242 (296)
|||++
T Consensus 284 p~~~~ 288 (290)
T 3fpq_A 284 AFFQE 288 (290)
T ss_dssp GGGC-
T ss_pred ccccC
Confidence 99975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=385.56 Aligned_cols=205 Identities=28% Similarity=0.461 Sum_probs=174.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||+++++|... ..+|||||||+| +|.+.+.. ..+++..++.|+.||+.||+|||+ +||+|
T Consensus 202 l~~l~HpnIV~l~~~~~~~-----~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiH 270 (423)
T 4fie_A 202 MRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIH 270 (423)
T ss_dssp HHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCceEEEEEEC-----CEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 4678999999999999544 349999999995 77776653 569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+|+.+... ....+.+||+.|||||++.+. .|+.++||||+||++|+|++|.+||.
T Consensus 271 RDiKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 271 RDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp CCCSTTTEEEC-TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCHHHEEEc-CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999 5788999999999876543 334567999999999999654 59999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..|..... +. ......+++++++||.+||++||.+|+|++|+|+||
T Consensus 349 ~~~~~~~~~~i~~~~~-~~-------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 349 NEPPLKAMKMIRDNLP-PR-------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp TSCHHHHHHHHHHSCC-CC-------------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CcCHHHHHHHHHcCCC-CC-------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 9998888877765211 00 001234899999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||++..
T Consensus 403 ~~~~~~ 408 (423)
T 4fie_A 403 FLAKAG 408 (423)
T ss_dssp GGGGCC
T ss_pred HhcCCC
Confidence 998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=380.95 Aligned_cols=204 Identities=24% Similarity=0.364 Sum_probs=174.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||++++++.+ ...+|||||||+ |+|.+.+.. .....+++..++.|+.||+.||+|||+ +||+|
T Consensus 77 l~~l~HpnIV~~~~~~~~-----~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiH 148 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEE-----NGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILH 148 (350)
T ss_dssp HHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEE
T ss_pred HHHCCCCCCCcEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 457899999999999954 344999999998 588888864 234568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+|+...... ...+.+||+.|||||++.+. .|+.++||||+||++|+|++|.+||.
T Consensus 149 RDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 149 RDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp TTCCGGGEEEC-TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCHHHEEEC-CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999 57889999999998764332 23456899999999999764 59999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+.++.+..-. ..+..+|+++++||.+||++||++|||++|+++||
T Consensus 227 ~~~~~~~~~~i~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 227 AGSMKNLVLKIISGSFP----------------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp CSSHHHHHHHHHHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CcCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 99998888888763110 01234799999999999999999999999999999
Q ss_pred Cccc
Q 022500 239 FFDE 242 (296)
Q Consensus 239 ~f~~ 242 (296)
||++
T Consensus 279 ~~~~ 282 (350)
T 4b9d_A 279 FIAK 282 (350)
T ss_dssp HHHT
T ss_pred Hhhc
Confidence 9975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=373.29 Aligned_cols=210 Identities=24% Similarity=0.373 Sum_probs=171.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||++++++.+ ...+|||||||+ |+|.+.++. .+.+++..++.|+.||+.||+|||+ +||+|
T Consensus 104 l~~l~HpnIV~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiH 173 (336)
T 4g3f_A 104 CAGLSSPRIVPLYGAVRE-----GPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILH 173 (336)
T ss_dssp TTTCCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred HHhCCCCCCCcEEEEEEE-----CCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcee
Confidence 678999999999999954 345999999999 588888764 3679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
|||||+|||++.++..+||+|||+|+....... ....+||+.|||||++.+. .|+.++||||+||++|+|++|
T Consensus 174 RDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG 252 (336)
T 4g3f_A 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNG 252 (336)
T ss_dssp SCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHS
T ss_pred cccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHC
Confidence 999999999985334699999999987644321 1235799999999999764 599999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
.+||.+.+..+.+.+|... .++ ...++..+++++.+||.+||++||.+|||+.|
T Consensus 253 ~~Pf~~~~~~~~~~~i~~~--~~~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~e 306 (336)
T 4g3f_A 253 CHPWTQYFRGPLCLKIASE--PPP------------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAME 306 (336)
T ss_dssp SCSSTTTCCSCCHHHHHHS--CCG------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCCCCHHHHHHHHHcC--CCC------------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999988776666666552 110 01133458999999999999999999999999
Q ss_pred H-------------hcCCCcccccCCC
Q 022500 234 A-------------CAHPFFDELREPN 247 (296)
Q Consensus 234 ~-------------l~hp~f~~~~~~~ 247 (296)
+ ++|||+.++.++.
T Consensus 307 l~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 307 LRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp HHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred HHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 7 6799998876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=379.76 Aligned_cols=283 Identities=49% Similarity=0.972 Sum_probs=239.2
Q ss_pred CCCCCCCCeeeeceeeeccCC---------------------------------CCcceEEEEeccCcccHHHHHHHhhh
Q 022500 1 MRVMDHPNVISLKHCFFSTTS---------------------------------KNELFLNLVMEYVPESMYRVLKHYSS 47 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~---------------------------------~~~~~~~lv~E~~~g~l~~~l~~~~~ 47 (296)
|+.++|||||++++++..... .+..++++||||++|+|.+.+..+..
T Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~ 133 (383)
T 3eb0_A 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR 133 (383)
T ss_dssp HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHHHHH
T ss_pred HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHh
Confidence 468899999999999865443 34556889999999999999988877
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchh
Q 022500 48 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 127 (296)
Q Consensus 48 ~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~ 127 (296)
.+..+++..++.++.||+.||+|||+ +||+||||||+||+++..++.+||+|||+|+............+|+.|+|||+
T Consensus 134 ~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~ 212 (383)
T 3eb0_A 134 SGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPEL 212 (383)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHH-CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHH
Confidence 88899999999999999999999999 79999999999999985578899999999987766666667789999999999
Q ss_pred ccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCC
Q 022500 128 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 207 (296)
Q Consensus 128 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (296)
+.+...++.++||||+||++|+|++|.+||.+.+..+++..+++..|.|..+.+..+.+.+....++......|...++.
T Consensus 213 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (383)
T 3eb0_A 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292 (383)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCT
T ss_pred hcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCC
Confidence 97766699999999999999999999999999999999999999999999999999999999999999888899999999
Q ss_pred CCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccC-------CCCCCCCC--CCCCCCCCchhhh-cCCCHHHHhhh
Q 022500 208 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE-------PNARLPNG--RPLPPLFNFKQEL-SGASPELVNKL 277 (296)
Q Consensus 208 ~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~ 277 (296)
.+++++.+||.+||++||.+|||+.|+++||||+.+++ .....+++ ..++..+++.... +...++...++
T Consensus 293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 372 (383)
T 3eb0_A 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRI 372 (383)
T ss_dssp TCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhc
Confidence 99999999999999999999999999999999998765 23333444 5677888887554 44588999999
Q ss_pred cHHHHHh
Q 022500 278 IPDHVKR 284 (296)
Q Consensus 278 ~~~~~~~ 284 (296)
+|++...
T Consensus 373 ~~~~~~~ 379 (383)
T 3eb0_A 373 LPKNFSP 379 (383)
T ss_dssp SCC----
T ss_pred Cchhhcc
Confidence 8887654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-53 Score=381.10 Aligned_cols=280 Identities=68% Similarity=1.216 Sum_probs=245.0
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||++++++..... .+..++++||||+++++.+.+..+......+++..++.++.||+.||+|||+ +||+|
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH 179 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICH 179 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 457899999999998865432 4566788999999999988888777777889999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++.+++.+||+|||+++...........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+
T Consensus 180 rDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999656778999999998776555556778999999999997766799999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+++.++++.+|.|..+.+..+.+.+..+.++.....+|...+...+++++++||.+||++||.+|+|+.|+++|||
T Consensus 260 ~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 99999999999999999999999999999999899888889988888889999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHH
Q 022500 240 FDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 281 (296)
Q Consensus 240 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (296)
|+.+++.....+.....+..+++........+++...+++.+
T Consensus 340 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (420)
T 1j1b_A 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPH 381 (420)
T ss_dssp GGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCGGGHHHHSCTT
T ss_pred hcccccccccCCCCCCCCccCCCCHHHhccChhHHHhhCCHh
Confidence 999988877767777777788877655555565555555443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=373.27 Aligned_cols=227 Identities=29% Similarity=0.470 Sum_probs=173.4
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+|||||+++++|.. ..++|||||||+ |+|.+.+. .+++..++.++.||+.||+|||+ +||+|||||
T Consensus 78 ~h~nIv~l~~~~~~-----~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiK 144 (361)
T 4f9c_A 78 GQDNVMGVKYCFRK-----NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVK 144 (361)
T ss_dssp SBTTBCCCSEEEEE-----TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCS
T ss_pred CCCCCceEEEEEEE-----CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCC
Confidence 69999999999944 445999999998 57766652 48999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCC-----------------------------CccceeecccccCchhccCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGE-----------------------------ANISYICSRFYRAPELIFGATEY 134 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~ 134 (296)
|+|||++.+.+.+||+|||+|+...... ...+.+||++|+|||++.+...|
T Consensus 145 PeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y 224 (361)
T 4f9c_A 145 PSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQ 224 (361)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCC
T ss_pred HHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC
Confidence 9999998655789999999997543221 12345799999999999877679
Q ss_pred CchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCHHHHhhcCcCC--cC-------------------cc
Q 022500 135 TTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNPNY--TD-------------------FR 192 (296)
Q Consensus 135 ~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~-------------------~~ 192 (296)
+.++||||+||++|+|++|+.|| .+.+..+++.+|.+..|++............ .. ..
T Consensus 225 ~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 304 (361)
T 4f9c_A 225 TTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSS 304 (361)
T ss_dssp CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----
T ss_pred CCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccc
Confidence 99999999999999999999888 5567889999999988876544332211000 00 00
Q ss_pred CCC----CCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 193 FPQ----IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 193 ~~~----~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
.+. .............+|++++|||++||++||++|+|++|+|+||||+++.
T Consensus 305 ~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 305 TPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred ccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000 0000111122345899999999999999999999999999999999763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=349.71 Aligned_cols=213 Identities=22% Similarity=0.391 Sum_probs=153.6
Q ss_pred CCCCCCCCeeeeceeeeccCC-------CCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-------KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 72 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-------~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH 72 (296)
|++|+|||||+++++|..... ....++|||||||+ |+|.+.+.... .....++..++.++.||+.||+|||
T Consensus 57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH 135 (299)
T 4g31_A 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLH 135 (299)
T ss_dssp HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999875442 23456899999998 58877776421 1123466778999999999999999
Q ss_pred hCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-------------ccceeecccccCchhccCCCCCCchhH
Q 022500 73 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-------------NISYICSRFYRAPELIFGATEYTTSID 139 (296)
Q Consensus 73 ~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 139 (296)
+ +||+||||||+|||++ .++.+||+|||+|+....... ..+.+||+.|||||++.+. .|+.++|
T Consensus 136 ~-~~IiHRDlKp~NILl~-~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~D 212 (299)
T 4g31_A 136 S-KGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVD 212 (299)
T ss_dssp H-TTCCCCCCCGGGEEEC-TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHH
T ss_pred H-CcCccccCcHHHeEEC-CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHH
Confidence 9 7999999999999999 478899999999987643221 2345799999999999764 5999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHc
Q 022500 140 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 219 (296)
Q Consensus 140 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 219 (296)
|||+||++|+|++ ||.+.. +....+........++.. ...++.+.+||.+
T Consensus 213 iwSlGvilyell~---Pf~~~~--~~~~~~~~~~~~~~p~~~-------------------------~~~~~~~~~li~~ 262 (299)
T 4g31_A 213 IFSLGLILFELLY---PFSTQM--ERVRTLTDVRNLKFPPLF-------------------------TQKYPCEYVMVQD 262 (299)
T ss_dssp HHHHHHHHHHHHS---CCSSHH--HHHHHHHHHHTTCCCHHH-------------------------HHHCHHHHHHHHH
T ss_pred HHHHHHHHHHHcc---CCCCcc--HHHHHHHHHhcCCCCCCC-------------------------cccCHHHHHHHHH
Confidence 9999999999996 775432 222222221111111110 1246788999999
Q ss_pred ccccCCCCCCCHHHHhcCCCcccccCCC
Q 022500 220 LLQYSPSLRCTALEACAHPFFDELREPN 247 (296)
Q Consensus 220 ~L~~~p~~R~t~~e~l~hp~f~~~~~~~ 247 (296)
||+.||.+|||+.|+++||||+++.++.
T Consensus 263 ~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 263 MLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 9999999999999999999999886654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=375.92 Aligned_cols=204 Identities=25% Similarity=0.364 Sum_probs=171.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|||||+++++|. +...+|||||||+ |+|.+.+.. .+.+++..++.|+.||+.||+|||+ +||+||
T Consensus 247 ~~~~HP~IV~l~~~f~-----~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHR 316 (689)
T 3v5w_A 247 STGDCPFIVCMSYAFH-----TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYR 316 (689)
T ss_dssp SSSCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECC
T ss_pred hhCCCCCEeEEEEEEE-----ECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 5679999999999994 4445999999999 588877764 4679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+|||++ .++.+||+|||+|+..... ...+.+||+.|||||++.+...|+.++||||+||++|+|++|.+||.+.
T Consensus 317 DLKPeNILld-~~G~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 317 DLKPANILLD-EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CCSGGGEEEC-TTSCEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CCchHHeEEe-CCCCEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999 5788999999999876433 3456799999999999965556999999999999999999999999765
Q ss_pred Ch---HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HH
Q 022500 161 NA---VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----AL 232 (296)
Q Consensus 161 ~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~ 232 (296)
+. .+....+... . ..++..+|+++++||.+||++||.+|++ ++
T Consensus 395 ~~~~~~~i~~~i~~~-----------------~------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ 445 (689)
T 3v5w_A 395 KTKDKHEIDRMTLTM-----------------A------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 445 (689)
T ss_dssp GCCCHHHHHHHHHHC-----------------C------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHH
T ss_pred ChHHHHHHHHhhcCC-----------------C------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHH
Confidence 32 2223333221 0 0123458999999999999999999998 79
Q ss_pred HHhcCCCcccccCC
Q 022500 233 EACAHPFFDELREP 246 (296)
Q Consensus 233 e~l~hp~f~~~~~~ 246 (296)
|+++||||+++.|.
T Consensus 446 ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 446 EVKESPFFRSLDWQ 459 (689)
T ss_dssp HHTTSGGGTTCCHH
T ss_pred HHhcCccccCCCHH
Confidence 99999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=374.53 Aligned_cols=211 Identities=24% Similarity=0.389 Sum_probs=179.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.|+|||||+++++|. +...+|||||||+ |+|++.+.. ..+.+++..++.|+.||+.||+|||+ +||+|
T Consensus 208 l~~l~hpnIv~l~~~~~-----~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiH 278 (573)
T 3uto_A 208 MSVLRHPTLVNLHDAFE-----DDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVH 278 (573)
T ss_dssp HHHTCCTTBCCEEEEEE-----CSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEE-----ECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 45789999999999994 4455999999999 587776642 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCC-CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++.. .+.+||+|||+|+.+.........+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.
T Consensus 279 RDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp CCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999999999743 368999999999987666666678899999999999764 59999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..|.+....... .....+|++++|||++||++||.+|||+.|+|+||
T Consensus 358 ~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 358 GENDDETLRNVKSCDWNMDD-------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp CSSHHHHHHHHHTTCCCCCS-------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CcCHHHHHHHHHhCCCCCCc-------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 99998888887763222111 12235899999999999999999999999999999
Q ss_pred CcccccCC
Q 022500 239 FFDELREP 246 (296)
Q Consensus 239 ~f~~~~~~ 246 (296)
||+...++
T Consensus 413 w~~~~~~~ 420 (573)
T 3uto_A 413 WLTPGNAP 420 (573)
T ss_dssp TTSCCCCT
T ss_pred CcCCCCCC
Confidence 99987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=338.25 Aligned_cols=202 Identities=22% Similarity=0.295 Sum_probs=159.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. + .+|||||||+ |+|.+.+.. ....+++..+..++.||+.||+|||+ ++|+|
T Consensus 86 l~~l~HpNIV~l~g~~~~-~-----~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiH 155 (307)
T 3omv_A 86 LRKTRHVNILLFMGYMTK-D-----NLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIH 155 (307)
T ss_dssp HTTCCCTTBCCEEEEECS-S-----SCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBC
T ss_pred HHhCCCCCEeeEEEEEEC-C-----eEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccC
Confidence 578999999999997632 1 2789999999 588877753 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+|||++ .++.+||+|||+|+...... .....+||+.|||||++.+. ..|+.++||||+||++|||+||.
T Consensus 156 RDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~ 234 (307)
T 3omv_A 156 RDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234 (307)
T ss_dssp SCCCSSSEEEE-TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCHHHEEEC-CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCC
Confidence 99999999999 57899999999998654322 23456899999999999643 34899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+....+..++.....+ +. ....+..+++++.+|+.+||+.||++|||+.|+
T Consensus 235 ~Pf~~~~~~~~~~~~~~~~~~~-----------------p~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 291 (307)
T 3omv_A 235 LPYSHINNRDQIIFMVGRGYAS-----------------PD------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQI 291 (307)
T ss_dssp CTTTTCCCHHHHHHHHHTTCCC-----------------CC------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred CCCCCCChHHHHHHHHhcCCCC-----------------CC------cccccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9999887776666655421111 00 011234579999999999999999999999887
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 292 ~~ 293 (307)
T 3omv_A 292 LS 293 (307)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=352.97 Aligned_cols=273 Identities=30% Similarity=0.543 Sum_probs=205.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++|||||++++++..........+|+||||++|+|.+.+. ....+++..++.++.||+.||+|||+ +||+|||
T Consensus 107 ~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrD 181 (458)
T 3rp9_A 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRD 181 (458)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCC
T ss_pred HhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCC
Confidence 468999999999998765545556689999999999887776 35679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC----------------------------CccceeecccccCchhccCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE----------------------------ANISYICSRFYRAPELIFGATE 133 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~ 133 (296)
|||+|||++ .++.+||+|||+|+...... .....+||++|+|||++.+...
T Consensus 182 lKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 260 (458)
T 3rp9_A 182 LKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260 (458)
T ss_dssp CCGGGEEEC-TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCC
T ss_pred CChhhEEEC-CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCC
Confidence 999999999 57889999999998653221 1234678999999998765567
Q ss_pred CCchhHHHHHHHHHHHHHh-----------CCCCCCCCC--------------------hHHHHHHHHHhcCCCCHHHHh
Q 022500 134 YTTSIDIWSAGCVLAELLL-----------GQPLFPGEN--------------------AVDQLVEIIKVLGTPTREEIR 182 (296)
Q Consensus 134 ~~~~~DiwslG~il~~ll~-----------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~ 182 (296)
++.++||||+||++|+|++ |.++|++.+ ..+++..|.+.+|.|..+.+.
T Consensus 261 ~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~ 340 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE 340 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHh
Confidence 9999999999999999998 778887765 367888999999999988776
Q ss_pred hcCcCCc-C--ccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCC
Q 022500 183 CMNPNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPL 259 (296)
Q Consensus 183 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~ 259 (296)
....... . ..++......+...+ ...++++++||++||++||.+|+|++|+|+||||+++++.........+..
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~-- 417 (458)
T 3rp9_A 341 ALEKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVR-- 417 (458)
T ss_dssp TSSCHHHHHHHTTSCCCCCCCGGGGS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCC--
T ss_pred hcCCHHHHHHHHhcCCCCCCCHHHHC-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCC--
Confidence 5432100 0 012222222333323 347999999999999999999999999999999999987654332222221
Q ss_pred CCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 260 FNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
+.+. +....+.+.+++++.+++..
T Consensus 418 ~~~~-~~~~~~~~~~~~~~~~e~~~ 441 (458)
T 3rp9_A 418 LPFN-DWMNMDEPQLRYAFVKEIQR 441 (458)
T ss_dssp CSSC-TTSCCCHHHHHHHHHHHHTT
T ss_pred CCcc-ccccCCHHHHHHHHHHHHHH
Confidence 2222 33456777788887777653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=336.75 Aligned_cols=206 Identities=22% Similarity=0.314 Sum_probs=170.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAY 70 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~---------~~~~~~~~~~~~~~~~qil~aL~~ 70 (296)
|++|+|||||++++++.... .+|||||||+ |+|.+.+.... .....+++..+..++.||+.||+|
T Consensus 69 l~~l~HpnIV~l~g~~~~~~-----~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 143 (299)
T 4asz_A 69 LTNLQHEHIVKFYGVCVEGD-----PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY 143 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSS-----SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCccEEEEEeeCC-----EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 57899999999999995433 3899999999 69988887532 223579999999999999999999
Q ss_pred HHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 71 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 71 LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
||+ ++|+||||||+|||++ .++.+||+|||+|+....... .....||+.|||||++.+. .|+.++||||+||++
T Consensus 144 LH~-~~iiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 144 LAS-QHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVL 220 (299)
T ss_dssp HHH-TTCCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred HHh-CCcccCccCHhhEEEC-CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHH
Confidence 999 7999999999999999 578899999999986543322 2345789999999999764 599999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 148 AELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 148 ~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|||+| |..||.+.+..+.+..+.+..- + ..+..+++++.+|+.+||+.||+
T Consensus 221 ~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~ 272 (299)
T 4asz_A 221 WEIFTYGKQPWYQLSNNEVIECITQGRV-L---------------------------QRPRTCPQEVYELMLGCWQREPH 272 (299)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHHTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCC-C---------------------------CCCccchHHHHHHHHHHcCCChh
Confidence 99998 8999999988887777655210 0 02245899999999999999999
Q ss_pred CCCCHHHHhcCCCccccc
Q 022500 227 LRCTALEACAHPFFDELR 244 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~ 244 (296)
+|||+.++ ++|++++.
T Consensus 273 ~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 273 MRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp GSCCHHHH--HHHHHHHH
T ss_pred HCcCHHHH--HHHHHHHH
Confidence 99999999 45777653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=356.60 Aligned_cols=271 Identities=30% Similarity=0.544 Sum_probs=194.8
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||++++++..... .+...+|+||||+++++.+.+. ..+++..++.++.||+.||+|||+ +||+|
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiH 187 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIH 187 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 356899999999999865432 2345689999999998776664 348999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+||+|||+|+...........+||++|+|||++.+. .|+.++||||+||++|+|++|.+||.+
T Consensus 188 rDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 188 RDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp CCCCGGGEEEC-TTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCChHhEEEe-CCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 5788999999999877655555678899999999999765 599999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCcc--CCCCCCCCcccccCCC-----------CCHHHHHHHHcccccCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR--FPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~dll~~~L~~~p~ 226 (296)
.+..+++.++++.+|.|..+.+.........+. .+......+...++.. .+++++|||.+||++||+
T Consensus 266 ~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 345 (464)
T 3ttj_A 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345 (464)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChh
Confidence 999999999999999999887765543221110 1111112222222221 156899999999999999
Q ss_pred CCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHH
Q 022500 227 LRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 283 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (296)
+|||++|+|+||||+....+..... +.+..+....+....+.+...+++.+++.
T Consensus 346 ~R~ta~e~L~Hp~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 399 (464)
T 3ttj_A 346 KRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELIYKEVM 399 (464)
T ss_dssp TSCCHHHHHTSTTTGGGCCHHHHSC---CC-----------CCCHHHHHHHHHHHHH
T ss_pred hCCCHHHHhcChhhhhccCcccccC---CCCccCCcchhhccCCHHHHHHHHHHHHH
Confidence 9999999999999997665432111 11122333333334455555555554443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=339.70 Aligned_cols=254 Identities=47% Similarity=0.937 Sum_probs=214.9
Q ss_pred CCCCCCeeeeceeeeccCC--CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcc
Q 022500 3 VMDHPNVISLKHCFFSTTS--KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--TVPRVC 78 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~--~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH--~~~~i~ 78 (296)
.++||||+++++++..... ....++++||||+++++...+..+......+++..++.++.|++.||.||| + +||+
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~iv 153 (360)
T 3e3p_A 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVC 153 (360)
T ss_dssp HHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCB
T ss_pred hcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCee
Confidence 4689999999999875443 345568899999999988888777777788999999999999999999999 9 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||||+||+++..++.+||+|||++.............||+.|+|||++.+...++.++||||+||++|+|++|..||.
T Consensus 154 H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 99999999999854789999999999877655555567889999999999776668999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCC---CCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
+.+....+..+++..+.+..+.+....+.............+|...++. ..++++.+||.+||+.||.+|||+.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 234 GDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 9999999999999999999998888776665555544444555544433 3678999999999999999999999999
Q ss_pred cCCCcccccCCCCCCCCCCCCC
Q 022500 236 AHPFFDELREPNARLPNGRPLP 257 (296)
Q Consensus 236 ~hp~f~~~~~~~~~~~~~~~~~ 257 (296)
+||||+++..+....+....++
T Consensus 314 ~hp~f~~~~~~~~~~~~~~~~~ 335 (360)
T 3e3p_A 314 CHPYFDELHDPATKLPNNKDLP 335 (360)
T ss_dssp TSGGGGGGGCTTCCCTTSCCCC
T ss_pred cCccccccCCccccCCCCCCCC
Confidence 9999999987766555444443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=346.94 Aligned_cols=274 Identities=29% Similarity=0.512 Sum_probs=205.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++..........+|+||||++|+|.+.+. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~-~givHr 153 (432)
T 3n9x_A 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHE-SGIIHR 153 (432)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCC
Confidence 3568999999999998755433335689999999999888776 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-----------------------CccceeecccccCchhccCCCCCCch
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-----------------------ANISYICSRFYRAPELIFGATEYTTS 137 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~ 137 (296)
||||+|||++ .++.+||+|||+|+...... .....+||++|+|||++.+...++.+
T Consensus 154 Dlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~ 232 (432)
T 3n9x_A 154 DLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232 (432)
T ss_dssp CCCGGGEEEC-TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTH
T ss_pred CCCHHHeEEC-CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc
Confidence 9999999999 57889999999998654322 12567889999999997666679999
Q ss_pred hHHHHHHHHHHHHHh-----------CCCCCCCCC-----------------hHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 022500 138 IDIWSAGCVLAELLL-----------GQPLFPGEN-----------------AVDQLVEIIKVLGTPTREEIRCMNPNYT 189 (296)
Q Consensus 138 ~DiwslG~il~~ll~-----------g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 189 (296)
+||||+||++|+|++ |.++|++.+ ..+++..|++.+|.|..+.+........
T Consensus 233 ~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~ 312 (432)
T 3n9x_A 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312 (432)
T ss_dssp HHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHH
Confidence 999999999999997 566666654 4688999999999999887765432110
Q ss_pred -Cc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhh
Q 022500 190 -DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL 266 (296)
Q Consensus 190 -~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (296)
.+ ..+.....++...+ ..+++++++||++||++||.+|||++|+|+||||+++++.........+.. +.+. +.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~-~~ 388 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKII--LPFD-DW 388 (432)
T ss_dssp HHHHHTSCCCCCCCHHHHS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCC--CSSC-TT
T ss_pred HHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCC--CChh-hc
Confidence 00 11111222222222 348999999999999999999999999999999999987654322222222 2222 22
Q ss_pred cCCCHHHHhhhcHHHHHh
Q 022500 267 SGASPELVNKLIPDHVKR 284 (296)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~ 284 (296)
...+.+.+++++.+++..
T Consensus 389 ~~~~~~~~~~~~~~e~~~ 406 (432)
T 3n9x_A 389 MVLSETQLRYIFLKEVQS 406 (432)
T ss_dssp CCCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHH
Confidence 456778888888777764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=341.39 Aligned_cols=268 Identities=28% Similarity=0.564 Sum_probs=200.3
Q ss_pred CCC-CCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.+. ||||+++++++... +...+|+|||||+|+|...+.. ..+++..++.++.||+.||+|||+ +||+|||
T Consensus 64 ~l~~h~niv~l~~~~~~~---~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrD 134 (388)
T 3oz6_A 64 ELSGHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRD 134 (388)
T ss_dssp HTTTCTTBCCEEEEEECT---TSSCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred hccCCCCCCeeeeEEecC---CCCEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCC
Confidence 455 99999999998642 2234889999999998887764 469999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccC----------------------CCccceeecccccCchhccCCCCCCchhH
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAG----------------------EANISYICSRFYRAPELIFGATEYTTSID 139 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 139 (296)
|||+|||++ .++.+||+|||+|+..... ......+||++|+|||++.+...++.++|
T Consensus 135 lkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 213 (388)
T 3oz6_A 135 MKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213 (388)
T ss_dssp CCGGGEEEC-TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHH
T ss_pred CCHHHeEEc-CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhh
Confidence 999999999 5788999999999765321 11234689999999999977667999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccC------CCCCCCCcccc---------
Q 022500 140 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF------PQIKAHPWHKV--------- 204 (296)
Q Consensus 140 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~--------- 204 (296)
|||+||++|+|++|.+||.+.+..+++..+++..|.|..+.+......+..... .......+...
T Consensus 214 iwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (388)
T 3oz6_A 214 MWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLL 293 (388)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcc
Confidence 999999999999999999999999999999999999998877654432211000 00000001100
Q ss_pred ---cCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHH
Q 022500 205 ---FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 281 (296)
Q Consensus 205 ---~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (296)
....+++++++||.+||++||.+|||++|+++||||+.+..+.........+...+ . +....+.+..++++.++
T Consensus 294 ~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~ 370 (388)
T 3oz6_A 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPI--N-DNVKHSIDDYRNLVYSE 370 (388)
T ss_dssp HHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC---------CCHHHHHHHHHHH
T ss_pred cccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCc--c-ccccCCHHHHHHHHHHH
Confidence 11257899999999999999999999999999999998877654333232222222 1 12334566666666666
Q ss_pred HH
Q 022500 282 VK 283 (296)
Q Consensus 282 ~~ 283 (296)
+.
T Consensus 371 ~~ 372 (388)
T 3oz6_A 371 IS 372 (388)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=337.25 Aligned_cols=200 Identities=23% Similarity=0.318 Sum_probs=159.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh-----------hcCCCCCHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS-----------SANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~-----------~~~~~~~~~~~~~~~~qil~aL 68 (296)
|++|+|||||++++++.... .+|||||||+ |+|.+.+.... ....++++..+..++.||+.||
T Consensus 97 l~~l~HpnIV~l~g~~~~~~-----~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl 171 (329)
T 4aoj_A 97 LTMLQHQHIVRFFGVCTEGR-----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171 (329)
T ss_dssp HTTCCCTTBCCEEEEECSSS-----SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECC-----EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHH
Confidence 57899999999999995433 4899999999 68888876432 1235699999999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
+|||+ ++|+||||||+|||++ .++.+||+|||+|+...... ......||+.|||||++.+. .|+.++||||+||
T Consensus 172 ~yLH~-~~iiHRDLKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 172 VYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGV 248 (329)
T ss_dssp HHHHH-TTCCCSCCCGGGEEEE-TTTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHH
T ss_pred HHHhc-CCeecccccHhhEEEC-CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHH
Confidence 99999 7999999999999999 58899999999998654332 22346789999999999764 5999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 146 VLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 146 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
++|||+| |+.||.+.+..+.+..+.+... + ..+..+++++.+|+.+||+.|
T Consensus 249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~-~---------------------------~~p~~~~~~~~~li~~cl~~d 300 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRE-L---------------------------ERPRACPPEVYAIMRGCWQRE 300 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHHHHHHHHHHTCC-C---------------------------CCCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C---------------------------CCcccccHHHHHHHHHHcCcC
Confidence 9999998 8999999988887777654210 0 122458999999999999999
Q ss_pred CCCCCCHHHHhc
Q 022500 225 PSLRCTALEACA 236 (296)
Q Consensus 225 p~~R~t~~e~l~ 236 (296)
|++|||+.|+++
T Consensus 301 P~~RPs~~ei~~ 312 (329)
T 4aoj_A 301 PQQRHSIKDVHA 312 (329)
T ss_dssp TTTSCCHHHHHH
T ss_pred hhHCcCHHHHHH
Confidence 999999999976
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=334.61 Aligned_cols=201 Identities=24% Similarity=0.291 Sum_probs=165.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~~~~qil~a 67 (296)
|++|+|||||++++++.... .+|||||||+ |+|.+.+.... .....+++..+..++.||+.|
T Consensus 83 l~~l~HpNIV~l~g~~~~~~-----~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 157 (308)
T 4gt4_A 83 RARLQHPNVVCLLGVVTKDQ-----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 157 (308)
T ss_dssp HHHCCCTTBCCEEEEECSSS-----SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCcceEEEECC-----EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHH
Confidence 35789999999999985433 3889999999 68888886421 113468999999999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|+|||+ ++|+||||||+|||++ .++.+||+|||+|+...... ......||+.|||||++.+. .|+.++||||+|
T Consensus 158 l~yLH~-~~iiHRDLK~~NILl~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfG 234 (308)
T 4gt4_A 158 MEYLSS-HHVVHKDLATRNVLVY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYG 234 (308)
T ss_dssp HHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHH
T ss_pred HHHHHh-CCCCCCCccccceEEC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHH
Confidence 999999 7999999999999999 57889999999998654322 23456789999999999764 599999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
|++|||+| |..||.+.+..+.+..+.+....| .+..+++++.+|+.+||+.
T Consensus 235 vvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~ 286 (308)
T 4gt4_A 235 VVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP----------------------------CPDDCPAWVYALMIECWNE 286 (308)
T ss_dssp HHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CcccchHHHHHHHHHHcCC
Confidence 99999998 899999998877776665421100 2245799999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 022500 224 SPSLRCTALEACAH 237 (296)
Q Consensus 224 ~p~~R~t~~e~l~h 237 (296)
||++|||+.|++++
T Consensus 287 dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 287 FPSRRPRFKDIHSR 300 (308)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=331.22 Aligned_cols=232 Identities=36% Similarity=0.694 Sum_probs=187.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++. +...+|+||||++|++.+.+.. ....+++..++.++.|++.||+|||+ +||+|||
T Consensus 74 ~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~D 144 (311)
T 3niz_A 74 KELHHPNIVSLIDVIH-----SERCLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRD 144 (311)
T ss_dssp HHCCCTTBCCEEEEEC-----CSSCEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred HHcCCCCEeeeeeEEc-----cCCEEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCC
Confidence 4689999999999984 3445899999999998887764 34569999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||+++...... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.
T Consensus 145 ikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 145 LKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CCGGGEEEC-TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CchHhEEEC-CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999 47789999999998764332 2344578999999999977666899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcC--CcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+..+.+..+.+..+.+....+...... +...........++.. ....+++++.+||.+||++||.+|||++|+++||
T Consensus 224 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 302 (311)
T 3niz_A 224 TDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302 (311)
T ss_dssp STTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred ChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 999999999999888876655433211 1111112222222322 3345899999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||+++.
T Consensus 303 ~f~~~~ 308 (311)
T 3niz_A 303 YFKDLD 308 (311)
T ss_dssp GGTTSC
T ss_pred ccccCC
Confidence 999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=324.38 Aligned_cols=234 Identities=33% Similarity=0.581 Sum_probs=186.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.. ...+|+||||++|++.+.+.. ..+.+++..++.++.|++.||+|||+ +||+||
T Consensus 55 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~ 125 (292)
T 3o0g_A 55 LKELKHKNIVRLHDVLHS-----DKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHR 125 (292)
T ss_dssp HTTCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhcCCCCCEeeEEeEEEe-----CCEEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 467899999999999854 344899999999988777654 45679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-CC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~ 158 (296)
||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+...++.++||||+||++|+|++|..| |.
T Consensus 126 dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 126 DLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCSGGGEEEC-TTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred CCCHHHEEEc-CCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 9999999999 57889999999998664332 234567899999999997766689999999999999999987655 77
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..+.+..+.+..+.+............+..............+++++++||.+||+.||++|||++|+++||
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 78888889999999888887665543321111111111111122223345899999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||+++.
T Consensus 285 ~f~~~~ 290 (292)
T 3o0g_A 285 YFSDFC 290 (292)
T ss_dssp GGTTC-
T ss_pred ccccCC
Confidence 999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=330.85 Aligned_cols=243 Identities=34% Similarity=0.665 Sum_probs=190.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++... ..+|+||||++|+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~ 124 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHR 124 (324)
T ss_dssp HSCCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEES
T ss_pred HHhcCCCCCCeeeeEEeeC-----CEEEEEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCC
Confidence 4678999999999998543 34899999999998887764 34569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+
T Consensus 125 Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 125 DLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp SCCGGGEEEC-TTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcCHHHEEEC-CCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 47789999999997654322 233457899999999997766789999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcC--CcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+..+.+..|.+....+...... +..+..+......... ....+++++.+||.+||+.||++|||++|+++|
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 9999999999999998887655433211 1112222222222222 234589999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCC
Q 022500 238 PFFDELREPNARLPNGR 254 (296)
Q Consensus 238 p~f~~~~~~~~~~~~~~ 254 (296)
|||.++.+.....+...
T Consensus 283 p~f~~~~~~~~~~~~~~ 299 (324)
T 3mtl_A 283 PFFLSLGERIHKLPDTT 299 (324)
T ss_dssp GGGGGGCSTTSSSCTTS
T ss_pred hhhhhcccccccCCCCC
Confidence 99999877655544433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=331.98 Aligned_cols=268 Identities=31% Similarity=0.573 Sum_probs=203.7
Q ss_pred CCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++..... .+...+|+||||++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~ 152 (367)
T 1cm8_A 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHR 152 (367)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 56899999999999865432 22344789999998888877764 569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||+++.... .....++|++|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus 153 Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 153 DLKPGNLAVN-EDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp CCCGGGEEEC-TTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcCHHHEEEc-CCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999 478899999999986533 2345688999999999987567999999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCc-Cc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+..+++..+++..|.|+.+.+..+..... .+ ..+......+... ....++++.+||.+||+.||.+|||++++++|
T Consensus 230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHH-CCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 99999999999999999887655432100 00 1222222333332 34579999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 238 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
|||+++.+...... . ..+.+..+....+.+..++++.+++..
T Consensus 309 p~f~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (367)
T 1cm8_A 309 PYFESLHDTEDEPQ-V----QKYDDSFDDVDRTLDEWKRVTYKEVLS 350 (367)
T ss_dssp GGGTTTC------C-C----CCCCCC-----CCHHHHHHHHHHHHHT
T ss_pred hHHHhhcCCccCCC-C----CCCCCChhhhcCCHHHHHHHHHHHHHH
Confidence 99999876543211 1 123333333455666777776666553
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=336.16 Aligned_cols=201 Identities=25% Similarity=0.371 Sum_probs=163.1
Q ss_pred CCC-CCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHH
Q 022500 3 VMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 3 ~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~aL 68 (296)
+++ |||||++++++.... ..+|||||||+ |+|.+.++.... ....+++..+..++.||+.||
T Consensus 123 ~l~hhpnIV~l~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl 198 (353)
T 4ase_A 123 HIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 198 (353)
T ss_dssp HHCCCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHH
T ss_pred HcCCCCcEEEEEEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHH
Confidence 454 599999999885432 23789999999 699888875332 134589999999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
+|||+ ++|+||||||+|||++ .++.+||+|||+|+....... ..+..||+.|||||++.+. .|+.++||||+||
T Consensus 199 ~yLH~-~~iiHRDLK~~NILl~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv 275 (353)
T 4ase_A 199 EFLAS-RKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGV 275 (353)
T ss_dssp HHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHH
T ss_pred HhHhh-CCeecCccCccceeeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHH
Confidence 99999 7999999999999999 578899999999987644332 2346789999999999764 5999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 146 VLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 146 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
++|||+| |..||.+.+..+.+.+++.....+. .+..+++++.++|.+||+.|
T Consensus 276 ~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~d 328 (353)
T 4ase_A 276 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGE 328 (353)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcC
Confidence 9999998 8999998765555555544211111 22347999999999999999
Q ss_pred CCCCCCHHHHhcC
Q 022500 225 PSLRCTALEACAH 237 (296)
Q Consensus 225 p~~R~t~~e~l~h 237 (296)
|++|||++++++|
T Consensus 329 P~~RPt~~eil~~ 341 (353)
T 4ase_A 329 PSQRPTFSELVEH 341 (353)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=320.76 Aligned_cols=231 Identities=35% Similarity=0.673 Sum_probs=182.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++.... .+|+||||++++|.+.+.. ..+.+++..++.++.||+.||+|||+ +||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 124 (288)
T 1ob3_A 54 LKELKHSNIVKLYDVIHTKK-----RLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHR 124 (288)
T ss_dssp GGGCCCTTBCCEEEEEECSS-----CEEEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HHhcCCCCEeeeeeEEccCC-----eEEEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 46789999999999985433 4899999999998887764 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+
T Consensus 125 dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 125 DLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp CCCGGGEEEC-TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCHHHEEEc-CCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 57889999999997654322 233457899999999997666689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+..+.+..+.+....+..... .+.. .+......++. .+...+++++.+||.+||+.||++|||++|+++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDP-NFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHHCCCChhhchhhhccccccc-ccccccCccHH-HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 999999999998888876554433211 1100 11111112222 2335689999999999999999999999999999
Q ss_pred CCcccc
Q 022500 238 PFFDEL 243 (296)
Q Consensus 238 p~f~~~ 243 (296)
|||++.
T Consensus 282 p~f~~~ 287 (288)
T 1ob3_A 282 AYFKEN 287 (288)
T ss_dssp GGGGC-
T ss_pred cchhhc
Confidence 999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=323.34 Aligned_cols=241 Identities=33% Similarity=0.602 Sum_probs=189.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA--NQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~--~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
|++++||||+++++++. +...+|+||||++|+|.+.+...... ...+++..++.++.||+.||.|||+ +||+
T Consensus 57 l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~iv 130 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKIL 130 (317)
T ss_dssp HTTCCBTTBCCEEEEEC-----CTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred HHhcCCCCcceEEEEEE-----ECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCee
Confidence 46789999999999984 34458999999999998888754322 2458999999999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||
T Consensus 131 H~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 209 (317)
T 2pmi_A 131 HRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209 (317)
T ss_dssp CCCCCGGGEEEC-TTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eCCCChHHeEEc-CCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999 47889999999998654322 2345678999999999976556899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCc----ccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
.+.+..+.+..+.+..|.+....+..... .+.. .........+ .......+++++.+||.+||+.||++|||+
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 288 (317)
T 2pmi_A 210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288 (317)
T ss_dssp CCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence 99999999999999888877654433211 1110 0011001111 112234588999999999999999999999
Q ss_pred HHHhcCCCcccccCCCCC
Q 022500 232 LEACAHPFFDELREPNAR 249 (296)
Q Consensus 232 ~e~l~hp~f~~~~~~~~~ 249 (296)
+|+++||||++....+..
T Consensus 289 ~e~l~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 289 KQALHHPWFAEYYHHASM 306 (317)
T ss_dssp HHHTTSGGGGGGCC----
T ss_pred HHHhCChhhhcccchhhc
Confidence 999999999998776543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=330.11 Aligned_cols=271 Identities=34% Similarity=0.667 Sum_probs=210.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++..........+|+||||++|+|.+.+.. ..+++..++.++.||+.||+|||+ +||+|||
T Consensus 80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 153 (364)
T 3qyz_A 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRD 153 (364)
T ss_dssp HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred HhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCC
Confidence 4689999999999986655444556899999999998887764 469999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||+||+++ .++.+||+|||++........ .....||+.|+|||++.+...++.++||||+||++|+|++|.+||
T Consensus 154 ikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 232 (364)
T 3qyz_A 154 LKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232 (364)
T ss_dssp CCGGGEEEC-TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CChHhEEEC-CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence 999999999 577899999999986543221 234588999999999876666899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCC-cC--ccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNY-TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.+.+..+.+..+....|.+..+.+......- .. ...+.....++.. ....+++++.+||.+||++||.+|||+.|+
T Consensus 233 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 311 (364)
T 3qyz_A 233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQA 311 (364)
T ss_dssp CCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 9999999999999999999988765432110 00 0122222223322 234579999999999999999999999999
Q ss_pred hcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 235 CAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 235 l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
++||||+....+..... ....+.+..+......+.+.+++.++++.
T Consensus 312 l~hp~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 357 (364)
T 3qyz_A 312 LAHPYLEQYYDPSDEPI----AEAPFKFDMELDDLPKEKLKELIFEETAR 357 (364)
T ss_dssp HTSGGGTTTCCGGGSCC----CSSCCCCC-----CCHHHHHHHHHHHTGG
T ss_pred hcCcchhhccCcccccC----CCCcCCcccccccCCHHHHHHHHHHHHHH
Confidence 99999998755432211 12345555666677788888888877654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=323.22 Aligned_cols=206 Identities=29% Similarity=0.444 Sum_probs=175.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. ...+|+||||++ |+|.+.+.. .+.+++..++.++.|++.||+|||+ +||+|
T Consensus 68 l~~l~hpnIv~l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivH 137 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIET-----EKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVH 137 (328)
T ss_dssp HHHCCCTTBCCEEEEEEC-----SSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEEE-----CCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEec
Confidence 356899999999999843 334899999997 588777753 3679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+
T Consensus 138 rDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 138 RDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp SCCCGGGEEEC-TTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCHHHEEEc-CCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999999 57889999999998776555556778999999999998766456899999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+....+..... . ++..+++++.+||++||+.||.+|||++++++|||
T Consensus 217 ~~~~~~~~~i~~~~~-----------------~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 217 QNLKELRERVLRGKY-----------------R------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp SSHHHHHHHHHHCCC-----------------C------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred CCHHHHHHHHHhCCC-----------------C------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 988877776665210 0 12347999999999999999999999999999999
Q ss_pred cccccCC
Q 022500 240 FDELREP 246 (296)
Q Consensus 240 f~~~~~~ 246 (296)
|+...+.
T Consensus 268 ~~~~~~~ 274 (328)
T 3fe3_A 268 INAGHEE 274 (328)
T ss_dssp TTTTCTT
T ss_pred hcCCCcc
Confidence 9876544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=330.40 Aligned_cols=268 Identities=33% Similarity=0.571 Sum_probs=197.6
Q ss_pred CCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++..... .+...+|+|+|+++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~ 156 (367)
T 2fst_X 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHR 156 (367)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred HhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeC
Confidence 46899999999999864321 22344789999999888776653 569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||+++.... ......+|++|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus 157 Dlkp~NIll~-~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 157 DLKPSNLAVN-EDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp CCCGGGEEEC-TTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCHhhEEEC-CCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999 578899999999986532 2345688999999999977567899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCC-cCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNY-TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+..+++..+++..|.|..+.+....... ..+ ..+......+...+ ...++++.+||.+||++||.+|||+.++++|
T Consensus 234 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 9999999999999999988766543210 000 11222222333322 3579999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 238 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
|||+.+..+.... ..+.+.+..+......+..++++.+++..
T Consensus 313 p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 354 (367)
T 2fst_X 313 AYFAQYHDPDDEP-----VADPYDQSLESRDLLIDEWKSLTYDEVIS 354 (367)
T ss_dssp GGGTTTCCGGGCC-----CCCCCCGGGSSCCCCHHHHHHHHHHHHHH
T ss_pred hhhhhccCCCCCC-----CCCCCCcchhhccCCHHHHHHHHHHHHHH
Confidence 9999887654321 11234444444566777888888777765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=320.60 Aligned_cols=233 Identities=30% Similarity=0.532 Sum_probs=188.6
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
++||||+++++++..........+++||||++|+|.+.+... ....+++..++.++.||+.||+|||+ +||+|||||
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlk 147 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLK 147 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCC
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCC
Confidence 469999999999977665566678999999999998887742 23449999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 163 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 163 (296)
|+||+++ .++.+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..
T Consensus 148 p~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 148 PENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp TTTEEEC-TTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred HHHEEEc-CCCCEEEeeCccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998 5778999999999876655555667899999999999765 4899999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccc
Q 022500 164 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 243 (296)
Q Consensus 164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~ 243 (296)
+.+..+.+..+.+....+..... .....++.....+.. .....+++++.+||.+||++||++|||+.|+++||||++.
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 226 DQLGKIFDLIGLPPEDDWPRDVS-LPRGAFPPRGPRPVQ-SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHHHHHHHCCCCTTTSCSSCS-SCGGGSCCCCCCCHH-HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHHHHHHHHhCCCChhhccchhh-ccccccCCCCCCcHH-HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 99999999888877654432211 011112211112222 2334589999999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=325.00 Aligned_cols=234 Identities=33% Similarity=0.633 Sum_probs=184.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++... ..+|+||||++|+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||
T Consensus 87 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~ 156 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHN-----HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHR 156 (329)
T ss_dssp GGGCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HHHcCCCCcceEEEEEecC-----CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECC
Confidence 4678999999999998543 34899999999998887763 4569999999999999999999999 799999
Q ss_pred CCCCCcEEEcC----CCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDP----LTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~----~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++. ..+.+||+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus 157 Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp CCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999952 3446999999999865432 223455789999999999776668999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
||.+.+..+.+..+.+..+.+....+..... .+. ...+......+...+...+++++.+||.+||+.||.+|||++|
T Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 315 (329)
T 3gbz_A 237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315 (329)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999999999999999888887655433211 111 1122333333444444558999999999999999999999999
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++||||++..+
T Consensus 316 ~l~hp~f~~~~~ 327 (329)
T 3gbz_A 316 ALEHPYFSHNDF 327 (329)
T ss_dssp HHTSGGGSSSCS
T ss_pred HhCCcccCCCCC
Confidence 999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=330.67 Aligned_cols=271 Identities=30% Similarity=0.533 Sum_probs=192.0
Q ss_pred CCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++..... .+...+|+||||++|+|.+.+. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 79 ~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~ 151 (371)
T 2xrw_A 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHR 151 (371)
T ss_dssp HHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 46899999999999864432 2334688999999999887764 358999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.
T Consensus 152 Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 152 DLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp CCCGGGEEEC-TTSCEEECCCCC----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCHHHEEEc-CCCCEEEEEeecccccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999 5778999999999876544444567889999999999764 5899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc--cCCCCCCCCcccccC-----------CCCCHHHHHHHHcccccCCCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDF--RFPQIKAHPWHKVFH-----------KRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~dll~~~L~~~p~~ 227 (296)
+..+.+..+++..|.+..+.+..+.+....+ ..+......+...++ ...++++++||++||+.||.+
T Consensus 230 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 9999999999999998877665443211110 001111111111111 112578999999999999999
Q ss_pred CCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 228 RCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 228 R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
|||++|+++||||+....+.... .+.+.......+......+..++++.+++..
T Consensus 310 R~t~~e~l~hp~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (371)
T 2xrw_A 310 RISVDEALQHPYINVWYDPSEAE---APPPKIPDKQLDEREHTIEEWKELIYKEVMD 363 (371)
T ss_dssp SCCHHHHHHSHHHHTTCCHHHHT---CCCCCCCTTTTCCCCCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHhCCcchhhhcCccccC---CCCCCCCChhhccccCcHHHHHHHHHHHHHH
Confidence 99999999999998765532211 1112222223334455677778887777653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=324.78 Aligned_cols=208 Identities=26% Similarity=0.420 Sum_probs=175.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++ |+|.+.+. ..+.+++..++.++.||+.||.|||+ +||+|
T Consensus 69 l~~l~hpnIv~l~~~~~~-----~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH 138 (361)
T 2yab_A 69 LRQVLHPNIITLHDVYEN-----RTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAH 138 (361)
T ss_dssp HTTCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCcCCCcEEEEEEe-----CCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 467899999999999843 345899999997 57777664 45679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCC---cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~---~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++..+. .+||+|||++.............||+.|+|||++.+ ..++.++||||+||++|+|++|.+|
T Consensus 139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~P 217 (361)
T 2yab_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 217 (361)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999984332 799999999987765555566789999999999965 4589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+.+..+.........+ ....+++++++||.+||+.||.+|||+.|+++
T Consensus 218 f~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 218 FLGDTKQETLANITAVSYDFDEE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHhcCCCCCch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999888887776532222211 12347999999999999999999999999999
Q ss_pred CCCccccc
Q 022500 237 HPFFDELR 244 (296)
Q Consensus 237 hp~f~~~~ 244 (296)
||||+...
T Consensus 273 hp~~~~~~ 280 (361)
T 2yab_A 273 HPWITPVD 280 (361)
T ss_dssp STTTSCSS
T ss_pred CcCcCCCc
Confidence 99998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=322.41 Aligned_cols=272 Identities=30% Similarity=0.560 Sum_probs=200.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++..........+|+||||++|+|.+.+.. ....+++..++.++.||+.||.|||+ +||+|||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~D 159 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRD 159 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecC
Confidence 4689999999999997766566667899999999998887763 44579999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|||+||+++ .++.+||+|||++.............+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+
T Consensus 160 lkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 160 LHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CCGGGEEEC-TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CChHHEEEc-CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999998 4778999999999866555555567889999999999775669999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcC----CcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
..+.+..+++..+.+..+........ +............+. ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 99999999999999987765432210 000011111122222 2334578999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 238 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
|||+++..+.... ......+.+. ....+.....+.+..++.+
T Consensus 318 p~f~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~e~~~ 359 (362)
T 3pg1_A 318 PYFESLFDPLDLT---EGLSERFHFD--ESVTDVYDMHKIFTAEVER 359 (362)
T ss_dssp GGGTTTCCGGGGT---TTCCCCCCCC--TTCCCHHHHHHHHHHHHHH
T ss_pred chhhhccCccccc---cccccccChh--hhhhhHHHHHHHHHHHHHH
Confidence 9999986553221 1222222222 2445566666666665543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=322.89 Aligned_cols=234 Identities=34% Similarity=0.614 Sum_probs=189.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++.. ...+|+||||++++|.+.+.. ....+++..++.++.|++.||+|||+ +||+|||
T Consensus 67 ~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~D 137 (346)
T 1ua2_A 67 QELSHPNIIGLLDAFGH-----KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRD 137 (346)
T ss_dssp HHCCCTTBCCEEEEECC-----TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCC
T ss_pred hhCCCCCCCeEEEEEee-----CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCC
Confidence 46799999999999843 334889999999988777653 34568999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||+++...... ......+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus 138 lkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 138 LKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEc-CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999999999 47889999999998764332 2345678999999999976666899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
+..+.+.++.+..+.+..+.+......-...........++.. ....+++++++||.+||+.||++|||++|+++||||
T Consensus 217 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 217 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 9999999999998888776655433221111122222222222 234578999999999999999999999999999999
Q ss_pred ccccCC
Q 022500 241 DELREP 246 (296)
Q Consensus 241 ~~~~~~ 246 (296)
++...+
T Consensus 296 ~~~~~~ 301 (346)
T 1ua2_A 296 SNRPGP 301 (346)
T ss_dssp TSSSCC
T ss_pred hcCCCC
Confidence 876544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=319.79 Aligned_cols=204 Identities=28% Similarity=0.450 Sum_probs=172.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.. ...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||
T Consensus 60 ~~l~hp~iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHr 129 (337)
T 1o6l_A 60 QNTRHPFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYR 129 (337)
T ss_dssp HSCCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCC
T ss_pred HhCCCCcCcceEEEEEe-----CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 56899999999999943 3458999999985 77766653 3679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+|+.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 130 Dlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 130 DIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCHHHEEEC-CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCC
Confidence 9999999999 578899999999986433 2334567899999999999654 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+..+....+.... . .++..+++++.+||.+||+.||.+|+ +++++
T Consensus 208 ~~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei 258 (337)
T 1o6l_A 208 QDHERLFELILMEE-----------------I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258 (337)
T ss_dssp SSHHHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH
T ss_pred CCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence 88877777665420 0 12235799999999999999999999 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+.+.+.
T Consensus 259 ~~h~~f~~~~~~ 270 (337)
T 1o6l_A 259 MEHRFFLSINWQ 270 (337)
T ss_dssp HTSGGGTTCCHH
T ss_pred HcCCCcCCCCHH
Confidence 999999988764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=327.22 Aligned_cols=201 Identities=27% Similarity=0.473 Sum_probs=167.8
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++.. ...+|+|||||+| +|...+.. ...+++..++.++.||+.||+|||+ +||+|||||
T Consensus 82 ~hp~Iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlk 151 (353)
T 3txo_A 82 NHPFLTQLFCCFQT-----PDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLK 151 (353)
T ss_dssp TCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCC
T ss_pred CCCceeeEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCC
Confidence 79999999999943 3458999999985 77776653 3679999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+|||++ .++.+||+|||+|+..... ......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.
T Consensus 152 p~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 152 LDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp GGGEEEC-TTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEC-CCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 9999999 5788999999999864332 334466899999999999754 489999999999999999999999999998
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH------HHHhc
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACA 236 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~------~e~l~ 236 (296)
.+....+.+.. . .++..+++++.+||++||++||.+|+++ +++++
T Consensus 230 ~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 230 DDLFEAILNDE-----------------V------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 88888877621 1 1223479999999999999999999998 89999
Q ss_pred CCCcccccCC
Q 022500 237 HPFFDELREP 246 (296)
Q Consensus 237 hp~f~~~~~~ 246 (296)
||||+++.|.
T Consensus 281 hp~f~~~~w~ 290 (353)
T 3txo_A 281 HPFFKEIDWA 290 (353)
T ss_dssp SGGGTTCCHH
T ss_pred CCcccCCCHH
Confidence 9999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=321.37 Aligned_cols=273 Identities=31% Similarity=0.607 Sum_probs=205.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++......+...+|+||||++|+|.+.+.. ..+++..++.++.|++.||.|||+ +||+|||
T Consensus 64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~D 137 (353)
T 2b9h_A 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRD 137 (353)
T ss_dssp HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred HhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCC
Confidence 4679999999999876543334456889999999998887764 569999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCC-----------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
|||+||+++ .++.+||+|||++........ .....||+.|+|||++.+...++.++||||+||++|+|
T Consensus 138 lkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 216 (353)
T 2b9h_A 138 LKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216 (353)
T ss_dssp CCGGGEEEC-TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHeEEc-CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHH
Confidence 999999998 477899999999986543211 12347899999999987656799999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC--CcCc--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 151 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN--YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 151 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
++|.+||.+.+..+.+..+....|.+........... ...+ ..+......+. .....+++++.+||.+||+.||+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~ 295 (353)
T 2b9h_A 217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPA 295 (353)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGG
T ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcc
Confidence 9999999999999999888888887763221100000 0000 01111111111 12245899999999999999999
Q ss_pred CCCCHHHHhcCCCcccccCCCCCCCCCCCCC-CCCCchhhhcCCCHHHHhhhcHHHHH
Q 022500 227 LRCTALEACAHPFFDELREPNARLPNGRPLP-PLFNFKQELSGASPELVNKLIPDHVK 283 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (296)
+|||+.++++||||+....+..... ..+.+ ..+.+.......+.+.+++++.+++.
T Consensus 296 ~Rpt~~ell~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 296 KRITAKEALEHPYLQTYHDPNDEPE-GEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp GSCCHHHHHTSGGGTTTCCTTSSCC-CCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred cCCCHHHHhcCccccccCCcccccc-cCCCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 9999999999999999877654432 33333 34555555666777888888777653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=329.01 Aligned_cols=243 Identities=33% Similarity=0.572 Sum_probs=179.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVP 75 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~-----~~~~~~~~~~~~~~qil~aL~~LH~~~ 75 (296)
|++++|||||++++++... +...+|+||||++|+|.+.+...... ...+++..++.++.||+.||.|||+ +
T Consensus 72 l~~l~hpniv~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~ 147 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSH---ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-N 147 (405)
T ss_dssp HHHCCCTTBCCCCEEEEET---TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred HHhcCCCCeeeEeeEEecC---CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence 3568999999999998642 23358899999999998888643322 2359999999999999999999999 7
Q ss_pred CcccCCCCCCcEEEc---CCCCcEEEeeccCccccccC----CCccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 76 RVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 76 ~i~H~dlkp~Nill~---~~~~~vkl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
||+||||||+|||+. ..++.+||+|||+|+..... ......+||+.|+|||++.+...++.++||||+||++|
T Consensus 148 ~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 227 (405)
T 3rgf_A 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227 (405)
T ss_dssp TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence 999999999999993 24678999999999865432 12245678999999999977666999999999999999
Q ss_pred HHHhCCCCCCCCCh---------HHHHHHHHHhcCCCCHHHHhhcCcC---------CcCccCCCCCCCCcccccCCCCC
Q 022500 149 ELLLGQPLFPGENA---------VDQLVEIIKVLGTPTREEIRCMNPN---------YTDFRFPQIKAHPWHKVFHKRMP 210 (296)
Q Consensus 149 ~ll~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 210 (296)
+|++|.+||.+... .+++..+++.+|.|....+...... +....+.......+........+
T Consensus 228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (405)
T 3rgf_A 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307 (405)
T ss_dssp HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTT
T ss_pred HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCC
Confidence 99999999987654 4888999999999887655433211 00000000000001111122347
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHhcCCCcccccCCC
Q 022500 211 PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 247 (296)
Q Consensus 211 ~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~~ 247 (296)
+++.+||.+||++||.+|||++|+|+||||++...+.
T Consensus 308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp SHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 8999999999999999999999999999998765543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=312.15 Aligned_cols=236 Identities=32% Similarity=0.583 Sum_probs=179.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++... ..+++||||+++++...+. .....+++..++.++.|++.||+|||+ +||+|||
T Consensus 57 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~d 127 (311)
T 4agu_A 57 KQLKHPNLVNLLEVFRRK-----RRLHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRD 127 (311)
T ss_dssp HHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred HhCCCCCccchhheeecC-----CeEEEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCC
Confidence 468999999999998543 3488999999976544433 245679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.
T Consensus 128 lkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 128 VKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp CSGGGEEEC-TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CChhhEEEc-CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999 57889999999998654322 2345678999999999987667899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhc--CcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCM--NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+..+....+.+..+.......... ...+.....+..............+++++.+||.+||+.||.+|||++++++||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 999999888888887766543322 111222222222111111112235899999999999999999999999999999
Q ss_pred CcccccCCC
Q 022500 239 FFDELREPN 247 (296)
Q Consensus 239 ~f~~~~~~~ 247 (296)
||+++++..
T Consensus 287 ~f~~~~~~~ 295 (311)
T 4agu_A 287 YFENIREIE 295 (311)
T ss_dssp GGTTCC---
T ss_pred HHHhccCHH
Confidence 999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=321.86 Aligned_cols=202 Identities=25% Similarity=0.474 Sum_probs=165.1
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.+|||||++++++.. ...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||
T Consensus 110 ~~hp~Iv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDL 179 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQT-----ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDL 179 (396)
T ss_dssp TTCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCC
T ss_pred CCCCCcCeeEEEEEE-----CCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccC
Confidence 389999999999843 4458999999985 77766653 3679999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccc-cCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
||+|||++ .++.+||+|||+|+... ......+.+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+..
T Consensus 180 Kp~NILl~-~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 180 KLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp CGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred CHHHEEEC-CCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999 57889999999998633 33345567899999999999764 58999999999999999999999996542
Q ss_pred h---------HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH-
Q 022500 162 A---------VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA- 231 (296)
Q Consensus 162 ~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~- 231 (296)
. ......+... . ..++..+++++++||++||+.||.+|+++
T Consensus 258 ~~~~~~~~~~~~~~~~i~~~-----------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 308 (396)
T 4dc2_A 258 SSDNPDQNTEDYLFQVILEK-----------------Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGCH 308 (396)
T ss_dssp C------CCHHHHHHHHHHC-----------------C------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCS
T ss_pred cccccchhhHHHHHHHHhcc-----------------c------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCC
Confidence 1 1122222221 0 01234589999999999999999999984
Q ss_pred -----HHHhcCCCcccccCC
Q 022500 232 -----LEACAHPFFDELREP 246 (296)
Q Consensus 232 -----~e~l~hp~f~~~~~~ 246 (296)
+|+++||||+.+.|.
T Consensus 309 ~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 309 PQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp TTTHHHHHHHSTTTTTCCHH
T ss_pred CCCCHHHHhcCccccCCCHH
Confidence 899999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=320.57 Aligned_cols=204 Identities=26% Similarity=0.463 Sum_probs=173.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|||||++++++.. ...+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||
T Consensus 94 ~~~~hp~Iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHr 163 (373)
T 2r5t_A 94 KNVKHPFLVGLHFSFQT-----ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYR 163 (373)
T ss_dssp CCCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred HhCCCCCCCCEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceec
Confidence 56899999999999843 3458999999985 77776653 3568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+|||++ .++.+||+|||+++.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 164 Dlkp~NIll~-~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 164 DLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp CCCGGGEEEC-TTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCHHHEEEC-CCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 9999999999 578899999999986433 3344567899999999999754 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH----HHHh
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEAC 235 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~----~e~l 235 (296)
.+..+....++... . .++..+++++++||.+||+.||.+|+++ .+++
T Consensus 242 ~~~~~~~~~i~~~~-----------------~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 242 RNTAEMYDNILNKP-----------------L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp SBHHHHHHHHHHSC-----------------C------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CCHHHHHHHHHhcc-----------------c------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 98888888776520 0 1223479999999999999999999986 6999
Q ss_pred cCCCcccccCC
Q 022500 236 AHPFFDELREP 246 (296)
Q Consensus 236 ~hp~f~~~~~~ 246 (296)
+||||+.+.|.
T Consensus 293 ~h~~f~~~~w~ 303 (373)
T 2r5t_A 293 SHVFFSLINWD 303 (373)
T ss_dssp TSGGGTTCCHH
T ss_pred CCccccCCCHH
Confidence 99999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=317.35 Aligned_cols=208 Identities=26% Similarity=0.412 Sum_probs=175.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ..+|+|||||+| +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||
T Consensus 56 ~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~ 126 (321)
T 1tki_A 56 NIARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHF 126 (321)
T ss_dssp HHSCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCCCeEeEEEecC-----CEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcC
Confidence 468999999999999543 348999999985 77776642 33579999999999999999999999 799999
Q ss_pred CCCCCcEEEcCC-CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++.. ++.+||+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 127 Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 999999999842 578999999999877655555667889999999999654 489999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+.+..+.+.........+ ..+++++.+||.+||+.||.+|||+.|+++|||
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~-------------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 206 ETNQQIIENIMNAEYTFDEEAF-------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp SSHHHHHHHHHHTCCCCCHHHH-------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCHHHHHHHHHcCCCCCChhhh-------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 9888888877764333322221 247999999999999999999999999999999
Q ss_pred ccccc
Q 022500 240 FDELR 244 (296)
Q Consensus 240 f~~~~ 244 (296)
|++..
T Consensus 261 ~~~~~ 265 (321)
T 1tki_A 261 LKQKI 265 (321)
T ss_dssp HHSCG
T ss_pred hccCc
Confidence 98643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=319.00 Aligned_cols=268 Identities=33% Similarity=0.591 Sum_probs=200.2
Q ss_pred CCCCCCCeeeeceeeeccCCC-CcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~-~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++...... ....+|+||||++++|.+.+. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~ 168 (371)
T 4exu_A 96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHR 168 (371)
T ss_dssp HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCC
Confidence 468999999999998654431 222358999999998766542 459999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||+++.... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.
T Consensus 169 Dikp~NIll~-~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 169 DLKPGNLAVN-EDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp CCCGGGEEEC-TTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcCHHHeEEC-CCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999 578899999999986532 2345678999999999977567999999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc---cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+..+.+..+++..|.+..+............ ..+......+.. ....+++++.+||.+||+.||++|||++++++|
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 9999999999999999877665443211000 011111112221 234579999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 238 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
|||+.+..+........++.. ..+....+.+..++.+.+++.+
T Consensus 325 p~f~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 367 (371)
T 4exu_A 325 PFFEPFRDPEEETEAQQPFDD----SLEHEKLTVDEWKQHIYKEIVN 367 (371)
T ss_dssp GGGTTTCCGGGCCCCSSCCCC----TTSSCCCCHHHHHHHHHHHHHH
T ss_pred cccccCCCcccccccccCcCc----chhhcccchHHHHHHHHHHHHh
Confidence 999988766543332222222 2233445566667766666543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=327.91 Aligned_cols=213 Identities=26% Similarity=0.435 Sum_probs=175.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|||||++++++. +...+|+|||||+ |+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 129 ~~~~hp~Iv~l~~~~~-----~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHr 199 (437)
T 4aw2_A 129 VNGDSKWITTLHYAFQ-----DDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHR 199 (437)
T ss_dssp HHSCTTTBCCEEEEEE-----CSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCEEEEEEEEe-----eCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEec
Confidence 3578999999999984 3445899999997 588777764 24679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhcc----CCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
||||+|||++ .++.+||+|||+|+........ ...+||+.|+|||++. +...++.++||||+||++|+|++|.
T Consensus 200 DLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 200 DIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp CCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred ccCHHHeeEc-CCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 9999999999 5788999999999866443322 3468999999999986 2345899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC--CCCHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTAL 232 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~--R~t~~ 232 (296)
+||.+.+..+.+.+|++.... +.++. ....+++++++||++||+.+|.+ |++++
T Consensus 279 ~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ 334 (437)
T 4aw2_A 279 TPFYAESLVETYGKIMNHKER---------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIE 334 (437)
T ss_dssp CTTCCSSHHHHHHHHHTHHHH---------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTH
T ss_pred CCCCCCChhHHHHhhhhcccc---------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHH
Confidence 999999988888888752110 00111 11247999999999999998888 99999
Q ss_pred HHhcCCCcccccCCCC
Q 022500 233 EACAHPFFDELREPNA 248 (296)
Q Consensus 233 e~l~hp~f~~~~~~~~ 248 (296)
|+++||||+++.|...
T Consensus 335 eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 335 DFKKHPFFSGIDWDNI 350 (437)
T ss_dssp HHHTSGGGTTCCTTTG
T ss_pred HHhCCCccCCCCHHHH
Confidence 9999999999988754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=312.78 Aligned_cols=202 Identities=29% Similarity=0.495 Sum_probs=173.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. +...+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||
T Consensus 61 ~~l~hp~Iv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHr 130 (318)
T 1fot_A 61 SIVTHPFIIRMWGTFQ-----DAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYR 130 (318)
T ss_dssp HSCCBTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECC
T ss_pred hhCCCCCCceEeEEEE-----eCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 4689999999999984 34458999999985 87777653 4679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||+++.... .....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus 131 Dlkp~NIll~-~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 131 DLKPENILLD-KNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp CCCGGGEEEC-TTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCChheEEEc-CCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 9999999998 578899999999986532 33456899999999999654 5899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHHh
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEAC 235 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~l 235 (296)
+..+...++.+.. . .++..+++++.++|++||+.||++|+ ++++++
T Consensus 207 ~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 207 NTMKTYEKILNAE-----------------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp SHHHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CHHHHHHHHHhCC-----------------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 8888887776521 0 02234799999999999999999999 899999
Q ss_pred cCCCcccccCC
Q 022500 236 AHPFFDELREP 246 (296)
Q Consensus 236 ~hp~f~~~~~~ 246 (296)
+||||+++.+.
T Consensus 258 ~hp~f~~~~~~ 268 (318)
T 1fot_A 258 NHPWFKEVVWE 268 (318)
T ss_dssp TSGGGSSCCHH
T ss_pred cCccccCCCHH
Confidence 99999988764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=313.00 Aligned_cols=206 Identities=20% Similarity=0.217 Sum_probs=150.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---- 75 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~---- 75 (296)
|++++|||||++++++.... .....+|||||||+ |+|.+.+.. ..+++..+..++.|++.||+|||+ +
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~ 123 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGT 123 (303)
T ss_dssp STTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCST
T ss_pred HhcCCCCCCCcEEEEEEecC-CCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhc
Confidence 45789999999999986543 22335889999999 688888764 468999999999999999999997 6
Q ss_pred ----CcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCC-----CCCchhHHH
Q 022500 76 ----RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIW 141 (296)
Q Consensus 76 ----~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diw 141 (296)
+|+||||||+|||++ .++.+||+|||+|+....... ....+||+.|||||++.+.. .++.++|||
T Consensus 124 ~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVw 202 (303)
T 3hmm_A 124 QGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202 (303)
T ss_dssp TCBCCEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred cCCCCEeeccCCcccEEEC-CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhh
Confidence 899999999999999 578999999999986644322 22457999999999996532 256799999
Q ss_pred HHHHHHHHHHhCCCCCCCCCh--------------HHHHHHHH-HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccC
Q 022500 142 SAGCVLAELLLGQPLFPGENA--------------VDQLVEII-KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 206 (296)
Q Consensus 142 slG~il~~ll~g~~pf~~~~~--------------~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (296)
|+||++|||+||.+||..... .+.+.+.+ ...-.|. .+. ....
T Consensus 203 S~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~---------------~p~-------~~~~ 260 (303)
T 3hmm_A 203 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN---------------IPN-------RWQS 260 (303)
T ss_dssp HHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC---------------CCG-------GGGS
T ss_pred hHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCC---------------CCc-------cccc
Confidence 999999999999877643221 11111111 1000000 000 0000
Q ss_pred CCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 207 KRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 207 ~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
...+..+.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 261 CEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 113457889999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=321.82 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=167.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++||||+++++++... ..+|+||||++|+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||
T Consensus 63 l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~ 132 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHR 132 (336)
T ss_dssp HTTCCCTTBCCEEEEEECS-----SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCC
T ss_pred HHhCCCCCCCeEEEEEEeC-----CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 4678999999999998543 34899999999998887764 3579999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.
T Consensus 133 Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 133 DLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp CCSTTTEEEC-TTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred CCchhhEEEc-CCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 9999999999 577899999999987655555566789999999999977654589999999999999999999999765
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
....... .. ......++..+++++.+||++||+.||.+|||++|+++||||
T Consensus 212 ~~~~~~~----------------------~i-------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 212 FIPNLFK----------------------KV-------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp SSTTCBC----------------------CC-------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred cHHHHHH----------------------HH-------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 4221100 00 000111334589999999999999999999999999999999
Q ss_pred ccc
Q 022500 241 DEL 243 (296)
Q Consensus 241 ~~~ 243 (296)
+.-
T Consensus 263 ~~~ 265 (336)
T 3h4j_B 263 NVN 265 (336)
T ss_dssp HTT
T ss_pred ccC
Confidence 853
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.15 Aligned_cols=208 Identities=26% Similarity=0.451 Sum_probs=173.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|||||++++++. +...+|+|||||+ |+|.+.+.. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 124 ~~l~hp~Iv~l~~~~~-----~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHr 192 (410)
T 3v8s_A 124 AFANSPWVVQLFYAFQ-----DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHR 192 (410)
T ss_dssp HHCCCTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCCCeEEEEEE-----ECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 4579999999999994 4445999999997 588776653 468999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCC---CCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+|||++ .++.+||+|||+|+....... ..+.+||+.|+|||++.+... ++.++||||+||++|+|++|..
T Consensus 193 DLKp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 193 DVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp CCSGGGEEEC-TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred cCCHHHeeEC-CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 9999999999 578899999999987644332 235689999999999975432 7789999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC--CCCHHH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALE 233 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~--R~t~~e 233 (296)
||.+.+..+.+.+|++.... ..++. ...+++++++||.+||+.+|.+ |++++|
T Consensus 272 Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~e 326 (410)
T 3v8s_A 272 PFYADSLVGTYSKIMNHKNS---------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEE 326 (410)
T ss_dssp TTCCSSHHHHHHHHHTHHHH---------------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHH
T ss_pred CCCCCChhhHHHHHHhcccc---------------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHH
Confidence 99999988888888753110 00110 1247999999999999999988 999999
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||+.+.|.
T Consensus 327 i~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 327 IKRHLFFKNDQWA 339 (410)
T ss_dssp HHTSGGGCCSSCC
T ss_pred HhcCccccCCCHH
Confidence 9999999998765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=317.61 Aligned_cols=202 Identities=29% Similarity=0.500 Sum_probs=171.5
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
++||||+++++++.. ...+|+||||++ |+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||
T Consensus 75 ~~hp~iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDl 144 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDL 144 (345)
T ss_dssp TTCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCC
T ss_pred CCCCCCCcEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCC
Confidence 489999999999943 345899999998 588777663 3569999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
||+||+++ .++.+||+|||+|+.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+
T Consensus 145 kp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 145 KLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChhhEEEC-CCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999 477899999999986433 2334567899999999999764 58999999999999999999999999998
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH-HHhcCCCc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFF 240 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~-e~l~hp~f 240 (296)
..+....+.... + .++..+++++++||.+||+.||++|+++. ++++||||
T Consensus 223 ~~~~~~~i~~~~--~---------------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 223 EEELFHSIRMDN--P---------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp HHHHHHHHHHCC--C---------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred HHHHHHHHHhCC--C---------------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 887777765421 0 02234799999999999999999999998 99999999
Q ss_pred ccccCC
Q 022500 241 DELREP 246 (296)
Q Consensus 241 ~~~~~~ 246 (296)
+.+.|.
T Consensus 274 ~~~~w~ 279 (345)
T 1xjd_A 274 REINWE 279 (345)
T ss_dssp TTCCHH
T ss_pred cCCCHH
Confidence 998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=315.96 Aligned_cols=238 Identities=26% Similarity=0.462 Sum_probs=182.7
Q ss_pred CCCCCCCeeeeceeeeccCC---CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 2 RVMDHPNVISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~---~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
++++||||+++++++..... .....+|+||||++|++.+.+.. ....+++..++.++.||+.||+|||+ +||+
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iv 146 (351)
T 3mi9_A 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKIL 146 (351)
T ss_dssp HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred HhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCee
Confidence 46799999999999865321 12345889999999988877764 34569999999999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccC-----CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
||||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|
T Consensus 147 H~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 147 HRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp CCCCSGGGEEEC-TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCCHHHEEEc-CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 999999999999 4778999999999865422 1223457899999999997766689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCc--CCcCccCCCCCCCCcccccC-CCCCHHHHHHHHcccccCCCCCCC
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
.+||.+.+..+....+.+..+.+..+.+..... .+................+. ...++++++||.+||+.||.+|||
T Consensus 226 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 305 (351)
T 3mi9_A 226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305 (351)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC
Confidence 999999999999999998888777554433211 11111111111111000000 013788999999999999999999
Q ss_pred HHHHhcCCCccccc
Q 022500 231 ALEACAHPFFDELR 244 (296)
Q Consensus 231 ~~e~l~hp~f~~~~ 244 (296)
++|+++||||++..
T Consensus 306 ~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 306 SDDALNHDFFWSDP 319 (351)
T ss_dssp HHHHHTSGGGGSSS
T ss_pred HHHHhCCCCcCCCC
Confidence 99999999998643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.08 Aligned_cols=229 Identities=33% Similarity=0.577 Sum_probs=185.1
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
..+|+||+++++++... ..+|+||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||
T Consensus 155 ~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDl 226 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFR-----NHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDL 226 (429)
T ss_dssp TTSCSCBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCC
T ss_pred ccCCcCEEEEEeecccC-----CeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCC
Confidence 35789999999998543 448999999999999888752 23459999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCc--EEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 83 KPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 83 kp~Nill~~~~~~--vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||+|||++. ++. +||+|||++.... ......+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.
T Consensus 227 Kp~NILl~~-~~~~~vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 227 KPENILLKQ-QGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SGGGEEESS-TTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHeEEcc-CCCcceEEeecccceecC--CcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999984 554 9999999997543 234456889999999999765 4899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcC-----------CcCcc-------------------CCCCCCCCcccccCCCCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPN-----------YTDFR-------------------FPQIKAHPWHKVFHKRMP 210 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~-----------~~~~~-------------------~~~~~~~~~~~~~~~~~~ 210 (296)
+..+.+..+++..|.|....+...... +.... ........|...+....+
T Consensus 303 ~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 382 (429)
T 3kvw_A 303 DEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382 (429)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCC
T ss_pred CHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccch
Confidence 999999999999999998766433210 00000 001112334444555668
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHhcCCCcccc
Q 022500 211 PEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 243 (296)
Q Consensus 211 ~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~ 243 (296)
+++.+||.+||++||++|||++|+|+||||++.
T Consensus 383 ~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred HHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 999999999999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=323.56 Aligned_cols=207 Identities=27% Similarity=0.407 Sum_probs=171.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. +...+|+|||||+| +|.+.+.. ...+++..+..++.||+.||.|||+ +||+|
T Consensus 64 l~~l~hpnIv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givH 133 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSIS-----EEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVH 133 (444)
T ss_dssp HHHCCBTTBCCEEEEEE-----CSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBC
T ss_pred HHhCCCcCCCeEEEEEE-----ECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 35689999999999984 44458999999985 77776653 4679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC--CCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDP--LTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++. .++.+||+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|.+|
T Consensus 134 rDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~P 212 (444)
T 3soa_A 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPP 212 (444)
T ss_dssp CCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCC
Confidence 999999999974 246799999999986654332 3456899999999999654 589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.......+. .....+++++++||.+||+.||.+|||+.|+++
T Consensus 213 f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 213 FWDEDQHRLYQQIKAGAYDFPS-------------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCSSHHHHHHHHHHTCCCCCT-------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCccHHHHHHHHHhCCCCCCc-------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999888887777653211110 011347999999999999999999999999999
Q ss_pred CCCcccc
Q 022500 237 HPFFDEL 243 (296)
Q Consensus 237 hp~f~~~ 243 (296)
||||+..
T Consensus 268 hp~~~~~ 274 (444)
T 3soa_A 268 HPWISHR 274 (444)
T ss_dssp SCTTHHH
T ss_pred CccccCC
Confidence 9999754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=314.47 Aligned_cols=201 Identities=29% Similarity=0.449 Sum_probs=171.1
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++.. ...+|+||||++| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+|||||
T Consensus 79 ~hp~iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlk 148 (353)
T 2i0e_A 79 KPPFLTQLHSCFQT-----MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLK 148 (353)
T ss_dssp CCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCC
T ss_pred CCCEEeeEEEEEEc-----CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCC
Confidence 79999999999843 3458999999985 88777663 3569999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+||+++ .++.+||+|||+|+.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.
T Consensus 149 p~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 149 LDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp GGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEc-CCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 9999999 578899999999986432 2334567899999999999654 589999999999999999999999999988
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHHhcC
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAH 237 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~l~h 237 (296)
.+....+.+.. . .++..+++++++||.+||+.||.+|++ ++++++|
T Consensus 227 ~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 227 DELFQSIMEHN-----------------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHHhCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 88887776521 0 122358999999999999999999994 6999999
Q ss_pred CCcccccCC
Q 022500 238 PFFDELREP 246 (296)
Q Consensus 238 p~f~~~~~~ 246 (296)
|||+.+.|.
T Consensus 278 ~~f~~~~w~ 286 (353)
T 2i0e_A 278 AFFRYIDWE 286 (353)
T ss_dssp GGGTTCCHH
T ss_pred ccccCCCHH
Confidence 999988764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=307.45 Aligned_cols=238 Identities=34% Similarity=0.581 Sum_probs=191.1
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.++||||+++++++..........+++||||++|+|.+.+... ....+++..++.++.||+.||.|||+ +||+||||
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dl 146 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDL 146 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccC
Confidence 3589999999999864433456678999999999998888753 23458999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
||+||+++ .++.+||+|||++.............+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.
T Consensus 147 kp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 147 KPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CGGGEEEC-TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CHHHeEEc-CCCCEEEecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999998 4778999999999866544444556789999999999654 589999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
.+.+..+++..+.+....+....... ...+....... ...+...+++.+.+||.+||+.||.+|||+.++++||||++
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 225 VDQLGKILDVIGLPGEEDWPRDVALP-RQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSSC-GGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcCCCCcccCccccccc-hhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 99999999988888766543321110 00111111111 12234568999999999999999999999999999999998
Q ss_pred ccCCC
Q 022500 243 LREPN 247 (296)
Q Consensus 243 ~~~~~ 247 (296)
+....
T Consensus 303 ~~~~~ 307 (326)
T 1blx_A 303 LERCK 307 (326)
T ss_dssp CCCCC
T ss_pred cchhh
Confidence 86553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=313.24 Aligned_cols=201 Identities=25% Similarity=0.480 Sum_probs=163.8
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+|||||++++++.. ...+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+|||||
T Consensus 68 ~hp~iv~l~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlk 137 (345)
T 3a8x_A 68 NHPFLVGLHSCFQT-----ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLK 137 (345)
T ss_dssp TCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCC
T ss_pred CCCccCeEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCC
Confidence 89999999999843 3458999999984 87776653 3569999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN- 161 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~- 161 (296)
|+||+++ .++.+||+|||+|+.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||....
T Consensus 138 p~NIll~-~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~ 215 (345)
T 3a8x_A 138 LDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215 (345)
T ss_dssp GGGEEEC-TTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC
T ss_pred HHHEEEC-CCCCEEEEeccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCccc
Confidence 9999999 578899999999986432 2334566899999999999764 58999999999999999999999997532
Q ss_pred --------hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH--
Q 022500 162 --------AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-- 231 (296)
Q Consensus 162 --------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~-- 231 (296)
.......+... .. .++..+++++++||++||+.||.+|+++
T Consensus 216 ~~~~~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 266 (345)
T 3a8x_A 216 SDNPDQNTEDYLFQVILEK-----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHP 266 (345)
T ss_dssp -------CHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCT
T ss_pred ccccccccHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCC
Confidence 12222222221 00 1234589999999999999999999995
Q ss_pred ----HHHhcCCCcccccCC
Q 022500 232 ----LEACAHPFFDELREP 246 (296)
Q Consensus 232 ----~e~l~hp~f~~~~~~ 246 (296)
+++++||||+.+.|.
T Consensus 267 ~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 267 QTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp TTHHHHHHTSGGGTTCCHH
T ss_pred cCCHHHHhcCCccCCCCHH
Confidence 899999999988764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=310.97 Aligned_cols=206 Identities=26% Similarity=0.424 Sum_probs=172.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+||||++ |+|.+.+. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 69 ~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~ 138 (326)
T 2y0a_A 69 KEIQHPNVITLHEVYEN-----KTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHF 138 (326)
T ss_dssp HHCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCCCcEEEEEEe-----CCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcC
Confidence 46899999999999843 344899999997 57777664 35679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCC----cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 81 DLKPQNLLVDPLTH----QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~----~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||+||+++. ++ .+||+|||++.............||+.|+|||++.+ ..++.++||||+||++|+|++|..|
T Consensus 139 Dlkp~NIll~~-~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 139 DLKPENIMLLD-RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp CCCGGGEEESC-SSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCCHHHEEEec-CCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 99999999984 44 799999999987655544556789999999999965 4589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+.+..+.......... ....+++.+.+||.+||+.||.+|||+.++++
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 217 FLGDTKQETLANVSAVNYEFEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCHH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCcCcc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99988887777766532222211 12347899999999999999999999999999
Q ss_pred CCCccccc
Q 022500 237 HPFFDELR 244 (296)
Q Consensus 237 hp~f~~~~ 244 (296)
||||+...
T Consensus 272 hp~~~~~~ 279 (326)
T 2y0a_A 272 HPWIKPKD 279 (326)
T ss_dssp STTTSCCS
T ss_pred CCCccCCc
Confidence 99998643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=313.37 Aligned_cols=203 Identities=26% Similarity=0.432 Sum_probs=173.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++.. ...+|+||||++ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+|
T Consensus 95 l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH 164 (350)
T 1rdq_E 95 LQAVNFPFLVKLEFSFKD-----NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIY 164 (350)
T ss_dssp HTTCCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEEc-----CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 467899999999999843 445899999997 588777764 3569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||+++.... .....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus 165 rDlkp~NIll~-~~g~~kL~DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 165 RDLKPENLLID-QQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp CCCSGGGEEEC-TTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCccceEEEC-CCCCEEEcccccceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 99999999998 578899999999986533 23456899999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~ 234 (296)
.+..+....+.... . .++..+++++.+||.+||+.||.+|++ ++++
T Consensus 241 ~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei 291 (350)
T 1rdq_E 241 DQPIQIYEKIVSGK-----------------V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291 (350)
T ss_dssp SSHHHHHHHHHHCC-----------------C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred CCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHH
Confidence 98888777776521 0 022357999999999999999999998 9999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+.+.+.
T Consensus 292 ~~h~~f~~~~w~ 303 (350)
T 1rdq_E 292 KNHKWFATTDWI 303 (350)
T ss_dssp HTSGGGTTCCHH
T ss_pred HhCcCcCCCCHH
Confidence 999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.84 Aligned_cols=206 Identities=29% Similarity=0.422 Sum_probs=171.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... ..+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+.+||+|
T Consensus 202 l~~l~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiH 272 (446)
T 4ejn_A 202 LQNSRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272 (446)
T ss_dssp CCCCSCTTSCCEEEEEEET-----TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHhCCCCeEeeEEEEEeeC-----CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEE
Confidence 5678999999999998543 348999999985 77666653 3579999999999999999999996139999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+|+..... ......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 273 rDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 273 RDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp CCCCGGGEEEC-SSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHEEEC-CCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCC
Confidence 99999999999 4778999999999864332 233456899999999999764 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e 233 (296)
+.+.......+..... .++..+++++.+||.+||+.||.+|| |++|
T Consensus 351 ~~~~~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~e 401 (446)
T 4ejn_A 351 NQDHEKLFELILMEEI-----------------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 401 (446)
T ss_dssp CSSHHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred CCCHHHHHHHHHhCCC-----------------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHH
Confidence 9888777776654210 12235799999999999999999999 9999
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||+.+.+.
T Consensus 402 ll~hp~f~~~~~~ 414 (446)
T 4ejn_A 402 IMQHRFFAGIVWQ 414 (446)
T ss_dssp HHTSGGGTTCCHH
T ss_pred HHhCccccCCCHH
Confidence 9999999998664
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=305.65 Aligned_cols=203 Identities=25% Similarity=0.408 Sum_probs=169.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.... .+|+||||++ |+|.+.+.. ..+++..++.++.|++.||.|||+ +||+||
T Consensus 72 ~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 140 (297)
T 3fxz_A 72 RENKNPNIVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHR 140 (297)
T ss_dssp HHCCCTTBCCEEEEEEETT-----EEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred hcCCCCCCCeEeEEEEECC-----EEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeC
Confidence 4689999999999985433 4899999997 587777653 358999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 141 Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 141 DIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp CCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCHHHEEEC-CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 47789999999998664433 23456789999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+.......+........ ..+..+++.+.+||.+||+.||.+|||++|+++|||
T Consensus 219 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 219 ENPLRALYLIATNGTPEL--------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp SCHHHHHHHHHHHCSCCC--------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CCHHHHHHHHHhCCCCCC--------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 887777666554211100 012347899999999999999999999999999999
Q ss_pred cccc
Q 022500 240 FDEL 243 (296)
Q Consensus 240 f~~~ 243 (296)
|+..
T Consensus 273 ~~~~ 276 (297)
T 3fxz_A 273 LKIA 276 (297)
T ss_dssp GGGC
T ss_pred hccc
Confidence 9864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=318.37 Aligned_cols=212 Identities=27% Similarity=0.456 Sum_probs=173.6
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. +...+|+||||++ |+|.+.+.. .+..+++..++.++.||+.||+|||+ +||+||
T Consensus 116 ~~~~hp~Iv~l~~~~~-----~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHr 186 (412)
T 2vd5_A 116 VNGDRRWITQLHFAFQ-----DENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR-LGYVHR 186 (412)
T ss_dssp HHSCTTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhcCCCCeeeEEEEEe-----eCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeec
Confidence 3578999999999984 4445999999997 688887764 23579999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccC------CCCCCchhHHHHHHHHHHHHHh
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~ 152 (296)
||||+|||++ .++.+||+|||+|+....... ....+||+.|+|||++.+ ...++.++||||+||++|+|++
T Consensus 187 DLKp~NILld-~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt 265 (412)
T 2vd5_A 187 DIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265 (412)
T ss_dssp CCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH
T ss_pred ccCHHHeeec-CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh
Confidence 9999999999 578899999999987644332 234589999999999862 2358999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCC---C
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---C 229 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R---~ 229 (296)
|..||.+.+..+.+.+|++.... ...+. ....+++++++||++||+ +|.+| +
T Consensus 266 G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~ 320 (412)
T 2vd5_A 266 GQTPFYADSTAETYGKIVHYKEH---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRG 320 (412)
T ss_dssp SSCTTCCSSHHHHHHHHHTHHHH---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTT
T ss_pred CCCCCCCCCHHHHHHHHHhcccC---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 99999999988888887752100 00010 113489999999999999 99998 4
Q ss_pred CHHHHhcCCCcccccCCCC
Q 022500 230 TALEACAHPFFDELREPNA 248 (296)
Q Consensus 230 t~~e~l~hp~f~~~~~~~~ 248 (296)
+++|+++||||+.+.|...
T Consensus 321 ~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 321 GAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp THHHHHTSGGGTTCCSTTS
T ss_pred CHHHHhcCCCcCCCCHHHH
Confidence 8999999999999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=316.15 Aligned_cols=206 Identities=29% Similarity=0.424 Sum_probs=171.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++|||||++++++. +....|+||||+.| +|.+.+. ....+++..+..++.||+.||.|||+ +||+||
T Consensus 83 ~~l~hpnIv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~ 152 (362)
T 2bdw_A 83 RKLQHPNIVRLHDSIQ-----EESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHR 152 (362)
T ss_dssp HHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCC
T ss_pred HhCCCCCCCeEEEEEE-----eCCEEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 4689999999999984 34458999999985 7766654 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++.. ++.+||+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|.+||.
T Consensus 153 Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 999999999743 246999999999877655555567899999999999654 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+....+.......+.. ....+++++++||.+||+.||.+|||+.++++||
T Consensus 232 ~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 232 DEDQHRLYAQIKAGAYDYPSP-------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp CSSHHHHHHHHHHTCCCCCTT-------------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred CCCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 988877777665531111100 1124789999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||...
T Consensus 287 ~~~~~ 291 (362)
T 2bdw_A 287 WICNR 291 (362)
T ss_dssp HHHTH
T ss_pred ccCCC
Confidence 99754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.68 Aligned_cols=210 Identities=27% Similarity=0.411 Sum_probs=169.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+|||||+ |+|.+.+.........+++..++.++.||+.||+|||+ +||+||
T Consensus 81 ~~l~hpnIv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHr 154 (351)
T 3c0i_A 81 HMLKHPHIVELLETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHR 154 (351)
T ss_dssp HHCCCTTBCCEEEEEEE-----TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhCCCCCCCcEEEEEEe-----CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceec
Confidence 46899999999999854 334899999999 58877776655555679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCC--CCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPL--THQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++.. ...+||+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus 155 Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf 233 (351)
T 3c0i_A 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPF 233 (351)
T ss_dssp CCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCC
Confidence 999999999742 23499999999987654332 3456799999999999654 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.. .+....+.+......... ...+++++++||.+||+.||.+|||+.++++|
T Consensus 234 ~~~~-~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 234 YGTK-ERLFEGIIKGKYKMNPRQ-------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CSSH-HHHHHHHHHTCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcH-HHHHHHHHcCCCCCCccc-------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8753 344444444211111111 12479999999999999999999999999999
Q ss_pred CCccccc
Q 022500 238 PFFDELR 244 (296)
Q Consensus 238 p~f~~~~ 244 (296)
|||+...
T Consensus 288 p~~~~~~ 294 (351)
T 3c0i_A 288 PWLKERD 294 (351)
T ss_dssp HHHHTHH
T ss_pred hhhcCCc
Confidence 9998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=311.24 Aligned_cols=232 Identities=32% Similarity=0.597 Sum_probs=182.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++||||+++++++.. ...+|+||||+++++...+.. ....+++..+..++.||+.||.|||+ +||+|||
T Consensus 79 ~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~d 149 (331)
T 4aaa_A 79 KQLRHENLVNLLEVCKK-----KKRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRD 149 (331)
T ss_dssp HHCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCC
T ss_pred hhCCCCCEeeEEEEeec-----CCEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccC
Confidence 46899999999999853 344899999999875555432 45679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.
T Consensus 150 lkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 150 IKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp CCGGGEEEC-TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cChheEEEc-CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998 47789999999997654322 2345678999999999977656899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhc--CcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCM--NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+..+.+..+....+.......... .+.+.....+..............+++++.+||.+||+.||.+|||+.|+++||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 999999999988888776544322 233333334433333333333446899999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||+..
T Consensus 309 ~f~~~ 313 (331)
T 4aaa_A 309 FFQMD 313 (331)
T ss_dssp HHHGG
T ss_pred hhccC
Confidence 99864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=309.57 Aligned_cols=204 Identities=28% Similarity=0.444 Sum_probs=168.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... ..+|+||||++ |+|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||
T Consensus 76 ~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~ 145 (327)
T 3a62_A 76 EEVKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYR 145 (327)
T ss_dssp HHCCCTTBCCEEEEEECS-----SCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred HhCCCCCccceeEEEEcC-----CEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcc
Confidence 467999999999998543 34899999998 577777653 3568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 146 Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 146 DLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp CCCTTTEEEC-TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCHHHeEEC-CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 9999999999 4788999999999764332 223456789999999999654 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+..+.+..+.+... .++..+++++.+||.+||+.||.+|| ++.++
T Consensus 224 ~~~~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~ 274 (327)
T 3a62_A 224 ENRKKTIDKILKCKL-----------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEV 274 (327)
T ss_dssp SSHHHHHHHHHHTCC-----------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHH
T ss_pred CCHHHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHH
Confidence 988887777765211 02234799999999999999999999 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+.+.+.
T Consensus 275 l~hp~f~~~~~~ 286 (327)
T 3a62_A 275 QAHPFFRHINWE 286 (327)
T ss_dssp HHSGGGSSCCHH
T ss_pred HcCCcccCCCHH
Confidence 999999988654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=311.17 Aligned_cols=268 Identities=33% Similarity=0.595 Sum_probs=198.5
Q ss_pred CCCCCCCeeeeceeeeccCCC-CcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~-~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++...... ....+|+||||++++|.+.+. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~ 150 (353)
T 3coi_A 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHS-AGVVHR 150 (353)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH-CCcccC
Confidence 467999999999998644321 122368999999987655432 459999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||++..... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.
T Consensus 151 dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 151 DLKPGNLAVN-EDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp SCCGGGEEEC-TTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred CCCHHHEeEC-CCCcEEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999 577899999999986532 2345678999999999976566899999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcC-c--cCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+..+.+..+.+..|.+..+....+...... + ..+......+.. ....+++++.+||.+||+.||.+|||++++++|
T Consensus 228 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 999999999999999887766543321000 0 011111111111 223579999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHHh
Q 022500 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284 (296)
Q Consensus 238 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (296)
|||+....+........ .+....+....+.+...+.+.+++.+
T Consensus 307 p~f~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (353)
T 3coi_A 307 PFFEPFRDPEEETEAQQ----PFDDSLEHEKLTVDEWKQHIYKEIVN 349 (353)
T ss_dssp GGGTTTCCGGGCCCCSS----CCCCTTTTCCCCHHHHHHHHHHHHHT
T ss_pred cchhhccCccccccCCC----CCccchhhccCCHHHHHHHHHHHHHh
Confidence 99998876543322222 23333334455666666666665543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=315.84 Aligned_cols=209 Identities=27% Similarity=0.429 Sum_probs=172.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ...+|+||||++| +|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 102 l~~l~hpnIv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH 172 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFED-----KYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVH 172 (387)
T ss_dssp HTTCCSTTBCCEEEEEEC-----SSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCcCCCeEEEEEEe-----CCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 467899999999999843 3458999999985 77665542 33579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC-CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++. ..+.+||+|||+++............||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 173 rDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp CCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 999999999974 246799999999987755555556688999999999965 458999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..+...... .+ ......+++++++||.+||+.||.+|||+.++++||
T Consensus 252 ~~~~~~~~~~i~~~~~~-----------------~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 252 GEDDLETLQNVKRCDWE-----------------FD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp CSSHHHHHHHHHHCCCC-----------------CC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCCHHHHHHHHHhCCCC-----------------CC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 98887777766542111 00 011234799999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||+...
T Consensus 307 ~~~~~~ 312 (387)
T 1kob_A 307 WLKGDH 312 (387)
T ss_dssp TTSSCC
T ss_pred cccCCc
Confidence 998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.74 Aligned_cols=209 Identities=29% Similarity=0.400 Sum_probs=174.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ...+|+||||++ ++|.+.+.. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 140 l~~l~hpnIv~~~~~~~~-----~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH 210 (373)
T 2x4f_A 140 MNQLDHANLIQLYDAFES-----KNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILH 210 (373)
T ss_dssp HTTCCCTTBCCEEEEEEC-----SSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 467899999999999854 334899999998 477776653 33468999999999999999999999 79999
Q ss_pred CCCCCCcEEEc-CCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~-~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||+. ..++.+||+|||+++............||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 211 ~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999984 2467899999999987765555556679999999999865 458999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..+......... .....+++++++||.+||+.||.+|||+.|+++||
T Consensus 290 ~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 290 GDNDAETLNNILACRWDLED-------------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp CSSHHHHHHHHHHTCCCSCS-------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCHHHHHHHHHhccCCCCh-------------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 99988888887763221110 11134799999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||++..
T Consensus 345 ~~~~~~ 350 (373)
T 2x4f_A 345 WLSDHK 350 (373)
T ss_dssp HHHCHH
T ss_pred CcCCCc
Confidence 998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=314.05 Aligned_cols=206 Identities=24% Similarity=0.398 Sum_probs=169.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||++++++.. ...+|+||||+.| +|...+. ....+++..++.++.||+.||.|||+ +||+|
T Consensus 69 l~~l~hp~Iv~l~~~~~~-----~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~givH 138 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQD-----EEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQN-QRIIH 138 (384)
T ss_dssp HHTCCCTTBCCEEEEEEC-----SSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCcEEEEEEe-----CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcee
Confidence 357899999999999954 3348999999985 7666655 45679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++ .++.+||+|||+|.............||+.|+|||++.+. ..++.++||||+||++|+|++|..||
T Consensus 139 rDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 139 RDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp CCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCcHHHeEEC-CCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 99999999999 5788999999999877655556678899999999998642 34889999999999999999999999
Q ss_pred CCCCh---HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-HHH
Q 022500 158 PGENA---VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALE 233 (296)
Q Consensus 158 ~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-~~e 233 (296)
.+.+. .+....+.... ..++..+++++.+||.+||+.||.+|++ +++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~ 268 (384)
T 4fr4_A 218 HIRSSTSSKEIVHTFETTV-----------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSD 268 (384)
T ss_dssp CCCTTSCHHHHHHHHHHCC-----------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHH
T ss_pred CCCCCccHHHHHHHHhhcc-----------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHH
Confidence 76432 22222222210 0122357999999999999999999998 899
Q ss_pred HhcCCCcccccCC
Q 022500 234 ACAHPFFDELREP 246 (296)
Q Consensus 234 ~l~hp~f~~~~~~ 246 (296)
+++||||+++.+.
T Consensus 269 l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 269 VQNFPYMNDINWD 281 (384)
T ss_dssp HHTSGGGTTCCHH
T ss_pred HHcChhhhcCCHH
Confidence 9999999988763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=300.45 Aligned_cols=208 Identities=28% Similarity=0.432 Sum_probs=165.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++| +|.+.+.........+++..++.++.|++.||+|||+ +||+|
T Consensus 74 l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH 147 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFED-----YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVH 147 (285)
T ss_dssp HHTCCCTTBCCEEEEEEC-----SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCchHHhHHHheec-----CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEE
Confidence 357899999999999843 3448999999985 8888887665666889999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC--CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDP--LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++. .++.+||+|||++.............+|+.|+|||++.+ .++.++||||+||++|+|++|..||
T Consensus 148 ~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf 225 (285)
T 3is5_A 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPF 225 (285)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCC
Confidence 999999999953 346799999999987655555556778999999999853 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+....+........ .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 226 TGTSLEEVQQKATYKEPNYA--------------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCSSHHHHHHHHHHCCCCCC--------------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCCCHHHHHhhhccCCcccc--------------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 98877666554433110000 0112368999999999999999999999999999
Q ss_pred CCccc
Q 022500 238 PFFDE 242 (296)
Q Consensus 238 p~f~~ 242 (296)
|||++
T Consensus 280 p~f~~ 284 (285)
T 3is5_A 280 EWFKQ 284 (285)
T ss_dssp GGGGC
T ss_pred HHhhc
Confidence 99985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=321.52 Aligned_cols=203 Identities=30% Similarity=0.456 Sum_probs=172.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++||||+++++++... ..+|+||||++ |+|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 70 l~~l~HpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH 139 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVH 139 (476)
T ss_dssp HTTCCCTTBCCEEEEEECS-----SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred HHhCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCc
Confidence 4678999999999998543 34899999997 57766554 45779999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+
T Consensus 140 rDLkp~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 140 RDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp SCCSGGGEEEC-TTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccHHHEEEe-cCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 99999999999 57789999999998766555556678999999999997765458999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+......++..... ..+..+++++.+||++||+.||.+|||+.++++|||
T Consensus 219 ~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 219 DHVPTLFKKICDGIF-----------------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp SSSHHHHHHHHTTCC-----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred CCHHHHHHHHhcCCc-----------------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 887777766654210 012347899999999999999999999999999999
Q ss_pred cccc
Q 022500 240 FDEL 243 (296)
Q Consensus 240 f~~~ 243 (296)
|+..
T Consensus 270 ~~~~ 273 (476)
T 2y94_A 270 FKQD 273 (476)
T ss_dssp HHTT
T ss_pred hhhc
Confidence 9863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.16 Aligned_cols=237 Identities=19% Similarity=0.293 Sum_probs=165.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++|||||++++++.... .+|+|||||+ |+|.+.+... ....+++..++.++.||+.||+|||+ +||+||
T Consensus 81 ~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHr 152 (389)
T 3gni_B 81 KLFNHPNIVPYRATFIADN-----ELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHR 152 (389)
T ss_dssp HHCCCTTBCCEEEEEEETT-----EEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCCCcEeEEEEECC-----EEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 5689999999999995433 4899999998 5887777642 23569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC--------CccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll 151 (296)
||||+|||++ .++.+||+|||.+....... ......||+.|+|||++.+. ..++.++||||+||++|+|+
T Consensus 153 Dlkp~NIll~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 231 (389)
T 3gni_B 153 SVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231 (389)
T ss_dssp CCSGGGEEEC-TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEc-CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence 9999999999 57789999999986543221 12234789999999999763 45899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCC--------CCHHHHhhcC---------cCCcCccCCCCCCCCcccccCCCCCHHHH
Q 022500 152 LGQPLFPGENAVDQLVEIIKVLGT--------PTREEIRCMN---------PNYTDFRFPQIKAHPWHKVFHKRMPPEAI 214 (296)
Q Consensus 152 ~g~~pf~~~~~~~~~~~i~~~~~~--------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (296)
+|..||.+.+....+..++...-. +......... ....................+..++++++
T Consensus 232 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 311 (389)
T 3gni_B 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311 (389)
T ss_dssp HSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHHH
T ss_pred HCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHH
Confidence 999999887766555443321100 0000000000 00000000000011111223456899999
Q ss_pred HHHHcccccCCCCCCCHHHHhcCCCcccccCCC
Q 022500 215 DLASRLLQYSPSLRCTALEACAHPFFDELREPN 247 (296)
Q Consensus 215 dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~~ 247 (296)
+||.+||+.||++|||++|+++||||+.+.+..
T Consensus 312 ~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 312 HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred HHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence 999999999999999999999999999887643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=302.06 Aligned_cols=208 Identities=27% Similarity=0.405 Sum_probs=161.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~-~i~H~ 80 (296)
+.++||||+++++++.... ..|+||||++|+|.+.+.........+++..++.++.|++.||.|||+ + ||+||
T Consensus 61 ~~~~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~ 134 (290)
T 3fme_A 61 RTVDCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHR 134 (290)
T ss_dssp TTCCCTTBCCEEEEEECSS-----SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCC
T ss_pred HhCCCCeEEEEeeeeeccC-----CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecC
Confidence 5689999999999985433 388999999999988888776777889999999999999999999999 7 99999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhc---cCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++ .++.+||+|||++.............||+.|+|||++ .....++.++||||+||++|+|++|..||
T Consensus 135 dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 135 DVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp CCSGGGCEEC-TTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred CCCHHHEEEC-CCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 9999999999 4778999999999876555444556789999999997 23445899999999999999999999999
Q ss_pred CCC-ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGE-NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+. .....+.......... .....+++++.++|.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 214 DSWGTPFQQLKQVVEEPSPQ---------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCSCHHHHHHHHHHSCCCC---------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccCchHHHHHHHhccCCCC---------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 864 3444444433311000 011347899999999999999999999999999
Q ss_pred CCCcccc
Q 022500 237 HPFFDEL 243 (296)
Q Consensus 237 hp~f~~~ 243 (296)
||||+..
T Consensus 267 hp~f~~~ 273 (290)
T 3fme_A 267 HPFFTLH 273 (290)
T ss_dssp SHHHHHH
T ss_pred CcccccC
Confidence 9999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=305.30 Aligned_cols=239 Identities=30% Similarity=0.529 Sum_probs=185.2
Q ss_pred CCCCCCCCeeeeceeeeccCC---------CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTS---------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 71 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~---------~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~L 71 (296)
|++++||||+++++++..... .+...+|+||||++|+|.+.+. .+.+++..++.++.|++.||+||
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~l 136 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYI 136 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHH
Confidence 357899999999998753321 2345688999999999877764 35799999999999999999999
Q ss_pred HhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC----CccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 72 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 72 H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
|+ +||+||||||+||+++..++.+||+|||++....... ......+|+.|+|||++.+...++.++||||+||++
T Consensus 137 H~-~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 215 (320)
T 2i6l_A 137 HS-ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215 (320)
T ss_dssp HH-TTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHH
T ss_pred Hh-CCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHH
Confidence 99 7999999999999998556789999999998653221 223446789999999987656799999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCc---cCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 148 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 148 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
|+|++|..||.+.+..+.+..+.+..+.+..+...........+ ... ....++ ......+++++++||.+||+.|
T Consensus 216 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~L~~d 293 (320)
T 2i6l_A 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMT-EPHKPL-TQLLPGISREAVDFLEQILTFS 293 (320)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT-SCCCCH-HHHSTTCCHHHHHHHHTTSCSS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccccccccc-CCCCCh-hHhcchhhHHHHHHHHHHcCCC
Confidence 99999999999999999999998887777666544332211100 000 001111 1223458999999999999999
Q ss_pred CCCCCCHHHHhcCCCcccccCCC
Q 022500 225 PSLRCTALEACAHPFFDELREPN 247 (296)
Q Consensus 225 p~~R~t~~e~l~hp~f~~~~~~~ 247 (296)
|.+|||++++++||||+....+.
T Consensus 294 P~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 294 PMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp GGGSCCHHHHHTSHHHHTTCC--
T ss_pred ccccCCHHHHhCCcccccccCcc
Confidence 99999999999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=308.56 Aligned_cols=228 Identities=26% Similarity=0.441 Sum_probs=178.3
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.++|||||++++++... ..+|+||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||
T Consensus 92 ~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDl 163 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYY-----DHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDL 163 (360)
T ss_dssp STTGGGBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCC
T ss_pred CCCCCCeecccceeeEC-----CeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCC
Confidence 34699999999998543 348999999988998888752 23459999999999999999999999 79999999
Q ss_pred CCCcEEEcC------------------------CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchh
Q 022500 83 KPQNLLVDP------------------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI 138 (296)
Q Consensus 83 kp~Nill~~------------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 138 (296)
||+|||++. .++.+||+|||++..... ......||+.|+|||++.+. .++.++
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~ 240 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSS 240 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTH
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCcc
Confidence 999999973 267899999999986433 23456789999999999764 599999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCc-CccCCCCCCCCccc--------------
Q 022500 139 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-DFRFPQIKAHPWHK-------------- 203 (296)
Q Consensus 139 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-------------- 203 (296)
||||+||++|+|++|..||.+.+..+.+..+....+.++............ .+.........|..
T Consensus 241 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 320 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred chHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence 999999999999999999999999999999988888877665543321110 00000000000000
Q ss_pred --ccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcc
Q 022500 204 --VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241 (296)
Q Consensus 204 --~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~ 241 (296)
......++.+.+||.+||+.||.+|||++|+++||||+
T Consensus 321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 01112357889999999999999999999999999995
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=322.66 Aligned_cols=208 Identities=30% Similarity=0.535 Sum_probs=175.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. +...+|+|||||. |+|.+.+. ....+++..++.++.||+.||.|||+ +||+|
T Consensus 80 l~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH 149 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFE-----DKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVH 149 (484)
T ss_dssp HTTCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCCCcEEEEEE-----eCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 46789999999999984 3445899999998 57766665 35679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC--CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDP--LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++. .++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||
T Consensus 150 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC
Confidence 999999999942 467899999999987766555566789999999999965 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+.+..+.+.......+ ....+++++++||++||++||.+|||+.++++|
T Consensus 228 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 228 NGANEYDILKKVEKGKYTFELP-------------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCSSHHHHHHHHHHCCCCCCSG-------------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcCCCCCCCc-------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 9999888887776532111110 112479999999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+....
T Consensus 283 ~~~~~~~~ 290 (484)
T 3nyv_A 283 EWIQTYTK 290 (484)
T ss_dssp HHHHHHTC
T ss_pred hhhccccc
Confidence 99987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=321.29 Aligned_cols=208 Identities=29% Similarity=0.495 Sum_probs=171.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ...+|+|||||.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+|
T Consensus 75 l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH 144 (486)
T 3mwu_A 75 LKKLDHPNIMKLFEILED-----SSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVH 144 (486)
T ss_dssp HHHCCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCcCeEEEEEEc-----CCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEe
Confidence 356899999999999843 4458999999984 77776653 3579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC--CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDP--LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++. .++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|.+||
T Consensus 145 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp SCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999963 345799999999987655555566789999999999965 4899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+.+..+.........+ ....+++++++||.+||+.||.+|||+.++++|
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 223 YGKNEYDILKRVETGKYAFDLP-------------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCSSHHHHHHHHHHTCCCSCSG-------------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCHHHHHHHHHhCCCCCCCc-------------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9998888877776532111111 112479999999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+....
T Consensus 278 p~~~~~~~ 285 (486)
T 3mwu_A 278 PWIQKYSS 285 (486)
T ss_dssp HHHHHTCC
T ss_pred HhhccCcc
Confidence 99987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=310.76 Aligned_cols=208 Identities=27% Similarity=0.506 Sum_probs=151.6
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ..+|+||||++ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||
T Consensus 71 ~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~ 140 (361)
T 3uc3_A 71 RSLRHPNIVRFKEVILTP-----THLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHR 140 (361)
T ss_dssp HHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSC
T ss_pred HhCCCCCCCcEEEEEeeC-----CEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccC
Confidence 468999999999999543 34899999997 587777653 3569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCC--cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~--~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++. ++ .+||+|||+++............||+.|+|||++.+....+.++||||+||++|+|++|..||.
T Consensus 141 Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 141 DLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp CCCGGGEEECS-SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCHHHEEEcC-CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 99999999984 33 4999999999865444445567899999999999776534455999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.........+++.... ..+..+ ....+++++.+||.+||+.||.+|||+.|+++||
T Consensus 220 ~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 220 DPEEPRDYRKTIQRILS-------------VKYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp ----CCCHHHHHHHHHT-------------TCCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCccHHHHHHHHHHHhc-------------CCCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 76443222222221000 000011 0124789999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||...
T Consensus 277 ~f~~~ 281 (361)
T 3uc3_A 277 WFLKN 281 (361)
T ss_dssp HHHTT
T ss_pred chhcC
Confidence 99654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=302.10 Aligned_cols=208 Identities=26% Similarity=0.404 Sum_probs=173.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+||||++ ++|.+.+. ....+++..+..++.|++.||+|||+ +||+||
T Consensus 70 ~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~ 139 (321)
T 2a2a_A 70 RQVLHHNVITLHDVYEN-----RTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHF 139 (321)
T ss_dssp HHCCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCcceEEEEEec-----CCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 46799999999999843 344899999997 58777765 34678999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCC---cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~---~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++..+. .+||+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus 140 dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp CCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCC
Confidence 99999999984332 7999999999876655445566789999999999654 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+.+..+.......... ....+++.+.+||.+||+.||.+|||++++++|
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 219 LGDTKQETLANITSVSYDFDEE-------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCSSHHHHHHHHHTTCCCCCHH-------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHhcccccChh-------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9988887777766532222211 123478999999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+...+
T Consensus 274 p~~~~~~~ 281 (321)
T 2a2a_A 274 PWITPVDN 281 (321)
T ss_dssp TTTSCSSH
T ss_pred ccccCCCc
Confidence 99987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=321.68 Aligned_cols=207 Identities=29% Similarity=0.492 Sum_probs=173.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+|
T Consensus 90 l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH 159 (494)
T 3lij_A 90 LKLLDHPNIMKLYDFFED-----KRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVH 159 (494)
T ss_dssp HTTCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEEe-----CCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcee
Confidence 467899999999999943 3448999999985 77776653 3569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++.. ++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|.+||
T Consensus 160 ~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCC
Confidence 9999999999742 34599999999987765555566789999999999853 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+.+..+.+.......+ ....+++++++||++||+.||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 238 GGQTDQEILRKVEKGKYTFDSP-------------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSSHHHHHHHHHHTCCCCCSG-------------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCHHHHHHHHHhCCCCCCch-------------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 9999888877776532221111 113479999999999999999999999999999
Q ss_pred CCccccc
Q 022500 238 PFFDELR 244 (296)
Q Consensus 238 p~f~~~~ 244 (296)
|||+...
T Consensus 293 p~~~~~~ 299 (494)
T 3lij_A 293 PWIKEMC 299 (494)
T ss_dssp HHHHHHH
T ss_pred cccccCc
Confidence 9998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=321.53 Aligned_cols=208 Identities=27% Similarity=0.483 Sum_probs=175.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. +...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+|
T Consensus 100 l~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH 169 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFE-----DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVH 169 (504)
T ss_dssp HHTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEE-----cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEe
Confidence 35789999999999994 44458999999985 77777653 3569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCC--CcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDPLT--HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++..+ ..+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||
T Consensus 170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 247 (504)
T 3q5i_A 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF 247 (504)
T ss_dssp SCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC
Confidence 99999999998533 2699999999987765555566789999999999853 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+.+..+.+......... ...+++++++||++||++||.+|||++|+++|
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 248 GGQNDQDIIKKVEKGKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCSSHHHHHHHHHHCCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcCCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99998888877766322222221 13479999999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+....
T Consensus 303 ~~~~~~~~ 310 (504)
T 3q5i_A 303 RWIKKYAN 310 (504)
T ss_dssp HHHHHTCC
T ss_pred Hhhhhchh
Confidence 99987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=295.79 Aligned_cols=206 Identities=30% Similarity=0.479 Sum_probs=173.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++| +|.+.+.. ...+++..+..++.|++.||+|||+ +||+|
T Consensus 60 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H 129 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFED-----NTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAH 129 (277)
T ss_dssp HHTCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCEeeEEEEEec-----CCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccC
Confidence 357899999999999843 3448999999985 77776653 3569999999999999999999999 79999
Q ss_pred CCCCCCcEEE---cCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill---~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||++ + .++.+||+|||++.............+|+.|+|||++.+ .++.++||||+|+++|+|++|..|
T Consensus 130 ~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p 206 (277)
T 3f3z_A 130 RDLKPENFLFLTDS-PDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPP 206 (277)
T ss_dssp CCCSGGGEEESSSS-TTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHEEEecCC-CCCcEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCC
Confidence 9999999999 5 467899999999987765555566789999999999854 489999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.+.........+ ..+++++.+||.+||+.||.+|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 207 FSAPTDSEVMLKIREGTFTFPEKDW-------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCHHHH-------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHHHHHHHhCCCCCCchhh-------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9998888877777664333222211 237899999999999999999999999999
Q ss_pred CCCccccc
Q 022500 237 HPFFDELR 244 (296)
Q Consensus 237 hp~f~~~~ 244 (296)
||||++..
T Consensus 262 h~~~~~~~ 269 (277)
T 3f3z_A 262 HEWFEKQL 269 (277)
T ss_dssp SHHHHHHH
T ss_pred CHHHhccc
Confidence 99998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.00 Aligned_cols=197 Identities=25% Similarity=0.314 Sum_probs=159.5
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
.+||||+++++++.. ...+|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+|||||
T Consensus 114 ~~h~~iv~l~~~~~~-----~~~~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dik 184 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEE-----GGILYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVK 184 (311)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCCCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCS
T ss_pred cCCCcEEEEEEEEEe-----CCEEEEEEeccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCC
Confidence 489999999999843 344899999999998887764 34679999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 163 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 163 (296)
|+|||++ .++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+....
T Consensus 185 p~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 261 (311)
T 3p1a_A 185 PANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW 261 (311)
T ss_dssp GGGEEEC-GGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH
T ss_pred HHHEEEC-CCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 9999998 577899999999987655544555678999999999865 5899999999999999999998777554322
Q ss_pred HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 164 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
..+.. +... ..+...+++++.+||.+||+.||.+|||++|+++||||++
T Consensus 262 ---~~~~~--~~~~-------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 262 ---QQLRQ--GYLP-------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ---HHHTT--TCCC-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ---HHHhc--cCCC-------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 22211 0101 1122357999999999999999999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=304.71 Aligned_cols=207 Identities=25% Similarity=0.369 Sum_probs=164.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++. +....|+|||||+| +|.+.+ .....+++..++.++.||+.||+|||+ +||+||
T Consensus 60 ~~l~hpnIv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~ 129 (323)
T 3tki_A 60 KMLNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHR 129 (323)
T ss_dssp HHCCCTTBCCEEEEEE-----CSSEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhCCCCCCCeEEEEEe-----cCCeEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 4679999999999984 34458999999985 655444 345679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+...++.++||||+||++|+|++|..||
T Consensus 130 Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 208 (323)
T 3tki_A 130 DIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (323)
T ss_dssp CCSGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccchHHEEEe-CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 9999999999 57789999999997653322 2235678999999999977654588999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+............... ..+ ...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~---------------------~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 209 DQPSDSCQEYSDWKEKKTY---------------------LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp SSSCTTSHHHHHHHTTCTT---------------------STT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCchHHHHHHHHhccccc---------------------CCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 8765432222221110000 000 12378999999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+....
T Consensus 263 ~~~~~~~~ 270 (323)
T 3tki_A 263 RWYNKPLK 270 (323)
T ss_dssp TTTTCCCC
T ss_pred hhhccccc
Confidence 99987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.79 Aligned_cols=201 Identities=29% Similarity=0.448 Sum_probs=172.7
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++. +...+||||||++ |+|...+.. .+.+++..++.|+.||+.||+|||+ +||+|||||
T Consensus 400 ~~~~i~~l~~~~~-----~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLK 469 (674)
T 3pfq_A 400 KPPFLTQLHSCFQ-----TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLK 469 (674)
T ss_dssp CCTTBCCEEEECB-----CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCC
T ss_pred CCCeEEEEEEEEE-----eCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCC
Confidence 7999999999984 4445999999998 577777664 3579999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+|||++ .++.+||+|||+|+.... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+.
T Consensus 470 p~NILl~-~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 470 LDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp STTEEEC-SSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhEEEc-CCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 9999999 578899999999986432 3344567899999999999654 599999999999999999999999999998
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH-----HHHhcC
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAH 237 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~-----~e~l~h 237 (296)
.+.+..|++.. . .++..+++++++||++||++||.+|+++ +|+++|
T Consensus 548 ~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 548 DELFQSIMEHN-----------------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHHSSC-----------------C------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHHhCC-----------------C------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 88888876521 1 1234589999999999999999999997 999999
Q ss_pred CCcccccCC
Q 022500 238 PFFDELREP 246 (296)
Q Consensus 238 p~f~~~~~~ 246 (296)
|||+.+.|.
T Consensus 599 ~ff~~i~w~ 607 (674)
T 3pfq_A 599 AFFRYIDWE 607 (674)
T ss_dssp GGGSSCCHH
T ss_pred ccccCCCHH
Confidence 999998765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=295.77 Aligned_cols=212 Identities=27% Similarity=0.404 Sum_probs=173.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++. +....|+||||++| +|.+.+.. ...+++..+..++.|++.||.|||+ +||+||
T Consensus 60 ~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 129 (284)
T 3kk8_A 60 RKLQHPNIVRLHDSIQ-----EESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHR 129 (284)
T ss_dssp HHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HHcCCCCcCeEEEEEE-----cCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcC
Confidence 4689999999999984 33448899999985 77666653 3569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++.+ +..+||+|||++.............||+.|+|||++.+. .++.++||||+|+++|+|++|..||.
T Consensus 130 dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCC
Confidence 999999999732 234999999999876655555567889999999999654 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+....+......... .....+++++.+||.+||+.||++|||++++++||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 209 DEDQHRLYAQIKAGAYDYPS-------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp CSSHHHHHHHHHHTCCCCCT-------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred CCchhHHHHHHHhccccCCc-------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 98887777666542211110 01134789999999999999999999999999999
Q ss_pred CcccccCCCCC
Q 022500 239 FFDELREPNAR 249 (296)
Q Consensus 239 ~f~~~~~~~~~ 249 (296)
||++..+....
T Consensus 264 ~~~~~~~~~~~ 274 (284)
T 3kk8_A 264 WICNRERVASA 274 (284)
T ss_dssp HHHSCCCGGGS
T ss_pred cccCChhHHhH
Confidence 99887655433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=304.82 Aligned_cols=206 Identities=28% Similarity=0.395 Sum_probs=156.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... ..+|+||||++ |+|.+.+. ..+.+++..++.++.||+.||.|||+ +||+||
T Consensus 103 ~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~ 172 (349)
T 2w4o_A 103 LRLSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHR 172 (349)
T ss_dssp HHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred HhCCCCCCcceeeeEecC-----CeEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence 467999999999998543 34889999998 57766654 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcC--CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDP--LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++. .++.+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 173 Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999999972 3678999999999876544444566789999999999764 58999999999999999999999998
Q ss_pred CCChHH-HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 159 GENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 159 ~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+..... ....+.+...... ......++.++.+||.+||+.||++|||+.++++|
T Consensus 252 ~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 252 DERGDQFMFRRILNCEYYFI-------------------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTCHHHHHHHHHTTCCCCC-------------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcccHHHHHHHHhCCCccC-------------------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 776554 3444433111000 01123479999999999999999999999999999
Q ss_pred CCcccc
Q 022500 238 PFFDEL 243 (296)
Q Consensus 238 p~f~~~ 243 (296)
|||...
T Consensus 307 p~~~~~ 312 (349)
T 2w4o_A 307 PWVTGK 312 (349)
T ss_dssp TTTTST
T ss_pred cccCCC
Confidence 999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.81 Aligned_cols=208 Identities=26% Similarity=0.399 Sum_probs=170.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+||||++ |+|.+.+.........+++..++.++.||+.||+|||+ +||+||
T Consensus 240 ~~l~hp~Iv~l~~~~~~-----~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHr 313 (543)
T 3c4z_A 240 AKVHSRFIVSLAYAFET-----KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYR 313 (543)
T ss_dssp HHCCCTTBCCEEEEEEC-----SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhcCCCCEeeEEEEEee-----CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCccc
Confidence 46799999999999843 344899999998 58877776544345679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||+++....... ....+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+
T Consensus 314 DLKP~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 314 DLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp CCCGGGEEEC-TTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChHHEEEe-CCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCC
Confidence 9999999999 578899999999987654433 2345899999999999764 599999999999999999999999987
Q ss_pred CC----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----
Q 022500 160 EN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----- 230 (296)
Q Consensus 160 ~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t----- 230 (296)
.+ ..+....+.... ..++..+++++.+||++||+.||.+||+
T Consensus 392 ~~~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~ 442 (543)
T 3c4z_A 392 RGEKVENKELKQRVLEQA-----------------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGS 442 (543)
T ss_dssp TTCCCCHHHHHHHHHHCC-----------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTB
T ss_pred CccchhHHHHHHHHhhcc-----------------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccC
Confidence 63 233444443310 0122458999999999999999999996
Q ss_pred HHHHhcCCCcccccCC
Q 022500 231 ALEACAHPFFDELREP 246 (296)
Q Consensus 231 ~~e~l~hp~f~~~~~~ 246 (296)
++++++||||+.+.+.
T Consensus 443 a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 443 CDGLRTHPLFRDISWR 458 (543)
T ss_dssp SHHHHTSGGGTTCCHH
T ss_pred HHHHHcCccccCCCHH
Confidence 5899999999988654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.49 Aligned_cols=206 Identities=29% Similarity=0.440 Sum_probs=169.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++|||||++++++.. ...+|+||||++ |+|.+.+... ....+++..++.++.||+.||+|||+ +||+||
T Consensus 239 ~~l~hp~Iv~l~~~~~~-----~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHr 310 (576)
T 2acx_A 239 EKVNSRFVVSLAYAYET-----KDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYR 310 (576)
T ss_dssp HHCCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHcCCCCEeeEEEEEee-----CCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecc
Confidence 46899999999999843 345899999997 5877766532 23459999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+|||++ .++.+||+|||+|+...........+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.
T Consensus 311 DLKPeNILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 311 DLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CCCGGGEEEC-TTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred CCchheEEEe-CCCCeEEEecccceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999 5788999999999877655555567899999999999764 5899999999999999999999999876
Q ss_pred Ch----HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CH
Q 022500 161 NA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TA 231 (296)
Q Consensus 161 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~ 231 (296)
+. ......+... ...++..+++++++||.+||+.||.+|+ ++
T Consensus 389 ~~~~~~~~i~~~i~~~-----------------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa 439 (576)
T 2acx_A 389 KKKIKREEVERLVKEV-----------------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSA 439 (576)
T ss_dssp SSCCCHHHHHHHHHHC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHH
T ss_pred ccchhHHHHHHHhhcc-----------------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCH
Confidence 42 2222222220 0012245899999999999999999999 79
Q ss_pred HHHhcCCCcccccCC
Q 022500 232 LEACAHPFFDELREP 246 (296)
Q Consensus 232 ~e~l~hp~f~~~~~~ 246 (296)
+|+++||||+.+.+.
T Consensus 440 ~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 440 REVKEHPLFKKLNFK 454 (576)
T ss_dssp HHHHTSGGGTTCCHH
T ss_pred HHHHhChhhccCCHH
Confidence 999999999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=301.98 Aligned_cols=232 Identities=29% Similarity=0.529 Sum_probs=173.6
Q ss_pred CCC-CCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 3 VMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 3 ~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+++ ||||+++++++... .....++||||+++ +|.+.+. .+++..++.++.||+.||+|||+ +||+||
T Consensus 86 ~l~~~~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 154 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS-MGIMHR 154 (330)
T ss_dssp HHTTSTTBCCEEEEEECT---TTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HcCCCCCEEEeeeeeccC---CCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh-CCeeeC
Confidence 454 99999999998542 23447899999995 5544432 38899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC-CC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~ 159 (296)
||||+||+++.++..+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|..|| .+
T Consensus 155 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99999999985555899999999987665555566788999999999977567999999999999999999999888 45
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhh-cCcCCcCc---cCCCCCCCCcccc----cCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRC-MNPNYTDF---RFPQIKAHPWHKV----FHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
.+..+.+..+.+..+.+.....-. ........ .........|... ....+++++++||.+||++||.+|||+
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta 314 (330)
T 3nsz_A 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 314 (330)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred CchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH
Confidence 566677777777666543322111 11000000 0000011111111 122379999999999999999999999
Q ss_pred HHHhcCCCcccccC
Q 022500 232 LEACAHPFFDELRE 245 (296)
Q Consensus 232 ~e~l~hp~f~~~~~ 245 (296)
+|+++||||+++.+
T Consensus 315 ~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 315 REAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHTSGGGTTCC-
T ss_pred HHHhcCccHhhhcc
Confidence 99999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=303.31 Aligned_cols=204 Identities=28% Similarity=0.443 Sum_probs=163.2
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++. +...+|+|||||+| +|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|||||
T Consensus 74 ~hp~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlk 143 (342)
T 2qr7_A 74 QHPNIITLKDVYD-----DGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLK 143 (342)
T ss_dssp TSTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCC
T ss_pred CCCCcCeEEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCC
Confidence 7999999999984 44458999999984 7777665 34679999999999999999999999 799999999
Q ss_pred CCcEEEcCCCC---cEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 84 PQNLLVDPLTH---QVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 84 p~Nill~~~~~---~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|+||++...++ .+||+|||+++...... .....+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 144 p~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp GGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred HHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 99999853332 59999999998664432 33456789999999999653 488999999999999999999999986
Q ss_pred C---ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 E---NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
. +..+....+.... +.. ....+..+++++++||++||+.||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~i~~~~-----------------~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 223 GPDDTPEEILARIGSGK-----------------FSL--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp STTSCHHHHHHHHHHCC-----------------CCC--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcCCHHHHHHHHccCC-----------------ccc--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3 3344444443310 000 01122358999999999999999999999999999
Q ss_pred CCCccccc
Q 022500 237 HPFFDELR 244 (296)
Q Consensus 237 hp~f~~~~ 244 (296)
||||.+..
T Consensus 278 hp~~~~~~ 285 (342)
T 2qr7_A 278 HPWIVHWD 285 (342)
T ss_dssp SHHHHTGG
T ss_pred CCeecCcc
Confidence 99997643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=298.04 Aligned_cols=204 Identities=27% Similarity=0.473 Sum_probs=168.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... .+|+||||++| +|.+.+. ...+++..+..++.|++.||+|||+ +||+|
T Consensus 96 l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH 164 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGE-----ELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIH 164 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETT-----EEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCcceEEEEEEECC-----EEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 46789999999999986443 38899999985 6665543 3569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 165 ~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 165 RDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp CCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCHHHEEEC-CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999 47789999999998664432 2345678999999999965 458999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+....+..... +. . .....+++++.++|.+||+.||++|||+.++++||
T Consensus 243 ~~~~~~~~~~~~~~~~-~~----------~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 243 SDSPVQAMKRLRDSPP-PK----------L---------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp TSCHHHHHHHHHHSSC-CC----------C---------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCCHHHHHHHHhcCCC-CC----------c---------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 8887776665544211 00 0 00123789999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||...
T Consensus 297 ~~~~~ 301 (321)
T 2c30_A 297 FLLQT 301 (321)
T ss_dssp GGGGC
T ss_pred hhccC
Confidence 99864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.31 Aligned_cols=211 Identities=24% Similarity=0.388 Sum_probs=158.9
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.++||||+++++++.... .+..++|||||||+| +|.+.+... ....+++..++.++.||+.||.|||+ +||+|||
T Consensus 111 ~~~hp~iv~l~~~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrD 186 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRD 186 (400)
T ss_dssp HTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred hcCCCCcceEeEEEeecc-cCCcEEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccC
Confidence 358999999999885422 234568999999985 888777642 23469999999999999999999999 7999999
Q ss_pred CCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+|||++.. ++.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+
T Consensus 187 lkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp CCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999842 57899999999987655444556788999999999865 4599999999999999999999999987
Q ss_pred CChHH----HHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 160 ENAVD----QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 160 ~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
..... ....+... .+.++. .....+++++.+||++||+.||.+|||+.+++
T Consensus 266 ~~~~~~~~~~~~~i~~~-----------------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil 320 (400)
T 1nxk_A 266 NHGLAISPGMKTRIRMG-----------------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 320 (400)
T ss_dssp CTTCSSCCSHHHHHHHT-----------------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CccccccHHHHHHHHcC-----------------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 65321 12222210 000110 01134799999999999999999999999999
Q ss_pred cCCCcccc
Q 022500 236 AHPFFDEL 243 (296)
Q Consensus 236 ~hp~f~~~ 243 (296)
+||||...
T Consensus 321 ~hp~~~~~ 328 (400)
T 1nxk_A 321 NHPWIMQS 328 (400)
T ss_dssp HSHHHHTT
T ss_pred cCccccCC
Confidence 99999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=299.66 Aligned_cols=205 Identities=26% Similarity=0.455 Sum_probs=164.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ....+|+||||+++ +|.+. .....+++..++.++.||+.||+|||+ +||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH 160 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIH 160 (298)
T ss_dssp HHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 3578999999999998542 23458899999985 44332 234579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCC--CCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+... ++.++||||+||++|+|++|..|
T Consensus 161 ~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 161 RDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCCGGGEEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCHHHEEEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999998 47789999999998664432 2245678999999999865432 47899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+.......+..... ..+ ....+++++.+||.+||+.||++|||+.|+++
T Consensus 240 f~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERIMCLHSKIKSQAL-----------------EFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSHHHHHHHHHHCCC-----------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccHHHHHHHHhcccC-----------------CCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 998876665555443110 000 01247899999999999999999999999999
Q ss_pred CCCccc
Q 022500 237 HPFFDE 242 (296)
Q Consensus 237 hp~f~~ 242 (296)
||||++
T Consensus 293 hp~~~~ 298 (298)
T 2zv2_A 293 HPWVTR 298 (298)
T ss_dssp CHHHHC
T ss_pred CccccC
Confidence 999963
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=303.37 Aligned_cols=202 Identities=27% Similarity=0.406 Sum_probs=169.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++|||||++++++.... ..|+||||+.|++.+.+.. ....+++..+..++.|++.||+|||+ +||+|||
T Consensus 109 ~~l~hpniv~~~~~~~~~~-----~~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 179 (348)
T 1u5q_A 109 QKLRHPNTIQYRGCYLREH-----TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRD 179 (348)
T ss_dssp HHCCCTTBCCEEEEEEETT-----EEEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCC
T ss_pred HhCCCCCEeeEEEEEEECC-----eEEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCC
Confidence 4689999999999985443 4889999999998887754 34679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+||+++ .++.+||+|||++..... .....||+.|+|||++.+ ...++.++||||+||++|+|++|..||.+
T Consensus 180 lkp~NIll~-~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 180 VKAGNILLS-EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp CSGGGEEEE-TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCHHHEEEC-CCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999 578899999999976532 235678999999999853 34589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+....+..+...... . .....+++.+.+||.+||+.||++|||++++++|||
T Consensus 256 ~~~~~~~~~~~~~~~~-~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 256 MNAMSALYHIAQNESP-A--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp SCHHHHHHHHHHSCCC-C--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CChHHHHHHHHhcCCC-C--------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 8877776666542110 0 011347899999999999999999999999999999
Q ss_pred cccc
Q 022500 240 FDEL 243 (296)
Q Consensus 240 f~~~ 243 (296)
|...
T Consensus 309 ~~~~ 312 (348)
T 1u5q_A 309 VLRE 312 (348)
T ss_dssp HHSC
T ss_pred hhcc
Confidence 9753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.66 Aligned_cols=205 Identities=27% Similarity=0.395 Sum_probs=145.0
Q ss_pred CCC-CCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 3 VMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 3 ~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
.+. ||||+++++++. +...+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||
T Consensus 61 ~l~~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~ 130 (325)
T 3kn6_A 61 LCEGHPNIVKLHEVFH-----DQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHR 130 (325)
T ss_dssp HTTTCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhcCCCCeeEEEEEEE-----cCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeec
Confidence 454 999999999994 34458999999985 87777663 4679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCC--CcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLT--HQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~--~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++..+ ..+||+|||+++...... ......+|+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus 131 Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf 209 (325)
T 3kn6_A 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPF 209 (325)
T ss_dssp CCCGGGEEEEC----CEEEECCCTTCEECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCC
Confidence 9999999997422 279999999998654332 23456789999999999654 5899999999999999999999999
Q ss_pred CCCCh-------HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 158 PGENA-------VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 158 ~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
.+.+. .+....+.+...... ......+++++++||.+||+.||.+|||
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt 264 (325)
T 3kn6_A 210 QSHDRSLTCTSAVEIMKKIKKGDFSFE-------------------------GEAWKNVSQEAKDLIQGLLTVDPNKRLK 264 (325)
T ss_dssp C-------CCCHHHHHHHHTTTCCCCC-------------------------SHHHHTSCHHHHHHHHHHHCCCTTTCCC
T ss_pred CCCccccccccHHHHHHHHHcCCCCCC-------------------------cccccCCCHHHHHHHHHHCCCChhHCCC
Confidence 87543 233333322111111 0111247999999999999999999999
Q ss_pred HHHHhcCCCcccc
Q 022500 231 ALEACAHPFFDEL 243 (296)
Q Consensus 231 ~~e~l~hp~f~~~ 243 (296)
++++++||||++.
T Consensus 265 ~~ell~h~w~~~~ 277 (325)
T 3kn6_A 265 MSGLRYNEWLQDG 277 (325)
T ss_dssp TTTSTTCGGGCTT
T ss_pred HHHHhcChhhccC
Confidence 9999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.70 Aligned_cols=214 Identities=28% Similarity=0.476 Sum_probs=167.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc--------------------------------
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA-------------------------------- 48 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~-------------------------------- 48 (296)
++++||||+++++++. +...+|+|||||+ |+|.+.+..+...
T Consensus 83 ~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (345)
T 3hko_A 83 KKLHHPNIARLYEVYE-----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGF 157 (345)
T ss_dssp HHCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--C
T ss_pred HhCCCCCcceeehhhc-----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccc
Confidence 4679999999999984 3445899999997 5777666421111
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCC-CcEEEeeccCccccccCC-----Cccceee
Q 022500 49 ----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGE-----ANISYIC 118 (296)
Q Consensus 49 ----~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~-~~vkl~Dfg~a~~~~~~~-----~~~~~~~ 118 (296)
...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ ..+||+|||++....... ......|
T Consensus 158 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 236 (345)
T 3hko_A 158 RESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236 (345)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CC
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCC
Confidence 1224678899999999999999999 7999999999999997422 279999999998653322 1245678
Q ss_pred cccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCC
Q 022500 119 SRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 197 (296)
Q Consensus 119 t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (296)
|+.|+|||++.+. ..++.++||||+||++|+|++|..||.+.+..+....+..........
T Consensus 237 t~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------ 298 (345)
T 3hko_A 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP------------------ 298 (345)
T ss_dssp CGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG------------------
T ss_pred CccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc------------------
Confidence 9999999998642 458999999999999999999999999998888877776632211111
Q ss_pred CCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccCC
Q 022500 198 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 198 ~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
....+++++.+||.+||+.||.+|||+.++++||||+++.+.
T Consensus 299 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 299 -------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp -------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred -------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 112378999999999999999999999999999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=291.21 Aligned_cols=207 Identities=25% Similarity=0.388 Sum_probs=167.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--c
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--V 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i 77 (296)
|++++||||+++++++.... .+..++|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +| |
T Consensus 79 l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i 152 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPI 152 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCC
T ss_pred HHhCCCCCeeeeeeeecccc-CCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCE
Confidence 46789999999999886543 345668899999974 88777764 3668999999999999999999999 69 9
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
+||||||+||+++..++.+||+|||++..... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||
T Consensus 153 ~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf 229 (290)
T 1t4h_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EECCCCHHHEEEECCCCCEEEeeCCCcccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCC
Confidence 99999999999975577899999999975432 23345678999999999864 4899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..........+.....+ ..+....++++.+||.+||+.||.+|||++++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 230 SECQNAAQIYRRVTSGVKP--------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTCSSHHHHHHHHTTTCCC--------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcCcHHHHHHHHhccCCc--------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 8866555444333211110 11223468899999999999999999999999999
Q ss_pred CCccc
Q 022500 238 PFFDE 242 (296)
Q Consensus 238 p~f~~ 242 (296)
|||++
T Consensus 284 ~~f~~ 288 (290)
T 1t4h_A 284 AFFQE 288 (290)
T ss_dssp GGGC-
T ss_pred ccccc
Confidence 99985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=299.59 Aligned_cols=197 Identities=24% Similarity=0.385 Sum_probs=164.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-c-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-E-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 78 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~ 78 (296)
|++++||||+++++++. +...+++||||+. | +|.+.+. ....+++..++.++.||+.||.|||+ +||+
T Consensus 83 l~~l~h~~Iv~~~~~~~-----~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iv 152 (335)
T 3dls_A 83 LSRVEHANIIKVLDIFE-----NQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDII 152 (335)
T ss_dssp HTTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred HHhCCCCCEeeEEEEEe-----eCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeE
Confidence 46789999999999984 3445889999996 4 7766665 45679999999999999999999999 7999
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||||+||+++ .++.+||+|||++.............||+.|+|||++.+...++.++||||+||++|+|++|..||.
T Consensus 153 H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 153 HRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp CSCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred EeccCHHHEEEc-CCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 999999999999 4788999999999877665555667899999999999776545899999999999999999999996
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
.... .... . ...+..+++++.+||.+||+.||.+|||+.++++||
T Consensus 232 ~~~~------~~~~-----------------~------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 232 ELEE------TVEA-----------------A------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp SGGG------GTTT-----------------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred hHHH------HHhh-----------------c------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 5221 0000 0 001234799999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||+..
T Consensus 277 ~~~~~ 281 (335)
T 3dls_A 277 WVTQP 281 (335)
T ss_dssp TTTCC
T ss_pred cccCC
Confidence 99864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=303.91 Aligned_cols=202 Identities=29% Similarity=0.481 Sum_probs=169.4
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++.. ....|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ .||+|||||
T Consensus 158 ~hp~iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlk 227 (365)
T 2y7j_A 158 GHPHIITLIDSYES-----SSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLK 227 (365)
T ss_dssp TCTTBCCEEEEEEB-----SSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCS
T ss_pred CCCCEeEEEEEEee-----CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCC
Confidence 79999999999844 3348999999985 77777653 3569999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|+||+++ .++.+||+|||++.............||+.|+|||++.+ ...++.++||||+||++|+|++|..||.
T Consensus 228 p~NIl~~-~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 228 PENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp GGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEEC-CCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 9999999 578899999999987765555566789999999999853 2247889999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+....+..+.........+.+ ..+++++.+||.+||+.||.+|||+.++++||
T Consensus 307 ~~~~~~~~~~i~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 307 HRRQILMLRMIMEGQYQFSSPEW-------------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp CSSHHHHHHHHHHTCCCCCHHHH-------------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCHHHHHHHHHhCCCCCCCccc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 88877777766653222222111 24689999999999999999999999999999
Q ss_pred Cccc
Q 022500 239 FFDE 242 (296)
Q Consensus 239 ~f~~ 242 (296)
||++
T Consensus 362 ~f~r 365 (365)
T 2y7j_A 362 FFER 365 (365)
T ss_dssp GGCC
T ss_pred ccCC
Confidence 9973
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=290.88 Aligned_cols=203 Identities=30% Similarity=0.479 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+++||||++ |+|.+.+.. ...+++..+..++.|++.||.|||+ +||+|
T Consensus 63 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H 132 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIH 132 (279)
T ss_dssp HTTCCCTTBCCEEEEEEC-----SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEE
T ss_pred HHcCCCCCCcchhheEec-----CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 467899999999999843 344899999999 477777654 2569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++ .++.+||+|||++...... ......||+.|+|||++.+. .++.++||||+|+++|+|++|..||.+
T Consensus 133 ~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 133 RDIKPENLLLG-SAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp CCCCGGGEEEC-TTSCEEECSCCEESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCChHhEEEc-CCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 99999999998 5788999999998654332 23456789999999999654 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+....+..... .++..+++++.+||.+||+.||.+|||+.|+++|||
T Consensus 210 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 210 NTYQETYKRISRVEF-----------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp SSHHHHHHHHHHTCC-----------------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred CcHHHHHHHHHhCCC-----------------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 887777766654211 122347899999999999999999999999999999
Q ss_pred cccccC
Q 022500 240 FDELRE 245 (296)
Q Consensus 240 f~~~~~ 245 (296)
|+....
T Consensus 261 ~~~~~~ 266 (279)
T 3fdn_A 261 ITANSS 266 (279)
T ss_dssp HHHHCS
T ss_pred ccCCcc
Confidence 987544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.41 Aligned_cols=210 Identities=25% Similarity=0.349 Sum_probs=167.2
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++. +...+|+||||+.| +|.+.+.. .....+++..++.++.||+.||+|||+ +||+|||||
T Consensus 87 ~~~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dik 158 (327)
T 3lm5_A 87 SCPRVINLHEVYE-----NTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLK 158 (327)
T ss_dssp TCTTBCCEEEEEE-----CSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCC
T ss_pred CCCCEEEEEEEEE-----eCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCC
Confidence 5799999999984 33448999999986 65554432 224679999999999999999999999 799999999
Q ss_pred CCcEEEcC--CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 84 PQNLLVDP--LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 84 p~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|+||+++. .++.+||+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+
T Consensus 159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp GGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999984 2578999999999876555444566899999999999654 58999999999999999999999999998
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~ 241 (296)
..+....+......... .....+++.+.+||.+||+.||.+|||++++++||||+
T Consensus 238 ~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 238 NQETYLNISQVNVDYSE-------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp HHHHHHHHHHTCCCCCT-------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred chHHHHHHHhcccccCc-------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 88777776653222111 11234789999999999999999999999999999999
Q ss_pred cccCCCC
Q 022500 242 ELREPNA 248 (296)
Q Consensus 242 ~~~~~~~ 248 (296)
.+.+...
T Consensus 293 ~~~~~~~ 299 (327)
T 3lm5_A 293 QWDFENL 299 (327)
T ss_dssp CCCTTCC
T ss_pred ccccccc
Confidence 8876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=292.30 Aligned_cols=210 Identities=28% Similarity=0.443 Sum_probs=168.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+++||||++ ++|.+.+.. ...+++..+..++.||+.||.|||+ +|++||
T Consensus 63 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 132 (283)
T 3bhy_A 63 REIRHPNIITLHDIFEN-----KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHF 132 (283)
T ss_dssp HHCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhCCCCCeeehhheecC-----CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCC
Confidence 46789999999999853 334889999997 588777753 3569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCC---CcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~---~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++..+ ..+||+|||++.............+|+.|+|||++.+. .++.++|+||+|+++|+|++|..||
T Consensus 133 dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp CCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCC
Confidence 9999999998432 17999999999876554444556789999999998654 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+....+.........+ ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 212 LGETKQETLTNISAVNYDFDEE-------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCSSHHHHHHHHHTTCCCCCHH-------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCcchHHHHHHhHhcccCCcch-------------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 9988777766655432221111 123478999999999999999999999999999
Q ss_pred CCcccccCCC
Q 022500 238 PFFDELREPN 247 (296)
Q Consensus 238 p~f~~~~~~~ 247 (296)
|||+.+++..
T Consensus 267 ~~~~~~~~~~ 276 (283)
T 3bhy_A 267 SWIKAIRRRN 276 (283)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHHHh
Confidence 9999876553
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=309.73 Aligned_cols=208 Identities=29% Similarity=0.474 Sum_probs=155.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. . .+|+||||++| +|.+.+ .....+++..++.++.|++.||+|||+ +||+|
T Consensus 194 l~~l~hpniv~l~~~~~~-----~-~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH 262 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFDA-----E-DYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIH 262 (419)
T ss_dssp HHHCCCTTBCCCCEEEES-----S-EEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEec-----C-ceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 356899999999998731 1 26899999985 654433 355789999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+|||++.. +..+||+|||+++............||+.|+|||++.+ ...++.++||||+||++|+|++|..
T Consensus 263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp SCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999732 33599999999987655544556789999999999853 3457899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+......+...+....... .......+++++.+||.+||+.||.+|||+++++
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 398 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCcchHHHHHHHhcCCCCC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9987644333322222111100 0011234799999999999999999999999999
Q ss_pred cCCCcccc
Q 022500 236 AHPFFDEL 243 (296)
Q Consensus 236 ~hp~f~~~ 243 (296)
+||||++.
T Consensus 399 ~hp~~~~~ 406 (419)
T 3i6u_A 399 RHPWLQDE 406 (419)
T ss_dssp HSGGGCCH
T ss_pred CCcccCCh
Confidence 99999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=302.54 Aligned_cols=231 Identities=30% Similarity=0.467 Sum_probs=176.4
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~-~i~H~dlk 83 (296)
.||||+++++++.... .+..++|+||||+++++.+.+... ....+++..++.++.||+.||+|||+ + ||+|||||
T Consensus 99 ~~~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDik 174 (397)
T 1wak_A 99 NREMVVQLLDDFKISG-VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIK 174 (397)
T ss_dssp GGGGBCCEEEEEEEEE-TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCS
T ss_pred CcceeeeeecceeecC-CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCC
Confidence 4889999999885332 244568999999999988877642 33569999999999999999999999 8 99999999
Q ss_pred CCcEEEcCCC------------------------------------------------CcEEEeeccCccccccCCCccc
Q 022500 84 PQNLLVDPLT------------------------------------------------HQVKICDFGSAKQLIAGEANIS 115 (296)
Q Consensus 84 p~Nill~~~~------------------------------------------------~~vkl~Dfg~a~~~~~~~~~~~ 115 (296)
|+|||++.++ ..+||+|||++...... ...
T Consensus 175 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~ 252 (397)
T 1wak_A 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTE 252 (397)
T ss_dssp GGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCS
T ss_pred HHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--Ccc
Confidence 9999998432 27999999999865432 345
Q ss_pred eeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCHHHHhhcCcCCc
Q 022500 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRCMNPNYT 189 (296)
Q Consensus 116 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 189 (296)
..||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+ ....+..+.+..|.++...+........
T Consensus 253 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 331 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331 (397)
T ss_dssp CCSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGG
T ss_pred CCCCCcccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccc
Confidence 6789999999999765 48999999999999999999999998765 5677888888888888765533221111
Q ss_pred Ccc----CCCC-CCCCcc--------cccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 190 DFR----FPQI-KAHPWH--------KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 190 ~~~----~~~~-~~~~~~--------~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
.+. .... ...++. ...+...++++.+||.+||+.||++|||+.|+++||||++
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 0000 000000 0011224567899999999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=300.15 Aligned_cols=228 Identities=32% Similarity=0.553 Sum_probs=174.5
Q ss_pred CCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCC
Q 022500 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--TVPRVCHRDLK 83 (296)
Q Consensus 6 HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH--~~~~i~H~dlk 83 (296)
|++|+++++++... ..+|+||||++|+|.+.+... ....+++..++.++.|++.||.||| . .||+|||||
T Consensus 115 ~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlk 186 (382)
T 2vx3_A 115 KYYIVHLKRHFMFR-----NHLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLK 186 (382)
T ss_dssp GGGBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCS
T ss_pred ceeEEEeeeeeccC-----CceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCC
Confidence 34699999988543 348999999999999888753 2245899999999999999999999 5 589999999
Q ss_pred CCcEEEcC-CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 84 PQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 84 p~Nill~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
|+|||++. .++.+||+|||+++.... ......+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+.
T Consensus 187 p~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 187 PENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccEEEecCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999952 356799999999986533 33456889999999999765 589999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcC---C-----cCcc----------CCCCCCCCcccccCC-----------------
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPN---Y-----TDFR----------FPQIKAHPWHKVFHK----------------- 207 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~---~-----~~~~----------~~~~~~~~~~~~~~~----------------- 207 (296)
.+.+..+++..+.++.......... + ..|. +.......+...+..
T Consensus 264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 343 (382)
T 2vx3_A 264 VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343 (382)
T ss_dssp HHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCH
T ss_pred HHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccc
Confidence 9999999999998887655321100 0 0000 000000000000000
Q ss_pred CCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 208 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 208 ~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
..++++++||.+||++||++|||++|+|+||||++..
T Consensus 344 ~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred hhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 0014789999999999999999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=289.06 Aligned_cols=211 Identities=28% Similarity=0.449 Sum_probs=170.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++||||+++++++... +...+|+||||+++++.+.+... ....+++..+..++.||+.||.|||+ +||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~ 133 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNE---EKQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHK 133 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC------CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HHhcCCCCeeEEEEEEEcC---CCCeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeec
Confidence 4678999999999988532 22348899999999887777653 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+.. .++.++||||+|+++|+|++|..|
T Consensus 134 dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (305)
T 2wtk_C 134 DIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212 (305)
T ss_dssp CCSGGGEEEC-TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCcccEEEc-CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCC
Confidence 9999999998 47889999999998654321 223456899999999986532 247899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.+.. + .++..+++++.+||.+||+.||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~i~~~~-----------------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 213 FEGDNIYKLFENIGKGS-----------------Y------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCCSSHHHHHHHHHHCC-----------------C------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCchHHHHHHHHhcCC-----------------C------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99888776666554310 0 022347899999999999999999999999999
Q ss_pred CCCcccccCCC
Q 022500 237 HPFFDELREPN 247 (296)
Q Consensus 237 hp~f~~~~~~~ 247 (296)
||||++.....
T Consensus 264 ~~~~~~~~~~~ 274 (305)
T 2wtk_C 264 HSWFRKKHPPA 274 (305)
T ss_dssp SHHHHSCCCC-
T ss_pred CcccccCCCCc
Confidence 99998865543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=290.36 Aligned_cols=219 Identities=26% Similarity=0.367 Sum_probs=164.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVP 75 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~----~~~~~~~~~~~~~~~qil~aL~~LH~~~ 75 (296)
|++++||||+++++++.... ..++||||++ ++|.+.+..... ....+++..+..++.||+.||.|||+ +
T Consensus 67 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~ 140 (303)
T 2vwi_A 67 MSQCHHPNIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-N 140 (303)
T ss_dssp CCCCCCTTBCCEEEEEESSS-----CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred HhhcCCCCEeeEEEEEeecC-----CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence 56789999999999985443 3889999997 588887765332 24568999999999999999999999 7
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHH
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 149 (296)
||+||||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+...++.++||||+||++|+
T Consensus 141 ~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 219 (303)
T 2vwi_A 141 GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219 (303)
T ss_dssp TCCCCCCSGGGEEEC-TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHH
T ss_pred CCCCCCCChhhEEEc-CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHH
Confidence 999999999999998 47789999999987653321 12345789999999998654458999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 150 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 150 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
|++|..||.+.................. ............+++++.++|.+||+.||.+||
T Consensus 220 l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 280 (303)
T 2vwi_A 220 LATGAAPYHKYPPMKVLMLTLQNDPPSL-------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280 (303)
T ss_dssp HHHSSCTTTTSCGGGHHHHHHTSSCCCT-------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCccCchhhHHHHHhccCCCcc-------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCc
Confidence 9999999988776555443332111000 000001112345789999999999999999999
Q ss_pred CHHHHhcCCCcccccC
Q 022500 230 TALEACAHPFFDELRE 245 (296)
Q Consensus 230 t~~e~l~hp~f~~~~~ 245 (296)
|+.++++||||++...
T Consensus 281 s~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 281 TAAELLRHKFFQKAKN 296 (303)
T ss_dssp CHHHHHTSTTC-----
T ss_pred CHHHHhhChhhhcCCC
Confidence 9999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=290.02 Aligned_cols=205 Identities=29% Similarity=0.448 Sum_probs=169.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+++||||++ ++|.+.+.. ...+++..+..++.|++.||+|||+ +||+||
T Consensus 70 ~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~ 139 (294)
T 2rku_A 70 RSLAHQHVVGFHGFFED-----NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHR 139 (294)
T ss_dssp HTCCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCEeeeeeeecc-----CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 57899999999999843 345899999999 577666553 3579999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|+||+|+++|+|++|..||.+
T Consensus 140 dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 140 DLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp CCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCChHhEEEc-CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 57789999999998654322 23445789999999999654 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
....+....+.... . .++..+++.+.++|.+||+.||++|||++++++|||
T Consensus 218 ~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 218 SCLKETYLRIKKNE-----------------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp SSHHHHHHHHHTTC-----------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred CCHHHHHHHHhhcc-----------------C------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 87766655544310 0 022347899999999999999999999999999999
Q ss_pred cccccCCC
Q 022500 240 FDELREPN 247 (296)
Q Consensus 240 f~~~~~~~ 247 (296)
|.+...+.
T Consensus 269 ~~~~~~~~ 276 (294)
T 2rku_A 269 FTSGYIPA 276 (294)
T ss_dssp HHTSCCCS
T ss_pred eecCCcCC
Confidence 98765544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=311.50 Aligned_cols=207 Identities=19% Similarity=0.219 Sum_probs=156.3
Q ss_pred CCCCCCCCeeeec-------eeeeccCC---------CCcc---eEEEEeccCcccHHHHHHHhhhcC---CCCCHHHHH
Q 022500 1 MRVMDHPNVISLK-------HCFFSTTS---------KNEL---FLNLVMEYVPESMYRVLKHYSSAN---QRMPLIYVK 58 (296)
Q Consensus 1 l~~l~HpnIv~l~-------~~~~~~~~---------~~~~---~~~lv~E~~~g~l~~~l~~~~~~~---~~~~~~~~~ 58 (296)
|++++|||||+++ +++...+. .+.. ..|+||||++|+|.+.+....... ..+++..+.
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~ 209 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHH
Confidence 4677999999998 44332211 1111 378999999999999887532211 123357888
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCC-------
Q 022500 59 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA------- 131 (296)
Q Consensus 59 ~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~------- 131 (296)
.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+... .......| +.|+|||++.+.
T Consensus 210 ~i~~qi~~aL~~LH~-~~ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~ 284 (377)
T 3byv_A 210 QLTLQVIRLLASLHH-YGLVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHR 284 (377)
T ss_dssp HHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred HHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccc
Confidence 899999999999999 7999999999999999 47889999999998532 23345567 999999999764
Q ss_pred ---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCC
Q 022500 132 ---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 208 (296)
Q Consensus 132 ---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (296)
..++.++||||+||++|+|++|..||.+.+.......+.. ....
T Consensus 285 ~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~---------------------------------~~~~ 331 (377)
T 3byv_A 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR---------------------------------SCKN 331 (377)
T ss_dssp CCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS---------------------------------SCCC
T ss_pred cccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh---------------------------------hccC
Confidence 2589999999999999999999999976543221111100 1134
Q ss_pred CCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccC
Q 022500 209 MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 209 ~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~ 245 (296)
+++++.+||.+||+.||.+|||+.++++||||++++.
T Consensus 332 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 7999999999999999999999999999999987653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=288.12 Aligned_cols=202 Identities=29% Similarity=0.421 Sum_probs=159.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ..+|+||||++ ++|.+.+.. ...+++..+..++.|++.||.|||+ +|++||
T Consensus 66 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 135 (276)
T 2h6d_A 66 KLFRHPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHR 135 (276)
T ss_dssp HTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCC
T ss_pred hcCCCCCEeEEEEEEecC-----CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Confidence 568999999999998443 34889999998 588777764 3568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||++.............+|+.|+|||++.+....+.++|+||+|+++|+|++|..||.+.
T Consensus 136 dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 136 DLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CCCGGGEEEC-TTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCChhhEEEC-CCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999 477899999999987655444455678999999999976554578999999999999999999999888
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
+.......+..... .++..++.++.++|.+||+.||.+|||+.++++||||
T Consensus 215 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 215 HVPTLFKKIRGGVF-----------------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp SHHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred cHHHHHHHhhcCcc-----------------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 77666555543110 0123478999999999999999999999999999999
Q ss_pred ccc
Q 022500 241 DEL 243 (296)
Q Consensus 241 ~~~ 243 (296)
++.
T Consensus 266 ~~~ 268 (276)
T 2h6d_A 266 KQD 268 (276)
T ss_dssp HTT
T ss_pred ccC
Confidence 763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=292.80 Aligned_cols=207 Identities=26% Similarity=0.348 Sum_probs=154.5
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
++||||+++++++... ..+|+||||++ |+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||
T Consensus 68 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dl 137 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEE-----DRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDL 137 (316)
T ss_dssp CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCC
T ss_pred cCCCCeeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCC
Confidence 5799999999998543 34899999998 588777764 3569999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCC--cEEEeeccCccccccCC--------CccceeecccccCchhccCC----CCCCchhHHHHHHHHHH
Q 022500 83 KPQNLLVDPLTH--QVKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 83 kp~Nill~~~~~--~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ 148 (296)
||+||+++..+. .+||+|||++....... ......||+.|+|||++.+. ..++.++||||+||++|
T Consensus 138 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~ 217 (316)
T 2ac3_A 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217 (316)
T ss_dssp CGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHH
T ss_pred CHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHH
Confidence 999999984322 39999999987653221 12244689999999998531 24788999999999999
Q ss_pred HHHhCCCCCCCCCh---------------HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHH
Q 022500 149 ELLLGQPLFPGENA---------------VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA 213 (296)
Q Consensus 149 ~ll~g~~pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (296)
+|++|..||.+... ......+.+.....+ ......+++++
T Consensus 218 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~ 272 (316)
T 2ac3_A 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP-------------------------DKDWAHISCAA 272 (316)
T ss_dssp HHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC-------------------------HHHHTTSCHHH
T ss_pred HHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC-------------------------chhcccCCHHH
Confidence 99999999987642 112222222110000 00112478999
Q ss_pred HHHHHcccccCCCCCCCHHHHhcCCCcccccC
Q 022500 214 IDLASRLLQYSPSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 214 ~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~ 245 (296)
++||.+||+.||.+|||++|+++||||+....
T Consensus 273 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 99999999999999999999999999997643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=288.11 Aligned_cols=201 Identities=27% Similarity=0.479 Sum_probs=168.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ +||+||
T Consensus 69 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 138 (284)
T 2vgo_A 69 SHLRHPNILRMYNYFHD-----RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHR 138 (284)
T ss_dssp HTCCCTTBCCEEEEEEC-----SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECC
T ss_pred hcCCCCCEeeEEEEEEc-----CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceec
Confidence 56899999999999843 3458999999985 88777764 3569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+|||++...... ......|++.|+|||++.+. .++.++|+||+|+++|+|++|..||.+.
T Consensus 139 dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 139 DIKPENLLMG-YKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp CCSGGGEEEC-TTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCCHHHEEEc-CCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 9999999998 4778999999998765332 23456789999999999754 5899999999999999999999999988
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
+..+....+.... . .++..++.++.++|.+||+.||.+|||++++++||||
T Consensus 216 ~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 216 SHTETHRRIVNVD-----------------L------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp SHHHHHHHHHTTC-----------------C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred CHhHHHHHHhccc-----------------c------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 8777666555421 0 0223478999999999999999999999999999999
Q ss_pred cccc
Q 022500 241 DELR 244 (296)
Q Consensus 241 ~~~~ 244 (296)
+...
T Consensus 267 ~~~~ 270 (284)
T 2vgo_A 267 KANS 270 (284)
T ss_dssp HHHC
T ss_pred Hhhc
Confidence 8653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=289.98 Aligned_cols=205 Identities=30% Similarity=0.434 Sum_probs=169.7
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++. +....|+||||++ ++|.+.+.. ...+++..+..++.||+.||.|||+ +|++|||||
T Consensus 82 ~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~ 151 (298)
T 1phk_A 82 GHPNIIQLKDTYE-----TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLK 151 (298)
T ss_dssp TCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCS
T ss_pred CCCCEeeeeeeec-----cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCC
Confidence 4999999999984 3445899999998 588777763 3579999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhcc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|+||+++ .++.+||+|||++.............+++.|+|||++. ....++.++|+||+|+++|+|++|..||.
T Consensus 152 p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 152 PENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp GGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceEEEc-CCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 9999998 57789999999998765555555677899999999985 23457899999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+.......+.........+ ....+++++.++|.+||+.||.+|||++++++||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 231 HRKQMLMLRMIMSGNYQFGSP-------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp CSSHHHHHHHHHHTCCCCCTT-------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred CccHHHHHHHHhcCCcccCcc-------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 888777766665521111100 1123789999999999999999999999999999
Q ss_pred CcccccC
Q 022500 239 FFDELRE 245 (296)
Q Consensus 239 ~f~~~~~ 245 (296)
||++...
T Consensus 286 ~~~~~~~ 292 (298)
T 1phk_A 286 FFQQYVV 292 (298)
T ss_dssp GGCTTC-
T ss_pred Hhhhccc
Confidence 9997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=293.98 Aligned_cols=185 Identities=22% Similarity=0.360 Sum_probs=140.8
Q ss_pred ceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccC
Q 022500 25 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 103 (296)
Q Consensus 25 ~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 103 (296)
.++|+|||||+| +|.+.+.... .....++..+..++.||+.||+|||+ +||+||||||+||+++ .++.+||+|||+
T Consensus 134 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~DfG~ 210 (332)
T 3qd2_B 134 VYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGDFGL 210 (332)
T ss_dssp CEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred ceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEe-CCCCEEEeecCc
Confidence 358899999995 7777776422 22345677789999999999999999 7999999999999999 577899999999
Q ss_pred ccccccCC-------------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022500 104 AKQLIAGE-------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170 (296)
Q Consensus 104 a~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 170 (296)
++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|..|+... ......+.
T Consensus 211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~ 287 (332)
T 3qd2_B 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR 287 (332)
T ss_dssp CEECSCC--------------CCCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH
T ss_pred ccccccchhhccccccccccccccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh
Confidence 98764432 12345789999999999764 5899999999999999999987664211 11111111
Q ss_pred HhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccc
Q 022500 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 243 (296)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~ 243 (296)
. +..+ . .....++++.+||.+||+.||.+|||+.|+++||||+++
T Consensus 288 ~--~~~~-~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 288 N--LKFP-L-------------------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp T--TCCC-H-------------------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred c--cCCC-c-------------------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 1 0000 0 001247788999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=294.49 Aligned_cols=204 Identities=30% Similarity=0.458 Sum_probs=169.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+||||++ ++|.+.+.. ...+++..+..++.||+.||.|||+ +||+||
T Consensus 96 ~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~ 165 (335)
T 2owb_A 96 RSLAHQHVVGFHGFFED-----NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHR 165 (335)
T ss_dssp HTCCCTTBCCEEEEEEC-----SSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhCCCCCCCeEEEEEec-----CCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEec
Confidence 57899999999999843 345899999999 477766553 3579999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++...... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 166 dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 166 DLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp CCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhEEEc-CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 9999999999 5778999999999866432 223446789999999999764 589999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
....+....+.... + .++..+++++.+||.+||+.||.+|||++++++|||
T Consensus 244 ~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 244 SCLKETYLRIKKNE-----------------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp SSHHHHHHHHHHTC-----------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred CCHHHHHHHHhcCC-----------------C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 88776665554310 0 012347899999999999999999999999999999
Q ss_pred cccccCC
Q 022500 240 FDELREP 246 (296)
Q Consensus 240 f~~~~~~ 246 (296)
|.....+
T Consensus 295 ~~~~~~~ 301 (335)
T 2owb_A 295 FTSGYIP 301 (335)
T ss_dssp HHTSCCC
T ss_pred ccCCCcc
Confidence 9876544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=304.04 Aligned_cols=194 Identities=14% Similarity=0.133 Sum_probs=146.3
Q ss_pred ceEEEEeccCcccHHHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEE
Q 022500 25 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV------KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 98 (296)
Q Consensus 25 ~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~------~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 98 (296)
..+||||||++|+|.+.+..... .++.... ..++.||+.||+|||+ +||+||||||+|||++ .++.+||
T Consensus 161 ~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivHrDikp~NIll~-~~~~~kL 235 (371)
T 3q60_A 161 ANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFIM-PDGRLML 235 (371)
T ss_dssp EEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEETTCSGGGEEEC-TTSCEEE
T ss_pred eeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCccCcCCHHHEEEC-CCCCEEE
Confidence 44889999999999998876422 2333334 5666999999999999 7999999999999999 5778999
Q ss_pred eeccCccccccCCCccceeecccccCchhccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 022500 99 CDFGSAKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177 (296)
Q Consensus 99 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 177 (296)
+|||+|+.... ......+|+.|+|||++.+ ...++.++||||+||++|+|++|..||.+.....
T Consensus 236 ~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------------- 300 (371)
T 3q60_A 236 GDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI------------- 300 (371)
T ss_dssp CCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------
T ss_pred EecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------
Confidence 99999986532 2224567799999999964 1358999999999999999999999998764210
Q ss_pred HHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcccccC
Q 022500 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~ 245 (296)
...+............+.......+++++.+||.+||+.||++|||+.++++||||+++.+
T Consensus 301 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 301 -------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp -------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred -------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 0011111111111111111122468999999999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=291.87 Aligned_cols=211 Identities=22% Similarity=0.363 Sum_probs=166.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++..... .....|+||||++ ++|.+.+.. .+.+++..+..++.|++.||+|||+ +||+|
T Consensus 66 l~~l~hp~iv~~~~~~~~~~~-~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH 139 (311)
T 3ork_A 66 AAALNHPAIVAVYDTGEAETP-AGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIH 139 (311)
T ss_dssp CCCCCCTTBCCEEEEEEEEET-TEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHcCCCCCcceEEEeeeccCC-CCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCc
Confidence 567899999999999865442 2334689999997 587777753 3579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.+||+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|..
T Consensus 140 ~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~ 217 (311)
T 3ork_A 140 RDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEP 217 (311)
T ss_dssp CCCCGGGEEEE-TTSCEEECCCSCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEEc-CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999998 477899999999986543321 2345689999999999764 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+....+......+... ....+++++.++|.+||+.||.+||++.+++
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 272 (311)
T 3ork_A 218 PFTGDSPVSVAYQHVREDPIPPSA-------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEM 272 (311)
T ss_dssp SCCCSSHHHHHHHHHHCCCCCHHH-------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred CCCCCChHHHHHHHhcCCCCCccc-------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence 999988877766665532222111 1234799999999999999999999999999
Q ss_pred cCCCccccc
Q 022500 236 AHPFFDELR 244 (296)
Q Consensus 236 ~hp~f~~~~ 244 (296)
.|+|++...
T Consensus 273 ~~~l~~~~~ 281 (311)
T 3ork_A 273 RADLVRVHN 281 (311)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHhc
Confidence 999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=300.78 Aligned_cols=201 Identities=24% Similarity=0.347 Sum_probs=157.7
Q ss_pred CCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 022500 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 85 (296)
Q Consensus 6 HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~ 85 (296)
|||||++++++... ..+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 115 ~~~iv~~~~~~~~~-----~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~ 184 (390)
T 2zmd_A 115 SDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPA 184 (390)
T ss_dssp CTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGG
T ss_pred CCeEEEEEEEEecC-----CEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHH
Confidence 69999999988543 34899999777888887764 3578999999999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCC----------CCCCchhHHHHHHHHHHHHHh
Q 022500 86 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 86 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~ 152 (296)
|||++ ++.+||+|||+++....... ....+||+.|+|||++.+. ..++.++||||+||++|+|++
T Consensus 185 NIll~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 262 (390)
T 2zmd_A 185 NFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262 (390)
T ss_dssp GEEES--SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH
T ss_pred HEEEE--CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH
Confidence 99997 46799999999987643321 2356799999999998641 358999999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 GQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|..||.+... ...+..++.... . ..++...++++.+||.+||+.||.+|||+
T Consensus 263 G~~Pf~~~~~~~~~~~~~~~~~~---------------~------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 315 (390)
T 2zmd_A 263 GKTPFQQIINQISKLHAIIDPNH---------------E------------IEFPDIPEKDLQDVLKCCLKRDPKQRISI 315 (390)
T ss_dssp SSCTTTTCCCHHHHHHHHHCTTS---------------C------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCcchhhhHHHHHHHHHhCccc---------------c------------CCCCccchHHHHHHHHHHcccChhhCCCH
Confidence 9999987643 333333332100 0 01122357899999999999999999999
Q ss_pred HHHhcCCCcccccC
Q 022500 232 LEACAHPFFDELRE 245 (296)
Q Consensus 232 ~e~l~hp~f~~~~~ 245 (296)
.++++||||+....
T Consensus 316 ~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 316 PELLAHPYVQIQTH 329 (390)
T ss_dssp HHHHTSHHHHSCC-
T ss_pred HHHhhCcCccccCc
Confidence 99999999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=289.67 Aligned_cols=231 Identities=27% Similarity=0.506 Sum_probs=178.0
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
..|++|+++++++.. ...+|+||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+|||||
T Consensus 74 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlk 145 (339)
T 1z57_A 74 NSTFRCVQMLEWFEH-----HGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLK 145 (339)
T ss_dssp TCTTCBCCEEEEEEE-----TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCC
T ss_pred CCceeeEeeeccccc-----CCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCC
Confidence 356679999999843 3358999999998998888642 23468999999999999999999999 799999999
Q ss_pred CCcEEEcCC------------------CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 84 PQNLLVDPL------------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 84 p~Nill~~~------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
|+||+++.. ++.+||+|||++..... ......||+.|+|||++.+. .++.++||||+||
T Consensus 146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~ 222 (339)
T 1z57_A 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGC 222 (339)
T ss_dssp GGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHH
T ss_pred HHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHH
Confidence 999999742 45799999999986432 23456789999999999764 5899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC-C-c--CccCCCCC---------CCCcc--cccCCCCC
Q 022500 146 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN-Y-T--DFRFPQIK---------AHPWH--KVFHKRMP 210 (296)
Q Consensus 146 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~-~--~~~~~~~~---------~~~~~--~~~~~~~~ 210 (296)
++|+|++|..||.+.+..+....+.+..+..+...+...... + . ........ ...+. .......+
T Consensus 223 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (339)
T 1z57_A 223 ILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302 (339)
T ss_dssp HHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhH
Confidence 999999999999999998888888888887776655433211 0 0 00000000 00000 00111235
Q ss_pred HHHHHHHHcccccCCCCCCCHHHHhcCCCcccccC
Q 022500 211 PEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 211 ~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~ 245 (296)
+++.+||.+||+.||.+|||+.|+++||||+.+++
T Consensus 303 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence 78999999999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=288.85 Aligned_cols=204 Identities=28% Similarity=0.460 Sum_probs=143.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ....|+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+|
T Consensus 65 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H 135 (278)
T 3cok_A 65 HCQLKHPSILELYNYFED-----SNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILH 135 (278)
T ss_dssp HTTBCCTTBCCEEEEEEC-----SSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCeEeEEEEEcc-----CCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 367899999999999843 3458999999985 77766653 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++|+||+|+++|+|++|..||.
T Consensus 136 ~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 136 RDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp SSCCGGGEEEC-TTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHEEEc-CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 47789999999998654322 23346789999999998654 58899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
.....+.+..+.. .. ...+..++.++.++|.+||+.||++|||++++++||
T Consensus 214 ~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 214 TDTVKNTLNKVVL-----------------AD------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CCSCC-----CCS-----------------SC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred ChhHHHHHHHHhh-----------------cc------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 7654333222110 00 012234789999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||....
T Consensus 265 ~~~~~~ 270 (278)
T 3cok_A 265 FMSRNS 270 (278)
T ss_dssp TTC---
T ss_pred cccCCC
Confidence 998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=296.21 Aligned_cols=203 Identities=24% Similarity=0.343 Sum_probs=157.6
Q ss_pred CCCC--CCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 3 VMDH--PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 3 ~l~H--pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+++| |||+++++++.. ..++|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||
T Consensus 63 ~l~~~~~~iv~~~~~~~~-----~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHr 132 (343)
T 3dbq_A 63 KLQQHSDKIIRLYDYEIT-----DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHS 132 (343)
T ss_dssp HHTTTCTTBCCEEEEEEC-----SSEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred hhhhcCCceEEEeeeEee-----CCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 4555 999999999853 345899999888898888764 4679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccC----------CCCCCchhHHHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFG----------ATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il 147 (296)
||||+|||++ ++.+||+|||+++....... .....||+.|+|||++.+ ...++.++||||+||++
T Consensus 133 Dikp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il 210 (343)
T 3dbq_A 133 DLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210 (343)
T ss_dssp CCCGGGEEEE--TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred CCCcceEEEE--CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence 9999999997 46799999999987643322 235678999999999853 24589999999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 148 AELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 148 ~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|+|++|..||.+.... ..+..++.... ...++...++++.+||.+||+.||.
T Consensus 211 ~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~L~~dp~ 263 (343)
T 3dbq_A 211 YYMTYGKTPFQQIINQISKLHAIIDPNH---------------------------EIEFPDIPEKDLQDVLKCCLKRDPK 263 (343)
T ss_dssp HHHHHSSCTTTTCCSHHHHHHHHHCTTS---------------------------CCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred HHHHhCCCcchhhhhHHHHHHHHhcCCc---------------------------ccCCcccCCHHHHHHHHHHcCCChh
Confidence 9999999999875432 33333322100 0112234678999999999999999
Q ss_pred CCCCHHHHhcCCCccccc
Q 022500 227 LRCTALEACAHPFFDELR 244 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~ 244 (296)
+|||+.++++||||+...
T Consensus 264 ~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 264 QRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TSCCHHHHHTSHHHHSCC
T ss_pred HCCCHHHHHhCccccccC
Confidence 999999999999998543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=288.22 Aligned_cols=199 Identities=18% Similarity=0.204 Sum_probs=159.5
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++... ..+++||||++| +|.+.+.........+++..++.++.||+.||.|||+ +||+|||||
T Consensus 69 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dik 142 (289)
T 1x8b_A 69 QHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIK 142 (289)
T ss_dssp SCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCS
T ss_pred CCCCeeeeeeeeecC-----CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCC
Confidence 899999999998543 348999999985 9998887655555779999999999999999999999 799999999
Q ss_pred CCcEEEcC------------------CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 84 PQNLLVDP------------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 84 p~Nill~~------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
|+||+++. ....+||+|||.+...... ....||+.|+|||++.+...++.++||||+||
T Consensus 143 p~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (289)
T 1x8b_A 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALAL 219 (289)
T ss_dssp GGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred HHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence 99999973 2346999999999866433 23468999999999976555778999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 146 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 146 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
++|+|++|.+++...... ..+.+. . . ..++..+++++.++|.+||+.||
T Consensus 220 il~~l~~~~~~~~~~~~~---~~~~~~--~-----------------~---------~~~~~~~~~~~~~li~~~l~~dp 268 (289)
T 1x8b_A 220 TVVCAAGAEPLPRNGDQW---HEIRQG--R-----------------L---------PRIPQVLSQEFTELLKVMIHPDP 268 (289)
T ss_dssp HHHHHTTCCCCCSSSHHH---HHHHTT--C-----------------C---------CCCSSCCCHHHHHHHHHHTCSSG
T ss_pred HHHHHhcCCCCCcchhHH---HHHHcC--C-----------------C---------CCCCcccCHHHHHHHHHHhCCCc
Confidence 999999999877554322 222210 0 0 01234579999999999999999
Q ss_pred CCCCCHHHHhcCCCcccc
Q 022500 226 SLRCTALEACAHPFFDEL 243 (296)
Q Consensus 226 ~~R~t~~e~l~hp~f~~~ 243 (296)
.+|||+.++++||||++.
T Consensus 269 ~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 269 ERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp GGSCCHHHHHTCTTC---
T ss_pred ccCCCHHHHhhChHhhhh
Confidence 999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=285.91 Aligned_cols=206 Identities=23% Similarity=0.358 Sum_probs=162.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ....|+||||++| +|.+.+ .....+++..+..++.|++.||.|||+ +|++||
T Consensus 60 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 129 (276)
T 2yex_A 60 KMLNHENVVKFYGHRRE-----GNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHR 129 (276)
T ss_dssp HTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhcCCCCceeeeeEEEc-----CCEEEEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeecc
Confidence 56899999999999853 3348899999985 655443 345679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++ .++.+||+|||.+....... ......||+.|+|||++.+...++.++|+||+|+++|+|++|..||
T Consensus 130 dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 208 (276)
T 2yex_A 130 DIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (276)
T ss_dssp CCSGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCChHHEEEc-cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence 9999999999 47789999999997653322 2234578999999999976554578999999999999999999999
Q ss_pred CCCChHHH-HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGENAVDQ-LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+...... ...+...... .. ....+++++.+||.+||+.||.+|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~----------------------~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 209 DQPSDSCQEYSDWKEKKTY----------------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp SCSCTTSHHHHHHHTTCTT----------------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCchHHHHHHHhhhcccc----------------------cC-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 87654322 2222110000 00 01237899999999999999999999999999
Q ss_pred CCCcccccC
Q 022500 237 HPFFDELRE 245 (296)
Q Consensus 237 hp~f~~~~~ 245 (296)
||||++...
T Consensus 262 ~~~~~~~~~ 270 (276)
T 2yex_A 262 DRWYNKPLK 270 (276)
T ss_dssp CTTTTCCCC
T ss_pred CccccChhh
Confidence 999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=289.64 Aligned_cols=204 Identities=26% Similarity=0.398 Sum_probs=168.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+||||++ ++|.+.+.. .+.+++..+..++.|++.||.|||+ +||+||
T Consensus 61 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 130 (304)
T 2jam_A 61 KKIKHENIVTLEDIYES-----TTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHR 130 (304)
T ss_dssp HHCCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred HhCCCCCeeehhhhccc-----CCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence 46899999999999843 345899999998 588777653 3569999999999999999999999 799999
Q ss_pred CCCCCcEEE---cCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill---~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||++ + .++.+||+|||++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus 131 dikp~NIl~~~~~-~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 131 DLKPENLLYLTPE-ENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp SCCGGGCEESSSS-TTCCEEBCSCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCHHHEEEecCC-CCCCEEEccCCcceecCC-CccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCC
Confidence 999999999 4 467899999999875432 223445789999999999654 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+.......+.+..... .......+++++.+||.+||+.||.+|||++++++|
T Consensus 208 ~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 208 YEETESKLFEKIKEGYYEF-------------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTSCHHHHHHHHHHCCCCC-------------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcCCCCC-------------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 9988777766665521110 011223579999999999999999999999999999
Q ss_pred CCcccc
Q 022500 238 PFFDEL 243 (296)
Q Consensus 238 p~f~~~ 243 (296)
|||+..
T Consensus 263 ~~~~~~ 268 (304)
T 2jam_A 263 PWIDGN 268 (304)
T ss_dssp HHHHSS
T ss_pred ccccCC
Confidence 999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=287.39 Aligned_cols=207 Identities=29% Similarity=0.491 Sum_probs=169.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+||||++ ++|.+.+.. ...+++..+..++.||+.||.|||+ +|++||
T Consensus 76 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~ 145 (287)
T 2wei_A 76 KKLDHPNIMKLFEILED-----SSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHR 145 (287)
T ss_dssp HTCCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HhccCCCccEEEEEEeC-----CCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 57899999999999843 334889999998 577766653 3569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++.. +..+||+|||++.............+|+.|+|||++.+ .++.++|+||+|+++|+|++|..||.
T Consensus 146 dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp CCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 999999999743 34699999999987655544455678999999999864 48999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+....+........ ......+++++.++|.+||+.||++|||+.++++||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 224 GKNEYDILKRVETGKYAFD-------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp CSSHHHHHHHHHHCCCCCC-------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred CCCHHHHHHHHHcCCCCCC-------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 9887776666554211100 001134789999999999999999999999999999
Q ss_pred CcccccC
Q 022500 239 FFDELRE 245 (296)
Q Consensus 239 ~f~~~~~ 245 (296)
||++..+
T Consensus 279 ~~~~~~~ 285 (287)
T 2wei_A 279 WIQKYSS 285 (287)
T ss_dssp HHHHHCC
T ss_pred HHhcccc
Confidence 9987644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=294.21 Aligned_cols=235 Identities=29% Similarity=0.506 Sum_probs=176.6
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~-~i~H~dlk 83 (296)
.||||+++++++.... .+..++++||||++++|.+.+... ....+++..++.++.||+.||+|||+ + ||+|||||
T Consensus 84 ~~~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dik 159 (373)
T 1q8y_A 84 GANHILKLLDHFNHKG-PNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIK 159 (373)
T ss_dssp HHTTBCCCCEEEEEEE-TTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCS
T ss_pred ccchHHHHHHHhhccC-CCCceEEEEEecCCCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCC
Confidence 4899999999986543 344568999999988998888753 23569999999999999999999999 8 99999999
Q ss_pred CCcEEEcC-----CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 84 PQNLLVDP-----LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 84 p~Nill~~-----~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|+||+++. ....+||+|||++...... .....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999952 2347999999999865432 3445789999999999765 48999999999999999999999998
Q ss_pred CCC------hHHHHHHHHHhcCCCCHHHHhhcCcC---CcC---c-cCCCCCCCCccc------ccCCCCCHHHHHHHHc
Q 022500 159 GEN------AVDQLVEIIKVLGTPTREEIRCMNPN---YTD---F-RFPQIKAHPWHK------VFHKRMPPEAIDLASR 219 (296)
Q Consensus 159 ~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~---~-~~~~~~~~~~~~------~~~~~~~~~~~dll~~ 219 (296)
+.+ ..+.+..+.+..|.++...+...... +.. + ........+... .++...++++.+||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 764 56677888888888876654332110 000 0 000000000000 1122356789999999
Q ss_pred ccccCCCCCCCHHHHhcCCCcccccCC
Q 022500 220 LLQYSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 220 ~L~~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
||+.||.+|||++|+++||||++....
T Consensus 317 ~L~~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp GGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred HhccCccccCCHHHHhhChhhhcccCc
Confidence 999999999999999999999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=297.17 Aligned_cols=233 Identities=25% Similarity=0.413 Sum_probs=165.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-Ccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVC 78 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~-~i~ 78 (296)
|++++||||+++++++... ..+|+||||++| +|.+.+.. ...+++..+..++.|++.||.|||+ + ||+
T Consensus 85 l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~ 154 (360)
T 3eqc_A 85 LHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIM 154 (360)
T ss_dssp GGGCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCC
T ss_pred HHHCCCCCEEEEeEEEEEC-----CEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEE
Confidence 4678999999999998543 348999999985 88777764 3569999999999999999999998 5 899
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||||+||+++ .++.+||+|||++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 155 H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 155 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp CSCCSGGGEEEC-TTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred cCCccHHHEEEC-CCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999 4778999999999755322 23356789999999999764 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHh---hcCcCCcCccCCCCC------------CCCcccccCCCCCHHHHHHHHccccc
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIR---CMNPNYTDFRFPQIK------------AHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~---~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
+.+..+....+............. ........+...... ...........+++++.+||.+||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 311 (360)
T 3eqc_A 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311 (360)
T ss_dssp CCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCS
T ss_pred CCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhc
Confidence 877655433322111110000000 000000000000000 00001111234789999999999999
Q ss_pred CCCCCCCHHHHhcCCCcccccCC
Q 022500 224 SPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 224 ~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
||.+|||++++++||||+.....
T Consensus 312 dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 312 NPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp STTTSCCHHHHHTSHHHHHHHHS
T ss_pred ChhhCCCHHHHhhChHhhcchHh
Confidence 99999999999999999876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=295.06 Aligned_cols=230 Identities=27% Similarity=0.449 Sum_probs=175.9
Q ss_pred CCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 022500 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 85 (296)
Q Consensus 6 HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~ 85 (296)
|++|+.+++++.. ...+|+||||+++++.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus 81 ~~~~~~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~ 152 (355)
T 2eu9_A 81 KFLCVLMSDWFNF-----HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPE 152 (355)
T ss_dssp CSCBCCEEEEEEE-----TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGG
T ss_pred ceeEEEeeeeeee-----CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHH
Confidence 4458999888843 3358999999999988877642 23569999999999999999999999 79999999999
Q ss_pred cEEEcC------------------CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 86 NLLVDP------------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 86 Nill~~------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
||+++. .++.+||+|||+++.... ......||+.|+|||++.+. .++.++||||+||++
T Consensus 153 NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il 229 (355)
T 2eu9_A 153 NILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCIL 229 (355)
T ss_dssp GEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHH
T ss_pred HEEEecccccccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHH
Confidence 999931 367899999999976432 23456789999999999754 589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcC----ccCCCCC---------CCCccc--ccCCCCCHH
Q 022500 148 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD----FRFPQIK---------AHPWHK--VFHKRMPPE 212 (296)
Q Consensus 148 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~--~~~~~~~~~ 212 (296)
|+|++|..||.+.+..+.+..+.+..+.++............. ...+... ..++.. ......+.+
T Consensus 230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 9999999999999998888888888888777655433211000 0000000 000000 001113468
Q ss_pred HHHHHHcccccCCCCCCCHHHHhcCCCcccccCC
Q 022500 213 AIDLASRLLQYSPSLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 213 ~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~~~ 246 (296)
+.+||.+||+.||++|||+.++++||||+++.+.
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcCCChh
Confidence 9999999999999999999999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=291.51 Aligned_cols=207 Identities=29% Similarity=0.476 Sum_probs=161.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... . +|+||||++| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 70 ~~l~h~~i~~~~~~~~~~-----~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 138 (322)
T 2ycf_A 70 KKLNHPCIIKIKNFFDAE-----D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHR 138 (322)
T ss_dssp HHCCCTTBCCEEEEEESS-----S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCCceEeeEEcCC-----c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 467999999999987421 1 7899999985 7766554 45679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCC--CcEEEeeccCccccccCCCccceeecccccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 81 DLKPQNLLVDPLT--HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||+||+++..+ ..+||+|||++.............||+.|+|||++. +...++.++||||+||++|+|++|..|
T Consensus 139 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (322)
T 2ycf_A 139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218 (322)
T ss_dssp CCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999998422 249999999998764433334567899999999974 344588999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+......+...+....... .......+++++.+||.+||+.||.+|||++++++
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 219 FSEHRTQVSLKDQITSGKYNF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SCSTTCSSCHHHHHHHTCCCC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccchHHHHHHHHHhCcccc------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 977644322222222110000 00112347899999999999999999999999999
Q ss_pred CCCcccc
Q 022500 237 HPFFDEL 243 (296)
Q Consensus 237 hp~f~~~ 243 (296)
||||+..
T Consensus 275 h~~~~~~ 281 (322)
T 2ycf_A 275 HPWLQDE 281 (322)
T ss_dssp SGGGCCH
T ss_pred CcCcCCH
Confidence 9999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.50 Aligned_cols=207 Identities=24% Similarity=0.440 Sum_probs=164.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++.... .+|+||||++| +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||
T Consensus 71 ~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 141 (302)
T 2j7t_A 71 ATCDHPYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHR 141 (302)
T ss_dssp HHCCCTTBCCEEEEEECC------CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred hcCCCCCEeeeeeeeeeCC-----eEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccC
Confidence 4679999999999985433 48899999985 66665543 34669999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhcc----CCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++ .++.+||+|||++...... .......||+.|+|||++. ....++.++||||+|+++|+|++|..
T Consensus 142 dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 220 (302)
T 2j7t_A 142 DLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220 (302)
T ss_dssp CCSGGGEEEC-TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEEC-CCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCC
Confidence 9999999998 4778999999987543211 1223457899999999984 33458899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+.......+....... ...+..++.++.++|.+||+.||.+|||+.+++
T Consensus 221 p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 221 PHHELNPMRVLLKIAKSDPPT--------------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp TTTTSCHHHHHHHHHHSCCCC--------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred CCccCCHHHHHHHHhccCCcc--------------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 999988777666555421100 001134788999999999999999999999999
Q ss_pred cCCCccccc
Q 022500 236 AHPFFDELR 244 (296)
Q Consensus 236 ~hp~f~~~~ 244 (296)
+||||+...
T Consensus 275 ~h~~~~~~~ 283 (302)
T 2j7t_A 275 EHPFVSSIT 283 (302)
T ss_dssp TSTTTTTCC
T ss_pred cChHHhhhc
Confidence 999998764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=289.05 Aligned_cols=213 Identities=28% Similarity=0.398 Sum_probs=148.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-Cccc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCH 79 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~-~~~~~~~~~~~~~~~qil~aL~~LH~~~-~i~H 79 (296)
+.++||||+++++++... ...|+||||++|+|.+.+..... ....+++..+..++.|++.||.|||+ + ||+|
T Consensus 76 ~~~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH 149 (327)
T 3aln_A 76 RSSDCPYIVQFYGALFRE-----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIH 149 (327)
T ss_dssp SSCCCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCC
T ss_pred HcCCCCcEeeeeeEEEeC-----CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeE
Confidence 568999999999998543 34889999999998887764322 35679999999999999999999999 8 9999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhcc---CCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++ .++.+||+|||++.............||+.|+|||++. ....++.++||||+||++|+|++|..|
T Consensus 150 ~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 150 RDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp SCCCGGGEEEE-TTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred CCCCHHHEEEc-CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999998 57889999999998765544444557899999999983 234588999999999999999999999
Q ss_pred CCCCChH-HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 157 FPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 157 f~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|.+.... +.+..+.. . ....+.......+++++.+||.+||+.||.+|||+.+++
T Consensus 229 f~~~~~~~~~~~~~~~-------------------~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 284 (327)
T 3aln_A 229 YPKWNSVFDQLTQVVK-------------------G-----DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284 (327)
T ss_dssp SSCC-------CCCCC-------------------S-----CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCcchHHHHHHHHhc-------------------C-----CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHH
Confidence 9765421 11110000 0 000011112235799999999999999999999999999
Q ss_pred cCCCcccccC
Q 022500 236 AHPFFDELRE 245 (296)
Q Consensus 236 ~hp~f~~~~~ 245 (296)
+||||....+
T Consensus 285 ~hp~~~~~~~ 294 (327)
T 3aln_A 285 KHPFILMYEE 294 (327)
T ss_dssp TSHHHHHHHH
T ss_pred hChHHHHhHh
Confidence 9999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=296.14 Aligned_cols=228 Identities=20% Similarity=0.273 Sum_probs=165.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.... ...+|+||||++ ++|.+.+.... ....+++..++.++.||+.||+|||+ +||+||
T Consensus 62 ~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~ 136 (319)
T 4euu_A 62 KKLNHKNIVKLFAIEEETT---TRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHR 136 (319)
T ss_dssp HHCCCTTBCCEEEEEECTT---TCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhcCCCCcceEEEEeecCC---CceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecC
Confidence 4689999999999885432 234789999998 58888776532 23449999999999999999999999 799999
Q ss_pred CCCCCcEEE----cCCCCcEEEeeccCccccccCCCccceeecccccCchhccC-------CCCCCchhHHHHHHHHHHH
Q 022500 81 DLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-------ATEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 81 dlkp~Nill----~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 149 (296)
||||+||++ + ..+.+||+|||+++............||+.|+|||++.. ...++.++||||+||++|+
T Consensus 137 Dlkp~NIll~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~e 215 (319)
T 4euu_A 137 NIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (319)
T ss_dssp CCSGGGEEEEECTT-SCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHH
T ss_pred CCCHHHEEEeccCC-CCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHH
Confidence 999999998 5 456799999999987766555566789999999999852 2458999999999999999
Q ss_pred HHhCCCCCCCCC----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 150 LLLGQPLFPGEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 150 ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
|++|..||.... ..+.+..++..........+.........| ....+....+...+++.+.+||++||+.||
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 291 (319)
T 4euu_A 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW----SGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (319)
T ss_dssp HHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEE----ESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCcccc----CccCCcccccchhHHHHhHHHHHHhccCCh
Confidence 999999997543 344444444421111101000000000000 000011112223456789999999999999
Q ss_pred CCCCCHHHHhcCCC
Q 022500 226 SLRCTALEACAHPF 239 (296)
Q Consensus 226 ~~R~t~~e~l~hp~ 239 (296)
++|||++|+++||-
T Consensus 292 ~~R~s~~ell~h~~ 305 (319)
T 4euu_A 292 EKCWGFDQFFAETS 305 (319)
T ss_dssp TTSCCHHHHHHHHH
T ss_pred hhhccHHHhhhccH
Confidence 99999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=283.08 Aligned_cols=211 Identities=26% Similarity=0.444 Sum_probs=162.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.++||||+++++++... ..+++||||++ ++|.+.+... .....+++..+..++.|++.||.|||+ +||+||
T Consensus 74 ~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 146 (295)
T 2clq_A 74 KHLKHKNIVQYLGSFSEN-----GFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHR 146 (295)
T ss_dssp HTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCEeeEeeEEEeC-----CcEEEEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEcc
Confidence 568999999999998543 34889999997 5887777642 223456799999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+||+++..++.+||+|||++....... ......||+.|+|||++.+. ..++.++||||+|+++|+|++|..||.
T Consensus 147 dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp CCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 9999999998547889999999998654322 23345789999999998643 237899999999999999999999997
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+.............. ...++..+++++.++|.+||+.||++|||++++++||
T Consensus 227 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 227 ELGEPQAAMFKVGMFKV--------------------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp GGSSHHHHHHHHHHHCC--------------------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred CCCchhHHHHhhccccc--------------------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 65433221111110000 0112345799999999999999999999999999999
Q ss_pred CcccccC
Q 022500 239 FFDELRE 245 (296)
Q Consensus 239 ~f~~~~~ 245 (296)
||+....
T Consensus 281 ~~~~~~~ 287 (295)
T 2clq_A 281 FLKVSSK 287 (295)
T ss_dssp GGCC---
T ss_pred hhhhccc
Confidence 9986543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.54 Aligned_cols=202 Identities=27% Similarity=0.457 Sum_probs=161.3
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 83 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlk 83 (296)
+||||+++++++... ..+|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+|||||
T Consensus 117 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlk 186 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIK 186 (355)
T ss_dssp TCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCC
T ss_pred CCCceeEEEEEEeeC-----ceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCC
Confidence 699999999998543 348899999984 88777764 3569999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 84 PQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 84 p~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. ..++.++||||+||++|+|++|..||...
T Consensus 187 p~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 187 LENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp GGGEEEC-TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred HHHEEEC-CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 9999998 57789999999998653322 22345789999999999752 34789999999999999999999999754
Q ss_pred Ch----HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CH
Q 022500 161 NA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TA 231 (296)
Q Consensus 161 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~ 231 (296)
+. ......+... . ..++..+++.+.+||.+||+.||.+|| |+
T Consensus 266 ~~~~~~~~~~~~~~~~--~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~ 316 (355)
T 1vzo_A 266 GEKNSQAEISRRILKS--E---------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 316 (355)
T ss_dssp TSCCCHHHHHHHHHHC--C---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred CccchHHHHHHHHhcc--C---------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCH
Confidence 32 2222222221 0 012235789999999999999999999 99
Q ss_pred HHHhcCCCcccccCC
Q 022500 232 LEACAHPFFDELREP 246 (296)
Q Consensus 232 ~e~l~hp~f~~~~~~ 246 (296)
+++++||||+.+.+.
T Consensus 317 ~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 317 DEIKEHLFFQKINWD 331 (355)
T ss_dssp HHHHTSGGGTTCCHH
T ss_pred HHHHcCcchhcCChh
Confidence 999999999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=283.97 Aligned_cols=207 Identities=29% Similarity=0.437 Sum_probs=168.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... .+|+||||++| +|.+.+.. ....+++..+..++.|++.||.|||+ .|++|
T Consensus 78 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H 148 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIH 148 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETT-----EEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCccEEEEEEeCC-----EEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcC
Confidence 35689999999999985433 48899999985 87777653 35679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++||||+|+++|+|++|..||.
T Consensus 149 ~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 149 RDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp CCCSGGGEEEC-TTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCcCHHHEEEC-CCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999998 47789999999997654332 23345789999999999654 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+.......+..... +. + ..+..++.++.+||.+||+.||.+|||+.++++||
T Consensus 227 ~~~~~~~~~~~~~~~~-~~----------~---------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 227 DIHPMRAIFMIPTNPP-PT----------F---------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp TSCHHHHHHHHHHSCC-CC----------C---------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CCChHHHHHHHhcCCC-cc----------c---------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 8876665544433110 00 0 01123689999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||+...
T Consensus 281 ~~~~~~ 286 (314)
T 3com_A 281 FVRSAK 286 (314)
T ss_dssp HHHTCC
T ss_pred HHhcCC
Confidence 998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=304.12 Aligned_cols=207 Identities=25% Similarity=0.326 Sum_probs=153.0
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++ +|||||++++++. +..++|||||||+|+|.+.+.. ......+..+..++.||+.||+|||+ +||+|||
T Consensus 73 ~l~~HpnIv~l~~~~~-----~~~~~~lv~E~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrD 143 (432)
T 3p23_A 73 ESDEHPNVIRYFCTEK-----DRQFQYIAIELCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRD 143 (432)
T ss_dssp HSCCCTTBCCEEEEEE-----ETTEEEEEEECCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCC
T ss_pred hccCCCCcCeEEEEEe-----cCCEEEEEEECCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCC
Confidence 45 7999999999884 4445899999999999888864 23345555678899999999999999 7999999
Q ss_pred CCCCcEEEcC----CCCcEEEeeccCccccccCC----CccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHH
Q 022500 82 LKPQNLLVDP----LTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 82 lkp~Nill~~----~~~~vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll 151 (296)
|||+||+++. ....+||+|||+|+...... ......||+.|+|||++.+ ...++.++||||+||++|+|+
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence 9999999952 12358899999998764332 2334678999999999964 345778999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 152 L-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 152 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
+ |..||....... ...+... .. ..... .....+..+++||.+||+.||.+|||
T Consensus 224 t~g~~pf~~~~~~~-~~~~~~~---~~---------------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps 277 (432)
T 3p23_A 224 SEGSHPFGKSLQRQ-ANILLGA---CS---------------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPS 277 (432)
T ss_dssp TTSCBTTBSTTTHH-HHHHTTC---CC---------------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred cCCCCCcchhhHHH-HHHHhcc---CC---------------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCC
Confidence 9 889986554332 2222111 00 00000 00123567899999999999999999
Q ss_pred HHHHhcCCCccccc
Q 022500 231 ALEACAHPFFDELR 244 (296)
Q Consensus 231 ~~e~l~hp~f~~~~ 244 (296)
+.++++||||..+.
T Consensus 278 ~~evl~hp~f~~~~ 291 (432)
T 3p23_A 278 AKHVLKHPFFWSLE 291 (432)
T ss_dssp HHHHHTSTTTCCHH
T ss_pred HHHHHhCccccChH
Confidence 99999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=285.18 Aligned_cols=208 Identities=24% Similarity=0.356 Sum_probs=156.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~-~i~H~ 80 (296)
+.++||||+++++++... ..+|+||||+++.+...... ....+++..+..++.|++.||.|||+ + ||+||
T Consensus 79 ~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~ 149 (318)
T 2dyl_A 79 KSHDCPYIVQCFGTFITN-----TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHR 149 (318)
T ss_dssp HTTTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCC
T ss_pred HhcCCCceeeEEEEEecC-----CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeC
Confidence 457999999999998543 34899999997655544432 34679999999999999999999998 6 99999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhcc----CCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||+||+++ .++.+||+|||++.............+|+.|+|||++. ....++.++||||+||++|+|++|..|
T Consensus 150 dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (318)
T 2dyl_A 150 DVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228 (318)
T ss_dssp CCCGGGEEEC-TTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCHHHEEEC-CCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCC
Confidence 9999999998 57789999999998765544445567899999999985 234588999999999999999999999
Q ss_pred CCCC-ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 157 FPGE-NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 157 f~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
|... ...+.+..+...... . .+ ....+++++.+||.+||+.||.+|||+++++
T Consensus 229 f~~~~~~~~~~~~~~~~~~~-~---------------~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (318)
T 2dyl_A 229 YKNCKTDFEVLTKVLQEEPP-L---------------LP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282 (318)
T ss_dssp TTTCCSHHHHHHHHHHSCCC-C---------------CC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCccHHHHHHHhccCCC-C---------------CC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9874 444445444432100 0 00 0124789999999999999999999999999
Q ss_pred cCCCcccccC
Q 022500 236 AHPFFDELRE 245 (296)
Q Consensus 236 ~hp~f~~~~~ 245 (296)
+||||++...
T Consensus 283 ~h~~~~~~~~ 292 (318)
T 2dyl_A 283 EHSFIKRYET 292 (318)
T ss_dssp TSHHHHHHHH
T ss_pred hCHHHHhccc
Confidence 9999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=281.22 Aligned_cols=208 Identities=26% Similarity=0.376 Sum_probs=169.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC----
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---- 76 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~---- 76 (296)
++++||||+++++++... ....+|+||||++| +|.+.+.........+++..+..++.|++.||+|||+ +|
T Consensus 60 ~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~ 135 (279)
T 2w5a_A 60 RELKHPNIVRYYDRIIDR---TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGH 135 (279)
T ss_dssp HHCCCTTBCCEEEEEEEG---GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC----
T ss_pred HhcCCCCCCeEEEEEecC---CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCC
Confidence 468999999999987532 23348899999985 8988887655556679999999999999999999999 69
Q ss_pred -cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 77 -VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 77 -i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+|+++|+|++|.
T Consensus 136 ~ivH~dl~p~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 136 TVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp --CCCCCSGGGEEEC-SSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSS
T ss_pred eeEEeccchhhEEEc-CCCCEEEecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999 577899999999976543322 2345789999999999764 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+..... ..++..+++++.++|.+||+.||.+|||+.++
T Consensus 214 ~p~~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 265 (279)
T 2w5a_A 214 PPFTAFSQKELAGKIREGKF----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265 (279)
T ss_dssp CSSCCSSHHHHHHHHHHTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCcccCHHHHHHHHhhccc----------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 99998887666655544110 01223478999999999999999999999999
Q ss_pred hcCCCcccc
Q 022500 235 CAHPFFDEL 243 (296)
Q Consensus 235 l~hp~f~~~ 243 (296)
++|+|+..-
T Consensus 266 l~~~~~~~~ 274 (279)
T 2w5a_A 266 LENPLILEH 274 (279)
T ss_dssp HTSTTCCGG
T ss_pred HhChhhhhh
Confidence 999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=285.48 Aligned_cols=208 Identities=25% Similarity=0.377 Sum_probs=161.1
Q ss_pred CCCCeeeeceeeeccCCC-CcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 5 DHPNVISLKHCFFSTTSK-NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~-~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
+||||+++++++...... ....+|+||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dl 155 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDI 155 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCC
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCC
Confidence 799999999998653311 13458899999985 888877653 23568999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||+||+++ .++.+||+|||++....... ......||+.|+|||++.+ ...++.++||||+||++|+|++|..||
T Consensus 156 kp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 234 (326)
T 2x7f_A 156 KGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234 (326)
T ss_dssp SGGGEEEC-TTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cHHHEEEc-CCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence 99999998 57889999999998654322 2334578999999999852 245889999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+.......+...... ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 235 CDMHPMRALFLIPRNPAP---------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp TTSCHHHHHHHHHHSCCC---------------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCcHHHHHHHhhcCccc---------------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 888877665554431100 00123478999999999999999999999999999
Q ss_pred CCcccc
Q 022500 238 PFFDEL 243 (296)
Q Consensus 238 p~f~~~ 243 (296)
|||++.
T Consensus 288 p~~~~~ 293 (326)
T 2x7f_A 288 PFIRDQ 293 (326)
T ss_dssp HHHHCC
T ss_pred hHHhhC
Confidence 999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=287.35 Aligned_cols=226 Identities=20% Similarity=0.346 Sum_probs=166.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHh--hhc--CCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY--SSA--NQRMPLIYVKLYTYQIFRGLAYIHT-V 74 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~--~~~--~~~~~~~~~~~~~~qil~aL~~LH~-~ 74 (296)
|++++||||+++++++... ..+|+||||++| +|.+.+... ... ...+++..+..++.|++.||.|||+ .
T Consensus 97 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 171 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171 (348)
T ss_dssp HTTCCCTTBCCCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHhCCCCCcceEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC
Confidence 4678999999999998543 358999999996 665441100 122 5779999999999999999999997 6
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCc-hhHHHHHHHHHHHHHhC
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT-SIDIWSAGCVLAELLLG 153 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g 153 (296)
||+||||||+||+++ .++.+||+|||++...... ......+|+.|+|||++.+...++. ++||||+||++|+|++|
T Consensus 172 -~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 172 -NICHRDVKPSNILMD-KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp -CEECCCCCGGGEEEC-TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred -CEeecCCChHhEEEc-CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 999999999999998 5778999999999865433 3345678999999999976534655 99999999999999999
Q ss_pred CCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 154 QPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 154 ~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
..||.+.+. .+....+.......+ .. ...+..+. ...........+++++.+||.+||+.||.+|||++
T Consensus 249 ~~pf~~~~~~~~~~~~i~~~~~~~~-~~-------~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ 318 (348)
T 2pml_X 249 VVPFSLKISLVELFNNIRTKNIEYP-LD-------RNHFLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318 (348)
T ss_dssp SCSSCCSSCSHHHHHHHTSCCCCCC-CS-------SSSSTTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCcHHHHHHHHhccCcCCc-cc-------hhhhhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence 999988776 555544433211000 00 00000000 00000112245899999999999999999999999
Q ss_pred HHhcCCCccccc
Q 022500 233 EACAHPFFDELR 244 (296)
Q Consensus 233 e~l~hp~f~~~~ 244 (296)
++++||||++..
T Consensus 319 e~l~hp~f~~~~ 330 (348)
T 2pml_X 319 DALKHEWLADTN 330 (348)
T ss_dssp HHHTSGGGTTCC
T ss_pred HHhcCccccCCC
Confidence 999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.27 Aligned_cols=208 Identities=27% Similarity=0.397 Sum_probs=160.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++. +...+|+||||++| +|.+.+.. .+.+++..+..++.|++.||+|||+ +||+|
T Consensus 65 l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H 134 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDE-----EDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVH 134 (294)
T ss_dssp HTTCCBTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HhcCCCCCCceEEEeee-----eCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 46789999999999984 34458999999985 88777764 3579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++ .++.+||+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus 135 ~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf 212 (294)
T 4eqm_A 135 RDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPF 212 (294)
T ss_dssp CCCCGGGEEEC-TTSCEEECCCSSSTTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCHHHEEEC-CCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCC
Confidence 99999999998 477899999999986543321 2345789999999999764 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+......+.+.... +. ........+++.+.++|.+||+.||.+||+..+.+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~-~~-----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~ 268 (294)
T 4eqm_A 213 NGETAVSIAIKHIQDSV-PN-----------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268 (294)
T ss_dssp CSSCHHHHHHHHHSSCC-CC-----------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred CCCChHHHHHHHhhccC-CC-----------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHH
Confidence 99887666554443211 11 0111234579999999999999999999966666666
Q ss_pred CCccccc
Q 022500 238 PFFDELR 244 (296)
Q Consensus 238 p~f~~~~ 244 (296)
.|..-+.
T Consensus 269 ~l~~~~~ 275 (294)
T 4eqm_A 269 DLSSVLH 275 (294)
T ss_dssp HHHTSSS
T ss_pred HHHHHHh
Confidence 6655443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=279.45 Aligned_cols=210 Identities=25% Similarity=0.368 Sum_probs=156.7
Q ss_pred CCCCCCCCeeeeceeeeccCC--------CCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTS--------KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 71 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~--------~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~L 71 (296)
|++++||||+++++++..... .+...+|+||||++ |+|.+.+.. ....+++..+..++.|++.||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L 132 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYI 132 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHH
Confidence 467899999999998764321 23556899999998 488887764 345678899999999999999999
Q ss_pred HhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccC---------------CCccceeecccccCchhccCCCCCCc
Q 022500 72 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTT 136 (296)
Q Consensus 72 H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~ 136 (296)
|+ +||+||||||+||+++ .++.+||+|||++...... .......||+.|+|||++.+...++.
T Consensus 133 H~-~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (303)
T 1zy4_A 133 HS-QGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE 210 (303)
T ss_dssp HH-TTCCCSCCCGGGEEEC-TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCT
T ss_pred Hh-CCeecccCCHHhEEEc-CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcc
Confidence 99 7999999999999998 4778999999999765321 12234578999999999976556899
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHH
Q 022500 137 SIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 215 (296)
Q Consensus 137 ~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 215 (296)
++||||+||++|+|++ ||..... ......+.... .. +...+....++.+.+
T Consensus 211 ~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~-----------------~~--------~~~~~~~~~~~~~~~ 262 (303)
T 1zy4_A 211 KIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVS-----------------IE--------FPPDFDDNKMKVEKK 262 (303)
T ss_dssp HHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTT-----------------CC--------CCTTCCTTTSHHHHH
T ss_pred hhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccc-----------------cc--------cCccccccchHHHHH
Confidence 9999999999999998 5543322 22222222110 00 011123456888999
Q ss_pred HHHcccccCCCCCCCHHHHhcCCCcccc
Q 022500 216 LASRLLQYSPSLRCTALEACAHPFFDEL 243 (296)
Q Consensus 216 ll~~~L~~~p~~R~t~~e~l~hp~f~~~ 243 (296)
+|.+||+.||.+|||+.++++||||+..
T Consensus 263 li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 263 IIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 9999999999999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.29 Aligned_cols=214 Identities=22% Similarity=0.368 Sum_probs=143.5
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.++||||+++++++.... .+..++++||||++| +|.+.+... ....+++..++.++.||+.||.|||+ +||+|||
T Consensus 78 ~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~d 153 (336)
T 3fhr_A 78 ASGGPHIVCILDVYENMH-HGKRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRD 153 (336)
T ss_dssp HTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred hcCCCChHHHHHHHhhcc-CCCceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 468999999999986433 235568899999985 888877642 23569999999999999999999999 7999999
Q ss_pred CCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+||+++.. ++.+||+|||++..... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+
T Consensus 154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCHHHEEEEecCCCceEEEeccccceeccc-cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999742 44599999999986543 23345678999999999854 4588999999999999999999999977
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
................ ..... .......+++++.+||.+||+.||.+|||+.++++|||
T Consensus 232 ~~~~~~~~~~~~~~~~-------------~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 232 NTGQAISPGMKRRIRL-------------GQYGF--------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp --------------------------------CC--------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred ccchhhhhhHHHhhhc-------------ccccc--------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 6543322111110000 00000 00112357999999999999999999999999999999
Q ss_pred cccc
Q 022500 240 FDEL 243 (296)
Q Consensus 240 f~~~ 243 (296)
|+..
T Consensus 291 ~~~~ 294 (336)
T 3fhr_A 291 INQS 294 (336)
T ss_dssp HHTG
T ss_pred cccc
Confidence 9864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=283.08 Aligned_cols=199 Identities=23% Similarity=0.340 Sum_probs=153.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--cc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VC 78 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i~ 78 (296)
++++||||+++++++... ..+++||||++| +|.+.+.... ....+++..+..++.|++.||+|||+ +| |+
T Consensus 89 ~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~iv 161 (309)
T 3p86_A 89 KRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161 (309)
T ss_dssp HHCCCTTBCCEEEEECST-----TCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCC
T ss_pred HhCCCCCEeeEEEEEEEC-----CceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEE
Confidence 568999999999998433 348899999985 8877776421 11238999999999999999999999 79 99
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus 162 H~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf 239 (309)
T 3p86_A 162 HRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPW 239 (309)
T ss_dssp CTTCCGGGEEEC-TTCCEEECCCC-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCChhhEEEe-CCCcEEECCCCCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999 57789999999997543332 23456789999999999764 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+.+..+....+....... .++..+++++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 240 GNLNPAQVVAAVGFKCKRL---------------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp TTSCHHHHHHHHHHSCCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9888776665553321110 123458999999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=296.21 Aligned_cols=209 Identities=30% Similarity=0.430 Sum_probs=150.9
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~---~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
.+|||||++++++. +...+|+|||||+|+|.+.+......... .++..+..++.||+.||+|||+ +||+||
T Consensus 66 ~~HpnIv~~~~~~~-----~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHr 139 (434)
T 2rio_A 66 DDHPNVIRYYCSET-----TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHR 139 (434)
T ss_dssp TTSTTBCCEEEEEE-----CSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred cCCCCcCeEEEEEe-----cCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCcccc
Confidence 48999999999884 34458999999999998888753221111 1333467899999999999999 799999
Q ss_pred CCCCCcEEEcCC------------CCcEEEeeccCccccccCCC-----ccceeecccccCchhccC------CCCCCch
Q 022500 81 DLKPQNLLVDPL------------THQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFG------ATEYTTS 137 (296)
Q Consensus 81 dlkp~Nill~~~------------~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~ 137 (296)
||||+||+++.. +..+||+|||+|+....... .....||+.|+|||++.+ ...++.+
T Consensus 140 DLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 219 (434)
T 2rio_A 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219 (434)
T ss_dssp CCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred CCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh
Confidence 999999999732 34799999999987644321 224578999999999965 2458999
Q ss_pred hHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHH
Q 022500 138 IDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 216 (296)
Q Consensus 138 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 216 (296)
+||||+||++|+|++ |..||.+....+ ..++..... .+... ......+++++.+|
T Consensus 220 ~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~-----------------~~~~~-----~~~~~~~~~~~~~l 275 (434)
T 2rio_A 220 IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFS-----------------LDEMK-----CLHDRSLIAEATDL 275 (434)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCC-----------------CCCCT-----TCCCHHHHHHHHHH
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCC-----------------ccccc-----ccccccchHHHHHH
Confidence 999999999999999 899997665433 223221100 00000 00011256889999
Q ss_pred HHcccccCCCCCCCHHHHhcCCCccc
Q 022500 217 ASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 217 l~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
|.+||+.||.+|||+.++++||||..
T Consensus 276 i~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 276 ISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHHhhCChhhCCCHHHHHhCCccCC
Confidence 99999999999999999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=280.34 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=166.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... ..+|+||||++| +|.+.+. ...+++..+..++.|++.||.|||+ +||+||
T Consensus 75 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 143 (303)
T 3a7i_A 75 SQCDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHR 143 (303)
T ss_dssp HHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCEeEEEEEEecC-----CeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Confidence 467999999999998543 348999999985 7666553 3579999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|+||+|+++|+|++|..||..
T Consensus 144 dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 144 DIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp CCSGGGEEEC-TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCChheEEEC-CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 9999999998 47789999999997654332 23345789999999999654 589999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.........+.+.. . ..+...++..+.+||.+||+.||.+|||+.++++|||
T Consensus 222 ~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 222 LHPMKVLFLIPKNN-P---------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp SCHHHHHHHHHHSC-C---------------------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred cCHHHHHHHhhcCC-C---------------------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 87766555443310 0 0122357899999999999999999999999999999
Q ss_pred cccc
Q 022500 240 FDEL 243 (296)
Q Consensus 240 f~~~ 243 (296)
|...
T Consensus 274 ~~~~ 277 (303)
T 3a7i_A 274 ILRN 277 (303)
T ss_dssp HHHH
T ss_pred hhcC
Confidence 9763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=282.23 Aligned_cols=213 Identities=19% Similarity=0.263 Sum_probs=155.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCC-cceEEEEeccCcc-cHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKN-ELFLNLVMEYVPE-SMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPR 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~-~~~~~lv~E~~~g-~l~~~l~~~~~--~~~~~~~~~~~~~~~qil~aL~~LH~~~~ 76 (296)
|++++||||+++++++......+ ....++||||+++ +|.+.+..... ....+++..+..++.||+.||+|||+ +|
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ 157 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RN 157 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CC
Confidence 46789999999999986544321 1224899999995 88887764322 12368999999999999999999999 79
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 152 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~- 152 (296)
|+||||||+||+++ .++.+||+|||+++....... .....+++.|+|||++.+. .++.++||||+||++|+|++
T Consensus 158 ivH~Dikp~NIli~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 158 FIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp CCCSCCSGGGEEEC-TTSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCCcceEEEc-CCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhC
Confidence 99999999999999 478899999999986543322 1234557889999999754 58999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC--
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-- 230 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-- 230 (296)
|..||.+.+..+....+...... ..+..+++++.+||.+||+.||.+|||
T Consensus 236 g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 287 (323)
T 3qup_A 236 GQTPYAGIENAEIYNYLIGGNRL----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFT 287 (323)
T ss_dssp SCCTTTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred CCCCccccChHHHHHHHhcCCCC----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 89999988877766665542110 012347899999999999999999999
Q ss_pred -----HHHHhcCCCccccc
Q 022500 231 -----ALEACAHPFFDELR 244 (296)
Q Consensus 231 -----~~e~l~hp~f~~~~ 244 (296)
++++++|||+....
T Consensus 288 ~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 288 CLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HHHHHHHHHHHC-------
T ss_pred HHHHHHHHHHHHhhhcCCC
Confidence 77889999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=288.06 Aligned_cols=210 Identities=15% Similarity=0.118 Sum_probs=160.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++||||+++++++.... .+..+.||||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+|||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrD 177 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGD 177 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred hhccCCCCCeEEeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEec
Confidence 5789999999999986543 33466899999997788887764 34679999999999999999999999 7999999
Q ss_pred CCCCcEEEcC-CCCcEEEeeccCccccccCCC--------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 82 LKPQNLLVDP-LTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 82 lkp~Nill~~-~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
|||+|||++. .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|+|++
T Consensus 178 lkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~ 256 (364)
T 3op5_A 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLT 256 (364)
T ss_dssp CCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHh
Confidence 9999999972 357899999999976533211 1334589999999999764 48999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHH-HhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREE-IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|..||.+................+.... .... + ....+++++.+++.+||+.||.+||++
T Consensus 257 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-----------~~~~~~~~~~~li~~cl~~~p~~RP~~ 317 (364)
T 3op5_A 257 GHLPWEDNLKDPKYVRDSKIRYRENIASLMDKC--------F-----------PAANAPGEIAKYMETVKLLDYTEKPLY 317 (364)
T ss_dssp SCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHH--------S-----------CTTCCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred CCCCccccccCHHHHHHHHHHhhhhHHHHHHHh--------c-----------ccccCHHHHHHHHHHHhcCCCCCCCCH
Confidence 9999986433222222222110111111 1000 0 013478999999999999999999999
Q ss_pred HHHhc
Q 022500 232 LEACA 236 (296)
Q Consensus 232 ~e~l~ 236 (296)
.++++
T Consensus 318 ~~l~~ 322 (364)
T 3op5_A 318 ENLRD 322 (364)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=282.21 Aligned_cols=202 Identities=23% Similarity=0.311 Sum_probs=161.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++. +...+|+||||++| +|.+.+.. ....+++..+..++.|++.||.|||+ +||+|
T Consensus 104 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH 174 (325)
T 3kul_A 104 MGQFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVH 174 (325)
T ss_dssp HTTCCCTTBCCEEEEEC-----GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCcEEEEEE-----eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeC
Confidence 46789999999999984 34448899999975 88777753 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+||+|||+++........ ....+|+.|+|||++.+. .++.++||||+||++|+|++ |.
T Consensus 175 ~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~ 252 (325)
T 3kul_A 175 RDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGE 252 (325)
T ss_dssp SCCSGGGEEEC-TTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCcceEEEC-CCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCC
Confidence 99999999998 5788999999999876433221 223447789999999654 58999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+....+....+......+ .+..+++++.+||.+||+.||.+|||+.++
T Consensus 253 ~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ei 304 (325)
T 3kul_A 253 RPYWNMTNRDVISSVEEGYRLP----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQI 304 (325)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCcccCCHHHHHHHHHcCCCCC----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999988877766655421111 123478999999999999999999999999
Q ss_pred hcCCCcccc
Q 022500 235 CAHPFFDEL 243 (296)
Q Consensus 235 l~hp~f~~~ 243 (296)
++ .+..+
T Consensus 305 l~--~L~~l 311 (325)
T 3kul_A 305 VS--VLDAL 311 (325)
T ss_dssp HH--HHHHH
T ss_pred HH--HHHHH
Confidence 86 34443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.40 Aligned_cols=205 Identities=17% Similarity=0.220 Sum_probs=165.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~---~~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
++++|||||++++++.... ..|+|||||+ |+|.+.+..... ....+++..+..++.||+.||+|||+ +||
T Consensus 129 ~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i 202 (367)
T 3l9p_A 129 SKFNHQNIVRCIGVSLQSL-----PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHF 202 (367)
T ss_dssp HHCCCTTBCCEEEEECSSS-----SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTC
T ss_pred HhCCCCCCCeEEEEEecCC-----CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 4679999999999985433 3789999997 588888875431 22468999999999999999999999 799
Q ss_pred ccCCCCCCcEEEcCC--CCcEEEeeccCccccccC---CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 78 CHRDLKPQNLLVDPL--THQVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 78 ~H~dlkp~Nill~~~--~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
+||||||+|||++.. +..+||+|||+++..... .......+|+.|+|||++.+. .++.++||||+||++|+|++
T Consensus 203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred eCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHh
Confidence 999999999999832 335999999999754322 222345678999999999754 59999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 -GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|..||.+.+..+....+...... ..+..+++++.+||.+||+.||.+|||+
T Consensus 282 ~g~~pf~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~ 333 (367)
T 3l9p_A 282 LGYMPYPSKSNQEVLEFVTSGGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNF 333 (367)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCH
Confidence 99999998887776665542110 0123478999999999999999999999
Q ss_pred HHHhcCCCcc
Q 022500 232 LEACAHPFFD 241 (296)
Q Consensus 232 ~e~l~hp~f~ 241 (296)
.+++++.++-
T Consensus 334 ~eil~~l~~~ 343 (367)
T 3l9p_A 334 AIILERIEYC 343 (367)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=287.00 Aligned_cols=199 Identities=24% Similarity=0.345 Sum_probs=159.9
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRG 67 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a 67 (296)
+++ +|||||++++++... ..+|+||||++| +|.+.+..... ....+++..+..++.||+.|
T Consensus 141 ~~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~a 215 (370)
T 2psq_A 141 KMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215 (370)
T ss_dssp HHSCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCEeeEEEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHH
Confidence 356 899999999998443 348899999985 88888875321 12458999999999999999
Q ss_pred HHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 68 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 68 L~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|+|||+ +||+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+|
T Consensus 216 L~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG 292 (370)
T 2psq_A 216 MEYLAS-QKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFG 292 (370)
T ss_dssp HHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHH
T ss_pred HHHHHh-CCeeccccchhhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHH
Confidence 999999 7999999999999998 578899999999986543321 2234567899999999764 599999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHccccc
Q 022500 145 CVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223 (296)
Q Consensus 145 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 223 (296)
|++|+|++ |..||.+....+....+..... ...+..+++++.++|.+||+.
T Consensus 293 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~ 344 (370)
T 2psq_A 293 VLMWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHA 344 (370)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence 99999999 9999998876655544432100 012234789999999999999
Q ss_pred CCCCCCCHHHHhc
Q 022500 224 SPSLRCTALEACA 236 (296)
Q Consensus 224 ~p~~R~t~~e~l~ 236 (296)
||.+|||+.|+++
T Consensus 345 dP~~Rpt~~ell~ 357 (370)
T 2psq_A 345 VPSQRPTFKQLVE 357 (370)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=285.01 Aligned_cols=220 Identities=22% Similarity=0.230 Sum_probs=160.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---- 75 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~---- 75 (296)
|++++|||||++++++.... .....+|+||||+++ +|.+.+.. ..+++..+..++.|++.||+|||+ .
T Consensus 72 l~~l~hpniv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l 144 (322)
T 3soc_A 72 LPGMKHENILQFIGAEKRGT-SVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGL 144 (322)
T ss_dssp STTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEE
T ss_pred HhcCCCCCchhhcceeccCC-CCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hcccc
Confidence 56889999999999986544 224457899999985 88887764 459999999999999999999999 8
Q ss_pred ------CcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCC----CCCCchhHHHH
Q 022500 76 ------RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----TEYTTSIDIWS 142 (296)
Q Consensus 76 ------~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~Diws 142 (296)
||+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+. ..++.++||||
T Consensus 145 ~~~~~~~ivH~Dlkp~Nill~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 223 (322)
T 3soc_A 145 KDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223 (322)
T ss_dssp TTEEECEEECSCCSGGGEEEC-TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHH
T ss_pred ccccCCCEEeCCCChHhEEEC-CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHH
Confidence 999999999999999 578899999999976543322 2346789999999999753 23566889999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcC-cCCcCccCCCCCCCCcccc-cCCCCCHHHHHHHHcc
Q 022500 143 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-PNYTDFRFPQIKAHPWHKV-FHKRMPPEAIDLASRL 220 (296)
Q Consensus 143 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~~ 220 (296)
+||++|+|++|..||.+..............+.+....+.... .... .+. .... .....++++.+||.+|
T Consensus 224 lG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~~~~l~~li~~c 295 (322)
T 3soc_A 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK---RPV-----LRDYWQKHAGMAMLCETIEEC 295 (322)
T ss_dssp HHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC---CCC-----CCGGGGSSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC---CCC-----ccccccccchHHHHHHHHHHH
Confidence 9999999999999998764322211122222333333322111 0000 000 0000 0012345699999999
Q ss_pred cccCCCCCCCHHHHhc
Q 022500 221 LQYSPSLRCTALEACA 236 (296)
Q Consensus 221 L~~~p~~R~t~~e~l~ 236 (296)
|+.||++|||+.++++
T Consensus 296 l~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 296 WDHDAEARLSAGCVGE 311 (322)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhhCcCHHHHHH
Confidence 9999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=274.48 Aligned_cols=198 Identities=18% Similarity=0.301 Sum_probs=161.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++| +|.+.+.. ....+++..+..++.|++.||+|||+ +||+|
T Consensus 59 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H 129 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIH 129 (269)
T ss_dssp HHTCCCTTBCCEEEEECS-----SSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEec-----CCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 357899999999999843 3348899999985 77777653 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++|+||+|+++|+|++ |..|
T Consensus 130 ~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p 207 (269)
T 4hcu_A 130 RDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIP 207 (269)
T ss_dssp SCCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCcchheEEEc-CCCCEEeccccccccccccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCC
Confidence 99999999998 46789999999997653321 12234567789999999654 58999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+...... ..+...++++.+++.+||+.||++|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 259 (269)
T 4hcu_A 208 YENRSNSEVVEDISTGFRL----------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 259 (269)
T ss_dssp TTTCCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHhcCccC----------------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9998887776665542110 112346899999999999999999999999987
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
|
T Consensus 260 ~ 260 (269)
T 4hcu_A 260 Q 260 (269)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=274.78 Aligned_cols=200 Identities=25% Similarity=0.342 Sum_probs=154.6
Q ss_pred CCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 022500 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 85 (296)
Q Consensus 6 HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~ 85 (296)
||||+++++++.. ...+|+|||+.+++|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+
T Consensus 87 ~~~iv~~~~~~~~-----~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~ 156 (313)
T 3cek_A 87 SDKIIRLYDYEIT-----DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPA 156 (313)
T ss_dssp CTTBCCEEEEEEC-----SSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGG
T ss_pred CCceEEEEEEeec-----CCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcc
Confidence 6999999998853 334899999888898888764 4678999999999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCC----------CCCCchhHHHHHHHHHHHHHh
Q 022500 86 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 86 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~ 152 (296)
||+++ ++.+||+|||++........ .....||+.|+|||++.+. ..++.++||||+||++|+|++
T Consensus 157 NIl~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 234 (313)
T 3cek_A 157 NFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234 (313)
T ss_dssp GEEEE--TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH
T ss_pred cEEEE--CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh
Confidence 99997 47899999999986543322 2345789999999998641 358899999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 GQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|..||...... ..+..+..... ...++...++++.++|.+||+.||.+|||+
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 287 (313)
T 3cek_A 235 GKTPFQQIINQISKLHAIIDPNH---------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287 (313)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTS---------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCchhhHHHHHHHHHHHHhccc---------------------------ccCCcccchHHHHHHHHHHccCCcccCcCH
Confidence 99999776432 22322222100 001223468899999999999999999999
Q ss_pred HHHhcCCCccccc
Q 022500 232 LEACAHPFFDELR 244 (296)
Q Consensus 232 ~e~l~hp~f~~~~ 244 (296)
.++++||||+...
T Consensus 288 ~ell~h~~~~~~~ 300 (313)
T 3cek_A 288 PELLAHPYVQIQT 300 (313)
T ss_dssp HHHHTSHHHHCC-
T ss_pred HHHhcCccccCCC
Confidence 9999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=276.76 Aligned_cols=206 Identities=25% Similarity=0.443 Sum_probs=159.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ..+++||||++| +|.+.+.. ....+++..+..++.|++.||+|||+ +||+|
T Consensus 61 l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH 131 (310)
T 3s95_A 61 MRCLEHPNVLKFIGVLYKD-----KRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIH 131 (310)
T ss_dssp HTTCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCcCcccEEEEEecC-----CeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccC
Confidence 4678999999999998543 348899999985 88877764 35679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---------------cceeecccccCchhccCCCCCCchhHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---------------ISYICSRFYRAPELIFGATEYTTSIDIWSAG 144 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 144 (296)
|||||+||+++ .++.+||+|||++......... ....||+.|+|||++.+ ..++.++||||+|
T Consensus 132 ~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG 209 (310)
T 3s95_A 132 RDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFG 209 (310)
T ss_dssp SCCSTTSEEEC-TTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHH
T ss_pred CCCCcCeEEEC-CCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHH
Confidence 99999999999 5788999999999865332211 14578999999999976 4589999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 145 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 145 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
|++|+|++|..||.......... ....... .....+..+++++.++|.+||+.|
T Consensus 210 ~~l~el~~g~~~~~~~~~~~~~~------~~~~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~d 263 (310)
T 3s95_A 210 IVLCEIIGRVNADPDYLPRTMDF------GLNVRGF--------------------LDRYCPPNCPPSFFPITVRCCDLD 263 (310)
T ss_dssp HHHHHHHHTCCSSTTTSCBCTTS------SBCHHHH--------------------HHHTCCTTCCTTHHHHHHHHTCSS
T ss_pred HHHHHHhcCCCCCcchhhhHHHH------hhhhhcc--------------------ccccCCCCCCHHHHHHHHHHccCC
Confidence 99999999999986542110000 0000000 001123457889999999999999
Q ss_pred CCCCCCHHHHhcCCCcccccC
Q 022500 225 PSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 225 p~~R~t~~e~l~hp~f~~~~~ 245 (296)
|++|||+.++++ ++..++.
T Consensus 264 P~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 264 PEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp GGGSCCHHHHHH--HHHHHHH
T ss_pred hhhCcCHHHHHH--HHHHHHH
Confidence 999999999987 6766543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=281.74 Aligned_cols=195 Identities=25% Similarity=0.367 Sum_probs=160.2
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~--g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.||||+++++++... ..+++|||++. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||
T Consensus 106 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dl 175 (320)
T 3a99_A 106 GFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDI 175 (320)
T ss_dssp SSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCC
T ss_pred CCCCceEEEEEEecC-----CcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCC
Confidence 479999999998543 34889999997 688777764 3679999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
||+||+++..++.+||+|||++...... ......||+.|+|||++.+...++.++||||+||++|+|++|..||.....
T Consensus 176 kp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 254 (320)
T 3a99_A 176 KDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254 (320)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred CHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh
Confidence 9999999855788999999999865432 334567899999999987655457899999999999999999999965421
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
+... . ..+...+++++.+||.+||+.||.+|||++++++||||++
T Consensus 255 ------~~~~--~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 255 ------IIRG--Q---------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp ------HHHC--C---------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred ------hhcc--c---------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 1110 0 0022357999999999999999999999999999999987
Q ss_pred ccC
Q 022500 243 LRE 245 (296)
Q Consensus 243 ~~~ 245 (296)
...
T Consensus 300 ~~~ 302 (320)
T 3a99_A 300 VLL 302 (320)
T ss_dssp CCC
T ss_pred ccC
Confidence 643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.19 Aligned_cols=199 Identities=23% Similarity=0.333 Sum_probs=161.6
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHH
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~aL 68 (296)
++ +|||||++++++... ..+|+||||++| +|.+.+..... ....+++..++.++.||+.||
T Consensus 130 ~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 204 (382)
T 3tt0_A 130 MIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204 (382)
T ss_dssp HHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHH
T ss_pred HhcCCchhhhheeeeccC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 34 899999999998543 338899999985 88888875321 124699999999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
+|||+ +||+||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||+||
T Consensus 205 ~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~ 281 (382)
T 3tt0_A 205 EYLAS-KKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGV 281 (382)
T ss_dssp HHHHH-TTCCCSCCCGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHH
T ss_pred HHHHh-CCEecCCCCcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHH
Confidence 99999 7999999999999999 47889999999998654332 22344668899999999764 5899999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 146 VLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 146 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
++|+|++ |..||.+.+..+....+.+... ...+..+++++.+||.+||+.|
T Consensus 282 il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~d 333 (382)
T 3tt0_A 282 LLWEIFTLGGSPYPGVPVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAV 333 (382)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCC
Confidence 9999999 9999998887766555443110 0012347899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 022500 225 PSLRCTALEACAH 237 (296)
Q Consensus 225 p~~R~t~~e~l~h 237 (296)
|++|||+.+++++
T Consensus 334 P~~Rps~~ell~~ 346 (382)
T 3tt0_A 334 PSQRPTFKQLVED 346 (382)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=283.91 Aligned_cols=199 Identities=25% Similarity=0.373 Sum_probs=158.4
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhc-----------------------------------
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA----------------------------------- 48 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~----------------------------------- 48 (296)
+|||||++++++.... ..+++|||||+| +|.+.+......
T Consensus 84 ~hpniv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (359)
T 3vhe_A 84 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS 159 (359)
T ss_dssp CCTTBCCEEEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------
T ss_pred CCcceeeeeeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcc
Confidence 7999999999985432 237899999994 888887653211
Q ss_pred ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeec
Q 022500 49 ---------------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 101 (296)
Q Consensus 49 ---------------------------~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 101 (296)
...+++..+..++.||+.||.|||+ +||+||||||+||+++ .++.+||+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~-~~~~~kl~Df 237 (359)
T 3vhe_A 160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLS-EKNVVKICDF 237 (359)
T ss_dssp ------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCC
T ss_pred ccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEc-CCCcEEEEec
Confidence 1228999999999999999999999 7999999999999998 4778999999
Q ss_pred cCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 022500 102 GSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 177 (296)
Q Consensus 102 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 177 (296)
|++........ .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+....+.+...+.....+.
T Consensus 238 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 316 (359)
T 3vhe_A 238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 316 (359)
T ss_dssp GGGSCTTSCTTCEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC
T ss_pred cceeeecccccchhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC
Confidence 99986543322 2345678999999999754 58999999999999999998 9999988775555544444211111
Q ss_pred HHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 317 ---------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 123478999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.78 Aligned_cols=196 Identities=28% Similarity=0.417 Sum_probs=151.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC---c
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---V 77 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~---i 77 (296)
+.++||||+++++++.. ...+|+||||++| +|.+.+. ...+++..+..++.|++.||.|||+ +| |
T Consensus 61 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i 129 (271)
T 3dtc_A 61 AMLKHPNIIALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPI 129 (271)
T ss_dssp HHCCCTTBCCEEEEECC-----C--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCC
T ss_pred HhcCCCCEeeEEEEEec-----CCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCce
Confidence 45799999999999843 3348899999985 6655543 3579999999999999999999999 69 8
Q ss_pred ccCCCCCCcEEEcC-------CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 78 CHRDLKPQNLLVDP-------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 78 ~H~dlkp~Nill~~-------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
+||||||+||+++. .++.+||+|||++...... ......||+.|+|||++.+. .++.++|+||+|+++|+|
T Consensus 130 ~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l 207 (271)
T 3dtc_A 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWEL 207 (271)
T ss_dssp CCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHH
T ss_pred eecCCchHHEEEecccccccccCcceEEccCCcccccccc-cccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHH
Confidence 99999999999974 2567999999999865433 23356789999999999754 589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 151 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 151 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
++|..||.+.+.......+...... ...+..+++++.++|.+||+.||.+|||
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps 260 (271)
T 3dtc_A 208 LTGEVPFRGIDGLAVAYGVAMNKLA---------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPS 260 (271)
T ss_dssp HHCCCTTTTSCHHHHHHHHHTSCCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHhhhcCCCC---------------------------CCCCcccCHHHHHHHHHHhcCCcccCcC
Confidence 9999999988776665544331100 0122457899999999999999999999
Q ss_pred HHHHhcC
Q 022500 231 ALEACAH 237 (296)
Q Consensus 231 ~~e~l~h 237 (296)
+.+++++
T Consensus 261 ~~e~l~~ 267 (271)
T 3dtc_A 261 FTNILDQ 267 (271)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=272.02 Aligned_cols=202 Identities=18% Similarity=0.302 Sum_probs=162.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++. +...+++||||++ ++|.+.+... ...+++..+..++.|++.||.|||+ +||+||
T Consensus 58 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~ 128 (268)
T 3sxs_A 58 MKLSHPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHR 128 (268)
T ss_dssp HHCCCTTBCCEEEEEC-----SSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEES
T ss_pred HhCCCCCEeeEEEEEc-----cCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecC
Confidence 4689999999999984 3344889999998 5788777642 3459999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc--cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
||||+||+++ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++||||+|+++|+|++ |..||
T Consensus 129 dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~ 206 (268)
T 3sxs_A 129 DLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPY 206 (268)
T ss_dssp SCSGGGEEEC-TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred CcCcceEEEC-CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCc
Confidence 9999999998 4788999999999865443221 233456789999999654 48899999999999999999 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+....+...... ..+...++++.++|.+||+.||.+|||+.+++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 207 DLYTNSEVVLKVSQGHRL----------------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TTSCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccChHHHHHHHHcCCCC----------------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 988877766655432110 0123468899999999999999999999999974
Q ss_pred CCccccc
Q 022500 238 PFFDELR 244 (296)
Q Consensus 238 p~f~~~~ 244 (296)
+..+.
T Consensus 259 --L~~l~ 263 (268)
T 3sxs_A 259 --IEPLR 263 (268)
T ss_dssp --HGGGC
T ss_pred --HHHhh
Confidence 44443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=279.87 Aligned_cols=201 Identities=22% Similarity=0.290 Sum_probs=160.3
Q ss_pred CCCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHH
Q 022500 1 MRVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFR 66 (296)
Q Consensus 1 l~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~~~~qil~ 66 (296)
|+++ +||||+++++++.. ...+|+||||++ |+|.+.+.... .....+++..+..++.||+.
T Consensus 79 l~~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 153 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeee-----CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHH
Confidence 3567 89999999999844 334899999997 58888876432 22357999999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHH
Q 022500 67 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 146 (296)
Q Consensus 67 aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 146 (296)
||.|||+ +||+||||||+||+++ .++.+||+|||+++............+++.|+|||++.+. .++.++||||+||+
T Consensus 154 aL~~LH~-~~ivH~dlkp~NIl~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i 230 (327)
T 1fvr_A 154 GMDYLSQ-KQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVL 230 (327)
T ss_dssp HHHHHHH-TTEECSCCSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHH
T ss_pred HHHHHHh-CCccCCCCccceEEEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHH
Confidence 9999999 7999999999999998 4778999999999754333333344568899999999654 48999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 147 LAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 147 l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
+|+|++ |..||.+.+..+....+..... ...+..+++++.+||.+||+.||
T Consensus 231 l~ellt~g~~pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp 282 (327)
T 1fvr_A 231 LWEIVSLGGTPYCGMTCAELYEKLPQGYR----------------------------LEKPLNCDDEVYDLMRQCWREKP 282 (327)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHGGGTCC----------------------------CCCCTTBCHHHHHHHHHHTCSSG
T ss_pred HHHHHcCCCCCCCCCcHHHHHHHhhcCCC----------------------------CCCCCCCCHHHHHHHHHHccCCh
Confidence 999998 9999998887666554433100 00123478999999999999999
Q ss_pred CCCCCHHHHhcC
Q 022500 226 SLRCTALEACAH 237 (296)
Q Consensus 226 ~~R~t~~e~l~h 237 (296)
.+|||+++++++
T Consensus 283 ~~Rps~~ell~~ 294 (327)
T 1fvr_A 283 YERPSFAQILVS 294 (327)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=277.16 Aligned_cols=201 Identities=23% Similarity=0.332 Sum_probs=160.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh--------------------cCCCCCHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS--------------------ANQRMPLIYVKL 59 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~--------------------~~~~~~~~~~~~ 59 (296)
|++++||||+++++++... ..+|+||||++ |+|.+.+..... ....+++..+..
T Consensus 80 l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154 (314)
T ss_dssp HTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHH
T ss_pred HhhCCCCceeeEEEEEecC-----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHH
Confidence 4678999999999998433 34889999998 688888875322 123489999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCc
Q 022500 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTT 136 (296)
Q Consensus 60 ~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~ 136 (296)
++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.
T Consensus 155 i~~qi~~~l~~lH~-~~ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ 231 (314)
T 2ivs_A 155 FAWQISQGMQYLAE-MKLVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTT 231 (314)
T ss_dssp HHHHHHHHHHHHHH-TTEECCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECH
T ss_pred HHHHHHHHHHHHHH-CCCcccccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCc
Confidence 99999999999999 7999999999999999 578899999999986543322 1233567889999999754 4899
Q ss_pred hhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHH
Q 022500 137 SIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 215 (296)
Q Consensus 137 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 215 (296)
++||||+||++|+|++ |..||.+.........+..... ...+..+++++.+
T Consensus 232 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~ 283 (314)
T 2ivs_A 232 QSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYR 283 (314)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHH
Confidence 9999999999999999 9999988876555544332100 0122357999999
Q ss_pred HHHcccccCCCCCCCHHHHhcC
Q 022500 216 LASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 216 ll~~~L~~~p~~R~t~~e~l~h 237 (296)
+|.+||+.||.+|||+.+++++
T Consensus 284 li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 284 LMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=275.20 Aligned_cols=210 Identities=23% Similarity=0.278 Sum_probs=167.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHT 73 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~------~~~~~~~~~~~~~~qil~aL~~LH~ 73 (296)
|++++||||+++++++... ...++||||++ |+|.+.+...... ...+++..+..++.||+.||.|||+
T Consensus 82 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 156 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156 (322)
T ss_dssp GGGCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCEeeeEEEEccC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999998433 34789999998 5888888653321 2457999999999999999999999
Q ss_pred CCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 74 ~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
+||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+||++|+|
T Consensus 157 -~~i~H~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el 233 (322)
T 1p4o_A 157 -NKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 233 (322)
T ss_dssp -TTCBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred -CCCccCCCccceEEEc-CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHH
Confidence 7999999999999999 577899999999986543221 2234668899999998654 589999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 151 LL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 151 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
++ |..||.+.+..+....+....-. ..+..+++++.++|.+||+.||.+||
T Consensus 234 ~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rp 285 (322)
T 1p4o_A 234 ATLAEQPYQGLSNEQVLRFVMEGGLL----------------------------DKPDNCPDMLFELMRMCWQYNPKMRP 285 (322)
T ss_dssp HHTSCCTTTTSCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhcCCCccccCCHHHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 99 89999988777666555431000 01234789999999999999999999
Q ss_pred CHHHHhcC------CCcccccCC
Q 022500 230 TALEACAH------PFFDELREP 246 (296)
Q Consensus 230 t~~e~l~h------p~f~~~~~~ 246 (296)
|+.++++| ++|+.+...
T Consensus 286 s~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 286 SFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp CHHHHHHHHGGGSCTTHHHHCST
T ss_pred CHHHHHHHHHHhhccCCcccccc
Confidence 99999876 666665443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=273.39 Aligned_cols=196 Identities=27% Similarity=0.387 Sum_probs=149.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. . ..|+||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +||+|
T Consensus 70 l~~l~h~~iv~~~~~~~~-~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H 139 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVITE-N-----PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVH 139 (281)
T ss_dssp HHTCCCTTBCCEEEEECS-S-----SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCccceEEEEEcc-C-----ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 357899999999998731 1 26799999995 88777764 34569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..|
T Consensus 140 ~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p 217 (281)
T 1mp8_A 140 RDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKP 217 (281)
T ss_dssp SCCSGGGEEEE-ETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccccHHHEEEC-CCCCEEECccccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCC
Confidence 99999999999 478899999999986643322 1233457889999999654 58999999999999999996 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....+....+...... ..+..+++++.++|.+||+.||.+|||+.++++
T Consensus 218 f~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 218 FQGVKNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp TTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9988776666555431100 022357999999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.56 Aligned_cols=198 Identities=17% Similarity=0.266 Sum_probs=161.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++ ++|.+.+.. ....+++..+..++.|++.||.|||+ +||+|
T Consensus 73 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H 143 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTK-----QRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLH 143 (283)
T ss_dssp HHTCCCTTBCCEEEEECS-----SSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HhcCCCCCEeeEEEEEec-----CCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccC
Confidence 357899999999999843 334889999997 588777764 23569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++||||+|+++|+|++ |..|
T Consensus 144 ~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p 221 (283)
T 3gen_A 144 RDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMP 221 (283)
T ss_dssp SSCSGGGEEEC-TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCccceEEEc-CCCCEEEccccccccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999 57789999999997653321 11233457889999999754 58999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.+.... ..+...++.+.++|.+||+.||.+|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 273 (283)
T 3gen_A 222 YERFTNSETAEHIAQGLRL----------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLS 273 (283)
T ss_dssp TTTSCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccccChhHHHHHHhcccCC----------------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 9998877776666542111 012346899999999999999999999999987
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
|
T Consensus 274 ~ 274 (283)
T 3gen_A 274 N 274 (283)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=277.58 Aligned_cols=199 Identities=17% Similarity=0.205 Sum_probs=156.7
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++| +||||+++++++.. ....|+||||++++|.+.+... ...+++..+..++.|++.||+|||+ +||+||
T Consensus 59 ~~l~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHr 129 (330)
T 2izr_A 59 KQLGSGDGIPQVYYFGPC-----GKYNAMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYR 129 (330)
T ss_dssp HHHCSCTTSCCEEEEEEE-----TTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHhhCCCCCCEEEEEEec-----CCccEEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecc
Confidence 345 89999999998844 3458899999988988887752 4679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCc-----EEEeeccCccccccCCC--------ccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 81 dlkp~Nill~~~~~~-----vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
||||+||+++. ++. +||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++
T Consensus 130 Dlkp~Nill~~-~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il 207 (330)
T 2izr_A 130 DVKPENFLIGR-PGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMF 207 (330)
T ss_dssp CCCGGGEEECC-GGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHH
T ss_pred CCCHHHeeecc-CCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHH
Confidence 99999999984 554 99999999986543322 2356789999999999764 589999999999999
Q ss_pred HHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 148 AELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 148 ~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
|+|++|..||.+.+ ..+.+..+.........+. .....+ ++.++|.+||+.|
T Consensus 208 ~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~ 262 (330)
T 2izr_A 208 MYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV------------------------LCENFP-EMATYLRYVRRLD 262 (330)
T ss_dssp HHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCC
T ss_pred HHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH------------------------HhccCh-HHHHHHHHHHhCC
Confidence 99999999998853 3333444432111111110 112234 9999999999999
Q ss_pred CCCCCCHHHHhc
Q 022500 225 PSLRCTALEACA 236 (296)
Q Consensus 225 p~~R~t~~e~l~ 236 (296)
|.+||+++++++
T Consensus 263 p~~RP~~~~l~~ 274 (330)
T 2izr_A 263 FFEKPDYDYLRK 274 (330)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999988765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=271.26 Aligned_cols=197 Identities=16% Similarity=0.158 Sum_probs=157.4
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
+|+||+++++++. +....|+||||++++|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||
T Consensus 64 ~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp 134 (298)
T 1csn_A 64 GCTGIPNVYYFGQ-----EGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKP 134 (298)
T ss_dssp TCTTCCCEEEEEE-----ETTEEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCG
T ss_pred cCCCCCeEEeecC-----CCceeEEEEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCH
Confidence 7999999999884 3445889999998899888864 24569999999999999999999999 7999999999
Q ss_pred CcEEEcCCCCc-----EEEeeccCccccccCCC--------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 85 QNLLVDPLTHQ-----VKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 85 ~Nill~~~~~~-----vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
+||+++. ++. +||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|+|+
T Consensus 135 ~NIl~~~-~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~ 212 (298)
T 1csn_A 135 DNFLIGR-PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFL 212 (298)
T ss_dssp GGEEECC-SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHH
T ss_pred HHEEecc-CCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHH
Confidence 9999973 333 99999999986644322 2345789999999999654 5899999999999999999
Q ss_pred hCCCCCCCCC---hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCC
Q 022500 152 LGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228 (296)
Q Consensus 152 ~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R 228 (296)
+|..||.+.+ ....+..+......+.... ....+++++.++|.+||+.||.+|
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~R 268 (298)
T 1csn_A 213 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDAT 268 (298)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCC
T ss_pred cCCCCcchhhccccHHHHHHHHhhccCccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccC
Confidence 9999998843 3344444433211111111 123479999999999999999999
Q ss_pred CCHHHHhc
Q 022500 229 CTALEACA 236 (296)
Q Consensus 229 ~t~~e~l~ 236 (296)
||++++++
T Consensus 269 P~~~~l~~ 276 (298)
T 1csn_A 269 PDYDYLQG 276 (298)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.75 Aligned_cols=207 Identities=14% Similarity=0.108 Sum_probs=157.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++||||+++++++.... .+..++|+||||++++|.+.+.. .+.+++..++.++.||+.||+|||+ +||+|||
T Consensus 103 ~~l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 176 (345)
T 2v62_A 103 KQLDYLGIPLFYGSGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGD 176 (345)
T ss_dssp HTCSCCCCCCEEEEEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred ccccccCcceeeccccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCC
Confidence 4679999999999986543 33556899999997787776653 3479999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCC--cEEEeeccCccccccCC--------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 82 LKPQNLLVDPLTH--QVKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 82 lkp~Nill~~~~~--~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
|||+||+++. ++ .+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++|+|+
T Consensus 177 lkp~NIll~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell 254 (345)
T 2v62_A 177 IKAANLLLGY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWL 254 (345)
T ss_dssp CSGGGEEEES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHH
T ss_pred cCHHHEEEcc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHH
Confidence 9999999984 44 89999999997653221 11345789999999999764 5899999999999999999
Q ss_pred hCCCCCCCC--ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 152 LGQPLFPGE--NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 152 ~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
+|..||.+. +...............+. ...... -...+++++.++|.+||+.||.+||
T Consensus 255 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rp 314 (345)
T 2v62_A 255 CGKLPWEQNLKDPVAVQTAKTNLLDELPQ-SVLKWA-------------------PSGSSCCEIAQFLVCAHSLAYDEKP 314 (345)
T ss_dssp HSSCTTGGGTTCHHHHHHHHHHHHHTTTH-HHHHHS-------------------CTTSCCHHHHHHHHHHHTCCTTCCC
T ss_pred hCCCCccccccccHHHHHHHHhhcccccH-HHHhhc-------------------cccccHHHHHHHHHHHhhcCcccCC
Confidence 999999653 222222211111111111 111000 0114799999999999999999999
Q ss_pred CHHHHhc
Q 022500 230 TALEACA 236 (296)
Q Consensus 230 t~~e~l~ 236 (296)
|++++++
T Consensus 315 s~~~l~~ 321 (345)
T 2v62_A 315 NYQALKK 321 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.04 Aligned_cols=206 Identities=23% Similarity=0.306 Sum_probs=163.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhc--------------------CCCCCHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA--------------------NQRMPLIYVKL 59 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~--------------------~~~~~~~~~~~ 59 (296)
|++++||||+++++++.. ...+|+||||++| +|.+.+...... ...+++..+..
T Consensus 104 l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 178 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178 (343)
T ss_dssp HHTCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHH
T ss_pred HHhCCCCCEEEEEEEEcc-----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHH
Confidence 357899999999999843 3348899999985 888888753211 25799999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCc
Q 022500 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTT 136 (296)
Q Consensus 60 ~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~ 136 (296)
++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.
T Consensus 179 i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ 255 (343)
T 1luf_A 179 IARQVAAGMAYLSE-RKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTT 255 (343)
T ss_dssp HHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCH
T ss_pred HHHHHHHHHHHHHh-CCeecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCc
Confidence 99999999999999 7999999999999998 57789999999997653321 22345678899999998754 5899
Q ss_pred hhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHH
Q 022500 137 SIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 215 (296)
Q Consensus 137 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 215 (296)
++||||+||++|+|++ |..||.+.+..+....+.+... ...+..+++++.+
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~ 307 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYN 307 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHH
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHH
Confidence 9999999999999999 9999998887766655543100 0022357899999
Q ss_pred HHHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 216 LASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 216 ll~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
+|.+||+.||.+|||+.++++ .++++.
T Consensus 308 li~~~l~~~p~~Rps~~~~~~--~L~~~~ 334 (343)
T 1luf_A 308 LMRLCWSKLPADRPSFCSIHR--ILQRMC 334 (343)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH--HHHHTT
T ss_pred HHHHHcccCcccCCCHHHHHH--HHHHHH
Confidence 999999999999999999986 455543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.18 Aligned_cols=217 Identities=22% Similarity=0.262 Sum_probs=159.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---C
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---R 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~---~ 76 (296)
|++++||||+++++++.... ..++||||++| +|.+.+.........+++..+..++.|++.||+|||+ + |
T Consensus 81 l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ 154 (326)
T 3uim_A 81 ISMAVHRNLLRLRGFCMTPT-----ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPK 154 (326)
T ss_dssp GGTCCCTTBCCCCEEECCSS-----CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSC
T ss_pred HHhccCCCccceEEEEecCC-----ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCC
Confidence 46789999999999985433 37899999985 8888887654455669999999999999999999999 8 9
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|+||||||+||+++ .++.+||+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|.
T Consensus 155 ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~ 232 (326)
T 3uim_A 155 IIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQ 232 (326)
T ss_dssp EECCCCSGGGEEEC-TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCC
T ss_pred eEeCCCchhhEEEC-CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCC
Confidence 99999999999999 577899999999986543322 2334589999999999654 4899999999999999999999
Q ss_pred CCCCCCC----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 155 PLFPGEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 155 ~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
.||.... ........+. .. ......................++++.+++.+||+.||.+|||
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~-----------~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 298 (326)
T 3uim_A 233 RAFDLARLANDDDVMLLDWVK-----------GL---LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298 (326)
T ss_dssp CSBCHHHHTTTSCSBHHHHHT-----------TT---TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC
T ss_pred CcccccccccccchhHHHHHH-----------HH---hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCC
Confidence 9995211 0000001110 00 0000011111111111122234578999999999999999999
Q ss_pred HHHHhcCCC
Q 022500 231 ALEACAHPF 239 (296)
Q Consensus 231 ~~e~l~hp~ 239 (296)
+.++++|-.
T Consensus 299 ~~ell~~L~ 307 (326)
T 3uim_A 299 MSEVVRMLE 307 (326)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhc
Confidence 999998644
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.25 Aligned_cols=206 Identities=19% Similarity=0.259 Sum_probs=156.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~--~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
|++++||||+++++++...........++||||++ |+|.+.+.... .....+++..+..++.||+.||.|||+ +||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i 168 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNF 168 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTC
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCc
Confidence 35789999999999987655444445789999999 48887775322 234679999999999999999999999 799
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-C
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-G 153 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g 153 (296)
+||||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++||||+|+++|+|++ |
T Consensus 169 vH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g 246 (313)
T 3brb_A 169 LHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRG 246 (313)
T ss_dssp CCCCCSGGGEEEC-TTSCEEECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCCCcceEEEc-CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcC
Confidence 9999999999999 47789999999998654332 12234568899999999764 58999999999999999999 8
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
..||.+....+....+...... ..+..+++++.++|.+||+.||.+|||+.+
T Consensus 247 ~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 298 (313)
T 3brb_A 247 MTPYPGVQNHEMYDYLLHGHRL----------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSV 298 (313)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCC----------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCCccCCHHHHHHHHHcCCCC----------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 8999888776666555432100 112347899999999999999999999999
Q ss_pred HhcC
Q 022500 234 ACAH 237 (296)
Q Consensus 234 ~l~h 237 (296)
++++
T Consensus 299 l~~~ 302 (313)
T 3brb_A 299 LRLQ 302 (313)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=279.74 Aligned_cols=196 Identities=21% Similarity=0.271 Sum_probs=155.6
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...++||||+. |+|.+.+.. ..+.+++..+..++.||+.||+|||+ +||+||
T Consensus 70 ~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 139 (325)
T 3kex_A 70 GSLDHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHR 139 (325)
T ss_dssp HTCCCTTBCCEEEEECB------SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred hcCCCCCcCeEEEEEcC------CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCC
Confidence 46799999999998731 12789999998 587777653 23568899999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..|
T Consensus 140 Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 140 NLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp CCSSTTEEES-SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccchheEEEC-CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCC
Confidence 9999999998 477899999999987644322 2344567899999999754 58999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....+....+..... ...+..++.++.++|.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~ 269 (325)
T 3kex_A 218 YAGLRLAEVPDLLEKGER----------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELAN 269 (325)
T ss_dssp TTTSCTTHHHHHHHTTCB----------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred ccccCHHHHHHHHHcCCC----------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 988776655544432100 0011236778999999999999999999999987
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
+
T Consensus 270 ~ 270 (325)
T 3kex_A 270 E 270 (325)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.95 Aligned_cols=197 Identities=22% Similarity=0.313 Sum_probs=158.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++... ..+|+||||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ +||+|
T Consensus 166 l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH 236 (377)
T 3cbl_A 166 LKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIH 236 (377)
T ss_dssp HTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCEEEEEEEEecC-----CCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCC
Confidence 4688999999999998433 33889999998 688887764 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+||+++ .++.+||+|||+++....... .....+++.|+|||++.+. .++.++||||+||++|+|++ |..
T Consensus 237 rDlkp~Nil~~-~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~ 314 (377)
T 3cbl_A 237 RDLAARNCLVT-EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGAS 314 (377)
T ss_dssp SCCSGGGEEEC-TTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccCHHHEEEc-CCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999998 577899999999986432211 1122457789999999654 58999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+....+.+. ..+ ..+..+++++.+||.+||+.||.+|||+.+++
T Consensus 315 p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 366 (377)
T 3cbl_A 315 PYPNLSNQQTREFVEKG-GRL---------------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366 (377)
T ss_dssp SSTTSCHHHHHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHcC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 99988776655444321 100 01234789999999999999999999999987
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 367 ~ 367 (377)
T 3cbl_A 367 Q 367 (377)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=275.37 Aligned_cols=196 Identities=26% Similarity=0.393 Sum_probs=156.3
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEecc-Cc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEY-VP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~-~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++||||+++++++... ...++|||+ +. ++|.+.+.. ...+++..+..++.||+.||+|||+ +||+|||
T Consensus 95 ~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~d 164 (312)
T 2iwi_A 95 GGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRD 164 (312)
T ss_dssp CCCSSBCCEEEEC----------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCC
T ss_pred CCCCCeeeEEEEEecC-----CeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecC
Confidence 3899999999998443 347899998 55 688777764 3569999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 161 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 161 (296)
|||+||+++..++.+||+|||++...... ......||+.|+|||++.+....+.++||||+||++|+|++|..||.+..
T Consensus 165 lkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 243 (312)
T 2iwi_A 165 IKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243 (312)
T ss_dssp CSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred CChhhEEEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence 99999999855788999999999865433 33456789999999998765544569999999999999999999996532
Q ss_pred hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCcc
Q 022500 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 241 (296)
Q Consensus 162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~ 241 (296)
.+... .. .++..+++++.++|.+||+.||++|||++++++||||+
T Consensus 244 ------~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 244 ------EILEA-----------------EL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp ------HHHHT-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred ------HHhhh-----------------cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 11110 00 12235789999999999999999999999999999999
Q ss_pred cccC
Q 022500 242 ELRE 245 (296)
Q Consensus 242 ~~~~ 245 (296)
...+
T Consensus 289 ~~~~ 292 (312)
T 2iwi_A 289 TPAE 292 (312)
T ss_dssp C---
T ss_pred Cchh
Confidence 7654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.57 Aligned_cols=198 Identities=19% Similarity=0.279 Sum_probs=159.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--c
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--V 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i 77 (296)
|++++||||+++++++.... ...+++||||++ |+|.+.+.. .....+++..+..++.|++.||+|||+ +| |
T Consensus 61 l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i 134 (271)
T 3kmu_A 61 LRIFSHPNVLPVLGACQSPP---APHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134 (271)
T ss_dssp GCCCSCTTEECEEEEECTTT---SSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCC
T ss_pred HHhcCCCchhheEEEEccCC---CCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCce
Confidence 46789999999999985431 234789999998 588887764 122358999999999999999999999 69 9
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCC--CCCchhHHHHHHHHHHHHHhCCC
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~ 155 (296)
+||||||+||+++ .++.++++|||++.... .....+|+.|+|||++.+.. .++.++||||+||++|+|++|..
T Consensus 135 ~H~dikp~Nil~~-~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 135 PRHALNSRSVMID-EDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp TTCCCSGGGEEEC-TTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred ecCCCccceEEEc-CCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999 57789999988876432 23457899999999997542 23348999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+....+......+ ..+..+++++.++|.+||+.||.+|||+++++
T Consensus 210 p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (271)
T 3kmu_A 210 PFADLSNMEIGMKVALEGLRP---------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIV 262 (271)
T ss_dssp TTTTSCHHHHHHHHHHSCCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CccccChHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 999888777766655421111 12345799999999999999999999999998
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 263 ~ 263 (271)
T 3kmu_A 263 P 263 (271)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.45 Aligned_cols=196 Identities=24% Similarity=0.308 Sum_probs=156.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.... .++|+||+. |+|.+.+.. ....+++..+..++.||+.||+|||+ +||+||
T Consensus 72 ~~l~h~~iv~~~~~~~~~~------~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~ 141 (327)
T 3poz_A 72 ASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHR 141 (327)
T ss_dssp HHCCBTTBCCEEEEEESSS------EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HhCCCCCEeEEEEEEecCC------eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCC
Confidence 4689999999999985321 668899988 688777764 34679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
||||+||+++ .++.+||+|||+|+........ ....+|+.|+|||++.+. .++.++||||+||++|+|++ |..|
T Consensus 142 Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 142 DLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp CCCGGGEEEE-ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCChheEEEC-CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCC
Confidence 9999999998 5788999999999866443322 233457899999999764 58999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....+....+...... ..+...+.++.+++.+||+.||.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 220 YDGIPASEISSILEKGERL----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TTTCCGGGHHHHHHTTCCC----------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9887765544433321100 012346889999999999999999999999987
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
+
T Consensus 272 ~ 272 (327)
T 3poz_A 272 E 272 (327)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=278.82 Aligned_cols=201 Identities=21% Similarity=0.320 Sum_probs=159.7
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc-------------------CCCCCHHHHHHH
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA-------------------NQRMPLIYVKLY 60 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~-------------------~~~~~~~~~~~~ 60 (296)
+++ +||||+++++++.... .+|+||||++ |+|.+.+...... ...+++..+..+
T Consensus 103 ~~l~~hp~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 177 (344)
T 1rjb_A 103 TQLGSHENIVNLLGACTLSG-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177 (344)
T ss_dssp HHHCCCTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHH
T ss_pred HhhcCCCCeeeEEEEEeeCC-----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHH
Confidence 345 8999999999985433 3889999998 5888887653211 134799999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCch
Q 022500 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTS 137 (296)
Q Consensus 61 ~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~ 137 (296)
+.||+.||+|||+ +||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.+
T Consensus 178 ~~qi~~aL~~LH~-~~ivH~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 254 (344)
T 1rjb_A 178 AYQVAKGMEFLEF-KSCVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIK 254 (344)
T ss_dssp HHHHHHHHHHHHH-TTEEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHH
T ss_pred HHHHHHHHHHHHh-CCcccCCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChh
Confidence 9999999999999 7999999999999999 578899999999986644332 2345678899999998654 58999
Q ss_pred hHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHH
Q 022500 138 IDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 216 (296)
Q Consensus 138 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 216 (296)
+||||+||++|+|++ |..||.+......+..++.....+ ..+..+++++.+|
T Consensus 255 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~l 307 (344)
T 1rjb_A 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYII 307 (344)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHH
T ss_pred HhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHH
Confidence 999999999999998 999998877555555544421110 0123478999999
Q ss_pred HHcccccCCCCCCCHHHHhcC
Q 022500 217 ASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 217 l~~~L~~~p~~R~t~~e~l~h 237 (296)
|.+||+.||.+|||+.++++|
T Consensus 308 i~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 308 MQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHH
Confidence 999999999999999999884
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.57 Aligned_cols=200 Identities=17% Similarity=0.212 Sum_probs=155.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... ..|+||||++ |+|.+.+.. ....+++..+..++.||+.||.|||+ +||+|
T Consensus 66 l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH 136 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGD-----ENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIH 136 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTT-----CCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeEEEEEEEeCC-----CCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeEC
Confidence 35789999999999985433 3789999998 588887764 23348999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCc--------EEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQ--------VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~--------vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
|||||+||+++. ++. +||+|||++..... .....+|+.|+|||++.+...++.++||||+||++|+|+
T Consensus 137 ~Dlkp~NIll~~-~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 212 (289)
T 4fvq_A 137 GNVCAKNILLIR-EEDRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212 (289)
T ss_dssp CCCCGGGEEEEE-CCBGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred CCcCcceEEEec-CCcccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence 999999999984 444 99999999875422 234567899999999976456899999999999999999
Q ss_pred hCC-CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 152 LGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 152 ~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
+|. +||...+..... ....... ..+...++++.+||.+||+.||.+|||
T Consensus 213 ~g~~~~~~~~~~~~~~-~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps 262 (289)
T 4fvq_A 213 SGGDKPLSALDSQRKL-QFYEDRH-----------------------------QLPAPKAAELANLINNCMDYEPDHRPS 262 (289)
T ss_dssp TTTCCTTTTSCHHHHH-HHHHTTC-----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCC
T ss_pred cCCCCCccccchHHHH-HHhhccC-----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 965 555554443333 2222100 012235778999999999999999999
Q ss_pred HHHHhcCCCcccccC
Q 022500 231 ALEACAHPFFDELRE 245 (296)
Q Consensus 231 ~~e~l~hp~f~~~~~ 245 (296)
+.++++| ++++..
T Consensus 263 ~~~ll~~--l~~l~~ 275 (289)
T 4fvq_A 263 FRAIIRD--LNSLFT 275 (289)
T ss_dssp HHHHHHH--HHTCC-
T ss_pred HHHHHHH--HHHhcC
Confidence 9999874 555433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=273.41 Aligned_cols=200 Identities=25% Similarity=0.359 Sum_probs=159.8
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHH
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS--------------ANQRMPLIYVKLYTYQIFR 66 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~--------------~~~~~~~~~~~~~~~qil~ 66 (296)
++ +||||+++++++.... ..++||||+++ +|.+.+..... ....+++..+..++.||+.
T Consensus 82 ~l~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 156 (313)
T 1t46_A 82 YLGNHMNIVNLLGACTIGG-----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156 (313)
T ss_dssp HHCCCTTBCCEEEEECSSS-----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred hcccCCCeeeEEEEEecCC-----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHH
Confidence 45 8999999999985433 37899999985 88888775321 1235899999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHH
Q 022500 67 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSA 143 (296)
Q Consensus 67 aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 143 (296)
||.|||+ +||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+
T Consensus 157 ~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~sl 233 (313)
T 1t46_A 157 GMAFLAS-KNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSY 233 (313)
T ss_dssp HHHHHHH-TTCCCSCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHH
T ss_pred HHHHHHH-CCeecCCCccceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHH
Confidence 9999999 7999999999999999 578899999999987644332 2234568899999998654 58999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccc
Q 022500 144 GCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222 (296)
Q Consensus 144 G~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 222 (296)
||++|+|++ |..||.+.........++.....+ ..+..+++++.++|.+||+
T Consensus 234 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~ 286 (313)
T 1t46_A 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWD 286 (313)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcC
Confidence 999999998 999998877555555544421110 0123478999999999999
Q ss_pred cCCCCCCCHHHHhcC
Q 022500 223 YSPSLRCTALEACAH 237 (296)
Q Consensus 223 ~~p~~R~t~~e~l~h 237 (296)
.||.+|||+.+++++
T Consensus 287 ~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 287 ADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCchhCcCHHHHHHH
Confidence 999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=280.62 Aligned_cols=198 Identities=22% Similarity=0.354 Sum_probs=149.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... ...|+||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 144 l~~l~hpnIv~~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH 215 (373)
T 3c1x_A 144 MKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVH 215 (373)
T ss_dssp STTCCCTTBCCCCEEECCCS----SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCcceEEEEEEcCC----CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEec
Confidence 57889999999999864322 237799999985 88877753 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-C
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-G 153 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g 153 (296)
|||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|+|++ |
T Consensus 216 rDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~ 293 (373)
T 3c1x_A 216 RDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG 293 (373)
T ss_dssp SCCCGGGEEEC-TTCCEEECCC---------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred CccchheEEEC-CCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCc
Confidence 99999999999 577899999999986533221 1234567889999999654 58999999999999999999 6
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
.+||.+.+..+....+.+... ...+..+++.+.++|.+||+.||.+|||+.+
T Consensus 294 ~~p~~~~~~~~~~~~~~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~e 345 (373)
T 3c1x_A 294 APPYPDVNTFDITVYLLQGRR----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 345 (373)
T ss_dssp CCSCTTSCSSCHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 788887765554444432100 0012347899999999999999999999999
Q ss_pred Hhc
Q 022500 234 ACA 236 (296)
Q Consensus 234 ~l~ 236 (296)
+++
T Consensus 346 ll~ 348 (373)
T 3c1x_A 346 LVS 348 (373)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=279.94 Aligned_cols=197 Identities=23% Similarity=0.300 Sum_probs=149.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ..+|+||||++ |+|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 100 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH 170 (373)
T 2qol_A 100 MGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVH 170 (373)
T ss_dssp HTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCCCeEEEEEeeC-----CceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeC
Confidence 4678999999999998433 34889999997 588877763 34579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+||+|||+++........ ....+++.|+|||++.+. .++.++||||+||++|+|++ |.
T Consensus 171 ~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~ 248 (373)
T 2qol_A 171 RDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGE 248 (373)
T ss_dssp SCCCGGGEEEC-TTCCEEECCC----------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-
T ss_pred CCCCcceEEEc-CCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCC
Confidence 99999999998 5788999999999866433211 122346789999999654 58999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+......+ .+..++.++.++|.+||+.||.+||++.++
T Consensus 249 ~P~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i 300 (373)
T 2qol_A 249 RPYWEMSNQDVIKAVDEGYRLP----------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300 (373)
T ss_dssp CTTTTCCHHHHHHHHHTTEECC----------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCC----------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence 9999888776665554321110 112478899999999999999999999988
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 301 ~~ 302 (373)
T 2qol_A 301 VS 302 (373)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=280.97 Aligned_cols=217 Identities=21% Similarity=0.186 Sum_probs=156.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+|+||||++| +|.+.+.........+++..+..++.|++.||+|||+ +||+|
T Consensus 89 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH 162 (321)
T 2qkw_B 89 LSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIH 162 (321)
T ss_dssp GGSCCCTTBCCEEEECCC-----TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCEeeEEEEEcC-----CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeec
Confidence 467899999999999843 3348899999984 7666554322223468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|..|
T Consensus 163 ~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 163 RDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp SCCCSTTEEEC-TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred CCCCHHHEEEC-CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCc
Confidence 99999999999 57889999999997643221 22345689999999998654 589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....+....+... ... ......... .............+..+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 308 (321)
T 2qkw_B 241 IVQSLPREMVNLAEWA-----VES--HNNGQLEQI-----VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308 (321)
T ss_dssp CSCSSSSSCCCHHHHT-----HHH--HTTTCCCSS-----SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCcHHHHHHHHHh-----hhc--cccccHHHh-----cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9765432211100000 000 000000100 0001111122234678999999999999999999999987
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
+
T Consensus 309 ~ 309 (321)
T 2qkw_B 309 K 309 (321)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=268.42 Aligned_cols=202 Identities=24% Similarity=0.318 Sum_probs=149.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||++++++.. . ..+++||||++ ++|.+.+.. ....+++..+..++.|++.||.|||+ +||+|
T Consensus 74 l~~l~h~~iv~~~~~~~-~-----~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H 143 (289)
T 3og7_A 74 LRKTRHVNILLFMGYST-A-----PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIH 143 (289)
T ss_dssp HTTCCCTTBCCEEEEEC-S-----SSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCcEEEEEeecc-C-----CccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 46789999999999642 1 12679999998 577666642 34669999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC---CCccceeecccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+||+++ .++.+||+|||++...... .......||+.|+|||++.. ...++.++||||+|+++|+|++|.
T Consensus 144 ~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (289)
T 3og7_A 144 RDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222 (289)
T ss_dssp SCCCGGGEEEE-TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCccceEEEC-CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence 99999999999 4788999999999755322 12234578999999999852 345788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+....+.+..++.....+.. .......+++++.+||.+||+.||.+|||+.++
T Consensus 223 ~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 223 LPYSNINNRDQIIEMVGRGSLSPD-----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp CTTSSCCCHHHHHHHHHHTSCCCC-----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCccccchHHHHHHHhcccccCcc-----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999987776666655543211110 001223478999999999999999999999999
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 280 l~ 281 (289)
T 3og7_A 280 LA 281 (289)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=273.88 Aligned_cols=196 Identities=26% Similarity=0.332 Sum_probs=152.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... .++|+||+. |+|.+.+.. ....+++..+..++.||+.||.|||+ +||+|
T Consensus 71 l~~l~hp~iv~~~~~~~~~~------~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH 140 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVH 140 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSS------EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCeeEEEEEEecCC------ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcC
Confidence 46789999999999985321 668889888 588777764 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+||+++ .++.+||+|||+++........ ....+|+.|+|||++.+. .++.++||||+||++|+|++ |..
T Consensus 141 ~Dikp~NIl~~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~ 218 (327)
T 3lzb_A 141 RDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp SCCCGGGEEEE-ETTEEEECCTTC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCHHHEEEc-CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCC
Confidence 99999999998 4788999999999865433222 233457789999999764 58999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+....+....+......+ .+..++.++.++|.+||+.||.+|||+.+++
T Consensus 219 p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 270 (327)
T 3lzb_A 219 PYDGIPASEISSILEKGERLP----------------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELI 270 (327)
T ss_dssp TTTTCCGGGHHHHHHTTCCCC----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 998887665554443311000 1234788999999999999999999999998
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 271 ~ 271 (327)
T 3lzb_A 271 I 271 (327)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=272.68 Aligned_cols=197 Identities=21% Similarity=0.294 Sum_probs=154.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ...+++||||++| +|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 100 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH 170 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVH 170 (333)
T ss_dssp HHTCCCTTBCCEEEEECS-----SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCCCcEEEEEec-----CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeC
Confidence 357899999999999843 3348899999985 88777754 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+||++|+|++ |.
T Consensus 171 ~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 171 RDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp SCCCGGGEEEC-TTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCChheEEEC-CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCC
Confidence 99999999999 578899999999986543321 1123457789999999754 58999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+.+....+ .+..+++++.++|.+||+.||.+||++.++
T Consensus 249 ~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 249 RPYWELSNHEVMKAINDGFRLP----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCcccCCHHHHHHHHHCCCcCC----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9998888776665554321100 123478999999999999999999999998
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 301 ~~ 302 (333)
T 1mqb_A 301 VS 302 (333)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=268.54 Aligned_cols=205 Identities=25% Similarity=0.337 Sum_probs=154.0
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------h
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------T 73 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH--------~ 73 (296)
.++||||+++++++.... .....+|+||||+++ +|.+.++ ...+++..+..++.|++.||+||| +
T Consensus 58 ~l~h~niv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~ 131 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSR-HSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131 (301)
T ss_dssp CCCCTTBCCEEEEEEEEE-TTEEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB
T ss_pred hccCcCeeeEEEeecccc-CCCceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC
Confidence 479999999999876443 334558899999985 8777764 357999999999999999999999 8
Q ss_pred CCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCC-----CCCchhHHHHH
Q 022500 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSA 143 (296)
Q Consensus 74 ~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diwsl 143 (296)
+||+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+.. .++.++||||+
T Consensus 132 -~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 132 -PAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp -CEEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred -CCeecCCCChHhEEEc-CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 7999999999999999 577899999999976543322 12347899999999996543 23479999999
Q ss_pred HHHHHHHHhC----------CCCCCCCC----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCC
Q 022500 144 GCVLAELLLG----------QPLFPGEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM 209 (296)
Q Consensus 144 G~il~~ll~g----------~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (296)
||++|+|++| ..||.... .......+....+.. +. ..........
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------------~~----~~~~~~~~~~ 268 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR-----------------PN----IPNRWFSDPT 268 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-----------------CC----CCGGGGGSHH
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCC-----------------CC----CChhhccCcc
Confidence 9999999999 88886532 222222222211100 00 0001112235
Q ss_pred CHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 210 PPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 210 ~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
++++.+||.+||+.||.+|||+.++++
T Consensus 269 ~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 269 LTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 678999999999999999999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=276.03 Aligned_cols=199 Identities=23% Similarity=0.339 Sum_probs=159.6
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhh----------cCCCCCHHHHHHHHHHHHHHHHH
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS----------ANQRMPLIYVKLYTYQIFRGLAY 70 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~----------~~~~~~~~~~~~~~~qil~aL~~ 70 (296)
++ +||||+++++++... ..+|+||||+++ +|.+.+..... ....+++..+..++.||+.||+|
T Consensus 105 ~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 179 (333)
T 2i1m_A 105 HLGQHENIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179 (333)
T ss_dssp HHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHH
T ss_pred hhcCCCCeeeEEEEEecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 45 899999999998443 348899999985 88888865332 13568999999999999999999
Q ss_pred HHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 71 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 71 LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
||+ +||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+||++
T Consensus 180 lH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il 256 (333)
T 2i1m_A 180 LAS-KNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILL 256 (333)
T ss_dssp HHH-TTEECSCCSGGGCEEE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred Hhc-CCcccCCcccceEEEC-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHH
Confidence 999 7999999999999998 577899999999986544322 2234568899999998754 589999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 148 AELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 148 ~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|+|++ |..||.+.........++.....+ ..+...++++.++|.+||+.||.
T Consensus 257 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~ 309 (333)
T 2i1m_A 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPT 309 (333)
T ss_dssp HHHTTTSCCSSTTCCSSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHcCCCCCCcccchhHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChh
Confidence 99998 999998876655555554421110 01234688999999999999999
Q ss_pred CCCCHHHHhc
Q 022500 227 LRCTALEACA 236 (296)
Q Consensus 227 ~R~t~~e~l~ 236 (296)
+|||+.++++
T Consensus 310 ~Rps~~~l~~ 319 (333)
T 2i1m_A 310 HRPTFQQICS 319 (333)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=275.50 Aligned_cols=199 Identities=25% Similarity=0.345 Sum_probs=140.1
Q ss_pred CCCCeeeeceeeeccC---CCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--ccc
Q 022500 5 DHPNVISLKHCFFSTT---SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCH 79 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~---~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i~H 79 (296)
+||||+++++++.... ..+...+++||||++|+|.+.+.... ..+.+++..+..++.||+.||.|||+ +| |+|
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH 161 (337)
T 3ll6_A 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIH 161 (337)
T ss_dssp TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBC
T ss_pred cCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEE
Confidence 4999999999885322 13455688999999999998887533 34679999999999999999999999 69 999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-------------ccceeecccccCchhcc--CCCCCCchhHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-------------NISYICSRFYRAPELIF--GATEYTTSIDIWSAG 144 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG 144 (296)
|||||+||+++ .++.+||+|||++........ .....+|+.|+|||++. ....++.++||||+|
T Consensus 162 ~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG 240 (337)
T 3ll6_A 162 RDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240 (337)
T ss_dssp CCCCGGGCEEC-TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHH
T ss_pred ccCCcccEEEC-CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHH
Confidence 99999999999 477899999999986543221 11456899999999983 234578999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 145 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 145 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
|++|+|++|..||.+............ . ......+..+.+||.+||+.|
T Consensus 241 ~il~el~~g~~p~~~~~~~~~~~~~~~---------------------~----------~~~~~~~~~~~~li~~~l~~~ 289 (337)
T 3ll6_A 241 CILYLLCFRQHPFEDGAKLRIVNGKYS---------------------I----------PPHDTQYTVFHSLIRAMLQVN 289 (337)
T ss_dssp HHHHHHHHSSCCC------------CC---------------------C----------CTTCCSSGGGHHHHHHHSCSS
T ss_pred HHHHHHHhCCCCCcchhHHHhhcCccc---------------------C----------CcccccchHHHHHHHHHccCC
Confidence 999999999999976543322111100 0 011235778999999999999
Q ss_pred CCCCCCHHHHhcC
Q 022500 225 PSLRCTALEACAH 237 (296)
Q Consensus 225 p~~R~t~~e~l~h 237 (296)
|.+|||+.++++|
T Consensus 290 p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 290 PEERLSIAEVVHQ 302 (337)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=264.44 Aligned_cols=195 Identities=23% Similarity=0.344 Sum_probs=154.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--c
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--V 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i 77 (296)
|++++||||+++++++. +.. ++||||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ +| |
T Consensus 77 l~~l~h~~i~~~~~~~~-----~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~i 145 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMH-----NPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPI 145 (287)
T ss_dssp HTTCCCTTBCCEEEEET-----TTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCC
T ss_pred HHhCCCCCchhhheeec-----CCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCe
Confidence 46789999999999883 222 49999998 687776653 44679999999999999999999999 79 9
Q ss_pred ccCCCCCCcEEEcCCCCc-----EEEeeccCccccccCCCccceeecccccCchhccC-CCCCCchhHHHHHHHHHHHHH
Q 022500 78 CHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~-----vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll 151 (296)
+||||||+||+++. ++. +||+|||+++.... ......||+.|+|||++.+ ...++.++||||+||++|+|+
T Consensus 146 vH~dikp~Nil~~~-~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 146 VHRDLRSPNIFLQS-LDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp BCSCCSGGGEEESC-CCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEec-cCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 99999999999974 443 99999999975432 3345678999999999843 234789999999999999999
Q ss_pred hCCCCCCCCChHHH--HHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 152 LGQPLFPGENAVDQ--LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 152 ~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
+|..||.+.+.... ...+... +. ...++..+++++.++|.+||+.||.+||
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rp 275 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIREE-GL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRP 275 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHHS-CC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCCCCccccccHHHHHHHHhcc-CC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCc
Confidence 99999987653322 2222221 10 0112345799999999999999999999
Q ss_pred CHHHHhc
Q 022500 230 TALEACA 236 (296)
Q Consensus 230 t~~e~l~ 236 (296)
|++++++
T Consensus 276 s~~~ll~ 282 (287)
T 4f0f_A 276 HFSYIVK 282 (287)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=269.08 Aligned_cols=198 Identities=23% Similarity=0.369 Sum_probs=157.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ....|+||||++| +|.+.+.. ....+++..+..++.|++.||+|||+ +||+|
T Consensus 80 l~~l~h~~iv~~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H 151 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRS----EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVH 151 (298)
T ss_dssp HHTCCCTTBCCCCEEECCS----SSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeeeeEEEcC----CCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccC
Confidence 3578999999999986432 2347899999995 88777753 34668999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-----CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-C
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-G 153 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g 153 (296)
|||||+||+++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++|+||+|+++|+|++ |
T Consensus 152 ~dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~ 229 (298)
T 3f66_A 152 RDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG 229 (298)
T ss_dssp SCCSGGGEEEC-TTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCchheEEEC-CCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCC
Confidence 99999999998 57789999999998653322 12344668899999999654 58999999999999999999 6
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
.+||.+.+..+....+...... ..+..+++++.++|.+||+.||.+|||+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 281 (298)
T 3f66_A 230 APPYPDVNTFDITVYLLQGRRL----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281 (298)
T ss_dssp CCSSTTSCTTTHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCccCCHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 6788777665555544432110 012347899999999999999999999999
Q ss_pred Hhc
Q 022500 234 ACA 236 (296)
Q Consensus 234 ~l~ 236 (296)
+++
T Consensus 282 ll~ 284 (298)
T 3f66_A 282 LVS 284 (298)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=265.36 Aligned_cols=197 Identities=17% Similarity=0.287 Sum_probs=159.8
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... ..+|+||||++ ++|.+.+.. ....+++..+..++.|++.||.|||+ +|++||
T Consensus 58 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 128 (267)
T 3t9t_A 58 MKLSHPKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHR 128 (267)
T ss_dssp HTCCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HhCCCCCEeeEEEEEccC-----CCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 578999999999998543 34889999998 588777764 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++|+||+|+++|+|++ |..||
T Consensus 129 dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~ 206 (267)
T 3t9t_A 129 DLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPY 206 (267)
T ss_dssp SCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCchheEEEC-CCCCEEEcccccccccccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCC
Confidence 9999999998 47789999999997653221 11234567889999999654 58999999999999999999 89999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+....+...... ..+...++++.+++.+||+.||.+|||+.+++++
T Consensus 207 ~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 207 ENRSNSEVVEDISTGFRL----------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TTCCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHhcCCcC----------------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 988877766655432100 0123468999999999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=283.06 Aligned_cols=197 Identities=22% Similarity=0.305 Sum_probs=158.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... ..+|+||||++ |+|.+.+... ....+++..+..++.||+.||+|||+ +||+|
T Consensus 240 l~~l~h~niv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH 312 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVH 312 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTT----SCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhccCCCEEEEEEEEEcCC----CceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeC
Confidence 46789999999999875432 23889999998 5888888752 23447999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+++..... .....+++.|+|||++.+. .++.++||||+||++|+|++ |..||.
T Consensus 313 rDlkp~Nill~-~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 313 RDLAARNVLVS-EDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp SCCCGGGEEEC-TTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCCHhhEEEC-CCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 4788999999999854322 2233568899999999764 59999999999999999998 999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+.+..+....+.+... ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus 389 ~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 389 RIPLKDVVPRVEKGYK----------------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TSCTTTHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8776655554433100 0122457999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=268.02 Aligned_cols=196 Identities=25% Similarity=0.342 Sum_probs=155.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. . ..|+||||++ ++|.+.+.. ....+++..+..++.|++.||.|||+ +||+||
T Consensus 68 ~~l~h~~i~~~~~~~~~-----~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 137 (281)
T 3cc6_A 68 KNLDHPHIVKLIGIIEE-----E-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHR 137 (281)
T ss_dssp HHHCCTTBCCEEEEECS-----S-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred HhCCCCCcceEEEEEcC-----C-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccC
Confidence 45789999999998732 1 1579999999 588877764 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
||||+||+++ .++.+||+|||++........ .....+++.|+|||++.+. .++.++||||+|+++|+|++ |..||
T Consensus 138 dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~ 215 (281)
T 3cc6_A 138 DIAVRNILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPF 215 (281)
T ss_dssp CCSGGGEEEE-ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCccceEEEC-CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCc
Confidence 9999999998 477899999999986543321 2234567889999999654 58999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
......+....+......+ .+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 216 FWLENKDVIGVLEKGDRLP----------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTSCGGGHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCChHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 8776665554443321100 123478999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=267.57 Aligned_cols=197 Identities=22% Similarity=0.340 Sum_probs=160.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. ...+|+||||++ ++|.+.+... ....+++..+..++.|++.||.|||+ +||+||
T Consensus 64 ~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~ 135 (288)
T 3kfa_A 64 KEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHR 135 (288)
T ss_dssp HHCCCTTBCCEEEEECS-----SSSEEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCS
T ss_pred HhCCCCCEeeEEEEEcc-----CCCEEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCC
Confidence 46899999999999843 334889999999 5888877642 34569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+|+++|+|++ |..||
T Consensus 136 dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~ 213 (288)
T 3kfa_A 136 DLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPY 213 (288)
T ss_dssp CCSGGGEEEC-GGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCcceEEEc-CCCCEEEccCccceeccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999998 477899999999986543322 2334568889999999654 58999999999999999999 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+.+.......+..... ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 214 PGIDLSQVYELLEKDYR----------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHhccCC----------------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 88776655544433110 0122357899999999999999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=283.39 Aligned_cols=197 Identities=25% Similarity=0.385 Sum_probs=159.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. .. .+|+||||++ |+|.+.+.... ...+++..+..++.||+.||+|||+ +||+|
T Consensus 237 l~~l~h~~iv~l~~~~~-~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH 307 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KE-----PIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIH 307 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SS-----SCEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HhhCCCCCEeeEEEEEe-CC-----ccEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccC
Confidence 57899999999999873 11 2789999998 58888886432 2358899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+|||++ .++.+||+|||+++...... ......+++.|+|||++.+. .++.++||||+||++|+|++ |..|
T Consensus 308 rDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P 385 (454)
T 1qcf_A 308 RDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIP 385 (454)
T ss_dssp SSCSGGGEEEC-TTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCHHHEEEC-CCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCC
Confidence 99999999999 57889999999998653221 11223457789999999654 58999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+......+ .+..+++++.+||.+||+.||.+|||++++++
T Consensus 386 ~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 386 YPGMSNPEVIRALERGYRMP----------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp STTCCHHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99988877766655421111 12347899999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=265.40 Aligned_cols=198 Identities=21% Similarity=0.347 Sum_probs=155.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++..... ..++||||+. |+|.+.+.. ....+++..+..++.|++.||+|||+ +||+|
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H 147 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEG----LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVH 147 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSS----CCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCeeeEEEEEecCCC----CcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 357899999999999854332 2479999997 688777753 34678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC-----CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG- 153 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g- 153 (296)
|||||+||+++ .++.+||+|||+++..... .......+|+.|+|||.+.+. .++.++||||+||++|+|++|
T Consensus 148 ~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~ 225 (298)
T 3pls_A 148 RDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRG 225 (298)
T ss_dssp SCCSGGGEEEC-TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTS
T ss_pred CCCCcceEEEc-CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCC
Confidence 99999999999 5778999999999754322 122344668899999999654 589999999999999999995
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
.+||.+.+..+....+...... ..+..+++++.++|.+||+.||.+|||+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 277 (298)
T 3pls_A 226 APPYRHIDPFDLTHFLAQGRRL----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRV 277 (298)
T ss_dssp CCTTTTSCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCccCCHHHHHHHhhcCCCC----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHH
Confidence 5566655555444443331110 012347899999999999999999999999
Q ss_pred Hhc
Q 022500 234 ACA 236 (296)
Q Consensus 234 ~l~ 236 (296)
+++
T Consensus 278 ll~ 280 (298)
T 3pls_A 278 LVG 280 (298)
T ss_dssp HHH
T ss_pred HHH
Confidence 886
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=269.67 Aligned_cols=209 Identities=27% Similarity=0.404 Sum_probs=151.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... ...+++||||++ |+|.+.+... ...+++..+..++.|++.||+|||+ +||+|
T Consensus 65 l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH 137 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAG---RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIH 137 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHH---HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEecCC---CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCccc
Confidence 35789999999999885422 223789999997 5888877642 3458999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.+||+|||++........ .....++..|+|||++.+. .++.++||||+|+++|+|++|..
T Consensus 138 ~Dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~ 215 (295)
T 3ugc_A 138 RDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 215 (295)
T ss_dssp SCCSGGGEEEE-ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCHhhEEEc-CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhccc
Confidence 99999999999 578899999999986543321 1233467789999999754 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCH-HH-----HhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTR-EE-----IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
||...... ..... +.... .. ....... . ....+..+++++.++|.+||+.||.+||
T Consensus 216 ~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rp 277 (295)
T 3ugc_A 216 KSKSPPAE--FMRMI---GNDKQGQMIVFHLIELLKNN-G------------RLPRPDGCPDEIYMIMTECWNNNVNQRP 277 (295)
T ss_dssp TTCSHHHH--HHHHH---CTTCCTHHHHHHHHHHHHTT-C------------CCCCCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred ccCCChHH--HHhhh---cCccccchhHHHHHHHHhcc-C------------cCCCCcCcCHHHHHHHHHHcCCChhhCC
Confidence 88654211 11111 11100 00 0000000 0 0012345799999999999999999999
Q ss_pred CHHHHhc
Q 022500 230 TALEACA 236 (296)
Q Consensus 230 t~~e~l~ 236 (296)
|+.++++
T Consensus 278 s~~el~~ 284 (295)
T 3ugc_A 278 SFRDLAL 284 (295)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=269.47 Aligned_cols=202 Identities=23% Similarity=0.320 Sum_probs=161.4
Q ss_pred CCCCCCCeeeeceeeeccC-----------CCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 022500 2 RVMDHPNVISLKHCFFSTT-----------SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 69 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~-----------~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~ 69 (296)
++++||||+++++++.... ......+|+||||+++ +|.+.+... ....+++..+..++.||+.||.
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~ 136 (284)
T 2a19_B 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVD 136 (284)
T ss_dssp HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHH
Confidence 4689999999999874311 1224458899999995 888887653 3357999999999999999999
Q ss_pred HHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHH
Q 022500 70 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 70 ~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 149 (296)
|||+ +||+||||||+||+++ .++.+||+|||++.............+|+.|+|||++.+. .++.++|+||+|+++|+
T Consensus 137 ~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ 213 (284)
T 2a19_B 137 YIHS-KKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAE 213 (284)
T ss_dssp HHHH-TTEECSCCSGGGEEEE-ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHH
T ss_pred HHHh-CCeeeccCCHHHEEEc-CCCCEEECcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHH
Confidence 9999 7999999999999998 5788999999999877655555566789999999999764 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 150 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 150 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
|++|..|+.... .....+.. ..++..+++++.++|.+||+.||.+||
T Consensus 214 l~~~~~~~~~~~--~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp 260 (284)
T 2a19_B 214 LLHVCDTAFETS--KFFTDLRD-------------------------------GIISDIFDKKEKTLLQKLLSKKPEDRP 260 (284)
T ss_dssp HHSCCSSHHHHH--HHHHHHHT-------------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhcCCcchhHH--HHHHHhhc-------------------------------ccccccCCHHHHHHHHHHccCChhhCc
Confidence 999998874221 11111110 001234789999999999999999999
Q ss_pred CHHHHhcCCCcc
Q 022500 230 TALEACAHPFFD 241 (296)
Q Consensus 230 t~~e~l~hp~f~ 241 (296)
|+.++++|.+.-
T Consensus 261 s~~e~l~~l~~~ 272 (284)
T 2a19_B 261 NTSEILRTLTVW 272 (284)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999987664
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.37 Aligned_cols=199 Identities=25% Similarity=0.371 Sum_probs=157.4
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHH
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA------------NQRMPLIYVKLYTYQIFRGLAYI 71 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~------------~~~~~~~~~~~~~~qil~aL~~L 71 (296)
+||||+++++++... ...+++||||++| +|.+.+...... ...+++..+..++.||+.||.||
T Consensus 89 ~hp~iv~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l 164 (316)
T 2xir_A 89 HHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 164 (316)
T ss_dssp CCTTBCCEEEEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH
T ss_pred cCCCeeeEEEEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH
Confidence 699999999988532 2337899999994 888877643211 12389999999999999999999
Q ss_pred HhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 72 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 72 H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
|+ +||+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|
T Consensus 165 H~-~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ 241 (316)
T 2xir_A 165 AS-RKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLW 241 (316)
T ss_dssp HH-TTCCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHH
T ss_pred Hh-CCcccccCccceEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHH
Confidence 99 7999999999999998 477899999999986544322 2345678899999999754 5899999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC
Q 022500 149 ELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 149 ~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~ 227 (296)
+|++ |..||.+....+.+...+.....+ ..+..+++++.++|.+||+.||.+
T Consensus 242 ~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~ 294 (316)
T 2xir_A 242 EIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQ 294 (316)
T ss_dssp HHHTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHhCCCCCCcccchhHHHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhh
Confidence 9998 999998876544444433321110 012347899999999999999999
Q ss_pred CCCHHHHhcC
Q 022500 228 RCTALEACAH 237 (296)
Q Consensus 228 R~t~~e~l~h 237 (296)
|||+.++++|
T Consensus 295 Rps~~ell~~ 304 (316)
T 2xir_A 295 RPTFSELVEH 304 (316)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.01 Aligned_cols=196 Identities=26% Similarity=0.303 Sum_probs=159.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++. .. .+++||||++| +|.+.+.. ....+++..+..++.|++.||.|||+ +||+||
T Consensus 65 ~~l~h~~i~~~~~~~~-~~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~ 134 (287)
T 1u59_A 65 HQLDNPYIVRLIGVCQ-AE-----ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHR 134 (287)
T ss_dssp HHCCCTTBCCEEEEEE-SS-----SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhCCCCCEeEEEEEec-CC-----CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeC
Confidence 4679999999999882 22 27899999995 77766642 34669999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
||||+||+++ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++|+||+|+++|+|++ |..
T Consensus 135 dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~ 212 (287)
T 1u59_A 135 DLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQK 212 (287)
T ss_dssp CCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCchheEEEc-CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999998 5788999999999866433221 223457889999999654 48999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+....+.... . ..++..+++++.++|.+||+.||.+|||+.+++
T Consensus 213 p~~~~~~~~~~~~i~~~~-~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 264 (287)
T 1u59_A 213 PYKKMKGPEVMAFIEQGK-R---------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVE 264 (287)
T ss_dssp TTTTCCTHHHHHHHHTTC-C---------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CcccCCHHHHHHHHhcCC-c---------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 999887766655544310 0 012235799999999999999999999999998
Q ss_pred cC
Q 022500 236 AH 237 (296)
Q Consensus 236 ~h 237 (296)
++
T Consensus 265 ~~ 266 (287)
T 1u59_A 265 QR 266 (287)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=266.48 Aligned_cols=206 Identities=19% Similarity=0.240 Sum_probs=158.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... .+++||||++ ++|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 83 l~~l~h~~iv~~~~~~~~~~-----~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H 153 (319)
T 2y4i_B 83 YRQTRHENVVLFMGACMSPP-----HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILH 153 (319)
T ss_dssp GTTCCCTTBCCCCEEEECSS-----CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HhcCCCCCEeEEEEEEecCC-----ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 46789999999999985443 3889999998 577666643 33468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccC------CCccceeecccccCchhccC--------CCCCCchhHHHHHHH
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYICSRFYRAPELIFG--------ATEYTTSIDIWSAGC 145 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~ 145 (296)
|||||+||+++ ++.+||+|||++...... .......||+.|+|||++.+ ...++.++||||+||
T Consensus 154 ~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 154 KDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp CCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred cCCChhhEEEe--CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 99999999998 467999999998754211 12233468999999999864 234789999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 146 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 146 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
++|+|++|..||.+.........+....... .....+++++.++|.+||+.||
T Consensus 232 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 232 IWYELHAREWPFKTQPAEAIIWQMGTGMKPN---------------------------LSQIGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp HHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC---------------------------CCCSSCCTTHHHHHHHHHCSST
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHhccCCCCC---------------------------CCcCCCCHHHHHHHHHHhcCCh
Confidence 9999999999999888776665544311000 0112368899999999999999
Q ss_pred CCCCCHHHHhcCCCcccccCC
Q 022500 226 SLRCTALEACAHPFFDELREP 246 (296)
Q Consensus 226 ~~R~t~~e~l~hp~f~~~~~~ 246 (296)
.+|||+.++++ .++.+...
T Consensus 285 ~~Rpt~~~l~~--~l~~l~~~ 303 (319)
T 2y4i_B 285 EERPTFTKLMD--MLEKLPKR 303 (319)
T ss_dssp TTSCCHHHHHH--HHTTC---
T ss_pred hhCcCHHHHHH--HHHHHHHh
Confidence 99999999987 56655443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=275.98 Aligned_cols=222 Identities=25% Similarity=0.349 Sum_probs=153.3
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP----- 75 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~----- 75 (296)
+.++||||+++++.+......+...+|+|||||+ |+|.+.+.. ...++..+..++.||+.||+|||+ +
T Consensus 62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~ 135 (336)
T 3g2f_A 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGD 135 (336)
T ss_dssp TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGG
T ss_pred HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhcccc
Confidence 4689999999998765544455667889999997 588887754 345889999999999999999999 8
Q ss_pred ----CcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---------CccceeecccccCchhccCC------CCCCc
Q 022500 76 ----RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---------ANISYICSRFYRAPELIFGA------TEYTT 136 (296)
Q Consensus 76 ----~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~ 136 (296)
||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. ..++.
T Consensus 136 ~~~~~ivH~Dikp~Nill~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 136 HYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp GCBCCEECSSCSGGGEEEC-TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred ccccceeecccccceEEEc-CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence 999999999999999 47889999999998654321 12244689999999999652 23567
Q ss_pred hhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHH-HHhcCCCCHHHHhhcC-cCCcCccCCCCCCCCcccccCCCCCHHH
Q 022500 137 SIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEI-IKVLGTPTREEIRCMN-PNYTDFRFPQIKAHPWHKVFHKRMPPEA 213 (296)
Q Consensus 137 ~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (296)
++||||+||++|+|++|..||. +....+....+ ......+......... .......++. .+. .....++++
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~~l 288 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWK--ENSLAVRSL 288 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCC--CCSHHHHHH
T ss_pred ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----ccc--cccchHHHH
Confidence 8999999999999999975553 33211100000 1111222222221110 0000000110 000 001145689
Q ss_pred HHHHHcccccCCCCCCCHHHHhc
Q 022500 214 IDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 214 ~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+||.+||+.||.+|||+.|+++
T Consensus 289 ~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 289 KETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCcchHHHHH
Confidence 99999999999999999999965
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=273.20 Aligned_cols=205 Identities=18% Similarity=0.227 Sum_probs=162.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA---NQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~---~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
++++||||+++++++... ..+|+||||++ |+|.+.+...... ...+++..+..++.||+.||.|||+ +||
T Consensus 88 ~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i 161 (327)
T 2yfx_A 88 SKFNHQNIVRCIGVSLQS-----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHF 161 (327)
T ss_dssp HHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTC
T ss_pred hhCCCCCCCeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCe
Confidence 467999999999998543 33789999996 5888888753211 1458999999999999999999999 799
Q ss_pred ccCCCCCCcEEEcC--CCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 78 CHRDLKPQNLLVDP--LTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 78 ~H~dlkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
+||||||+||+++. .+..+||+|||++....... ......+|+.|+|||++.+. .++.++||||+||++|+|++
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt 240 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFS 240 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHc
Confidence 99999999999983 23469999999987543322 12334678899999998654 58999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 153 -GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|..||.+.+..+....+..... + ..+..+++.+.++|.+||+.||.+|||+
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~ 292 (327)
T 2yfx_A 241 LGYMPYPSKSNQEVLEFVTSGGR-M---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNF 292 (327)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCCcCHHHHHHHHhcCCC-C---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999998877666555443110 0 0123478999999999999999999999
Q ss_pred HHHhcCCCcc
Q 022500 232 LEACAHPFFD 241 (296)
Q Consensus 232 ~e~l~hp~f~ 241 (296)
.++++|.|+-
T Consensus 293 ~~ll~~l~~~ 302 (327)
T 2yfx_A 293 AIILERIEYC 302 (327)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998774
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=266.15 Aligned_cols=207 Identities=23% Similarity=0.244 Sum_probs=157.9
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++|++++..+..+.. .....++||||++++|.+.+.. ....+++..+..++.|++.||+|||+ +||+|||
T Consensus 59 ~~l~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~d 130 (296)
T 3uzp_A 59 KMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRD 130 (296)
T ss_dssp HHHTTSTTCCCEEEEEE----ETTEEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred HHhhcCCCCCccccccC----CCCceEEEEEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCC
Confidence 35678887766665543 2334789999998898888764 34579999999999999999999999 7999999
Q ss_pred CCCCcEEEc--CCCCcEEEeeccCccccccCCC--------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 82 LKPQNLLVD--PLTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 82 lkp~Nill~--~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
|||+||+++ ..++.+||+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|+
T Consensus 131 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~ 209 (296)
T 3uzp_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHH
T ss_pred CCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHH
Confidence 999999994 2467899999999986644322 2355789999999999764 5899999999999999999
Q ss_pred hCCCCCCCCCh---HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCC
Q 022500 152 LGQPLFPGENA---VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228 (296)
Q Consensus 152 ~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R 228 (296)
+|..||.+... ...+..+.........+ .....+++++.++|.+||+.||.+|
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~R 265 (296)
T 3uzp_A 210 LGSLPWQGLKAATKRQKYERISEKKMSTPIE------------------------VLCKGYPSEFATYLNFCRSLRFDDK 265 (296)
T ss_dssp HSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred hCCCCCCCcCchhhhhhhhhhcccccCCchH------------------------HHHhhCCHHHHHHHHHHHhcCcCcC
Confidence 99999987432 22333332211111110 1123478999999999999999999
Q ss_pred CCHHHHhcCCCcccc
Q 022500 229 CTALEACAHPFFDEL 243 (296)
Q Consensus 229 ~t~~e~l~hp~f~~~ 243 (296)
||++++++ .|+++
T Consensus 266 ps~~~l~~--~l~~~ 278 (296)
T 3uzp_A 266 PDYSYLRQ--LFRNL 278 (296)
T ss_dssp CCHHHHHH--HHHHH
T ss_pred CCHHHHHH--HHHHH
Confidence 99999886 45444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=296.04 Aligned_cols=236 Identities=24% Similarity=0.319 Sum_probs=167.0
Q ss_pred CCCCCCCeeeeceeeeccCC-CCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++++||||+++++++..... ......|+|||||+ |+|.+.+.... ....+++..++.++.|++.||+|||+ +||+|
T Consensus 67 ~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVH 144 (676)
T 3qa8_A 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE-NRIIH 144 (676)
T ss_dssp HHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCC
T ss_pred HhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Confidence 46899999999998743211 12445789999997 58887776421 22368899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCC--cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~~--~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++..+. .+||+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus 145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCC
Confidence 999999999984322 4899999999877665555667899999999999654 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..........+. ..................+ ....+....+...+++.+.+||.+||++||.+|||+.++++|
T Consensus 224 ~~~~~~~~~~~~i~---~~~~~~~~~~~~l~g~~~~--~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 224 LPNWQPVQWHGKVR---EKSNEHIVVYDDLTGAVKF--SSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp CSSCHHHHSSTTCC---------CCSCCCCSSSCCC--CSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred Ccccchhhhhhhhh---cccchhhhhhhhhcccccc--ccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 87654322111110 0000000000000000111 111122223344577899999999999999999999999999
Q ss_pred CCcccccC
Q 022500 238 PFFDELRE 245 (296)
Q Consensus 238 p~f~~~~~ 245 (296)
|||+.+..
T Consensus 299 p~F~~l~~ 306 (676)
T 3qa8_A 299 GCFQALDS 306 (676)
T ss_dssp TTHHHHHH
T ss_pred HHHHHHHH
Confidence 99987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=286.37 Aligned_cols=198 Identities=21% Similarity=0.336 Sum_probs=159.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++... ..+||||||++ |+|.+.+... ....+++..+..++.||+.||+|||+ +||+|
T Consensus 270 l~~l~hpniv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH 341 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIH 341 (495)
T ss_dssp HHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhcCCCCEeeEEEEEecC-----CcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 3568999999999998443 33889999998 6888887642 33568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+|||++ .++.+||+|||+++....... .....+++.|+|||++.+. .++.++||||+||++|+|++ |..|
T Consensus 342 rDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p 419 (495)
T 1opk_A 342 RNLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP 419 (495)
T ss_dssp SCCSGGGEEEC-GGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCChhhEEEC-CCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCC
Confidence 99999999998 477899999999986543221 1233457789999999654 58999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.+... ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 420 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 420 YPGIDLSQVYELLEKDYR----------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 998876655544332100 0122357899999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=266.17 Aligned_cols=198 Identities=22% Similarity=0.247 Sum_probs=148.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ..+|+||||++| +|.+.+.. ...+++..+..++.|++.||.|||+ +||+|
T Consensus 88 l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H 157 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEID-----GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATH 157 (309)
T ss_dssp HTTCCCTTBCCEEEEEEET-----TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HhhcCCCCeeEEEEEEeeC-----CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCc
Confidence 4678999999999998543 348899999985 88777764 3569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++||||+|+++|+|++|..||
T Consensus 158 ~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf 235 (309)
T 2h34_A 158 RDVKPENILVS-ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPY 235 (309)
T ss_dssp SCCCGGGEEEC-TTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred CCCChHHEEEc-CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCC
Confidence 99999999999 47789999999987654332 12345789999999999654 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-CHHHHhc
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACA 236 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-t~~e~l~ 236 (296)
.+.+.... ...+..... . .......+++++.++|.+||+.||.+|| +++++++
T Consensus 236 ~~~~~~~~-~~~~~~~~~-~------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 236 QGDQLSVM-GAHINQAIP-R------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CSCHHHHH-HHHHHSCCC-C------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCchHHHH-HHHhccCCC-C------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 88765432 222221100 0 1112345789999999999999999999 7887765
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=288.42 Aligned_cols=224 Identities=21% Similarity=0.304 Sum_probs=160.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.... ....|+|||||+ |+|.+.+.... ....+++..++.++.||+.||+|||+ +||+||
T Consensus 62 ~~l~hpnIv~~~~~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~ 136 (396)
T 4eut_A 62 KKLNHKNIVKLFAIEEETT---TRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHR 136 (396)
T ss_dssp HHCCCTTBCCEEEEEECTT---TCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhcCCCCCCeEEEeeccCC---CCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEC
Confidence 4689999999999885432 234789999998 58777765422 23349999999999999999999999 799999
Q ss_pred CCCCCcEEE----cCCCCcEEEeeccCccccccCCCccceeecccccCchhccCC-------CCCCchhHHHHHHHHHHH
Q 022500 81 DLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 81 dlkp~Nill----~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ 149 (296)
||||+||++ + .++.+||+|||+++............||+.|+|||++.+. ..++.++||||+||++|+
T Consensus 137 Dlkp~NIll~~~~~-~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~e 215 (396)
T 4eut_A 137 NIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (396)
T ss_dssp CCCGGGEEEEECTT-SCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEeecCC-CceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHH
Confidence 999999998 5 4567999999999876555444566789999999998531 347789999999999999
Q ss_pred HHhCCCCCCCC----ChHHHHHHHHHhcCCCCHHHHhhcCcC-CcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 150 LLLGQPLFPGE----NAVDQLVEIIKVLGTPTREEIRCMNPN-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 150 ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
|++|..||.+. ...+.+.+++.. .|. ..+...... ...+.+ ....+....+...+++.+.++|++||+.|
T Consensus 216 l~tg~~Pf~~~~~~~~~~~~~~~~~~~--~p~-~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~l~~ll~~~L~~d 290 (396)
T 4eut_A 216 AATGSLPFRPFEGPRRNKEVMYKIITG--KPS-GAISGVQKAENGPIDW--SGDMPVSCSLSRGLQVLLTPVLANILEAD 290 (396)
T ss_dssp HHHSSCSEECTTCTTTCHHHHHHHHHS--CCT-TCCEEEECSTTCCEEE--ESSCCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHCCCCCCCCCcccchHHHHHHHhcC--CCc-ccchhheeccCCCccc--CccCCcccccchHHHhhchHHHHHhhccC
Confidence 99999999653 334455555442 221 111110000 000000 00001111222345678999999999999
Q ss_pred CCCCCCHHHHhc
Q 022500 225 PSLRCTALEACA 236 (296)
Q Consensus 225 p~~R~t~~e~l~ 236 (296)
|++|+|++++++
T Consensus 291 P~~R~s~~e~l~ 302 (396)
T 4eut_A 291 QEKCWGFDQFFA 302 (396)
T ss_dssp TTTSCCHHHHHH
T ss_pred hhhhccHHHHHH
Confidence 999999998854
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=264.46 Aligned_cols=194 Identities=24% Similarity=0.285 Sum_probs=156.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++. .. .+|+||||++ ++|.+.+.. ...+++..+..++.||+.||+|||+ +||+||
T Consensus 73 ~~l~h~~i~~~~~~~~-~~-----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~ 141 (291)
T 1xbb_A 73 QQLDNPYIVRMIGICE-AE-----SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHR 141 (291)
T ss_dssp HTCCCTTBCCEEEEEE-SS-----SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhCCCCCEEEEEEEEC-CC-----CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcC
Confidence 5689999999999882 22 2789999998 577777653 4669999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
||||+||+++ .++.+||+|||++......... ....+++.|+|||++.+. .++.++||||+|+++|+|++ |..
T Consensus 142 dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~ 219 (291)
T 1xbb_A 142 DLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQK 219 (291)
T ss_dssp CCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEEe-CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCC
Confidence 9999999998 4788999999999866443321 123456889999999654 48899999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+....+... ..+ ..+..+++++.++|.+||+.||.+|||+.+++
T Consensus 220 p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 271 (291)
T 1xbb_A 220 PYRGMKGSEVTAMLEKG-ERM---------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVE 271 (291)
T ss_dssp SSTTCCHHHHHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHcC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99988776655544331 000 12235799999999999999999999999987
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 272 ~ 272 (291)
T 1xbb_A 272 L 272 (291)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=264.63 Aligned_cols=207 Identities=27% Similarity=0.428 Sum_probs=153.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... .+++||||+++ +|.+.+.........+++..+..++.|++.||.|||+ +|++|
T Consensus 86 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H 159 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDN-----ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMH 159 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETT-----EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEEcCC-----cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeC
Confidence 35789999999999985433 48899999995 8888887766667789999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++........ .....+++.|+|||++.+. .++.++||||+|+++|+|++|..||.
T Consensus 160 ~dl~p~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 160 RDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp CCCCGGGEEEC-TTSCEEECCC------------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCcHHHEEEc-CCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999 577899999999976543322 2345789999999998654 58999999999999999999999997
Q ss_pred CCCh--HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENA--VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+... ......+.. ...+ . .....+++++.++|.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~-~~~~------------------~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 238 GDKMNLYSLCKKIEQ-CDYP------------------P--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ---CCHHHHHHHHHT-TCSC------------------C--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHHHHhhc-ccCC------------------C--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6532 222222211 1100 0 011347899999999999999999999999987
Q ss_pred CCCccccc
Q 022500 237 HPFFDELR 244 (296)
Q Consensus 237 hp~f~~~~ 244 (296)
.++++.
T Consensus 291 --~l~~l~ 296 (310)
T 2wqm_A 291 --VAKRMH 296 (310)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 455543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=271.52 Aligned_cols=199 Identities=24% Similarity=0.347 Sum_probs=159.0
Q ss_pred CC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHH
Q 022500 3 VM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGL 68 (296)
Q Consensus 3 ~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~aL 68 (296)
++ +||||+++++++.. ...+|+||||++| +|.+.+..... ....+++..+..++.||+.||
T Consensus 96 ~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 170 (334)
T 2pvf_A 96 MIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170 (334)
T ss_dssp HHCCCTTBCCEEEEECS-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHH
T ss_pred HhhcCCCEeeEEEEEcc-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 34 89999999999843 3348899999985 88888775321 123489999999999999999
Q ss_pred HHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHH
Q 022500 69 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGC 145 (296)
Q Consensus 69 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 145 (296)
.|||+ +||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+||
T Consensus 171 ~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ 247 (334)
T 2pvf_A 171 EYLAS-QKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGV 247 (334)
T ss_dssp HHHHH-TTEECSCCSGGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHH
T ss_pred HHHHh-CCeeCCCCccceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHH
Confidence 99999 7999999999999998 578899999999986543322 2233567889999998654 4899999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 146 VLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 146 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
++|+|++ |..||.+.+..+....+...... ..+..+++++.++|.+||+.|
T Consensus 248 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~d 299 (334)
T 2pvf_A 248 LMWEIFTLGGSPYPGIPVEELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAV 299 (334)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCcCcCCHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCC
Confidence 9999999 99999988776665554432100 012347899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 022500 225 PSLRCTALEACAH 237 (296)
Q Consensus 225 p~~R~t~~e~l~h 237 (296)
|.+|||+.+++++
T Consensus 300 p~~Rps~~ell~~ 312 (334)
T 2pvf_A 300 PSQRPTFKQLVED 312 (334)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.08 Aligned_cols=201 Identities=25% Similarity=0.348 Sum_probs=160.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.... .++||||++ ++|.+.+... ...+++..+..++.|++.||.|||+ +|++||
T Consensus 76 ~~l~h~~i~~~~~~~~~~~------~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~ 145 (291)
T 1u46_A 76 HSLDHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHR 145 (291)
T ss_dssp HHCCCTTBCCEEEEECSSS------CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhCCCCCcccEEEEEccCC------ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 4679999999999885321 679999998 5888777642 3568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
||||+||+++ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++||||+|+++|+|++ |..
T Consensus 146 dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~ 223 (291)
T 1u46_A 146 DLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQE 223 (291)
T ss_dssp CCCGGGEEEE-ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCchheEEEc-CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999998 4778999999999876443321 234567789999999654 48899999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+....+......+. .+..+++++.++|.+||+.||.+|||+.+++
T Consensus 224 p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 276 (291)
T 1u46_A 224 PWIGLNGSQILHKIDKEGERLP---------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 276 (291)
T ss_dssp TTTTCCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcccCCHHHHHHHHHccCCCCC---------------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 9999887776666544211100 1234789999999999999999999999998
Q ss_pred cCCCcccc
Q 022500 236 AHPFFDEL 243 (296)
Q Consensus 236 ~hp~f~~~ 243 (296)
+ ++.++
T Consensus 277 ~--~l~~~ 282 (291)
T 1u46_A 277 D--FLLEA 282 (291)
T ss_dssp H--HHHHH
T ss_pred H--HHHHh
Confidence 7 45543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=270.94 Aligned_cols=205 Identities=24% Similarity=0.332 Sum_probs=150.4
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP------ 75 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~------ 75 (296)
.++||||+++++++.... .....+|+||||++| +|.+.++. ..+++..+..++.|++.||.|||+ +
T Consensus 87 ~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ 159 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGT-GSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQG 159 (337)
T ss_dssp TCCCTTBCCEEEEEEESC-GGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTC
T ss_pred hhcCCCeeeEEEEEccCC-CCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhcc
Confidence 469999999999886543 222458899999985 88887753 469999999999999999999999 8
Q ss_pred --CcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCc-----cceeecccccCchhccCCCCCCc------hhHHHH
Q 022500 76 --RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTT------SIDIWS 142 (296)
Q Consensus 76 --~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~Diws 142 (296)
||+||||||+||+++ .++.+||+|||++......... ....||+.|+|||++.+.. +.. ++||||
T Consensus 160 ~~~ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~Diws 237 (337)
T 3mdy_A 160 KPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYS 237 (337)
T ss_dssp BCCEECSCCCGGGEEEC-TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHH
T ss_pred CCCEEecccchHHEEEC-CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHH
Confidence 999999999999998 5778999999999765433221 2457899999999996543 333 499999
Q ss_pred HHHHHHHHHhC----------CCCCCCCC----hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCC
Q 022500 143 AGCVLAELLLG----------QPLFPGEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 208 (296)
Q Consensus 143 lG~il~~ll~g----------~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (296)
+||++|+|++| ..||.... ............+. .+. .+ .......
T Consensus 238 lG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~-----~~-------~~~~~~~ 296 (337)
T 3mdy_A 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL---------RPS-----FP-------NRWSSDE 296 (337)
T ss_dssp HHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC---------CCC-----CC-------GGGGGSH
T ss_pred HHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhcc---------Ccc-----cc-------ccchhhH
Confidence 99999999999 66665432 12222222211000 000 00 0001123
Q ss_pred CCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 209 MPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 209 ~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
+++++.+||.+||+.||.+|||+.++++|
T Consensus 297 ~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 297 CLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 56789999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=268.91 Aligned_cols=206 Identities=23% Similarity=0.246 Sum_probs=157.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
+.++|+|++..+..+.. .....++||||++++|.+.+.. ....+++..+..++.||+.||.|||+ +||+|||
T Consensus 59 ~~l~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~D 130 (296)
T 4hgt_A 59 KMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRD 130 (296)
T ss_dssp HHHTTSTTCCCEEEEEE----ETTEEEEEEECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred HHhcCCCCCCeeeeecC----CCCceEEEEEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCC
Confidence 34678887777666543 2334789999998898887764 34569999999999999999999999 7999999
Q ss_pred CCCCcEEE---cCCCCcEEEeeccCccccccCCC--------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 82 LKPQNLLV---DPLTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 82 lkp~Nill---~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
|||+||++ + .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|+|
T Consensus 131 lkp~NIl~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l 208 (296)
T 4hgt_A 131 VKPDNFLMGLGK-KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYF 208 (296)
T ss_dssp CSGGGEEECCGG-GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeeccC-CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHH
Confidence 99999999 5 477899999999986644322 2345789999999999764 589999999999999999
Q ss_pred HhCCCCCCCCChH---HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC
Q 022500 151 LLGQPLFPGENAV---DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 151 l~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~ 227 (296)
++|..||.+.+.. ..+..+.......+. ......+++++.++|.+||+.||++
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~ 264 (296)
T 4hgt_A 209 NLGSLPWQGLKAATKRQKYERISEKKMSTPI------------------------EVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH------------------------HHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred hcCCCCCcccchhhhhhhhhhhhcccccchh------------------------hhhhccCCHHHHHHHHHHHhcCCCC
Confidence 9999999875422 222222221100110 1112347899999999999999999
Q ss_pred CCCHHHHhcCCCcccc
Q 022500 228 RCTALEACAHPFFDEL 243 (296)
Q Consensus 228 R~t~~e~l~hp~f~~~ 243 (296)
|||++++++ .++++
T Consensus 265 Rpt~~~l~~--~l~~~ 278 (296)
T 4hgt_A 265 KPDYSYLRQ--LFRNL 278 (296)
T ss_dssp CCCHHHHHH--HHHHH
T ss_pred CCCHHHHHH--HHHHH
Confidence 999999986 44443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.95 Aligned_cols=210 Identities=22% Similarity=0.356 Sum_probs=159.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.... .....+|+||||+.+ +|.+.+.........+++..+..++.||+.||.|||+ +||+||
T Consensus 81 ~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~ 158 (317)
T 2buj_A 81 RLFNHPNILRLVAYCLRER-GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHR 158 (317)
T ss_dssp HTCCCTTBCCCCEEEEEEE-TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred hhcCCCCeeeEEEEEEecc-CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 5689999999999986432 234458899999995 9988888765567789999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC----------ccceeecccccCchhccCCC--CCCchhHHHHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----------NISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLA 148 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ 148 (296)
||||+||+++ .++.+||+|||++........ .....||+.|+|||++.+.. .++.++||||+||++|
T Consensus 159 dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 237 (317)
T 2buj_A 159 DLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237 (317)
T ss_dssp CCCGGGEEEC-TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHH
T ss_pred CCCHHHEEEc-CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHH
Confidence 9999999998 477899999999875422111 12345699999999986432 2688999999999999
Q ss_pred HHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC
Q 022500 149 ELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 149 ~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~ 227 (296)
+|++|..||...... ......... ....+ ....+++++.++|.+||+.||.+
T Consensus 238 el~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 238 AMMFGEGPYDMVFQKGDSVALAVQN-----------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp HHHHSSCTTHHHHHTTSCHHHHHHC-----------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHhCCCChhhhhcccchhhHHhhc-----------------cCCCC----------ccccCCHHHHHHHHHHhhcChhh
Confidence 999999999531100 000111110 00000 11347899999999999999999
Q ss_pred CCCHHHHhcCCCcccc
Q 022500 228 RCTALEACAHPFFDEL 243 (296)
Q Consensus 228 R~t~~e~l~hp~f~~~ 243 (296)
|||+.+++++ +..+
T Consensus 291 Rps~~~ll~~--L~~~ 304 (317)
T 2buj_A 291 RPHIPLLLSQ--LEAL 304 (317)
T ss_dssp SCCHHHHHHH--HHHT
T ss_pred CCCHHHHHHH--hhhc
Confidence 9999999984 4444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=270.28 Aligned_cols=209 Identities=23% Similarity=0.281 Sum_probs=156.6
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... ...|+||||++ ++|.+.+... .....+++..+..++.|++.||+|||+ +||+||
T Consensus 85 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~ 157 (307)
T 2nru_A 85 AKCQHENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHR 157 (307)
T ss_dssp HHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhcCCCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecC
Confidence 467999999999998543 34889999997 5887777643 334679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
||||+||+++ .++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+|+++|+|++|..||
T Consensus 158 dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 158 DIKSANILLD-EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp CCCGGGEEEC-TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred CCCHHHEEEc-CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCc
Confidence 9999999999 577899999999976543222 223578999999999864 4789999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCC--CCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 158 PGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
.+......+..+.+.... .....+ .... . .......++.+.+++.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~ 298 (307)
T 2nru_A 235 DEHREPQLLLDIKEEIEDEEKTIEDY--IDKK-----M---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298 (307)
T ss_dssp CTTBSSSBTTHHHHHHHTTSCCHHHH--SCSS-----C---------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccCcchHHHHHHHHHhhhhhhhhhhh--cccc-----c---------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 876543322222221100 000000 0000 0 001112457799999999999999999999998
Q ss_pred c
Q 022500 236 A 236 (296)
Q Consensus 236 ~ 236 (296)
+
T Consensus 299 ~ 299 (307)
T 2nru_A 299 Q 299 (307)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=262.17 Aligned_cols=197 Identities=21% Similarity=0.315 Sum_probs=152.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++... ...+|+||||+++ +|.+.+.... ...+++..+..++.|++.||+|||+ +|++|
T Consensus 68 l~~l~h~~iv~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 140 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEE----KGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVH 140 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEEcC----CCceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 4678999999999987532 2247899999985 8888876432 2348899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 158 (296)
|||||+||+++ .++.+||+|||++...... .....+++.|+|||++.+. .++.++|+||+|+++|+|++ |..||.
T Consensus 141 ~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 141 RDLAARNVLVS-EDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp SCCSGGGEEEC-TTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred cCCCcceEEEe-CCCcEEEeecccccccccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 4778999999998754332 2234668899999999654 58999999999999999998 999998
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+....+....+.+.. ....+..+++++.++|.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 217 RIPLKDVVPRVEKGY----------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TSCGGGHHHHHTTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHhcCC----------------------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 877655544443210 00122457999999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=280.88 Aligned_cols=197 Identities=25% Similarity=0.323 Sum_probs=155.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. ..+|+||||++ |+|.+.+... ....+++..+..++.||+.||+|||+ +||+|
T Consensus 233 l~~l~hp~iv~~~~~~~~------~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH 303 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVH 303 (452)
T ss_dssp HHHCCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEcC------CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeC
Confidence 356899999999998742 22789999998 5888877642 23568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+|||++ .++.+||+|||+++....... .....+++.|+|||++.+. .++.++||||+||++|+|++ |..|
T Consensus 304 rDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P 381 (452)
T 1fmk_A 304 RDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP 381 (452)
T ss_dssp SCCSGGGEEEC-GGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCCChhhEEEC-CCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCC
Confidence 99999999998 477899999999986543221 1234457889999998654 58999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....+....+.+.... ..+..+++.+.++|.+||+.||++|||++++++
T Consensus 382 ~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 382 YPGMVNREVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp STTCCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9998877766655432110 012347899999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=264.50 Aligned_cols=210 Identities=24% Similarity=0.370 Sum_probs=154.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... ...+++||||++| +|.+.+.. ....+++..+..++.|++.||+|||+ +||+|
T Consensus 77 l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H 149 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDG---GNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVH 149 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCeeeeeeEEecCC---CceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCccc
Confidence 35789999999999986432 2347899999985 88887754 34569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.+||+|||++........ .....+|..|+|||++.+. .++.++|+||+||++|+|++|..
T Consensus 150 ~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 150 RDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp SCCSGGGEEEE-ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCchheEEEc-CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccC
Confidence 99999999998 477899999999987654332 2234568889999999654 48899999999999999999998
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHH----HHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCH
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTRE----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 231 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~ 231 (296)
|+.... ...... .+..... .......... ....+..+++++.+||.+||+.||.+|||+
T Consensus 228 p~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 290 (302)
T 4e5w_A 228 SDSSPM--ALFLKM---IGPTHGQMTVTRLVNTLKEGK------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSF 290 (302)
T ss_dssp GGGSHH--HHHHHH---HCSCCGGGHHHHHHHHHHTTC------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred CCcchh--hHHhhc---cCCcccccCHHHHHHHHhccC------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCH
Confidence 864321 111111 1111100 0000000000 011224579999999999999999999999
Q ss_pred HHHhc
Q 022500 232 LEACA 236 (296)
Q Consensus 232 ~e~l~ 236 (296)
.++++
T Consensus 291 ~~ll~ 295 (302)
T 4e5w_A 291 QNLIE 295 (302)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=269.96 Aligned_cols=213 Identities=24% Similarity=0.331 Sum_probs=157.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.. .+...+|+||||++ ++|.+.+... ...+++..+..++.|++.||+|||+ +||+|
T Consensus 78 l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH 150 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVH 150 (327)
T ss_dssp HHTCCCTTBCCEEEEEEC---SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhcCCCceeEEEEEEec---CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccC
Confidence 357899999999998753 23445889999996 5888877642 3459999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+||++|+|++|..
T Consensus 151 ~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~ 228 (327)
T 3lxl_A 151 RDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCD 228 (327)
T ss_dssp SCCSGGGEEEE-ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChhhEEEC-CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCC
Confidence 99999999998 478899999999986643332 2234578889999999654 48999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcC-CCCHHHHh-hcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 156 LFPGENAVDQLVEIIKVLG-TPTREEIR-CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
||........ ....... .+...... ...... ....+..+++++.+||.+||+.||.+|||+.+
T Consensus 229 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 293 (327)
T 3lxl_A 229 KSCSPSAEFL--RMMGCERDVPALSRLLELLEEGQ-------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSA 293 (327)
T ss_dssp GGGSHHHHHH--HHCC----CCHHHHHHHHHHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCccccchhh--hhcccccccccHHHHHHHhhccc-------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence 9865432211 1100000 00000000 000000 01122457999999999999999999999999
Q ss_pred HhcC
Q 022500 234 ACAH 237 (296)
Q Consensus 234 ~l~h 237 (296)
++++
T Consensus 294 ll~~ 297 (327)
T 3lxl_A 294 LGPQ 297 (327)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=290.65 Aligned_cols=195 Identities=24% Similarity=0.291 Sum_probs=156.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. . .+++||||++ |+|.+.+. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 424 l~~l~hpnIv~l~~~~~~-~-----~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiH 492 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICEA-E-----SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVH 492 (635)
T ss_dssp HHHCCCTTBCCEEEEEES-S-----SEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEec-C-----CEEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeC
Confidence 356899999999998732 1 2779999998 57777765 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|+|++ |.
T Consensus 493 rDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 493 RDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp SCCSGGGEEEE-ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChHhEEEe-CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 578899999999986643322 1233457889999999654 59999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+.+.... ..+..+++++.+||.+||+.||.+|||++++
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 622 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERM----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 622 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 999998887766655442100 1223579999999999999999999999998
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 623 ~~ 624 (635)
T 4fl3_A 623 EL 624 (635)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.70 Aligned_cols=196 Identities=26% Similarity=0.305 Sum_probs=156.3
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. . .+|+|||||+| +|.+.+.. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 390 l~~l~hpniv~l~~~~~~-~-----~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH 459 (613)
T 2ozo_A 390 MHQLDNPYIVRLIGVCQA-E-----ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVH 459 (613)
T ss_dssp HTTCCCTTBCCEEEEEES-S-----SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEecc-C-----CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEc
Confidence 468899999999998843 1 27899999985 77766643 34669999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+|||++ .++.+||+|||+++........ ....+++.|+|||++.+. .++.++||||+||++|+|++ |.
T Consensus 460 rDlkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~ 537 (613)
T 2ozo_A 460 RNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQ 537 (613)
T ss_dssp SCCSGGGEEEE-ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCCHHHEEEc-CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999 5788999999999876433221 122346789999999654 59999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+.+... ...+..+++++.+||.+||+.||.+|||+.++
T Consensus 538 ~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 538 KPYKKMKGPEVMAFIEQGKR----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp CTTTTCCSHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999887776665543110 01223579999999999999999999999987
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 590 ~~ 591 (613)
T 2ozo_A 590 EQ 591 (613)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=263.86 Aligned_cols=195 Identities=23% Similarity=0.362 Sum_probs=146.8
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.++||||+++++++.... .+...+|+||||++| +|.+.+... ....+++..++.++.|++.||+|||+ +||+|||
T Consensus 67 ~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~d 142 (299)
T 3m2w_A 67 ASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRD 142 (299)
T ss_dssp HTTSTTBCCEEEEEEEEE-TTEEEEEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred hccCCCchhHHhhhhhhc-CCCceEEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 468999999999885422 234568999999985 888887752 23469999999999999999999999 7999999
Q ss_pred CCCCcEEEcCC--CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+||+++.. ++.+||+|||++.... ...++.++||||+||++|+|++|..||.+
T Consensus 143 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 143 VKPENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp CSGGGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHHHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999843 5689999999986431 12478899999999999999999999977
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.........+.. ..... ...........+++++.+||.+||+.||.+|||++|+++|||
T Consensus 201 ~~~~~~~~~~~~------------------~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 201 NHGLAISPGMKT------------------RIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp -------CCSCC------------------SSCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CcchhhhHHHHH------------------HHhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 654322111000 00000 001111111357999999999999999999999999999999
Q ss_pred ccccc
Q 022500 240 FDELR 244 (296)
Q Consensus 240 f~~~~ 244 (296)
|++..
T Consensus 260 ~~~~~ 264 (299)
T 3m2w_A 260 IMQST 264 (299)
T ss_dssp HHTGG
T ss_pred hcccc
Confidence 98754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.34 Aligned_cols=206 Identities=13% Similarity=0.147 Sum_probs=154.6
Q ss_pred CCCCCCCeeee---------------ceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHH
Q 022500 2 RVMDHPNVISL---------------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 66 (296)
Q Consensus 2 ~~l~HpnIv~l---------------~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~ 66 (296)
++++||||+++ ++++.. +...+|+||||++++|.+.+... ....+++..+..++.||+.
T Consensus 97 ~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~ 170 (352)
T 2jii_A 97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH----QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLD 170 (352)
T ss_dssp HHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEE----TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHH
T ss_pred HHhcccchhhhhhhhccCCccCccchhhcccc----CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHH
Confidence 35678888874 444432 23458899999988998888743 2367999999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCcEEEcCCCC--cEEEeeccCccccccCCC--------ccceeecccccCchhccCCCCCCc
Q 022500 67 GLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTT 136 (296)
Q Consensus 67 aL~~LH~~~~i~H~dlkp~Nill~~~~~--~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~ 136 (296)
||+|||+ +||+||||||+||+++. ++ .+||+|||+++....... .....||+.|+|||++.+. .++.
T Consensus 171 ~L~~LH~-~~ivH~Dikp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 247 (352)
T 2jii_A 171 ALEFLHE-NEYVHGNVTAENIFVDP-EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSR 247 (352)
T ss_dssp HHHHHHH-TTCBCSCCCGGGEEEET-TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCH
T ss_pred HHHHHHh-CCccCCCCCHHHEEEcC-CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCc
Confidence 9999999 79999999999999994 55 899999999976543211 1334789999999999764 5899
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhc-CCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHH
Q 022500 137 SIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 214 (296)
Q Consensus 137 ~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (296)
++||||+||++|+|++|..||.+.. ..+.+....... ..+. .+.. . ......+++++.
T Consensus 248 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~---~--------~~~~~~~~~~l~ 307 (352)
T 2jii_A 248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPG---------PFVG---P--------CGHWIRPSETLQ 307 (352)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCC---------CEEC---T--------TSCEECCCHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChh---------hhhh---h--------ccccCCCcHHHH
Confidence 9999999999999999999998764 333333322211 0000 0000 0 000124789999
Q ss_pred HHHHcccccCCCCCCCHHHHhc
Q 022500 215 DLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 215 dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+||.+||+.||.+|||++++++
T Consensus 308 ~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 308 KYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhCChhhCCCHHHHHH
Confidence 9999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=260.75 Aligned_cols=196 Identities=24% Similarity=0.323 Sum_probs=157.5
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++.. . ..++||||++ ++|.+.+... ....+++..+..++.|++.||+|||+ +||+||
T Consensus 63 ~~l~h~~i~~~~~~~~~-~-----~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~ 133 (279)
T 1qpc_A 63 KQLQHQRLVRLYAVVTQ-E-----PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHR 133 (279)
T ss_dssp HHCCCTTBCCEEEEECS-S-----SCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhCCCcCcceEEEEEcC-C-----CcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 46899999999998742 1 2679999997 5887776532 12368999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
||||+||+++ .++.+||+|||++........ .....+++.|+|||++.+. .++.++||||+|+++|+|++ |..||
T Consensus 134 dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~ 211 (279)
T 1qpc_A 134 DLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPY 211 (279)
T ss_dssp CCSGGGEEEC-TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCHhhEEEc-CCCCEEECCCcccccccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999 577899999999986643321 1234567889999999653 48999999999999999999 89999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+.+..+....+.+... ...+..+++++.++|.+||+.||++|||++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 212 PGMTNPEVIQNLERGYR----------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHhcccC----------------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 98887766655543110 0112347899999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=261.84 Aligned_cols=196 Identities=29% Similarity=0.421 Sum_probs=145.4
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcc
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVC 78 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~--~~i~ 78 (296)
++++||||+++++++. +. .|+||||++ |+|.+.+... .....+++..+..++.|++.||+|||+. +||+
T Consensus 56 ~~l~hp~iv~~~~~~~-----~~--~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~iv 127 (307)
T 2eva_A 56 SRVNHPNIVKLYGACL-----NP--VCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127 (307)
T ss_dssp HHCCCTTBCCEEEBCT-----TT--TEEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCC
T ss_pred hcCCCCCcCeEEEEEc-----CC--cEEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCee
Confidence 4689999999999873 22 579999998 5887777642 1112478899999999999999999992 2899
Q ss_pred cCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 79 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 79 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||||+||+++.++..+||+|||++...... .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 128 H~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~ 204 (307)
T 2eva_A 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFD 204 (307)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred cCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCch
Confidence 99999999999854445899999999765332 2345689999999999654 58999999999999999999999997
Q ss_pred CCChH--HHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENAV--DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
..... .....+.. +.. ......+++.+.++|.+||+.||.+|||++++++
T Consensus 205 ~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 205 EIGGPAFRIMWAVHN--GTR--------------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp TTCSSHHHHHHHHHT--TCC--------------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhCccHHHHHHHHhc--CCC--------------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 64322 11111111 000 0112347899999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=263.70 Aligned_cols=212 Identities=28% Similarity=0.374 Sum_probs=155.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++...+ ...+++||||+++ +|.+.+.. ..+++..+..++.||+.||.|||+ +||+||
T Consensus 88 ~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~ 158 (318)
T 3lxp_A 88 RTLYHEHIIKYKGCCEDAG---AASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHR 158 (318)
T ss_dssp HHCCCTTBCCEEEEEEETT---TTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhCCCcchhhEEEEEecCC---CceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCC
Confidence 4689999999999986432 3458899999985 77766643 359999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+||++|+|++|..|
T Consensus 159 Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p 236 (318)
T 3lxp_A 159 DLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDS 236 (318)
T ss_dssp CCSGGGEEEC-TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred CCchheEEEc-CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCc
Confidence 9999999999 578899999999987644332 2234568889999999754 488999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHH----HHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 157 FPGENAVDQLVEIIKVLGTPTRE----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|........ .. .+..... .......... ....+..+++++.+||++||+.||.+|||+.
T Consensus 237 ~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 299 (318)
T 3lxp_A 237 SQSPPTKFL--EL---IGIAQGQMTVLRLTELLERGE------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFE 299 (318)
T ss_dssp GGSHHHHHH--HH---HCSCCHHHHHHHHHHHHHTTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccccchhhh--hh---hcccccchhHHHHHHHHhccc------------CCCCCccccHHHHHHHHHHcCCCcccCcCHH
Confidence 965432110 00 0000000 0000000000 0112245789999999999999999999999
Q ss_pred HHhcCCCcccc
Q 022500 233 EACAHPFFDEL 243 (296)
Q Consensus 233 e~l~hp~f~~~ 243 (296)
++++ +++.+
T Consensus 300 ell~--~L~~l 308 (318)
T 3lxp_A 300 NLIP--ILKTV 308 (318)
T ss_dssp HHHH--HHHHH
T ss_pred HHHH--HHHHH
Confidence 9985 44443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.64 Aligned_cols=197 Identities=26% Similarity=0.331 Sum_probs=159.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||++++++.. ..+||||||++ |+|.+.+... ....+++..+..++.||+.||+|||+ +||+|
T Consensus 316 l~~l~hpniv~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH 386 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVH 386 (535)
T ss_dssp HHHCCCTTBCCEEEEECS------SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEee------ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeC
Confidence 457899999999998742 22789999998 5888887642 23468999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+. .++.++||||+||++|+|++ |..|
T Consensus 387 rDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P 464 (535)
T 2h8h_A 387 RDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP 464 (535)
T ss_dssp SCCSGGGEEEC-GGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred CCCCHhhEEEc-CCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999998 47789999999998653221 11223457789999998654 58999999999999999999 8999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+....+.+..+.+.... ..+..+++++.+||.+||+.||.+|||++++++
T Consensus 465 ~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 465 YPGMVNREVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp STTCCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9998877766655432110 012347899999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=280.02 Aligned_cols=182 Identities=21% Similarity=0.216 Sum_probs=146.0
Q ss_pred ceEEEEeccCcccHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeec
Q 022500 25 LFLNLVMEYVPESMYRVLKHYS---SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 101 (296)
Q Consensus 25 ~~~~lv~E~~~g~l~~~l~~~~---~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 101 (296)
..++++|+++.++|.+.+.... .....+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||+||
T Consensus 178 ~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrDiKp~NILl~-~~~~~kL~DF 255 (413)
T 3dzo_A 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLD-QRGGVFLTGF 255 (413)
T ss_dssp CSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCG
T ss_pred cceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcccceEEEe-cCCeEEEEec
Confidence 3478999999999988886432 223457788899999999999999999 7999999999999999 4778999999
Q ss_pred cCccccccCCCccceeecccccCchhcc---------CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022500 102 GSAKQLIAGEANISYICSRFYRAPELIF---------GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172 (296)
Q Consensus 102 g~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 172 (296)
|+++..... ....+| +.|+|||++. ....++.++||||+||++|+|++|..||.+.+..+....++
T Consensus 256 G~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~-- 330 (413)
T 3dzo_A 256 EHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF-- 330 (413)
T ss_dssp GGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG--
T ss_pred cceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH--
Confidence 998765332 344567 9999999983 33347889999999999999999999997764322111110
Q ss_pred cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccccc
Q 022500 173 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 244 (296)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~~~ 244 (296)
. ....+++++.+||.+||+.||.+|||+.++++||||+.+.
T Consensus 331 ---------------------~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 331 ---------------------R----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp ---------------------S----------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ---------------------h----------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 0 0124789999999999999999999999999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=285.36 Aligned_cols=195 Identities=27% Similarity=0.383 Sum_probs=157.2
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++|||||++++++.. . .+|+||||++ |+|.+.+.. ....+++..+..++.|++.||.|||+ +||+||
T Consensus 446 ~~l~HpnIv~l~~~~~~-~-----~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHr 515 (656)
T 2j0j_A 446 RQFDHPHIVKLIGVITE-N-----PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHR 515 (656)
T ss_dssp HHCCCTTBCCEEEEECS-S-----SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HhCCCCCCCeEEEEEec-C-----ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccc
Confidence 46899999999998731 1 2779999999 588877764 34568999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 157 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 157 (296)
||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||
T Consensus 516 Dikp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 516 DIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPF 593 (656)
T ss_dssp CCSGGGEEEE-ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccchHhEEEe-CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999 478899999999987643322 1233457899999999654 58999999999999999997 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+.+..+....+...... ..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 594 ~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 594 QGVKNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TTCCHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCC----------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 998887777666542110 012347899999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=267.48 Aligned_cols=193 Identities=12% Similarity=0.165 Sum_probs=149.2
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
..|+||+++++++..... .|+|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||+ +||+|||
T Consensus 124 ~~~~~iv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrD 197 (365)
T 3e7e_A 124 SMQHMFMKFYSAHLFQNG-----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGD 197 (365)
T ss_dssp GGGGGBCCEEEEEECSSC-----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCC
T ss_pred hhhhhhhhhheeeecCCC-----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCC
Confidence 349999999999855443 889999998 688888875433 34679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCC----------CCcEEEeeccCcccccc---CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHH
Q 022500 82 LKPQNLLVDPL----------THQVKICDFGSAKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLA 148 (296)
Q Consensus 82 lkp~Nill~~~----------~~~vkl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 148 (296)
|||+|||++.. ++.+||+|||+|+.... .......+||+.|+|||++.+. .++.++||||+||++|
T Consensus 198 iKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 276 (365)
T 3e7e_A 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVY 276 (365)
T ss_dssp CSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHH
T ss_pred CCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHH
Confidence 99999999731 57899999999975432 2223456789999999999765 4899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCC
Q 022500 149 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228 (296)
Q Consensus 149 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R 228 (296)
+|++|..||....... ......+ .. ...++.+.+++.+||+.+|.+|
T Consensus 277 elltg~~pf~~~~~~~-----------------~~~~~~~-----~~-----------~~~~~~~~~~~~~~l~~~p~~r 323 (365)
T 3e7e_A 277 CMLFGTYMKVKNEGGE-----------------CKPEGLF-----RR-----------LPHLDMWNEFFHVMLNIPDCHH 323 (365)
T ss_dssp HHHHSSCCCEEEETTE-----------------EEECSCC-----TT-----------CSSHHHHHHHHHHHHCCCCTTC
T ss_pred HHHhCCCccccCCCCc-----------------eeechhc-----cc-----------cCcHHHHHHHHHHHcCCCCCCc
Confidence 9999999995442100 0000000 00 0136788999999999999999
Q ss_pred CCHHHHhc
Q 022500 229 CTALEACA 236 (296)
Q Consensus 229 ~t~~e~l~ 236 (296)
++..+.+.
T Consensus 324 ~~~~~~l~ 331 (365)
T 3e7e_A 324 LPSLDLLR 331 (365)
T ss_dssp CCCHHHHH
T ss_pred chHHHHHH
Confidence 76544443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=258.08 Aligned_cols=205 Identities=20% Similarity=0.237 Sum_probs=153.0
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------h
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------T 73 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH--------~ 73 (296)
.++||||+++++++.... .....+|+||||+++ +|.+.+.. ..+++..+..++.|++.||.||| +
T Consensus 92 ~l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~ 165 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165 (342)
T ss_dssp CCCCTTBCCEEEEEECCC-SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred hcCCCcEEEEEeeecccC-CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc
Confidence 379999999999986543 122358899999995 88887764 46899999999999999999999 8
Q ss_pred CCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCC-----CCchhHHHHH
Q 022500 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATE-----YTTSIDIWSA 143 (296)
Q Consensus 74 ~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~Diwsl 143 (296)
+||+||||||+||+++ .++.+||+|||++........ .....||+.|+|||++.+... ++.++||||+
T Consensus 166 -~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 166 -PAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp -CEEECSCCSGGGEEEC-TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred -CCeeeCCCCHHHEEEC-CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 6999999999999998 477899999999986644332 234578999999999965422 2368999999
Q ss_pred HHHHHHHHhC----------CCCCCCCC----hHHHHHHHHHh-cCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCC
Q 022500 144 GCVLAELLLG----------QPLFPGEN----AVDQLVEIIKV-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 208 (296)
Q Consensus 144 G~il~~ll~g----------~~pf~~~~----~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (296)
||++|+|++| ..||.... ..+.+...+.. ...+. .+ .......
T Consensus 244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~-------~~~~~~~ 301 (342)
T 1b6c_B 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN---------------IP-------NRWQSCE 301 (342)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC---------------CC-------GGGGTSH
T ss_pred HHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCC---------------Cc-------ccccchh
Confidence 9999999999 77886542 12222222111 00000 00 0001112
Q ss_pred CCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 209 MPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 209 ~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+..+.+||.+||+.||++|||+.++++|
T Consensus 302 ~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 302 ALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 45679999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=270.56 Aligned_cols=201 Identities=20% Similarity=0.244 Sum_probs=152.7
Q ss_pred CCCCCC-CeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHP-NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~Hp-nIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+.|+|+ +|..+..++. ...+.+|||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 57 ~~L~~~~~i~~i~~~~~-----~~~~~~lvme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHr 127 (483)
T 3sv0_A 57 RILQGGTGIPNVRWFGV-----EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHR 127 (483)
T ss_dssp HHTTTSTTCCCEEEEEE-----ETTEEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHhcCCCCCCeEEEEEe-----eCCEEEEEEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeec
Confidence 346664 4444444432 2334789999998899888864 24579999999999999999999999 799999
Q ss_pred CCCCCcEEEc--CCCCcEEEeeccCccccccCCC--------ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 81 DLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 81 dlkp~Nill~--~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
||||+|||++ ..++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 128 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~el 206 (483)
T 3sv0_A 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYF 206 (483)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHH
T ss_pred ccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHH
Confidence 9999999993 2467899999999987644322 1256789999999999764 589999999999999999
Q ss_pred HhCCCCCCCCCh---HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCC
Q 022500 151 LLGQPLFPGENA---VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227 (296)
Q Consensus 151 l~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~ 227 (296)
++|..||.+... ...+..+.........+ .+...+++++.+||.+||+.||.+
T Consensus 207 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~ 262 (483)
T 3sv0_A 207 LRGSLPWQGLKAGTKKQKYEKISEKKVATSIE------------------------ALCRGYPTEFASYFHYCRSLRFDD 262 (483)
T ss_dssp HHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTC
T ss_pred HhCCCCCccccchhHHHHHHHHhhccccccHH------------------------HHhcCCcHHHHHHHHHHhcCChhh
Confidence 999999987543 33333333221111111 112347899999999999999999
Q ss_pred CCCHHHHhc
Q 022500 228 RCTALEACA 236 (296)
Q Consensus 228 R~t~~e~l~ 236 (296)
||++.++++
T Consensus 263 RPs~~el~~ 271 (483)
T 3sv0_A 263 KPDYSYLKR 271 (483)
T ss_dssp CCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=260.55 Aligned_cols=210 Identities=26% Similarity=0.391 Sum_probs=153.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++||||+++++++.... ...+++||||++| +|.+.+.. ....+++..+..++.|++.||.|||+ +||+|
T Consensus 96 l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH 168 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAG---RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIH 168 (326)
T ss_dssp HHTCCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCeeeEEEEEEecC---CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 35789999999999875432 2247899999984 88887764 34569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.+||+|||++........ .....++..|+|||++.+. .++.++||||+||++|+|++|..
T Consensus 169 ~dikp~NIli~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~ 246 (326)
T 2w1i_A 169 RDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE 246 (326)
T ss_dssp SCCCGGGEEEE-ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTC
T ss_pred cCCCcceEEEc-CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCC
Confidence 99999999998 478899999999987644322 1223467789999999654 48899999999999999999998
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHH-----HhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREE-----IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
||..... ... +..+...... +......... ...+..+++++.++|.+||+.||.+|||
T Consensus 247 ~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~dP~~Rps 309 (326)
T 2w1i_A 247 KSKSPPA--EFM---RMIGNDKQGQMIVFHLIELLKNNGR------------LPRPDGCPDEIYMIMTECWNNNVNQRPS 309 (326)
T ss_dssp GGGSHHH--HHH---HHHCTTCCTHHHHHHHHHHHHTTCC------------CCCCTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCHH--HHH---HhhccccchhhhHHHHHHHhhcCCC------------CCCCCcccHHHHHHHHHHcCCChhhCcC
Confidence 8864311 111 1111111000 0000000000 0122457899999999999999999999
Q ss_pred HHHHhc
Q 022500 231 ALEACA 236 (296)
Q Consensus 231 ~~e~l~ 236 (296)
+.++++
T Consensus 310 ~~el~~ 315 (326)
T 2w1i_A 310 FRDLAL 315 (326)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.74 Aligned_cols=178 Identities=17% Similarity=0.124 Sum_probs=132.5
Q ss_pred cceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCCcEEEcCCCC-------
Q 022500 24 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-TVPRVCHRDLKPQNLLVDPLTH------- 94 (296)
Q Consensus 24 ~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH-~~~~i~H~dlkp~Nill~~~~~------- 94 (296)
...+|||||||++ ++.+.+. ...+++..++.++.||+.||+||| + +||+||||||+|||++. ++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~ 206 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYT 206 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEE
T ss_pred cCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeee
Confidence 4458999999975 4444432 256899999999999999999999 9 69999999999999984 44
Q ss_pred -------------cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHH-HHHHHhCCCCCCCC
Q 022500 95 -------------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPGE 160 (296)
Q Consensus 95 -------------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~ 160 (296)
.+||+|||+|+.... ...+||+.|+|||++.+. .+.++||||+|++ .++++.|..||.+.
T Consensus 207 ~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~ 280 (336)
T 2vuw_A 207 LNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNV 280 (336)
T ss_dssp ETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC--SSHHHHHHHHHHHHHTTCTTSCCTHHHH
T ss_pred ccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC--CccceehhhhhCCCCcccccccCCCcch
Confidence 899999999986543 245899999999999764 3899999998776 77788899998542
Q ss_pred Ch-HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh-cCC
Q 022500 161 NA-VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHP 238 (296)
Q Consensus 161 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l-~hp 238 (296)
.. ......+.+..... ... .......+++++++||++||++| |++|+| +||
T Consensus 281 ~~~~~~~~~~~~~~~~~------------------~~~----~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 281 LWLHYLTDKMLKQMTFK------------------TKC----NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HHHHHHHHHHHHTCCCS------------------SCC----CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred hhhhHHHHhhhhhhccC------------------ccc----chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCC
Confidence 11 11222222210000 000 00011236889999999999987 999999 999
Q ss_pred Ccc
Q 022500 239 FFD 241 (296)
Q Consensus 239 ~f~ 241 (296)
||+
T Consensus 334 ~f~ 336 (336)
T 2vuw_A 334 LFK 336 (336)
T ss_dssp GGC
T ss_pred CcC
Confidence 995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=279.23 Aligned_cols=194 Identities=25% Similarity=0.366 Sum_probs=153.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++......+....||||||++| +|.+.+. ..+++..++.++.||+.||.|||+ +||+|
T Consensus 133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiH 205 (681)
T 2pzi_A 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVY 205 (681)
T ss_dssp GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCee
Confidence 467899999999999876554444557899999995 5544332 369999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+||+++. +.+||+|||+++..... ....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+
T Consensus 206 rDlkp~NIll~~--~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 206 NDLKPENIMLTE--EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp CCCSGGGEEECS--SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cccChHHeEEeC--CcEEEEecccchhcccC---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcc
Confidence 999999999984 47999999999865433 45678999999999865 358999999999999999999988865
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.... +.+. ..+ ....++.+.++|.+||+.||.+||+..+++.|+|
T Consensus 279 ~~~~----------~~~~--------------------~~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 279 RYVD----------GLPE--------------------DDP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp EECS----------SCCT--------------------TCH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cccc----------cccc--------------------ccc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 3110 0000 000 0114678999999999999999999999999998
Q ss_pred cccc
Q 022500 240 FDEL 243 (296)
Q Consensus 240 f~~~ 243 (296)
+.-+
T Consensus 324 ~~~~ 327 (681)
T 2pzi_A 324 TGVL 327 (681)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8644
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-32 Score=231.27 Aligned_cols=178 Identities=15% Similarity=0.094 Sum_probs=133.0
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++++++... ..+|+||||++| +|.+.++. + .....+..++.|++.||+|||+ +||+||
T Consensus 86 ~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~ 153 (286)
T 3uqc_A 86 SRIDKPGVARVLDVVHTR-----AGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALS 153 (286)
T ss_dssp HTCCCTTBCCEEEEEEET-----TEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred hcCCCCCcceeeEEEEEC-----CcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccC
Confidence 568999999999998543 348999999985 77766632 2 4556788899999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+||+++ .++.+||+++| |++ .++.++||||+||++|+|++|..||.+.
T Consensus 154 Dikp~NIll~-~~g~~kl~~~~-------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 154 IDHPSRVRVS-IDGDVVLAYPA-------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp CCSGGGEEEE-TTSCEEECSCC-------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred CCCcccEEEc-CCCCEEEEecc-------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 9999999999 57789987443 222 3789999999999999999999999876
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCc
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f 240 (296)
+..+.+....+. . .............+++++.++|.+||+.||.+| |+.++++ .+
T Consensus 206 ~~~~~~~~~~~~------------------~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L 260 (286)
T 3uqc_A 206 GVRSGLAPAERD------------------T----AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LM 260 (286)
T ss_dssp SBCCCSEECCBC------------------T----TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HH
T ss_pred CcchhhHHHHHH------------------h----ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HH
Confidence 532111000000 0 000011112334589999999999999999999 9999987 45
Q ss_pred cccc
Q 022500 241 DELR 244 (296)
Q Consensus 241 ~~~~ 244 (296)
..+.
T Consensus 261 ~~~~ 264 (286)
T 3uqc_A 261 QQAT 264 (286)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 4443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-32 Score=254.59 Aligned_cols=137 Identities=20% Similarity=0.112 Sum_probs=98.2
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
+++ .|+||+++++++ +++..+|||||||+| +|.+.+. .++++++. .|+.||+.||+|+|+ +||+|
T Consensus 296 ~~~~~~~~i~~~~~~~-----ed~~~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~-~GIIH 362 (569)
T 4azs_A 296 TQPPAGFDAPAVLAHG-----ENAQSGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEK-QGFWH 362 (569)
T ss_dssp HSCCTTCCCCCEEEEE-----ECSSEEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHH-TTCEE
T ss_pred HhcCCCCCeeEEEEEE-----EECCEEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHH-CCcee
Confidence 456 799999999999 445559999999996 8777776 45667764 588999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+|||++ .++.+||+|||+|+...... ...+.+||+.|+|||++.+ .+..++|+||+|++++.+.++.
T Consensus 363 RDIKPeNILL~-~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 363 DDVRPWNVMVD-ARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp SCCCGGGEEEC-TTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred ccCchHhEEEC-CCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence 99999999999 57889999999998764432 3456789999999999965 3678899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.2e-24 Score=195.99 Aligned_cols=135 Identities=17% Similarity=0.202 Sum_probs=105.7
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
++++||||+++..+...... .||||||++ ++|.+.+.. +..++.|++.||+|||+ +||+||
T Consensus 394 ~~l~h~nIv~~~~~~~~~~~-----~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHr 455 (540)
T 3en9_A 394 ALVKDFGIPAPYIFDVDLDN-----KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHN 455 (540)
T ss_dssp HHGGGGTCCCCCEEEEETTT-----TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECT
T ss_pred HhcCCCCcCceEEEEEeCCc-----cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccC
Confidence 46799999955544443222 579999998 577766542 56799999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC--------ccceeecccccCchhccC-CCCCCchhHHHHHHHHHHHHH
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll 151 (296)
||||+|||++. .+||+|||+|+....... .....||+.|+|||++.+ ...|+..+|+||..+-..+-.
T Consensus 456 DiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v 532 (540)
T 3en9_A 456 DLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV 532 (540)
T ss_dssp TCCTTSEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred CCCHHHEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 99999999993 899999999987644321 135678999999999954 123788899999988888877
Q ss_pred hCCCCC
Q 022500 152 LGQPLF 157 (296)
Q Consensus 152 ~g~~pf 157 (296)
.++.+|
T Consensus 533 ~~r~rY 538 (540)
T 3en9_A 533 ERRARY 538 (540)
T ss_dssp HTCSCC
T ss_pred Hhcccc
Confidence 776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.8e-17 Score=140.02 Aligned_cols=88 Identities=18% Similarity=0.200 Sum_probs=67.6
Q ss_pred eeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEE
Q 022500 10 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 88 (296)
Q Consensus 10 v~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nil 88 (296)
+++.+++.. ...|+||||++| +|.+ +. . .....++.|++.||.|||+ +||+||||||+|||
T Consensus 164 ~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~--------~--~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NIL 225 (282)
T 1zar_A 164 LAVPKVYAW------EGNAVLMELIDAKELYR-VR--------V--ENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVL 225 (282)
T ss_dssp SSSCCEEEE------ETTEEEEECCCCEEGGG-CC--------C--SCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEE
T ss_pred CCcCeEEec------cceEEEEEecCCCcHHH-cc--------h--hhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEE
Confidence 666665422 126799999986 6544 21 1 2355799999999999999 79999999999999
Q ss_pred EcCCCCcEEEeeccCccccccCCCccceeecccccCchhcc
Q 022500 89 VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 129 (296)
Q Consensus 89 l~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 129 (296)
++ ++.+||+|||+|+. +..++|||.+.
T Consensus 226 l~--~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS--EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EE--TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred EE--CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 99 67899999999963 33467888873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=2.8e-13 Score=113.76 Aligned_cols=70 Identities=20% Similarity=0.296 Sum_probs=55.9
Q ss_pred EEEEeccCcc------cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCCcEEEcCCCCcEEEe
Q 022500 27 LNLVMEYVPE------SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-TVPRVCHRDLKPQNLLVDPLTHQVKIC 99 (296)
Q Consensus 27 ~~lv~E~~~g------~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH-~~~~i~H~dlkp~Nill~~~~~~vkl~ 99 (296)
.+|||||+++ .|.+.... .++..+..++.|++.||.||| + .||+||||||+|||++. .++|+
T Consensus 143 ~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~-~givHrDlkp~NILl~~---~~~li 211 (258)
T 1zth_A 143 NVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE-AELVHADLSEYNIMYID---KVYFI 211 (258)
T ss_dssp TEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT-SCEECSSCSTTSEEESS---SEEEC
T ss_pred CEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEEcC---cEEEE
Confidence 5699999952 44433211 224457889999999999999 9 79999999999999983 79999
Q ss_pred eccCcccc
Q 022500 100 DFGSAKQL 107 (296)
Q Consensus 100 Dfg~a~~~ 107 (296)
|||+|...
T Consensus 212 DFG~a~~~ 219 (258)
T 1zth_A 212 DMGQAVTL 219 (258)
T ss_dssp CCTTCEET
T ss_pred ECcccccC
Confidence 99999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.12 E-value=9.6e-12 Score=109.39 Aligned_cols=90 Identities=12% Similarity=0.080 Sum_probs=60.9
Q ss_pred CCCeeeeceeeeccCCC-CcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 6 HPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 6 HpnIv~l~~~~~~~~~~-~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
|+|++++++..+..... +....+|||||++|.. +... .....+..++.||+.+|.+||+ +|||||||||
T Consensus 164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~---L~~l------~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp 233 (397)
T 4gyi_A 164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALP---MRQV------SSVPDPASLYADLIALILRLAK-HGLIHGDFNE 233 (397)
T ss_dssp HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEE---GGGC------CCCSCHHHHHHHHHHHHHHHHH-TTEECSCCST
T ss_pred HHHHHHHHhcCCCCCeeeeccCceEEEEecCCcc---Hhhh------cccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCH
Confidence 67777776544321110 0011259999999742 1111 1112356788999999999999 7999999999
Q ss_pred CcEEEcCCCC----------cEEEeeccCccc
Q 022500 85 QNLLVDPLTH----------QVKICDFGSAKQ 106 (296)
Q Consensus 85 ~Nill~~~~~----------~vkl~Dfg~a~~ 106 (296)
.|||++. ++ .+.|+||+-+..
T Consensus 234 ~NILl~~-dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 234 FNILIRE-EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TSEEEEE-EECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHEEEeC-CCCcccccccccceEEEEeCCccc
Confidence 9999973 33 388999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2.9e-07 Score=76.77 Aligned_cols=85 Identities=15% Similarity=0.079 Sum_probs=59.7
Q ss_pred CCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------
Q 022500 6 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV---------- 74 (296)
Q Consensus 6 HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~---------- 74 (296)
+..+.+++++... ....|+||||++| ++.+.+ .+......++.++..+|..||+.
T Consensus 69 ~~~vP~v~~~~~~-----~~~~~lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~ 134 (263)
T 3tm0_A 69 KLPVPKVLHFERH-----DGWSNLLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNS 134 (263)
T ss_dssp TSCCCCEEEEEEE-----TTEEEEEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCC
T ss_pred CCCCCeEEEEEec-----CCceEEEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcch
Confidence 4567777776632 2347899999998 433221 01122346778899999999981
Q ss_pred ------------------------------------------------CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 ------------------------------------------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ------------------------------------------------~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
..++|+|++|.||+++. +..+.|+||+.+.
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 135 LDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 14899999999999983 4556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.24 E-value=1.2e-06 Score=72.54 Aligned_cols=28 Identities=25% Similarity=0.280 Sum_probs=24.0
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
++|+|++|+||+++. +..+.|+||+.+.
T Consensus 186 l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 999999999999983 4556799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.18 E-value=4.3e-07 Score=77.60 Aligned_cols=123 Identities=16% Similarity=0.189 Sum_probs=75.7
Q ss_pred eEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------
Q 022500 26 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------ 74 (296)
Q Consensus 26 ~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~------------------------------ 74 (296)
..|+|||+++| .+..... ..++......++.|+...|..||+.
T Consensus 90 ~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp CSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 34689999998 3322111 2356666777777777777777751
Q ss_pred ---------------------------CCcccCCCCCCcEEEcCC-CCcEEEeeccCccccccCCCc---cce---ee--
Q 022500 75 ---------------------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEAN---ISY---IC-- 118 (296)
Q Consensus 75 ---------------------------~~i~H~dlkp~Nill~~~-~~~vkl~Dfg~a~~~~~~~~~---~~~---~~-- 118 (296)
..++|+|++|.||+++.+ +..+.++||+.+......... ... .+
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 136999999999999843 445789999998643111000 000 00
Q ss_pred -------cccccC-chhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 119 -------SRFYRA-PELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 119 -------t~~y~a-PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
...... |+.... .....+.|++|.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001111 222210 123368999999999999998776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.12 E-value=3.9e-06 Score=73.33 Aligned_cols=93 Identities=17% Similarity=0.146 Sum_probs=64.9
Q ss_pred CCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------
Q 022500 7 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------ 74 (296)
Q Consensus 7 pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~------------ 74 (296)
..+.+++.++.... .....|+||||++|... .. ..-..++......++.++...|..||+.
T Consensus 98 vpvP~~~~~~~~~~--~~g~~~~vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~ 170 (359)
T 3dxp_A 98 VPVAKMYALCEDES--VIGRAFYIMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGK 170 (359)
T ss_dssp SCCCCEEEEECCTT--TTSSCEEEEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSC
T ss_pred CCCCcEEEECCCCC--ccCCeEEEEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCC
Confidence 44666766653221 11235699999998421 10 0123467888888999999999999972
Q ss_pred ---------------------------------------------CCcccCCCCCCcEEEcCCCC-cEEEeeccCccc
Q 022500 75 ---------------------------------------------PRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQ 106 (296)
Q Consensus 75 ---------------------------------------------~~i~H~dlkp~Nill~~~~~-~vkl~Dfg~a~~ 106 (296)
..++|+|++++||+++.++. .+.|+||+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 171 PGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999985432 368999999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0038 Score=49.90 Aligned_cols=101 Identities=17% Similarity=0.030 Sum_probs=64.4
Q ss_pred cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccce
Q 022500 37 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 116 (296)
Q Consensus 37 ~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 116 (296)
+|.++|.. .+.++++.++..++.|.+.+|.-+-..+.-..+=+.|..|++. .+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW-RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe-cCCceeccc-cccc-----------
Confidence 67888876 4678999999999999999987762101222333456888988 477777664 1110
Q ss_pred eecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 117 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
.....+.|||... ...+.+.=|+|||+++|.-+--..
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122456888763 246788899999999998886443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0012 Score=56.21 Aligned_cols=31 Identities=39% Similarity=0.578 Sum_probs=24.7
Q ss_pred CcccCCCCCCcEEEcC---CCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDP---LTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~---~~~~vkl~Dfg~a~~ 106 (296)
.++|+|++|.||+++. .+..+.|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4699999999999984 133458999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0022 Score=53.10 Aligned_cols=28 Identities=29% Similarity=0.431 Sum_probs=23.8
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
++|+|+.+.||+++. ++.+-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~-~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDE-GKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEEC-CeEEEEEECcccc
Confidence 789999999999983 5556799999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0095 Score=50.90 Aligned_cols=30 Identities=27% Similarity=0.589 Sum_probs=25.9
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
..++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGE-NEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECG-GGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeC-CCcEEEEehhhcc
Confidence 57999999999999973 5679999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=95.92 E-value=0.013 Score=50.64 Aligned_cols=31 Identities=19% Similarity=0.209 Sum_probs=25.9
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
..++|+|+.+.||+++ ++..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~-~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYR-DFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEE-TTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEe-CCcEEEEEccccccc
Confidence 4789999999999998 344578999998863
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.99 E-value=0.02 Score=50.72 Aligned_cols=79 Identities=13% Similarity=-0.041 Sum_probs=44.4
Q ss_pred HhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceee--cccccCchhccCCCC--CCchhHHHHHHHHH
Q 022500 72 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATE--YTTSIDIWSAGCVL 147 (296)
Q Consensus 72 H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~--~~~~~DiwslG~il 147 (296)
+. ..++|+|++|.||+++. ++ +.++||+.+.............. ...|.+|+....... -....++.+....+
T Consensus 230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45 58999999999999984 44 99999999874321111111111 123555554421110 11233444666677
Q ss_pred HHHHhC
Q 022500 148 AELLLG 153 (296)
Q Consensus 148 ~~ll~g 153 (296)
|..+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 766654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.75 E-value=0.048 Score=45.84 Aligned_cols=29 Identities=24% Similarity=0.324 Sum_probs=24.2
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.++|+|+.+.||+.+ ++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~~--~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLDT--GERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEEC--SSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEEC--CCCEEEEecccccC
Confidence 489999999999954 55689999998863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.70 E-value=0.11 Score=43.94 Aligned_cols=29 Identities=21% Similarity=0.165 Sum_probs=24.9
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 3689999999999998 3 699999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.58 E-value=0.038 Score=46.83 Aligned_cols=30 Identities=27% Similarity=0.203 Sum_probs=24.7
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.+++|+|+++.||+++. +..+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLG-DELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence 36899999999999983 4445799999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.20 E-value=0.078 Score=45.19 Aligned_cols=32 Identities=41% Similarity=0.476 Sum_probs=26.6
Q ss_pred CCcccCCCCCCcEEEcCC---CCcEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~---~~~vkl~Dfg~a~~ 106 (296)
..++|||+.+.||+++.+ .+.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999842 15789999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.20 E-value=0.12 Score=44.65 Aligned_cols=29 Identities=24% Similarity=0.494 Sum_probs=24.2
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.++|+|+++.||+++. + .+.++||..|..
T Consensus 213 ~l~HgDl~~~Nil~~~-~-~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTN-K-CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC---CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecC-C-cEEEEEecCCCC
Confidence 5899999999999973 3 489999998853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=89.70 E-value=0.27 Score=44.12 Aligned_cols=15 Identities=33% Similarity=0.656 Sum_probs=14.0
Q ss_pred CcccCCCCCCcEEEc
Q 022500 76 RVCHRDLKPQNLLVD 90 (296)
Q Consensus 76 ~i~H~dlkp~Nill~ 90 (296)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.63 E-value=0.23 Score=42.49 Aligned_cols=31 Identities=26% Similarity=0.473 Sum_probs=26.1
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
..++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~-~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGN-EESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECG-GGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeC-CCeEEEEECCCCee
Confidence 36899999999999983 55699999988764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=89.48 E-value=0.15 Score=44.58 Aligned_cols=30 Identities=20% Similarity=0.229 Sum_probs=25.3
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
..++|+|+.+.||+++. + .++++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~-~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASE-H-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECS-S-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeC-C-CeEEEeCccccc
Confidence 57999999999999984 3 489999988763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=87.89 E-value=0.18 Score=44.84 Aligned_cols=31 Identities=29% Similarity=0.520 Sum_probs=23.8
Q ss_pred CcccCCCCCCcEEEcCC---------------------------CCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPL---------------------------THQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~---------------------------~~~vkl~Dfg~a~~ 106 (296)
.++|+|+.+.||+++.+ .+.+.++||..|..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 58999999999999853 14688899988753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=87.67 E-value=0.25 Score=43.07 Aligned_cols=31 Identities=23% Similarity=0.456 Sum_probs=25.7
Q ss_pred CcccCCCCCCcEEEcCC---CCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPL---THQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~---~~~vkl~Dfg~a~~ 106 (296)
.++|+|+.+.||+++.+ .+.+.++||..|..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 58999999999999853 25799999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.33 E-value=0.43 Score=41.89 Aligned_cols=30 Identities=23% Similarity=0.451 Sum_probs=24.7
Q ss_pred cccCCCCCCcEEEc-----CCCCcEEEeeccCccc
Q 022500 77 VCHRDLKPQNLLVD-----PLTHQVKICDFGSAKQ 106 (296)
Q Consensus 77 i~H~dlkp~Nill~-----~~~~~vkl~Dfg~a~~ 106 (296)
++|+|+.+.||++. ..+..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 57999999999993 2356799999999863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 296 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-98 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-56 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-55 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-51 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-51 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-49 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-46 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-44 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-39 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-28 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-25 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-24 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-11 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 291 bits (745), Expect = 2e-98
Identities = 191/284 (67%), Positives = 236/284 (83%), Gaps = 2/284 (0%)
Query: 1 MRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKL
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
Y YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL+ GE N+SYICS
Sbjct: 127 YMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T LEACAH F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 240 FDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 283
FDELR+PN +LPNGR P LFNF + ++P L LIP H +
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-59
Identities = 94/291 (32%), Positives = 153/291 (52%), Gaps = 19/291 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ H N+I + + T + + LV + +Y++LK Q + ++ +
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYF 114
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SY 116
YQI RGL YIH+ V HRDLKP NLL++ T +KICDFG A+ + Y
Sbjct: 115 LYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEY 172
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ +R+YRAPE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
Query: 177 TREEIRCM---NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
++E++ C+ P PW+++F +A+DL ++L ++P R +
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQ 291
Query: 234 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 284
A AHP+ ++ +P+ F F EL E + +LI + R
Sbjct: 292 ALAHPYLEQYYDPSDE----PIAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-56
Identities = 62/255 (24%), Positives = 107/255 (41%), Gaps = 26/255 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ + P ++ F+S +++ ME++ L R+P +
Sbjct: 58 LHECNSPYIVGFYGAFYSDGE-----ISICMEHMD---GGSLDQVLKKAGRIPEQILGKV 109
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+ + +GL Y+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTR 167
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTRE 179
Y +PE + G T Y+ DIWS G L E+ +G+ P +A +L+ +V G
Sbjct: 168 SYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
Query: 180 EIRCMNPNYTDFRF--------------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225
R P + I P K+ E D ++ L +P
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286
Query: 226 SLRCTALEACAHPFF 240
+ R + H F
Sbjct: 287 AERADLKQLMVHAFI 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-55
Identities = 81/254 (31%), Positives = 126/254 (49%), Gaps = 14/254 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN+I L F ++ ++LV +++ + + + ++K Y
Sbjct: 54 LQELSHPNIIGLLDAFGHKSN-----ISLVFDFMETDL---EVIIKDNSLVLTPSHIKAY 105
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 119
+GL Y+H + HRDLKP NLL+D +K+ DFG AK + ++ +
Sbjct: 106 MLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVT 163
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPEL+FGA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT E
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+ M F P H +F + +DL L ++P R TA +A +
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282
Query: 240 FDELR--EPNARLP 251
F P +LP
Sbjct: 283 FSNRPGPTPGCQLP 296
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-52
Identities = 81/244 (33%), Positives = 127/244 (52%), Gaps = 7/244 (2%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ +HPNV+ L + + E L LV E+V + + L +P +K
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 121
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+Q+ RGL ++H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + +
Sbjct: 122 MFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTL 179
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPE++ + Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+
Sbjct: 180 WYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
+ F A P K + DL + L ++P+ R +A A +HP+F
Sbjct: 239 W-PRDVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
Query: 241 DELR 244
+L
Sbjct: 297 QDLE 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-51
Identities = 87/286 (30%), Positives = 138/286 (48%), Gaps = 17/286 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ M H NVI L F S E ++ ++ + + Q++ +V+
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFL 126
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
YQI RGL YIH+ + HRDLKP NL V+ KI DFG A+ + Y+ +R
Sbjct: 127 IYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATR 182
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+YRAPE++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 181 IRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
++ ++ Q+ + VF P A+DL ++L R TA +A AH
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 238 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 283
+F + +P+ P+ ++ E + L D V
Sbjct: 302 AYFAQYHDPDD-----EPVADPYDQSFESRDLLIDEWKSLTYDEVI 342
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 3e-51
Identities = 85/265 (32%), Positives = 140/265 (52%), Gaps = 15/265 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
++ M H NVI L F + ++ LVM ++ + +++KH +++ ++
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQF 125
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ +GL YIH + HRDLKP NL V+ ++KI DFG A+Q Y+ +
Sbjct: 126 LVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVT 181
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 180 EIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
++ + + P+++ + + P A++L ++L R TA EA A
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
Query: 237 HPFFDELREPNARLPNGRPLPPLFN 261
HP+F+ L + P + F+
Sbjct: 301 HPYFESLHDTE-DEPQVQKYDDSFD 324
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 168 bits (427), Expect = 5e-51
Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 19/253 (7%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ PN+I+L S+ LV E+V + ++ L Q + ++ Y
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY------QTLTDYDIRFY 134
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
Y+I + L Y H++ + HRD+KP N+++D ++++ D+G A+ G+ + SR
Sbjct: 135 MYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 193
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTRE 179
+++ PEL+ Y S+D+WS GC+LA ++ + P F G + DQLV I KVLGT
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 180 EIRCMNPNYTDFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTA 231
+ D RF I W + H + PEA+D +LL+Y R TA
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 232 LEACAHPFFDELR 244
EA HP+F +
Sbjct: 314 REAMEHPYFYTVV 326
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-50
Identities = 85/256 (33%), Positives = 139/256 (54%), Gaps = 15/256 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ ++HPN++ L E L LV E++ + + + + SA +PL +K Y
Sbjct: 55 LKELNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSY 107
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICS 119
+Q+ +GLA+ H+ RV HRDLKPQNLL++ +K+ DFG A+ + +
Sbjct: 108 LFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
+YRAPE++ G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 180 EI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ FP+ + KV + + L S++L Y P+ R +A A AHP
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284
Query: 239 FFDELREPNARLPNGR 254
FF ++ +P +P+ R
Sbjct: 285 FFQDVTKP---VPHLR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 8e-50
Identities = 63/258 (24%), Positives = 116/258 (44%), Gaps = 16/258 (6%)
Query: 1 MRVMDHPNVISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 57
++++ H NV++L + S + + + LV ++ + S+ + L +
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEI 119
Query: 58 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--- 114
K + GL YIH ++ HRD+K N+L+ +K+ DFG A+ + +
Sbjct: 120 KRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNR 177
Query: 115 --SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 172
+ + + +YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 173 LGTPTREEIRCMNPNYTDFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRC 229
G+ T E ++ + +K ++ P A+DL +LL P+ R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 230 TALEACAHPFFDELREPN 247
+ +A H FF P+
Sbjct: 298 DSDDALNHDFFWSDPMPS 315
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (410), Expect = 6e-49
Identities = 82/244 (33%), Positives = 129/244 (52%), Gaps = 13/244 (5%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N++ L + L LV E++ + + ++L + + K +
Sbjct: 54 LKELKHSNIVKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSF 105
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICS 119
Q+ G+AY H RV HRDLKPQNLL++ ++KI DFG A+ I I +
Sbjct: 106 LLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVT 163
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
+YRAP+++ G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP +
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 180 EI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
D F + PW K + IDL S++L+ P+ R TA +A H
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 239 FFDE 242
+F E
Sbjct: 283 YFKE 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 7e-48
Identities = 82/248 (33%), Positives = 129/248 (52%), Gaps = 12/248 (4%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + H N++ L ++ L LV E+ + K++ S N + VK +
Sbjct: 55 LKELKHKNIVRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSF 106
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICS 119
+Q+ +GL + H+ V HRDLKPQNLL++ ++K+ +FG A+ S + +
Sbjct: 107 LFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVT 164
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTR 178
+YR P+++FGA Y+TSID+WSAGC+ AEL +PLFPG + DQL I ++LGTPT
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
E+ M +P A ++ DL LL+ +P R +A EA HP
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 239 FFDELREP 246
+F + P
Sbjct: 285 YFSDFCPP 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 161 bits (407), Expect = 1e-47
Identities = 56/276 (20%), Positives = 104/276 (37%), Gaps = 37/276 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M V+ HP +++L F NE+ + + E++ + + + + +M Y
Sbjct: 77 MSVLRHPTLVNLHDAF---EDDNEMVM--IYEFMSGGE--LFEKVADEHNKMSEDEAVEY 129
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICS 119
Q+ +GL ++H H DLKP+N++ ++++K+ DFG L ++ +
Sbjct: 130 MRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
+ APE+ G D+WS G + LL G F GEN + L +
Sbjct: 189 AEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+ + D +LL P+ R T +A HP+
Sbjct: 248 A-------------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282
Query: 240 FDELREP--NARLPNGRPLPPLFNFKQELSGASPEL 273
P ++++P+ R + K + L
Sbjct: 283 LTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-46
Identities = 56/285 (19%), Positives = 111/285 (38%), Gaps = 30/285 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKL 59
R P+++ + + + + + L +VME + ++ ++ +Q
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASE 115
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 117
I + Y+H++ + HRD+KP+NLL +K+ DFG AK+ + + +
Sbjct: 116 IMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ +Y APE++ +Y S D+WS G ++ LL G P F + + +
Sbjct: 175 YTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------- 225
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
+ IR + + + ++ E L LL+ P+ R T E H
Sbjct: 226 KTRIRMGQYEFPNPEWSEV-------------SEEVKMLIRNLLKTEPTQRMTITEFMNH 272
Query: 238 PFF-DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 281
P+ + P L R L +++ + + D+
Sbjct: 273 PWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDY 317
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-46
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 34/241 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN++ + + +T K + + LV E + LK Y + M + ++ +
Sbjct: 62 LKGLQHPNIVRF-YDSWESTVKGKKCIVLVTELMTSGT---LKTYLKRFKVMKIKVLRSW 117
Query: 61 TYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
QI +GL ++HT P + HRDLK N+ + T VKI D G A A A + I +
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGT 176
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
+ APE+ +Y S+D+++ G + E+ + + Q+ + P
Sbjct: 177 PEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS- 233
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
F K PE ++ ++ + R + + H F
Sbjct: 234 -------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268
Query: 240 F 240
F
Sbjct: 269 F 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-46
Identities = 56/245 (22%), Positives = 93/245 (37%), Gaps = 39/245 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKL 59
+R + HPN++ T+ L +VMEY + V+ + Q + +V
Sbjct: 57 LRELKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113
Query: 60 YTYQIFRGLAYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI- 114
Q+ L H V HRDLKP N+ +D VK+ DFG A+ L +
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAK 172
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
+++ + +Y +PE + Y DIWS GC+L EL P F + + +I +
Sbjct: 173 AFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-- 229
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+F +I E ++ +R+L R + E
Sbjct: 230 -----------------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEI 263
Query: 235 CAHPF 239
+P
Sbjct: 264 LENPL 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-46
Identities = 53/251 (21%), Positives = 92/251 (36%), Gaps = 39/251 (15%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++++H NV+ L +EY + MP + +
Sbjct: 57 NKMLNHENVVKFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRF 108
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYI 117
+Q+ G+ Y+H + HRD+KP+NLL+D +KI DFG A
Sbjct: 109 FHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ Y APEL+ + +D+WS G VL +L G+ + + Q K T
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
+PW K+ + L ++L +PS R T +
Sbjct: 227 ---------------------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKD 260
Query: 238 PFFDELREPNA 248
++++ + A
Sbjct: 261 RWYNKPLKKGA 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 9e-46
Identities = 50/245 (20%), Positives = 89/245 (36%), Gaps = 40/245 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ DHPN++ L F+ + L +++E+ + + +++
Sbjct: 63 LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVD--AVMLELERPLTESQIQVV 115
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICS 119
Q L Y+H ++ HRDLK N+L +K+ DFG + + S+I +
Sbjct: 116 CKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGT 173
Query: 120 RFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
++ APE++ T Y D+WS G L E+ +P N + L++I
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------ 227
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
K+ P R D + L+ + R T +
Sbjct: 228 --------------------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267
Query: 236 AHPFF 240
HPF
Sbjct: 268 QHPFV 272
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 8e-45
Identities = 81/292 (27%), Positives = 147/292 (50%), Gaps = 26/292 (8%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 59
M+ ++H N+ISL + F + E + LVME + ++ +V++ + +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSY 123
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +
Sbjct: 124 LLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
R+YRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E
Sbjct: 182 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 180 EIRCMNPNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPS 226
++ + P ++ P+ + K+F +K +A DL S++L P+
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 227 LRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 278
R + +A HP+ + +P P P +++ + + + E +LI
Sbjct: 301 KRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELI 349
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (380), Expect = 1e-44
Identities = 64/247 (25%), Positives = 95/247 (38%), Gaps = 40/247 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+V HPN+I LK + + F LV + + + L Y + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGE---LFDYLTEKVTLSEKETRKI 115
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+ + +H + HRDLKP+N+L+D + +K+ DFG + QL GE +
Sbjct: 116 MRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTP 173
Query: 121 FYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 175
Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
E DL SR L P R TA EA
Sbjct: 234 FGSPE-------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
Query: 236 AHPFFDE 242
AHPFF +
Sbjct: 269 AHPFFQQ 275
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-44
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 41/240 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ HPN++ L F T + L++EY P + + Y
Sbjct: 60 QSHLRHPNILRLYGYFHDATR-----VYLILEYAPLGT---VYRELQKLSKFDEQRTATY 111
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
++ L+Y H+ RV HRD+KP+NLL+ ++KI DFG + + + +
Sbjct: 112 ITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRT-TLCGTL 168
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y PE+I G + +D+WS G + E L+G+P F + I +V
Sbjct: 169 DYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------- 219
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 240
+F FP + A DL SRLL+++PS R E HP+
Sbjct: 220 ---------EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 152 bits (385), Expect = 2e-44
Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 38/273 (13%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M + HP +I+L F +++ + L++E++ + ++ + +M V Y
Sbjct: 80 MNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINY 132
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICS 119
Q GL ++H + H D+KP+N++ + VKI DFG A +L E +
Sbjct: 133 MRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
+ APE++ D+W+ G + LL G F GE+ ++ L + + +
Sbjct: 192 AEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 250
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+ PEA D LLQ P R T +A HP+
Sbjct: 251 AF-------------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285
Query: 240 FDELREPNARLPNGRPLPPLFNFKQELSGASPE 272
+ ++ L + P +Q++ +
Sbjct: 286 L---KGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (379), Expect = 5e-44
Identities = 58/253 (22%), Positives = 93/253 (36%), Gaps = 42/253 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPN I + C+ E LVMEY S + + + +
Sbjct: 69 LQKLRHPNTIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAV 120
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
T+ +GLAY+H+ + HRD+K N+L+ VK+ DFGSA + S++ +
Sbjct: 121 THGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM---APANSFVGTP 175
Query: 121 FYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
++ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------- 228
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ + + LQ P R T+ H
Sbjct: 229 --------------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268
Query: 239 FFDELREPNARLP 251
F R P +
Sbjct: 269 FVLRERPPTVIMD 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 3e-43
Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 37/291 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M +++ L F+ N + + +V E + E++ ++K Y ++ +PLIYVK
Sbjct: 74 EDSMGANHILKL-LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQI 130
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIAGEANIS 115
+ Q+ GL Y+H + H D+KP+N+L++ + Q+KI D G+A E +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTN 188
Query: 116 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEI 169
I +R YR+PE++ GA + DIWS C++ EL+ G LF + D + +I
Sbjct: 189 SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 170 IKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKV------FHKRMPPEAIDL 216
I++LG +R T F ++K P V F K E D
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 217 ASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPLPPLF 260
S +LQ P R A HP+ +E+R P+ L +G +P F
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-43
Identities = 55/248 (22%), Positives = 98/248 (39%), Gaps = 37/248 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKL 59
+ + H N++ L F S L ++ E++ ++ + ++ + +
Sbjct: 55 LNIARHRNILHLHESFESMEE-----LVMIFEFISGLDIFERIN---TSAFELNEREIVS 106
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAGEANISYIC 118
Y +Q+ L ++H+ + H D++P+N++ +KI +FG A+QL G+
Sbjct: 107 YVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE+ +T+ D+WS G ++ LL G F E + I+ T
Sbjct: 166 APEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
E K + EA+D RLL R TA EA HP
Sbjct: 225 EAF-------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 239 FFDELREP 246
+ + E
Sbjct: 260 WLKQKIER 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-42
Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 46/268 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR +PN+++ + +EL++ VMEY + M +
Sbjct: 71 MRENKNPNIVNYLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAV 121
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 119
+ + L ++H+ +V HRD+K N+L+ VK+ DFG Q+ ++ S + +
Sbjct: 122 CRECLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
++ APE++ Y +DIWS G + E++ G+P + EN + L I GTP
Sbjct: 180 PYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP--- 234
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239
+ + P +++ D +R L R +A E H F
Sbjct: 235 ----------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272
Query: 240 FDELREPNARLPNGRPLPPLFNFKQELS 267
+ L PL +E +
Sbjct: 273 LKIAKPL-------SSLTPLIAAAKEAT 293
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 1e-41
Identities = 56/253 (22%), Positives = 92/253 (36%), Gaps = 37/253 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ + HPN+++L + S L+L +M+ V L
Sbjct: 61 LHKIKHPNIVALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRL 112
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC 118
+Q+ + Y+H + HRDLKP+NLL L ++ I DFG +K G +
Sbjct: 113 IFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 171
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ Y APE++ Y+ ++D WS G + LL G P F EN +I+K
Sbjct: 172 TPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 230
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ + A D L++ P R T +A HP
Sbjct: 231 P-------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265
Query: 239 FFDELREPNARLP 251
+ + +
Sbjct: 266 WIAGDTALDKNIH 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-41
Identities = 68/268 (25%), Positives = 106/268 (39%), Gaps = 52/268 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M +DHP + L F +L+ + Y L Y + Y
Sbjct: 62 MSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAKNGE---LLKYIRKIGSFDETCTRFY 113
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYI 117
T +I L Y+H + HRDLKP+N+L++ ++I DFG+AK L S++
Sbjct: 114 TAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ Y +PEL+ S D+W+ GC++ +L+ G P F N +IIK+
Sbjct: 172 GTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----- 225
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-- 235
++ FP+ + P+A DL +LL + R E
Sbjct: 226 ------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261
Query: 236 ----AHPFFDELREPNARLPNGRPLPPL 259
AHPFF+ + L P P L
Sbjct: 262 GPLKAHPFFESVT--WENLHQQTP-PKL 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-39
Identities = 57/262 (21%), Positives = 100/262 (38%), Gaps = 39/262 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ + HPNVI+L + +N+ + L++E V L + + + + +
Sbjct: 67 LKEIQHPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEATEF 118
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAGEANISYI 117
QI G+ Y+H+ ++ H DLKP+N+++ ++KI DFG A ++ G +
Sbjct: 119 LKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ + APE++ D+WS G + LL G F G+ + L + V
Sbjct: 178 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
E + A D RLL P R T ++ H
Sbjct: 237 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 238 PFFDELREPNARLPNGRPLPPL 259
P+ A L + P
Sbjct: 272 PWIKPKDTQQA-LSSAWSHPQF 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-38
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 40/243 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKL 59
+R H N++ L +V ++ S+Y L + +I +
Sbjct: 58 LRKTRHVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLID 108
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY--- 116
Q +G+ Y+H + HRDLK N+ + VKI DFG A + +
Sbjct: 109 IARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 117 ICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 174
S + APE+I Y+ D+++ G VL EL+ GQ + N DQ++ ++
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--- 223
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
+ P + P L + L+ R +
Sbjct: 224 --------------RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 235 CAH 237
A
Sbjct: 264 LAS 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 8e-38
Identities = 74/285 (25%), Positives = 112/285 (39%), Gaps = 54/285 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+HP + + F + + L VMEY+ L ++ + + L Y
Sbjct: 57 SLAWEHPFLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFY 108
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 119
+I GL ++H+ + +RDLK N+L+D H KI DFG K+ + G+A + C +
Sbjct: 109 AAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGT 166
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 179
Y APE++ G +Y S+D WS G +L E+L+GQ F G++ +
Sbjct: 167 PDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------H 213
Query: 180 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHP 238
IR NP Y + + EA DL +L P R HP
Sbjct: 214 SIRMDNPFYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256
Query: 239 FFDELREPNARLPNGRPLPP----------LFNFKQELSGASPEL 273
F E+ L PP NF +E P L
Sbjct: 257 LFREINW--EELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 5e-37
Identities = 49/242 (20%), Positives = 84/242 (34%), Gaps = 44/242 (18%)
Query: 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 64
VI L F S L++E L + + + + + +Q+
Sbjct: 67 GFSGVIRLLDWFERPDS-----FVLILERPEPVQD--LFDFITERGALQEELARSFFWQV 119
Query: 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 124
+ + H V HRD+K +N+L+D ++K+ DFGS L+ + +R Y
Sbjct: 120 LEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSP 177
Query: 125 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 184
PE I + S +WS G +L +++ G F + + +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------- 218
Query: 185 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 244
F +R+ E L L PS R T E HP+ ++
Sbjct: 219 ----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
Query: 245 EP 246
P
Sbjct: 263 LP 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 8e-37
Identities = 59/265 (22%), Positives = 97/265 (36%), Gaps = 45/265 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ D P ++ + + F + L+ +++ + L ++ S + ++ Y
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDK-----LSFILDLMNGGD---LHYHLSQHGVFSEADMRFY 112
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+I GL ++H V +RDLKP N+L+D H V+I D G A + + S +
Sbjct: 113 AAEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTH 169
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y APE++ Y +S D +S GC+L +LL G F D+ L
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-- 227
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEAC 235
PE L LLQ + R A E
Sbjct: 228 ------------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
Query: 236 AHPFFDELREPNARLPNGRPLPPLF 260
PFF L + ++ + PP
Sbjct: 264 ESPFFRSL---DWQMVFLQKYPPPL 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (319), Expect = 3e-35
Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 47/248 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ ++ HP +I + F ++ + ++M+Y+ L +QR P K Y
Sbjct: 58 LSIVTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFY 109
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
++ L Y+H+ + +RDLKP+N+L+D H +KI DFG AK + + + +
Sbjct: 110 AAEVCLALEYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTP 165
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
Y APE++ Y SID WS G ++ E+L G F N + +I+
Sbjct: 166 DYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------- 215
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEAC 235
+ RFP + DL SRL+ S R +
Sbjct: 216 --------AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255
Query: 236 AHPFFDEL 243
HP+F E+
Sbjct: 256 NHPWFKEV 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (308), Expect = 7e-34
Identities = 49/243 (20%), Positives = 89/243 (36%), Gaps = 36/243 (14%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++HP ++++ + T L +VMEYV L+ M
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVT---LRDIVHTEGPMTPKRAIEV 116
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SY 116
+ L + H + HRD+KP N+++ T+ VK+ DFG A+ + ++ +
Sbjct: 117 IADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAV 174
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
I + Y +PE G D++S GCVL E+L G+P F G++ V + ++ P
Sbjct: 175 IGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
H+ + + + + L +P R
Sbjct: 234 PSA-------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
Query: 237 HPF 239
Sbjct: 269 ADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-34
Identities = 61/263 (23%), Positives = 101/263 (38%), Gaps = 46/263 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ HP + +LK+ F + L VMEY L + S + + Y
Sbjct: 59 LQNTRHPFLTALKYAFQT-----HDRLCFVMEYANGGE---LFFHLSRERVFTEERARFY 110
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+I L Y+H+ V +RD+K +NL++D +KI DFG K+ I+ A + C
Sbjct: 111 GAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGT 168
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
+ +Y ++D W G V+ E++ G+ F ++ I+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------- 219
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEAC 235
+ RFP + + PEA L + LL+ P R A E
Sbjct: 220 --------EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 236 AHPFFDELREPNARLPNGRPLPP 258
H FF + + + LPP
Sbjct: 260 EHRFFLSIN--WQDVVQKKLLPP 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-33
Identities = 42/239 (17%), Positives = 83/239 (34%), Gaps = 41/239 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL 59
M + H N++ L L +V EY+ + S+ L+ S + +
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGG----LYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLK 107
Query: 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 119
++ + + Y+ HRDL +N+LV + K+ DFG K+ +
Sbjct: 108 FSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLP 163
Query: 120 RFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ APE + +++T D+WS G +L E+ G+ +P D + + K
Sbjct: 164 VKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------- 215
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
++ PP ++ ++R + L+
Sbjct: 216 -----------GYKMD----------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (282), Expect = 5e-30
Identities = 34/220 (15%), Positives = 73/220 (33%), Gaps = 22/220 (10%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+++ I + F L LV++ + S+ +L ++ + V +
Sbjct: 54 YKLLAGCTGIPNVYYFGQE----GLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMA 106
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANI-- 114
Q+ + IH + +RD+KP N L+ + + + DFG K
Sbjct: 107 AKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 115 ------SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 168
+ + Y + G E + D+ + G V L G + G A +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 169 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 208
++ +R + + + F + + + F
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 8e-30
Identities = 58/266 (21%), Positives = 103/266 (38%), Gaps = 45/266 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ P +++L + F + E L+L+++Y+ L + S +R V++Y
Sbjct: 83 EHIRQSPFLVTLHYAF-----QTETKLHLILDYI---NGGELFTHLSQRERFTEHEVQIY 134
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-- 118
+I L ++H + +RD+K +N+L+D V + DFG +K+ +A E +Y
Sbjct: 135 VGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 119 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 177
+ + G + + ++D WS G ++ ELL G F + + EI +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR------ 246
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTAL 232
P + + M A DL RLL P R A
Sbjct: 247 ---------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
Query: 233 EACAHPFFDELREPNARLPNGRPLPP 258
E H FF ++ L + P
Sbjct: 288 EIKEHLFFQKINW--DDLAAKKVPAP 311
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 8e-30
Identities = 49/237 (20%), Positives = 81/237 (34%), Gaps = 41/237 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M +DH N+I L + + +V E P + +L L + Y
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRY 116
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYI 117
Q+ G+ Y+ + R HRDL +NLL+ VKI DFG + L + + +
Sbjct: 117 AVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 118 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 176
F ++ + D W G L E+ GQ + G N L +I K
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----- 229
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
R P+ + P + ++ + + P R T +
Sbjct: 230 ------------EGERLPRP----------EDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-29
Identities = 49/251 (19%), Positives = 89/251 (35%), Gaps = 32/251 (12%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKL 59
++ H N++ + + L LV +Y S++ L Y + + +
Sbjct: 51 TVMLRHENILGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIK 104
Query: 60 YTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 112
GLA++H P + HRDLK +N+LV I D G A + +
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATD 163
Query: 113 NISYICSRF-----YRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162
I + Y APE++ + E DI++ G V E+ + G +
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHE 222
Query: 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222
QL V P+ EE+R + +++ + ++ +
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276
Query: 223 YSPSLRCTALE 233
+ + R TAL
Sbjct: 277 ANGAARLTALR 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (277), Expect = 2e-29
Identities = 44/255 (17%), Positives = 80/255 (31%), Gaps = 43/255 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++M I + + +VME + S+ ++ +++ L V L
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLL 108
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANI---- 114
Q+ + YIH+ HRD+KP N L+ + V I DFG AK+ +
Sbjct: 109 ADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 115 ----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 170
+ + Y + G E + D+ S G VL LG + G A + +
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 171 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 230
++ I + Y P E + +
Sbjct: 227 RISEKKMSTPIEVLCKGY---------------------PSEFATYLNFCRSLRFDDKPD 265
Query: 231 A---LEACAHPFFDE 242
+ + F +
Sbjct: 266 YSYLRQLFRNLFHRQ 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 5e-29
Identities = 47/261 (18%), Positives = 87/261 (33%), Gaps = 59/261 (22%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK---------------- 43
++ H N+++L T ++L + EY + L+
Sbjct: 95 TQLGSHENIVNLLGAC---TLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149
Query: 44 ---HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 100
+ + + YQ+ +G+ ++ HRDL +N+LV VKICD
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICD 207
Query: 101 FGSAKQLIAGEANISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPL 156
FG A+ +++ + +R + APE +F YT D+WS G +L E+ LG
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 216
+PG ++I+ F+ E +
Sbjct: 267 YPGIPVDANFYKLIQ-----------------NGFKMD----------QPFYATEEIYII 299
Query: 217 ASRLLQYSPSLRCTALEACAH 237
+ R + +
Sbjct: 300 MQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-28
Identities = 52/253 (20%), Positives = 87/253 (34%), Gaps = 48/253 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M+ +D+P ++ + + + LVME L Y N+ + +
Sbjct: 62 MQQLDNPYIVRMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIEL 112
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISY 116
+Q+ G+ Y+ HRDL +N+L+ H KI DFG +K L A E A
Sbjct: 113 VHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 117 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 175
+ APE I ++++ D+WS G ++ E GQ + G + + K
Sbjct: 171 KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---- 225
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
R P E DL + Y R
Sbjct: 226 --------------GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261
Query: 236 A---HPFFDELRE 245
+ ++D + E
Sbjct: 262 LRLRNYYYDVVNE 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-28
Identities = 52/251 (20%), Positives = 85/251 (33%), Gaps = 43/251 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M+ + H ++ L S+ +++ V EY+ + + + L +
Sbjct: 66 MKKLRHEKLVQLYAVV----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDM 118
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYIC 118
QI G+AY+ HRDL+ N+LV K+ DFG A+ + E A
Sbjct: 119 AAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKF 176
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 177
+ APE +T D+WS G +L EL G+ +PG + L ++ + P
Sbjct: 177 PIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 236
E P DL + + P R T A
Sbjct: 236 PPEC----------------------------PESLHDLMCQCWRKEPEERPTFEYLQAF 267
Query: 237 -HPFFDELREP 246
+F
Sbjct: 268 LEDYFTSTEPQ 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 1e-27
Identities = 38/247 (15%), Positives = 78/247 (31%), Gaps = 41/247 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M + HP ++ L + LV E++ + + + +
Sbjct: 54 MMKLSHPKLVQLYGVCLEQA-----PICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGM 106
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-- 118
+ G+AY+ V HRDL +N LV +K+ DFG + ++ + S
Sbjct: 107 CLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKF 164
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ +PE+ + Y++ D+WS G ++ E+ + + ++VE I
Sbjct: 165 PVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------- 216
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
+ + + + + P R
Sbjct: 217 --------------------TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ- 255
Query: 239 FFDELRE 245
E+ E
Sbjct: 256 -LAEIAE 261
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (267), Expect = 2e-27
Identities = 47/265 (17%), Positives = 92/265 (34%), Gaps = 50/265 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
++ ++ P ++ L+ F + + + + + R + + Y
Sbjct: 95 LQAVNFPFLVKLEFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY 146
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
QI Y+H++ + +RDLKP+NLL+D +++ DFG AK++ + +
Sbjct: 147 AAQIVLTFEYLHSL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVK--GRTWTLCGTP 202
Query: 121 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 180
APE+I Y ++D W+ G ++ E+ G P F + + +I
Sbjct: 203 EALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------- 250
Query: 181 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP-----SLRCTALEAC 235
F + DL LLQ +L+ +
Sbjct: 251 ------------------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292
Query: 236 AHPFFDELREPNARLPNGRPLPPLF 260
H +F + R + F
Sbjct: 293 NHKWF---ATTDWIAIYQRKVEAPF 314
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-27
Identities = 57/254 (22%), Positives = 90/254 (35%), Gaps = 44/254 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M +D+P+V L ++T + L+ + +P L + + Y+ +
Sbjct: 65 MASVDNPHVCRLLGICLTST------VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNW 116
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
QI +G+ Y+ R+ HRDL +N+LV H VKI DFG AK L A E +
Sbjct: 117 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 121 ---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 176
+ A E I YT D+WS G + EL+ G + G A ++ I++
Sbjct: 175 VPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE----- 227
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236
R P + + + R E
Sbjct: 228 ------------KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELII 265
Query: 237 HPFFDELREPNARL 250
F R+P L
Sbjct: 266 E-FSKMARDPQRYL 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-27
Identities = 52/254 (20%), Positives = 87/254 (34%), Gaps = 47/254 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M +D+P ++ L + L LVME + K + +P+ V
Sbjct: 63 MHQLDNPYIVRLIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAEL 114
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
+Q+ G+ Y+ HRDL +N+L+ H KI DFG +K L A ++ + +
Sbjct: 115 LHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 121 ----FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 175
+ APE I ++++ D+WS G + E L GQ + + + I +
Sbjct: 173 KWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231
Query: 176 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235
E PPE L S Y R L
Sbjct: 232 ECPPEC----------------------------PPELYALMSDCWIYKWEDRPDFLTVE 263
Query: 236 A---HPFFDELREP 246
++ +
Sbjct: 264 QRMRACYYSLASKV 277
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-27
Identities = 48/245 (19%), Positives = 84/245 (34%), Gaps = 43/245 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M+ + H ++ L ++ +++ + EY+ S ++ + +
Sbjct: 62 MKQLQHQRLVRLYAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDM 114
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-- 118
QI G+A+I HRDL+ N+LV KI DFG A+ + E
Sbjct: 115 AAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKF 172
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 177
+ APE I +T D+WS G +L E++ G+ +PG + + + +
Sbjct: 173 PIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------ 225
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 236
+ V P E L + P R T +
Sbjct: 226 ----------------------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 237 -HPFF 240
FF
Sbjct: 264 LEDFF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (262), Expect = 4e-27
Identities = 51/255 (20%), Positives = 93/255 (36%), Gaps = 46/255 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M DHPNVI L+ +T + ++ E++ + + + +I +
Sbjct: 81 MGQFDHPNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGM 133
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
I G+ Y+ HRDL +N+LV+ K+ DFG ++ L ++ +Y +
Sbjct: 134 LRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 121 ------FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 173
+ APE I ++T++ D+WS G V+ E++ G+ + D + I +
Sbjct: 192 GGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-- 248
Query: 174 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
D+R P P L Q + R +
Sbjct: 249 ----------------DYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 234 ACAHPFFDELREPNA 248
+R PN+
Sbjct: 283 IVNT-LDKMIRNPNS 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-26
Identities = 49/243 (20%), Positives = 93/243 (38%), Gaps = 43/243 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M+ HPNV+SL ++E +V+ Y+ R + + +
Sbjct: 82 MKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGF 135
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 120
Q+ +G+ ++ + + HRDL +N ++D VK+ DFG A+ + E + + +
Sbjct: 136 GLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTG 193
Query: 121 -----FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 174
+ A E + ++TT D+WS G +L EL+ G P +P N D V +++
Sbjct: 194 AKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--- 249
Query: 175 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234
R + P Y P ++ + +R + E
Sbjct: 250 -----GRRLLQPEY--------------------CPDPLYEVMLKCWHPKAEMRPSFSEL 284
Query: 235 CAH 237
+
Sbjct: 285 VSR 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 5e-26
Identities = 46/250 (18%), Positives = 84/250 (33%), Gaps = 48/250 (19%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLK------------HYSS 47
++ HPN+I+L + +L L +EY P ++ L+ +S
Sbjct: 65 CKLGHHPNIINLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119
Query: 48 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 107
+ + + + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQ 177
Query: 108 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 167
+ A E + + YTT+ D+WS G +L E++ +L
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 168 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 227
E + +R E DL + + P
Sbjct: 237 EKLP-----------------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYE 269
Query: 228 RCTALEACAH 237
R + +
Sbjct: 270 RPSFAQILVS 279
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 7e-26
Identities = 38/240 (15%), Positives = 82/240 (34%), Gaps = 41/240 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M + H ++ L T + +F+ + EY+ +L + R +
Sbjct: 53 MMNLSHEKLVQLYGVC---TKQRPIFI--ITEYMANGC--LLNYLREMRHRFQTQQLLEM 105
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YIC 118
+ + Y+ + + HRDL +N LV+ VK+ DFG ++ ++ E S
Sbjct: 106 CKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 177
+ PE++ +++++ DIW+ G ++ E+ LG+ + + I + L
Sbjct: 164 PVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY- 221
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
P + + + R T ++
Sbjct: 222 ---------------RPHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.8 bits (248), Expect = 3e-25
Identities = 45/249 (18%), Positives = 90/249 (36%), Gaps = 40/249 (16%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M+ + HPN++ L ++ E++ + Q + + +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPP-----FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYM 120
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYIC 118
QI + Y+ HRDL +N LV H VK+ DFG ++ + A+
Sbjct: 121 ATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 178
+ APE + +++ D+W+ G +L E+ + Q+ E+++
Sbjct: 179 PIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------- 230
Query: 179 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238
D+R + P + +L Q++PS R + E H
Sbjct: 231 ----------KDYRME----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQ 268
Query: 239 FFDELREPN 247
F+ + + +
Sbjct: 269 AFETMFQES 277
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 7e-25
Identities = 52/252 (20%), Positives = 89/252 (35%), Gaps = 54/252 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHY-------------- 45
+ +H N+++L T + + EY + L+
Sbjct: 81 SYLGNHMNIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 46 SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105
+ L + ++YQ+ +G+A++ + HRDL +N+L+ KICDFG A+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLAR 193
Query: 106 QLIAGEANISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 161
+ + +R + APE IF YT D+WS G L EL LG +PG
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 162 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 221
+ ++IK + + + P E D+
Sbjct: 253 VDSKFYKMIK---------------------------EGFRMLSPEHAPAEMYDIMKTCW 285
Query: 222 QYSPSLRCTALE 233
P R T +
Sbjct: 286 DADPLKRPTFKQ 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 7e-25
Identities = 55/240 (22%), Positives = 85/240 (35%), Gaps = 42/240 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
MR DHP+++ L E + ++ME R + L + LY
Sbjct: 62 MRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILY 113
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-- 118
YQ+ LAY+ + R HRD+ +N+LV VK+ DFG ++ + +
Sbjct: 114 AYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 119 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 177
+ APE I +T++ D+W G + E+L+ G F G D + I P
Sbjct: 172 PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 178 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237
PP L ++ Y PS R E A
Sbjct: 231 PPNC----------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 1e-24
Identities = 55/265 (20%), Positives = 94/265 (35%), Gaps = 53/265 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SS 47
+ + H NV++L L +++E+ ++ L+
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 48 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 107
+ L ++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDI 184
Query: 108 IAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAV 163
+ + APE IF YT D+WS G +L E+ +PG
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 164 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223
++ +K T R P PE
Sbjct: 244 EEFCRRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHG 276
Query: 224 SPSLRCTALEACAHPFFDELREPNA 248
PS R T E H L + NA
Sbjct: 277 EPSQRPTFSELVEH--LGNLLQANA 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 5e-24
Identities = 43/237 (18%), Positives = 75/237 (31%), Gaps = 41/237 (17%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
M H N+I L+ + ++ EY+ K + ++ +
Sbjct: 63 MGQFSHHNIIRLEGVISKYKP-----MMIITEYMENGAL--DKFLREKDGEFSVLQLVGM 115
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-- 118
I G+ Y+ HRDL +N+LV+ K+ DFG ++ L
Sbjct: 116 LRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 119 --SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 176
+ APE I + S D+WS G V+ E++ E + ++++ I
Sbjct: 174 KIPIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----- 227
Query: 177 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233
FR P P L + Q + R +
Sbjct: 228 ------------DGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 3e-23
Identities = 51/251 (20%), Positives = 93/251 (37%), Gaps = 53/251 (21%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SS 47
+ H N+I+L + L +++EY + ++ L+ +
Sbjct: 73 KMIGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 48 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 107
+++ + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDI 185
Query: 108 IAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 163
+ + + APE +F YT D+WS G +L E+ LG +PG V
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-V 243
Query: 164 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 223
++L +++K R E +
Sbjct: 244 EELFKLLK-----------------EGHRMD----------KPSNCTNELYMMMRDCWHA 276
Query: 224 SPSLRCTALEA 234
PS R T +
Sbjct: 277 VPSQRPTFKQL 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.0 bits (230), Expect = 1e-22
Identities = 51/270 (18%), Positives = 85/270 (31%), Gaps = 63/270 (23%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP---------------------ESMY 39
M D+PN++ + L + EY+ +
Sbjct: 70 MAEFDNPNIV---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 40 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 99
+ S + Q+ G+AY+ + HRDL +N LV VKI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIA 182
Query: 100 DFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQP 155
DFG ++ + + + A+ + + PE IF YTT D+W+ G VL E+ G
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 215
+ G + + + I A P + P E +
Sbjct: 242 PYYGMAHEEVIYYVRD----------------------GNILACP------ENCPLELYN 273
Query: 216 LASRLLQYSPSLRCTALEACAHPFFDELRE 245
L P+ R + H + E
Sbjct: 274 LMRLCWSKLPADRPSFCS--IHRILQRMCE 301
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 7e-20
Identities = 47/260 (18%), Positives = 88/260 (33%), Gaps = 53/260 (20%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI---- 55
M+ + +V+ L ++ME + + L+ A P++
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 56 --YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 113
+ +I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 132 LSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYY 189
Query: 114 ISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 169
+ +PE + +TT D+WS G VL E+ L + + G + L +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 170 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229
++ P +L QY+P +R
Sbjct: 249 ME----------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRP 280
Query: 230 TA------LEACAHPFFDEL 243
+ ++ P F E+
Sbjct: 281 SFLEIISSIKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 59.4 bits (143), Expect = 3e-11
Identities = 25/155 (16%), Positives = 46/155 (29%), Gaps = 29/155 (18%)
Query: 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 60
+ + L+ E ++ME + R+ +
Sbjct: 60 SARNEFRALQKLQGLAVPKVYAWEGNA-VLMELIDAKELY----------RVRVENPDEV 108
Query: 61 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------NI 114
I +A + + H DL N+LV + I DF + ++ ++
Sbjct: 109 LDMILEEVAKFYH-RGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDV 165
Query: 115 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 149
I + F R Y T DI SA + +
Sbjct: 166 RNIITYFSR---------TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.68 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 91.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 91.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 90.56 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 81.64 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-57 Score=396.18 Aligned_cols=279 Identities=68% Similarity=1.213 Sum_probs=243.4
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||+++++|..... .+..++|||||||++++.+.+..+......+++..++.++.||+.||+|||+ +||+|
T Consensus 67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiH 145 (350)
T d1q5ka_ 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICH 145 (350)
T ss_dssp HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcc
Confidence 457899999999999875443 4667789999999999888888777777889999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++.++..+||+|||+|+.........+.+||+.|+|||.+.+...++.++||||+||++|+|++|.+||.+
T Consensus 146 rDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 99999999998655689999999998876666666788999999999987766799999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+++.++++..|.+..+.+......+....++.....++.......+++++.|||++||++||.+|||+.|+|+|||
T Consensus 226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 99999999999999999999999888888888888877777777777789999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHH
Q 022500 240 FDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPD 280 (296)
Q Consensus 240 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (296)
|+++..++...++....+..+++..+.....++....++|.
T Consensus 306 f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~p~ 346 (350)
T d1q5ka_ 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPP 346 (350)
T ss_dssp GGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCGGGHHHHSCT
T ss_pred hccccCCCCCCCCCCCCCccCCCCHhhccCCccccccCCCc
Confidence 99999888777777777788888877777777766666654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=369.03 Aligned_cols=234 Identities=34% Similarity=0.610 Sum_probs=191.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++|||||++++++.. ..++|||||||.|++...+. ..+..+++..++.++.||+.||+|||+ +||+||
T Consensus 54 l~~l~hpnIv~~~~~~~~-----~~~~~ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHr 124 (299)
T d1ua2a_ 54 LQELSHPNIIGLLDAFGH-----KSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHR 124 (299)
T ss_dssp HHHCCCTTBCCEEEEECC-----TTCCEEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCC
T ss_pred HHhCCCCCEeEEEeeecc-----CCceeehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecc
Confidence 356899999999999944 34489999999987655443 356779999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+|||++ .++.+||+|||+|+...... .....+||+.|+|||++.+...|+.++||||+||++|+|++|.+||.+
T Consensus 125 DiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 125 DLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCcceEEec-CCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 9999999999 57889999999998764433 334568999999999997666789999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+++.+|.+..|.|..+.+..................++... ...++++++|||++||++||++|||++|+|+|||
T Consensus 204 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHh-cccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 999999999999999988776544332222222222223333332 2357999999999999999999999999999999
Q ss_pred cccccC
Q 022500 240 FDELRE 245 (296)
Q Consensus 240 f~~~~~ 245 (296)
|++...
T Consensus 283 f~~~p~ 288 (299)
T d1ua2a_ 283 FSNRPG 288 (299)
T ss_dssp GTSSSC
T ss_pred hCCCCC
Confidence 987543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=357.74 Aligned_cols=200 Identities=31% Similarity=0.515 Sum_probs=171.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. +...+|+|||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+|
T Consensus 60 l~~l~hpnIv~~~~~~~-----~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivH 129 (263)
T d2j4za1 60 QSHLRHPNILRLYGYFH-----DATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIH 129 (263)
T ss_dssp HHTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhcCCCCCCeEEEEEE-----ECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 45789999999999995 3445899999999 587777763 3679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+||+|||+|+..... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 130 rDiKp~Nill~-~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 130 RDIKPENLLLG-SAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp CCCCGGGEEEC-TTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eeeccccceec-CCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 99999999999 4778999999999865433 34566899999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+..+.+..+.+.. + .++..+++++++||.+||+.||++|||++|+++|||
T Consensus 207 ~~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 207 NTYQETYKRISRVE-----------------F------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp SSHHHHHHHHHTTC-----------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred CCHHHHHHHHHcCC-----------------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 98887777765421 0 122357999999999999999999999999999999
Q ss_pred ccc
Q 022500 240 FDE 242 (296)
Q Consensus 240 f~~ 242 (296)
|++
T Consensus 258 ~~~ 260 (263)
T d2j4za1 258 ITA 260 (263)
T ss_dssp HHH
T ss_pred cCC
Confidence 974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=358.30 Aligned_cols=205 Identities=24% Similarity=0.355 Sum_probs=166.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ...+|||||||+| +|.+.+ ...+.+++..++.++.||+.||+|||+ +||+|
T Consensus 57 l~~l~HpnIv~~~~~~~~-----~~~~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiH 126 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRRE-----GNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITH 126 (271)
T ss_dssp HHTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCEeeEeeeecc-----CceeEEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCcc
Confidence 467899999999999954 3458999999995 765554 345779999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+|||++ .++.+||+|||+|+...... ...+.+||+.|+|||++.+...++.++||||+||++|+|++|.+|
T Consensus 127 rDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p 205 (271)
T d1nvra_ 127 RDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205 (271)
T ss_dssp SCCCGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcccHHHEEEC-CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence 99999999998 47789999999998764332 234568999999999998765567889999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+................. .. ....+++++++||.+||+.||++|||++|+++
T Consensus 206 f~~~~~~~~~~~~~~~~~~~---------------------~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 206 WDQPSDSCQEYSDWKEKKTY---------------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CSSSSTTSHHHHHHHTTCTT---------------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCChHHHHHHHHhcCCCC---------------------CC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 98765443333322211100 00 11247999999999999999999999999999
Q ss_pred CCCccc
Q 022500 237 HPFFDE 242 (296)
Q Consensus 237 hp~f~~ 242 (296)
||||++
T Consensus 260 hpwf~~ 265 (271)
T d1nvra_ 260 DRWYNK 265 (271)
T ss_dssp CTTTTC
T ss_pred CHhhCc
Confidence 999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=351.97 Aligned_cols=206 Identities=24% Similarity=0.381 Sum_probs=168.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC--c
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--V 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--i 77 (296)
|++++|||||++++++.... .+...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ ++ |
T Consensus 62 l~~l~HpnIv~~~~~~~~~~-~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~I 135 (270)
T d1t4ha_ 62 LKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPI 135 (270)
T ss_dssp HTTCCCTTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCC
T ss_pred HHhCCCCCeeeEEEEEeecc-ccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCE
Confidence 57899999999999986543 345568899999995 77777653 3679999999999999999999999 68 9
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
+||||||+|||++..++.+||+|||+|+... .....+.+||+.|+|||++.+ .++.++||||+||++|+|++|..||
T Consensus 136 iHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EeCCcChhhceeeCCCCCEEEeecCcceecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCC
Confidence 9999999999997557789999999997543 233456789999999999864 4999999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+......+.+.+.....+ ..++...++++++||.+||+.||++|||++|+++|
T Consensus 213 ~~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 213 SECQNAAQIYRRVTSGVKP--------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTCSSHHHHHHHHTTTCCC--------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcccHHHHHHHHHcCCCC--------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 8776555444333211110 11223478999999999999999999999999999
Q ss_pred CCcc
Q 022500 238 PFFD 241 (296)
Q Consensus 238 p~f~ 241 (296)
|||+
T Consensus 267 p~fk 270 (270)
T d1t4ha_ 267 AFFQ 270 (270)
T ss_dssp GGGC
T ss_pred cccC
Confidence 9996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=359.04 Aligned_cols=206 Identities=30% Similarity=0.530 Sum_probs=172.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. +...+|+|||||+| +|.+.+.. .+.+++..++.++.|++.||+|||+ +||+|
T Consensus 62 l~~l~HpnIv~l~~~~~-----~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiH 131 (288)
T d1uu3a_ 62 MSRLDHPFFVKLYFTFQ-----DDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIH 131 (288)
T ss_dssp HHHCCSTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHHcCCCCeeEEEEEEE-----ECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEc
Confidence 35689999999999994 34458999999995 77776653 4679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+|||++ .++.+||+|||+|+...... ...+.+||+.|+|||++.+. .|+.++||||+||++|+|++|..|
T Consensus 132 rDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~P 209 (288)
T d1uu3a_ 132 RDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPP 209 (288)
T ss_dssp SCCSGGGEEEC-TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCccccccC-CCceEEecccccceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCC
Confidence 99999999999 57789999999998764322 23456799999999999765 589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH---
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE--- 233 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e--- 233 (296)
|.+.+..+.+.++.+.. + .++..+++++++||++||+.||++|||++|
T Consensus 210 f~~~~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 210 FRAGNEYLIFQKIIKLE-----------------Y------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp SCCSSHHHHHHHHHTTC-----------------C------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCcCHHHHHHHHHcCC-----------------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 99998888887776521 1 123458999999999999999999999987
Q ss_pred ---HhcCCCcccccCCC
Q 022500 234 ---ACAHPFFDELREPN 247 (296)
Q Consensus 234 ---~l~hp~f~~~~~~~ 247 (296)
+++||||+++.+..
T Consensus 261 ~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 261 YGPLKAHPFFESVTWEN 277 (288)
T ss_dssp HHHHHTSGGGTTCCCTT
T ss_pred CHHHHcCCccCCCCHHH
Confidence 58999999987764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=357.34 Aligned_cols=203 Identities=26% Similarity=0.421 Sum_probs=170.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++... .++|||||||+| +|.+.+.. ..+++..++.++.||+.||+|||+ +||+|
T Consensus 71 l~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~-~~iiH 139 (293)
T d1yhwa1 71 MRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIH 139 (293)
T ss_dssp HHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCEeeEeEEEEEC-----CEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCCcc
Confidence 4578999999999999543 348999999995 76655442 469999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+|+...... .....+||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 140 rDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 140 RDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp CCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCcHHHeEEC-CCCcEeeccchhheeeccccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCC
Confidence 99999999998 47889999999998764433 34566899999999999764 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..+..... +. ...+..+++++++||.+||+.||.+|||++|+++||
T Consensus 218 ~~~~~~~~~~~~~~~~-~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 218 NENPLRALYLIATNGT-PE-------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp TSCHHHHHHHHHHHCS-CC-------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred CCCHHHHHHHHHhCCC-CC-------------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 9988887777665311 10 001234799999999999999999999999999999
Q ss_pred Cccc
Q 022500 239 FFDE 242 (296)
Q Consensus 239 ~f~~ 242 (296)
||+.
T Consensus 272 ~~~~ 275 (293)
T d1yhwa1 272 FLKI 275 (293)
T ss_dssp GGGG
T ss_pred hhCC
Confidence 9974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=355.36 Aligned_cols=237 Identities=34% Similarity=0.583 Sum_probs=194.0
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.++|||||+++++|.........++|++||||++++...... .....+++..++.++.|++.||+|||+ +||+||||
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDi 142 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDL 142 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCC
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCC
Confidence 358999999999987665566677999999999876655443 345679999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
||+|||++ ..+.+||+|||+++............||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+.
T Consensus 143 Kp~NILi~-~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 143 KPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CGGGEEEC-TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CccEEEEc-CCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 99999999 5778999999999876555555678899999999999764 599999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
.+.+.++++..|.+....+........ .........+ ...+...++++++|||++||++||++|||++|+|+||||++
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 221 VDQLGKILDVIGLPGEEDWPRDVALPR-QAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSSCG-GGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHhhCCCchhcccccccchh-hhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 999999999999988766543221111 1111111111 22244568999999999999999999999999999999998
Q ss_pred ccCC
Q 022500 243 LREP 246 (296)
Q Consensus 243 ~~~~ 246 (296)
+.+.
T Consensus 299 i~~~ 302 (305)
T d1blxa_ 299 LERC 302 (305)
T ss_dssp CCCC
T ss_pred chhh
Confidence 8653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-52 Score=356.29 Aligned_cols=206 Identities=26% Similarity=0.415 Sum_probs=161.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. +...+|||||||+ |+|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 61 l~~l~HpnIv~l~~~~~-----~~~~~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiH 130 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYE-----SGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-LGIVH 130 (307)
T ss_dssp HHTCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCCCcEEEEEE-----ECCEEEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhh-ceeee
Confidence 46789999999999994 3445899999999 58877775 35679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC--CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDP--LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+||++.. .++.+||+|||+|+.........+.+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||
T Consensus 131 rDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCC
Confidence 999999999952 3578999999999876655555677899999999999764 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
.+.+..+....+.+....+. ......+|+++++||.+||++||++|||++|+++|
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 210 YDENDAKLFEQILKAEYEFD-------------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCSSHHHHHHHHHTTCCCCC-------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHHHhccCCCCC-------------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 99988888777765321111 11223589999999999999999999999999999
Q ss_pred CCccc
Q 022500 238 PFFDE 242 (296)
Q Consensus 238 p~f~~ 242 (296)
|||+.
T Consensus 265 p~~~~ 269 (307)
T d1a06a_ 265 PWIAG 269 (307)
T ss_dssp TTTTS
T ss_pred HhhCC
Confidence 99975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=357.37 Aligned_cols=204 Identities=28% Similarity=0.458 Sum_probs=174.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++. +...+|+|||||+| +|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 59 l~~l~hp~Iv~l~~~~~-----~~~~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~-~~iiH 128 (337)
T d1o6la_ 59 LQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVY 128 (337)
T ss_dssp HHSCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBC
T ss_pred HHhCCCCCEEEEEeeec-----cccccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhh-cCccc
Confidence 46789999999999994 44559999999995 7766655 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCcccccc-CCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++ .++.+||+|||+|+.... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.
T Consensus 129 RDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 129 RDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCHHHeEec-CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCC
Confidence 99999999999 478899999999987644 3344567899999999999765 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHH
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALE 233 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e 233 (296)
+.+..+....+... .. .++..+|+++++||++||++||.+|++ ++|
T Consensus 207 ~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~e 257 (337)
T d1o6la_ 207 NQDHERLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257 (337)
T ss_dssp CSSHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred CcCHHHHHHHHhcC-----------------CC------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHH
Confidence 99988777766552 11 123458999999999999999999994 999
Q ss_pred HhcCCCcccccC
Q 022500 234 ACAHPFFDELRE 245 (296)
Q Consensus 234 ~l~hp~f~~~~~ 245 (296)
+++||||+++.+
T Consensus 258 il~Hp~f~~i~~ 269 (337)
T d1o6la_ 258 VMEHRFFLSINW 269 (337)
T ss_dssp HHTSGGGTTCCH
T ss_pred HHcCcccccCCH
Confidence 999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=352.15 Aligned_cols=236 Identities=34% Similarity=0.666 Sum_probs=190.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++|||||++++++.+. ..+|+|||||+|++...+.. .....+++..++.++.||+.||+|||+ +||+||
T Consensus 55 l~~l~Hp~Iv~~~~~~~~~-----~~~~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHr 126 (298)
T d1gz8a_ 55 LKELNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHR 126 (298)
T ss_dssp HTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HHhCCCCcEEEeccccccc-----cceeEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEcc
Confidence 5789999999999999544 34999999999987776653 245679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccC-CCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+|||++ .++.+||+|||+|+..... .......||+.|+|||++.....++.++|+||+||++|+|++|..||.+
T Consensus 127 DiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 127 DLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp CCCGGGEEEC-TTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCchheeec-ccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 9999999999 4778999999999866433 2344568999999999987766678999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCc-CccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
.+..+.+.++.+..+.+....+......-. ....+......... ....++++++|||++||++||.+|||++|+++||
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence 999999999999888877554433211100 00111122222222 2235899999999999999999999999999999
Q ss_pred CcccccCC
Q 022500 239 FFDELREP 246 (296)
Q Consensus 239 ~f~~~~~~ 246 (296)
||+++..+
T Consensus 285 ff~~~~~p 292 (298)
T d1gz8a_ 285 FFQDVTKP 292 (298)
T ss_dssp GGTTCCCC
T ss_pred hhccCCCC
Confidence 99987554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.9e-52 Score=361.57 Aligned_cols=211 Identities=24% Similarity=0.386 Sum_probs=178.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||++++++.. ...+|||||||+ |+|.+.+.. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 77 l~~l~HpnIv~~~~~~~~-----~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiH 147 (350)
T d1koaa2 77 MSVLRHPTLVNLHDAFED-----DNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVH 147 (350)
T ss_dssp HHHTCCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCcEEEEEEE-----CCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCee
Confidence 357899999999999954 345999999999 587776642 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC-CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++. .++.+||+|||+|+.........+..||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 148 rDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 999999999963 3568999999999987666666678899999999999765 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..+.+....+.. .....+++++++||.+||++||++|||++|+++||
T Consensus 227 ~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 227 GENDDETLRNVKSCDWNMDD-------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp CSSHHHHHHHHHHTCCCSCC-------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred CCCHHHHHHHHHhCCCCCCc-------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 99988888888764222111 11134799999999999999999999999999999
Q ss_pred CcccccCC
Q 022500 239 FFDELREP 246 (296)
Q Consensus 239 ~f~~~~~~ 246 (296)
||+....+
T Consensus 282 ~~~~~~~~ 289 (350)
T d1koaa2 282 WLTPGNAP 289 (350)
T ss_dssp TTSCTTCC
T ss_pred ccCCCCCC
Confidence 99976544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-52 Score=349.30 Aligned_cols=206 Identities=27% Similarity=0.385 Sum_probs=163.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC---
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--- 76 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~--- 76 (296)
|++++|||||++++++.... ...+|||||||+ |+|.+.+......+..+++..++.++.||+.||+|||+ +|
T Consensus 57 l~~l~HpnIv~~~~~~~~~~---~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~ 132 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRT---NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGG 132 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC--
T ss_pred HHHCCCCCEeeEEEEEEeCC---CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCC
Confidence 67899999999999886422 234889999998 58988887766667889999999999999999999998 56
Q ss_pred --cccCCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 022500 77 --VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 153 (296)
Q Consensus 77 --i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 153 (296)
|+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+ ..|+.++||||+||++|+|++|
T Consensus 133 ~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg 210 (269)
T d2java1 133 HTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCAL 210 (269)
T ss_dssp -------CCGGGEEEC-TTSCEEECCHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCEEeCcCchhhcCcC-CCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhC
Confidence 99999999999999 47889999999998765433 2345789999999999965 4599999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 154 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
..||.+.+..+....+.+..- ..++..+|+++.+||.+||+.||.+|||++|
T Consensus 211 ~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~e 262 (269)
T d2java1 211 MPPFTAFSQKELAGKIREGKF----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEE 262 (269)
T ss_dssp SCSCCCSSHHHHHHHHHHTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCC----------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999888877776654200 0122357999999999999999999999999
Q ss_pred HhcCCCc
Q 022500 234 ACAHPFF 240 (296)
Q Consensus 234 ~l~hp~f 240 (296)
+++|||+
T Consensus 263 ll~hp~i 269 (269)
T d2java1 263 ILENPLI 269 (269)
T ss_dssp HHTSTTC
T ss_pred HHhCCcC
Confidence 9999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-52 Score=353.07 Aligned_cols=206 Identities=25% Similarity=0.403 Sum_probs=169.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++... ..+|+|||||+| +|.+.+.. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 63 l~~l~HpnIv~l~~~~~~~-----~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivH 133 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIH 133 (288)
T ss_dssp HHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEeeC-----CeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEE
Confidence 3578999999999999543 348999999995 76666553 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+|||++ .++.+||+|||+|+...... ...+..||+.|+|||++.+ ...|+.++||||+||++|+|++|.
T Consensus 134 rDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~ 212 (288)
T d2jfla1 134 RDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212 (288)
T ss_dssp CCCSGGGEEEC-TTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSS
T ss_pred eecChhheeEC-CCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCC
Confidence 99999999999 47889999999997653321 2235689999999999842 344889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+.+.++.+.... . ...+..+++++++||++||+.||.+|||++|+
T Consensus 213 ~Pf~~~~~~~~~~~i~~~~~~-~-------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el 266 (288)
T d2jfla1 213 PPHHELNPMRVLLKIAKSEPP-T-------------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266 (288)
T ss_dssp CTTTTSCGGGHHHHHHHSCCC-C-------------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCC-C-------------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999999888887777652110 0 00123479999999999999999999999999
Q ss_pred hcCCCccc
Q 022500 235 CAHPFFDE 242 (296)
Q Consensus 235 l~hp~f~~ 242 (296)
++||||+.
T Consensus 267 l~hp~~~~ 274 (288)
T d2jfla1 267 LQHPFVTV 274 (288)
T ss_dssp TTSGGGCC
T ss_pred hcCcccCC
Confidence 99999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-51 Score=358.66 Aligned_cols=208 Identities=26% Similarity=0.420 Sum_probs=176.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||+++++|. +...+|||||||+| +|.+.+. ....++++..++.++.||+.||+|||+ +||+|
T Consensus 80 l~~l~HpnIv~~~~~~~-----~~~~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiH 150 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFE-----DKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVH 150 (352)
T ss_dssp HTTCCSTTBCCEEEEEE-----CSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCcEEEEEE-----ECCEEEEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeee
Confidence 57899999999999994 34458999999994 7665443 234579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcC-CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++. .++.+||+|||+|+............||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 151 RDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCC
Confidence 999999999973 3578999999999987666666678899999999999764 59999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..+.+....+. ......+++++++||.+||++||.+|||++|+|+||
T Consensus 230 ~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 230 GEDDLETLQNVKRCDWEFD-------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp CSSHHHHHHHHHHCCCCCC-------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCCHHHHHHHHHhCCCCCC-------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 9998888888776322111 112235899999999999999999999999999999
Q ss_pred Ccccc
Q 022500 239 FFDEL 243 (296)
Q Consensus 239 ~f~~~ 243 (296)
||+..
T Consensus 285 ~~~~~ 289 (352)
T d1koba_ 285 WLKGD 289 (352)
T ss_dssp TTSSC
T ss_pred hhCCC
Confidence 99864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-51 Score=351.49 Aligned_cols=202 Identities=27% Similarity=0.415 Sum_probs=169.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++|+|||||++++++.+.. .+|+|||||.|++...+. ..+..+++..++.++.||+.||.|||+ +||+||
T Consensus 69 l~~l~HpnIv~~~~~~~~~~-----~~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHr 139 (309)
T d1u5ra_ 69 LQKLRHPNTIQYRGCYLREH-----TAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHR 139 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETT-----EEEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCC
T ss_pred HHHCCCCCEeeEEEEEEECC-----EEEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecc
Confidence 57899999999999995443 489999999976554433 245779999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
||||+|||++ .++.+||+|||+|..... .....||+.|+|||++.+. ..|+.++||||+||++|+|++|..||.
T Consensus 140 DiKp~NILl~-~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 140 DVKAGNILLS-EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp CCSGGGEEEE-TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCcceEEEC-CCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 9999999999 578999999999986533 3456899999999998642 358999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+.++......+ ..+..+|+++++||.+||+.||.+|||++|+++||
T Consensus 216 ~~~~~~~~~~i~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 216 NMNAMSALYHIAQNESPA---------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp TSCHHHHHHHHHHSCCCC---------------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCHHHHHHHHHhCCCCC---------------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 998888777776521100 01234799999999999999999999999999999
Q ss_pred Cccc
Q 022500 239 FFDE 242 (296)
Q Consensus 239 ~f~~ 242 (296)
||..
T Consensus 269 ~~~~ 272 (309)
T d1u5ra_ 269 FVLR 272 (309)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=349.14 Aligned_cols=210 Identities=26% Similarity=0.417 Sum_probs=175.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||++++++. +...+|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+|
T Consensus 67 l~~l~HpnIv~~~~~~~-----~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivH 136 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYE-----NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAH 136 (293)
T ss_dssp HHHCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCcEEEEEE-----ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceee
Confidence 35689999999999994 4445999999999 588777764 3579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCC---cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~---~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++..+. .+|++|||+|..........+..||+.|+|||++.+ ..++.++||||+||++|+|++|..|
T Consensus 137 rDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp CCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCC
Confidence 999999999984332 599999999988766666667789999999999975 4589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+.+..+.+........ .+..+|+++++||++||+.||++|||++|+++
T Consensus 216 f~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 216 FLGDTKQETLANVSAVNYEFEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCHH-------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCch-------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999888887776642222211 22347999999999999999999999999999
Q ss_pred CCCcccccCC
Q 022500 237 HPFFDELREP 246 (296)
Q Consensus 237 hp~f~~~~~~ 246 (296)
||||+...+.
T Consensus 271 hp~~~~~~~~ 280 (293)
T d1jksa_ 271 HPWIKPKDTQ 280 (293)
T ss_dssp STTTCC----
T ss_pred CcccCCCChh
Confidence 9999876543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=359.55 Aligned_cols=233 Identities=27% Similarity=0.458 Sum_probs=165.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||+++++|.+. ..+|||||||+| +|.+.+.. .+.+++..++.++.||+.||.|||+.+||+|
T Consensus 58 l~~l~HpnIv~l~~~~~~~-----~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiH 128 (322)
T d1s9ja_ 58 LHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMH 128 (322)
T ss_dssp GGGCCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred HHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 5789999999999999543 348999999995 88777763 3579999999999999999999997138999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+||+|||+|+..... ...+.+||++|+|||++.+. .|+.++||||+||++|+|++|+.||.+
T Consensus 129 RDiKP~NILl~-~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 129 RDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp SCCSGGGEEEC-TTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred cccCHHHeeEC-CCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999998 5788999999999865432 23467899999999999875 599999999999999999999999988
Q ss_pred CChHHH-HHHHHHhcCCCCHHHHhhcCc--CCcCc---cCCCC---------CCCCcccccCCCCCHHHHHHHHcccccC
Q 022500 160 ENAVDQ-LVEIIKVLGTPTREEIRCMNP--NYTDF---RFPQI---------KAHPWHKVFHKRMPPEAIDLASRLLQYS 224 (296)
Q Consensus 160 ~~~~~~-~~~i~~~~~~~~~~~~~~~~~--~~~~~---~~~~~---------~~~~~~~~~~~~~~~~~~dll~~~L~~~ 224 (296)
.+..+. ...+....|.+.......... ..... ..+.. ............+|++++|||.+||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 285 (322)
T d1s9ja_ 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285 (322)
T ss_dssp CCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCC
Confidence 764432 222222222211110000000 00000 00000 0000111112346899999999999999
Q ss_pred CCCCCCHHHHhcCCCcccccC
Q 022500 225 PSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 225 p~~R~t~~e~l~hp~f~~~~~ 245 (296)
|.+|||++|+|+||||++..+
T Consensus 286 P~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 286 PAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp TTTSCCHHHHHTSHHHHHHHH
T ss_pred hhHCcCHHHHhhCHhhCcCCc
Confidence 999999999999999987543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=350.44 Aligned_cols=268 Identities=31% Similarity=0.559 Sum_probs=204.3
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||+++++|..... .....+|+|||||++++....+. ..+++..++.++.||+.||+|||+ +||+|
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiH 144 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIH 144 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcc
Confidence 457899999999999865442 23445789999998887766543 579999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+|++|||+|+.... ......||+.|+|||++.+...++.++||||+||++|+|++|.+||.+
T Consensus 145 rDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 145 RDLKPGNLAVN-EDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CCCCGGGEEEC-TTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCcchhhcc-cccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 99999999999 578899999999986533 345678999999999998766789999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCc---CccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+....+..+....+.++.+.+........ ....+......+.. ....++++++|||.+||++||++|||++|+|+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 999999999999999998877654432110 00122223333333 23458999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHH
Q 022500 237 HPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 283 (296)
Q Consensus 237 hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (296)
||||+.+.+...... .+.+....+....+.+..++++-+++.
T Consensus 301 Hp~f~~~~~~~~~~~-----~~~~~~~~~~~~~~~~e~k~~~~~e~~ 342 (346)
T d1cm8a_ 301 HPYFESLHDTEDEPQ-----VQKYDDSFDDVDRTLDEWKRVTYKEVL 342 (346)
T ss_dssp SGGGTTTC------C-----CCCCCCC-----CCHHHHHHHHHHHHH
T ss_pred ChhhCcCCCcccccc-----CCCCCCchhhhhcCHHHHHHHHHHHhh
Confidence 999998875433211 112222223334566677777666654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-50 Score=350.10 Aligned_cols=203 Identities=29% Similarity=0.483 Sum_probs=173.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ...+|+|||||+| ++...+. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 58 l~~l~HpnIv~~~~~~~~-----~~~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiH 127 (316)
T d1fota_ 58 LSIVTHPFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIY 127 (316)
T ss_dssp HHSCCBTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred HHhccCcChhheeeeEee-----CCeeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEc
Confidence 467899999999999953 4459999999996 5544443 45778999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+||+|||+|+.... ...+.+||+.|+|||++.+. .|+.++||||+||++|+|++|..||.+
T Consensus 128 rDiKp~NILl~-~~g~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 128 RDLKPENILLD-KNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp CCCCGGGEEEC-TTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccCchheeEc-CCCCEEEecCccceEecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCC
Confidence 99999999999 578899999999987643 33467899999999999654 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+..+...++.+... .++..++++++++|.+||++||.+|+ |++++
T Consensus 204 ~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~i 254 (316)
T d1fota_ 204 SNTMKTYEKILNAEL-----------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254 (316)
T ss_dssp SSHHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH
T ss_pred cCHHHHHHHHHcCCC-----------------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHH
Confidence 998888888765210 12234799999999999999999996 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+++.+.
T Consensus 255 l~Hp~f~~i~~~ 266 (316)
T d1fota_ 255 KNHPWFKEVVWE 266 (316)
T ss_dssp HTSGGGSSCCHH
T ss_pred HcCcccccCCHH
Confidence 999999998654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-50 Score=341.21 Aligned_cols=231 Identities=35% Similarity=0.660 Sum_probs=185.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++++|||||++++++...+ ..|++|||+.+++...+.. ..+.+++..++.++.||+.||+|||+ .||+||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~-----~~~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHr 124 (286)
T d1ob3a_ 54 LKELKHSNIVKLYDVIHTKK-----RLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHR 124 (286)
T ss_dssp GGGCCCTTBCCEEEEEECSS-----CEEEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred HHhCCCCcEEeeeeecccCC-----ceeEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEec
Confidence 57899999999999996544 3899999999887666643 46789999999999999999999999 699999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
||||+|||++ .++.+|++|||.|....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+
T Consensus 125 DiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 125 DLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp CCCGGGEEEC-TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCceeeEc-CCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 9999999999 47889999999998764332 234567899999999998777789999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCc-CccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
.+..+++.++.+..|.+....+......-. ..........++ ......++++++|||++||++||++|||++|+++||
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 999999999999988887665543321110 111111112222 234456899999999999999999999999999999
Q ss_pred Cccc
Q 022500 239 FFDE 242 (296)
Q Consensus 239 ~f~~ 242 (296)
||++
T Consensus 283 ~f~~ 286 (286)
T d1ob3a_ 283 YFKE 286 (286)
T ss_dssp GGGC
T ss_pred ccCc
Confidence 9974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-50 Score=341.71 Aligned_cols=205 Identities=30% Similarity=0.435 Sum_probs=173.9
Q ss_pred CCC-CCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 3 VMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 3 ~l~-HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+++ |||||++++++. ++..+|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||
T Consensus 65 ~l~~hpnIv~~~~~~~-----~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHr 134 (277)
T d1phka_ 65 KVSGHPNIIQLKDTYE-----TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHR 134 (277)
T ss_dssp HHTTCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred HhcCCCCeEEEEeecc-----cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCccc
Confidence 455 999999999994 4455999999998 588888764 3679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccC-----CCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
||||+||+++ .++.+||+|||+|+............||+.|+|||.+.+ ...++.++||||+||++|+|++|+.
T Consensus 135 Dlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 135 DLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp CCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccceEEEc-CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence 9999999999 578899999999998766656667789999999999852 3347889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+....+.+..-.+.. .....+|+++++||.+||+.||++|||++|++
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCCCCCHHHHHHHHHhCCCCCCC-------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 99999988888777763111110 01124899999999999999999999999999
Q ss_pred cCCCcccc
Q 022500 236 AHPFFDEL 243 (296)
Q Consensus 236 ~hp~f~~~ 243 (296)
+||||++.
T Consensus 269 ~h~~~~~~ 276 (277)
T d1phka_ 269 AHPFFQQY 276 (277)
T ss_dssp TSGGGCTT
T ss_pred cCHHHHHh
Confidence 99999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.8e-50 Score=353.20 Aligned_cols=208 Identities=26% Similarity=0.357 Sum_probs=169.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|+.++|||||++++++.. ...+|+|||||+ |+|.+.+.. ...+++..++.++.||+.||+|||+ +||+|
T Consensus 61 l~~~~hpnIv~l~~~~~~-----~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiH 130 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVY 130 (364)
T ss_dssp HSSSCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HhcCCCCcEEEEEEEEEE-----CCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 356789999999999954 344899999999 588777763 4678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+||+|||+|+..... ......||+.|+|||++.+...|+.++||||+||++|+|++|..||.+
T Consensus 131 rDlKP~NILl~-~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 131 RDLKPANILLD-EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCCSGGGEEEC-SSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeeccceeEEc-CCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 99999999999 5788999999999876443 344668999999999997655689999999999999999999999987
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCC-----HHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t-----~~e~ 234 (296)
.+..+........... ...++..+++++++||.+||++||.+||| ++|+
T Consensus 209 ~~~~~~~~~~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei 262 (364)
T d1omwa3 209 HKTKDKHEIDRMTLTM--------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262 (364)
T ss_dssp SCSSCHHHHHHHSSSC--------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH
T ss_pred CCHHHHHHHHHhcccC--------------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH
Confidence 6543322211111000 01123458999999999999999999999 7999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+++.+.
T Consensus 263 l~Hp~f~~i~~~ 274 (364)
T d1omwa3 263 KESPFFRSLDWQ 274 (364)
T ss_dssp HTSGGGTTCCHH
T ss_pred HcCccccCCCHH
Confidence 999999988653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-49 Score=348.52 Aligned_cols=203 Identities=26% Similarity=0.429 Sum_probs=173.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ...+|+||||+.| +|...+.. .+.+++..++.++.||+.||.|||+ +||+|
T Consensus 95 l~~l~hpnIv~~~~~~~~-----~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiH 164 (350)
T d1rdqe_ 95 LQAVNFPFLVKLEFSFKD-----NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIY 164 (350)
T ss_dssp HTTCCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHHcCCCcEeeccccccc-----ccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEec
Confidence 578999999999999943 4448999999995 76666653 3679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+||+|||+|+.... ...+..||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 165 RDIKP~NILl~-~~g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 165 RDLKPENLLID-QQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp CCCSGGGEEEC-TTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcCCHHHcccC-CCCCEEeeeceeeeeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCC
Confidence 99999999999 478899999999987643 33467899999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CHHHH
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEA 234 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~~e~ 234 (296)
.+....+.++...... ++..+++++.+||++||++||.+|+ |++++
T Consensus 241 ~~~~~~~~~i~~~~~~-----------------------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~el 291 (350)
T d1rdqe_ 241 DQPIQIYEKIVSGKVR-----------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291 (350)
T ss_dssp SSHHHHHHHHHHCCCC-----------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred cCHHHHHHHHhcCCCC-----------------------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHH
Confidence 9888888777652110 2235899999999999999999995 89999
Q ss_pred hcCCCcccccCC
Q 022500 235 CAHPFFDELREP 246 (296)
Q Consensus 235 l~hp~f~~~~~~ 246 (296)
++||||+++.+.
T Consensus 292 l~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 292 KNHKWFATTDWI 303 (350)
T ss_dssp HTSGGGTTCCHH
T ss_pred HcCccccCCCHH
Confidence 999999988653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=346.83 Aligned_cols=207 Identities=26% Similarity=0.422 Sum_probs=176.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||+++++|.+ ...+|||||||+| +|.+.+.. ....+++.+++.++.||+.||+|||+ +||+|
T Consensus 55 l~~l~HpnIv~~~~~~~~-----~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiH 125 (321)
T d1tkia_ 55 LNIARHRNILHLHESFES-----MEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGH 125 (321)
T ss_dssp HHHSCCTTBCCEEEEEEE-----TTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEEE-----CCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCc
Confidence 457899999999999954 3449999999995 77776653 33479999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCC-CCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 022500 80 RDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 158 (296)
|||||+|||++.+ ...+||+|||+++............+|+.|+|||.+.+. .|+.++||||+||++|+|++|..||.
T Consensus 126 rDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCC
Confidence 9999999999742 347999999999877665556677889999999998654 58999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+..|.+.....+.+. ...+|+++++||++||+.||.+|||++|+++||
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 205 AETNQQIIENIMNAEYTFDEEA-------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CSSHHHHHHHHHHTCCCCCHHH-------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCHHHHHHHHHhCCCCCChhh-------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 9999988888877433333222 134799999999999999999999999999999
Q ss_pred Cccc
Q 022500 239 FFDE 242 (296)
Q Consensus 239 ~f~~ 242 (296)
||++
T Consensus 260 ~~~~ 263 (321)
T d1tkia_ 260 WLKQ 263 (321)
T ss_dssp HHHS
T ss_pred hhcc
Confidence 9975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=344.61 Aligned_cols=202 Identities=29% Similarity=0.517 Sum_probs=172.2
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.++|||||++++++. +...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+|||
T Consensus 59 ~~~hp~Iv~~~~~~~-----~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrD 128 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQ-----TKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRD 128 (320)
T ss_dssp HTTCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCC
T ss_pred hCCCCcEEEEEEEEc-----cCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence 579999999999994 44459999999994 77777653 4679999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEeeccCccccccCC-CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 82 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 82 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
|||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.
T Consensus 129 ikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 129 LKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp CCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ccccceeec-CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 999999999 57889999999998664433 33456899999999999764 5999999999999999999999999999
Q ss_pred ChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH-HHhcCCC
Q 022500 161 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPF 239 (296)
Q Consensus 161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~-e~l~hp~ 239 (296)
+..+...++... .+. ++..+|+++++||++||++||.+|||+. ++++|||
T Consensus 207 ~~~~~~~~i~~~--~~~---------------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 207 DEEELFHSIRMD--NPF---------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257 (320)
T ss_dssp SHHHHHHHHHHC--CCC---------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred CHHHHHHHHHcC--CCC---------------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence 888877776541 111 2235899999999999999999999995 8999999
Q ss_pred cccccC
Q 022500 240 FDELRE 245 (296)
Q Consensus 240 f~~~~~ 245 (296)
|+++++
T Consensus 258 f~~~~~ 263 (320)
T d1xjda_ 258 FREINW 263 (320)
T ss_dssp GTTCCH
T ss_pred hccCCH
Confidence 998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=342.37 Aligned_cols=271 Identities=34% Similarity=0.659 Sum_probs=204.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|++|+|||||++++++.........++|+++++++|+|.+.+.. ..+++..++.++.||+.||+|||+ +||+||
T Consensus 60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHR 133 (345)
T d1pmea_ 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHR 133 (345)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCC
Confidence 45789999999999987655445556788888888899988763 469999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCC----CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 156 (296)
||||+|||++ +++.+||+|||+|....... .....+||+.|+|||++.....++.++||||+||++|+|++|..|
T Consensus 134 DIKp~NILl~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~p 212 (345)
T d1pmea_ 134 DLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212 (345)
T ss_dssp CCCGGGEEEC-TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCcceEEEC-CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCC
Confidence 9999999999 57889999999997653322 234567899999999986666789999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCC---cCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNY---TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
|.+.+..+.........+.+............ .....+.....++.... ..+++++++||.+||++||.+|||++|
T Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 213 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99999999999998888888866543221100 00112222233333333 358999999999999999999999999
Q ss_pred HhcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHH
Q 022500 234 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 283 (296)
Q Consensus 234 ~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (296)
+|+||||+....+..... ....+++..+......+.+++++.++..
T Consensus 292 ~L~hpf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~l~~~e~~ 337 (345)
T d1pmea_ 292 ALAHPYLEQYYDPSDEPI----AEAPFKFDMELDDLPKEKLKELIFEETA 337 (345)
T ss_dssp HHTSGGGTTTCCGGGSCC----CSSCC--------CCHHHHHHHHHHHSG
T ss_pred HhcCHhhccCCCCccCcc----ccCccCCChhhhhCCHHHHHHHHHHHHH
Confidence 999999997765432211 1233555566667777888887766544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=349.84 Aligned_cols=214 Identities=23% Similarity=0.385 Sum_probs=167.8
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.++|||||+++++|.+.. ....++|||||||+ |+|.+.+.. .....+++..++.++.||+.||+|||+ +||+|||
T Consensus 61 ~~~hpnIv~l~~~~~~~~-~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRD 136 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRD 136 (335)
T ss_dssp HTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred hcCCCCCCeEEEEEeecc-cCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCcccc
Confidence 358999999999985432 23456899999998 588888864 223579999999999999999999999 7999999
Q ss_pred CCCCcEEEcC--CCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 82 LKPQNLLVDP--LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 82 lkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||+|||++. ..+.+||+|||+|+............||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+
T Consensus 137 iKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred ccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 9999999974 2457999999999877666666678899999999999654 599999999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 239 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~ 239 (296)
.+.......+...... ..+.++ ......+|+++++||++||++||++|||+.|+++|||
T Consensus 216 ~~~~~~~~~~~~~i~~-------------~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 216 NHGLAISPGMKTRIRM-------------GQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp TTCC--------CCCS-------------CSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred CCHHHHHHHHHHHHhc-------------CCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 7654444333221100 001111 0111247999999999999999999999999999999
Q ss_pred ccc
Q 022500 240 FDE 242 (296)
Q Consensus 240 f~~ 242 (296)
|.+
T Consensus 275 ~~~ 277 (335)
T d2ozaa1 275 IMQ 277 (335)
T ss_dssp HHT
T ss_pred hhC
Confidence 975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=342.35 Aligned_cols=270 Identities=30% Similarity=0.537 Sum_probs=192.0
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||+++++|...+. ++..++|+|||||.|++++.+. ..+++..++.++.||+.||+|||+ +||+|
T Consensus 70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~-~giiH 142 (355)
T d2b1pa1 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIH 142 (355)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh-ccccc
Confidence 356899999999999864432 3456799999999998776553 568999999999999999999999 69999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+|++|||+++............+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+
T Consensus 143 rDlKP~Nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 143 RDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp SCCCGGGEEEC-TTCCEEECCCCC---------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCccccccc-cccceeeechhhhhccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCC
Confidence 99999999999 4778999999999877666666677899999999999764 589999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcCcc--CCCCCCCCccc-----------ccCCCCCHHHHHHHHcccccCCC
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR--FPQIKAHPWHK-----------VFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
.+......+++...+.+..+.+.........+. .+......+.. ......+++++|||++||++||+
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 300 (355)
T d2b1pa1 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 999999999999999988887765443221110 00111111111 11112467899999999999999
Q ss_pred CCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHH
Q 022500 227 LRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 282 (296)
Q Consensus 227 ~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (296)
+||||+|+|+||||+...++.... ...+..++...+....+.+.+.+++-.++
T Consensus 301 ~R~ta~elL~Hpw~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (355)
T d2b1pa1 301 KRISVDDALQHPYINVWYDPAEVE---APPPQIYDKQLDEREHTIEEWKELIYKEV 353 (355)
T ss_dssp TSCCHHHHHTSTTTGGGCCHHHHT---CCCC-------CCCCCCHHHHHHHHHHHH
T ss_pred HCcCHHHHhcCcccCCCCCccccc---CCCCCCCCcchhhhhcCHHHHHHHHHHHh
Confidence 999999999999999865432211 11223444444445556666666655544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=330.07 Aligned_cols=194 Identities=25% Similarity=0.380 Sum_probs=160.4
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g--~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
.|||||++++++... ..+|+||||+.+ ++.+.+.. ...+++..++.++.||+.||+|||+ +||+||||
T Consensus 67 ~h~nIv~~~~~~~~~-----~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDi 136 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDI 136 (273)
T ss_dssp SSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCC
T ss_pred CCCCccEEEEEEeeC-----CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccC
Confidence 399999999999543 348999999974 55555543 4679999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 162 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 162 (296)
||+|||++.+++.+||+|||+|+.... ....+..||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+
T Consensus 137 Kp~NIll~~~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~- 214 (273)
T d1xwsa_ 137 KDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE- 214 (273)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred cccceEEecCCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-
Confidence 999999986567899999999976433 334567899999999999766556788999999999999999999997632
Q ss_pred HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCCCccc
Q 022500 163 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 242 (296)
Q Consensus 163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp~f~~ 242 (296)
.+.+. . ..++..+|+++++||++||+.||++|||++|+++||||++
T Consensus 215 -----~i~~~-----------------~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 215 -----EIIRG-----------------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp -----HHHHC-----------------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -----HHhhc-----------------c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 22221 0 0122458999999999999999999999999999999987
Q ss_pred cc
Q 022500 243 LR 244 (296)
Q Consensus 243 ~~ 244 (296)
+.
T Consensus 261 ~~ 262 (273)
T d1xwsa_ 261 VL 262 (273)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=334.97 Aligned_cols=268 Identities=33% Similarity=0.565 Sum_probs=201.0
Q ss_pred CCCCCCCCeeeeceeeeccCC-CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~-~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++|+|||||++++++..... ++...+++++++++|+|.+.+. ...+++..++.++.||+.||+|||+ +||+|
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiH 144 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIH 144 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcc
Confidence 357899999999999864433 2334455666666678877664 3569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
|||||+|||++ .++.+|++|||+|.... ....+..||+.|+|||++.+...++.++||||+||++|+|++|.+||.+
T Consensus 145 rDiKp~NILi~-~~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 145 RDLKPSNLAVN-EDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp CCCCGGGEEEC-TTCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCcccccc-ccccccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 99999999999 57889999999997542 3345668899999999987776689999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCHHHHhhcCcCCcC---ccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 160 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
.+.......+.+..+.+..+........... ..........+... ...++++++|||++||++||.+|+|++|+|+
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 9999999999999988887665433211100 01112222222222 2458999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHH
Q 022500 237 HPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 283 (296)
Q Consensus 237 hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (296)
||||+++..+.. .+..+.+....+......+.+.+++-+++.
T Consensus 301 Hp~f~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~k~~~~~e~~ 342 (348)
T d2gfsa1 301 HAYFAQYHDPDD-----EPVADPYDQSFESRDLLIDEWKSLTYDEVI 342 (348)
T ss_dssp SGGGTTTCCTTS-----CCCCCCCCCGGGGCCCCHHHHHHHHHHHHH
T ss_pred CHhhCCCCCCcc-----CCCCCCCCCcccchhcCHHHHHHHHHHHhh
Confidence 999998765432 223334455555566666777777666553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=325.12 Aligned_cols=234 Identities=33% Similarity=0.583 Sum_probs=185.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
|+.++|||||++++++.. ...+++|+|++.|+....+. ...+.+++..++.++.|++.||+|||+ +||+||
T Consensus 55 l~~l~h~niv~~~~~~~~-----~~~~~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHr 125 (292)
T d1unla_ 55 LKELKHKNIVRLHDVLHS-----DKKLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHR 125 (292)
T ss_dssp HTTCCCTTBCCEEEEEEC-----SSEEEEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHhcCcCCEEeecccccc-----ccceeEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeee
Confidence 478999999999999954 34488999999986544443 356789999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCC-ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-CC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FP 158 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~ 158 (296)
||||+|||++ .++.+||+|||.|+....... .....+++.|+|||++.+...++.++||||+||++|+|++|..| |.
T Consensus 126 DiKP~NIli~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 126 DLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCSGGGEEEC-TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cccCcccccc-cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 9999999999 477899999999987654332 33456788999999997766689999999999999999999876 56
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcCC
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 238 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~hp 238 (296)
+.+..+.+.++....+.+....+............+..............++++++|||++||++||.+|||++|+|+||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred CCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence 67778888888888888776655443222111122222222223334456899999999999999999999999999999
Q ss_pred Cccccc
Q 022500 239 FFDELR 244 (296)
Q Consensus 239 ~f~~~~ 244 (296)
||+++.
T Consensus 285 ~f~~~~ 290 (292)
T d1unla_ 285 YFSDFC 290 (292)
T ss_dssp GGSSCS
T ss_pred hhcCCC
Confidence 998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.3e-48 Score=335.39 Aligned_cols=233 Identities=30% Similarity=0.522 Sum_probs=179.1
Q ss_pred CCC-CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 022500 2 RVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 80 (296)
Q Consensus 2 ~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~ 80 (296)
+++ .||||++++++|... ...++|+|||||+++.+ .. ....+++..++.++.||+.||+|||+ +||+||
T Consensus 84 ~~l~~hpnIv~~~~~~~~~---~~~~~~~v~e~~~~~~L---~~---~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHr 153 (328)
T d3bqca1 84 ENLRGGPNIITLADIVKDP---VSRTPALVFEHVNNTDF---KQ---LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHR 153 (328)
T ss_dssp HHHTTSTTBCCEEEEEECT---TTCSEEEEEECCCSCBG---GG---TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HhccCCCCCcEEEEEEEec---CCCceeEEEeecCCCcH---HH---HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccc
Confidence 345 499999999998532 23458899999996422 11 23569999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 022500 81 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 160 (296)
Q Consensus 81 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 160 (296)
||||+|||++.+++.+||+|||+|+...........++|+.|+|||.+.+...++.++|+||+||++|+|++|..||...
T Consensus 154 DiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 99999999986566799999999987766666667789999999999987767899999999999999999999998654
Q ss_pred -ChHHHHHHHHHhcCCCCHHHHhhcCcC-----CcCccCCCCCCCCcc----cccCCCCCHHHHHHHHcccccCCCCCCC
Q 022500 161 -NAVDQLVEIIKVLGTPTREEIRCMNPN-----YTDFRFPQIKAHPWH----KVFHKRMPPEAIDLASRLLQYSPSLRCT 230 (296)
Q Consensus 161 -~~~~~~~~i~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~~~~~~dll~~~L~~~p~~R~t 230 (296)
+..++...+.+.+|.+........... +... ........+. ......++++++|||++||++||++|+|
T Consensus 234 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t 312 (328)
T d3bqca1 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312 (328)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGT-CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC
T ss_pred chhHHHHHHHHHHHCCchhhhhhhhcccccCcccchh-cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC
Confidence 556667777777776555444322111 1111 1111111111 1122347899999999999999999999
Q ss_pred HHHHhcCCCcccccC
Q 022500 231 ALEACAHPFFDELRE 245 (296)
Q Consensus 231 ~~e~l~hp~f~~~~~ 245 (296)
++|+|+||||+++.+
T Consensus 313 a~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 313 AREAMEHPYFYTVVK 327 (328)
T ss_dssp HHHHHTSGGGTTSCC
T ss_pred HHHHhcCcccCCCCC
Confidence 999999999998765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=330.35 Aligned_cols=237 Identities=26% Similarity=0.475 Sum_probs=180.5
Q ss_pred CCCCCCCCeeeeceeeeccCC---CCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022500 1 MRVMDHPNVISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 77 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~---~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i 77 (296)
|++++||||+++++++..... .....+|+|||||++++..... .....+++..++.++.||+.||+|||+ +||
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~i 138 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKI 138 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCE
Confidence 457899999999998864321 2244588999999987665443 345679999999999999999999999 799
Q ss_pred ccCCCCCCcEEEcCCCCcEEEeeccCccccccCC-----CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 022500 78 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 152 (296)
Q Consensus 78 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 152 (296)
+||||||+|||++ .++.+|++|||+|+...... ...+.+||+.|+|||++.+...++.++||||+||++|+|++
T Consensus 139 vHrDlKp~NILl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~ 217 (318)
T d3blha1 139 LHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217 (318)
T ss_dssp ECCCCCGGGEEEC-TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred EecCcCchheeec-CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh
Confidence 9999999999999 47889999999997654221 22346789999999999876679999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcC--CcCccCCCCCCCCccccc-CCCCCHHHHHHHHcccccCCCCCC
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN--YTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
|++||.+.+..+....+.+..+.+..+........ +..+.............+ ....+++++|||.+||++||++|+
T Consensus 218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 297 (318)
T d3blha1 218 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297 (318)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc
Confidence 99999999999999999998888776544332211 111111111111111100 112478899999999999999999
Q ss_pred CHHHHhcCCCccc
Q 022500 230 TALEACAHPFFDE 242 (296)
Q Consensus 230 t~~e~l~hp~f~~ 242 (296)
|++|+|+||||+.
T Consensus 298 sa~elL~Hpff~~ 310 (318)
T d3blha1 298 DSDDALNHDFFWS 310 (318)
T ss_dssp CHHHHHHSGGGSS
T ss_pred CHHHHHcChhhcc
Confidence 9999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=322.05 Aligned_cols=203 Identities=24% Similarity=0.277 Sum_probs=160.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||+++++... . .+|||||||+ |+|.+.+.. .+..+++..+..++.||+.||+|||+ +||+|
T Consensus 58 l~~l~HpnIv~~~~~~~~-~-----~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivH 127 (276)
T d1uwha_ 58 LRKTRHVNILLFMGYSTA-P-----QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 127 (276)
T ss_dssp HTTCCCTTBCCEEEEECS-S-----SCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeeeEEEec-c-----EEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEec
Confidence 478999999999997632 1 2789999999 588777753 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+|||++ .++.+||+|||+|+...... ...+..||+.|+|||++.+. ..|+.++||||+||++|||++|.
T Consensus 128 rDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~ 206 (276)
T d1uwha_ 128 RDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206 (276)
T ss_dssp SCCCGGGEEEE-TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cccCHHHEEEc-CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence 99999999999 57889999999998654322 22356789999999998643 34899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+....+..++.....++ .....+..+++++.+||.+||+.||.+|||++++
T Consensus 207 ~Pf~~~~~~~~~~~~~~~~~~~p-----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i 263 (276)
T d1uwha_ 207 LPYSNINNRDQIIFMVGRGYLSP-----------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263 (276)
T ss_dssp CTTTTCCCHHHHHHHHHHTSCCC-----------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHhcCCCCC-----------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 99998877766665554321111 0011234579999999999999999999999999
Q ss_pred hcC
Q 022500 235 CAH 237 (296)
Q Consensus 235 l~h 237 (296)
+++
T Consensus 264 l~~ 266 (276)
T d1uwha_ 264 LAS 266 (276)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=329.66 Aligned_cols=198 Identities=22% Similarity=0.328 Sum_probs=162.2
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh-------------------cCCCCCHHHHHHHHHHH
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------ANQRMPLIYVKLYTYQI 64 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~-------------------~~~~~~~~~~~~~~~qi 64 (296)
+|||||++++++.... .+|+|||||+ |+|.+.+..... ....+++..++.++.||
T Consensus 99 ~HpnIv~l~~~~~~~~-----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 99 SHENIVNLLGACTLSG-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp CCTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred CCCcEeEEEEEEeeCC-----eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 8999999999995433 4889999999 688888864321 12458999999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHH
Q 022500 65 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIW 141 (296)
Q Consensus 65 l~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 141 (296)
+.||+|||+ +||+||||||+||+++ .++.+||+|||+|+....... ..+..||+.|+|||++.+. .++.++|||
T Consensus 174 ~~gl~yLH~-~~IiHRDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Diw 250 (325)
T d1rjba_ 174 AKGMEFLEF-KSCVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHH-TTEEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHH
T ss_pred HHHHHHHHh-CCeeeccCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceecc
Confidence 999999999 7999999999999999 578999999999987654432 2346789999999999754 599999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcc
Q 022500 142 SAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 220 (296)
Q Consensus 142 slG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 220 (296)
|+||++|||++ |.+||.+.+..+.+.++++....+. .+..+++++++||.+|
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~l~~li~~c 303 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD---------------------------QPFYATEEIYIIMQSC 303 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCCcCCHHHHHHHHHH
Confidence 99999999997 8999998877666766665321111 2235799999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 022500 221 LQYSPSLRCTALEACAH 237 (296)
Q Consensus 221 L~~~p~~R~t~~e~l~h 237 (296)
|+.||++|||++|+++|
T Consensus 304 l~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 304 WAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhHCcCHHHHHHH
Confidence 99999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-46 Score=321.74 Aligned_cols=198 Identities=24% Similarity=0.319 Sum_probs=153.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... .+|+|||||+| +|.+.+.. ..+.+++..+..++.||+.||+|||+ +||+|
T Consensus 81 l~~l~HpnIv~l~g~~~~~~-----~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiH 151 (299)
T d1jpaa_ 81 MGQFDHPNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVH 151 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSS-----SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCCccEEEEEeeCC-----EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCcc
Confidence 57899999999999985443 38899999995 66665553 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc------cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 152 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~- 152 (296)
|||||+|||++ .++.+||+|||+|+........ ....+|+.|+|||++.+. .++.++||||+||++|||++
T Consensus 152 rDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 152 RDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp SCCCGGGEEEC-TTCCEEECCC-----------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred CccccceEEEC-CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhC
Confidence 99999999999 5788999999999876443221 124568899999999764 59999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHH
Q 022500 153 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 232 (296)
Q Consensus 153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~ 232 (296)
|.+||.+.+..+.+..+.+....+ .+..+++++.+||.+||+.||++|||+.
T Consensus 230 g~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ 281 (299)
T d1jpaa_ 230 GERPYWDMTNQDVINAIEQDYRLP----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFG 281 (299)
T ss_dssp SCCTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 899999988877776665421111 1234789999999999999999999999
Q ss_pred HHhcC
Q 022500 233 EACAH 237 (296)
Q Consensus 233 e~l~h 237 (296)
+++++
T Consensus 282 ei~~~ 286 (299)
T d1jpaa_ 282 QIVNT 286 (299)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=319.82 Aligned_cols=201 Identities=24% Similarity=0.302 Sum_probs=162.1
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. . ..|||||||+ |+|.+.+. ....+++..+..++.||+.||+|||+ +||+|
T Consensus 62 l~~l~HpnIv~~~g~~~~-~-----~~~lvmE~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiH 130 (277)
T d1xbba_ 62 MQQLDNPYIVRMIGICEA-E-----SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVH 130 (277)
T ss_dssp HHTCCCTTBCCEEEEEES-S-----SEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCceEEEEecc-C-----CEEEEEEcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh-CCccc
Confidence 467899999999998732 1 1679999999 57776665 45679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+|||++ .++.+||+|||+|+........ ....||+.|+|||++.+. .++.++||||+||++|||++ |.
T Consensus 131 rDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 131 RDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp SCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCcchhhccc-ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCC
Confidence 99999999999 5788999999999876443322 234678999999999754 58999999999999999997 89
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+.+. ..+ ..+..+++++.+||.+||+.||++|||++++
T Consensus 209 ~Pf~~~~~~~~~~~i~~~-~~~---------------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i 260 (277)
T d1xbba_ 209 KPYRGMKGSEVTAMLEKG-ERM---------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260 (277)
T ss_dssp CSSTTCCHHHHHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcC-CCC---------------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 999998877666555431 000 1224579999999999999999999999988
Q ss_pred ---hcCCCccc
Q 022500 235 ---CAHPFFDE 242 (296)
Q Consensus 235 ---l~hp~f~~ 242 (296)
|+|+|++-
T Consensus 261 ~~~L~~~~~~~ 271 (277)
T d1xbba_ 261 ELRLRNYYYDV 271 (277)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHhhCHHhhc
Confidence 46666543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-46 Score=316.13 Aligned_cols=204 Identities=21% Similarity=0.302 Sum_probs=161.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... .+|||||||+ |+|.+.+.. .....+++..++.++.||+.||+|||+ +||+|
T Consensus 67 l~~l~HpnIv~~~~~~~~~~-----~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiH 138 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREP-----PFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIH 138 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEecCCccEeeCC-----eeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence 45789999999999985433 3889999999 687777754 234678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 157 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 157 (296)
|||||+|||++ .++.+||+|||+|+....... .....|++.|+|||++.+. .|+.++||||+||++|+|++|..||
T Consensus 139 rDlKp~NILl~-~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 139 RDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp SCCSGGGEEEC-GGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccccCeEEEC-CCCcEEEccccceeecCCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCC
Confidence 99999999999 578899999999987644332 2334678999999998764 5999999999999999999976655
Q ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhcC
Q 022500 158 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 237 (296)
Q Consensus 158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~h 237 (296)
........+.+++..... ...+..+++++.+||.+||+.||.+|||++++++
T Consensus 217 ~~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~- 268 (287)
T d1opja_ 217 YPGIDLSQVYELLEKDYR---------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ- 268 (287)
T ss_dssp STTCCHHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-
T ss_pred CCcchHHHHHHHHhcCCC---------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH-
Confidence 444444444444432111 0123458999999999999999999999999976
Q ss_pred CCcccc
Q 022500 238 PFFDEL 243 (296)
Q Consensus 238 p~f~~~ 243 (296)
+|+.+
T Consensus 269 -~L~~~ 273 (287)
T d1opja_ 269 -AFETM 273 (287)
T ss_dssp -HHHHT
T ss_pred -HHHHH
Confidence 56554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=314.17 Aligned_cols=198 Identities=18% Similarity=0.294 Sum_probs=152.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... .+|+|||||+ |+|.+.+.. ....+++..+..++.||+.||+|||+ ++|+|
T Consensus 54 l~~l~HpnIv~~~g~~~~~~-----~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiH 124 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQA-----PICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIH 124 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhcCCCCcccccceeccCC-----ceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceee
Confidence 35689999999999985443 3889999998 577776653 44678999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||++ |.+|
T Consensus 125 rDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~ 202 (263)
T d1sm2a_ 125 RDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIP 202 (263)
T ss_dssp TTCSGGGEEEC-GGGCEEECSCC------------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccchhheeec-CCCCeEecccchheeccCCCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCC
Confidence 99999999999 578899999999987644332 2345789999999999764 59999999999999999999 5677
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+.+..+...... ..+...++++.+|+.+||+.||++|||++++++
T Consensus 203 ~~~~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 254 (263)
T d1sm2a_ 203 YENRSNSEVVEDISTGFRL----------------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254 (263)
T ss_dssp TCSCCHHHHHHHHHHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCC----------------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7777766666655442110 112347899999999999999999999999998
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
|
T Consensus 255 ~ 255 (263)
T d1sm2a_ 255 Q 255 (263)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=319.07 Aligned_cols=202 Identities=25% Similarity=0.312 Sum_probs=164.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. . .+|||||||+| +|.+.+.. .+..+++..+..++.||+.||+|||+ +||+|
T Consensus 63 l~~l~HpnIv~l~g~~~~-~-----~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiH 132 (285)
T d1u59a_ 63 MHQLDNPYIVRLIGVCQA-E-----ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVH 132 (285)
T ss_dssp HHHCCCTTBCCEEEEEES-S-----SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCEeeEeeeecc-C-----eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 357899999999998742 1 27899999995 77665542 44679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||++ |.
T Consensus 133 rDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~ 210 (285)
T d1u59a_ 133 RDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQ 210 (285)
T ss_dssp CCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCchhheeec-cCCceeeccchhhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCC
Confidence 99999999999 578899999999987644322 1234678999999999654 58999999999999999998 89
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+....+.+.. .+ ..+..+++++.+||.+||+.||++|||+.++
T Consensus 211 ~Pf~~~~~~~~~~~i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i 262 (285)
T d1u59a_ 211 KPYKKMKGPEVMAFIEQGK-RM---------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTV 262 (285)
T ss_dssp CTTTTCCTHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCC-CC---------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9999988777666554310 00 1234589999999999999999999999877
Q ss_pred ---hcCCCccc
Q 022500 235 ---CAHPFFDE 242 (296)
Q Consensus 235 ---l~hp~f~~ 242 (296)
|+|+|++-
T Consensus 263 ~~~L~~~~~~~ 273 (285)
T d1u59a_ 263 EQRMRACYYSL 273 (285)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 67888754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-46 Score=316.04 Aligned_cols=208 Identities=23% Similarity=0.376 Sum_probs=160.4
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... .....+|||||||+| +|.+.+. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 61 l~~~~hpniv~~~~~~~~~~-~~~~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiH 134 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAET-PAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ-NGIIH 134 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhcCCCCCCcccceeeecc-CCCceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccC
Confidence 45789999999999987554 334458899999995 6665554 34679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC----CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 155 (296)
|||||+||+++ .++.++++|||.+....... .....+||+.|+|||++.+. .++.++||||+||++|+|++|.+
T Consensus 135 rDiKP~NIll~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 135 RDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp CCCSGGGEEEE-TTSCEEECCCTTCEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCcccccC-ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCC
Confidence 99999999999 47789999999987553322 23456899999999999764 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+...++++....+. ......+|+++.+||.+||++||.+||+..+.+
T Consensus 213 Pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l 267 (277)
T d1o6ya_ 213 PFTGDSPVSVAYQHVREDPIPP-------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267 (277)
T ss_dssp SCCCSSHHHHHHHHHHCCCCCG-------------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred CCCCcCHHHHHHHHHhcCCCCC-------------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHH
Confidence 9999998888877766322211 112245899999999999999999999544444
Q ss_pred cCCCcc
Q 022500 236 AHPFFD 241 (296)
Q Consensus 236 ~hp~f~ 241 (296)
.|+|.+
T Consensus 268 ~~~l~r 273 (277)
T d1o6ya_ 268 RADLVR 273 (277)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 456653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=314.67 Aligned_cols=203 Identities=25% Similarity=0.327 Sum_probs=162.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. . .+|+|||||+ |+|.+.+... ....+++..+..++.||+.||+|||+ ++|+|
T Consensus 62 l~~l~HpnIv~~~g~~~~-~-----~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivH 132 (272)
T d1qpca_ 62 MKQLQHQRLVRLYAVVTQ-E-----PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIH 132 (272)
T ss_dssp HHHCCCTTBCCEEEEECS-S-----SCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCEeEEEeeecc-C-----CeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 357899999999997632 1 2679999999 5776655432 23458999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~p 156 (296)
|||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||+|| .+|
T Consensus 133 rDiKp~NIll~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 133 RDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp SCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred Cccchhheeee-cccceeeccccceEEccCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCC
Confidence 99999999999 578899999999987654332 2345788999999999754 589999999999999999995 566
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|...+..+.+..+.+.. .+ ..+..+++++.+||.+||+.||.+|||++++++
T Consensus 211 ~~~~~~~~~~~~i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 211 YPGMTNPEVIQNLERGY-RM---------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp STTCCHHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcC-CC---------------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 66666666555554311 00 122357999999999999999999999999988
Q ss_pred --CCCccc
Q 022500 237 --HPFFDE 242 (296)
Q Consensus 237 --hp~f~~ 242 (296)
|+||.+
T Consensus 263 ~L~~~fts 270 (272)
T d1qpca_ 263 VLEDFFTA 270 (272)
T ss_dssp HHHHHHHH
T ss_pred Hhhhhhhc
Confidence 788864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=307.34 Aligned_cols=198 Identities=17% Similarity=0.261 Sum_probs=163.7
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... .+++||||++ |++...+.. ....+++..+..++.|++.||+|||+ +||+|
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~-----~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH 123 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQR-----PIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLH 123 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSS-----SEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCC
T ss_pred HHhcCCCceeeEEEEEeeCC-----ceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCccc
Confidence 35789999999999985433 3899999998 566666543 34568999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|||++ |..|
T Consensus 124 ~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~P 201 (258)
T d1k2pa_ 124 RDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMP 201 (258)
T ss_dssp SCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccccceeEEEc-CCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCC
Confidence 99999999999 578899999999986544322 2345689999999999764 58999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.+.... ..+...++++.+||++||+.||++|||++++++
T Consensus 202 f~~~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 253 (258)
T d1k2pa_ 202 YERFTNSETAEHIAQGLRL----------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLS 253 (258)
T ss_dssp TTTSCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhCCCC----------------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9999888777666542111 112347899999999999999999999999998
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
|
T Consensus 254 ~ 254 (258)
T d1k2pa_ 254 N 254 (258)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=310.37 Aligned_cols=197 Identities=27% Similarity=0.384 Sum_probs=152.2
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. ..+|+|||||++ ++.+.+.. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 62 l~~l~HpnIv~l~~~~~~------~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiH 131 (273)
T d1mp8a_ 62 MRQFDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVH 131 (273)
T ss_dssp HHTCCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEec------CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeec
Confidence 467899999999998832 137899999994 66655443 45679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 156 (296)
|||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++ |.+|
T Consensus 132 rDlKp~NIll~-~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P 209 (273)
T d1mp8a_ 132 RDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKP 209 (273)
T ss_dssp SCCSGGGEEEE-ETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccchhheeec-CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCC
Confidence 99999999999 57889999999998754332 22345678999999999654 59999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
|.+.+..+....+.+.... .++..+++++.+||.+||+.||.+|||+.|+++
T Consensus 210 ~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~ 261 (273)
T d1mp8a_ 210 FQGVKNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261 (273)
T ss_dssp TTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9998887777666542100 123458999999999999999999999999987
Q ss_pred C
Q 022500 237 H 237 (296)
Q Consensus 237 h 237 (296)
|
T Consensus 262 ~ 262 (273)
T d1mp8a_ 262 Q 262 (273)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=304.37 Aligned_cols=197 Identities=20% Similarity=0.248 Sum_probs=150.0
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... .+++|||||.+ ++.+.+.. ....+++..+..++.||+.||+|||+ ++|+|
T Consensus 63 l~~l~H~nIv~~~g~~~~~~-----~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiH 133 (283)
T d1mqba_ 63 MGQFSHHNIIRLEGVISKYK-----PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVH 133 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSS-----SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhcCCCCEeeeeEEEecCC-----ceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-ccccc
Confidence 45789999999999985443 38899999996 55554443 45679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC-
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ- 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~- 154 (296)
|||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||++|.
T Consensus 134 rDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~ 211 (283)
T d1mqba_ 134 RDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGE 211 (283)
T ss_dssp SCCCGGGEEEC-TTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccccceEEEC-CCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCC
Confidence 99999999999 578999999999987644322 2234678999999999764 5999999999999999999965
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
+|+.+.+..+.+..+.+. ..+ ..+..+++++.+||.+||+.||++|||+.|+
T Consensus 212 ~~~~~~~~~~~~~~i~~~-~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 212 RPYWELSNHEVMKAINDG-FRL---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp CTTTTCCHHHHHHHHHTT-CCC---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CccccCCHHHHHHHHhcc-CCC---------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 555555555544443321 111 1223478999999999999999999999999
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 264 l~ 265 (283)
T d1mqba_ 264 VS 265 (283)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=318.48 Aligned_cols=209 Identities=27% Similarity=0.445 Sum_probs=166.2
Q ss_pred CCCCC-CCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 2 RVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 2 ~~l~H-pnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
++++| |||+++++++.. ...+|+||||+. |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+|
T Consensus 83 ~~l~h~pnIv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivH 152 (322)
T d1vzoa_ 83 EHIRQSPFLVTLHYAFQT-----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIY 152 (322)
T ss_dssp HHHHTCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HhccCCCeEEEeeeeecc-----CCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEe
Confidence 45656 899999999844 344999999999 577766653 3568899999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCC--CccceeecccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p 156 (296)
|||||+||+++ .++.+||+|||+|+...... ...+..|++.|+|||.+.+.. .++.++||||+||++|+|++|..|
T Consensus 153 rDiKp~Nill~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P 231 (322)
T d1vzoa_ 153 RDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231 (322)
T ss_dssp CCCCGGGEEEC-TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCccceeec-CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999 47889999999998654332 234567899999999996543 478899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC-----CH
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TA 231 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~-----t~ 231 (296)
|.+.+..+....+.+...... ..++..+++++++||++||++||.+|+ |+
T Consensus 232 F~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~ 286 (322)
T d1vzoa_ 232 FTVDGEKNSQAEISRRILKSE-------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286 (322)
T ss_dssp TSCTTSCCCHHHHHHHHHHCC-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred CCCCCHHHHHHHHHHhcccCC-------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccH
Confidence 988765554444443210000 012345899999999999999999999 58
Q ss_pred HHHhcCCCcccccCC
Q 022500 232 LEACAHPFFDELREP 246 (296)
Q Consensus 232 ~e~l~hp~f~~~~~~ 246 (296)
+|+++||||+.+.+.
T Consensus 287 ~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 287 DEIKEHLFFQKINWD 301 (322)
T ss_dssp HHHHTSGGGTTCCHH
T ss_pred HHHHcCHhhcCCCHH
Confidence 999999999987653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=304.58 Aligned_cols=204 Identities=25% Similarity=0.324 Sum_probs=157.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.. . .+++|||||++ ++...+... ....+++..++.++.||+.||+|||+ +||+|
T Consensus 66 l~~l~h~nIv~~~g~~~~-~-----~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH 136 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSE-E-----PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVH 136 (285)
T ss_dssp HHHCCCTTBCCEEEEECS-S-----SCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhcccCCEeEEEEEEec-C-----CeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheec
Confidence 357899999999998732 1 16799999995 666555432 33569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC--ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPL 156 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~p 156 (296)
|||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||++| .+|
T Consensus 137 ~DlKp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 137 RDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp SCCSGGGEEEC-GGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccceEEEEC-CCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCC
Confidence 99999999998 578899999999986543322 2345689999999999754 589999999999999999996 555
Q ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 157 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+.+....+.+..+.+.... ..+..+++++++||.+||+.||++|||++++++
T Consensus 215 ~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 215 YPGMVNREVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp STTCCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCC----------------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 6666666666555432110 122357999999999999999999999999987
Q ss_pred --CCCcccc
Q 022500 237 --HPFFDEL 243 (296)
Q Consensus 237 --hp~f~~~ 243 (296)
++||...
T Consensus 267 ~L~~~~~~~ 275 (285)
T d1fmka3 267 FLEDYFTST 275 (285)
T ss_dssp HHHTTTSCS
T ss_pred HHhhhhcCC
Confidence 8888764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=306.35 Aligned_cols=200 Identities=25% Similarity=0.349 Sum_probs=154.9
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHH
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAY 70 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------------~~~~~~~~~~~~~~~qil~aL~~ 70 (296)
.+|||||++++++.... ..+++|||||+ |+|.+.+..... ....+++..++.++.||+.||+|
T Consensus 74 ~~h~~iv~~~~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 149 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149 (299)
T ss_dssp CCCTTBCCEEEEECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHH
T ss_pred cCCCeEEEeeeeeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHH
Confidence 47999999998875332 34789999999 688888865322 13458999999999999999999
Q ss_pred HHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 71 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 71 LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
||+ +||+||||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++
T Consensus 150 lH~-~~ivHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 150 LAS-RKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLL 226 (299)
T ss_dssp HHH-TTCCCSCCCGGGEEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred HHh-CCCcCCcCCccceeEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHH
Confidence 999 7999999999999999 578899999999986543322 2346789999999999764 599999999999999
Q ss_pred HHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 148 AELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 148 ~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|||++| .+||.+....+.+..++.....+. .+..+++++.+||.+||+.||.
T Consensus 227 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1ywna1 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPS 279 (299)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChh
Confidence 999986 578888766666655554321111 2234799999999999999999
Q ss_pred CCCCHHHHhcC
Q 022500 227 LRCTALEACAH 237 (296)
Q Consensus 227 ~R~t~~e~l~h 237 (296)
+|||++|+++|
T Consensus 280 ~Rpt~~eil~~ 290 (299)
T d1ywna1 280 QRPTFSELVEH 290 (299)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=302.86 Aligned_cols=197 Identities=25% Similarity=0.346 Sum_probs=160.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.+. .+++|||||+ |++.+.+.. ..+.+++..++.++.||+.||+|||+ +||+|
T Consensus 65 l~~l~H~nIv~~~g~~~~~------~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiH 134 (273)
T d1u46a_ 65 MHSLDHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIH 134 (273)
T ss_dssp HHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCEEEEEEEEeec------chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEee
Confidence 3578999999999998432 2679999999 577766553 34569999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc----cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~ 154 (296)
|||||+||+++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++||||+||++|||++ |.
T Consensus 135 rDikp~NIll~-~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~ 212 (273)
T d1u46a_ 135 RDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQ 212 (273)
T ss_dssp SCCCGGGEEEE-ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSC
T ss_pred eeecHHHhccc-cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCC
Confidence 99999999999 4778999999999876444322 234567899999999764 58999999999999999998 89
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHH
Q 022500 155 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 234 (296)
Q Consensus 155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~ 234 (296)
.||.+.+..+.+..+.+....++ .+..+++++.+||.+||+.||.+|||++++
T Consensus 213 ~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei 265 (273)
T d1u46a_ 213 EPWIGLNGSQILHKIDKEGERLP---------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265 (273)
T ss_dssp CTTTTCCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCcCHHHHHHHHHhCCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999998888877765311111 224578999999999999999999999998
Q ss_pred hc
Q 022500 235 CA 236 (296)
Q Consensus 235 l~ 236 (296)
++
T Consensus 266 ~~ 267 (273)
T d1u46a_ 266 RD 267 (273)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=306.60 Aligned_cols=197 Identities=25% Similarity=0.320 Sum_probs=157.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... .++++||+. |+|.+.+.. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 65 l~~l~HpnIv~l~g~~~~~~------~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiH 134 (317)
T d1xkka_ 65 MASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVH 134 (317)
T ss_dssp HHHCCCTTBCCEEEEEESSS------EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEecCC------eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCccc
Confidence 35789999999999985321 557777777 677776653 45679999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCc---cceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 155 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 155 (296)
|||||+|||++ .++.+||+|||+|+........ ....||+.|+|||++.+. .++.++||||+||++|||+| |.+
T Consensus 135 rDlKp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~ 212 (317)
T d1xkka_ 135 RDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSK 212 (317)
T ss_dssp SCCCGGGEEEE-ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CcchhhcceeC-CCCCeEeeccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCC
Confidence 99999999999 5788999999999876443322 234679999999999764 59999999999999999998 789
Q ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHh
Q 022500 156 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 235 (296)
Q Consensus 156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l 235 (296)
||.+.+..+....+.+. ..++ .+..+++++.+|+.+||+.||.+|||+.+++
T Consensus 213 p~~~~~~~~~~~~i~~~-~~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil 264 (317)
T d1xkka_ 213 PYDGIPASEISSILEKG-ERLP---------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELI 264 (317)
T ss_dssp TTTTSCGGGHHHHHHHT-CCCC---------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHcC-CCCC---------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHH
Confidence 99887766555444331 1110 1234789999999999999999999999999
Q ss_pred cC
Q 022500 236 AH 237 (296)
Q Consensus 236 ~h 237 (296)
+|
T Consensus 265 ~~ 266 (317)
T d1xkka_ 265 IE 266 (317)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=304.58 Aligned_cols=201 Identities=22% Similarity=0.279 Sum_probs=163.2
Q ss_pred CCCC-CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHh------------hhcCCCCCHHHHHHHHHHHHH
Q 022500 1 MRVM-DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHY------------SSANQRMPLIYVKLYTYQIFR 66 (296)
Q Consensus 1 l~~l-~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~------------~~~~~~~~~~~~~~~~~qil~ 66 (296)
|+++ +|||||++++++.... .+|+|||||+ |+|.+.+... ......+++..+..++.||+.
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~-----~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~ 138 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 138 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETT-----EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCC-----eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHH
Confidence 3566 7999999999995443 4899999999 6888887642 123467999999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHH
Q 022500 67 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 146 (296)
Q Consensus 67 aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 146 (296)
||.|||+ ++|+||||||+|||++ .++.+||+|||+|+............||..|+|||.+.+. .++.++||||+||+
T Consensus 139 gl~~lH~-~~iiHrDlkp~NIL~~-~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvi 215 (309)
T d1fvra_ 139 GMDYLSQ-KQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVL 215 (309)
T ss_dssp HHHHHHH-TTEECSCCSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHH
T ss_pred HHHhhhc-CCccccccccceEEEc-CCCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHH
Confidence 9999999 7999999999999999 5778999999999866554444556789999999999754 58999999999999
Q ss_pred HHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 147 LAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 147 l~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
+|+|++|. +||.+.+..+....+.+.. . ...+..+++++.+||.+||+.||
T Consensus 216 l~ell~~~~~p~~~~~~~~~~~~i~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~dP 267 (309)
T d1fvra_ 216 LWEIVSLGGTPYCGMTCAELYEKLPQGY-R---------------------------LEKPLNCDDEVYDLMRQCWREKP 267 (309)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHGGGTC-C---------------------------CCCCTTBCHHHHHHHHHHTCSSG
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhcC-C---------------------------CCCCccCCHHHHHHHHHHcCCCh
Confidence 99999965 6788888777666554310 0 01223578999999999999999
Q ss_pred CCCCCHHHHhcC
Q 022500 226 SLRCTALEACAH 237 (296)
Q Consensus 226 ~~R~t~~e~l~h 237 (296)
++|||++|+++|
T Consensus 268 ~~RPs~~eil~~ 279 (309)
T d1fvra_ 268 YERPSFAQILVS 279 (309)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=295.08 Aligned_cols=197 Identities=21% Similarity=0.310 Sum_probs=154.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... ..+|+||||++ |+|.+.+... ....+++..++.++.||+.||.|||+ ++|+|
T Consensus 54 l~~l~HpnIv~~~g~~~~~~----~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH 126 (262)
T d1byga_ 54 MTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVH 126 (262)
T ss_dssp HTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeeEEEEEEecC----CcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-Cceec
Confidence 47899999999999885322 23789999998 5888887642 22358999999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 158 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 158 (296)
|||||+||+++ .++.+|++|||+++..... .....+|+.|+|||++.+. .++.++||||+||++|||++ |.+||.
T Consensus 127 ~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 127 RDLAARNVLVS-EDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp SCCSGGGEEEC-TTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred cccchHhheec-CCCCEeecccccceecCCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 99999999999 5788999999999865332 3345678899999999764 59999999999999999998 788898
Q ss_pred CCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHHHhc
Q 022500 159 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e~l~ 236 (296)
+.+..+....+.+.. ...++..+++++.+||++||..||.+|||+.++++
T Consensus 203 ~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 203 RIPLKDVVPRVEKGY----------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp TSCGGGHHHHHTTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCC----------------------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 887766665553310 01123457899999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=295.71 Aligned_cols=197 Identities=23% Similarity=0.322 Sum_probs=160.1
Q ss_pred CCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHH
Q 022500 4 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAY 70 (296)
Q Consensus 4 l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~------------~~~~~~~~~~~~~~~~qil~aL~~ 70 (296)
.+|||||++++++... ..+++|||||+ |+|.+.+.... .....+++..+..++.||+.||+|
T Consensus 76 ~~HpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~y 150 (299)
T d1fgka_ 76 GKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150 (299)
T ss_dssp CCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCeEEecccccccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 3899999999999543 34889999999 68888876432 123568999999999999999999
Q ss_pred HHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHH
Q 022500 71 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 147 (296)
Q Consensus 71 LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 147 (296)
||+ ++|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .|+.++||||+||++
T Consensus 151 lH~-~~ivHrDiKp~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl 227 (299)
T d1fgka_ 151 LAS-KKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLL 227 (299)
T ss_dssp HHH-TTCCCSCCSGGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred hhh-CCEEeeeecccceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHH
Confidence 999 7999999999999999 578899999999987654332 2346789999999999764 599999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 148 AELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 148 ~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|+|++ |.+||.+.+..+....+.+. ..+. .+..+++++.+||.+||+.||+
T Consensus 228 ~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1fgka_ 228 WEIFTLGGSPYPGVPVEELFKLLKEG-HRMD---------------------------KPSNCTNELYMMMRDCWHAVPS 279 (299)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTT-CCCC---------------------------CCSSCCHHHHHHHHHHTCSSGG
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHcC-CCCC---------------------------CCccchHHHHHHHHHHccCCHh
Confidence 99998 78999887776555444321 1111 2235799999999999999999
Q ss_pred CCCCHHHHhc
Q 022500 227 LRCTALEACA 236 (296)
Q Consensus 227 ~R~t~~e~l~ 236 (296)
+|||+.|+++
T Consensus 280 ~Rps~~eil~ 289 (299)
T d1fgka_ 280 QRPTFKQLVE 289 (299)
T ss_dssp GSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-42 Score=296.01 Aligned_cols=200 Identities=24% Similarity=0.299 Sum_probs=160.8
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh--------------------hcCCCCCHHHHHH
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS--------------------SANQRMPLIYVKL 59 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~--------------------~~~~~~~~~~~~~ 59 (296)
|++++||||+++++++.... .+++||||++ |+|.+.+.... .....+++..+..
T Consensus 70 l~~l~h~niv~~~~~~~~~~-----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (301)
T d1lufa_ 70 MAEFDNPNIVKLLGVCAVGK-----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 144 (301)
T ss_dssp HHTCCCTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHH
T ss_pred HHhcCCCCcccceeeeccCC-----ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHH
Confidence 46789999999999985433 3889999998 68888775421 1123589999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCC---CccceeecccccCchhccCCCCCCc
Q 022500 60 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTT 136 (296)
Q Consensus 60 ~~~qil~aL~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~ 136 (296)
++.|++.||+|||+ ++|+||||||+|||++ .++.+||+|||+|+...... ...+..+|+.|+|||.+.+. .|+.
T Consensus 145 i~~qi~~gl~ylH~-~~ivHrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ 221 (301)
T d1lufa_ 145 IARQVAAGMAYLSE-RKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTT 221 (301)
T ss_dssp HHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCH
T ss_pred HHHHHHHHhhhccc-CCeEeeEEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCCh
Confidence 99999999999999 7999999999999999 57889999999998653332 22345778999999999764 5999
Q ss_pred hhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHH
Q 022500 137 SIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 215 (296)
Q Consensus 137 ~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 215 (296)
++||||+||++|||++|. +||.+.+..+....+.+... + ..+..+++++.+
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~-~---------------------------~~p~~~~~~~~~ 273 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI-L---------------------------ACPENCPLELYN 273 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-C---------------------------CCCTTCCHHHHH
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC-C---------------------------CCCccchHHHHH
Confidence 999999999999999985 78988888877776554210 0 123458999999
Q ss_pred HHHcccccCCCCCCCHHHHhc
Q 022500 216 LASRLLQYSPSLRCTALEACA 236 (296)
Q Consensus 216 ll~~~L~~~p~~R~t~~e~l~ 236 (296)
||.+||+.||++|||+.|+++
T Consensus 274 li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 274 LMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999965
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=294.13 Aligned_cols=206 Identities=23% Similarity=0.283 Sum_probs=166.5
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHT 73 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~------~~~~~~~~~~~~~~~qil~aL~~LH~ 73 (296)
|++++|||||++++++.... ..++|||||+ |+|.+.+..... ....+++..+..++.|++.||.|||+
T Consensus 77 l~~l~h~nIv~~~~~~~~~~-----~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~ 151 (308)
T d1p4oa_ 77 MKEFNCHHVVRLLGVVSQGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 151 (308)
T ss_dssp GGGCCCTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCEeeeeeEEecCC-----ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 56899999999999985433 3889999998 688777654221 12347889999999999999999999
Q ss_pred CCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHH
Q 022500 74 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 150 (296)
Q Consensus 74 ~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 150 (296)
++|+||||||+|||++ .++++||+|||+|+....... .....+|+.|+|||.+.+. .++.++||||+||++|||
T Consensus 152 -~~ivHrDlk~~NiLld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El 228 (308)
T d1p4oa_ 152 -NKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 228 (308)
T ss_dssp -TTCBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred -CCeeeceEcCCceeec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHH
Confidence 7999999999999999 578899999999986544322 2345789999999999764 589999999999999999
Q ss_pred HhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCC
Q 022500 151 LLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 229 (296)
Q Consensus 151 l~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~ 229 (296)
++| .+||.+.+..+.+..+.+... + ..+..+++.+.++|.+||+.||++||
T Consensus 229 ~t~~~~p~~~~~~~~~~~~i~~~~~-~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RP 280 (308)
T d1p4oa_ 229 ATLAEQPYQGLSNEQVLRFVMEGGL-L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRP 280 (308)
T ss_dssp HHTSCCTTTTSCHHHHHHHHHTTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhCCCCCCCCCCHHHHHHHHHhCCC-C---------------------------CCcccchHHHHHHHHHHcCCChhHCc
Confidence 998 588988888877776654210 0 01234789999999999999999999
Q ss_pred CHHHHhc------CCCccc
Q 022500 230 TALEACA------HPFFDE 242 (296)
Q Consensus 230 t~~e~l~------hp~f~~ 242 (296)
|+.++++ +|+|++
T Consensus 281 s~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 281 SFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CHHHHHHHHGGGSCTTHHH
T ss_pred CHHHHHHHHHHhcCCCCcC
Confidence 9999987 566654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=294.35 Aligned_cols=199 Identities=20% Similarity=0.292 Sum_probs=154.6
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCcc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 79 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g-~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H 79 (296)
|++++|||||++++++.... ..+++|||||++ +|.+.+.. ....+++..+..++.|++.||.|||+ .+|+|
T Consensus 82 l~~l~HpnIv~~~g~~~~~~----~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiH 153 (311)
T d1r0pa_ 82 MKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVH 153 (311)
T ss_dssp HHTCCCTTBCCCCEEEEETT----TEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred HHhCCCCCEeEEeEEEEecC----CceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCccc
Confidence 46789999999999875332 248899999995 66655543 44567888999999999999999999 79999
Q ss_pred CCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 022500 80 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 154 (296)
Q Consensus 80 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 154 (296)
|||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+|+++|||++|.
T Consensus 154 rDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~ 231 (311)
T d1r0pa_ 154 RDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG 231 (311)
T ss_dssp SCCSGGGEEEC-TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCccHHhEeEC-CCCCEEEecccchhhccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCC
Confidence 99999999999 578899999999987643322 2235679999999998654 5999999999999999999987
Q ss_pred CCCCCCC-hHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCCCCHHH
Q 022500 155 PLFPGEN-AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 233 (296)
Q Consensus 155 ~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R~t~~e 233 (296)
.||.... ..+....+.+. -.+ ..+..+++++.+||.+||+.||.+|||+.|
T Consensus 232 ~p~~~~~~~~~~~~~i~~g-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 232 APPYPDVNTFDITVYLLQG-RRL---------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp CCSCC------CHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHcC-CCC---------------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 7765543 33333333221 000 122347899999999999999999999999
Q ss_pred HhcC
Q 022500 234 ACAH 237 (296)
Q Consensus 234 ~l~h 237 (296)
+++|
T Consensus 284 i~~~ 287 (311)
T d1r0pa_ 284 LVSR 287 (311)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=292.22 Aligned_cols=197 Identities=25% Similarity=0.356 Sum_probs=160.2
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhh--------------hcCCCCCHHHHHHHHHHHHHHHH
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS--------------SANQRMPLIYVKLYTYQIFRGLA 69 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~--------------~~~~~~~~~~~~~~~~qil~aL~ 69 (296)
+|||||++++++... ..+|+|||||+ |+|.+.+.... .....+++..++.++.||+.||+
T Consensus 85 ~HpnIv~~~g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 85 NHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp CCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 799999999999543 33889999999 58777776432 12346899999999999999999
Q ss_pred HHHhCCCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC---ccceeecccccCchhccCCCCCCchhHHHHHHHH
Q 022500 70 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 146 (296)
Q Consensus 70 ~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 146 (296)
|||+ +|++||||||+||+++ .++.+|++|||.++....... .....||+.|+|||++.+ ..++.++||||+||+
T Consensus 160 ~LH~-~~ivHrDLKp~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 160 FLAS-KNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIF 236 (311)
T ss_dssp HHHH-TTCCCSCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHH
T ss_pred HHHh-CCeeeccccccccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHH
Confidence 9999 7999999999999999 478899999999987654332 234578999999999975 458999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCC
Q 022500 147 LAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 225 (296)
Q Consensus 147 l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p 225 (296)
+|+|++ |.+||.+.+..+.+.++++....+. .+..+++++.+||.+||+.||
T Consensus 237 l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP 289 (311)
T d1t46a_ 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADP 289 (311)
T ss_dssp HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCCh
Confidence 999998 6777878777777777765322111 123478999999999999999
Q ss_pred CCCCCHHHHhc
Q 022500 226 SLRCTALEACA 236 (296)
Q Consensus 226 ~~R~t~~e~l~ 236 (296)
.+|||++++++
T Consensus 290 ~~RPs~~~il~ 300 (311)
T d1t46a_ 290 LKRPTFKQIVQ 300 (311)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-41 Score=287.80 Aligned_cols=222 Identities=21% Similarity=0.186 Sum_probs=152.9
Q ss_pred CCCCCCCCeeeeceeeeccCCCCcceEEEEeccCc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----
Q 022500 1 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV----- 74 (296)
Q Consensus 1 l~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~-g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~----- 74 (296)
+++++|||||++++++...+ .....+|+|||||+ |+|.+.++. ..+++.....++.|++.||.|||+.
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~ 124 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124 (303)
T ss_dssp STTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred HhhCCCCcCcceEEEEEeCC-CcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 45789999999999987554 34456889999998 588888764 4689999999999999999999961
Q ss_pred --CCcccCCCCCCcEEEcCCCCcEEEeeccCccccccCCC-----ccceeecccccCchhccCCC-----CCCchhHHHH
Q 022500 75 --PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWS 142 (296)
Q Consensus 75 --~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diws 142 (296)
+||+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+.. .++.++||||
T Consensus 125 ~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S 203 (303)
T d1vjya_ 125 GKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203 (303)
T ss_dssp CBCEEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred cCCCeeccccCccceEEc-CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhh
Confidence 4999999999999999 578999999999987644332 23467899999999986432 1567899999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccc
Q 022500 143 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 222 (296)
Q Consensus 143 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 222 (296)
+||++|||++|.+||.......... .......+.......... .....+... ...........+.+|+.+||+
T Consensus 204 ~Gvvl~el~tg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~ 276 (303)
T d1vjya_ 204 MGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWY 276 (303)
T ss_dssp HHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCSSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHhhCCCCCCcccccccch-hhcccccchHHHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcc
Confidence 9999999999988774322110000 000000111111110000 000000000 000011133568999999999
Q ss_pred cCCCCCCCHHHHhc
Q 022500 223 YSPSLRCTALEACA 236 (296)
Q Consensus 223 ~~p~~R~t~~e~l~ 236 (296)
.||++|||+.|+++
T Consensus 277 ~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 277 ANGAARLTALRIKK 290 (303)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cCHhHCcCHHHHHH
Confidence 99999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=285.81 Aligned_cols=207 Identities=22% Similarity=0.231 Sum_probs=154.1
Q ss_pred CCCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 2 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 2 ~~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
++++|+|+|..+..+.. +....++||||+++++...+.. ....+++..+..++.|++.||+|||+ +||+|||
T Consensus 57 ~~l~~~~~i~~~~~~~~----~~~~~~ivme~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrD 128 (299)
T d1ckia_ 57 KMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRD 128 (299)
T ss_dssp HHSTTSTTCCCEEEEEE----ETTEEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred HHccCCCcccEEEEEEe----cCCEEEEEEEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeecc
Confidence 45777776555544432 2334889999999988776653 45679999999999999999999999 7999999
Q ss_pred CCCCcEEEcC--CCCcEEEeeccCccccccCC--------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHH
Q 022500 82 LKPQNLLVDP--LTHQVKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 151 (296)
Q Consensus 82 lkp~Nill~~--~~~~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 151 (296)
|||+|||++. .+..+||+|||+|+...... ...+..||+.|+|||++.+. .++.++||||+||++|+|+
T Consensus 129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHH
T ss_pred CCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHH
Confidence 9999999853 24579999999998764332 12345799999999999764 5999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcC---CCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCCCC
Q 022500 152 LGQPLFPGENAVDQLVEIIKVLG---TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 228 (296)
Q Consensus 152 ~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~~R 228 (296)
+|..||.+.........+.+... .++. ......+++++.+||.+||+.||++|
T Consensus 208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~p~~~~~li~~cl~~~p~~R 263 (299)
T d1ckia_ 208 LGSLPWQGLKAATKRQKYERISEKKMSTPI------------------------EVLCKGYPSEFATYLNFCRSLRFDDK 263 (299)
T ss_dssp HSSCTTCCCC-------HHHHHHHHHHSCH------------------------HHHTTTSCHHHHHHHHHHHHSCTTCC
T ss_pred hCCCcccccchHHHHHHHHHhhcccCCCCh------------------------hHhccCCCHHHHHHHHHHccCChhHC
Confidence 99999988765544433322110 0000 11224589999999999999999999
Q ss_pred CCHHH---HhcCCCcc
Q 022500 229 CTALE---ACAHPFFD 241 (296)
Q Consensus 229 ~t~~e---~l~hp~f~ 241 (296)
|++++ +|+|+|.+
T Consensus 264 P~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 264 PDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHH
Confidence 99874 56777654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-39 Score=286.29 Aligned_cols=235 Identities=30% Similarity=0.495 Sum_probs=166.9
Q ss_pred CCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 022500 5 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 84 (296)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dlkp 84 (296)
.|+|||++++++.... ......+++++++.++...... ......+++..++.++.||+.||+|||+..||+||||||
T Consensus 78 ~~~~iv~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp 154 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKG-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 154 (362)
T ss_dssp HHTTBCCCCEEEEEEE-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred CcCceEEEEEEeeecc-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCCh
Confidence 5799999999875432 2233333444444445444333 335577999999999999999999999734899999999
Q ss_pred CcEEEcCCCC-----cEEEeeccCccccccCCCccceeecccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 022500 85 QNLLVDPLTH-----QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 159 (296)
Q Consensus 85 ~Nill~~~~~-----~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 159 (296)
+|||++..+. .+|++|||.|..... .....+||+.|+|||++.+. .++.++|+||+||++++|++|+.||.+
T Consensus 155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 155 ENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred hHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCC
Confidence 9999973221 489999999986533 33456899999999999764 589999999999999999999999976
Q ss_pred CC------hHHHHHHHHHhcCCCCHHHHhhcCcCCcCc-------cCCCCCCCCccc------ccCCCCCHHHHHHHHcc
Q 022500 160 EN------AVDQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHK------VFHKRMPPEAIDLASRL 220 (296)
Q Consensus 160 ~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~dll~~~ 220 (296)
.. ..+.+...+..+|.++.+...........+ ........++.. ......+++++|||.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence 53 345677778888988877654322110000 111111111111 11223567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCcccccC
Q 022500 221 LQYSPSLRCTALEACAHPFFDELRE 245 (296)
Q Consensus 221 L~~~p~~R~t~~e~l~hp~f~~~~~ 245 (296)
|++||.+|||++|+|+||||++...
T Consensus 312 L~~dP~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp GCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred CCCChhHCcCHHHHhcCcccCCCCC
Confidence 9999999999999999999997643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-39 Score=277.09 Aligned_cols=200 Identities=16% Similarity=0.150 Sum_probs=156.1
Q ss_pred CCCC-CCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 022500 3 VMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 81 (296)
Q Consensus 3 ~l~H-pnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~d 81 (296)
.|+| +||+.+++++. .....|+||||++++|.+.+.. ....+++..+..++.|++.||+|||+ +||+|||
T Consensus 56 ~l~~~~~i~~~~~~~~-----~~~~~~~vme~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrD 126 (293)
T d1csna_ 56 LLAGCTGIPNVYYFGQ-----EGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRD 126 (293)
T ss_dssp HTTTCTTCCCEEEEEE-----ETTEEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCC
T ss_pred HhcCCCCCCEEEEEee-----cCCccEEEEEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceecc
Confidence 4554 89999999884 3344889999999998887764 34579999999999999999999999 7999999
Q ss_pred CCCCcEEEcC----CCCcEEEeeccCccccccCC--------CccceeecccccCchhccCCCCCCchhHHHHHHHHHHH
Q 022500 82 LKPQNLLVDP----LTHQVKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 149 (296)
Q Consensus 82 lkp~Nill~~----~~~~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 149 (296)
|||+||+++. ..+.+||+|||+|+...... ...+..||+.|+|||++.+. .++.++||||+||++|+
T Consensus 127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~e 205 (293)
T d1csna_ 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMY 205 (293)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHH
T ss_pred CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHH
Confidence 9999999963 24679999999998654321 12345799999999999764 59999999999999999
Q ss_pred HHhCCCCCCCCCh---HHHHHHHHHhcCCCCHHHHhhcCcCCcCccCCCCCCCCcccccCCCCCHHHHHHHHcccccCCC
Q 022500 150 LLLGQPLFPGENA---VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 226 (296)
Q Consensus 150 ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~~p~ 226 (296)
|++|..||.+... .....++......+... .+...+++++.+++..|+..+|+
T Consensus 206 lltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~ 261 (293)
T d1csna_ 206 FLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR------------------------ELCAGFPEEFYKYMHYARNLAFD 261 (293)
T ss_dssp HHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH------------------------HHTTTSCHHHHHHHHHHHHCCTT
T ss_pred HHhCCCcCCCccchhHHHHHHHHHhccCCCChH------------------------HhcCCCCHHHHHHHHHHhcCCcc
Confidence 9999999986543 33333333221111111 12234789999999999999999
Q ss_pred CCCCHHHHhc
Q 022500 227 LRCTALEACA 236 (296)
Q Consensus 227 ~R~t~~e~l~ 236 (296)
+||+.+.+.+
T Consensus 262 ~rP~y~~l~~ 271 (293)
T d1csna_ 262 ATPDYDYLQG 271 (293)
T ss_dssp CCCCHHHHHH
T ss_pred cCcCHHHHHH
Confidence 9999877654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.68 E-value=1.6e-18 Score=137.33 Aligned_cols=118 Identities=18% Similarity=0.080 Sum_probs=79.5
Q ss_pred CCCCCCeeeeceeeeccCCCCcceEEEEeccCcccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 022500 3 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 82 (296)
Q Consensus 3 ~l~HpnIv~l~~~~~~~~~~~~~~~~lv~E~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~qil~aL~~LH~~~~i~H~dl 82 (296)
++.|++++..+++. . .+++|||+++... ..++...+..++.|++.||+|||+ +||+||||
T Consensus 70 ~l~~~~v~~~~~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDi 129 (191)
T d1zara2 70 KLQGLAVPKVYAWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDL 129 (191)
T ss_dssp HTTTSSSCCEEEEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCC
T ss_pred HccCCCcceEEEec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccC
Confidence 46788888776543 1 2599999997411 124445577899999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEeeccCccccccCCCccceee-cccccCchhccCCCCCCchhHHHHHHHH
Q 022500 83 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCV 146 (296)
Q Consensus 83 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~i 146 (296)
||+|||++. ..++|+|||.|........ ..... ... .-.+.+ . ..|+.++|+||+.--
T Consensus 130 KP~NILv~~--~~~~liDFG~a~~~~~~~~-~~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 130 SQYNVLVSE--EGIWIIDFPQSVEVGEEGW-REILERDVR-NIITYF-S-RTYRTEKDINSAIDR 188 (191)
T ss_dssp STTSEEEET--TEEEECCCTTCEETTSTTH-HHHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred ChhheeeeC--CCEEEEECCCcccCCCCCc-HHHHHHHHH-HHHHHH-c-CCCCCcccHHHHHHH
Confidence 999999983 4599999999976532221 11110 000 001222 1 347888999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.27 E-value=0.0025 Score=50.50 Aligned_cols=28 Identities=25% Similarity=0.355 Sum_probs=23.4
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred EEEeeccCcceeec-CCceEEEeechhcc
Confidence 78999999999998 34445699999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.53 E-value=0.0052 Score=50.19 Aligned_cols=30 Identities=27% Similarity=0.203 Sum_probs=25.5
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
.|+||+|+.++||+++. +...-++||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred cccccCCcchhhhhccc-ccceeEecccccc
Confidence 57999999999999993 5556799999885
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=91.79 E-value=0.029 Score=43.74 Aligned_cols=28 Identities=25% Similarity=0.280 Sum_probs=23.8
Q ss_pred cccCCCCCCcEEEcCCCCcEEEeeccCcc
Q 022500 77 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 105 (296)
Q Consensus 77 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 105 (296)
++|+|+.|.||+++. +..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~-~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVEN-GRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeC-CceEEEEEchhcc
Confidence 799999999999983 4456799999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=91.08 E-value=0.098 Score=42.51 Aligned_cols=29 Identities=21% Similarity=0.206 Sum_probs=23.7
Q ss_pred CCcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 75 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 75 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.+++|+|+.++|||++ ++ ..++||+-|..
T Consensus 192 ~~liHgDlh~~NvL~~--~~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWR--DG-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEES--SS-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEe--CC-ceEEechhccc
Confidence 4689999999999997 33 45899998863
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=90.56 E-value=0.053 Score=45.52 Aligned_cols=29 Identities=21% Similarity=0.243 Sum_probs=24.9
Q ss_pred CcccCCCCCCcEEEcCCCCcEEEeeccCccc
Q 022500 76 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 106 (296)
Q Consensus 76 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 106 (296)
.++|+|+.|.|||+++ + .++++||..|..
T Consensus 224 ~LiHGDl~~gNIlv~~-~-~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASE-H-ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECS-S-CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcC-C-ceEEechhhccc
Confidence 5899999999999984 3 489999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=81.64 E-value=0.24 Score=41.21 Aligned_cols=14 Identities=43% Similarity=0.911 Sum_probs=12.7
Q ss_pred cccCCCCCCcEEEc
Q 022500 77 VCHRDLKPQNLLVD 90 (296)
Q Consensus 77 i~H~dlkp~Nill~ 90 (296)
++|+|+.+.||++.
T Consensus 220 ~CHnDL~~~NiL~~ 233 (395)
T d1nw1a_ 220 FCHNDLQEGNILLP 233 (395)
T ss_dssp EECSCCCGGGEEEE
T ss_pred EEecCCCcccEeec
Confidence 57999999999985
|